{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 292,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import csv, re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 293,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def loadSentences(filename):\n",
    "    f = open(filename, encoding=\"utf8\")\n",
    "    reader = csv.DictReader(f, delimiter='\\t')\n",
    "    sentences = [row for row in reader]\n",
    "    return sentences"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 294,
   "metadata": {},
   "outputs": [],
   "source": [
    "def tokeniseBEL(bs):\n",
    "    bs = re.subn(r',GOCCID:\\d+', '', bs) # Replace GOCCID (additional parameters of tloc)\n",
    "    terms = re.findall(r'(a|bp|path|g|m|r|p)\\(([A-Z]+)\\:([^\"]*?|\".*?\")(,pmod\\(P.*?\\))?\\)', bs[0])\n",
    "    # print(terms)\n",
    "    bs = re.subn(r'(a|bp|path|g|m|r|p)\\(([A-Z]+)\\:([^\"]*?|\".*?\")(,pmod\\(P.*?\\))?\\)', '@', bs[0])\n",
    "    assert bs[1] == len(terms)\n",
    "    # print(bs)\n",
    "    relations = re.findall(r'\\s((?:increases)|(?:decreases)|(?:directlyIncreases)|(?:directlyDecreases))\\s', bs[0])\n",
    "    # print(relations)\n",
    "    bs = re.subn(r'\\s((?:increases)|(?:decreases)|(?:directlyIncreases)|(?:directlyDecreases))\\s', '&', bs[0])\n",
    "    assert bs[1] == len(relations)\n",
    "    # print(bs)\n",
    "    functions = re.findall(r'((?:act)|(?:complex)|(?:tloc)|(?:deg)|(?:kin)|(?:tscript)|(?:cat)|(?:sec)|(?:chap)|(?:gtp)|(?:pep)|(?:phos)|(?:ribo)|(?:tport))', bs[0])\n",
    "    # print(functions)\n",
    "    bs = re.subn(r'((?:act)|(?:complex)|(?:tloc)|(?:deg)|(?:kin)|(?:tscript)|(?:cat)|(?:sec)|(?:chap)|(?:gtp)|(?:pep)|(?:phos)|(?:ribo)|(?:tport))', '$', bs[0])\n",
    "    assert bs[1] == len(functions)\n",
    "    # print(bs[0]) # Term = @, Function = $, Relation = &\n",
    "    template = bs[0]\n",
    "    return stringToTokens(template, terms, relations, functions)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 295,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def normaliseBEL(bs):\n",
    "    return ''.join(tokeniseBEL(bs))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 296,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def stringToTokens(template, terms, relations, functions):\n",
    "    aList = []\n",
    "    relationDict = {'increases':' -> ', 'decreases':' -| ', 'directlyIncreases':' -> ', 'directlyDecreases':' -| '}\n",
    "    functionDict = {'act':'act', 'kin':'act', 'tscript':'act', 'cat':'act', 'chap':'act', 'gtp':'act', 'pep':'act', 'phos':'act', 'ribo':'act', 'tport':'act',\n",
    "                    'complex':'complex', \n",
    "                    'tloc': 'tloc', 'sec':'tloc', \n",
    "                    'deg': 'deg'}\n",
    "    for s in template:\n",
    "        if s == '@': # Term\n",
    "            termTuple = terms.pop(0)\n",
    "            if termTuple[3] == '':\n",
    "                aList.extend([termTuple[0], '(', termTuple[1]+':'+termTuple[2], ')'])\n",
    "            else:\n",
    "                aList.extend([termTuple[0], '(', termTuple[1]+':'+termTuple[2], ',', 'pmod(P)', ')'])\n",
    "        elif s == '&': # Relation\n",
    "            aList.append(relationDict[relations.pop(0)])\n",
    "        elif s == '$': # Function\n",
    "            aList.append(functionDict[functions.pop(0)])\n",
    "        else: # brackets and comma\n",
    "            aList.append(s)\n",
    "    return aList"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 297,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:FOS))', 'cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:MYC))', 'cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:TP53))']\n",
      "6353\n"
     ]
    }
   ],
   "source": [
    "sentences = loadSentences('dataset/Training.BEL')\n",
    "BELofSentence = dict()\n",
    "for s in sentences:\n",
    "    sid = s['Sentence-ID'][4:]\n",
    "    if sid not in BELofSentence:\n",
    "        BELofSentence[sid] = [s['BEL original'].strip()]\n",
    "    else:\n",
    "        BELofSentence[sid].append(s['BEL original'].strip())\n",
    "print(BELofSentence['10000092'])\n",
    "print(len(BELofSentence))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 303,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.\n",
      "6353\n"
     ]
    }
   ],
   "source": [
    "text = loadSentences('dataset/Training.sentence')\n",
    "TrainingSentence = dict()\n",
    "for s in text:\n",
    "    sid = s['Sentence-ID'][4:]\n",
    "    TrainingSentence[sid] = s['Sentence'].strip()\n",
    "print(TrainingSentence['10000092'])\n",
    "print(len(TrainingSentence))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 304,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10000006 : Induction of C/EBP beta DNA-binding activity in NIH-3T3 beta 2 cells exposed to dexamethasone in the presence of insulin and fetal bovine serum activates the expression of an adipocyte-specific nuclear hormone receptor, PPAR gamma, that stimulates the conversion of these fibroblasts into committed preadipocytes\n",
      "act(p(MGI:Cebpb)) -> p(MGI:Pparg)\n",
      "a(CHEBI:dexamethasone) -> act(p(MGI:Cebpb))\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Pparg)\n",
      "act(p(MGI:Nr3c1)) -> act(p(MGI:Cebpb))\n",
      "act(p(MGI:Pparg)) -> bp(GOBP:\"fat cell differentiation\")\n",
      "----------------------\n",
      "10000010 : Pulse-chase biosynthetic labeling studies showed that AtT-20 cells expressed much less RESP18 than the endogenous prohormone, POMC, but that glucocorticoid treatment lowered POMC and raised RESP18 biosynthetic rates so that they were nearly equimolar.\n",
      "a(CHEBI:glucocorticoid) -| p(MGI:Pomc)\n",
      "a(CHEBI:glucocorticoid) -> p(MGI:Resp18)\n",
      "----------------------\n",
      "10000046 : Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-kappa B activation\n",
      "act(p(HGNC:F2R)) -> p(HGNC:IL6)\n",
      "act(p(HGNC:F2R)) -> p(HGNC:CSF3)\n",
      "----------------------\n",
      "10000092 : UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.\n",
      "act(p(HGNC:UBE2L3)) -> deg(p(HGNC:FOS))\n",
      "act(p(HGNC:UBE2L3)) -> deg(p(HGNC:MYC))\n",
      "act(p(HGNC:UBE2L3)) -> deg(p(HGNC:TP53))\n",
      "----------------------\n",
      "10000108 : Human TSA1 exhibited high catalytic activity for the reduction of the fatty acid hydroperoxide as indicated by K(m) and V(max) (89.9 microM for linoleic acid hydroperoxide, 28.64 micromol(-1) min(-1) mg(-1), respectively)\n",
      "act(p(HGNC:PRDX2)) -> deg(a(CHEBI:\"lipid hydroperoxide\"))\n",
      "act(p(HGNC:PRDX2)) -| a(CHEBI:\"lipid hydroperoxide\")\n",
      "----------------------\n",
      "10000116 : Interestingly, BLP also activates caspase 1 through TLR2, resulting in proteolysis and secretion of mature IL-1beta.\n",
      "p(HGNC:TLR2) -> act(p(HGNC:CASP1))\n",
      "act(p(HGNC:CASP1)) -> p(HGNC:IL1B)\n",
      "----------------------\n",
      "10000118 : Here we show that the adaptor molecule, myeloid differentiation factor 88 (MyD88), mediates both apoptosis and nuclear factor-kappaB (NF-kappaB) activation by BLP-stimulated TLR2.\n",
      "act(p(HGNC:MYD88)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:TLR2)) -> act(p(HGNC:MYD88))\n",
      "----------------------\n",
      "10000132 : Tankyrase is a novel signaling target of mitogen-activated protein kinase (MAPK); it is stoichiometrically phosphorylated upon insulin stimulation.\n",
      "bp(GOBP:\"MAPK cascade\") -> act(p(MGI:Tnks))\n",
      "bp(GOBP:\"MAPK cascade\") -> p(MGI:Tnks,pmod(P))\n",
      "----------------------\n",
      "10000138 : Ambient hypoxia resulted in temporally sequential CREB serine phosphorylation, ubiquitination, and degradation (in vitro and in vivo).\n",
      "bp(GOBP:\"response to hypoxia\") -> deg(p(HGNC:CREB1))\n",
      "bp(GOBP:\"response to hypoxia\") -> p(HGNC:CREB1,pmod(P))\n",
      "----------------------\n",
      "10000150 : The association of lyn with IL-2Rbeta was markedly elevated by IL-2 stimulation. Furthermore the activity of lyn kinase, evaluated by an in vitro kinase assay with enolase as a substrate, increased following IL-2 stimulation.\n",
      "act(p(HGNC:IL2)) -> act(p(HGNC:LYN))\n",
      "act(p(HGNC:IL2)) -> complex(p(HGNC:LYN), p(HGNC:IL2RB))\n",
      "----------------------\n",
      "10000154 : Both of the PI3K inhibitors inhibited the induction of CHOP in a dose-dependent manner, with wortmannin producing maximal inhibition at 100 nM and LY294002 producing maximal inhibition at 5Î¼ M (Fig.3)\n",
      "a(CHEBI:wortmannin) -| p(MGI:Ddit3)\n",
      "a(CHEBI:LY294002) -| p(MGI:Ddit3)\n",
      "----------------------\n",
      "10000156 : LPS-induced NO synthesis feedback regulates itself through up-regulation of OPN promoter activity and gene transcription.\n",
      "a(CHEBI:lipopolysaccharide) -> a(CHEBI:\"nitric oxide\")\n",
      "p(MGI:Spp1) -| a(CHEBI:\"nitric oxide\")\n",
      "----------------------\n",
      "10000158 : Expression of a truncated Src mutant lacking the kinase domain induced osteopetrosis in wildtype and Src +/- mice and worsened osteopetrosis in Src -/- mice by increased osteoclast apoptosis.\n",
      "act(p(MGI:Src)) -| path(MESHD:Osteopetrosis)\n",
      "act(p(MGI:Src)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10000182 : Moreover, we demonstrate that DCC interacts with both caspase-3 and caspase-9 and drives the activation of caspase-3 through caspase-9 without a requirement for cytochrome c or Apaf-1.\n",
      "p(HGNC:DCC) -> act(p(HGNC:CASP9))\n",
      "act(p(HGNC:CASP9)) -> act(p(HGNC:CASP3))\n",
      "complex(p(HGNC:DCC),p(HGNC:APPL1)) -> act(p(HGNC:CASP9))\n",
      "----------------------\n",
      "10000196 : In the absence of CdCl2 pretreatment, ionizing radiation increased both expression (Fig. 3A) and phosphorylation (Fig. 3B) of c-Jun in MRC5CV1 cells but not in AT5BIVA cells.\n",
      "bp(GOBP:\"response to ionizing radiation\") -> p(HGNC:JUN)\n",
      "bp(GOBP:\"response to ionizing radiation\") -> p(HGNC:JUN,pmod(P))\n",
      "----------------------\n",
      "10000216 : Caspase-activated DNase (CAD) is a deoxyribonuclease that causes DNA fragmentation during apoptosis. In proliferating cells, CAD is complexed with ICAD (inhibitor of CAD) and its DNase activity is suppressed\n",
      "complex(p(HGNC:DFFA), p(HGNC:DFFB)) -| act(p(HGNC:DFFB))\n",
      "act(p(HGNC:DFFA)) -| act(p(HGNC:DFFB))\n",
      "----------------------\n",
      "10000218 : In conclusion, metabolic acidosis increases ET-1 expression, which increases NHE3 activity via the ET(B) receptor.\n",
      "act(p(MGI:Ednrb)) -> act(p(MGI:Slc9a3))\n",
      "complex(p(MGI:Edn1),p(MGI:Ednrb)) -> act(p(MGI:Slc9a3))\n",
      "path(MESHD:Acidosis) -> p(MGI:Edn1)\n",
      "----------------------\n",
      "10000240 : hepatic expression of both apoC2 and phospholipid transfer protein mRNAs increases when mice are fed diets supplemented with cholic acid, an Fxr ligand, and this induction is attenuated in Fxr null mice\n",
      "a(CHEBI:\"cholic acid\") -> r(MGI:Apoc2)\n",
      "a(CHEBI:\"cholic acid\") -> r(MGI:Pltp)\n",
      "p(MGI:Nr1h4) -> r(MGI:Apoc2)\n",
      "p(MGI:Nr1h4) -> r(MGI:Pltp)\n",
      "----------------------\n",
      "10000242 : caspase-3 prevented the inhibition of DNAS1L3 endonuclease activity by wild-type PARP-1\n",
      "p(HGNC:PARP1) -| act(p(HGNC:DNASE1L3))\n",
      "act(p(HGNC:CASP3)) -| p(HGNC:PARP1)\n",
      "----------------------\n",
      "10000252 : macrophage-stimulating protein (MSP), through activation of its receptor RON, negatively regulates NO production in response to IFN-gamma and LPS by inhibiting the expression of inducible NO synthase (iNOS).\n",
      "p(MGI:Mst1) -> act(p(MGI:Mst1r))\n",
      "act(p(MGI:Mst1r)) -| r(MGI:Nos2)\n",
      "act(p(MGI:Mst1r)) -| a(CHEBI:\"nitric oxide\")\n",
      "p(MGI:Mst1r) -| a(CHEBI:\"nitric oxide\")\n",
      "p(MGI:Mst1r) -| r(MGI:Nos2)\n",
      "----------------------\n",
      "10000254 : Recent studies have demonstrated in humans that fibrates increase plasma HDL cholesterol in humans, at least in part, through induction of the expression of the human apoa1 ans apoa2 genes.\n",
      "p(MGI:Apoa1) -> complex(a(CHEBI:\"high-density lipoprotein\"),a(CHEBI:cholesterol))\n",
      "p(MGI:Apoa2) -> complex(a(CHEBI:\"high-density lipoprotein\"),a(CHEBI:cholesterol))\n",
      "----------------------\n",
      "10000276 : Thus, FADD is not only necessary for recruitment and activation of caspase-8, but also for recruitment and activation of caspase-10 at the TRAIL and the CD95 DISCs.\n",
      "act(p(HGNC:FADD)) -> act(p(HGNC:CASP8))\n",
      "act(p(HGNC:FADD)) -> act(p(HGNC:CASP10))\n",
      "----------------------\n",
      "10000278 : Both Pla2g6 and cPLA2 are activated during apoptosis.\n",
      "bp(GOBP:\"apoptotic process\") -> act(p(MGI:Pla2g4a))\n",
      "bp(GOBP:\"apoptotic process\") -> act(p(MGI:Pla2g6))\n",
      "----------------------\n",
      "10000286 : It has also become apparent that macrophage-derived metalloproteases, including gelatinase A (MMP-2), gelatinase B (MMP-9), matrilysin MMP-7), and macrophage metalloelastase (MMP-12), can degrade elastin and collagen (11, 13, 14).\n",
      "act(p(HGNC:MMP12)) -> deg(p(HGNC:ELN))\n",
      "act(p(HGNC:MMP2)) -> deg(p(HGNC:ELN))\n",
      "act(p(HGNC:MMP7)) -> deg(p(HGNC:ELN))\n",
      "act(p(HGNC:MMP9)) -> deg(p(HGNC:ELN))\n",
      "----------------------\n",
      "10000316 : O2-dependent hydroxylation of asparagine (N) residue 803 in HIF-1a by the enzyme FIH-1 (factor inhibiting HIF-1) blocks the binding of p300 and CBP to HIF-1a and therefore inhibits HIF-1-mediated gene transcription.\n",
      "act(p(HGNC:HIF1AN)) -| complex(p(HGNC:HIF1A),p(HGNC:EP300))\n",
      "act(p(HGNC:HIF1AN)) -| complex(p(HGNC:HIF1A),p(HGNC:CREBBP))\n",
      "act(p(HGNC:HIF1AN)) -| act(p(HGNC:HIF1A))\n",
      "p(HGNC:CREBBP) -> act(p(HGNC:HIF1A))\n",
      "p(HGNC:EP300) -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10000336 : Inactivation of Icmt inhibited cell growth and K-Ras-induced oncogenic transformation, both in soft agar assays and in a nude mice model.\n",
      "act(p(MGI:Icmt)) -> bp(GOBP:\"cell growth\")\n",
      "act(p(MGI:Kras)) -> path(MESHD:Neoplasms)\n",
      "----------------------\n",
      "10000350 : Down-regulation of endogenous galectin-12 expression by RNA interference greatly reduced the expression of the adipogenic transcription factors CCAAT/enhancer-binding protein-beta and -alpha and peroxisome proliferator-activated receptor-gamma and severely suppressed adipocyte differentiation as a result of defective adipogenic signaling.\n",
      "act(p(MGI:Lgals12)) -> r(MGI:Cebpa)\n",
      "act(p(MGI:Lgals12)) -> r(MGI:Cebpb)\n",
      "act(p(MGI:Lgals12)) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10000364 : When initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7\n",
      "act(p(HGNC:CASP8)) -> act(p(HGNC:CASP3))\n",
      "act(p(HGNC:CASP9)) -> act(p(HGNC:CASP3))\n",
      "act(p(HGNC:CASP9)) -> act(p(HGNC:CASP6))\n",
      "act(p(HGNC:CASP9)) -> act(p(HGNC:CASP7))\n",
      "----------------------\n",
      "10000378 : hyperoxia stimulated ERK-1 and ERK-2 phosphorylation\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Mapk1))\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10000382 : As was seen for wild-type MEFs, hyperoxia enhanced the phosphorylation of endogenous Nrf2 (lane 6) when compared with room air-exposed controls (lane 5).\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Nfe2l2,pmod(P))\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Nfe2l2,pmod(P))\n",
      "----------------------\n",
      "10000384 : In ERK-1+/+ MEFs, hyperoxia stimulated phosphorylation of Nrf2 (lane 4), when compared with room air-exposed controls (lane 3).\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Nfe2l2,pmod(P))\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Nfe2l2,pmod(P))\n",
      "----------------------\n",
      "10000396 : Activation of poly(ADP-ribose) polymerase (PARP) by DNA breaks catalyzes poly(ADP-ribosyl)ation and results in depletion of NAD+ and ATP, which is thought to induce necrosis.\n",
      "a(CHEBI:ATP) -| bp(GOBP:\"necrotic cell death\")\n",
      "act(p(HGNC:PARP1)) -| a(CHEBI:ATP)\n",
      "----------------------\n",
      "10000420 : Naturally occurring dietary polyphenols, such as resveratrol, curcumin, quercetin, and catechins, have antioxidant and anti-inflammatory properties via modulating different pathways, such as NF-kappaB- and mitogen activated protein kinase-dependent signaling pathways. In addition, these polyphenols have also been shown to activate SIRT1 directly or indirectly in a variety of models.\n",
      "a(CHEBI:curcumin) -> act(p(HGNC:SIRT1))\n",
      "a(CHEBI:quercetin) -> act(p(HGNC:SIRT1))\n",
      "----------------------\n",
      "10000422 : Dietary curcumin led to increase in NF-E2-related factor-2 (Nrf2) protein levels and enhanced its nuclear translocation in liver and lungs of mice as compared with controls.\n",
      "a(CHEBI:curcumin) -> p(HGNC:NFE2L2)\n",
      "a(CHEBI:curcumin) -> tloc(p(MGI:Nfe2l2))\n",
      "a(CHEBI:curcumin) -> p(MGI:Nfe2l2)\n",
      "----------------------\n",
      "10000436 : The requirement for CD44 binding and hyaluronan internalization could be bypassed by intracellular administration of hyaluronan oligosaccharides (10-18-mer) in lipopolysaccharide-primed macrophages\n",
      "a(CHEBI:\"hyaluronic acid\") -> p(HGNC:CD44)\n",
      "a(CHEBI:\"hyaluronic acid\") -> p(MGI:Cd44)\n",
      "----------------------\n",
      "10000450 : Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.\n",
      "a(CHEBI:\"leukotriene B4\") -> act(p(HGNC:PPARA))\n",
      "act(p(HGNC:PPARA)) -| p(HGNC:IL10)\n",
      "act(p(HGNC:PPARA)) -| p(HGNC:IL12B)\n",
      "a(CHEBI:\"leukotriene B4\") -> act(p(MGI:Ppara))\n",
      "act(p(MGI:Ppara)) -| p(MGI:Il10)\n",
      "act(p(MGI:Ppara)) -| p(MGI:Il12b)\n",
      "----------------------\n",
      "10000458 : LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappaB-dependent pathway\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(HGNC:TLR4))\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Tlr4))\n",
      "act(p(MGI:Tlr4)) -| p(MGI:Bambi)\n",
      "act(p(MGI:Tlr4)) -> p(MGI:Tgfb1)\n",
      "----------------------\n",
      "10000488 : We conclude that HNE induces MUC5AC mucin expression via a cascade involving PKC-ROS-TACE in human airway epithelial cells.\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:ADAM17))\n",
      "act(p(HGNC:ADAM17)) -> p(HGNC:MUC5AC)\n",
      "----------------------\n",
      "10000498 : Treatment with PM2.5 resulted in the ROS-mediated activation of the oxidant-sensitive kinase ASK1 and its downstream kinase JNK.\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:MAP3K5))\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(MGI:Map3k5))\n",
      "----------------------\n",
      "10000500 : In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:MAPK1))\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:MAPK3))\n",
      "act(p(HGNC:NOX1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(MGI:Mapk1))\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(MGI:Mapk3))\n",
      "act(p(MGI:Nox1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10000522 : Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS)\n",
      "a(CHEBI:\"reactive oxygen species\") -> p(HGNC:CCL3)\n",
      "a(CHEBI:\"reactive oxygen species\") -> p(HGNC:CXCL2)\n",
      "a(CHEBI:\"reactive oxygen species\") -> p(MGI:Ccl3)\n",
      "a(CHEBI:\"reactive oxygen species\") -> p(MGI:Cxcl2)\n",
      "----------------------\n",
      "10000534 : We demonstrate that inactivation of the S1P producing enzyme, sphingosine kinase, leads to cell death in cardiac tissue which is rescued by exogenous S1P treatment.\n",
      "a(CHEBI:\"sphingosine 1-phosphate\") -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Sphk1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10000544 : These observations suggested that the inverse gene expression of PGIS and TXS in macrophages contributes to immune responses by modulating the relative levels of prostacyclin and thromboxane A2.\n",
      "a(CHEBI:\"thromboxane A2\") -> bp(GOBP:\"macrophage activation\")\n",
      "act(p(HGNC:TBXAS1)) -> a(CHEBI:\"thromboxane A2\")\n",
      "----------------------\n",
      "10000692 : We investigated upstream components of the response to hypertonicity in lung epithelial cells and found that before extracellular signal-regulated kinase activation and aquaporin synthesis, the membrane-bound prohormone neuregulin 1-beta is cleaved and binds to human epidermal growth factor receptor 3 (HER3).\n",
      "bp(GOBP:\"hyperosmotic response\") -> p(HGNC:NRG1)\n",
      "p(HGNC:NRG1) -> act(p(HGNC:ERBB3))\n",
      "----------------------\n",
      "10000710 : In the light of recent reports that strongly support critical roles for IL-9 and IL-13 in allergic lung inflammation, our results emphasize the potential clinical importance of LPS as an enhancer of mast cell-derived IL-9 and IL-13 production in the course of inflammatory reactions and allergic diseases.\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:IL13)\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:IL9)\n",
      "bp(GOBP:\"mast cell activation\") -> p(MGI:Il13)\n",
      "bp(GOBP:\"mast cell activation\") -> p(MGI:Il9)\n",
      "----------------------\n",
      "10000742 : These results suggest that specific ER stress signaling transmitted by ATF6 leads to naturally occurring apoptosis during muscle development.\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> act(p(HGNC:ATF6))\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> act(p(MGI:Atf6))\n",
      "act(p(MGI:Atf6)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10000766 : Plasma and lung endothelin-1 levels were increased by chronic hypoxia, but these levels were not significantly different between the 2 genotypes.\n",
      "bp(GOBP:\"response to hypoxia\") -> p(HGNC:EDN1)\n",
      "bp(GOBP:\"response to hypoxia\") -> p(MGI:Edn1)\n",
      "----------------------\n",
      "10000854 : We propose a novel signaling pathway in murine macrophages involving synergy between TLRs 2, 4, 7, and 9 and A(2A)Rs, that up-regulates VEGF and down-regulates TNFalpha expression, thus acting as an angiogenic switch\n",
      "act(p(HGNC:ADORA2A)) -> p(HGNC:VEGFA)\n",
      "act(p(HGNC:TLR2)) -> p(HGNC:VEGFA)\n",
      "act(p(HGNC:TLR4)) -> p(HGNC:VEGFA)\n",
      "act(p(HGNC:TLR7)) -> p(HGNC:VEGFA)\n",
      "act(p(HGNC:TLR9)) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10000880 : BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X(L) to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1.\n",
      "act(p(HGNC:BAD)) -> act(p(HGNC:BAK1))\n",
      "act(p(HGNC:BAD)) -> act(p(HGNC:BAX))\n",
      "act(p(MGI:Bad)) -> act(p(MGI:Bak1))\n",
      "act(p(MGI:Bad)) -> act(p(MGI:Bax))\n",
      "----------------------\n",
      "10000908 : Exposure of hBEC to CS or CS extract (CSE) caused expression of endogenous ER stress markers GRP78 and CHOP and induction of apoptosis evidenced by nuclear condensation, membrane blebbing, and activation of caspase-3 and caspase-4\n",
      "act(p(HGNC:CASP3)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP4)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10000910 : Preincubation with the caspase-9 inhibitor z-LEHD-fmk, the caspase-3 inhibitor z-DEVD-fmk, or the specific pan-caspase inhibitor Q-VD-oph decreased the percentage of propidium iodide-positive neurons\n",
      "act(p(HGNC:CASP3)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Casp3)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Casp9)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10000952 : We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.\n",
      "act(p(HGNC:CCR7)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:CCR7)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10000976 : Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)\n",
      "act(p(HGNC:CYP1A1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:CYP1A2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:CYP1B1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10000988 : Cellular iron is needed for cell survival and hydroxylation of hypoxia-inducible factor-1alpha (HIF-alpha) by prolyl hydroxylases (PHD). One mechanism of iron uptake is mediated by the cell surface transferrin receptor (TfR). Because iron is required for cell growth and suppression of HIF-alpha levels\n",
      "act(p(HGNC:EGLN1)) -> deg(p(HGNC:HIF1A))\n",
      "act(p(HGNC:EGLN2)) -> deg(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10000990 : Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect.\n",
      "act(p(HGNC:EP300)) -> p(HGNC:WRN)\n",
      "act(p(HGNC:SIRT1)) -| p(HGNC:WRN)\n",
      "----------------------\n",
      "10001020 : Nrf2(-/-) MEFs exhibited greater accumulation of glutathione disulfide and cytotoxicity compared to Nrf2(+/+) MEFs in response to t-butylhydroquinone, which was rescued by restoring GSR\n",
      "act(p(HGNC:GSR)) -> a(CHEBI:glutathione)\n",
      "act(p(MGI:Gsr)) -> a(CHEBI:glutathione)\n",
      "act(p(MGI:Gsr)) -| bp(GOBP:\"cell death\")\n",
      "act(p(MGI:Nfe2l2)) -| a(CHEBI:glutathione)\n",
      "act(p(MGI:Nfe2l2)) -| bp(GOBP:\"cell death\")\n",
      "----------------------\n",
      "10001046 : Upon ER stress, transcription factor ATF6 translocates from the ER to Golgi, where it is sequentially cleaved by site 1 and site 2 proteases, S1P and S2P, to a 50-kDa form that activates transcription of ERSE genes\n",
      "act(p(HGNC:MBTPS1)) -> act(p(HGNC:ATF6))\n",
      "act(p(HGNC:MBTPS2)) -> act(p(HGNC:ATF6))\n",
      "----------------------\n",
      "10001062 : OS exists in three distinct isoforms: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). NO derived from the constitutive isoforms of NOS (nNOS and eNOS) and other NO-adduct molecules (nitrosothiols) have been shown to be modulators of bronchomotor tone.\n",
      "act(p(HGNC:NOS1)) -> a(CHEBI:\"nitric oxide\")\n",
      "act(p(HGNC:NOS3)) -> a(CHEBI:\"nitric oxide\")\n",
      "----------------------\n",
      "10001066 : Vascular endothelium participates in the control of vascular tone and function via the release of nitric oxide (NO) by the endothelial-type NO synthase (eNOS). Inducible NO synthase (iNOS) expression in endothelial cells occurs in many clinical conditions following induction by lipopolysaccharide or cytokines and generates large quantities of NO that result in endothelial cell activation and dysfunction.\n",
      "act(p(HGNC:NOS2)) -> a(CHEBI:\"nitric oxide\")\n",
      "act(p(HGNC:NOS3)) -> a(CHEBI:\"nitric oxide\")\n",
      "----------------------\n",
      "10001104 : In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.\n",
      "act(p(HGNC:RAD50)) -> bp(GOBP:\"double-strand break repair\")\n",
      "p(HGNC:NBN) -> bp(GOBP:\"double-strand break repair\")\n",
      "----------------------\n",
      "10001106 : stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA\n",
      "act(p(HGNC:SHC1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:SHC1)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10001112 : Moreover, inhibition of ROS generating enzymes or treatment of antioxidants impairs sphingomyelinase activation and ceramide production\n",
      "act(p(HGNC:SMPD1)) -> a(CHEBI:ceramide)\n",
      "act(p(HGNC:SMPD2)) -> a(CHEBI:ceramide)\n",
      "----------------------\n",
      "10001130 : Both interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) signal via the adapter molecule MyD88.\n",
      "act(p(HGNC:TLR2)) -> act(p(HGNC:MYD88))\n",
      "act(p(MGI:Il1r1)) -> act(p(MGI:Myd88))\n",
      "----------------------\n",
      "10001164 : The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumour necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3)\n",
      "act(p(HGNC:TNFRSF1A)) -> act(p(HGNC:RIPK1))\n",
      "act(p(HGNC:TNFRSF1A)) -> act(p(HGNC:RIPK3))\n",
      "act(p(HGNC:RIPK1)) -> bp(GOBP:\"necrotic cell death\")\n",
      "act(p(HGNC:RIPK3)) -> bp(GOBP:\"necrotic cell death\")\n",
      "----------------------\n",
      "10001170 : We therefore conclude that TNFR2 activates a novel Src-regulated pathway involving FAK tyrosine phosphorylation that enhances migration of intestinal epithelial cells\n",
      "act(p(HGNC:TNFRSF1B)) -> act(p(HGNC:SRC))\n",
      "act(p(MGI:Tnfrsf1b)) -> act(p(MGI:Src))\n",
      "----------------------\n",
      "10001206 : Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments.\n",
      "act(p(HGNC:XIAP)) -| act(p(HGNC:CASP7))\n",
      "act(p(HGNC:XIAP)) -| act(p(HGNC:CASP9))\n",
      "----------------------\n",
      "10001214 : .....rapid export of caspase-1-processed IL-1 beta from monocytes/macrophages in response to activation of P2X7 receptors (P2X7R) by extracellular ATP.\n",
      "act(p(MGI:P2rx7)) -> act(p(HGNC:CASP1))\n",
      "a(CHEBI:ATP) -> act(p(MGI:P2rx7))\n",
      "act(p(MGI:Casp1)) -> tloc(p(MGI:Il1b))\n",
      "act(p(MGI:P2rx7)) -> act(p(MGI:Casp1))\n",
      "----------------------\n",
      "10001280 : Redox-sensing molecules such as thioredoxin (TRX) and glutaredoxin (GRX) bind to apoptosis signal-regulating kinase 1 (ASK1) and suppress its activation\n",
      "complex(p(HGNC:TXN),p(HGNC:MAP3K5)) -| act(p(HGNC:MAP3K5))\n",
      "act(p(HGNC:MAP3K5)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10001506 : COX-2 protein and activity measured as prostaglandin E(2) level were up-regulated in cells expressing mutant K-ras(V12);\n",
      "act(p(HGNC:KRAS)) -> act(p(HGNC:PTGS2))\n",
      "p(MGI:Kras,sub(G,12,V)) -> act(p(MGI:Ptgs2))\n",
      "act(p(MGI:Kras)) -> act(p(MGI:Ptgs2))\n",
      "----------------------\n",
      "10001518 : Induction of STAT3 Tyr705 and Ser727 phosphorylations by Galpha(s)QL was suppressed by inhibition of protein kinase A, Janus kinase 2/3, Rac1, c-Jun N-terminal kinase (JNK), or phosphatidylinositol 3-kinase, and a similar profile was observed in response to beta2-adrenergic receptor stimulation\n",
      "act(p(HGNC:RAC1)) -> p(HGNC:STAT3,pmod(P))\n",
      "act(p(HGNC:RAC1)) -> p(HGNC:STAT3,pmod(P))\n",
      "----------------------\n",
      "10000610 : Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation\n",
      "act(p(HGNC:RAP1A)) -> act(p(HGNC:TIAM1))\n",
      "act(p(HGNC:RAP1A)) -> act(p(HGNC:VAV2))\n",
      "----------------------\n",
      "10001568 : ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration\n",
      "act(p(HGNC:ACVRL1)) -> act(p(HGNC:SMAD1))\n",
      "act(p(HGNC:ACVRL1)) -> act(p(HGNC:SMAD5))\n",
      "act(p(HGNC:SMAD1)) -> bp(GOBP:\"cell migration\")\n",
      "act(p(HGNC:SMAD1)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:SMAD2)) -| bp(GOBP:\"cell migration\")\n",
      "act(p(HGNC:SMAD2)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:SMAD3)) -| bp(GOBP:\"cell migration\")\n",
      "act(p(HGNC:SMAD3)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:SMAD5)) -> bp(GOBP:\"cell migration\")\n",
      "act(p(HGNC:SMAD5)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10001570 : GSK-3 activity is inhibited through phosphorylation of serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta. These serine residues of GSK-3 have been previously identified as targets of protein kinase B (PKB/Akt), a serine/threonine kinase located downstream of phosphatidylinositol 3-kinase.\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:GSK3B,pmod(P))\n",
      "p(HGNC:GSK3B,pmod(P)) -| act(p(HGNC:GSK3B))\n",
      "----------------------\n",
      "10001582 : AKT2 interacts with and phosphorylates ASK1 at Ser-83 resulting in inhibition of its kinase activity.\n",
      "act(p(HGNC:AKT2)) -| act(p(HGNC:MAP3K5))\n",
      "p(HGNC:MAP3K5,pmod(P)) -| act(p(HGNC:MAP3K5))\n",
      "----------------------\n",
      "10001586 : Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.\n",
      "act(p(HGNC:ATM)) -> p(HGNC:CHEK1,pmod(P))\n",
      "act(p(HGNC:ATR)) -> p(HGNC:CHEK1,pmod(P))\n",
      "----------------------\n",
      "10001590 : Highly purified ATM phosphorylated PHAS-I, the 32-kDa subunit of RPA, serine 15 of p53, and Chk2 in vitro.\n",
      "act(p(HGNC:ATM)) -> p(HGNC:TP53,pmod(P))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:CHEK2,pmod(P))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:EIF4EBP1,pmod(P))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:RPA2,pmod(P))\n",
      "----------------------\n",
      "10001604 : In this report, we demonstrate that the CDC25B phosphatase, an activator of cyclin dependent kinases at mitosis, is phosphorylated both in vitro and in vivo by Aurora-A on serine 353 and that this phosphorylated form of CDC25B is located at the centrosome during mitosis.\n",
      "act(p(HGNC:AURKA)) -> p(HGNC:CDC25B,pmod(P))\n",
      "p(HGNC:CDC25B,pmod(P)) -> act(p(HGNC:CDC25B))\n",
      "----------------------\n",
      "10001618 : Two peptides derived from the DNA-binding domain of p53 bind to CHK2 and stimulate phosphorylation of full-length p53 at Thr 18 and Ser 20, thus identifying CHK2-docking sites.\n",
      "act(p(HGNC:CHEK2)) -> p(HGNC:TP53,pmod(P))\n",
      "act(p(HGNC:CHEK2)) -> p(HGNC:TP53,pmod(P))\n",
      "----------------------\n",
      "10001456 : both hCKIdelta and hCKIepsilon phosphorylated and caused protein instability of human period 2 protein (hPER2)\n",
      "act(p(HGNC:CSNK1D)) -> p(HGNC:PER2,pmod(P))\n",
      "act(p(HGNC:CSNK1E)) -> p(HGNC:PER2,pmod(P))\n",
      "----------------------\n",
      "10001624 : GRP induced rapid activation of p44/42 MAPK in lung cancer cells through EGFR.\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10001630 : The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10001634 : The stimulatory EGFR signal is insensitive to inhibition of JAKs and appears to involve Src kinases and STAT proteins as shown by inhibition through overexpression of C-terminal Src kinase (Csk) and transdominant negative STAT3, respectively\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:STAT3))\n",
      "act(p(MGI:Egfr)) -> act(p(MGI:Src))\n",
      "act(p(MGI:Egfr)) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10001648 : The activated GSK-3beta phosphorylates Fyn at threonine residue(s). Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568.\n",
      "act(p(HGNC:GSK3B)) -> p(HGNC:FYN,pmod(P))\n",
      "p(HGNC:FYN,pmod(P)) -> act(p(HGNC:FYN))\n",
      "----------------------\n",
      "10001700 : The dual phosphorylation of Thr-183 and Tyr-185 in ERK2 is catalyzed by MAPK/ERK kinase 1 (MEK1).\n",
      "act(p(HGNC:MAP2K1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:MAP2K1)) -> p(HGNC:MAPK1,pmod(P))\n",
      "----------------------\n",
      "10001706 : Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183) in three SAPK1/JNK1 isoforms tested (JNK1 alpha 1, JNK2 alpha 2 and JNK3 alpha 1)\n",
      "act(p(HGNC:MAP2K4)) -> p(HGNC:MAPK8,pmod(P))\n",
      "act(p(HGNC:MAP2K4)) -> p(HGNC:MAPK9,pmod(P))\n",
      "act(p(HGNC:MAP2K7)) -> p(HGNC:MAPK8,pmod(P))\n",
      "act(p(HGNC:MAP2K7)) -> p(HGNC:MAPK9,pmod(P))\n",
      "----------------------\n",
      "10001748 : deletion of p38alpha mitogen-activated protein (MAP) kinase in adult mice results in increased proliferation\n",
      "act(p(HGNC:MAPK14)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Mapk14)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10001750 : In addition, p38alpha controls self-renewal of the lung stem and progenitor cell population by inhibiting proliferation-inducing signals, most notably epidermal growth factor receptor\n",
      "act(p(HGNC:MAPK14)) -| act(p(HGNC:EGFR))\n",
      "act(p(MGI:Mapk14)) -| act(p(MGI:Egfr))\n",
      "----------------------\n",
      "10001754 : We found that p38alpha positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation.\n",
      "act(p(HGNC:MAPK14)) -> bp(GOBP:\"cell differentiation\")\n",
      "act(p(MGI:Mapk14)) -> bp(GOBP:\"cell differentiation\")\n",
      "----------------------\n",
      "10001760 : Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways\n",
      "act(p(HGNC:MAPK1)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:MAPK3)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Gstp1)) -| act(p(MGI:Mapk1))\n",
      "act(p(MGI:Gstp1)) -| act(p(MGI:Mapk3))\n",
      "act(p(MGI:Mapk1)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Mapk3)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10001762 : hyperactivation of the extracellular signal-regulated kinase (ERK) via the hematopoietic-specific Rho GTPase, Rac2, directly contributes to the hyperproliferation of Nf1-deficient mast cells in vitro and in vivo\n",
      "act(p(HGNC:MAPK1)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Rac2)) -> act(p(MGI:Mapk1))\n",
      "act(p(MGI:Mapk1)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10001764 : We conclude that TNFalpha and IGF-I may additively contribute to fibrosis during intestinal inflammation. TNFR2 is a primary mediator of fibrogenic actions of TNFalpha acting through ERK1/2 to stimulate proliferation and through STAT3 to stimulate TIMP-1 and inhibit collagen degradation.\n",
      "act(p(HGNC:MAPK1)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Mapk1)) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Igf1) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10001768 : These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.\n",
      "act(p(HGNC:MAPK1)) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "act(p(HGNC:MAPK3)) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(HGNC:CSF3) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:CSF3) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10001770 : Leptin-induced MUC5B expression was blocked by the ERK1/2 and p38 pathway inhibitors, but not by the JAK2/STAT3 pathway inhibitor.\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:MUC5B)\n",
      "act(p(HGNC:MAPK3)) -> p(HGNC:MUC5B)\n",
      "----------------------\n",
      "10001800 : The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.\n",
      "act(p(HGNC:PDGFRA)) -> act(p(HGNC:PTGS2))\n",
      "act(p(MGI:Pdgfra)) -> act(p(MGI:Ptgs1))\n",
      "act(p(MGI:Pdgfra)) -> act(p(MGI:Ptgs2))\n",
      "act(p(MGI:Pdgfrb)) -> act(p(MGI:Ptgs1))\n",
      "act(p(MGI:Pdgfrb)) -> act(p(MGI:Ptgs2))\n",
      "----------------------\n",
      "10001812 : AMPKalpha1 plays an essential role in VEGF-induced angiogenesis in vitro (tube formation and sprouting from spheroids) and in vivo (Matrigel plug assay)\n",
      "act(p(HGNC:PRKAA1)) -> bp(GOBP:\"blood vessel development\")\n",
      "p(HGNC:VEGFA) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10001816 : Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.\n",
      "act(p(HGNC:PRKCD)) -> p(HGNC:PRKD1,pmod(P))\n",
      "act(p(HGNC:PRKCD)) -> p(HGNC:PRKD1,pmod(P))\n",
      "p(HGNC:PRKD1,pmod(P)) -> act(p(HGNC:PRKD1))\n",
      "p(HGNC:PRKD1,pmod(P)) -> act(p(HGNC:PRKD1))\n",
      "----------------------\n",
      "10001840 : This Raf-1-mediated fine tuning of Rok-a signaling allows the activation of junctional myosin and the timely maturation of AJ essential for maintaining cell cohesion during sprouting angiogenesis\n",
      "act(p(HGNC:RAF1)) -> act(p(HGNC:ROCK2))\n",
      "act(p(HGNC:ROCK2)) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10001852 : We identified the protein kinase receptor-interacting protein 3 (RIP3) as a molecular switch between TNF-induced apoptosis and necrosis in NIH 3T3 cells and found that RIP3 was required for necrosis in other cells\n",
      "act(p(HGNC:RIPK3)) -> bp(GOBP:\"necrotic cell death\")\n",
      "act(p(MGI:Ripk3)) -> bp(GOBP:\"necrotic cell death\")\n",
      "----------------------\n",
      "10001864 : PTPD1 activates src tyrosine kinase and increases the magnitude and duration of epidermal growth factor (EGF) signaling. EGF receptor phosphorylation and downstream activation of ERK 1/2 and Elk1-dependent gene transcription are enhanced by PTPD1.\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:EGFR))\n",
      "p(HGNC:EGFR,pmod(P)) -> act(p(HGNC:EGFR))\n",
      "----------------------\n",
      "10001868 : Pretreatment with PP2, a specific inhibitor of Src family tyrosine kinase, completely blocked the NHERF2-dependent increase of the phosphorylation of ERK and Akt, suggesting that NHERF2 up-regulates Erk phosphorylation through a Src family kinase-dependent pathway.\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10001872 : pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:MAPK8))\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:MAPK9))\n",
      "p(HGNC:ATF2,pmod(P)) -> act(p(HGNC:ATF2))\n",
      "p(HGNC:ATF2,pmod(P)) -> act(p(HGNC:ATF2))\n",
      "----------------------\n",
      "10002022 : Phosphorylation of wild-type but not kinase-inactive FRAP occurs at Ser-2481 in vivo, suggesting that Ser-2481 phosphorylation is a marker of FRAP autokinase activity in cells.\n",
      "p(EGID:2475,pmod(P)) -> act(p(EGID:2475))\n",
      "act(p(HGNC:MTOR)) -> p(HGNC:MTOR,pmod(P))\n",
      "p(HGNC:MTOR,pmod(P)) -> act(p(HGNC:MTOR))\n",
      "----------------------\n",
      "10002032 : Besides regulating the systemic availability of the proinflammatory cytokine TNF, our results demonstrate that ADAM17 is needed for vital regenerative activities during the immune response\n",
      "p(HGNC:ADAM17) -> p(HGNC:TNF)\n",
      "p(MGI:Adam17) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10002066 : Autophagic death required the genes ATG7 and beclin 1 and was induced by caspase-8 inhibition.\n",
      "p(HGNC:ATG7) -> bp(GOBP:autophagy)\n",
      "p(HGNC:BECN1) -> bp(GOBP:autophagy)\n",
      "----------------------\n",
      "10002080 : We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1\n",
      "p(HGNC:BCL2A1) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BCL2) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BCL2L1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10002132 : Development of secondary pulmonary granulomata in response to Schistosoma mansoni eggs was blunted in MCP-1(-/-) mice, as was expression of IL-4, IL-5, and interferon gamma in splenocytes.\n",
      "p(HGNC:CCL2) -> p(HGNC:IFNG)\n",
      "p(MGI:Ccl2) -> p(MGI:Ifng)\n",
      "p(MGI:Ccl2) -> p(MGI:Il4)\n",
      "p(MGI:Ccl2) -> p(MGI:Il5)\n",
      "----------------------\n",
      "10002184 : The cyclin-dependent kinase 2 (Cdk2) inhibitors p21(CIP1) and p27(KIP1) are negatively regulated by anchorage during cell proliferation, but it is unclear how integrin signaling may affect these Cdk2 inhibitors.\n",
      "p(HGNC:CDKN1A) -| act(p(HGNC:CDK2))\n",
      "p(HGNC:CDKN1B) -| act(p(HGNC:CDK2))\n",
      "----------------------\n",
      "10002200 : Silencing FLIP expression significantly increased human sarcoma cells to both FasL-induced and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, and ectopic expression of IRF8 also significantly increased the sensitivity of these human sarcoma cells to FasL- and TRAIL-induced apoptosis.\n",
      "p(HGNC:CFLAR) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Cflar) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10002202 : This was accompanied by reduced lung caspase-3 activity and defective degradation of NF-kappaB inhibitor IkappaB-alpha.\n",
      "p(HGNC:CFTR) -| p(HGNC:NFKBIA)\n",
      "p(MGI:Cftr) -| p(MGI:Nfkbia)\n",
      "----------------------\n",
      "10002206 : Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells\n",
      "p(HGNC:COL18A1) -| act(p(HGNC:KDR))\n",
      "p(HGNC:COL18A1) -| act(p(HGNC:MAPK1))\n",
      "p(HGNC:COL18A1) -| act(p(HGNC:MAPK3))\n",
      "p(HGNC:COL18A1) -| act(p(HGNC:PTK2))\n",
      "----------------------\n",
      "10002224 : In conclusion, 67LR up-regulation in G-CSF-mobilized HSCs correlates with their successful mobilization and reflects its increase in marrow HSCs, which contributes to the egress from bone marrow by mediating laminin-dependent cell adhesion and transendothelial migration.\n",
      "p(HGNC:CSF3) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Csf3) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10002226 : NCA was inhibited by leukotriene B4 receptor antagonist and anti-IL-8 and G-CSF Abs.\n",
      "p(HGNC:CSF3) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(HGNC:IL8) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10002236 : beta-Catenin phosphorylation at serine 45 (Ser45), threonine 41 (Thr41), Ser37, and Ser33 is critical for beta-catenin degradation, and regulation of beta-catenin phosphorylation is a central part of the canonical Wnt signaling pathway.\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10001360 : Serine-33 and -37 of beta-catenin are GSK3 phosphorylation sites that serve as recognition sites for the beta-TRCP-ubiquitin ligase complex, which ultimately triggers beta-catenin degradation.\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10002238 : It is established that Ser45 phosphorylation by casein kinase I (CKI) initiates phosphorylation at Thr41, Ser37, and Ser33 by glycogen synthase kinase 3 (GSK3) and that phosphorylated Ser37 and Ser33 are recognized by the F-box protein beta-TrCP, a component of a ubiquitin ligase complex that mediates beta-catenin degradation.\n",
      "p(HGNC:CTNNB1,pmod(P)) -> p(HGNC:CTNNB1,pmod(P))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> p(HGNC:CTNNB1,pmod(P))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> p(HGNC:CTNNB1,pmod(P))\n",
      "----------------------\n",
      "10002252 : MIP-2 mRNA expression was observed in lung tissue after CLP and numerous neutrophils were accumulated in the lung under those conditions. Anti-MIP-2 antibody contributed to the inhibition of the CD11b expression and chemotaxis of pulmonary neutrophils, lung edema, and thus the reduction in peritonitis-related mortality.\n",
      "p(HGNC:CXCL2) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(MGI:Cxcl2) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10002264 : We observed that two stress-induced proteins, RTP801/Redd1 and RTP801L/Redd2, potently inhibit signaling through mTOR.\n",
      "p(HGNC:DDIT4) -| act(p(EGID:2475))\n",
      "p(HGNC:DDIT4L) -| act(p(EGID:2475))\n",
      "p(MGI:Ddit4) -| act(p(MGI:Mtor))\n",
      "p(MGI:Ddit4l) -| act(p(MGI:Mtor))\n",
      "----------------------\n",
      "10002306 : We used mass spectrometry-based proteomics to comprehensively compare proteins that were tyrosine phosphorylated in response to EGF and PDGF and their associated partners. More than 90% of these signaling proteins were used by both ligands, whereas the phosphatidylinositol 3-kinase (PI3K) pathway was exclusively activated by PDGF,\n",
      "p(HGNC:EGF) -> p(HGNC:EGFR,pmod(P))\n",
      "p(HGNC:EGF) -> p(HGNC:PLCG1,pmod(P))\n",
      "----------------------\n",
      "10002340 : The protein Daxx promotes Fas-mediated cell death through activation of apoptosis signal-regulating kinase 1, leading to the activation of the MAPKs JNK and p38.\n",
      "p(HGNC:FASLG) -> act(p(HGNC:FAS))\n",
      "p(MGI:Daxx) -> act(p(MGI:Map3k5))\n",
      "p(MGI:Fasl) -> act(p(MGI:Fas))\n",
      "----------------------\n",
      "10002368 : Insulin disrupts IRS-dependent transactivation by FKHR, and phosphorylation of Ser-256 by PKB is necessary and sufficient to mediate this effect.\n",
      "p(HGNC:FOXO1,pmod(P)) -| act(p(HGNC:FOXO1))\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:FOXO1,pmod(P))\n",
      "act(p(HGNC:AKT1)) -| act(p(HGNC:FOXO1))\n",
      "----------------------\n",
      "10002372 : The GABARAP family members (GABARAP, GABARAPL1 and GABARAPL2) and their close homologs (LC3 and Atg8) are not only involved in the transport of proteins or vesicles but are also implicated in various mechanisms such as autophagy, cell death, cell proliferation and tumor progression.\n",
      "p(HGNC:GABARAP) -> bp(GOBP:autophagy)\n",
      "p(HGNC:GABARAPL1) -> bp(GOBP:autophagy)\n",
      "----------------------\n",
      "10002382 : The current study evaluated the contribution of each of the three known Gas6 receptors (Axl, Sky and Mer) in human and mouse platelet function.\n",
      "p(HGNC:GAS6) -> act(p(HGNC:AXL))\n",
      "p(HGNC:GAS6) -> act(p(HGNC:MERTK))\n",
      "----------------------\n",
      "10002386 : In mammals GSK3 is present in two isoforms, alpha and beta regulated by phosphorylation: phosphorylation of Ser9 in GSK3beta or Ser21 in GSK3alpha leads to inactivation while phosphorylation of Tyr216 in GSK3beta or Tyr279 in GSK3alpha leads to activation.\n",
      "p(HGNC:GSK3B,pmod(P)) -| act(p(HGNC:GSK3B))\n",
      "p(HGNC:GSK3B,pmod(P)) -> act(p(HGNC:GSK3B))\n",
      "----------------------\n",
      "10002406 : SSB-1 also enhanced HGF-induced Erk phosphorylation\n",
      "p(HGNC:HGF) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:HGF) -> act(p(HGNC:MAPK3))\n",
      "p(HGNC:MAPK1,pmod(P)) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:MAPK3,pmod(P)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10002414 : Retroviral transduction with a Hoxa-9 expression vector dramatically enhanced the cytokine-driven proliferation and in vivo engraftment of Hoxa-9-/- marrow cells.\n",
      "p(HGNC:HOXA9) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Hoxa9) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10002434 : It has been demonstrated that macrophages can produce 1alpha,25(OH)2D3 on activation with interferon gamma (IFN-gamma)\n",
      "p(HGNC:IFNG) -> a(CHEBI:calcitriol)\n",
      "p(MGI:Ifng) -> a(CHEBI:calcitriol)\n",
      "----------------------\n",
      "10002464 : IL-4 and IL-13 induced phosphorylation of STAT6 in mtCC cells, which binds to the proximal STAT-binding element (SBE) in the Ugrp2 gene promoter, leading to transcriptional activation of this gene.\n",
      "p(HGNC:IL13) -> act(p(HGNC:STAT6))\n",
      "p(HGNC:IL4) -> act(p(HGNC:STAT6))\n",
      "----------------------\n",
      "10002538 : In the present study we investigated the impact of GM-CSF, IL-4, and IFN-gamma on anaphylatoxin receptor expression in monocytes and dendritic cells (DC). IL-4 was identified as the strongest down-regulator of the receptors for C5a and C3a in monocytes and monocyte-derived DC (MoDC).\n",
      "p(HGNC:IL4) -| p(HGNC:C3AR1)\n",
      "p(HGNC:IL4) -| p(HGNC:C5AR1)\n",
      "----------------------\n",
      "10002540 : Immunoblotting analysis using a specific Ab against phosphorylated p38 MAP kinase (Thr(180)/Tyr(182)) showed that IL-4 induced phosphorylation of p38 MAP kinase in human dermal fibroblasts.  Furthermore, the p38 MAP kinase assay showed that IL-4 induces p38 MAPK activation in human dermal fibroblasts.\n",
      "p(HGNC:IL4) -> act(p(HGNC:MAPK14))\n",
      "p(HGNC:MAPK14,pmod(P)) -> act(p(HGNC:MAPK14))\n",
      "p(HGNC:MAPK14,pmod(P)) -> act(p(HGNC:MAPK14))\n",
      "----------------------\n",
      "10002556 : These results suggest that IL-4 inhibition of IFN-gamma-induced CD40 gene expression is mediated by direct STAT-6 binding to the CD40 promoter.\n",
      "p(HGNC:IL4) -> act(p(HGNC:STAT6))\n",
      "p(MGI:Il4) -> act(p(MGI:Stat6))\n",
      "act(p(MGI:Stat6)) -| r(MGI:Cd40)\n",
      "----------------------\n",
      "10002564 : Treatment of bleomycin-challenged mice with soluble TNF receptor (sTNFr) or anti-IL-6 antibodies significantly decreased MIP-1alpha protein expression in the lungs.\n",
      "p(HGNC:IL6) -> p(HGNC:CCL3)\n",
      "p(HGNC:TNF) -> p(HGNC:CCL3)\n",
      "p(MGI:Il6) -> p(MGI:Ccl3)\n",
      "p(MGI:Tnf) -> p(MGI:Ccl3)\n",
      "----------------------\n",
      "10002578 : results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program.\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "p(MGI:Il6) -> act(p(MGI:Stat3))\n",
      "r(MGI:Il6) -> p(MGI:Il6)\n",
      "act(p(MGI:Bcl6)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10002580 : Signal transducer and activator of transcription 3 (STAT3) is activated by the IL-6 family of cytokines and growth factors. STAT3 requires phosphorylation on Ser-727, in addition to tyrosine phosphorylation on Tyr-705, to be transcriptionally active.\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10002588 : The mouse tumors mimic molecular hallmarks of their human tumor counterparts, including elevated IL-6/Stat3/Bcl-X(L) signaling. The newly developed mouse strains may provide a good preclinical research tool for the design and testing of new approaches to target IL-6 in treatment and prevention of human PCNs.\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "p(MGI:Il6) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10002596 : gp130-mediated Stat1/3 activation is required to maintain the normal balance of hematopoietic progenitors during fetal and adult hematopoiesis\n",
      "p(HGNC:IL6ST) -> act(p(HGNC:STAT3))\n",
      "p(MGI:Il6st) -> act(p(MGI:Stat1))\n",
      "p(MGI:Il6st) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10002600 : There are 2 known ligands for IL-7Ralpha: IL-7 itself and thymic stromal lymphopoietin (TSLP).\n",
      "p(HGNC:IL7) -> act(p(HGNC:IL7R))\n",
      "p(HGNC:TSLP) -> act(p(HGNC:IL7R))\n",
      "----------------------\n",
      "10002660 : ERK1/2 and JNK inactivation was associated with Ets-like transcription factor-1 (ELK-1) dephosphorylation.\n",
      "p(HGNC:MAPK1,pmod(P)) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:MAPK3,pmod(P)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10002664 : Additionally, genistein enhanced RA-induced neuronal differentiation by increasing the activation of extracellular signal-related kinase 1/2 (ERK1/2) via phosphorylation at Thr183 and Tyr185 in 3-7 days.\n",
      "p(HGNC:MAPK1,pmod(P)) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:MAPK1,pmod(P)) -> act(p(HGNC:MAPK1))\n",
      "----------------------\n",
      "10002674 : JNKs are activated by phosphorylation on two critical residues, the threonine 183 and tyrosine 185, within the TPY motif. The activated JNKs, in turn, phosphorylate the nuclear protein c-Jun, a major component of the transcription factor AP1.\n",
      "p(HGNC:MAPK8,pmod(P)) -> act(p(HGNC:MAPK8))\n",
      "p(HGNC:MAPK8,pmod(P)) -> act(p(HGNC:MAPK8))\n",
      "p(HGNC:MAPK9,pmod(P)) -> act(p(HGNC:MAPK9))\n",
      "p(HGNC:MAPK9,pmod(P)) -> act(p(HGNC:MAPK9))\n",
      "----------------------\n",
      "10002686 : The c-Myc oncoprotein functions as a transcription factor that can transform normal cells into tumor cells, as well as playing a direct role in normal cell proliferation.\n",
      "p(HGNC:MYC) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Myc) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10002722 : Essential to activation of AMPK is its phosphorylation at Thr-172 by an upstream kinase, AMPKK, whose identity in mammalian cells has remained elusive.\n",
      "p(HGNC:PRKAA1,pmod(P)) -> act(p(HGNC:PRKAA1))\n",
      "p(MGI:Prkaa1,pmod(P)) -> act(p(MGI:Prkaa1))\n",
      "----------------------\n",
      "10002724 : together, these data indicate that CD45 inhibits PMA-dependent PKCdelta activation by impeding PMA-dependent PKCdelta tyrosine phosphorylation.\n",
      "p(HGNC:PRKCD,pmod(P)) -> act(p(HGNC:PRKCD))\n",
      "act(p(HGNC:PTPRC)) -| p(HGNC:PRKCD,pmod(P))\n",
      "----------------------\n",
      "10002728 : Inhibition of COX2 markedly reduced both IL-1 beta and IL-6 release.\n",
      "p(HGNC:PTGS2) -> p(HGNC:IL1B)\n",
      "p(HGNC:PTGS2) -> p(HGNC:IL6)\n",
      "----------------------\n",
      "10002746 : Although TRAF2 levels remained constant in TNF-treated wild-type cells, TNF stimulation of RIPK1(-/-) cells caused TRAF2 and cIAP1 to be rapidly degraded by the proteasome, which led to an increase in NIK levels.\n",
      "p(HGNC:RIPK1) -> p(HGNC:TRAF2)\n",
      "p(MGI:Ripk1) -> p(MGI:Birc2)\n",
      "p(MGI:Ripk1) -| p(MGI:Map3k14)\n",
      "p(MGI:Ripk1) -> p(MGI:Traf2)\n",
      "----------------------\n",
      "10002750 : conditional inactivation of Cdc2 reduces phosphorylation of S6K1 at S/TP sites while simultaneously increasing phosphorylation of Thr(389) and of the S6K1 substrate, RPS6.\n",
      "p(HGNC:RPS6KB1,pmod(P)) -| act(p(HGNC:RPS6KB1))\n",
      "p(HGNC:RPS6KB1,pmod(P)) -> act(p(HGNC:RPS6KB1))\n",
      "----------------------\n",
      "10002754 : The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.\n",
      "p(HGNC:S100A8) -> act(p(HGNC:TLR4))\n",
      "p(HGNC:S100A9) -> act(p(HGNC:TLR4))\n",
      "p(MGI:S100a8) -> act(p(MGI:Tlr4))\n",
      "p(MGI:S100a9) -> act(p(MGI:Tlr4))\n",
      "----------------------\n",
      "10002758 : In studying the molecular mechanism of this increased stabilization of p53, we found that 14-3-3 sigma antagonized the biological functions of Mdm2 by blocking Mdm2-mediated p53 ubiquitination and nuclear export. In addition, we found that 14-3-3 sigma facilitated the oligomerization of p53 and enhanced p53's transcriptional activity.\n",
      "p(HGNC:SFN) -| p(HGNC:MDM2)\n",
      "p(MGI:Sfn) -| p(MGI:Mdm2)\n",
      "p(MGI:Sfn) -> act(p(MGI:Trp53))\n",
      "----------------------\n",
      "10002766 : TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation\n",
      "p(HGNC:SMAD2,pmod(P)) -> act(p(HGNC:SMAD2))\n",
      "p(HGNC:SMAD3,pmod(P)) -> act(p(HGNC:SMAD3))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD2))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10002770 : Mice deficient in Smad3 demonstrated suppressed type I procollagen mRNA expression and reduced hydroxyproline content in the lungs compared with wild-type mice treated with bleomycin\n",
      "p(HGNC:SMAD3) -> a(CHEBI:hydroxyproline)\n",
      "p(MGI:Smad3) -> a(CHEBI:hydroxyproline)\n",
      "----------------------\n",
      "10002780 : IFN-gamma-induced inhibition of STAT6 phosphorylation and eotaxin production were mediated by SOCS-1 induced in STAT1-dependent manner.\n",
      "p(HGNC:SOCS1) -| act(p(HGNC:STAT6))\n",
      "p(MGI:Ifng) -> act(p(MGI:Stat1))\n",
      "p(MGI:Socs1) -| p(MGI:Ccl11)\n",
      "p(MGI:Socs1) -| act(p(MGI:Stat6))\n",
      "act(p(MGI:Stat1)) -> p(MGI:Socs1)\n",
      "----------------------\n",
      "10002786 : We demonstrated that SOCS3 deletion in the liver resulted in hyperactivation of STAT3 and promoted ConA- and chemical-induced liver fibrosis.\n",
      "p(HGNC:SOCS3) -| act(p(HGNC:STAT3))\n",
      "p(MGI:Socs3) -| act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10002792 : Biochemical analysis illustrated that the mechanism of this transcriptional synergy involves interaction between BRCA1 aa 502-802 and the C-terminal transcriptional activation domain of STAT1 including Ser-727 whose phosphorylation is crucial for transcriptional activation.\n",
      "p(HGNC:STAT1,pmod(P)) -> act(p(HGNC:STAT1))\n",
      "p(HGNC:STAT1,pmod(P)) -> complex(p(HGNC:BRCA1),p(HGNC:STAT1))\n",
      "----------------------\n",
      "10002798 : We found that the Tyr701 phosphorylation kinetics of Stat1 mediated by IFN stimulation was higher when cells were incubated with IFN-alpha5 than when using IFN-alpha2. Similarly, Tyr(1054/1055) phosphorylation kinetics of Tyk2 were more intense after exposure to IFN-alpha5 than when using IFN-alpha2. Concomitantly, Tyr705 phosphorylation of Stat3 was higher after stimulation with IFN-alpha5 than with IFN-alpha2.\n",
      "p(HGNC:STAT1,pmod(P)) -> act(p(HGNC:STAT1))\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:TYK2,pmod(P)) -> act(p(HGNC:TYK2))\n",
      "p(HGNC:TYK2,pmod(P)) -> act(p(HGNC:TYK2))\n",
      "----------------------\n",
      "10002802 : LIGHT, a member of tumor necrosis factor superfamily, activates Stat3 in cancer cells. LIGHT induces dose-dependent activation of Stat3 by phosphorylation at both the tyrosine 705 and serine 727 residues.\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10002808 : Stat3 is activated by phosphorylation on Tyr-705, which leads to dimer formation, nuclear translocation, and regulation of gene expression.\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> complex(p(HGNC:STAT3),p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> tloc(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10002820 : Transforming growth factor (TGF)-alpha is a ligand for the epidermal growth factor receptor (EGFR).\n",
      "p(HGNC:TGFA) -> act(p(HGNC:EGFR))\n",
      "p(MGI:Tgfa) -> act(p(MGI:Egfr))\n",
      "----------------------\n",
      "10002836 : TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.\n",
      "p(HGNC:TGFB1) -> p(HGNC:CD80)\n",
      "p(HGNC:TGFB1) -> p(HGNC:CTLA4)\n",
      "act(p(MGI:Cd80)) -> r(MGI:Foxp3)\n",
      "p(MGI:Ctla4) -> act(p(MGI:Cd80))\n",
      "p(MGI:Tgfb1) -> p(MGI:Cd80)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "p(MGI:Tgfb1) -> p(MGI:Ctla4)\n",
      "----------------------\n",
      "10002858 : Both SMAD2 and SMAD1/5 were activated upon exposure to TGF-beta1\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD1))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD2))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD5))\n",
      "----------------------\n",
      "10002864 : Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD2))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Smad2))\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Smad3))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Smad2))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Smad3))\n",
      "----------------------\n",
      "10002872 : Neutralizing Ab to TGF-beta1 eliminated TMEV-induced IL-23 production and SMAD-3 activation in RAW264.7 cells, BMM, and SPM.\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "p(MGI:Tgfb1) -> p(MGI:Il23a)\n",
      "p(MGI:Tgfb1) -> r(MGI:Il23a)\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Smad3))\n",
      "----------------------\n",
      "10002886 : Similar injuries to TGase 1 knockout mouse skins grafted on athymic nude mice showed substantial delays in wound healing concomitant with sustained K6alpha mRNA induction.\n",
      "p(HGNC:TGM1) -> bp(GOBP:\"wound healing\")\n",
      "p(MGI:Tgm1) -> bp(GOBP:\"wound healing\")\n",
      "p(MGI:Tgm1) -| r(MGI:Krt17)\n",
      "----------------------\n",
      "10002900 : TIMP-1 knockout mice also displayed greater degree of liver fibrosis after chronic CCl4 injection when compared with wild-type mice.\n",
      "p(HGNC:TIMP1) -| path(MESHD:Fibrosis)\n",
      "p(MGI:Timp1) -| path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10002912 : Mice carrying a deletion in the tumor necrosis factor (TNF) AU-rich elements (ARE) are reported as a model for human CD and are characterized by elevated TNF-alpha levels and inflammations in the terminal ileum\n",
      "p(HGNC:TNF) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Tnf) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10003014 : VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:FLT1))\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10003016 : Pharmacological intervention with a VEGFR-2-neutralizing Ab (anti-Flk1 mAb) abolished the production of IL-6 (but not IL-12p70) and the subsequent development of allergen-specific Th17 cell response.\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:KDR))\n",
      "act(p(MGI:Kdr)) -> p(MGI:Il6)\n",
      "p(MGI:Vegfa) -> act(p(MGI:Kdr))\n",
      "----------------------\n",
      "10003066 : We synthesized a VIP analog that combines mutations that decrease the affinity for the VPAC1 receptor but maintain a high affinity for the VPAC2 receptor with an amino-terminal hexanoylation that increases the affinity for the VPAC2 receptor with a limited decrease in the affinity of the VPAC1 receptor.\n",
      "p(HGNC:VIP) -> act(p(HGNC:VIPR1))\n",
      "p(HGNC:VIP) -> act(p(HGNC:VIPR2))\n",
      "----------------------\n",
      "10003178 : Here, we show that Foxo1 and Foxo3a are the most abundant Foxo isoforms in mature endothelial cells and that overexpression of constitutively active Foxo1 or Foxo3a, but not Foxo4, significantly inhibits endothelial cell migration and tube formation in vitro.\n",
      "act(p(HGNC:FOXO1)) -| bp(GOBP:\"cell migration\")\n",
      "act(p(HGNC:FOXO3)) -| bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10003208 : Several transcription factors have also been implicated in megakaryopoiesis including, GATA-1, friend of GATA-1 (FOG-1), nuclear factor-erythroid 2 (NF-E2), and Fli-1.\n",
      "act(p(HGNC:NFE2)) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "p(MGI:Zfpm1) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "act(p(MGI:Fli1)) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "act(p(MGI:Gata1)) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "act(p(MGI:Nfe2)) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "----------------------\n",
      "10003232 : Smad7 expression inhibited both Smad2- and Smad3-mediated TGF-beta signaling in podocytes\n",
      "act(p(HGNC:SMAD7)) -| act(p(HGNC:SMAD2))\n",
      "act(p(HGNC:SMAD7)) -| act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10003240 : Sox2 is required for proliferation and differentiation of Clara cells that serve as the progenitor cells from which Clara, ciliated, and goblet cells are derived.\n",
      "act(p(HGNC:SOX2)) -> bp(GOBP:\"epithelial cell differentiation\")\n",
      "act(p(MGI:Sox2)) -> bp(GOBP:\"epithelial cell differentiation\")\n",
      "----------------------\n",
      "10003254 : Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.\n",
      "act(p(HGNC:TBX21)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "act(p(MGI:Tbx21)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "act(p(MGI:Tbx21)) -| bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "act(p(MGI:Tbx21)) -| p(MGI:Il4)\n",
      "act(p(MGI:Tbx21)) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10003256 : DP1, the DNA binding partner of the E2F family of factors (E2Fs)\n",
      "act(p(HGNC:TFDP1)) -> act(p(HGNC:E2F1))\n",
      "act(p(HGNC:TFDP1)) -> act(p(HGNC:E2F2))\n",
      "act(p(HGNC:TFDP1)) -> act(p(HGNC:E2F3))\n",
      "----------------------\n",
      "10003272 : Phosphorylation of 4E-BP1, S6k1(Thr(389)), and Erk 1/2 was reduced 2 h following IP injection of alcohol.\n",
      "a(CHEBI:alcohol) -| p(MGI:Eif4ebp1,pmod(P))\n",
      "a(CHEBI:alcohol) -| p(MGI:Mapk1,pmod(P))\n",
      "a(CHEBI:alcohol) -| p(MGI:Mapk3,pmod(P))\n",
      "a(CHEBI:alcohol) -| p(MGI:Rps6ka1,pmod(P))\n",
      "----------------------\n",
      "10003286 : Incubation of cells with the cholinergic agonist oxotremorine-M (Oxo-M) induced an approximately 6-fold increase in the tyrosine phosphorylation of ACK-1 which was inhibited by atropine.\n",
      "a(CHEBI:atropine) -| p(HGNC:TNK2,pmod(P))\n",
      "a(CHEBI:\"oxotremorine M\") -> p(HGNC:TNK2,pmod(P))\n",
      "----------------------\n",
      "10003346 : The level of phosphorylation at Ser577, a canonical PKA-phosphorylation site, was elevated by ACTH treatment. The disruption of the serine residue inhibited the nuclear export and enhanced the transcription repression activity of SIK.\n",
      "a(CHEBI:corticotropin) -> p(MGI:Sik1,pmod(P))\n",
      "p(MGI:Sik1,pmod(P)) -| tloc(p(MGI:Sik1))\n",
      "----------------------\n",
      "10003378 : We demonstrated that lung myofibroblasts, incubated in the presence of E2, showed a rapid phosphorylation on serine-259 of Raf1 and tyrosine-204 of ERK1/2 MAP kinase at 15 min, by approximately 3- and 5-fold, respectively\n",
      "a(CHEBI:estradiol) -> p(MGI:Mapk1,pmod(P))\n",
      "a(CHEBI:estradiol) -> p(MGI:Mapk3,pmod(P))\n",
      "a(CHEBI:estradiol) -> p(MGI:Raf1,pmod(P))\n",
      "----------------------\n",
      "10003428 : Using the specific Abl tyrosine kinase inhibitor STI 571, we purified unphosphorylated murine type IV c-Abl\n",
      "a(CHEBI:imatinib) -| p(MGI:Abl1,pmod(P))\n",
      "a(CHEBI:imatinib) -| p(MGI:Abl1,pmod(P))\n",
      "a(CHEBI:imatinib) -| act(p(MGI:Abl1))\n",
      "----------------------\n",
      "10003446 : However, LK-induced hyperphosphorylation of AATYK at multiple sites was blocked by kainate, lithium, and protein kinase C-delta inhibitor.\n",
      "a(CHEBI:\"kainic acid\") -| p(MGI:Aatk,pmod(P))\n",
      "p(MGI:Prkcd) -> p(MGI:Aatk,pmod(P))\n",
      "----------------------\n",
      "10003612 : Staurosporine and ML-9, which inhibited the phosphorylation of PTP36 in vivo, induced the translocation of PTP36 too.\n",
      "a(CHEBI:staurosporine) -| p(MGI:Ptpn14,pmod(P))\n",
      "a(CHEBI:staurosporine) -> act(p(MGI:Ptpn14))\n",
      "a(CHEBI:staurosporine) -> tloc(p(MGI:Ptpn14))\n",
      "----------------------\n",
      "10004050 : In mouse fibroblasts adhered to substrates, PTP36 was phosphorylated on serine residues. PTP36 was found to make complexes with serine/threonine kinase(s), which phosphorylated PTP36 in vitro. PTP36 was dephosphorylated rapidly when the cell-substrate adhesion was disrupted and it was phosphorylated again along with the reattachment of the cells to fibronectin.\n",
      "bp(GOBP:\"cell adhesion\") -> p(MGI:Ptpn14,pmod(P))\n",
      "p(MGI:Ptpn14,pmod(P)) -| act(p(MGI:Ptpn14))\n",
      "bp(GOBP:\"cell adhesion\") -| act(p(MGI:Ptpn14))\n",
      "----------------------\n",
      "10004052 : % Integrin regulation of neutrophils is essential for appropriate adhesion and transmigration into tissues. Vav proteins are Rho family guanine nucleotide exchange factors that become tyrosine phosphorylated in response to adhesion.\n",
      "bp(GOBP:\"cell adhesion\") -> p(MGI:Vav1,pmod(P))\n",
      "bp(GOBP:\"cell adhesion\") -> p(MGI:Vav3,pmod(P))\n",
      "----------------------\n",
      "10000050 : Mitogen-activated protein (MAP) kinases phosphorylate the estrogen receptor and activate transcription from estrogen receptor-regulated genes.\n",
      "bp(GOBP:\"MAPK cascade\") -> p(HGNC:ESR1,pmod(P))\n",
      "p(HGNC:ESR1,pmod(P)) -> act(p(HGNC:ESR1))\n",
      "bp(GOBP:\"MAPK cascade\") -> act(p(HGNC:ESR1))\n",
      "----------------------\n",
      "10004102 : Immunoblotting with antiphosphopeptide antibodies specific for Thr(188/37) of C/EBPbeta (anti-P-C/EBPbeta) shows that GH rapidly and transiently promotes phosphorylation of mLAP and mLIP on the MAPK site. MEK inhibitors prevent this GH-promoted phosphorylation of LAP and LIP, suggesting that such phosphorylation depends on GH-activated MAPK signaling.\n",
      "bp(GOBP:\"MAPK cascade\") -> p(MGI:Cebpb,pmod(P))\n",
      "bp(GOBP:\"MAPK cascade\") -> p(MGI:Cebpb,pmod(P))\n",
      "p(MGI:Gh) -> p(MGI:Cebpb,pmod(P))\n",
      "p(MGI:Gh) -> p(MGI:Cebpb,pmod(P))\n",
      "----------------------\n",
      "10004100 : Tankyrase is a novel signaling target of mitogen-activated protein kinase (MAPK); it is stoichiometrically phosphorylated upon insulin stimulation. Phosphorylation enhances the poly(ADP-ribose) polymerase activity of tankyrase\n",
      "bp(GOBP:\"MAPK cascade\") -> p(MGI:Tnks,pmod(P))\n",
      "p(MGI:Tnks,pmod(P)) -> act(p(MGI:Tnks))\n",
      "bp(GOBP:\"MAPK cascade\") -> act(p(MGI:Tnks))\n",
      "----------------------\n",
      "10004208 : The coactivators CBP and P300 interact with, acetylate, and enhance its activity, helping to explain its role as a transcription activator.\n",
      "act(complex(p(HGNC:CREBBP),p(HGNC:EP300))) -> p(HGNC:KLF1,pmod(A))\n",
      "p(HGNC:KLF1,pmod(A)) -> act(p(HGNC:KLF1))\n",
      "act(complex(p(HGNC:CREBBP),p(HGNC:EP300))) -> act(p(HGNC:KLF1))\n",
      "----------------------\n",
      "10000032 : Fas stimulation of Jurkat cells is known to induce p38 kinase and we find a pronounced increase in Rb phosphorylation within 30 min of Fas stimulation\n",
      "act(p(HGNC:FAS)) -> p(HGNC:RB1,pmod(P))\n",
      "p(HGNC:RB1,pmod(P)) -| act(p(HGNC:RB1))\n",
      "act(p(HGNC:FAS)) -> act(p(HGNC:MAPK14))\n",
      "act(p(HGNC:FAS)) -| act(p(HGNC:RB1))\n",
      "----------------------\n",
      "10005138 : In this current study, using a system of LPS-treated RAW264.7 macrophages, we go on to demonstrate that OPN increases STAT1 ubiquitination and subsequent 26s proteasome-mediated degradation to inhibit STAT1 dependent iNOS promoter activity, transcription, and protein expression.\n",
      "act(p(MGI:Spp1)) -| p(MGI:Stat1,pmod(U))\n",
      "p(MGI:Stat1,pmod(U)) -> deg(p(MGI:Stat1))\n",
      "act(p(MGI:Stat1)) -> r(MGI:Nos2)\n",
      "----------------------\n",
      "10005400 : Cyclin D3-cdk4/cdk6 specifically phosphorylate C/EBPalpha at Ser193 in vitro and in the liver and support growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.\n",
      "complex(p(MGI:Ccnd3),p(MGI:Cdk4)) -> p(MGI:Cebpa,pmod(P))\n",
      "complex(p(MGI:Cdk6),p(MGI:Ccnd3)) -> p(MGI:Cebpa,pmod(P))\n",
      "complex(p(MGI:Cebpa),p(MGI:Cdk2)) -| bp(GOBP:\"cell proliferation\")\n",
      "complex(p(MGI:Cebpa),p(MGI:Smarca2)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10005424 : MyoD acetylation by CBP/p300 (as well as by PCAF) increases its activity on a muscle-specific promoter, as assessed by microinjection experiments.\n",
      "complex(p(MGI:Crebbp),p(MGI:Ep300)) -> p(MGI:Myod1,pmod(A))\n",
      "p(MGI:Kat2b) -> p(MGI:Myod1,pmod(A))\n",
      "----------------------\n",
      "10005428 : Activated KRAS is known to induce tyrosine phosphorylation of beta-catenin, leading to its release from E-cadherin at the adherens junction\n",
      "act(p(MGI:Kras)) -> p(MGI:Ctnnb1,pmod(P))\n",
      "p(MGI:Ctnnb1,pmod(P)) -| complex(p(MGI:Ctnnb1),p(MGI:Cdh1))\n",
      "complex(p(MGI:Ctnnb1),p(MGI:Cdh1)) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10005842 : Wild-type WNK3 activates Na-(K)-Cl cotransporters by increasing their phosphorylation, and catalytically inactive kinase inhibits Na-(K)-Cl cotransporters by decreasing their phosphorylation, such that our data suggest that WNK3 is a crucial component of the kinase/phosphatase signaling pathway that coordinately regulates the Cl- influx and efflux branches of the SLC12A cotransporter family.\n",
      "act(p(EGID:279561)) -> p(MGI:Slc12a4,pmod(P))\n",
      "act(p(EGID:279561)) -> p(MGI:Slc12a4,pmod(P))\n",
      "----------------------\n",
      "10005878 : The DYRK isoforms also phosphorylate human microtubule-associated protein tau at Thr(212) in vitro, a residue that is phosphorylated in foetal tau and hyperphosphorylated in filamentous tau from Alzheimer's-disease brain. Phosphorylation of Thr(212) primes tau for phosphorylation by GSK3 at Ser(208) in vitro, suggesting a more general role for DYRK isoforms in priming phosphorylation of GSK3 substrates.\n",
      "act(p(HGNC:DYRK1A)) -> p(HGNC:MAPT,pmod(P))\n",
      "act(p(HGNC:GSK3B)) -> p(HGNC:MAPT,pmod(P))\n",
      "----------------------\n",
      "10005880 : Recently, we identified a similar cohort of tyrosine phosphorylation sites for the epidermal growth factor receptor (EGFR) with a predominant phosphorylation of tyrosine residue Y657 and binding of Syp [Lehr, S. et al. (1999) Biochemistry 38, 151-159].\n",
      "act(p(HGNC:EGFR)) -> p(HGNC:GAB1,pmod(P))\n",
      "p(HGNC:GAB1,pmod(P)) -> complex(p(HGNC:GAB1),p(HGNC:SYP))\n",
      "act(p(HGNC:EGFR)) -> complex(p(HGNC:GAB1),p(HGNC:SYP))\n",
      "----------------------\n",
      "10005890 : STAM2 is downstream of the Jak family of kinases since coexpression of STAM2 with Jak1 or Jak2 but not an unrelated Tec family kinase, Etk, resulted in its tyrosine phosphorylation.\n",
      "act(p(HGNC:EPHA3)) -> p(HGNC:STAM2,pmod(P))\n",
      "act(p(HGNC:JAK1)) -> p(HGNC:STAM2,pmod(P))\n",
      "act(p(HGNC:JAK2)) -> p(HGNC:STAM2,pmod(P))\n",
      "----------------------\n",
      "10005894 : When combined with immunoprecipitation analysis, this assay showed that p94(fer) can lead to the tyrosine phosphorylation and activation of Stat3 but not of Stat1 or Stat2.\n",
      "act(p(HGNC:FER)) -> p(HGNC:STAT3,pmod(P))\n",
      "act(p(HGNC:FER)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10005896 : In this study, we show that both Gab1 and Gab2 are rapidly tyrosine phosphorylated after Flt3 ligand stimulation of Flt3 ligand-responsive cells.\n",
      "act(p(HGNC:FLT3)) -> p(HGNC:GAB1,pmod(P))\n",
      "act(p(HGNC:FLT3)) -> p(HGNC:GAB2,pmod(P))\n",
      "----------------------\n",
      "10001338 : Axin, a Wnt signal negative regulator, enhances glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of beta-catenin and stimulates the degradation of beta-catenin.\n",
      "act(p(HGNC:GSK3B)) -> p(HGNC:CTNNB1,pmod(P))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "act(p(HGNC:GSK3B)) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10005906 : Accordingly, pull down assays with human HepG2 cell lysates showed that IR-specific phosphorylation of wild-type hGab-1 strongly enhanced PI-3 kinase binding.\n",
      "act(p(HGNC:INSR)) -> p(HGNC:GAB1,pmod(P))\n",
      "p(HGNC:GAB1,pmod(P)) -> complex(p(HGNC:GAB1),p(HGNC:PIK3R1))\n",
      "act(p(HGNC:INSR)) -> complex(p(HGNC:GAB1),p(HGNC:PIK3R1))\n",
      "----------------------\n",
      "10005918 : In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail. We furthermore demonstrate that the adapter protein Grb2 is a specific binding partner for both phosphorylated Tyr-703 and phosphorylated Tyr-936,\n",
      "act(p(HGNC:KIT)) -> p(HGNC:KIT,pmod(P))\n",
      "act(p(HGNC:KIT)) -> p(HGNC:KIT,pmod(P))\n",
      "p(HGNC:KIT,pmod(P)) -> complex(p(HGNC:KIT),p(HGNC:GRB2))\n",
      "p(HGNC:KIT,pmod(P)) -> complex(p(HGNC:KIT),p(HGNC:GRB2))\n",
      "----------------------\n",
      "10005936 : In support of these data, we also show that MEK1 is highly phosphorylated in vivo on Ser 217/221 in MLK3-transformed fibroblasts\n",
      "act(p(HGNC:MAP3K11)) -> p(HGNC:MAP2K1,pmod(P))\n",
      "act(p(HGNC:MAP3K11)) -> p(HGNC:MAP2K1,pmod(P))\n",
      "----------------------\n",
      "10005946 : However, K8/19 tyrosine phosphorylation is independent of EGF signaling or ERK activation while inhibition of p38 kinase activity blocks pervanadate-induced K8/19 tyrosine phosphorylation\n",
      "act(p(HGNC:MAPK14)) -> p(HGNC:KRT19,pmod(P))\n",
      "act(p(HGNC:MAPK14)) -> p(HGNC:KRT8,pmod(P))\n",
      "----------------------\n",
      "10005952 : We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK.\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:MYC,pmod(P))\n",
      "act(p(HGNC:MAPK3)) -> p(HGNC:MYC,pmod(P))\n",
      "p(HGNC:MYC,pmod(P)) -| deg(p(HGNC:MYC))\n",
      "----------------------\n",
      "10005940 : Activation of SAPK by forced expression of DeltaMEKK1 increased overall ATF2 ubiquitination, presumably because of the enhanced dimerization of ATF2.\n",
      "act(p(HGNC:MAPK9)) -> p(HGNC:ATF2,pmod(U,K))\n",
      "act(p(HGNC:MAP3K1)) -> act(p(HGNC:MAPK9))\n",
      "----------------------\n",
      "10005986 : By using human components, we have evaluated how binding to the lipoyl domains of the dihydrolipoyl acetyltransferase (E2) produces the predominant changes in the rates of phosphorylation of the pyruvate dehydrogenase (E1) component by PDK2 and PDK3\n",
      "act(p(HGNC:PDK2)) -> p(HGNC:PDHA1,pmod(P))\n",
      "act(p(HGNC:PDK3)) -> p(HGNC:PDHA1,pmod(P))\n",
      "----------------------\n",
      "10003898 : Activation of protein kinase C-zeta (PKC-zeta) by insulin requires phosphatidylinositol (PI) 3-kinase-dependent increases in phosphatidylinositol-3,4,5-(PO(4))(3) (PIP(3)) and phosphorylation of activation loop and autophosphorylation sites\n",
      "act(p(HGNC:PDPK1)) -> p(HGNC:PRKCZ,pmod(P))\n",
      "act(p(HGNC:PRKCZ)) -> p(HGNC:PRKCZ,pmod(P))\n",
      "----------------------\n",
      "10006002 : The two members of the atypical protein kinase C (aPKC) subfamily of isozymes (zetaPKC and lambda/iotaPKC) are involved in the control of nuclear factor kappaB (NF-kappaB) through IKKbeta activation.\n",
      "act(p(HGNC:PRKCI)) -> p(HGNC:IKBKB,pmod(P))\n",
      "act(p(HGNC:PRKCZ)) -> p(HGNC:IKBKB,pmod(P))\n",
      "----------------------\n",
      "10006016 : treatment of the interphase cells with calyculin A revealed phosphorylation at all the three sites of desmin. We also found that an antibody, which specifically recognizes vimentin phosphorylated at Ser-71 by Rho kinase, became immunoreactive after calyculin A treatment.\n",
      "act(p(HGNC:ROCK1)) -> p(HGNC:DES,pmod(P))\n",
      "act(p(HGNC:ROCK1)) -> p(HGNC:DES,pmod(P))\n",
      "act(p(HGNC:ROCK1)) -> p(HGNC:DES,pmod(P))\n",
      "act(p(HGNC:ROCK1)) -> p(HGNC:VIM,pmod(P))\n",
      "----------------------\n",
      "10000878 : Rsk1 directly phosphorylated the pro-apoptotic protein Bad at the serine %residues that, when phosphorylated, abrogate Bad's pro-apoptotic function.\n",
      "act(p(HGNC:RPS6KA1)) -> p(HGNC:BAD,pmod(P))\n",
      "p(HGNC:BAD,pmod(P)) -| act(p(HGNC:BAD))\n",
      "act(p(HGNC:BAD)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:RPS6KA1)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10006036 : Coexpression of v-Src and Etk led to a transphosphorylation on tyrosine 566 of Etk and subsequent autophosphorylation. These events correlated with a substantial increase in the kinase activity of Etk.\n",
      "act(p(HGNC:SRC)) -> p(HGNC:BMX,pmod(P))\n",
      "p(HGNC:BMX,pmod(P)) -> act(p(HGNC:BMX))\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:BMX))\n",
      "----------------------\n",
      "10006044 : Inhibition of p72(Syk) by piceatannol resulted in partial or total inhibition of FcgammaRII phosphorylation, after immunological activation or addition of thrombin, respectively, suggesting that p72(Syk) participates in FcgammaRII phosphorylation.\n",
      "act(p(HGNC:SYK)) -> p(HGNC:FCGR2B,pmod(P))\n",
      "p(HGNC:FCGR2B,pmod(P)) -> act(p(HGNC:FCGR2B))\n",
      "act(p(HGNC:SYK)) -> act(p(HGNC:FCGR2B))\n",
      "----------------------\n",
      "10006046 : More recent studies have suggested that tyrosine kinase (syk)-mediated phosphorylation of shc is responsible for the ras-ERK cascade via the formation of shc-Grb2-Sos2 following stimulation with anti-IgE antibody, but not FMLP, in human basophils\n",
      "act(p(HGNC:SYK)) -> p(HGNC:SHC1,pmod(P))\n",
      "p(HGNC:SHC1,pmod(P)) -> act(p(HGNC:SHC1))\n",
      "act(p(HGNC:SYK)) -> act(p(HGNC:SHC1))\n",
      "----------------------\n",
      "10006048 : Inhibition of Syk activity by piceatannol prevents both in vitro and in vivo Vav tyrosine phosphorylation, its association with the regulatory subunit of phosphoinositide 3-kinase, and the nuclear modifications typically observed during granulocytic differentiation of this cell line.\n",
      "act(p(HGNC:SYK)) -> p(HGNC:VAV1,pmod(P))\n",
      "p(HGNC:VAV1,pmod(P)) -> act(p(HGNC:VAV1))\n",
      "act(p(HGNC:SYK)) -> act(p(HGNC:VAV1))\n",
      "----------------------\n",
      "10006052 : TGF-beta-mediated activation of TGF-beta type I receptor stimulates the phosphorylation of Smad2 and Smad3 and subsequent heteromeric complex formation with Smad4.\n",
      "act(p(HGNC:TGFBR1)) -> p(HGNC:SMAD2,pmod(P))\n",
      "act(p(HGNC:TGFBR1)) -> p(HGNC:SMAD3,pmod(P))\n",
      "----------------------\n",
      "10006058 : The autophosphorylation rate was dependent on Abl protein concentration consistent with an intermolecular reaction.\n",
      "act(p(MGI:Abl1)) -> p(MGI:Abl1,pmod(P))\n",
      "act(p(MGI:Abl1)) -> p(MGI:Abl1,pmod(P))\n",
      "----------------------\n",
      "10006062 : The result suggests that tolerance to kappa agonists includes phosphorylation of serine 369 within KOR by GRK3\n",
      "act(p(MGI:Adrbk2)) -> p(MGI:Oprk1,pmod(P))\n",
      "p(MGI:Oprk1,pmod(P)) -| act(p(MGI:Oprk1))\n",
      "act(p(MGI:Adrbk2)) -| act(p(MGI:Oprk1))\n",
      "----------------------\n",
      "10005396 : CDK2-cyclin A1/E1 and CDK1-cyclin B1 phosphorylate BARD1 on its NH(2) terminus in vivo and in vitro.\n",
      "act(p(MGI:Cdk2)) -> p(MGI:Bard1,pmod(P))\n",
      "complex(p(MGI:Ccna1),p(MGI:Cdk2)) -> act(p(MGI:Cdk2))\n",
      "complex(p(MGI:Ccnb1),p(MGI:Cdk2)) -> act(p(MGI:Cdk2))\n",
      "complex(p(MGI:Ccne1),p(MGI:Cdk2)) -> act(p(MGI:Cdk2))\n",
      "----------------------\n",
      "10006100 : Furthermore, Chk1 also phosphorylates Cdc25A on serine 123 which accelerates its degradation through the ubiquitin-proteasome pathway and arrests cells in late G2-phase after DNA damage.\n",
      "act(p(MGI:Chek1)) -> p(MGI:Cdc25c,pmod(P))\n",
      "p(MGI:Cdc25a,pmod(P)) -| act(p(MGI:Cdc25a))\n",
      "----------------------\n",
      "10006104 : Coexpression of catalytically inactive mutants of the catalytic subunit of protein kinase A/mitogen- and stress-activated kinase 1 or IKK1/IKK2, which phosphorylate RelA on serine 276 or serine 536, respectively, sharply inhibited RelA acetylation on lysine 310.\n",
      "act(p(MGI:Chuk)) -> p(MGI:Rela,pmod(P))\n",
      "act(p(MGI:Ikbkb)) -> p(MGI:Rela,pmod(P))\n",
      "p(MGI:Rela,pmod(P)) -| p(MGI:\"Rela\",pmod(A,K,310))\n",
      "p(MGI:Rela,pmod(P)) -| p(MGI:Rela,pmod(A,K,310))\n",
      "p(MGI:Rela,pmod(P)) -| p(MGI:Rela,pmod(A,K,310))\n",
      "----------------------\n",
      "10006118 : A search for SCAMP kinase activities has shown that SCAMPs 1 and 3, but not SCAMP2, are tyrosine phosphorylated in EGF-stimulated murine fibroblasts overexpressing the EGF receptor (EGFR).\n",
      "act(p(MGI:Egfr)) -> p(MGI:Scamp1,pmod(P))\n",
      "act(p(MGI:Egfr)) -> p(MGI:Scamp3,pmod(P))\n",
      "----------------------\n",
      "10006126 : This response centers on the phosphorylation state of eukaryotic initiation factor (eIF)-2 alpha, which is induced by kinases like protein kinase R-like ER kinase (PERK) and GCN2 to suppress translation and is later reversed so translation resumes.\n",
      "act(p(MGI:Eif2ak3)) -> p(MGI:Eif2s1,pmod(P))\n",
      "act(p(MGI:Eif2ak4)) -> p(MGI:Eif2s1,pmod(P))\n",
      "----------------------\n",
      "10006142 : We demonstrate that siRNA targeting ULK2 in mouse P19 cells results in elevated FGFR1 mediated FRS3 and SHP2 tyrosyl phosphorylation.\n",
      "act(p(MGI:Fgfr1)) -> p(MGI:Frs3,pmod(P))\n",
      "act(p(MGI:Fgfr1)) -> p(MGI:Ptpn11,pmod(P))\n",
      "----------------------\n",
      "10006152 : Employing fyn-deficient mouse embryonic fibroblast cells and tissues, we demonstrate that fyn is essential for phosphorylating PIKE-A and protects it from apoptotic cleavage. Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues.\n",
      "act(p(MGI:Fyn)) -> p(MGI:Agap2,pmod(P))\n",
      "act(p(MGI:Fyn)) -| deg(p(MGI:Agap2))\n",
      "----------------------\n",
      "10006156 : Further experiments with small interfering RNA revealed that Fyn phosphorylated Nrf 2Y568 leading to nuclear export and degradation of Nrf 2.\n",
      "act(p(MGI:Fyn)) -> p(MGI:Nfe2l2,pmod(P))\n",
      "p(MGI:Nfe2l2,pmod(P)) -> deg(p(MGI:Nfe2l2))\n",
      "p(MGI:Nfe2l2,pmod(P)) -> tloc(p(MGI:Nfe2l2))\n",
      "----------------------\n",
      "10006154 : Transient expression of mSKAP55R in COS cells demonstrated that tyrosine 260 was the predominant site of phosphorylation by FYN kinase. Furthermore, this phosphotyrosine was essential for coimmunoprecipitation of FYN with mSKAP55R\n",
      "act(p(MGI:Fyn)) -> p(MGI:Skap2,pmod(P))\n",
      "p(MGI:Skap2,pmod(P)) -> act(p(MGI:Skap2))\n",
      "act(p(MGI:Fyn)) -> act(p(MGI:Skap2))\n",
      "----------------------\n",
      "10006184 : Overexpression of wild-type IKK-i phosphorylated serine residues Ser32 and Ser36 of IkappaB-alpha (preferentially Ser36), and significantly stimulated NF-kappaB activation.\n",
      "act(p(MGI:Ikbke)) -> p(MGI:Nfkbia,pmod(P))\n",
      "act(p(MGI:Ikbke)) -> p(MGI:Nfkbia,pmod(P))\n",
      "----------------------\n",
      "10006186 : We demonstrate that IKKepsilon is activated by IFNbeta and that IKKepsilon directly phosphorylates signal transducer and activator of transcription 1 (STAT1), a component of ISGF3.\n",
      "act(p(MGI:Ikbke)) -> p(MGI:Stat1,pmod(P))\n",
      "p(MGI:Ifnb1) -> act(p(MGI:Ikbke))\n",
      "----------------------\n",
      "10006198 : IRAK-1 itself, an endogenous substrate with an apparent molecular weight of 24kDa (p24), and exogenous substrates like histone and myelin basic protein are phosphorylated by nuclear located IRAK-1.\n",
      "act(p(MGI:Irak1)) -> p(MGI:Irak1,pmod(P))\n",
      "act(p(MGI:Irak1)) -> p(MGI:Mbp,pmod(P))\n",
      "----------------------\n",
      "10006222 : Mitogen-activated protein (MAP) kinase is central to a signal transduction pathway that triggers cell proliferation or differentiation. Activation of the p42mapk isoform requires its phosphorylation at two residues, Thr 183 and Tyr 185, and this phosphorylation is catalysed by MAP kinase kinase (MAPKK).\n",
      "act(p(MGI:Map2k1)) -> p(MGI:Mapk1,pmod(P))\n",
      "act(p(MGI:Map2k1)) -> p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Mapk1,pmod(P)) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Mapk1,pmod(P)) -> act(p(MGI:Mapk1))\n",
      "----------------------\n",
      "10006232 : MLK3 appears to activate C/EBP-beta in response to IFN-gamma by a mechanism involving decreased phosphorylation of a specific phosphoacceptor residue, Ser(64), within the transactivation domain.\n",
      "act(p(MGI:Map3k11)) -| p(MGI:Cebpb,pmod(P))\n",
      "p(MGI:Cebpb,pmod(P)) -> act(p(MGI:Cebpb))\n",
      "act(p(MGI:Map3k11)) -> act(p(MGI:Cebpb))\n",
      "p(MGI:Ifng) -> act(p(MGI:Map3k11))\n",
      "----------------------\n",
      "10006254 : PDGF-BB induces phosphorylation of alphaB-crystallin via p38 MAP kinase during myocardial infarction\n",
      "act(p(MGI:Mapk14)) -> p(MGI:Cryab,pmod(P))\n",
      "p(MGI:Pdgfb) -> p(MGI:Cryab,pmod(P))\n",
      "p(MGI:Pdgfb) -> act(p(MGI:Mapk14))\n",
      "----------------------\n",
      "10006290 : The activation domain of Pax2 is phosphorylated by the c-Jun N-terminal kinase (JNK) to enhance Pax2-dependent transcription.\n",
      "act(p(MGI:Mapk8)) -> p(MGI:Pax2,pmod(P))\n",
      "act(p(MGI:Mapk9)) -> p(MGI:Pax2,pmod(P))\n",
      "p(MGI:Pax2,pmod(P)) -> act(p(MGI:Pax2))\n",
      "----------------------\n",
      "10006292 : JNK2-dependent phosphorylation of SR-A promotes uptake of lipids in macrophages, thereby regulating foam cell formation, a critical step in atherogenesis\n",
      "act(p(MGI:Mapk9)) -> p(MGI:Msr1,pmod(P))\n",
      "p(MGI:Msr1,pmod(P)) -> act(p(MGI:Msr1))\n",
      "act(p(MGI:Mapk9)) -> act(p(MGI:Msr1))\n",
      "----------------------\n",
      "10006314 : we demonstrated that the ShcY317F mutant exerts an inhibitory effect on TRK-T3 transforming activity.\n",
      "act(p(MGI:Ntrk1)) -> p(MGI:Frs2,pmod(P))\n",
      "act(p(MGI:Ntrk1)) -> p(MGI:Shc1,pmod(P))\n",
      "----------------------\n",
      "10006346 : Here we demonstrate that Ser311 accounts for zetaPKC phosphorylation of RelA and that this site is phosphorylated in vivo in response to TNF-alpha.\n",
      "act(p(MGI:Prkcz)) -> p(MGI:Rela,pmod(P))\n",
      "p(MGI:Tnf) -> p(MGI:Rela,pmod(P))\n",
      "----------------------\n",
      "10006356 : Only a few substrates have been identified for BRK/Sik, including the KH domain containing RNA-binding protein Sam68 and the novel adaptor protein BKS\n",
      "act(p(MGI:Ptk6)) -> p(MGI:Khdrbs1,pmod(P))\n",
      "act(p(MGI:Ptk6)) -> p(MGI:Stap2,pmod(P))\n",
      "----------------------\n",
      "10006380 : Further more, we show that histone H3 and HMG-14 phosphorylation is severely reduced or abolished in mice lacking MSK1 and MSK2\n",
      "act(p(MGI:Rps6ka4)) -> p(MGI:Hmgn1,pmod(P))\n",
      "act(p(MGI:Rps6ka5)) -> p(MGI:Hmgn1,pmod(P))\n",
      "----------------------\n",
      "10006386 : Activated SIK2 in turn stimulated the Ser 171 phosphorylation and cytoplasmic translocation of TORC2. Phosphorylated TORC2 was degraded by the 26S proteasome during re-feeding through an association with COP1, a substrate receptor for an E3 ligase complex that promoted TORC2 ubiquitination at Lys 628.\n",
      "act(p(MGI:Sik2)) -> p(MGI:Crtc2,pmod(P))\n",
      "p(MGI:Crtc2,pmod(P)) -> deg(p(MGI:Crtc2))\n",
      "----------------------\n",
      "10006108 : However, phosphorylation by src kinase decreased the affinity constant from approximately 260 nM to 4 microM. Interestingly, phosphorylation of E-cadherin by CK1 or CK2 prevented the inhibition of beta-catenin binding by src phosphorylation.\n",
      "act(p(MGI:Src)) -> p(MGI:Cdh1,pmod(P))\n",
      "p(MGI:Cdh1,pmod(P)) -| complex(p(MGI:Ctnnb1),p(MGI:Cdh1))\n",
      "----------------------\n",
      "10006396 : Northern blotting revealed the ubiquitous expression of mSRPK1 in all tissues examined and the tissue-specific expression of mSRPK2 in testis, lung, and brain. Both kinases phosphorylated SF2/ASF, a member of SR proteins in vitro and the phosphopeptide mappings were identical, indicating that these kinases phosphorylate the same site of SF2/ASF.\n",
      "act(p(MGI:Srpk1)) -> p(EGID:110809,pmod(P))\n",
      "act(p(MGI:Srpk2)) -> p(EGID:110809,pmod(P))\n",
      "----------------------\n",
      "10006400 : 3BP2 was predominantly phosphorylated on Tyr174, Tyr183, and Tyr446 when it was coexpressed with Syk.\n",
      "act(p(MGI:Syk)) -> p(MGI:Sh3bp2,pmod(P))\n",
      "act(p(MGI:Syk)) -> p(MGI:Sh3bp2,pmod(P))\n",
      "act(p(MGI:Syk)) -> p(MGI:Sh3bp2,pmod(P))\n",
      "----------------------\n",
      "10006412 : SSTK phosphorylated histones H1, H2A, H2AX, and H3 but not H2B or H4 or transition protein 1 in vitro.\n",
      "act(p(MGI:Tssk6)) -> p(MGI:H1f0,pmod(P))\n",
      "act(p(MGI:Tssk6)) -> p(MGI:H2afx,pmod(P))\n",
      "act(p(MGI:Tssk6)) -> p(MGI:H3f3a,pmod(P))\n",
      "act(p(MGI:Tssk6)) -> p(MGI:Hist3h2a,pmod(P))\n",
      "----------------------\n",
      "10006032 : Tyr131 phosphorylation is followed by a strong (about 25-fold) increase of the enzyme specific activity, whereas phosphorylation at Tyr132 leads to Grb2 recruitment. These differing effects are discussed on the light of the enzyme structure.\n",
      "p(HGNC:ACP1,pmod(P)) -> complex(p(HGNC:ACP1),p(HGNC:GRB2))\n",
      "p(HGNC:ACP1,pmod(P)) -> act(p(HGNC:ACP1))\n",
      "act(p(HGNC:SRC)) -> complex(p(HGNC:ACP1),p(HGNC:GRB2))\n",
      "----------------------\n",
      "10006600 : More recently, we discovered that PMCA is phosphorylated on tyrosine residues during thrombin-stimulated platelet aggregation and that this phosphorylation causes inhibition of PMCA activity.\n",
      "p(HGNC:ATP2B1,pmod(P)) -| act(p(HGNC:ATP2B1))\n",
      "p(HGNC:F2) -> p(HGNC:ATP2B1,pmod(P))\n",
      "----------------------\n",
      "10006672 : During treatment of NB-4 human cells with IFN-gamma, c-cbl protooncogene product is rapidly phosphorylated on tyrosine and provides a docking site for the src homology 2 domain of CrkL, which also undergoes IFN-gamma-dependent tyrosine phosphorylation.\n",
      "p(HGNC:CBL,pmod(P)) -> complex(p(HGNC:CBL),p(HGNC:CRKL))\n",
      "p(HGNC:IFNG) -> p(HGNC:CBL,pmod(P))\n",
      "p(HGNC:IFNG) -> p(HGNC:CRKL,pmod(P))\n",
      "----------------------\n",
      "10002192 : Whereas cdk4/cdk6 inhibition and Rb dephosphorylation are expected on p16Ink4a expression, we have also observed indirect cdk2 inhibition.\n",
      "p(HGNC:CDKN2A) -| p(HGNC:RB1,pmod(P))\n",
      "p(HGNC:CDKN2A) -| act(p(HGNC:CDK2))\n",
      "p(HGNC:CDKN2A) -| act(p(HGNC:CDK4))\n",
      "p(HGNC:CDKN2A) -| act(p(HGNC:CDK6))\n",
      "----------------------\n",
      "10001364 : We identified a human F-box/WD40 repeats protein (HOS), which is homologous to Slimb/h betaTrCP. Being a part of SCF complex with Skp1 and Cullin1, HOS specifically interacted with the phosphorylated IkappaB and beta-catenin, targeting these proteins for proteasome-dependent degradation in vivo.\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:FBXW11) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10006852 : Tyrosine phosphorylation of STAM2 is induced by growth factors such as epidermal growth factor and platelet-derived growth factor as well as by cytokines like IL-3.\n",
      "p(HGNC:EGF) -> p(HGNC:STAM2,pmod(P))\n",
      "p(HGNC:IL3) -| p(HGNC:STAM2,pmod(P))\n",
      "----------------------\n",
      "10006844 : epidermal growth factor (EGF) signaling via the Ras-Mek pathway causes the phosphorylation of TGIF at two Erk MAP kinase sites, leading to TGIF stabilization\n",
      "p(HGNC:EGF) -> p(HGNC:TGIF1,pmod(P))\n",
      "p(HGNC:TGIF1,pmod(P)) -> p(HGNC:TGIF1)\n",
      "p(HGNC:EGF) -| deg(p(HGNC:TGIF1))\n",
      "p(HGNC:EGF) -> p(HGNC:TGIF1)\n",
      "----------------------\n",
      "10006876 : Mutation to alanine of S383, F378 or W379, which virtually abolishes transcriptional activation by Elk-1, does not affect phosphorylation of any sites tested.\n",
      "p(HGNC:ELK1,sub(F,378,A)) -| act(p(HGNC:ELK1))\n",
      "p(HGNC:ELK1,sub(S,383,A)) -| act(p(HGNC:ELK1))\n",
      "p(HGNC:ELK1,sub(W,379,A)) -| act(p(HGNC:ELK1))\n",
      "----------------------\n",
      "10006894 : Here, we demonstrate that these transformation-competent neu mutants activate extracellular signal-regulated kinases and stimulate Ets-2-dependent transcription.\n",
      "p(HGNC:ERBB2,pmod(P)) -> act(p(HGNC:ETS2))\n",
      "p(HGNC:ERBB2,pmod(P)) -> act(p(HGNC:ETS2))\n",
      "p(HGNC:ERBB2,pmod(P)) -> act(p(HGNC:ETS2))\n",
      "p(HGNC:ERBB2,pmod(P)) -> act(p(HGNC:ETS2))\n",
      "----------------------\n",
      "10006960 : We found that both Tyr-627 and Tyr-659 of Gab1 were required for SHP2 binding to Gab1 and for ERK2 activation by EGF.\n",
      "p(HGNC:GAB1,pmod(P)) -> complex(p(HGNC:GAB1),p(HGNC:PTPN11))\n",
      "p(HGNC:GAB1,pmod(P)) -> act(p(HGNC:PTPN11))\n",
      "p(HGNC:GAB1,pmod(P)) -> complex(p(HGNC:GAB1),p(HGNC:PTPN11))\n",
      "p(HGNC:GAB1,pmod(P)) -> act(p(HGNC:PTPN11))\n",
      "----------------------\n",
      "10007008 : Acetylation also increases HNF-4 DNA binding activity and its affinity of interaction with CBP itself and is required for target gene activation.\n",
      "p(HGNC:HNF4A,pmod(A,K)) -> complex(p(HGNC:CREBBP),p(HGNC:HNF4A))\n",
      "p(HGNC:HNF4A,pmod(A,K)) -> act(p(HGNC:HNF4A))\n",
      "----------------------\n",
      "10007122 : PKC-theta acts directly or indirectly to stimulate phosphorylation of IKKbeta, leading to activation of this enzyme\n",
      "p(HGNC:IKBKB,pmod(P)) -> act(p(HGNC:IKBKB))\n",
      "p(HGNC:PRKCQ) -> p(HGNC:IKBKB,pmod(P))\n",
      "----------------------\n",
      "10007368 : CD45 selectively dephosphorylates the Src-family protein tyrosine kinase Lyn and inhibits its kinase activity.\n",
      "p(HGNC:LYN,pmod(P)) -> act(p(HGNC:LYN))\n",
      "act(p(HGNC:PTPRC)) -| p(HGNC:LYN,pmod(P))\n",
      "act(p(HGNC:PTPRC)) -| act(p(HGNC:LYN))\n",
      "----------------------\n",
      "10005950 : ASK1/p38 silences the Fas promoter by inhibition of IkappaBalpha phosphorylation - thereby limiting NF-kappaB activity.\n",
      "p(HGNC:MAPK14) -| p(HGNC:NFKBIA,pmod(P))\n",
      "act(p(HGNC:MAPK14)) -| r(HGNC:FAS)\n",
      "----------------------\n",
      "10007384 : These results indicate that CD146 is coupled to a FYN-dependent pathway that triggers Ca(2+) flux via phospholipase C-gamma activation leading subsequently to the tyrosine phosphorylation of downstream targets such as Pyk2, p130(Cas), FAK, and paxillin.\n",
      "p(HGNC:MCAM) -> p(HGNC:PTK2,pmod(P))\n",
      "p(HGNC:MCAM) -> p(HGNC:PXN,pmod(P))\n",
      "----------------------\n",
      "10004484 : GEF activity of Ras-GRF1 toward Ha-Ras, as defined by in vitro GDP binding and release assays, was augmented after tyrosine phosphorylation by ACK1.\n",
      "p(HGNC:RASGRF1,pmod(P)) -> act(p(HGNC:HRAS))\n",
      "act(p(HGNC:RASGRF1)) -> act(p(HGNC:HRAS))\n",
      "----------------------\n",
      "10004486 : Ras-GRF1 acts as a GEF for Rac when tyrosine-phosphorylated following G protein-coupled receptor stimulation.\n",
      "p(HGNC:RASGRF1,pmod(P)) -> act(p(HGNC:RAC1))\n",
      "act(p(HGNC:RASGRF1)) -> act(p(HGNC:RAC1))\n",
      "----------------------\n",
      "10007542 : Rem interacts with a series of 14-3-3 isoforms (epsilon, eta, theta, and zeta). Rem is phosphorylated in vivo, and binding of Rem to 14-3-3zeta is abolished by pretreating Rem with protein phosphatase 1. Thus, the association of Rem and 14-3-3zeta is phosphorylation-dependent.\n",
      "p(HGNC:REM1,pmod(P)) -> complex(p(HGNC:REM1),p(HGNC:YWHAE))\n",
      "p(HGNC:REM1,pmod(P)) -> complex(p(HGNC:REM1),p(HGNC:YWHAH))\n",
      "p(HGNC:REM1,pmod(P)) -> complex(p(HGNC:REM1),p(HGNC:YWHAQ))\n",
      "p(HGNC:REM1,pmod(P)) -> complex(p(HGNC:REM1),p(HGNC:YWHAZ))\n",
      "----------------------\n",
      "10007596 : Inhibition of SHP2 activation leads to increased SOCS3-mRNA levels, whereas increased expression of SOCS3 results in a reduction of SHP2 phosphorylation after activation of the interleukin-6 signal transduction pathway.\n",
      "p(HGNC:SOCS3) -| p(HGNC:PTPN11,pmod(P))\n",
      "act(p(HGNC:PTPN11)) -| r(HGNC:SOCS3)\n",
      "----------------------\n",
      "10005366 : Introduction of an additional mutation (Y694F) to STAT5A-N642H, which disrupted critical tyrosine 694 required for dimerization of STAT5, abolished all the activities manifested by the mutant STAT5A-N642H, which indicates that dimerization is required for the activity of STAT5A-N642H as was the case for the wild-type STAT5A. T\n",
      "p(HGNC:STAT5A,pmod(P)) -> complex(p(HGNC:STAT5A),p(HGNC:STAT5A))\n",
      "complex(p(HGNC:STAT5A),p(HGNC:STAT5A)) -> act(p(HGNC:STAT5A))\n",
      "----------------------\n",
      "10007630 : its immunoreactivity with RS-11 is up-regulated by malignant transformation or stimulation with either epidermal growth factor or transforming growth factor alpha.\n",
      "p(HGNC:TGFA) -> p(HGNC:KRT18,pmod(P))\n",
      "p(HGNC:TGFA) -> p(HGNC:KRT8,pmod(P))\n",
      "----------------------\n",
      "10007686 : These findings indicate that TNF-induced MT stabilization is mediated by hyperphosphorylation of Op18 and that this promotes cell death.\n",
      "p(HGNC:TNF) -> p(HGNC:STMN1,pmod(P))\n",
      "p(HGNC:TNF) -> p(HGNC:STMN1,pmod(P))\n",
      "p(HGNC:TNF) -> p(HGNC:STMN1,pmod(P))\n",
      "p(HGNC:TNF) -> p(HGNC:STMN1,pmod(P))\n",
      "----------------------\n",
      "10005962 : Forced expression of MKP5, a JNK phosphatase, in JNK kinase-expressing cells decreased T81 phosphorylation while reducing p53 transcriptional activity and p53-mediated apoptosis.\n",
      "p(HGNC:TP53,pmod(P)) -> act(p(HGNC:TP53))\n",
      "act(p(HGNC:MAPK8)) -> act(p(HGNC:TP53))\n",
      "act(p(HGNC:DUSP10)) -| act(p(HGNC:MAPK8))\n",
      "----------------------\n",
      "10007794 : Furthermore, the hCdc14 phosphatases were found to dephosphorylate p53 specifically at the p34(Cdc2)/clb phosphorylation site (p53-phosphor-Ser(315)).\n",
      "act(p(HGNC:CDC14A)) -| p(HGNC:TP53,pmod(P))\n",
      "act(p(HGNC:CDC14B)) -| p(HGNC:TP53,pmod(P))\n",
      "----------------------\n",
      "10007826 : Here we show that Forkhead transcription factors FKHRL1 and FKHR, substrates of the Akt kinase, are aberrantly localized to the cytoplasm and cannot activate transcription in PTEN-deficient cells. Restoration of PTEN function restores FKHR to the nucleus and restores transcriptional activation.\n",
      "act(p(HGNC:PTEN)) -| p(HGNC:FOXO1,pmod(P))\n",
      "act(p(HGNC:PTEN)) -| p(HGNC:FOXO3,pmod(P))\n",
      "act(p(HGNC:PTEN)) -> act(p(HGNC:FOXO1))\n",
      "act(p(HGNC:PTEN)) -> act(p(HGNC:FOXO3))\n",
      "----------------------\n",
      "10007824 : The latter was accompanied by a decrease in the phosphorylation of insulin receptor substrate 1 (IRS-1) and the association of IRS-1 with Grb2/Sos\n",
      "act(p(HGNC:PTEN)) -| p(HGNC:IRS1,pmod(P))\n",
      "act(p(HGNC:PTEN)) -| complex(p(HGNC:IRS1),p(HGNC:GRB2))\n",
      "----------------------\n",
      "10001008 : Consistently, substrate-trapping experiments with a SHP2 catalytic inactive mutant suggested that Gab1 was a SHP2 PTPase substrate in the cells. Therefore, Gab1 not only is a SHP2 activator but also is a target of its PTPase.\n",
      "act(p(HGNC:PTPN11)) -| p(HGNC:GAB1,pmod(P))\n",
      "act(p(HGNC:GAB1)) -> act(p(HGNC:PTPN11))\n",
      "----------------------\n",
      "10007508 : Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta\n",
      "act(p(HGNC:PTPRB)) -| p(HGNC:CTNNB1,pmod(P))\n",
      "act(p(HGNC:PTPRZ1)) -| p(HGNC:CTNNB1,pmod(P))\n",
      "p(HGNC:PTN) -| act(p(HGNC:PTPRB))\n",
      "p(HGNC:PTN) -| act(p(HGNC:PTPRZ1))\n",
      "----------------------\n",
      "10007838 : The specific effect of LAR on FGF-induced MAPK activation appeared to be mediated by specific inhibition of the phosphorylation of two signal transducers that act downstream of the FGF receptor, FRS2 and a 180 kDa protein, and by prevention of their interaction with the adaptor protein GRB2.\n",
      "act(p(HGNC:PTPRF)) -| p(HGNC:FRS2,pmod(P))\n",
      "act(p(HGNC:PTPRF)) -| complex(p(HGNC:FRS2),p(HGNC:GRB2))\n",
      "----------------------\n",
      "10007854 : GADD34 was recently identified as the factor that activates the type 1 protein serine/threonine phosphatase (PP1), which dephosphorylates eIF-2 alpha during cellular stresses.\n",
      "act(p(MGI:Ppp1cc)) -| p(MGI:Eif2s1,pmod(P))\n",
      "p(MGI:Ppp1r15a) -> act(p(MGI:Ppp1cc))\n",
      "p(MGI:Ppp1r15a) -> p(MGI:Ppp1cc)\n",
      "----------------------\n",
      "10007862 : SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei\n",
      "act(p(MGI:Ptpn11)) -| p(MGI:Stat1,pmod(P))\n",
      "act(p(MGI:Ptpn11)) -| p(MGI:Stat1,pmod(P))\n",
      "----------------------\n",
      "10007866 : Protein tyrosine phosphatase alpha (PTPalpha) is believed to dephosphorylate physiologically the Src proto-oncogene at phosphotyrosine (pTyr)527, a critical negative-regulatory residue. It thereby activates Src\n",
      "act(p(MGI:Ptpra)) -| p(MGI:Src,pmod(P))\n",
      "p(MGI:Src,pmod(P)) -| act(p(MGI:Src))\n",
      "act(p(MGI:Ptpra)) -> act(p(MGI:Src))\n",
      "----------------------\n",
      "10007882 : We further demonstrate that phosphorylation of Lin-11, Isl-1, Mec-3 (LIM) kinase and cofilin is promoted by treating macrophages with alpha2M*.\n",
      "p(MGI:A2m) -> p(MGI:Cd2bp2,pmod(P))\n",
      "p(MGI:A2m) -> p(MGI:Cfl1,pmod(P))\n",
      "p(MGI:A2m) -> p(MGI:Isl1,pmod(P))\n",
      "p(MGI:A2m) -> p(MGI:Limk1,pmod(P))\n",
      "----------------------\n",
      "10005098 : SIRT1 expression also led to a pronounced increase in AceCS1-dependent fatty-acid synthesis from acetate.\n",
      "p(MGI:Acss2,pmod(A,K,661)) -| act(p(MGI:Acss2))\n",
      "act(p(MGI:Sirt1)) -> act(p(MGI:Acss2))\n",
      "----------------------\n",
      "10008056 : In the absence of Cdc42, degradation of beta-catenin was increased corresponding to a decreased phosphorylation of GSK3beta at Ser 9 and an increased phosphorylation of axin, which is known to be required for binding of beta-catenin to the degradation machinery\n",
      "p(MGI:Axin1,pmod(P)) -> deg(p(MGI:Ctnnb1))\n",
      "p(MGI:Cdc42) -| p(MGI:Axin1,pmod(P))\n",
      "p(MGI:Cdc42) -> p(MGI:Gsk3b,pmod(P))\n",
      "p(MGI:Cdc42) -| deg(p(MGI:Ctnnb1))\n",
      "----------------------\n",
      "10008080 : We have previously shown that B cell lymphoma/leukemia-2 (bcl-2) -/- mice develop cystic kidneys and exhibit sustained phosphorylation of FAK and paxillin.\n",
      "p(MGI:Bcl2) -| p(MGI:Ptk2,pmod(P))\n",
      "p(MGI:Bcl2) -| p(MGI:Pxn,pmod(P))\n",
      "----------------------\n",
      "10005420 : formation of the hCAF-1/BTG1 complex is driven by phosphorylation at BTG1 (Ser-159) and implicates this complex in the signalling events of cell division that lead to changes in cellular proliferation associated with cell-cell contact.\n",
      "p(MGI:Btg1,pmod(P)) -> complex(p(MGI:Cnot7),p(MGI:Btg1))\n",
      "complex(p(MGI:Cnot7),p(MGI:Btg1)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10008446 : This phosphorylation creates a priming site for glycogen synthase kinase 3beta (GSK3beta) and is both necessary and sufficient to initiate the beta-catenin phosphorylation-degradation cascade\n",
      "p(MGI:Ctnnb1,pmod(P)) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Ctnnb1,pmod(P)) -> deg(p(MGI:Ctnnb1))\n",
      "p(MGI:Ctnnb1,pmod(P)) -| p(MGI:Ctnnb1)\n",
      "p(MGI:Ctnnb1,pmod(P)) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "----------------------\n",
      "10008448 : We have previously reported that beta-catenin forms a complex with c-Met (HGF receptor) that undergoes dissociation because of beta-catenin tyrosine phosphorylation on stimulation by HGF.\n",
      "p(MGI:Ctnnb1,pmod(P)) -| complex(p(MGI:Met),p(MGI:Ctnnb1))\n",
      "p(MGI:Hgf) -> p(MGI:Ctnnb1,pmod(P))\n",
      "p(MGI:Hgf) -| complex(p(MGI:Met),p(MGI:Ctnnb1))\n",
      "----------------------\n",
      "10008564 : Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes.\n",
      "p(MGI:Efna1) -> p(MGI:Epha2,pmod(P))\n",
      "p(MGI:Ngef) -| act(p(MGI:Cdc42))\n",
      "p(MGI:Ngef) -| act(p(MGI:Rac1))\n",
      "p(MGI:Ngef) -> act(p(MGI:Rhoa))\n",
      "----------------------\n",
      "10003864 : Similarly, EGF but not IL-4 strongly activated phosphorylation of p42/p44 extracellular regulated kinase isoforms, a reaction blocked by the mitogen-activated protein kinase (MAPK) inhibitor, PD98059.\n",
      "p(MGI:Egf) -> p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Egf) -> p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10008592 : Phosphorylation of eIF2alpha in mouse embryo fibroblast (MEF) cells subjected to proteasome inhibition leads to a significant reduction in protein synthesis, concomitant with induced expression of the bZIP transcription regulator, ATF4, and its target gene CHOP/GADD153\n",
      "p(MGI:Eif2s1,pmod(P)) -| bp(GOBP:\"protein metabolic process\")\n",
      "p(MGI:Eif2s1,pmod(P)) -> r(MGI:Atf4)\n",
      "act(p(MGI:Atf4)) -> r(MGI:Ddit3)\n",
      "----------------------\n",
      "10008622 : The present study demonstrates that erythropoietin (Epo) and IL-3 induce tyrosine phosphorylation of the SH2/SH3-containing adapter protein CrkL and its transient association with tyrosine-phosphorylated SHP-2, Shc, and Cbl in a murine IL-3-dependent cell line, 32D, expressing the Epo receptor (EpoR).\n",
      "p(MGI:Epo) -> p(MGI:Crkl,pmod(P))\n",
      "p(MGI:Il3) -> p(MGI:Crkl,pmod(P))\n",
      "----------------------\n",
      "10008794 : We show that Gadd45a not only directly associates with two components of the APC complex, namely protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta) but also promotes GSK3beta dephosphorylation at Ser9, which is essential for GSK3beta activation, and resultant activation of the APC destruction complex.\n",
      "p(MGI:Gadd45a) -| p(MGI:Gsk3b,pmod(P))\n",
      "p(MGI:Gsk3b,pmod(P)) -| act(p(MGI:Gsk3b))\n",
      "p(MGI:Gadd45a) -> act(p(MGI:Gsk3b))\n",
      "----------------------\n",
      "10008796 : Phosphorylation of GATA-1 increases GATA-1-mediated transcription of the E4bp4 survival gene without significantly changing the DNA-binding affinity of GATA-1.\n",
      "p(MGI:Gata1,pmod(P)) -> r(MGI:Nfil3)\n",
      "p(MGI:Gata1,pmod(P)) -> act(p(MGI:Gata1))\n",
      "act(p(MGI:Gata1)) -> r(MGI:Nfil3)\n",
      "----------------------\n",
      "10003974 : endogenous GMF is rapidly phosphorylated upon stimulation of astrocytes by phorbol 12-myristate 13-acetate We further observed that protein kinase A (PKA)-phosphorylated GMF is a potent inhibitor (IC50 = 3 nM) of the ERK1/ERK2 (p44/p42) subfamily of mitogen-activated protein (MAP) kinase.\n",
      "p(MGI:Gmfb,pmod(P)) -| act(p(MGI:Mapk1))\n",
      "p(MGI:Gmfb,pmod(P)) -| act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10008872 : PGI-overexpressing cells also exhibited elevated expression of Skp2 involved in p27Kip1 ubiquitination and elevation in the levels of retinoblastoma protein hyperphosphorylation.\n",
      "p(MGI:Gpi1) -> p(MGI:Rb1,pmod(P))\n",
      "p(MGI:Gpi1) -> p(MGI:Skp2)\n",
      "----------------------\n",
      "10009006 : Germline expression of the endogenous H-RasG12V oncogene, even in homozygosis, resulted in hyperplasia of the mammary gland.\n",
      "p(MGI:Hras,sub(G,12,V)) -> act(p(MGI:Hras))\n",
      "p(MGI:Hras,sub(G,12,V)) -> path(MESHD:Hyperplasia)\n",
      "----------------------\n",
      "10009184 : Overexpression of mSef in NIH3T3 cells results in a decrease in FGF-induced cell proliferation associated with a decrease in Tyr phosphorylation of FGFR1 and FRS2. As a consequence, there is a reduction in the phosphorylation of Raf-1 at Ser(338), MEK1/2 at Ser(217) and Ser(221), and ERK1/2 at Thr(202) and Tyr(204).\n",
      "p(MGI:Il17rd) -| p(MGI:Fgfr1,pmod(P))\n",
      "p(MGI:Il17rd) -| p(MGI:Frs2,pmod(P))\n",
      "p(MGI:Il17rd) -| p(MGI:Map2k1,pmod(P))\n",
      "p(MGI:Il17rd) -| p(MGI:Map2k1,pmod(P))\n",
      "----------------------\n",
      "10009192 : Importantly, endogenous mPLK/IRAK was activated in response to TNF-alpha or interleukin 1 treatment of primary adipose cells.\n",
      "p(MGI:Il1b) -> p(MGI:Irs1,pmod(P))\n",
      "p(MGI:Tnf) -> p(MGI:Irs1,pmod(P))\n",
      "p(MGI:Il1a) -> act(p(MGI:Irak1))\n",
      "----------------------\n",
      "10009356 : However, IRS-3- or IRS-4-expressing cells also showed a marked decrease in IRS-1 and IRS-2 phosphorylation compared to the host cells.\n",
      "p(MGI:Irs3) -| p(MGI:Irs1,pmod(P))\n",
      "p(MGI:Irs3) -| p(MGI:Irs2,pmod(P))\n",
      "p(MGI:Irs4) -| p(MGI:Irs1,pmod(P))\n",
      "p(MGI:Irs4) -| p(MGI:Irs2,pmod(P))\n",
      "----------------------\n",
      "10006354 : The phosphorylation of SLM-1 and SLM-2 has functional relevance and leads to inhibition of their RNA-binding abilities\n",
      "p(MGI:Khdrbs2,pmod(P)) -| act(p(MGI:Khdrbs2))\n",
      "p(MGI:Khdrbs3,pmod(P)) -| act(p(MGI:Khdrbs3))\n",
      "act(p(MGI:Ptk6)) -| act(p(MGI:Khdrbs2))\n",
      "act(p(MGI:Ptk6)) -| act(p(MGI:Khdrbs3))\n",
      "----------------------\n",
      "10005810 : Our results suggest that shear stress activates AMPK in ECs, which contributes to elevated eNOS activity\n",
      "p(MGI:Nos3,pmod(P)) -> act(p(MGI:Nos3))\n",
      "p(MGI:Prkaa1,pmod(P)) -> act(p(MGI:Nos3))\n",
      "----------------------\n",
      "10005732 : the expression of the pfkfb3 gene in C2C12 cells and its downregulation during myogenic cell differentiation. We also show that the decrease of ubiquitous 6-phosphofructo-2-kinase isozyme levels, product of pfkfb3 gene, is due to its enhanced degradation through the ubiquitin-proteasome proteolytic pathway.\n",
      "p(MGI:Pfkfb3,pmod(U)) -> deg(p(MGI:Pfkfb3))\n",
      "p(MGI:Pfkfb3,pmod(U)) -| r(MGI:Pfkfb3)\n",
      "deg(p(MGI:Pfkfb3)) -| p(MGI:Pfkfb3)\n",
      "----------------------\n",
      "10004174 : The elongating hyperphosphorylated Rpb1 is subject to ubiquitination, particularly in response to UV radiation and DNA-damaging agents.\n",
      "p(MGI:Polr2a,pmod(P)) -> deg(p(MGI:Polr2a))\n",
      "bp(GOBP:\"response to UV\") -> deg(p(MGI:Polr2a))\n",
      "----------------------\n",
      "10006090 : All these findings strongly suggest that Cdk5-mediated phosphorylation of PPARgamma may be involved in the pathogenesis of insulin-resistance\n",
      "p(MGI:Pparg,pmod(P)) -> path(MESHD:\"Insulin Resistance\")\n",
      "act(p(MGI:Cdk5)) -> path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10009942 : In SHP-2-/- mouse fibroblast cells, Stat1 phosphorylation at both the tyrosine residue Tyr(701) and the serine residue Ser(727) by IFNgamma was enhanced and prolonged.\n",
      "p(MGI:Ptpn11) -| p(MGI:Stat1,pmod(P))\n",
      "p(MGI:Ptpn11) -| p(MGI:Stat1,pmod(P))\n",
      "----------------------\n",
      "10009950 : pTyr789 in PTPalpha is constitutively phosphorylated and binds Grb2, an interaction that may inhibit PTPalpha activity. We show here that this phosphorylation also specifically enables PTPalpha to dephosphorylate pTyr527\n",
      "p(MGI:Ptpra,pmod(P)) -> complex(p(MGI:Ptpra),p(MGI:Grb2))\n",
      "p(MGI:Ptpra,pmod(P)) -> act(p(MGI:Ptpra))\n",
      "----------------------\n",
      "10009956 : Tyr31/118-phosphorylated paxillin serves as a template for the localized suppression of RhoA activity\n",
      "p(MGI:Pxn,pmod(P)) -| act(p(MGI:Rhoa))\n",
      "p(MGI:Pxn,pmod(P)) -| act(p(MGI:Rhoa))\n",
      "----------------------\n",
      "10009992 : Also, an inactivating mutation of that residue severely impairs RelA transcriptional activity, blocks its anti-apoptotic function and abrogates the interaction of RelA with the co-activator CBP as well as its recruitment, and that of RNA polymerase II (Pol II) with the interleukin-6 (IL-6) promoter.\n",
      "p(MGI:Rela,pmod(P)) -> complex(p(MGI:Crebbp),p(MGI:Rela))\n",
      "p(MGI:Rela,pmod(P)) -> act(p(MGI:Rela))\n",
      "----------------------\n",
      "10010224 : Next, they bind to the adaptor protein Grb2 and inhibit the recruitment of the Grb2-Sos complex either to the fibroblast growth factor receptor (FGFR) docking adaptor protein FRS2 or to Shp2. Membrane translocation of Spry is necessary for its phosphorylation, which is essential for its inhibitor activity.\n",
      "p(MGI:Spry1,pmod(P)) -| act(p(MGI:Sos1))\n",
      "p(MGI:Spry2,pmod(P)) -| act(p(MGI:Sos1))\n",
      "----------------------\n",
      "10006398 : The reintroduction of wild-type LKB1 into a cancer cell line that lacks LKB1 suppressed growth, but mutants of LKB1 in which Ser(431) was mutated to Ala to prevent phosphorylation of LKB1 were ineffective in inhibiting growth.\n",
      "p(MGI:Stk11,pmod(P)) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Stk11,pmod(P)) -> act(p(MGI:Stk11))\n",
      "act(p(MGI:Stk11)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10010312 : Using a doxycycline-regulatable transgenic mouse model of lung-specific TGF-alpha expression, we observed increased PCNA protein and phosphorylation of Akt and p70S6K in whole lung homogenates in association with induction of TGF-alpha. Induction in the lung of TGF-alpha caused progressive pulmonary fibrosis over a 7-week period.\n",
      "p(MGI:Tgfa) -> p(MGI:Rps6kb1,pmod(P))\n",
      "p(MGI:Tgfa) -> p(MGI:Pcna)\n",
      "----------------------\n",
      "10010376 : This finding suggests that TGF-beta3 is required for inhibiting MEE proliferation during palatal fusion. The inhibition of MEE proliferation may be mediated by TGF-beta3-dependent phosphorylation of SMAD2\n",
      "p(MGI:Tgfb3) -> p(MGI:Smad2,pmod(P))\n",
      "p(MGI:Tgfb3) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10010448 : TNFalpha, but not IGF-I, induced tissue inhibitor of metalloproteinase-1 (TIMP-1) expression and reduced matrix metalloproteinases-2 activity and collagen degradation. TNFalpha also activated ERK1/2.\n",
      "p(MGI:Tnf) -> p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Tnf) -| act(p(MGI:Mmp2))\n",
      "p(MGI:Tnf) -> r(MGI:Timp1)\n",
      "----------------------\n",
      "10010470 : Our results also demonstrate that TNFalpha-induced acetylation of p53 attenuated its transcriptional activation via CBP depletion.\n",
      "p(MGI:Tnf) -> p(MGI:Trp53,pmod(A))\n",
      "p(MGI:Trp53,pmod(A)) -| act(p(MGI:Trp53))\n",
      "----------------------\n",
      "10010576 : In addition, reduced expression of ERp46 by siRNA increased the expression of CHOP and peIF2a, indicating development of ER stress.\n",
      "p(MGI:Txndc5) -| p(MGI:Eif2s1,pmod(P))\n",
      "p(MGI:Txndc5) -| p(MGI:Ddit3)\n",
      "----------------------\n",
      "10004190 : Here we show that after stimulation by growth factors Spry1 and Spry2 translocate to the plasma membrane and become phosphorylated on a conserved tyrosine.\n",
      "tloc(p(MGI:Spry1)) -> p(MGI:Spry1,pmod(P))\n",
      "tloc(p(MGI:Spry1)) -> p(MGI:Spry1,pmod(P))\n",
      "----------------------\n",
      "10003264 : BH4 is a cofactor for three pteridine-requiring monooxygenases that hydroxylate aromatic L-amino acids, i.e., tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and phenylalanine hydroxylase (PAH), as well as for nitric oxide synthase (NOS)\n",
      "a(CHEBI:\"5,6,7,8-tetrahydrobiopterin\") -> act(p(MGI:Nos1))\n",
      "a(CHEBI:\"5,6,7,8-tetrahydrobiopterin\") -> act(p(MGI:Th))\n",
      "a(CHEBI:\"5,6,7,8-tetrahydrobiopterin\") -> act(p(MGI:Tph1))\n",
      "----------------------\n",
      "10015394 : Figure 6. MMP-2 and MMP-9 activity were increased in the lungs of wild-type, but not Cd8(?/?) mice, exposed to acrolein (by gelatin zymography)\n",
      "a(CHEBI:acrolein) -| act(p(MGI:Mmp2))\n",
      "a(CHEBI:acrolein) -| act(p(MGI:Mmp9))\n",
      "----------------------\n",
      "10015396 : our present study also showed that acrolein increased MMP-9 production with an increased MMP-9 activity in murine macrophages in a concentration- and timedependent manners (Figs. 1C and D).\n",
      "a(CHEBI:acrolein) -> act(p(MGI:Mmp9))\n",
      "a(CHEBI:acrolein) -> p(MGI:Mmp9)\n",
      "----------------------\n",
      "10015398 : Upon exposure of J774A.1 cells to acrolein, EGFR phosphorylation increased significantly within minutes, and further increased up to 10 min (Fig. 6A), confirming a direct effect of acrolein on the activation of the EGFR pathway.\n",
      "a(CHEBI:acrolein) -> act(p(MGI:Egfr))\n",
      "a(CHEBI:acrolein) -> act(p(HGNC:EGFR))\n",
      "----------------------\n",
      "10015430 : Angiotensin II induces the tyrosine and serine phosphorylation of Stat1 and Stat3. Under High Glucose condition both the extent and the duration of phosphorylation of Stat1 and Stat3 was increased.\n",
      "a(CHEBI:\"angiotensin II\") -> p(HGNC:STAT1,pmod(P))\n",
      "a(CHEBI:\"angiotensin II\") -> p(HGNC:STAT1,pmod(P))\n",
      "a(CHEBI:\"angiotensin II\") -> p(HGNC:STAT3,pmod(P))\n",
      "a(CHEBI:\"angiotensin II\") -> p(HGNC:STAT3,pmod(P))\n",
      "----------------------\n",
      "10015436 : Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97\n",
      "a(CHEBI:\"angiotensin II\") -> p(MGI:Cdkn1a)\n",
      "a(CHEBI:\"angiotensin II\") -> p(MGI:Trp53)\n",
      "----------------------\n",
      "10015456 : As shown in Fig. 6A, we found that AA and EPA, from 1 to 250 microM, mildly induced TR4-mediated and PPARgamma/RXR-mediated CD36 expression.\n",
      "a(CHEBI:\"arachidonic acid\") -> p(MGI:Cd36)\n",
      "a(CHEBI:\"icosapentaenoic acid\") -> p(MGI:Cd36)\n",
      "----------------------\n",
      "10003288 : Brain endothelial cells were protected against hypoxia and H(2)O(2) by the lipoxygenase inhibitor baicalein. After focal ischemia, 12/15-LOX was increased in neurons and endothelial cells. The vascular tight junction protein claudin-5 underwent extensive degradation in the peri-infarct area, which was partially prevented by the lipoxygenase inhibitor baicalein.\n",
      "a(CHEBI:baicalein) -| p(MGI:Cldn5)\n",
      "path(MESHD:Ischemia) -> p(MGI:Alox12)\n",
      "----------------------\n",
      "10003292 : We have shown that bezafibrate and clofibric acid, known hypolipidemic agents, are potent inhibitors of PE methylation\n",
      "a(CHEBI:bezafibrate) -| act(p(MGI:Pemt))\n",
      "a(CHEBI:clofibrate) -| act(p(MGI:Pemt))\n",
      "----------------------\n",
      "10015474 : Mice were sacrificed 12 h after fasting, and the livers were removed for Northern blot analysis. Bile acid homeostasis is tightly controlled by the feedback mechanism in which an atypical orphan nuclear receptor (NR) small heterodimer partner (SHP) inactivates several NRs such as liver receptor homologue-1 and hepatocyte nuclear factor 4.\n",
      "a(CHEBI:\"bile salt\") -> act(p(MGI:Nr0b2))\n",
      "act(p(MGI:Nr0b2)) -| act(p(MGI:Hnf4a))\n",
      "act(p(MGI:Nr0b2)) -| act(p(MGI:Nr5a2))\n",
      "----------------------\n",
      "10003300 : The concentrations of IL-8, G-CSF, monocyte chemoattractant protein-1, GM-CSF, and TGF-beta in the supernatant fluids significantly increased in response to bleomycin.\n",
      "a(CHEBI:bleomycin) -> p(HGNC:CCL2)\n",
      "a(CHEBI:bleomycin) -> p(HGNC:CSF3)\n",
      "a(CHEBI:bleomycin) -> p(HGNC:TGFB1)\n",
      "----------------------\n",
      "10015486 : The former studies demonstrate that TGF-1 and bleomycin are potent stimulators of the propeptide and mature forms of MMP-12 (Fig. 10,Aand B).\n",
      "a(CHEBI:bleomycin) -> p(MGI:Mmp12)\n",
      "p(MGI:Tgfb1) -> p(MGI:Mmp12)\n",
      "p(HGNC:TGFB1) -> p(HGNC:MMP12)\n",
      "----------------------\n",
      "10003304 : When cells were treated with brefeldin A (BFA) or nocodazole, drugs that promote Golgi disorganization, we observed STK16 translocation to the nuclear compartment.\n",
      "a(CHEBI:\"brefeldin A\") -> tloc(p(MGI:Stk16))\n",
      "a(CHEBI:nocodazole) -> tloc(p(MGI:Stk16))\n",
      "----------------------\n",
      "10015516 : Addition of LPS strongly increased TF expression, which was significantly suppressed (by 72.7%, 57.1%, and 51.9% after 5, 9, and 15 hr, respectively) (Figure 4B) in cells exposed to CO.\n",
      "a(CHEBI:\"carbon monoxide\") -| p(MGI:F3)\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:F3)\n",
      "----------------------\n",
      "10015518 : Because LPS induces Egr-1 activation via phosphorylation of the transcription factor Elk-1 (Guha et al., 2001), we investigated whether PPARgamma modulates LPS-induced Elk-1 phosphorylation. Phosphorylation of Elk-1 was barely detectable in untreated cells; addition of LPS resulted in a rapid increase in nuclear Elk-1 phosphorylation. This increase was inhibited an average of 36% in the presence of CO (Figures 3A?3C).\n",
      "a(CHEBI:\"carbon monoxide\") -| act(p(MGI:Elk1))\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Elk1))\n",
      "----------------------\n",
      "10015530 : Incubation of adipocytes with 100 micromol/l C(2)-ceramide (N-acetyl-sphingosine) resulted in a time-dependent decrease of PDE3B activity, accompanied by decreased PDE3B protein expression.\n",
      "a(CHEBI:ceramide) -| act(p(MGI:Pde3b))\n",
      "a(CHEBI:ceramide) -| p(MGI:Pde3b)\n",
      "----------------------\n",
      "10003320 : We have reported that ceramide mediates binding of atypical protein kinase C (PKC) zeta to its inhibitor protein, PAR-4 (prostate apoptosis response-4), thereby inducing apoptosis in differentiating embryonic stem cells.\n",
      "a(CHEBI:ceramide) -> complex(p(MGI:Prkcz),p(MGI:Pawr))\n",
      "complex(p(MGI:Prkcz),p(MGI:Pawr)) -| act(p(MGI:Prkcz))\n",
      "----------------------\n",
      "10015532 : Ceramide and its analogs activated PKCzeta prior to binding to PAR-4, as determined by increased levels of phosphorylated PKCzeta and glycogen synthase kinase-3beta and emergence of a PAR-4-to-phosphorylated PKCzeta fluorescence resonance energy transfer signal that co-localizes with ceramide.\n",
      "a(CHEBI:ceramide) -> act(p(MGI:Prkcz))\n",
      "a(CHEBI:ceramide) -> p(MGI:Prkcz,pmod(P))\n",
      "p(MGI:Prkcz,pmod(P)) -> act(p(MGI:Prkcz))\n",
      "----------------------\n",
      "10015558 : other examples of apoB degradation that appear to occur post-ER include regulation by choline deficiency, dexamethasone, and the interaction of newly assembled apoB lipoproteins with LDL receptors in the secretory pathway or at the cell surface cell surface heparin sulfate proteoglycans may also serve an LDL receptor-like function\n",
      "a(CHEBI:choline) -> tloc(p(MGI:Apob))\n",
      "a(CHEBI:dexamethasone) -| tloc(p(MGI:Apob))\n",
      "a(CHEBI:heparin) -| tloc(p(MGI:Apob))\n",
      "act(p(MGI:Nr3c1)) -| tloc(p(MGI:Apob))\n",
      "----------------------\n",
      "10015560 : At day 4 after cisplatin injection mRNA, protein levels and enzyme activity of proapoptotic renal endonuclease G (Endo G) were increased compared with saline-treated mice. % In situ hybridization and immunohistochemical studies localized the increased expression of Endo G mRNA to the cytosolic compartment and Endo G protein to the nuclear compartment of proximal tubules in cisplatin-treated mice\n",
      "a(CHEBI:cisplatin) -> act(p(MGI:Endog))\n",
      "a(CHEBI:cisplatin) -> p(MGI:Endog)\n",
      "----------------------\n",
      "10003336 : Treatment of cells with cisplatin induces a sustained activation of the stress activated protein kinase SAPK/JNK and the mitogen-activated protein kinase p38.\n",
      "a(CHEBI:cisplatin) -> act(p(HGNC:MAPK14))\n",
      "a(CHEBI:cisplatin) -> act(p(HGNC:MAPK8))\n",
      "----------------------\n",
      "10015564 : Western blot analysis confirmed that CFB enhances protein expression of liver Bcrp, Mrp3, and Mrp4 in CD-1 mice.\n",
      "a(CHEBI:clofibrate) -> p(MGI:Abcc3)\n",
      "a(CHEBI:clofibrate) -> p(MGI:Abcc4)\n",
      "a(CHEBI:clofibrate) -> p(MGI:Abcg2)\n",
      "----------------------\n",
      "10015590 : Importantly, cycloheximide treatment also completely suppressed PERK (Thr980) phosphorylation in both Tsc1-/- and Tsc2-/- cells (Figure S1C), supporting the hypothesis that increased protein synthesis is likely the underlying mechanism for activation of UPR in TSC1- and TSC2-deficient cells.\n",
      "a(CHEBI:cycloheximide) -| p(MGI:Eif2ak3,pmod(P))\n",
      "bp(GOBP:\"protein metabolic process\") -> bp(GOBP:\"response to endoplasmic reticulum stress\")\n",
      "----------------------\n",
      "10015600 : Rephosphorylation of PTP36 seemed to depend on actin polymerization since it was inhibited by cytochalasin D.\n",
      "a(CHEBI:\"cytochalasin D\") -> act(p(MGI:Ptpn14))\n",
      "a(CHEBI:\"cytochalasin D\") -| p(MGI:Ptpn14,pmod(P))\n",
      "a(CHEBI:\"cytochalasin D\") -> tloc(p(MGI:Ptpn14))\n",
      "----------------------\n",
      "10003354 : The binding of versican to L- and P-selectin was inhibited by CS B, CS E, and heparan sulfate (HS)\n",
      "a(CHEBI:\"dermatan sulfate\") -| complex(p(HGNC:VCAN),p(HGNC:SELL))\n",
      "a(CHEBI:\"dermatan sulfate\") -| complex(p(HGNC:VCAN),p(HGNC:SELP))\n",
      "----------------------\n",
      "10003356 : Using real-time quantitative PCR, we establish that hypothalamic CRF expression is significantly reduced after swim exposure in DMI-treated wild-type mice, however DMI is unable to blunt hypothalamic CRF expression in ICER-deficient mice.\n",
      "a(CHEBI:desipramine) -> act(p(MGI:Crem))\n",
      "act(p(MGI:Crem)) -| r(MGI:Crh)\n",
      "----------------------\n",
      "10015606 : Both activation of glycerophosphate dehydrogenase and stimulation of insulin-dependent 2-deoxyglucose uptake induced by hormones/IBMX were enhanced in protein kinase C-depleted cells exposed to phorbol 12-myristate 13-acetate (PMA)\n",
      "a(CHEBI:dexamethasone) -> act(p(MGI:Gpd1))\n",
      "a(CHEBI:glucocorticoid) -> act(p(MGI:Gpd1))\n",
      "act(p(MGI:Nr3c1)) -> act(p(MGI:Gpd1))\n",
      "----------------------\n",
      "10015608 : insulin stimulated whereas dexamethasone inhibited 11beta-HSD1 activity and expression in a time- and concentration-dependent manner\n",
      "a(CHEBI:dexamethasone) -| act(p(MGI:Hsd11b1))\n",
      "p(HGNC:INS) -> act(p(MGI:Hsd11b1))\n",
      "----------------------\n",
      "10015610 : Inhibition of LPL activity by Wy-14643 did not reduce the ability of insulin plus dexamethasone to stimulate cellular and heparin-releasable LPL activities. A similar inhibitory effect on cellular and heparin-releasable LPL activity was observed when cardiomyocytes were cultured with 60 microM linoleic acid.\n",
      "a(CHEBI:dexamethasone) -> act(p(MGI:Lpl))\n",
      "p(MGI:Nr3c1) -> act(p(MGI:Lpl))\n",
      "----------------------\n",
      "10015624 : Lysyl oxidase transcription was stimulated by dexamethasone treatment of cells, but this effect could not be assigned within the approximately 3 kb region tested in reporter gene constructs.\n",
      "a(CHEBI:dexamethasone) -> act(p(HGNC:NR3C1))\n",
      "act(p(HGNC:NR3C1)) -> r(HGNC:LOX)\n",
      "----------------------\n",
      "10015644 : Finally, we determined that bacterial DNA stimulated CD11b up-regulation in TLR9(-/-) but not in MyD88(-/-) mouse neutrophils, supporting that bacterial DNA induces neutrophil activation through a TLR9-independent and MyD88-dependent pathway.\n",
      "a(CHEBI:\"double-stranded DNA\") -> act(p(MGI:Myd88))\n",
      "a(CHEBI:\"double-stranded DNA\") -> act(p(HGNC:MYD88))\n",
      "----------------------\n",
      "10003376 : The vaginae cultured with 5 microg/ml E2 or 5 microg/ml KGF had a cornified thick epithelium, while the epithelium of the vehicle-treated controls stayed thin. The E2 effect was blocked by concurrent treatment with anti-KGF antibody or KGFR inhibitory peptide.\n",
      "a(CHEBI:estradiol) -> p(MGI:Fgf7)\n",
      "p(MGI:Fgf7) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10015666 : Treatment with cycloheximide indicated that ER directly controls GREB1 expression...The pattern of expression suggests a critical role for these two genes in the response of tissues and tumors to beta-estradiol.\n",
      "a(CHEBI:estradiol) -> act(p(HGNC:ESR1))\n",
      "act(p(HGNC:ESR1)) -> r(EGID:9687)\n",
      "----------------------\n",
      "10003388 : Beyond E2, preliminary examination of other steroid metabolites and synthetic steroid receptor agonists/antagonists revealed that inhibition of 5-HT transport is additionally attributable only to estriol (E3, an E2 metabolite) and tamoxifen (a nonsteroidal, E2 receptor antagonist).\n",
      "a(CHEBI:estriol) -| act(p(MGI:Slc6a4))\n",
      "a(CHEBI:tamoxifen) -| act(p(MGI:Slc6a4))\n",
      "----------------------\n",
      "10015678 : Two peroxisome proliferator-activated receptor a agonsists: Wy-14643 and a marketed fribrate drug, fenofibrate\n",
      "a(CHEBI:fenofibrate) -> act(p(MGI:Ppara))\n",
      "a(CHEBI:\"pirinixic acid\") -> act(p(MGI:Ppara))\n",
      "----------------------\n",
      "10003396 : In the intestinal mucosa, ketohexokinase, aldolase, triokinase, fructose-diphosphatase, and glucose-6-phosphatase specific activities were still entirely or partially stimulated on the 15th day after return to the standard diet.\n",
      "a(CHEBI:fructose) -> act(p(MGI:Fbp1))\n",
      "a(CHEBI:fructose) -> act(p(MGI:G6pc))\n",
      "a(CHEBI:fructose) -> act(p(MGI:Khk))\n",
      "----------------------\n",
      "10015682 : there are also animal models of post-transcriptional regulation of apoB secretion hamsters fed a high fructose diet had increased assembly and secretion of VLDL apoB with no change in apoB mRNA levels but with decreased non-proteasomal degradation of apoB\n",
      "a(CHEBI:fructose) -| deg(p(MGI:Apob))\n",
      "a(CHEBI:fructose) -> tloc(p(MGI:Apob))\n",
      "----------------------\n",
      "10015684 : It was increased in mammary carcinoma MCF-7 cells treated by retinoids and by the anti-estrogen ICI 182,780 but not by 4-hydroxytamoxifen.\n",
      "a(CHEBI:fulvestrant) -> p(HGNC:NDRG1)\n",
      "act(p(HGNC:ESR1)) -| p(HGNC:NDRG1)\n",
      "act(p(HGNC:ESR1)) -| r(HGNC:NDRG1)\n",
      "----------------------\n",
      "10015708 : Glucocorticoids and IL-10 stimulated the production of GILZ by macrophages both in vitro and in vivo.\n",
      "a(CHEBI:glucocorticoid) -> p(MGI:Il10)\n",
      "a(CHEBI:glucocorticoid) -> p(MGI:Tsc22d3)\n",
      "----------------------\n",
      "10015712 : Pulse-chase biosynthetic labeling studies showed that AtT-20 cells expressed much less RESP18 than the endogenous prohormone, POMC, but that glucocorticoid treatment lowered POMC and raised RESP18 biosynthetic rates so that they were nearly equimolar. Surprisingly, RESP18 was not processed to smaller peptides to any significant extent, nor was RESP18 or any smaller peptide secreted.\n",
      "a(CHEBI:glucocorticoid) -| p(MGI:Pomc)\n",
      "a(CHEBI:glucocorticoid) -> p(MGI:Resp18)\n",
      "----------------------\n",
      "10000018 : We have identified glucocorticoids as physiological inhibitors of tenascin-X and suggest that glucocorticoids may in part participate in the downregulation of tenascin-X in fibroblasts in vivo.\n",
      "a(CHEBI:glucocorticoid) -| p(MGI:Tnxb)\n",
      "act(p(MGI:Nr3c1)) -| p(MGI:Tnxb)\n",
      "----------------------\n",
      "10015718 : We also demonstrated that glucosamine % infusion results in O-linked N-acetylglucosamine modification of IRS-1 and % IRS-2.\n",
      "a(CHEBI:glucosamine) -> p(HGNC:IRS1,pmod(G,S))\n",
      "a(CHEBI:\"UDP-N-acetyl-D-galactosamine\") -> p(HGNC:IRS1,pmod(G,S))\n",
      "p(HGNC:IRS1,pmod(G,S)) -| act(p(HGNC:IRS1))\n",
      "----------------------\n",
      "10015726 : Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements.\n",
      "a(CHEBI:heme) -| act(p(MGI:Bach1))\n",
      "act(p(MGI:Nfe2l2)) -> r(MGI:Hmox1)\n",
      "----------------------\n",
      "10003404 : The tight binding of chymase to heparin PG results in increased activity of the protease toward certain substrates, e.g., thrombin and MeO-Suc-Arg-Pro-Tyr-pNA (S-2586).\n",
      "a(CHEBI:heparin) -> act(p(HGNC:CMA1))\n",
      "complex(a(CHEBI:heparin),p(HGNC:CMA1)) -> act(p(HGNC:CMA1))\n",
      "----------------------\n",
      "10003412 : activation of the human H(2) receptor (hH(2)R) leads to an increase in c-fos transcription and cell proliferation\n",
      "a(CHEBI:histamine) -> act(p(HGNC:HRH2))\n",
      "act(p(HGNC:HRH2)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:HRH2)) -> r(HGNC:FOS)\n",
      "----------------------\n",
      "10015746 : freezing or disruption of the matrix by subcutaneous sterile bead injection, induce the release of fragments of HA that in turn stimulates a TLR4-dependent increase in CXCL2 chemokines\n",
      "a(CHEBI:\"hyaluronic acid\") -> act(p(MGI:Tlr4))\n",
      "act(p(MGI:Tlr4)) -> p(MGI:Cxcl2)\n",
      "----------------------\n",
      "10015752 : we next examined whether HA can directly induce IL-1beta release. Peritoneal macrophages of WT mice, but not cryopyrin null mice (Nlrp3-/-), showed a large increase in IL-1beta release\n",
      "a(CHEBI:\"hyaluronic acid\") -> tloc(p(MGI:Il1b))\n",
      "p(MGI:Nlrp3) -> tloc(p(MGI:Il1b))\n",
      "----------------------\n",
      "10003424 : It was found that 5-LO in the Epstein-Barr virus-transformed B-lymphocytic cell line BL41-E95-A is activated by addition of hydrogen peroxide or xanthine/xanthine oxidase and after increasing the oxidative state of the cell\n",
      "a(CHEBI:\"hydrogen peroxide\") -> act(p(HGNC:ALOX5))\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:ALOX5))\n",
      "bp(GOBP:\"response to oxidative stress\") -> act(p(HGNC:ALOX5))\n",
      "act(p(HGNC:XDH)) -> act(p(HGNC:ALOX5))\n",
      "----------------------\n",
      "10015764 : The present studies demonstrate that treatment of cells with hydrogen peroxide (H(2)O(2)) induces binding of the PKCdelta isoform and the c-Abl protein-tyrosine kinase. The results show that c-Abl phosphorylates PKCdelta in the H(2)O(2) response. We also show that PKCdelta phosphorylates and activates c-Abl in vitro.\n",
      "a(CHEBI:\"hydrogen peroxide\") -> complex(p(HGNC:PRKCD),p(HGNC:ABL1))\n",
      "act(p(HGNC:ABL1)) -> p(HGNC:PRKCD,pmod(P))\n",
      "act(p(HGNC:PRKCD)) -> act(p(HGNC:ABL1))\n",
      "act(p(HGNC:PRKCD)) -> p(HGNC:ABL1,pmod(P))\n",
      "----------------------\n",
      "10015754 : In neutrophils challenged with LPS, IkB-a underwent time-dependent degradation (Fig. 8C). However, in neutrophils incubated with both LPS and H2O2, no degradation of IkB-a was apparent.\n",
      "a(CHEBI:\"hydrogen peroxide\") -| deg(p(MGI:Nfkbia))\n",
      "a(CHEBI:lipopolysaccharide) -> deg(p(MGI:Nfkbia))\n",
      "----------------------\n",
      "10015768 : 3) H(2)O(2) rapidly activated Ras (peak at 2-5 min), which preceded p90RSK activation (peak at 20 min).\n",
      "a(CHEBI:\"hydrogen peroxide\") -> act(p(MGI:Hras))\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(MGI:Hras))\n",
      "----------------------\n",
      "10015770 : which are dual-specificity (serine/threonine and tyrosine) kinases that regulate downstream responses to a broad range of mitogenic, apoptotic, and differentiation-inducing stimuli [368-372]. Interestingly, MEK1 but not MEK2 is stimulated by H2O2 treatment, suggesting that only MEK1 is redox-sensitive [154].\n",
      "a(CHEBI:\"hydrogen peroxide\") -> act(p(HGNC:MAP2K1))\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:MAP2K1))\n",
      "----------------------\n",
      "10015776 : a part of the phosphorylation of Sap-1a upon stimulation with H2O2 is due to p38 MAPK, while the rest can most likely be attributed to JNKs that are also inducible by H2O2.\n",
      "a(CHEBI:\"hydrogen peroxide\") -> act(p(MGI:Mapk14))\n",
      "act(p(MGI:Mapk14)) -> p(MGI:Elk4,pmod(P))\n",
      "----------------------\n",
      "10015784 : in view of the ability of H2O2 to inhibit protein tyrosine phosphatases (PTPases), such as PTP-1B (68), and SH-2 domain-containing tyrosine phosphatase (SHP)-2 (69),\n",
      "a(CHEBI:\"hydrogen peroxide\") -| act(p(MGI:Ptpn11))\n",
      "a(CHEBI:\"hydrogen peroxide\") -| act(p(MGI:Ptpn1))\n",
      "----------------------\n",
      "10015792 : Therefore, we also analyzed NIH 3T3 cells that were serum deprived and then stimulated with either H2O2, anisomycin or UV light. All of these stimuli resulted in increased phosphorylation of MycâSap-1a, most prominently seen with H2O2 (Figure 8B)\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(MGI:Elk4,pmod(P))\n",
      "bp(GOBP:\"response to UV\") -> p(MGI:Elk4,pmod(P))\n",
      "----------------------\n",
      "10015794 : As was the case for p38, ERK1/2 was both rapidly and persistently activated in neutrophils exposed to H2O2 (Fig. 2A).\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(MGI:Mapk1,pmod(P))\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(MGI:Mapk1,pmod(P))\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(MGI:Mapk3,pmod(P))\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10015796 : Similar to the patterns seen with ERK1/2 and p38, JNK activation in neutrophils exposed to H2O2 was both rapid and persistent (Fig. 2B).\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(MGI:Mapk8,pmod(P))\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(MGI:Mapk8,pmod(P))\n",
      "----------------------\n",
      "10015806 : Increased expression of ATR enhanced the phosphorylation of BRCA1 on Ser 1423 following cellular exposure to HU or UV light, whereas doxycycline-induced expression of a kinase-inactive ATR mutant protein inhibited HU- or UV light-induced Ser 1423 phosphorylation in GM847 fibroblasts, and partially suppressed the phosphorylation of this site in response to IR.\n",
      "a(CHEBI:hydroxyurea) -> p(HGNC:BRCA1,pmod(P))\n",
      "bp(GOBP:\"response to UV\") -> p(HGNC:BRCA1,pmod(P))\n",
      "----------------------\n",
      "10003432 : Treatment of the LPS-sensitive mice with intraperitoneal indomethacin (5 mg/kg per day, 3 days) significantly decreased enzyme activities for CYP3A11, CYP2D9 and CYP1A2 but not CYP2E1.\n",
      "a(CHEBI:indometacin) -| act(p(MGI:Cyp1a2))\n",
      "a(CHEBI:indometacin) -| act(p(MGI:Cyp2d9))\n",
      "a(CHEBI:indometacin) -| act(p(MGI:Cyp2e1))\n",
      "a(CHEBI:indometacin) -| act(p(MGI:Cyp3a11))\n",
      "----------------------\n",
      "10015812 : we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin. Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells\n",
      "a(CHEBI:indometacin) -| p(HGNC:PTGS1)\n",
      "a(CHEBI:indometacin) -| p(HGNC:PTGS2)\n",
      "p(HGNC:PTGS1) -> bp(GOBP:\"wound healing\")\n",
      "p(HGNC:PTGS2) -> bp(GOBP:\"wound healing\")\n",
      "----------------------\n",
      "10015820 : Insulin signaling inhibits gluconeogenesis by disrupting this interaction between FoxO1 and PGC-1 and/or by inhibiting PGC-1 (Schilling et al., 2006; Li et al., 2007b).\n",
      "p(HGNC:INS) -| complex(p(MGI:Ppargc1a),p(MGI:Foxo1))\n",
      "p(HGNC:INS) -| act(p(MGI:Ppargc1a))\n",
      "----------------------\n",
      "10003438 : In contrast, SOCS-6-associated p85 was not degraded and could be recruited to the newly synthesized SOCS-6 molecules in the presence of insulin, suggesting that SOCS-6 expression and its interaction with p85, but not the degradation, is regulated by insulin.\n",
      "p(HGNC:INS) -> complex(p(MGI:Ppp1r13b),p(MGI:Socs6))\n",
      "complex(p(MGI:Ppp1r13b),p(MGI:Socs6)) -| deg(p(MGI:Socs6))\n",
      "----------------------\n",
      "10003440 : (i) insulin signaling stimulates Rab4 activity, the association of Rab4 with kinesin, and the interaction of KIF3 with microtubules and (ii) this process is mediated by insulin-induced PI3-kinase-dependent PKC-lambda activation and participates in GLUT4 exocytosis in 3T3-L1 adipocytes.\n",
      "p(HGNC:INS) -> act(p(MGI:Rab4a))\n",
      "complex(p(MGI:Rab4a),p(MGI:Kif3a)) -> act(p(MGI:Kif3a))\n",
      "----------------------\n",
      "10015826 : Whereas treatment of wild type MEFs with insulin induced a marked increase in S6K1 activity, the basal activity of S6K1 isolated from Tsc1- and Tsc2-null MEFs was high and was not increased further by insulin (Fig. 1B).\n",
      "p(HGNC:INS) -> act(p(MGI:Rps6kb1))\n",
      "p(MGI:Tsc1) -| act(p(MGI:Rps6kb1))\n",
      "p(MGI:Tsc2) -| act(p(MGI:Rps6kb1))\n",
      "----------------------\n",
      "10015842 : Insulin reduces the tyrosine phosphorylation and increases the serine phosphorylation of STAT3, thereby reducing its nuclear localization and transcriptional activity\n",
      "p(HGNC:INS) -> p(MGI:Stat3,pmod(P))\n",
      "p(HGNC:INS) -| p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Stat3,pmod(P)) -> act(p(MGI:Stat3))\n",
      "p(MGI:Stat3,pmod(P)) -| act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10015862 : A selective inhibitor of leukotriene synthesis MK886 as well as an antagonist of the high affinity LTB(4) receptor (BLT(1)) U-75302 slightly inhibited zymosan-, but not LPS-stimulated interleukin (IL)-10 release from BM-DCs.\n",
      "a(CHEBI:\"leukotriene B4\") -> act(p(MGI:Ltb4r1))\n",
      "a(CHEBI:\"leukotriene B4\") -> p(MGI:Il10)\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Il10)\n",
      "----------------------\n",
      "10015866 : Consistent with the effects of leukotriene antagonists, exogenous LTB(4) enhanced LPS-stimulated IL-10 release by approximately 39% and inhibited IL-12 p40 release by approximately 22%\n",
      "a(CHEBI:\"leukotriene B4\") -| p(MGI:Il10)\n",
      "a(CHEBI:\"leukotriene B4\") -| p(MGI:Il12b)\n",
      "a(CHEBI:\"leukotriene B4\") -| p(HGNC:IL12B)\n",
      "----------------------\n",
      "10015870 : hypolipidemic fibrates and eicosanoids such as leukotriene B4 and 8(S)-hydroxyeicosatetraenoic acid (8(S)-HETE) are synthetic and natural ligands respectively for PPARa.\n",
      "a(CHEBI:\"leukotriene B4\") -> act(p(MGI:Ppara))\n",
      "a(CHEBI:\"leukotriene B4\") -> act(p(HGNC:PPARA))\n",
      "----------------------\n",
      "10015386 : Because IFN-g is known to induce NOS2, an important mediator of inflammation and host defense, we also analyzed effects of acrolein exposure on LPS-mediated induction of NOS2 (28) and observed a strong trend toward reduced NOS2 expression after acrolein exposure\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Nos2))\n",
      "p(MGI:Ifng) -> act(p(MGI:Nos2))\n",
      "----------------------\n",
      "10015902 : Lipopolysaccharides (LPS), which activate Toll-like receptor 4 (TLR4), reduced PPARgamma expression and function in peritoneal macrophages and macrophage cell lines\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Tlr4))\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(HGNC:TLR4))\n",
      "----------------------\n",
      "10015910 : Stimulation of neutrophils with LPS primarily resulted in increased activation of IKKb (Fig. 4A), although late increases in IKKa activity also appeared to be present (Fig. 4B).\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Chuk))\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Ikbkb))\n",
      "----------------------\n",
      "10015914 : Thus, LPS-stimulated Tpl2(-/-) macrophages express low levels of COX-2 and PGE2, compared with wild-type Tpl2(+/+) cells. {Tpl2 Official Gene Symbol: MAP3K8}\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Map3k8))\n",
      "act(p(MGI:Map3k8)) -> p(MGI:Ptgs2)\n",
      "----------------------\n",
      "10015916 : Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Mapk1))\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10015920 : Progesterone, lipopolysaccharide, tumour necrosis factor-alpha, and interleukin-1beta significantly stimulated the expression of ENA-78 by ESC. ....The expression of ENA-78 was also detected in cyclic endometrium by immunohistochemistry.\n",
      "a(CHEBI:lipopolysaccharide) -> p(HGNC:CXCL5)\n",
      "a(CHEBI:progesterone) -> p(HGNC:CXCL5)\n",
      "p(HGNC:IL1B) -> p(HGNC:CXCL5)\n",
      "p(HGNC:TNF) -> p(HGNC:CXCL5)\n",
      "----------------------\n",
      "10015930 : whereas exposure of neutrophils to LPS or TNF-a resulted in increased levels of the transcriptionally active serine 133-phosphorylated form of CREB\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Creb1,pmod(P))\n",
      "p(MGI:Tnf) -> p(MGI:Creb1,pmod(P))\n",
      "----------------------\n",
      "10015932 : AEC grown on Matrigel:collagen matrix, thereby maintained in the \\\"classical\\\" type II phenotype until Day 3 of culture ... similarly expressed and released GM-CSF on LPS stimulation in the coculture and responded to GM-CSF stimulation with enhanced proliferation (Figure E2), further supporting the concept that the proliferative response to GM-CSF is related to the type II AEC phenotype.\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Csf2)\n",
      "p(MGI:Csf2) -> act(complex(p(MGI:Csf2ra),p(MGI:Csf2rb)))\n",
      "----------------------\n",
      "10015934 : 4 h after exposure to LPS, which corresponds to the peak in KC levels in our model (43). Intravascular KC levels are increased in PAI-1-deficient mice compared with C57BL/6J wt controls\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Cxcl1)\n",
      "p(MGI:Serpine1) -| p(MGI:Cxcl1)\n",
      "----------------------\n",
      "10015938 : In RAW 267.4 mouse macrophages, LPS induced maximum Egr-1 mRNA expression 1 hour after treatment (data not shown). Maximum Egr-1 protein expression and DNA binding activity occurred 2 hours after treatment (data not shown).\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Egr1)\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Egr1))\n",
      "----------------------\n",
      "10015940 : LPS administration to macrophages led to a dose-dependent decrease in endogenous Elk-3 mRNA levels, and this decrease in Elk-3 preceded the induction of NOS2 mRNA.\n",
      "a(CHEBI:lipopolysaccharide) -| p(MGI:Elk3)\n",
      "p(MGI:Elk3) -| p(MGI:Nos2)\n",
      "----------------------\n",
      "10003464 : HoxC4 was 'preferentially' expressed in germinal center B cells and was upregulated by engagement of CD40 by CD154, as well as by lipopolysaccharide and interleukin 4.\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Hoxc4)\n",
      "act(p(MGI:Cd40)) -> p(MGI:Hoxc4)\n",
      "p(MGI:Il4) -> p(MGI:Hoxc4)\n",
      "----------------------\n",
      "10015946 : After being treated with different concentrations of LPS for 24h, tumor supernatants of LLC cells were obtained and TGFb1 and IL-10 concentrations were detected by ELISA. The results showed that with increasing concentrations of LPS, the levels of TGFb1 and IL-10 protein were also increased\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Il10)\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Tgfb1)\n",
      "----------------------\n",
      "10015950 : interleukin 1 receptor antagonist (IL-1ra) is induced in mouse liver after lipopolysaccharide (LPS) or recombinant interleukin 1 (IL-1\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Il1rn)\n",
      "p(MGI:Il1a) -> p(MGI:Il1rn)\n",
      "----------------------\n",
      "10003466 : In vivo production of VEGF and Th1- and Th17-polarizing cytokines (IL-12p70 and IL-6, respectively) were upregulated by airway exposure to LPS.\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Il6)\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Vegfa)\n",
      "----------------------\n",
      "10015962 : We used a murine macrophage-like cell line, RAW264.7, to demonstrate that Janus kinase (JAK)2 is tyrosine phosphorylated immediately after LPS stimulation. Anti-Toll-like receptor (TLR)4 neutralization antibody inhibits the phosphorylation of JAK2 and the c-Jun NH2-terminal protein kinase (JNK).\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Jak2,pmod(P))\n",
      "act(p(MGI:Tlr4)) -> act(p(MGI:Jak2))\n",
      "act(p(MGI:Tlr4)) -> p(MGI:Jak2,pmod(P))\n",
      "----------------------\n",
      "10015966 : Exposure of neutrophils to LPS resulted in persistence of p38 activation that was similar to that produced by H2O2, but the increase in phosphorylated p38 was less rapid, rising above baseline values more than 5 min after LPS was added to the neutrophils.\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk14,pmod(P))\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk14,pmod(P))\n",
      "----------------------\n",
      "10015968 : Phosphorylation of ERK1/2 after exposure of neutrophils with LPS was only apparent after 20-min incubation and was less intense than that produced by stimulation of neutrophils with H2O2.\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk1,pmod(P))\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk1,pmod(P))\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk3,pmod(P))\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10015970 : JNK activation induced by LPS only became apparent 20 min after LPS was added to the cells and was of a lesser degree than that induced by H2O2 at all time points.\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk8,pmod(P))\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mapk8,pmod(P))\n",
      "----------------------\n",
      "10015972 : The notion of MIF as a proinflammatory protein was further evaluated using a mouse model of septic shock [28] . After applying LPS, a potent activator of the innate immune system, MIF secretion and production measured by mRNA and protein synthesis increased compared to controls.\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Mif)\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Mif))\n",
      "----------------------\n",
      "10003472 : A significant dose-dependent increase in the inducible nitric oxide synthase (NOS2) expression and NO production were observed by various concentrations of TNF-alpha (1, 5, and 10 ng/mL) and LPS (1 and 5 microg/mL) which was completely inhibited by a NOS2 inhibitor, L-N6-(1-iminoethyl) lysine (L-NIL) (1 mM).\n",
      "a(CHEBI:lipopolysaccharide) -> p(MGI:Nos2)\n",
      "p(MGI:Tnf) -> a(CHEBI:\"nitric oxide\")\n",
      "p(MGI:Tnf) -> p(MGI:Nos2)\n",
      "----------------------\n",
      "10015982 : As shownin Fig.2Aand B, LPS-inducedup-regulation of AEBP1 expression is accompanied by significant inhibition of PPAR1 and LXR expression where their levels drop by 5 and 3 folds, respectively, 24 h post LPS treatment.\n",
      "a(CHEBI:lipopolysaccharide) -| p(MGI:Nr1h3)\n",
      "a(CHEBI:lipopolysaccharide) -| p(MGI:Pparg)\n",
      "----------------------\n",
      "10016016 : In smokers and in controls, LPS increased the release of both TNF-alpha and IL-10 (Figure 4), with the increase in TNF-alpha being greater than the increase in IL-10. IL-1beta had no effect on TNF-alpha and IL-10 levels in smokers, whereas in nonsmokers this cytokine increased the production of TNF-alpha but not that of IL-10, although TNF-alpha levels remained very low.\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(HGNC:IL10))\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(HGNC:TNF))\n",
      "p(HGNC:IL1B) -> tloc(p(HGNC:TNF))\n",
      "----------------------\n",
      "10016018 : As expected, concentrations of TNF-a, IL-1b, and MIP-2 were increased in supernatants of neutrophils stimulated with LPS (Fig. 2).\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Cxcl2))\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Il1b))\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10016020 : he most effective in vitro concentration of 1 mg/ml is less than the normal plasma concentration of A1AT, and thus is probably achievable locally (i.e., microscopically) in areas of cigarette smokeâinduced leakage of plasma (15, 16) into the lung. Fairly similar concentrations have been shown to inhibit LPS-induced TNF-{alpha} and IL-1beta release (10).\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Il1b))\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10003476 : Our analyses using epiregulin-deficient mice with mixed and inbred genetic backgrounds revealed that epiregulin deficiency results in the reduction of IL-6 production levels in both cell types upon peptidoglycan stimulation, and that the extent of this reduction is more evident under the BALB/c background compared with the C57BL/6J background.\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Il6))\n",
      "a(CHEBI:peptidoglycan) -> tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10016022 : In this study, we show that LPS and IFN-G induce shedding of LRP1 from RAW 264.7 cells and BMMs in vitro.\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Lrp1))\n",
      "p(MGI:Ifng) -> tloc(p(MGI:Lrp1))\n",
      "----------------------\n",
      "10016024 : Since macrophages activated by lipopolysaccharide, tumor necrosis factor (TNF)-?, and interferon-? have been shown to secret substantial amounts of preformed MIF [17], it is reasonable to assume that macrophage-derived MIF could be involved in atherogenesis.\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Mif))\n",
      "p(MGI:Ifng) -> tloc(p(MGI:Mif))\n",
      "p(MGI:Tnf) -> tloc(p(MGI:Mif))\n",
      "----------------------\n",
      "10016036 : In addition, the secretion of Ucn I from HL-1 cardiomyocytes was stimulated by LPS and TNF-alpha.\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Ucn))\n",
      "p(MGI:Tnf) -> tloc(p(MGI:Ucn))\n",
      "----------------------\n",
      "10016038 : The results indicate that unstimulated RAW264.7 cells express low constitutive levels of nuclear NF-nB p50 and p65 (Fig. 3). As expected, LPS was a powerful inducer of both p50 and p65 nuclear localization.\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Nfkb1))\n",
      "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Rela))\n",
      "----------------------\n",
      "10003486 : Serum amyloid A-activating factor-1 (SAF-1) is a zinc finger transcription factor that is activated by many mediators of inflammation including IL-1, IL-6, and bacterial LPS.\n",
      "a(CHEBI:lipopolysaccharide) -> act(p(MGI:Maz))\n",
      "p(MGI:Il1a) -> act(p(MGI:Maz))\n",
      "p(MGI:Il6) -> act(p(MGI:Maz))\n",
      "----------------------\n",
      "10016046 : Nuclear hormone receptors that heterodimerize with retinoid X receptor (RXR), such as thyroid receptors, peroxisome proliferator-activated receptors, and liver X receptors, modulate lipid metabolism. We recently demonstrated that these nuclear hormone receptors are repressed during the acute phase response induced by lipopolysaccharide (LPS), consistent with the known decreases in genes that they regulate.\n",
      "a(CHEBI:lipopolysaccharide) -| act(p(MGI:Nr1h2))\n",
      "a(CHEBI:lipopolysaccharide) -| act(p(MGI:Nr1h3))\n",
      "a(CHEBI:lipopolysaccharide) -| act(p(MGI:Ppara))\n",
      "a(CHEBI:lipopolysaccharide) -| act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10003492 : telmisartan, and to a lesser extent, losartan, increased production and secretion of adiponectin from 3T3-L1 adipocytes compared to the other antihypertensive drugs\n",
      "a(CHEBI:losartan) -> tloc(p(MGI:Adipoq))\n",
      "a(CHEBI:telmisartan) -> tloc(p(MGI:Adipoq))\n",
      "----------------------\n",
      "10016094 : To determine if BAX and BAK are activated in response to NO, wild type MEFs were treated with DETA-NO for 24 hours and BAX and BAK activation was determined using antibodies that specifically recognize the activated form of these proteins [20], [23]. Indeed, BAX and BAK are activated in response to NO treatment indicating that both of these proteins regulate NO-mediated apoptosis (Figure 1E/FFigure 1).\n",
      "a(CHEBI:\"nitric oxide\") -> act(p(MGI:Bak1))\n",
      "a(CHEBI:\"nitric oxide\") -> act(p(MGI:Bax))\n",
      "----------------------\n",
      "10003508 : Here we demonstrate that exposure to NO donor or iNOS transfection reduced insulin receptor substrate (IRS)-1 protein expression without altering the mRNA level in cultured skeletal muscle cells. NO donor increased IRS-1 ubiquitination, and proteasome inhibitors blocked NO donor-induced reduction in IRS-1 expression in cultured skeletal muscle cells.\n",
      "a(CHEBI:\"nitric oxide\") -> deg(p(MGI:Irs1))\n",
      "a(CHEBI:\"S-nitrosoglutathione\") -> deg(p(MGI:Irs1))\n",
      "p(MGI:Nos2) -> deg(p(MGI:Irs1))\n",
      "----------------------\n",
      "10003510 : NO modulation of the signaling pathway was shown by its inhibitory effect on shear stress-induced ERK1/ERK2 phosphorylation and activity.\n",
      "a(CHEBI:\"nitric oxide\") -| act(p(HGNC:MAPK1))\n",
      "a(CHEBI:\"nitric oxide\") -| act(p(HGNC:MAPK3))\n",
      "act(p(HGNC:NOS3)) -| act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:NOS3)) -| act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10016100 : To determine if NO activates JNK upstream of BAX and BAK, we treated Bax?/?/Bak?/? MEFs with DETA-NO and assessed JNK activity by measuring expression of phoshpo-cJun, a downstream target of JNK. NO activates JNK as early as 8 hours after exposure to NO, and this activation was sustained to 24 hours (Figure 6AFigure 6).\n",
      "a(CHEBI:\"nitric oxide\") -> act(p(MGI:Mapk8))\n",
      "a(CHEBI:\"nitric oxide\") -> p(MGI:Jun,pmod(P))\n",
      "----------------------\n",
      "10003520 : Administration of the somatostatin analogue octreotide to pituitary intact rats in a manner previously shown to acutely suppress the GH/IGF-I axis, up-regulated mammary gland MDGI expression\n",
      "a(CHEBI:octreotide) -| p(MGI:Gh)\n",
      "a(CHEBI:octreotide) -| p(MGI:Igf1)\n",
      "----------------------\n",
      "10016120 : On the contrary, when the dephosphorylation of PTP36 was inhibited by okadaic acid, no translocation of PTP36 was induced by the cell detachment\n",
      "a(CHEBI:\"okadaic acid\") -| act(p(MGI:Ptpn14))\n",
      "a(CHEBI:\"okadaic acid\") -> p(MGI:Ptpn14,pmod(P))\n",
      "a(CHEBI:\"okadaic acid\") -| tloc(p(MGI:Ptpn14))\n",
      "----------------------\n",
      "10016152 : This revealed that the C/EBPa antibody disrupted the 3rd DNAprotein complex (Fig. 7C, ââ) and supershifted the complex (Fig. 7C, arrow), whereas rabbit IgG had no effect. These results indicated that the binding of C/EBPa to the C/EBP binding site on the HO-1 promoter is specific and increased by PGN.\n",
      "a(CHEBI:peptidoglycan) -> act(p(MGI:Cebpa))\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Hmox1)\n",
      "----------------------\n",
      "10016154 : In the presence of PGN (Fig. 5, filled bars), Elk-1 and Ets-2 further increased HO-1 promoter activity by 12.2- and 7.5-fold, respectively, compared with baseline pCI control (P 0.05; Fig. 5A).\n",
      "a(CHEBI:peptidoglycan) -> act(p(MGI:Elk1))\n",
      "a(CHEBI:peptidoglycan) -> act(p(MGI:Ets2))\n",
      "----------------------\n",
      "10016160 : Peroxynitrite-mediated JNK activation has been associated with apoptotic cell death in murine alveolar C10 cells, in which JNK was activated upon the oxidation of the death receptor Fas.\n",
      "a(CHEBI:peroxynitrite) -> act(p(MGI:Mapk8))\n",
      "p(MGI:Fas) -> act(p(MGI:Mapk8))\n",
      "----------------------\n",
      "10016168 : CAR activators [phenobarbital, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, and diallyl sulfide] decreased Oatp1a1 mRNA expression.\n",
      "a(CHEBI:phenobarbital) -> act(p(MGI:Nr1i3))\n",
      "act(p(MGI:Nr1i3)) -| r(MGI:Slco1a1)\n",
      "----------------------\n",
      "10016170 : In PIO-treated embryos, the levels of beta-catenin and c-MYC in the kidneys at E16.5 were similar in Pkd1-/- and wild-type\n",
      "a(CHEBI:pioglitazone) -| deg(p(MGI:Ctnnb1))\n",
      "a(CHEBI:pioglitazone) -| deg(p(MGI:Myc))\n",
      "----------------------\n",
      "10016186 : in the liver nuclei, addition of Ppara agonist enhanced binding of Ppara to Rxr, decreased the amount of Lxr/Rxr heterodimers, leading to suppression of Lxr ligand-activated Srebf1c expresssion\n",
      "a(CHEBI:\"pirinixic acid\") -| complex(p(MGI:Nr1h2),p(MGI:Rxra))\n",
      "a(CHEBI:\"pirinixic acid\") -| complex(p(MGI:Nr1h3),p(MGI:Rxra))\n",
      "a(CHEBI:\"pirinixic acid\") -> complex(p(MGI:Ppara),p(MGI:Rxra))\n",
      "----------------------\n",
      "10016192 : In addition to its activation in response to peroxisome proliferators such as Wy14,643, Ppara is also activated by a variety of medium and long-chain fatty acids and has been shown to stimulate lipid metabolism by teh induction of peroxisomal B-oxidation and faty acid w-hydroxylation.\n",
      "a(CHEBI:\"pirinixic acid\") -> act(p(MGI:Ppara))\n",
      "act(p(MGI:Ppara)) -> r(MGI:Acox1)\n",
      "----------------------\n",
      "10003554 : PGD(2) induced a reduction in adiponectin and leptin mRNA, and the secretion of these adipokines was also inhibited, the effect being greater with leptin (up to 10-fold) than with adiponectin (twofold).\n",
      "a(CHEBI:\"prostaglandin D2\") -| p(MGI:Adipoq)\n",
      "a(CHEBI:\"prostaglandin D2\") -| p(MGI:Lep)\n",
      "----------------------\n",
      "10016206 : In contrast, PGD(2) induced a marked stimulation of IL-6 and MCP-1 expression; with IL-6, this was rapid, the mRNA level increasing by >50-fold by 1 h. The rise in mRNA was accompanied by an increase in IL-6 and MCP-1 release (up to 100- and 6.5-fold, respectively).\n",
      "a(CHEBI:\"prostaglandin D2\") -> tloc(p(MGI:Ccl2))\n",
      "a(CHEBI:\"prostaglandin D2\") -> tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10016214 : Quinidine-treated MCF-7 cells showed elevated p21(WAF1), hypophosphorylation and suppression of retinoblastoma protein, and down-regulation of cyclin D1, similar to the cell cycle response observed with cells induced to differentiate by histone deacetylase inhibitors, trichostatin A, and trapoxin.\n",
      "a(CHEBI:quinidine) -| p(HGNC:CCND1)\n",
      "a(CHEBI:quinidine) -> p(HGNC:CDKN1A)\n",
      "a(CHEBI:quinidine) -| p(HGNC:RB1)\n",
      "a(CHEBI:quinidine) -| p(HGNC:RB1,pmod(P))\n",
      "----------------------\n",
      "10016226 : MAO-A can promote apoptosis through ROS-dependent sphingosine kinase inhibition that results in the accumulation of ceramide [64].\n",
      "a(CHEBI:\"reactive oxygen species\") -| act(p(MGI:Sphk1))\n",
      "p(MGI:Maoa) -> a(CHEBI:ceramide)\n",
      "p(MGI:Maoa) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10003564 : Secretion levels of adipokines were also changed by oxidative stress in parallel with mRNA expression levels.\n",
      "a(CHEBI:\"reactive oxygen species\") -| tloc(p(MGI:Adipoq))\n",
      "a(CHEBI:\"reactive oxygen species\") -| tloc(p(MGI:Lep))\n",
      "a(CHEBI:\"reactive oxygen species\") -| tloc(p(MGI:Retn))\n",
      "a(CHEBI:\"reactive oxygen species\") -> tloc(p(MGI:Serpine1))\n",
      "----------------------\n",
      "10003570 : Resveratrol produces changes associated with longer lifespan, including increased insulin sensitivity, reduced insulin-like growth factor-1 (IGF-I) levels, increased AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) activity, increased mitochondrial number\n",
      "a(CHEBI:resveratrol) -| p(MGI:Igf1)\n",
      "a(CHEBI:resveratrol) -> act(p(MGI:Ppargc1a))\n",
      "----------------------\n",
      "10016246 : we developed novel phosphorylation state-specific antibodies directed against Ser744 and Ser748 in the PKD activation loop (52). By using these antibodies, we demonstrate here that PKD Ser744/Ser748 phosphorylation is rapidly triggered in Swiss 3T3-PKD.GFP cells by stimulation of cells with either bombesin or PDBu (Fig. 3E).\n",
      "a(CHEBI:\"Ro 31-8220\") -> p(MGI:Prkd1,pmod(P))\n",
      "a(CHEBI:\"Ro 31-8220\") -> p(MGI:Prkd1,pmod(P))\n",
      "----------------------\n",
      "10003578 : Marimastat (100 mg/kg), dexamethasone (10 mg/kg) and rolipram (0.3 mg/kg) reduced significantly IL-6, KC/CXCL1, MIP-1alpha/CCL3 and MMP-9 levels in bronchoalveolar lavage fluid.\n",
      "a(CHEBI:rolipram) -| p(MGI:Ccl3)\n",
      "a(CHEBI:rolipram) -| p(MGI:Il6)\n",
      "a(CHEBI:rolipram) -| p(MGI:Mmp9)\n",
      "----------------------\n",
      "10003580 : Our results suggest that rolipram and amrinone decrease the immune activation in endotoxemia through inhibition of the production of pro-inflammatory mediators IL-12, IFN-gamma, TNF-alpha and NO.\n",
      "a(CHEBI:rolipram) -| p(MGI:Ifng)\n",
      "a(CHEBI:rolipram) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10003588 : Administration of rolipram, in a dose-dependent manner, significantly prevented both changes in RL and Cdyn, as well as eosinophil, lymphocyte, and neutrophil accumulation in the BALF; IL-4 and IL-5 levels in BALF were also significantly reduced.\n",
      "a(CHEBI:rolipram) -| p(MGI:Il4)\n",
      "a(CHEBI:rolipram) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10016254 : Citrate synthase, localized exclusively to the mitochondrial matrix, catalyzes the conversion of acetyl-CoA to citrate, the initial step in the TCA cycle. The activity in inguinal adipose tissue from db/db mice was significantly lower than that from db/ mice (Fig. 5B). RSG dosedependently increased the activity, reaching a plateau at 3 and 10 mg/kg.\n",
      "a(CHEBI:rosiglitazone) -> act(p(MGI:Cs))\n",
      "p(MGI:Lep) -> act(p(MGI:Cs))\n",
      "----------------------\n",
      "10016262 : Furthermore, it has been shown that activation of PPARg by the thiozolidinedione, rosiglitazaone, decreased scavenger receptor class A expresion.\n",
      "a(CHEBI:rosiglitazone) -> act(p(MGI:Pparg))\n",
      "act(p(MGI:Pparg)) -> r(MGI:Abca1)\n",
      "act(p(MGI:Pparg)) -| r(MGI:Msr1)\n",
      "----------------------\n",
      "10003598 : However, Sol AspAP and Sol pGluAP progressively decreased with the degree of saturation of the fatty acid used in the diet\n",
      "a(CHEBI:\"saturated fatty acid\") -| act(p(MGI:Dnpep))\n",
      "a(CHEBI:\"saturated fatty acid\") -| act(p(MGI:Trhde))\n",
      "----------------------\n",
      "10016268 : MAO-A, which preferentially catalyzes the oxidative deamination of norepinephrine (NE) and serotonin (5-HT), is inhibited by low concentrations of clorgyline. In contrast, MAO-B, which has a higher affinity for phenylethylamine and benzylamine, is inhibited by selegiline [79].\n",
      "a(CHEBI:selegiline) -| act(p(MGI:Maob))\n",
      "act(p(MGI:Maoa)) -| a(CHEBI:serotonin)\n",
      "----------------------\n",
      "10016292 : Two PXR ligands [pregnenolone-16alpha-carbonitrile (PCN) and spironolactone] increased Oatp1a4 mRNA expression in liver,\n",
      "a(CHEBI:spironolactone) -> act(p(MGI:Nr1i2))\n",
      "act(p(MGI:Nr1i2)) -> r(MGI:Slco1c1)\n",
      "----------------------\n",
      "10016298 : recombinant caspase-3 efficiently cleaved PARG in vitro, suggesting the involvement of this protease in PARG processing in vivo caspase-3-deficient MCF-7 cells did not show any PARG cleavage in response to staurosporine treatment\n",
      "a(CHEBI:staurosporine) -> deg(p(HGNC:PARG))\n",
      "act(p(HGNC:CASP3)) -> deg(p(HGNC:PARG))\n",
      "----------------------\n",
      "10016308 : cellular sterol deprivation results in 2 sequential proteolytic cleavages of Srebp and the release of a mature 68-kDa amino-terminal domain of the protein from the endoplasmic reticulum mature Srebp enters the nucleus and activates transcription of target genes by a process that is dependent upon the binding of Srebp and either Nfy and/or Sp1 to the proximal promoters of these genes\n",
      "a(CHEBI:sterol) -| act(p(HGNC:SREBF1))\n",
      "a(CHEBI:sterol) -| act(p(HGNC:SREBF2))\n",
      "----------------------\n",
      "10016328 : Endogenous IRE1alpha was recovered in the TRAF2 immunoprecipitates only when the cells were treated with an agent that causes ER stress (Fig. 3B). These results suggest that ER stress-induced activation of IRE1 kinase activity is important for TRAF2 recruitment, whereas endonuclease activity of IRE1 is dispensable.\n",
      "a(CHEBI:thapsigargin) -> act(p(HGNC:ERN1))\n",
      "act(p(HGNC:ERN1)) -> complex(p(HGNC:ERN1),p(HGNC:TRAF2))\n",
      "----------------------\n",
      "10016334 : ER stress led to a twofold increase in JNK activity in wild-type fibroblasts, whereas in the IRE1alpha-^sup 1^- fibroblasts JNK activity was decreased by ER stress (Fig. 2B).\n",
      "a(CHEBI:thapsigargin) -> act(p(MGI:Ern1))\n",
      "bp(GOBP:\"response to UV\") -> act(p(MGI:Ern1))\n",
      "act(p(MGI:Ern1)) -> act(p(MGI:Mapk8))\n",
      "----------------------\n",
      "10016338 : The ATF4 target genes ATF3 and CHOP were not induced by hypertonic stress at the protein level but were induced by thapsigargin, which triggers the UPR (supplemental Fig. 3A).\n",
      "a(CHEBI:thapsigargin) -> p(MGI:Atf3)\n",
      "a(CHEBI:thapsigargin) -> p(MGI:Ddit3)\n",
      "----------------------\n",
      "10016350 : Although the rates of BiP synthesis before ER stress were comparable in the two MEFs, BiP protein induction during the course of ER stress was almost completely abolished in cells lacking ATF4 expression (Fig. 3D).\n",
      "a(CHEBI:thapsigargin) -> p(MGI:Hspa5)\n",
      "p(MGI:Atf4) -> p(MGI:Hspa5)\n",
      "----------------------\n",
      "10016362 : The redox regulator thioredoxin-1 also exerts a positive effect on HIF-1a expression. Thioredoxin inhibitors block HIF-1a expression and xenograft growth.\n",
      "a(CHEBI:thioredoxin) -> p(MGI:Hif1a)\n",
      "p(MGI:Txn1) -> r(MGI:Hif1a)\n",
      "----------------------\n",
      "10016372 : Treatment of 3T3-L1 adipocytes with the PPAR{gamma} ligand troglitazone significantly increases the amount of secreted HMW adiponectin and attenuates secretion of adipsin, whereas T0070907, a PPAR{gamma} antagonist, has the opposite effect (Fig. 3A and B). Interestingly, activation of PPAR{gamma} induces expression of SIRT1 (Fig. 3A), consistent with the fact that SIRT1 expression is enhanced during adipogenesis (26).\n",
      "a(CHEBI:troglitazone) -> tloc(p(MGI:Adipoq))\n",
      "a(CHEBI:troglitazone) -| tloc(p(MGI:Cfd))\n",
      "act(p(MGI:Pparg)) -> p(MGI:Sirt1)\n",
      "act(p(MGI:Pparg)) -> tloc(p(MGI:Adipoq))\n",
      "----------------------\n",
      "10016376 : Finally, uric acid, which is the by-product of xanthine oxidase-dependent xanthine metabolism, has also been reported to mediate autocrine growth (257). Exposure of VSMC to uric acid stimulated accumulation of PDGF-A mRNA and secretion of PDGF-like material in conditioned medium (>10-fold at 24 h). Thus uric acid stimulates VSMC growth via an autocrine mechanism involving PDGF-A\n",
      "a(CHEBI:\"uric acid\") -> tloc(p(MGI:Pdgfa))\n",
      "act(p(MGI:Xdh)) -> a(CHEBI:\"uric acid\")\n",
      "----------------------\n",
      "10003638 : UA increased the protein release of IL-1beta, IL-6, and MIF, but not of TNF-alpha, in dose- and time-dependent manners.\n",
      "a(CHEBI:\"ursolic acid\") -> tloc(p(MGI:Il1b))\n",
      "a(CHEBI:\"ursolic acid\") -> tloc(p(MGI:Il6))\n",
      "a(CHEBI:\"ursolic acid\") -> tloc(p(MGI:Mif))\n",
      "----------------------\n",
      "10017960 : Cell adhesion is critical for receptor activation based on two experimental observations: (i) VEGF-A165-dependent VEGFR-2 phosphorylation was strongly activated in adherent cell, but showed a substantially reduced response in suspended cells; and\n",
      "bp(GOBP:\"cell adhesion\") -> act(p(HGNC:KDR))\n",
      "bp(GOBP:\"integrin-mediated signaling pathway\") -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10004056 : We demonstrate that the binding between AldA-NRE and p97 decreases during differentiation of human Caco-2 cells and is inversely correlated with L-type mRNA expression.\n",
      "bp(GOBP:\"cell differentiation\") -| complex(p(HGNC:ALDOA),p(HGNC:EIF4G2))\n",
      "p(HGNC:ALDOA) -| complex(p(HGNC:ALDOA),p(HGNC:EIF4G2))\n",
      "----------------------\n",
      "10004058 : In undifferentiated ES cells, there was no significant difference in gene expression in the presence or absence of Tlx3, even after ES cells were cultured for an extensive time period. In contrast, expression levels of Mash1, Ngn1, and NeuroD were significantly higher in Tlx3-expressing cells after neural induction for 4 days compared with those in cells expressing the control vector.\n",
      "bp(GOBP:\"cell differentiation\") -> act(p(MGI:Tlx3))\n",
      "act(p(MGI:Tlx3)) -> r(MGI:Acsl1)\n",
      "act(p(MGI:Tlx3)) -> r(MGI:Neurod1)\n",
      "act(p(MGI:Tlx3)) -> r(MGI:Neurog1)\n",
      "----------------------\n",
      "10004060 : During onset of irreversible growth arrest associated with terminal differentiation, the level of p21 declined with a concomitant, dramatic increase in p18 and a sustained level of p27.\n",
      "bp(GOBP:\"cell growth\") -> p(MGI:Cdkn1a)\n",
      "bp(GOBP:\"cell growth\") -| p(MGI:Cdkn2c)\n",
      "----------------------\n",
      "10004064 : Activation of poly(ADP-ribose) polymerase (PARP) by DNA breaks catalyzes poly(ADP-ribosyl)ation and results in depletion of NAD+ and ATP, which is thought to induce necrosis.\n",
      "bp(GOBP:\"cellular response to DNA damage stimulus\") -> act(p(MGI:Parp1))\n",
      "act(p(MGI:Parp1)) -| a(CHEBI:ATP)\n",
      "----------------------\n",
      "10017968 : <A4> c-Abl binds to p53 in response to 1-b-d-arabinofuransylcytosine or methylmethanesulfonate (Yuan et al., 1996); this interaction does not require c-Abl kinase activity. Moreover, c-Abl kinase activity does not require p53. Binding of c-Abl to p53 inhibits the Mdm2-mediated degradation of p53 (Sionov et al., 1999).\n",
      "bp(GOBP:\"cellular response to DNA damage stimulus\") -> complex(p(HGNC:ABL1),p(HGNC:TP53))\n",
      "complex(p(HGNC:ABL1),p(HGNC:TP53)) -| deg(p(HGNC:TP53))\n",
      "----------------------\n",
      "10004082 : Cotransfections of AQP5-luciferase with HIF-1alpha and HIF-1beta expression plasmids in MLE-15 cells led to dose-dependent transcriptional enhancement, which was partially abrogated by mutagenesis of putative HIF-1alpha binding sites in the proximal AQP5 promoter.Importantly, hypertonic induction of AQP5 was significantly inhibited by preventing HIF-1alpha induction with small interfering RNA.\n",
      "bp(GOBP:\"hyperosmotic response\") -> act(p(MGI:Hif1a))\n",
      "act(p(MGI:Hif1a)) -> r(MGI:Aqp5)\n",
      "----------------------\n",
      "10018008 : GSK3-beta is also phosphorylated in response to hormonal stimuli not involving mechanical stress, such as insulin28; this pathway, however, was unaffected in the melusin-null background.\n",
      "bp(GOBP:\"insulin receptor signaling pathway\") -| act(p(MGI:Gsk3b))\n",
      "act(p(MGI:Insr)) -| act(p(MGI:Gsk3b))\n",
      "----------------------\n",
      "10018010 : The FAK and Fyn/Shc pathways. Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Srcfamily kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (4, 7).\n",
      "bp(GOBP:\"integrin-mediated signaling pathway\") -> act(p(HGNC:ABL1))\n",
      "bp(GOBP:\"integrin-mediated signaling pathway\") -> act(p(HGNC:ILK))\n",
      "bp(GOBP:\"integrin-mediated signaling pathway\") -> act(p(HGNC:PTK2))\n",
      "----------------------\n",
      "10018016 : (38). Integrins also stimulate the p70 S6- kinase, which may promote cyclin D1 translation (39). Finally, anchorage to the ECM is necessary for the down-regulation of the Cdk 2 inhibitors p21 and p27 and, thus, the activation of cyclin E-Cdk 2\n",
      "bp(GOBP:\"integrin-mediated signaling pathway\") -| p(HGNC:CDKN1A)\n",
      "bp(GOBP:\"integrin-mediated signaling pathway\") -| p(HGNC:CDKN1B)\n",
      "----------------------\n",
      "10004096 : This induced production is enhanced after in vitro maturation of the monocytes toward macrophages but markedly decreased after maturation toward dendritic cells.\n",
      "bp(GOBP:\"macrophage activation\") -> tloc(p(MGI:Cxcl13))\n",
      "bp(GOBP:\"myeloid dendritic cell activation\") -| tloc(p(MGI:Cxcl13))\n",
      "----------------------\n",
      "10004098 : PON2 expression (mRNA and protein) and activity gradually increased during monocyte/macrophage differentiation\n",
      "bp(GOBP:\"macrophage differentiation\") -> act(p(MGI:Pon2))\n",
      "bp(GOBP:\"macrophage differentiation\") -> p(MGI:Pon2)\n",
      "----------------------\n",
      "10018042 : In response to IFN-gamma, C/EBP-beta undergoes phosphorylation at a critical ERK1/2 phosphorylation motif.\n",
      "bp(GOBP:\"MAPK cascade\") -> p(MGI:Cebpb,pmod(P))\n",
      "p(MGI:Ifng) -> p(MGI:Cebpb,pmod(P))\n",
      "----------------------\n",
      "10004108 : Although inhibitors of PKC had no effect on this suppression, MAPK inhibitors completely prevented the TPA effect. RasGRP1 activates the MAPK pathway through activation of the small G protein H-Ras.\n",
      "bp(GOBP:\"MAPK cascade\") -| surf(p(MGI:Slc12a3))\n",
      "act(p(MGI:Rasgrp1)) -> act(p(MGI:Hras))\n",
      "act(p(MGI:Hras)) -> bp(GOBP:\"MAPK cascade\")\n",
      "----------------------\n",
      "10018046 : The hsp90beta gene promoter contains binding sites for the transcription factors nuclear factor IL-6 (\\\"NF-IL6\\\") and signal transducer and activator of transcription 3 (STAT-3), which are activated respectively by the mitogen-activated-protein-kinase and Jak-kinase pathways following IL-6 treatment.\n",
      "bp(GOBP:\"MAPK cascade\") -> act(p(MGI:Cebpb))\n",
      "p(MGI:Il6) -> bp(GOBP:\"MAPK cascade\")\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Hsp90ab1)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Hsp90ab1)\n",
      "----------------------\n",
      "10018052 : Using immunocytochemistry, Bradding et al. [1Â±4] reported that interleukin (IL)-4, IL-5, IL-6, and tumour necrosis factor (TNF)-a were present within mast cells in nasal and bronchial mucosa taken from both normal subjects and patients with allergic perennial rhinitis,\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:IL4)\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:IL6)\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:TNF)\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:IL5)\n",
      "----------------------\n",
      "10018050 : Jaffe et al. [22,23] reported IL-5 and IL-13 production from human lung mast cells following IgE-mediated activation.\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:IL5)\n",
      "bp(GOBP:\"mast cell activation\") -> p(HGNC:IL13)\n",
      "----------------------\n",
      "10004112 : Chymases are highly basic chymotrypsin-like serine proteases expressed exclusively by mast cells. Large amounts of chymases complexed with heparin proteoglycan (PG) are released in vivo during mast cell activation.\n",
      "bp(GOBP:\"mast cell activation\") -> tloc(complex(a(CHEBI:heparin),p(HGNC:CMA1)))\n",
      "bp(GOBP:\"mast cell activation\") -> tloc(p(HGNC:CMA1))\n",
      "----------------------\n",
      "10018060 : Whereas FAK is phosphorylated on tyrosine upon assembly of focal adhesions, it becomes phosphorylated on serine and disassociates from Src and p130CAS during mitosis (14). These events may loosen cell-substrate contacts and allow cells to divide and move apart.\n",
      "bp(GOBP:mitosis) -> p(HGNC:PTK2,pmod(P))\n",
      "p(HGNC:PTK2,pmod(P)) -| complex(p(HGNC:PTK2),p(HGNC:GRB2),p(HGNC:SOS1))\n",
      "p(HGNC:PTK2,pmod(P)) -| act(p(HGNC:PTK2))\n",
      "----------------------\n",
      "10018076 : In the mouse system, Toxoplasma Gondii-stimulated neutrophils secrete CCL3, CCL4, CCL5 and CCL20 chemokines\n",
      "bp(GOBP:\"neutrophil activation\") -> tloc(p(MGI:Ccl20))\n",
      "bp(GOBP:\"neutrophil activation\") -> tloc(p(MGI:Ccl3))\n",
      "bp(GOBP:\"neutrophil activation\") -> tloc(p(MGI:Ccl4))\n",
      "bp(GOBP:\"neutrophil activation\") -> tloc(p(MGI:Ccl5))\n",
      "----------------------\n",
      "10018096 : ER stress induces CREB1 phosphorylation and ATF1/CREB1 binding to the Grp78 promoter. Through the use of adenoviral vector expression systems, we provide evidence that when ATF4 function is suppressed and its binding partners are not able to compensate for its function, Grp78 induction by Tg and Tu is partially inhibited.\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> complex(p(MGI:Atf1),p(MGI:Creb1))\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> p(MGI:Creb1,pmod(P))\n",
      "complex(p(MGI:Atf1),p(MGI:Creb1)) -> r(MGI:Hspa5)\n",
      "----------------------\n",
      "10004132 : We also found that TNFR1 functions downstream of IRE1 and that IRE1 is present in the same complex with TNFR1 under ER stress condition. Therefore, our study shows a novel role of TNFR1 in mediating ER stress-induced JNK activation.\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> complex(p(MGI:Tnfrsf1a),p(MGI:Ern1))\n",
      "complex(p(MGI:Tnfrsf1a),p(MGI:Ern1)) -> act(p(MGI:Tnfrsf1a))\n",
      "act(p(MGI:Ern1)) -> act(p(MGI:Tnfrsf1a))\n",
      "----------------------\n",
      "10018100 : As shown in Fig 1C, ER stressinduced JNK activation was recovered in RIP-reconstituted RIP-/- cells, even though the protein level of RIP was much lower in RIP-reconstituted cells than in WT cells (Fig 1B). These results indicate that RIP, like TRAF2, is essential for JNK activation in response to ER stress.\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> act(p(MGI:Ripk1))\n",
      "act(p(MGI:Ripk1)) -> act(p(MGI:Mapk8))\n",
      "----------------------\n",
      "10018102 : Recently, Novoa et al. (29, 31) demonstrated that GADD34, also known as Myd116 in mouse, promotes the dephosphorylation of eIF-2alpha and is induced by both ER stress and amino acid deprivation.\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> act(p(MGI:Ppp1r15a))\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -| p(MGI:Eif2s1,pmod(P))\n",
      "act(p(MGI:Ppp1r15a)) -| p(MGI:Eif2s1,pmod(P))\n",
      "----------------------\n",
      "10004134 : Insr(-/-) macrophages showed diminished Akt phosphorylation and an augmented ER stress response, leading to induction of scavenger receptor A and increased apoptosis when challenged with cholesterol loading or nutrient deprivation.\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> p(MGI:Msr1)\n",
      "act(p(MGI:Akt1)) -| p(MGI:Msr1)\n",
      "p(MGI:Insr) -| bp(GOBP:\"response to endoplasmic reticulum stress\")\n",
      "p(MGI:Insr) -> act(p(MGI:Akt1))\n",
      "----------------------\n",
      "10018104 : ATF6 has been implicated in the endoplasmic reticulum (ER) stress response pathway since it can activate expression of GRP78 and other genes induced by the ER stress response. ER stress appears to activate ATF6 by cleavage from the ER membrane and translocation to the nucleus\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> tloc(p(HGNC:ATF6))\n",
      "tloc(p(HGNC:ATF6)) -> act(p(HGNC:ATF6))\n",
      "act(p(HGNC:ATF6)) -> r(HGNC:HSPA5)\n",
      "----------------------\n",
      "10018120 : Ambient hypoxia resulted in temporally sequential CREB serine phosphorylation, ubiquitination, and degradation (in vitro and in vivo)....Thus, hypoxia establishes conditions that target CREB to proteasomal degradation.\n",
      "bp(GOBP:\"response to hypoxia\") -> deg(p(HGNC:CREB1))\n",
      "bp(GOBP:\"response to hypoxia\") -> p(HGNC:CREB1,pmod(P))\n",
      "bp(GOBP:\"response to hypoxia\") -> p(HGNC:CREB1,pmod(U))\n",
      "----------------------\n",
      "10000178 : In addition, our results demonstrate that the p42/p44 MAPK protein kinases are activated by hypoxia.\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(HGNC:MAPK1))\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10004144 : AMPK transmits a portion of the signal by which muscle contraction increases glucose uptake, but other AMPK-independent pathways also contribute to the response.\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(MGI:Prkaa2))\n",
      "act(p(MGI:Prkaa2)) -> r(MGI:Slc2a4)\n",
      "----------------------\n",
      "10018134 : In hypoxia, HIF-1A expression by densitometry was significantly (P < 0.005) reduced in hypoxic lungs and tumors. HIF-2A expression was 2-fold higher in hypoxic lungs and 2.7-fold higher in tumors from hypoxic mice compared with those in normoxia (P = 0.05; Fig. 2A and C).\n",
      "bp(GOBP:\"response to hypoxia\") -> p(MGI:Epas1)\n",
      "bp(GOBP:\"response to hypoxia\") -| p(MGI:Hif1a)\n",
      "----------------------\n",
      "10018144 : As seen in Fig. 2A, exposure to hypoxia resulted in 3.8-fold induction in HO-1 mRNA expression and 2.7-fold induction of iNOS mRNA as assessed by QPCR (P 0.001 vs. control). ...Western blot analysis showed significant increases in HO-1 and iNOS protein expression (Fig. 2B).\n",
      "bp(GOBP:\"response to hypoxia\") -> p(MGI:Hmox1)\n",
      "bp(GOBP:\"response to hypoxia\") -> p(MGI:Nos2)\n",
      "----------------------\n",
      "10004148 : Here, we demonstrate that hypoxia per se is able to induce a rapid systemic hedgehog response in adult mice, as evident from expression of the pathway ligand, Sonic hedgehog, as well as the pathway activity marker Patched1 in various organs.\n",
      "bp(GOBP:\"response to hypoxia\") -> p(MGI:Ptch1)\n",
      "bp(GOBP:\"response to hypoxia\") -> p(MGI:Shh)\n",
      "----------------------\n",
      "10018164 : We further show that p42/p44 MAPK is critical for the hypoxia-induced transactivation of endothelial PAS-domain protein 1 (EPAS1),\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(HGNC:EPAS1))\n",
      "act(p(HGNC:MAPK1)) -> act(p(HGNC:EPAS1))\n",
      "act(p(HGNC:MAPK3)) -> act(p(HGNC:EPAS1))\n",
      "----------------------\n",
      "10018168 : Thus hypoxia or DMOG exposure potently stabilizes HIF-1 and induces HIF-1-dependent transactivation in HL-1 cardiomyocytes.\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(MGI:Hif1a))\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10018170 : Under hypoxic condition, HIF proteins enhance this transcriptional activation response by co-occupying Notch target genes together with Notch ICD[30] (Fig. 2).\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(MGI:Hif1a))\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10018174 : The MEFs that were positive for HIF-1? were capable of inducing miR-210, which is in contrast to the MEFs that were deficient in HIF-1? ( Fig. 2B, top). In parallel, the hypoxia-inducible gene DEC1 was seen to be up-regulated only in the HIF-1??expressing MEFs ( Fig. 2B, bottom).\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(MGI:Hif1a))\n",
      "act(p(MGI:Hif1a)) -> r(EGID:387206)\n",
      "act(p(MGI:Hif1a)) -> r(MGI:Bhlhe40)\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10004158 : In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis.\n",
      "bp(GOBP:\"response to ionizing radiation\") -| deg(p(MGI:Trp53))\n",
      "p(MGI:Trp53) -| bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Trp53) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10018190 : Mouse embryonic fibroblasts (MEFs) from C57BL/6 mice (S/S) treated for 1 h with hypertonic media showed increased eIF2a phosphorylation with increasing stress intensity, without a change in total eIF2A (Fig. 1A). As shown in earlier studies, osmotic stress reduced the phosphorylation of ribosomal protein S6 and 4EBP1 consistent with the inhibition of the mammalian target of rapamycin pathway (25).\n",
      "bp(GOBP:\"response to osmotic stress\") -> p(MGI:Eif2s1,pmod(P))\n",
      "bp(GOBP:\"response to osmotic stress\") -| p(MGI:Eif4ebp1,pmod(P))\n",
      "bp(GOBP:\"response to osmotic stress\") -| p(MGI:Rps6,pmod(P))\n",
      "bp(GOBP:\"response to osmotic stress\") -| p(MGI:Rps6,pmod(P))\n",
      "----------------------\n",
      "10018204 : oxidative and electrophilic stresses induce the nuclear accumulation of Nrf2 by affecting the Keap1-mediated rapid turnover of Nrf2\n",
      "bp(GOBP:\"response to oxidative stress\") -| complex(p(MGI:Keap1),p(MGI:Nfe2l2))\n",
      "bp(GOBP:\"response to oxidative stress\") -> act(p(MGI:Nfe2l2))\n",
      "----------------------\n",
      "10018206 : We have shown that FOXO3 and p53 are acetylated when SIRT1 is reduced in response to oxidants/CS exposure in mouse lung and in lung epithelial cells [39] and [158] S. Rajendrasozhan, S.R. Yang, S. Caito and I. Rahman, Am. J. Respir. Crit. Care Med. 177 (2008), p. A266.[158]\n",
      "bp(GOBP:\"response to oxidative stress\") -> p(MGI:Foxo3,pmod(A))\n",
      "bp(GOBP:\"response to oxidative stress\") -> p(MGI:Trp53,pmod(A))\n",
      "----------------------\n",
      "10004170 : Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies.\n",
      "bp(GOBP:\"response to oxidative stress\") -> act(p(MGI:Bach2))\n",
      "act(p(MGI:Bach2)) -| act(p(MGI:Maf))\n",
      "----------------------\n",
      "10018212 : These results suggest that Bach1 is a negative regulator of the p53-mediated senescence program in response to oxidative stress, although Bach1 could be either parallel or upstream to p53 in this process.\n",
      "bp(GOBP:\"response to oxidative stress\") -> act(p(MGI:Trp53))\n",
      "act(p(MGI:Bach1)) -| act(p(MGI:Trp53))\n",
      "act(p(MGI:Trp53)) -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "bp(GOBP:\"response to oxidative stress\") -> act(p(HGNC:TP53))\n",
      "----------------------\n",
      "10018248 : Whereas UV treatment led to robust JNK activation in both WT and TNFR1-/- cells, TNF activates JNK only in WT and not in TNFR1-/- cells.\n",
      "bp(GOBP:\"response to UV\") -> act(p(MGI:Mapk8))\n",
      "p(MGI:Tnf) -> act(p(MGI:Mapk8))\n",
      "----------------------\n",
      "10018250 : Elk-1 is phosphorylated by both kinases (MAPK8 and MAPK9) , each of which is strongly stimulated by pre-treatment of cells with ultraviolet light.\n",
      "bp(GOBP:\"response to UV\") -> act(p(MGI:Mapk8))\n",
      "bp(GOBP:\"response to UV\") -> act(p(MGI:Mapk9))\n",
      "act(p(MGI:Mapk8)) -> p(MGI:Elk1,pmod(P))\n",
      "act(p(MGI:Mapk9)) -> p(MGI:Elk1,pmod(P))\n",
      "----------------------\n",
      "10018254 : p53 and p21 expression was increased by 2- and 5-fold, respectively, 3 days post-UV in Egfr-wild-type skin when compared with sham-irradiated controls (Figure 5). Both p21 and p53 expression were elevated several fold in Egfr-null compared with wild-type skin at both 24 and 48 h post-UV (Figure 5).\n",
      "bp(GOBP:\"response to UV\") -> p(MGI:Cdkn1a)\n",
      "bp(GOBP:\"response to UV\") -> p(MGI:Trp53)\n",
      "----------------------\n",
      "10018268 : Interleukin (IL)-17 is a pro-inflammatory cytokine that is produced by activated T cells. We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion. IL-23 also induced expression of the related cytokine IL-17F.IL-23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles.\n",
      "bp(GOBP:\"T cell activation\") -> p(MGI:Il17a)\n",
      "bp(GOBP:\"T cell activation\") -> p(MGI:Il17f)\n",
      "----------------------\n",
      "10004184 : To examine mechanisms of VPAC(2) promotion of the Th2 phenotype, we analyzed controls of IL-4 transcription in CD4 T cells from T cell-targeted VPAC(2) transgenic (Tg), VPAC(2) knockout, and wild-type (WT) mice. c-maf and junB mRNA, protein, and activity were significantly up-regulated to a higher level in TCR-stimulated CD4 T cells from Tg mice compared with those from knockout and WT C57BL/6 mice.\n",
      "bp(GOBP:\"T cell activation\") -> p(MGI:Maf)\n",
      "bp(GOBP:\"T cell activation\") -> act(p(MGI:Junb))\n",
      "----------------------\n",
      "10018270 : Taken together, these results indicate that IRF8 is induced during T-cell activation, and that TH17-cell differentiation is enhanced in cells deficient in IRF8.\n",
      "bp(GOBP:\"T cell activation\") -> act(p(MGI:Irf8))\n",
      "p(MGI:Irf8) -| bp(GOBP:\"T-helper 17 cell differentiation\")\n",
      "----------------------\n",
      "10018280 : The accumulation of beta-catenin results from the inhibition of the GSK3b kinase, which normally would phosphorylate beta-catenin as a degradation signal.\n",
      "bp(GOBP:\"Wnt receptor signaling pathway\") -| act(p(MGI:Gsk3b))\n",
      "act(p(MGI:Gsk3b)) -> deg(p(MGI:Ctnnb1))\n",
      "act(p(MGI:Gsk3b)) -| p(MGI:Ctnnb1)\n",
      "act(p(HGNC:GSK3B)) -| p(HGNC:CTNNB1)\n",
      "----------------------\n",
      "10018288 : both Pla2g6 and cPLA2 are activated during apoptosis Pla2g6 is involved in the hydrolysis of plasma membrane phospholipids and exposure of the epitope recognized by IgM\n",
      "bp(GOBP:\"apoptotic process\") -> act(p(MGI:Pla2g4a))\n",
      "bp(GOBP:\"apoptotic process\") -> act(p(MGI:Pla2g6))\n",
      "p(MGI:Pla2g6) -| a(CHEBI:phospholipid)\n",
      "p(MGI:Pla2g6) -> act(p(MGI:Ighm))\n",
      "----------------------\n",
      "10018286 : Eukaryotic initiation factor (eIF) 4B interacts with several components of the initiation pathway and is targeted for cleavage during apoptosis. In a cell-free system, cleavage of eIF4B by caspase-3 coincides with a general inhibition of protein synthetic activity.\n",
      "bp(GOBP:\"apoptotic process\") -> deg(p(HGNC:EIF4B))\n",
      "act(p(HGNC:CASP3)) -> deg(p(HGNC:EIF4B))\n",
      "----------------------\n",
      "10018300 : Necrotic but not apoptotic cell death leads to release of HSP gp96, calreticulin, hsp90 and hsp70.\n",
      "bp(GOBP:\"necrotic cell death\") -> tloc(p(HGNC:CALR))\n",
      "bp(GOBP:\"necrotic cell death\") -> tloc(p(HGNC:HSP90AA1))\n",
      "bp(GOBP:\"necrotic cell death\") -> tloc(p(HGNC:HSP90B1))\n",
      "----------------------\n",
      "10018334 : Certain integrins may regulate proliferation by additional mechanisms. For example, the a6b1 integrin may in part promote exit from the cell cycle in myoblasts, because the cytoplasmic domain of a6 inhibits paxillin signaling (44).\n",
      "act(complex(p(HGNC:ITGA6),p(HGNC:ITGB1))) -| p(HGNC:PXN)\n",
      "p(HGNC:PXN) -> bp(GOBP:\"cell cycle\")\n",
      "----------------------\n",
      "10018346 : Alternatively, this integrin complex can interact with tenascin-C, thus favoring the clustering of EGF receptors and EGF-dependent growth (Jones et al., 1997).\n",
      "act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) -> act(p(HGNC:EGFR))\n",
      "p(HGNC:TNC) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))\n",
      "----------------------\n",
      "10018348 : For example, avb3 associates with the PDGF receptor, and fibroblasts show greater proliferation in response to PDGFb when adhering to the avb3 ligand vitronectin than when they adhere to the b1 integrin ligand collagen (26).\n",
      "act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) -> act(p(HGNC:PDGFRA))\n",
      "act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) -> act(p(HGNC:PDGFRB))\n",
      "p(HGNC:VTN) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))\n",
      "----------------------\n",
      "10004212 : These results suggest that POEM is a novel ligand for alpha(8)beta(1) integrin and that POEM may be involved in the development and function of various tissues, such as kidney, bone, muscles, and endocrine organs.\n",
      "act(complex(p(MGI:Itga8),p(MGI:Itgb1))) -> bp(GOBP:\"cell adhesion\")\n",
      "complex(p(MGI:Npnt),p(MGI:Itga8),p(MGI:Itgb1)) -> bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Npnt) -> bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Npnt) -> act(complex(p(MGI:Itga8),p(MGI:Itgb1)))\n",
      "----------------------\n",
      "10018354 : To examine whether D2 can support leukocyte migration, we have examined the ability of vitronectin, as a representative ECM protein, to mediate migration of IC-21 cells. As shown in Figure 5B, cells efficiently migrated toward vitronectin and this process depended on both D2 and M2 because anti-D polyclonal antibody and anti-M mAb M1/70 blocked the response.\n",
      "act(complex(p(MGI:Itgad),p(MGI:Itgb2))) -> act(p(MGI:Vtn))\n",
      "act(complex(p(MGI:Itgam),p(MGI:Itgb2))) -> act(p(MGI:Vtn))\n",
      "----------------------\n",
      "10018356 : In this study, we show that purified Fisp12 (mCTGF) protein promotes the adhesion of microvascular endothelial cells through the integrin receptor alphavbeta3.\n",
      "act(complex(p(MGI:Itgav),p(MGI:Itgb3))) -> bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Ctgf) -> bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Ctgf) -> act(complex(p(MGI:Itgav),p(MGI:Itgb3)))\n",
      "----------------------\n",
      "10004218 : Furthermore, Fisp12 stimulates the migration of microvascular endothelial cells in culture, also through an integrin-alphavbeta3-dependent mechanism.\n",
      "act(complex(p(MGI:Itgav),p(MGI:Itgb3))) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Ctgf) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10004230 : Furthermore, TSGA impairs the ability of ER71 to activate transcription from the matrix metalloproteinase-1 promoter.\n",
      "act(p(EGID:104263)) -| act(p(MGI:Etv2))\n",
      "act(p(MGI:Etv2)) -> r(MGI:Mmp13)\n",
      "----------------------\n",
      "10018374 : In addition to chemotaxis, Fprs also mediate neutrophil activation by Listeria lysate as shown by increased phosphorylation of extracellular regulatory kinase (Erk) 1/2 in WT mouse neutrophils, which was reduced by Fpr1 or Fpr2 antagonist.\n",
      "act(p(EGID:116816)) -> act(p(MGI:Mapk1))\n",
      "act(p(EGID:116816)) -> act(p(MGI:Mapk3))\n",
      "act(p(EGID:116817)) -> act(p(MGI:Mapk1))\n",
      "act(p(EGID:116817)) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10004232 : RICS is mainly expressed in the brain and functions as a RhoGAP protein for Cdc42 and Rac1 in vitro.\n",
      "act(p(EGID:330914)) -| act(p(MGI:Cdc42))\n",
      "act(p(EGID:330914)) -| act(p(MGI:Rac1))\n",
      "----------------------\n",
      "10004236 : Interleukin 8 (IL-8) activation of the chemokine receptor CXCRI was found to stimulate rapid formation of beta-arrestin complexes with Hck or c-Fgr. Formation of beta-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions.\n",
      "act(p(EGID:3577)) -> complex(p(HGNC:FGR),p(HGNC:AP2B1))\n",
      "act(p(EGID:3577)) -> complex(p(HGNC:HCK),p(HGNC:AP2B1))\n",
      "complex(p(HGNC:HCK),p(HGNC:AP2B1)) -> act(p(HGNC:HCK))\n",
      "p(HGNC:IL8) -> act(p(EGID:3577))\n",
      "----------------------\n",
      "10004242 : ADAM 12-S has IGFBP-3 protease activity, and it may contribute to the IGFBP-3 protease activity present in pregnancy serum.\n",
      "act(p(HGNC:ADAM12)) -> deg(p(HGNC:IGFBP3))\n",
      "deg(p(HGNC:IGFBP3)) -> p(HGNC:IGF1)\n",
      "p(HGNC:IGF1) -> act(p(HGNC:IGF1R))\n",
      "----------------------\n",
      "10018384 : Importantly, the increase in LOX-1 mRNA expression in response to Ang II was completely blocked by losartan, a specific AT1 blocker, but not by PD123319, a specific AT2 blocker (n56, Figure 5). The increased LOX-1 protein expression in response to Ang II was also blocked by pretreatment of HCAECs with losartan, but not with PD123319 (n56, Figure 6).\n",
      "act(p(HGNC:AGTR1)) -> p(HGNC:OLR1)\n",
      "act(p(HGNC:AGTR1)) -> r(HGNC:OLR1)\n",
      "----------------------\n",
      "10018392 : We have recently identified two novel stimulators of OCL osteoclast formation, annexin II and osteoclast stimulatory factor (3), and an inhibitor of OCL formation,human ScaI\n",
      "act(p(HGNC:ANXA2)) -> bp(GOBP:\"osteoclast differentiation\")\n",
      "act(p(HGNC:ATXN1)) -| bp(GOBP:\"osteoclast differentiation\")\n",
      "----------------------\n",
      "10018394 : The mutational inactivation of a tumor suppressor gene, adenomatous polyposis coli (APC), results in the accumulation of cytoplasmic beta-catenin protein and the activation of T-cell factor (TCF)/lymphoid enhancer factor transcriptional factors.\n",
      "act(p(HGNC:APC)) -| p(HGNC:CTNNB1)\n",
      "act(p(HGNC:APC)) -| act(p(HGNC:LEF1))\n",
      "----------------------\n",
      "10018408 : This freed Bim to translocate together with LC8 to Bcl-2 and to neutralize its antiapoptotic activity.\n",
      "act(p(HGNC:BCL2L11)) -> complex(p(HGNC:BCL2),p(HGNC:BCL2L11))\n",
      "complex(p(HGNC:BCL2),p(HGNC:BCL2L11)) -| act(p(HGNC:BCL2))\n",
      "----------------------\n",
      "10000142 : Because Cabin-1 also associates with mSin3a and histone deacetylases 1 and 2 (HDAC1/2), its dissociation from MEF2 may replace a repressing complex with an activating complex (51). In a like manner, MEF2 binds and is repressed by HDAC4 but is released by Ca2+/CaM binding to HDAC4 (52).\n",
      "act(p(HGNC:CALM1)) -| complex(p(HGNC:MEF2A),p(HGNC:HDAC4))\n",
      "complex(p(HGNC:MEF2A),p(HGNC:HDAC4)) -| act(p(HGNC:MEF2A))\n",
      "----------------------\n",
      "10018422 : Caspase-3 cleaves Bcl-2 and Bcl-XL, which destroys the anti-apoptotic function of these proteins and releases C-terminal fragments that are pro-apoptotic.\n",
      "act(p(HGNC:CASP3)) -| act(p(HGNC:BCL2))\n",
      "act(p(HGNC:CASP3)) -| act(p(HGNC:BCL2L1))\n",
      "----------------------\n",
      "10004290 : Following FAS stimulation, caspase-8 activates caspase-3, which in turn activates the caspase-activated DNAse (CAD) by proteolysis of its inhibitor (ICAD)\n",
      "act(p(HGNC:CASP3)) -| act(p(HGNC:DFFA))\n",
      "act(p(HGNC:CASP3)) -> act(p(HGNC:DFFB))\n",
      "act(p(HGNC:CASP8)) -> act(p(HGNC:CASP3))\n",
      "p(HGNC:FAS) -> act(p(HGNC:CASP8))\n",
      "----------------------\n",
      "10018432 : Caspase-3 also cleaves and activates gelsolin, a protein that regulates actin dynamics. Interestingly, activated gelsolin promotes both cytoplasmic and nuclear apoptosis, including DNA fragmentation.\n",
      "act(p(HGNC:CASP3)) -> act(p(HGNC:GSN))\n",
      "act(p(HGNC:GSN)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10000920 : These results suggest that PKC eta protects MCF-7 cells against TNF-induced cell death by preventing the activation of caspases.\n",
      "act(p(HGNC:CASP7)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP8)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10002144 : Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation.\n",
      "act(p(HGNC:CCL4)) -> act(p(HGNC:SYK))\n",
      "act(p(HGNC:PTK2B)) -> act(p(HGNC:SYK))\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "p(HGNC:CCL4) -> act(p(HGNC:CCR5))\n",
      "----------------------\n",
      "10000958 : Following exposure to either CD40-specific mAbs or the soluble trimeric ligand (sCD40L), high responder (HR) lines showed rapid aggregation, activation of NF-kappa B, up-regulation of cell surface markers ICAM-1/CD54 and Fas/CD95, and growth inhibition\n",
      "act(p(HGNC:CD40)) -| bp(GOBP:\"cell growth\")\n",
      "act(p(HGNC:CD40)) -> r(HGNC:FAS)\n",
      "act(p(HGNC:CD40)) -> r(HGNC:ICAM1)\n",
      "----------------------\n",
      "10018458 : Importantly, CD40 ligation enhanced the sensitivity of airway epithelial cells to the effects of TNF-alpha and/or IL-1beta on expression of RANTES, MCP-1, IL-8, and VCAM-1. In contrast, neither IL-4 nor IL-13 modified the effects of CD40 engagement on the expression of RANTES, MCP-1, IL-8, or VCAM-1; however, both IL-4 and IL-13 attenuated the effects of CD40 cross-linking on ICAM-1 expression\n",
      "act(p(HGNC:CD40)) -> p(HGNC:CCL2)\n",
      "act(p(HGNC:CD40)) -> p(HGNC:CCL5)\n",
      "act(p(HGNC:CD40)) -> p(HGNC:ICAM1)\n",
      "act(p(HGNC:CD40)) -> p(HGNC:IL8)\n",
      "----------------------\n",
      "10004310 : SB203580 strongly blocked CD40-induced IL-12 p40 production in DCs at both mRNA and protein levels, while having minimal effect on CD40-induced expression of the chemokine RANTES.\n",
      "act(p(HGNC:CD40)) -> r(HGNC:CCL5)\n",
      "p(HGNC:CD40) -> r(HGNC:IL12B)\n",
      "----------------------\n",
      "10018466 : Importantly, the heparin proteoglycan-bound chymase, but not unbound chymase, degraded its inhibitor (alpha1-antitrypsin) in the presence of its substrate (HDL3).\n",
      "act(p(HGNC:CMA1)) -> deg(p(HGNC:SERPINA1))\n",
      "act(p(HGNC:SERPINA1)) -| act(p(HGNC:CMA1))\n",
      "----------------------\n",
      "10018476 : uPA is secreted as an inactive single-chain proenzyme. Secreted pro-uPA binds to the uPA receptor (uPAR) present on many different cell types. Cleavage of pro-uPA by plasmin, Factor XIIa or cathepsin B yields the active enzyme consisting of two disulfide-linked chains (17).\n",
      "act(p(HGNC:CTSB)) -> act(p(HGNC:PLAU))\n",
      "act(p(HGNC:F12)) -> act(p(HGNC:PLAU))\n",
      "act(p(HGNC:PLG)) -> act(p(HGNC:PLAU))\n",
      "----------------------\n",
      "10018490 : Thus, mTOR also controls eIF4E function, which is particularly important in the translation of mRNAs containing a highly structured 5' untranslated region (UTR), such as the transcripts encoding cyclin D1 and the c-myc oncogene ([82]).\n",
      "act(p(HGNC:EIF4E)) -> p(HGNC:CCND1)\n",
      "act(p(HGNC:EIF4E)) -> p(HGNC:MYC)\n",
      "----------------------\n",
      "10004342 : IFN-gamma induced Fas expression of the cells without the activation of caspase8 or caspase3 during 16 hours of incubation, while deprivation of EPO induced expression of Fas and the activation of both caspase8 and caspase3\n",
      "act(p(HGNC:EPO)) -| act(p(HGNC:CASP3))\n",
      "act(p(HGNC:EPO)) -| act(p(HGNC:CASP8))\n",
      "act(p(HGNC:EPO)) -| r(HGNC:FAS)\n",
      "p(HGNC:IFNG) -> r(HGNC:FAS)\n",
      "----------------------\n",
      "10000096 : Stimulation of human platelets with thrombin or thrombin receptor agonist peptide (TRAP/ Ser-Phe-Leu-Leu-Arg-Asn) resulted in phosphorylation of the protease-activated receptor 1 (PAR1)\n",
      "act(p(HGNC:F2)) -> act(p(HGNC:F2R))\n",
      "act(p(HGNC:F2)) -> p(HGNC:F2R,pmod(P))\n",
      "p(HGNC:F2R,pmod(P)) -> act(p(HGNC:F2R))\n",
      "----------------------\n",
      "10004386 : ligation of Fas induces expression of the chemokines macrophage inflammatory protein-1beta (MIP-1beta), MIP-1alpha, and MIP-2\n",
      "act(p(HGNC:FAS)) -> r(HGNC:CCL3)\n",
      "act(p(HGNC:FAS)) -> r(HGNC:CCL4)\n",
      "act(p(HGNC:FAS)) -> r(HGNC:CXCL2)\n",
      "----------------------\n",
      "10018538 : We found that fMLP, ... induced macrophage inflammatory protein (MIP)-1ss (CCL4) and monocyte chemoattractant protein-1 (CCL2) mRNA and protein.\n",
      "act(p(HGNC:FPR1)) -> r(HGNC:CCL2)\n",
      "act(p(HGNC:FPR1)) -> r(HGNC:CCL4)\n",
      "----------------------\n",
      "10018568 : The mannose 6-phosphate/IGF2 receptor (M6P/IGF2R) plays a key role in regulating cell growth, by ensuring the clearance and inactivation of IGF-II and facilitating activation of the growth inhibitor, transforming growth factor beta (TGFbeta1).\n",
      "act(p(HGNC:IGF2R)) -> bp(GOBP:\"cell growth\")\n",
      "complex(p(HGNC:IGF2R),p(HGNC:IGF2)) -> deg(p(HGNC:IGF2))\n",
      "complex(p(HGNC:IGF2R),p(HGNC:IGF2)) -| p(HGNC:IGF2)\n",
      "----------------------\n",
      "10018572 : The suppressive effect of IL-18 on PGE(2) production was mediated by interferon (IFN)-gamma because anti-human IFN-gamma-antibody prevented IL-18-induced reduction in PGE(2).\n",
      "act(p(HGNC:IL18R1)) -> p(HGNC:IFNG)\n",
      "p(HGNC:IL18) -> p(HGNC:IFNG)\n",
      "----------------------\n",
      "10001026 : the association of lyn with IL-2Rbeta was markedly elevated by IL-2 stimulation. Furthermore the activity of lyn kinase, evaluated by an in vitro kinase assay with enolase as a substrate, increased following IL-2 stimulation.\n",
      "act(p(HGNC:IL2RB)) -> act(p(HGNC:LYN))\n",
      "p(HGNC:IL2) -> act(p(HGNC:IL2RB))\n",
      "----------------------\n",
      "10018580 : Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.\n",
      "act(p(HGNC:IL6R)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:IL6R) -> act(p(HGNC:MAPK1))\n",
      "----------------------\n",
      "10018586 : In addition to activating FAK, some b1 and av integrins also activate the tyrosine kinase Fyn and, through it, the adapter protein Shc (4).\n",
      "act(p(HGNC:ITGAV)) -> act(p(HGNC:FYN))\n",
      "act(p(HGNC:ITGB1)) -> act(p(HGNC:FYN))\n",
      "----------------------\n",
      "10018588 : The degree of FAK activation during myogenesis by b1A-integrin signaling can regulate myoblast progression through proliferation and differentiation (52).\n",
      "act(p(HGNC:ITGB1)) -> bp(GOBP:\"myoblast differentiation\")\n",
      "act(p(HGNC:PTK2)) -> bp(GOBP:\"myoblast differentiation\")\n",
      "----------------------\n",
      "10018592 : Downstream Signaling Mediator: FAK FAK is recruited to focal adhesion complexes. The clustering of integrins and formation of the focal adhesion complex can induce tyrosine phosphorylation of FAK, as can other stimuli (32, 54).\n",
      "act(p(HGNC:ITGB1)) -> act(p(HGNC:PTK2))\n",
      "act(p(HGNC:ITGB1)) -> p(HGNC:PTK2,pmod(P))\n",
      "p(HGNC:PTK2,pmod(P)) -> act(p(HGNC:PTK2))\n",
      "----------------------\n",
      "10018602 : Ectopic expression of galectin-12 in cancer cells causes cell cycle arrest at the G(1) phase and cell growth suppression. We conclude that galectin-12 is a novel regulator of cellular homeostasis.\n",
      "act(p(HGNC:LGALS12)) -| bp(GOBP:\"cell cycle\")\n",
      "act(p(HGNC:LGALS12)) -| bp(GOBP:\"cell growth\")\n",
      "----------------------\n",
      "10018604 : POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates.\n",
      "act(p(HGNC:LIG3)) -> bp(GOBP:\"base-excision repair\")\n",
      "act(p(HGNC:POLB)) -> bp(GOBP:\"base-excision repair\")\n",
      "act(p(HGNC:POLB)) -> complex(p(HGNC:XRCC1),p(HGNC:LIG3))\n",
      "complex(p(HGNC:XRCC1),p(HGNC:LIG3)) -> act(p(HGNC:LIG3))\n",
      "----------------------\n",
      "10018610 : <p30> p53 is rapidly degraded by the process of ubiquitiation and proteasome. <p31> mdm2 stimulates p53 degradation\n",
      "act(p(HGNC:MDM2)) -> deg(p(HGNC:TP53))\n",
      "p(HGNC:MDM2) -> deg(p(HGNC:TP53))\n",
      "----------------------\n",
      "10001474 : In vitro sumoylation of Mdm2 abrogates its self-ubiquitination and increases its ubiquitin ligase activity toward p53\n",
      "act(p(HGNC:MDM2)) -> deg(p(HGNC:TP53))\n",
      "p(HGNC:SUMO1) -> act(p(HGNC:MDM2))\n",
      "p(HGNC:SUMO1) -| deg(p(HGNC:MDM2))\n",
      "p(HGNC:SUMO1) -> deg(p(HGNC:TP53))\n",
      "----------------------\n",
      "10018612 : Figure 2. Inhibition by doxycycline (DOXY) of digestion of type II collagen by collagenases 1, 2, or 3.\n",
      "act(p(HGNC:MMP13)) -> deg(p(HGNC:COL2A1))\n",
      "act(p(HGNC:MMP1)) -> deg(p(HGNC:COL2A1))\n",
      "act(p(HGNC:MMP8)) -> deg(p(HGNC:COL2A1))\n",
      "----------------------\n",
      "10018620 : MyD88 initiates a signaling pathway which sequentially involves IL-1R-associated kinase 1 (IRAK1), tumor necrosis factor-{alpha} receptor (TNFR)-associated factor 6 (TRAF6) and nuclear factor (NF)-{kappa}B-inducing kinase (NIK) (Medzhitov et al., 1998; Muzio et al., 1998a; O'Neill and Greene, 1998; Kopp and Medzhitov, 1999; Yang et al., 1999; Zhang et al., 1999).\n",
      "act(p(HGNC:MYD88)) -> act(p(HGNC:IRAK1))\n",
      "p(HGNC:MYD88) -> p(HGNC:TRAF6)\n",
      "----------------------\n",
      "10018624 : Using reporter systems, we found that both the basal activation and the T3-dependent activation mediated by TRbeta1 were repressed by Ear-2 in CV1 cells. The repression effect of Ear-2 was reversed by steroid hormone receptor coactivator 1.\n",
      "act(p(HGNC:NCOA1)) -| act(p(HGNC:NR2F6))\n",
      "act(p(HGNC:NR2F6)) -| act(p(HGNC:THRB))\n",
      "----------------------\n",
      "10018632 : These findings demonstrate that sensitization of human ovarian carcinoma cell lines to Fas-mediated apoptosis by IFN-gamma can be due, in part, to the induction of iNOS and the subsequent upregulation of Fas gene expression by reactive nitrogen intermediates\n",
      "act(p(HGNC:NOS2)) -> a(CHEBI:\"nitric oxide\")\n",
      "act(p(HGNC:NOS2)) -> r(HGNC:FAS)\n",
      "p(HGNC:IFNG) -> act(p(HGNC:NOS2))\n",
      "----------------------\n",
      "10018648 : Moreover, the phosphorylation and activation of PDE3B correlates with the inactivation of PKA and the dephosphorylation of HSL\n",
      "act(p(HGNC:PDE3B)) -| p(HGNC:LIPE,pmod(P))\n",
      "p(HGNC:PDE3B,pmod(P)) -> act(p(HGNC:PDE3B))\n",
      "----------------------\n",
      "10000170 : The interaction of uPA with its receptor concentrates the enzyme activity to the so-called \\\"focal attachment sites\\\" on the cell surface and stimulates signal transduction through the uPAR, leading to induction of cell migration and invasion (19).\n",
      "act(p(HGNC:PLAU)) -> complex(p(HGNC:PLAU),p(HGNC:PLAUR))\n",
      "act(p(HGNC:PLAUR)) -> bp(GOBP:\"cell migration\")\n",
      "complex(p(HGNC:PLAU),p(HGNC:PLAUR)) -> act(p(HGNC:PLAUR))\n",
      "----------------------\n",
      "10018652 : In addition, plasmin may activate several matrix metalloproteinases such as MMP-1, MMP-3 and MMP-9 (163).\n",
      "act(p(HGNC:PLG)) -> act(p(HGNC:MMP1))\n",
      "act(p(HGNC:PLG)) -> act(p(HGNC:MMP3))\n",
      "act(p(HGNC:PLG)) -> act(p(HGNC:MMP9))\n",
      "----------------------\n",
      "10018666 : Eosinophils Human Superoxide production Human Transmigration through epithelial cells Human Transmigration through Matrigel Human CD11b/CD18 (Mac-1) translocation, degranulation Human IL-8 release\n",
      "act(p(HGNC:PTAFR)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:PTAFR)) -> p(HGNC:IL8)\n",
      "----------------------\n",
      "10018674 : We also have found that an active site-containing domain of RPTP beta zeta both binds beta-catenin and functionally reduces its levels of tyrosine phosphorylation Finally, in parallel to its ability to inactivate endogenous RPTP beta zeta, PTN sharply increases tyrosine phosphorylation of beta-catenin in PTN-treated cells\n",
      "act(p(HGNC:PTN)) -> p(HGNC:CTNNB1,pmod(P))\n",
      "act(p(HGNC:PTPRB)) -| p(HGNC:CTNNB1,pmod(P))\n",
      "----------------------\n",
      "10004488 : RasGRP2 also catalyzes nucleotide exchange on Rap1, but this RapGEF activity is less potent than that associated with CalDAG-GEFI.\n",
      "act(p(HGNC:RASGRP2)) -> act(p(HGNC:RAP1A))\n",
      "act(p(HGNC:RASGRP2)) -> act(p(HGNC:RAP1B))\n",
      "----------------------\n",
      "10018684 : TNF-sensitive cells, when exposed to 4-10 microg/ml concentrations of TIP-B1 prior to the addition of TNF, are completely protected from TNF-induced lysis. Furthermore, TIP-B1 protects cells from apoptotic lysis induced by TNF.\n",
      "act(p(HGNC:SH3BGRL3)) -| p(HGNC:TNF)\n",
      "p(HGNC:TNF) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10004502 : Ectopic expression of Smurf2 was sufficient to reduce the steady-state levels of Smad1 and Smad2 but not Smad3 or Smad4\n",
      "act(p(HGNC:SMURF2)) -> deg(p(HGNC:SMAD1))\n",
      "act(p(HGNC:SMURF2)) -> deg(p(HGNC:SMAD2))\n",
      "----------------------\n",
      "10004504 : In this study we show that CD43 ligation on human normal peripheral T cells was sufficient to induce interleukin-2, CD69, and CD40-L gene expression, without requiring signals provided by additional receptor molecules.\n",
      "act(p(HGNC:SPN)) -> r(HGNC:CD40LG)\n",
      "act(p(HGNC:SPN)) -> r(HGNC:CD69)\n",
      "act(p(HGNC:SPN)) -> r(HGNC:IL2)\n",
      "----------------------\n",
      "10004506 : AP-1 complexes bound to the AP-1 sequence contained c-Jun, and those bound to the NF-AT-AP-1 composite site contained c-Jun and Fos.\n",
      "act(p(HGNC:SPN)) -> act(p(HGNC:FOS))\n",
      "act(p(HGNC:SPN)) -> act(p(HGNC:JUN))\n",
      "----------------------\n",
      "10018698 : We show here that the N-terminal inhibitory domain of TIMP-3, a member of the TIMP family that has functional properties distinct from other TIMPs, is a strong inhibitor of human aggrecanases 1 and 2, with K(i) values in the subnanomolar range.\n",
      "act(p(HGNC:TIMP3)) -| act(p(HGNC:ADAMTS4))\n",
      "act(p(HGNC:TIMP3)) -| act(p(HGNC:ADAMTS5))\n",
      "----------------------\n",
      "10004510 : Here we show that TLR2 stimulation by Staphylococcus aureus induces a fast and transient activation of the Rho GTPases Rac1 and Cdc42 in the human monocytic cell line THP-1 and in 293 cells expressing TLR2.\n",
      "act(p(HGNC:TLR2)) -> act(p(HGNC:CDC42))\n",
      "act(p(HGNC:TLR2)) -> act(p(HGNC:RAC1))\n",
      "----------------------\n",
      "10018702 : Here we show that TRAIL-R1-, TRAIL-R2-, and TRAIL-R4-induced NF-kappaB activation are mediated by a TRAF2-NIK-IkappaB kinase alpha/beta signaling cascade but is MEKK1 independent.\n",
      "act(p(HGNC:TNFRSF10A)) -> act(p(HGNC:TRAF2))\n",
      "act(p(HGNC:TNFRSF10B)) -> act(p(HGNC:TRAF2))\n",
      "----------------------\n",
      "10018706 : Adipocyte precursor cells exposed to the 60-kDa TNF receptor (p60-TNFR)-specific TNF(R32W-S86T) showed a marked decrease in the percentage of differentiating cells in response to adipogenic factors as well as a reduction in peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) messenger RNA (mRNA) and glycerophosphate dehydrogenase (GPDH) activity, but increased endogenous TNF mRNA expression\n",
      "act(p(HGNC:TNFRSF1A)) -| r(HGNC:PPARG)\n",
      "p(HGNC:TNFRSF1A) -| bp(GOBP:\"fat cell differentiation\")\n",
      "p(HGNC:TNFRSF1A) -| act(p(HGNC:GPD1))\n",
      "p(HGNC:TNFRSF1A) -> r(HGNC:TNF)\n",
      "----------------------\n",
      "10004522 : When cells were incubated with the p80-TNFR-specific TNF(D143N-A145R), adipogenesis and PPARgamma2 mRNA expression were stimulated, GPDH activity was unchanged, and TNF mRNA was completely suppressed\n",
      "act(p(HGNC:TNFRSF1B)) -> r(HGNC:PPARG)\n",
      "p(HGNC:TNFRSF1B) -> bp(GOBP:\"fat cell differentiation\")\n",
      "p(HGNC:TNFRSF1B) -| r(HGNC:TNF)\n",
      "----------------------\n",
      "10018716 : Lo and MassaguÃ©1 found that the ubiquitination of Smad2 was achieved by certain E2 enzymes, including UbcH5b or UbcH5c and, to a lesser extent, Ubc3, but not by others, such as E2-20K.\n",
      "act(p(HGNC:UBE2D3)) -> p(HGNC:SMAD2,pmod(U,K))\n",
      "deg(p(HGNC:SMAD2)) -| act(p(HGNC:SMAD2))\n",
      "p(HGNC:SMAD2,pmod(U,K)) -> deg(p(HGNC:SMAD2))\n",
      "----------------------\n",
      "10001404 : % UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.\n",
      "act(p(HGNC:UBE2L3)) -> deg(p(HGNC:FOS))\n",
      "act(p(HGNC:UBE2L3)) -> deg(p(HGNC:MYC))\n",
      "act(p(HGNC:UBE2L3)) -> deg(p(HGNC:TP53))\n",
      "----------------------\n",
      "10004530 : The human UDP glucuronosyltransferase UGT2B17, glucuronidates androgens and is expressed in the liver and the prostate.\n",
      "act(p(HGNC:UGT2B17)) -| a(CHEBI:androgen)\n",
      "act(p(HGNC:UGT2B17)) -> deg(a(CHEBI:androgen))\n",
      "----------------------\n",
      "10018726 : An XO enzyme activity of 5.0 mU/ml led to a twofold increase in IL-6 secretion in NHBE cells. And incubation of HS-24 cells with XO (20 mU/ml) induced a 1.8-fold increase in IL-6 production\n",
      "act(p(HGNC:XDH)) -> p(HGNC:IL6)\n",
      "act(p(HGNC:XDH)) -> tloc(p(HGNC:IL6))\n",
      "----------------------\n",
      "10018742 : AdipoR1 and AdipoR2 are able to mediate the binding of globular and full-length adiponectin, as well as increases in PPAR-a ligand activity and fatty-acid oxidation by globular and full-length adiponectin in C2C12 myocytes\n",
      "act(p(MGI:Adipor1)) -> bp(GOBP:\"fatty acid oxidation\")\n",
      "act(p(MGI:Adipor1)) -> act(p(MGI:Ppara))\n",
      "act(p(MGI:Adipor2)) -> bp(GOBP:\"fatty acid oxidation\")\n",
      "act(p(MGI:Adipor2)) -> act(p(MGI:Ppara))\n",
      "----------------------\n",
      "10018746 : Expression of AdipoR1 or AdipoR2 alone or in combination made it possible for globular adiponectin to bind to hepatocytes (Supplementary Fig. 3e) and further increased fulllength adiponectin binding to hepatocytes (Supplementary Fig. 3f), both of which were associated with increases in PPAR-a ligand activity\n",
      "act(p(MGI:Adipor1)) -> act(p(MGI:Ppara))\n",
      "act(p(MGI:Adipor2)) -> act(p(MGI:Ppara))\n",
      "----------------------\n",
      "10018750 : Pretreatment with CCPA (A1 receptor agonist), NECA (non-specific A1 and A2 receptor agonist), and CGS21680 (A2A receptor agonist) all resulted in a 14- to 15-fold increase in STAT1 activity over control cells, levels comparable to what was observed in cells treated with IFN-gamma alone (Fig. 6, A?C)\n",
      "act(p(MGI:Adora1)) -> act(p(MGI:Stat1))\n",
      "act(p(MGI:Adora2a)) -> act(p(MGI:Stat1))\n",
      "----------------------\n",
      "10004542 : Moreover, the brain dopamine and serotonin balance, but not norepinephrine turnover, was dependent on alpha2C-AR expression, and the expression of c-fos and junB mRNA was increased in alpha2C-KO mice.\n",
      "act(p(MGI:Adra2c)) -| r(MGI:Fos)\n",
      "act(p(MGI:Adra2c)) -| r(MGI:Junb)\n",
      "----------------------\n",
      "10004544 : beta(3)-AR is required for leptin-mediated regulation of ob mRNA expression in WAT, but is interchangeable with the beta(1)/beta(2)-ARs in mediating leptin's effect on UCP1 mRNA expression in brown adipose tissue\n",
      "act(p(MGI:Adrb1)) -> r(MGI:Ucp1)\n",
      "act(p(MGI:Adrb2)) -> r(MGI:Ucp1)\n",
      "act(p(MGI:Adrb3)) -> r(MGI:Ucp1)\n",
      "----------------------\n",
      "10004548 : Zinc-alpha2-glycoprotein also increased its own expression and this was attenuated by SR59230A, suggesting that it was mediated through the beta3-AR\n",
      "act(p(MGI:Adrb3)) -> r(MGI:Azgp1)\n",
      "act(p(MGI:Azgp1)) -> act(p(MGI:Adrb3))\n",
      "act(p(MGI:Azgp1)) -> r(MGI:Azgp1)\n",
      "----------------------\n",
      "10018770 : AGE-treated wild-type mice showed a significant increase in inner retinal ischemia and a reduction in neovascularization compared with non-AGE controls (P < 0.001). However, ablation of galectin-3 abolished the AGE-mediated increase in retinal ischemia and restored the neovascular response to that seen in controls. AGE:AGER^ischemia; occursInTissue; retina\n",
      "act(p(MGI:Ager)) -| bp(GOBP:angiogenesis)\n",
      "act(p(MGI:Ager)) -> path(MESHD:Ischemia)\n",
      "----------------------\n",
      "10018784 : \\\"Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.\\\" Mice in which diabetes was induced through streptozotocin (STZ) treatment, but not nondiabetic mice, expressing human AR (hAR) crossed with LDL receptor-deficient (Ldlr-/-) C57BL/6 male mice had increased aortic atherosclerosis.\n",
      "act(p(MGI:Akr1b8)) -> path(MESHD:Atherosclerosis)\n",
      "act(p(MGI:Ldlr)) -| path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10003762 : Prostaglandin F(2)alpha (PGF(2)alpha) binding to its receptor on the rat corpus luteum triggers various signal transduction pathways that lead to the activation of a steroidogenic enzyme, 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD), which in turn catabolizes progesterone\n",
      "act(p(MGI:Akr1c6)) -> deg(a(CHEBI:progesterone))\n",
      "act(p(MGI:Ptgfr)) -> r(MGI:Akr1c6)\n",
      "----------------------\n",
      "10004572 : We conclude that macrophage 12/15-LO plays a dominant role in the development of atherosclerosis by promoting endothelial inflammation and foam cell formation\n",
      "act(p(MGI:Alox12)) -> bp(GOBP:\"inflammatory response\")\n",
      "act(p(MGI:Alox12)) -> path(MESHD:Atherosclerosis)\n",
      "act(p(MGI:Alox15)) -> bp(GOBP:\"inflammatory response\")\n",
      "act(p(MGI:Alox15)) -> path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10018790 : We demonstrate that IL-10 suppresses the production of LTB4 from DC by inhibiting FLAP protein expression without any effect on 5-LO and cytosolic phospholipase A2.\n",
      "act(p(MGI:Alox5ap)) -> a(CHEBI:\"leukotriene B4\")\n",
      "p(MGI:Il10) -| p(MGI:Alox5ap)\n",
      "p(MGI:Il10) -| r(MGI:Alox5ap)\n",
      "----------------------\n",
      "10004576 : By light microscopy, the earliest synovial lesion was inflammatory followed by synovial proliferation and cartilage erosions.\n",
      "act(p(MGI:Ank)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Ank)) -| bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10018798 : the LrpICD is translocated to the nucleus, where it co-localizes in the nucleus with a transcription modulator, Tip60, which is known to interact with Fe65 and with the APP-derived intracellular domain, AICD LrpICD has a close interaction with Tip60 in the nucleus\n",
      "act(p(MGI:App)) -> act(p(MGI:Kat5))\n",
      "p(MGI:Apbb1) -> act(p(MGI:Kat5))\n",
      "----------------------\n",
      "10018808 : Reduction of atg7-deficient tumor burden was coincident with reduced proliferation (Ki67) and decreased levels of phospho-MEK1/2 (P-MEK1/2) and P-ERK1/2 and p53 and p21 induction, compared with wild-type tumors (Fig. 1I; Supplemental Figs. S4AâC, S5AâC), suggesting that inhibition of tumor cell proliferation upon atg7 deletion is the main cause of reduced tumor burden.\n",
      "act(p(MGI:Atg7)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Atg7)) -| p(MGI:Cdkn1a)\n",
      "act(p(MGI:Atg7)) -| act(p(MGI:Trp53))\n",
      "----------------------\n",
      "10018812 : atg7 deficiency in tumors prevented LC3-I processing to LC3-II and caused accumulation of LC3-I and autophagy substrate p62 in large aggregates apparent at 6 wk that increased throughout tumorigenesis\n",
      "act(p(MGI:Atg7)) -| p(MGI:Map1lc3a)\n",
      "act(p(MGI:Atg7)) -| p(MGI:Sqstm1)\n",
      "----------------------\n",
      "10004604 : These results implicate Mtch2 as a mitochondrial target of tBID and raise the possibility that the Mtch2-resident complex participates in the mitochondrial apoptotic program.\n",
      "act(p(MGI:Bid)) -> act(p(MGI:Mtch2))\n",
      "act(p(MGI:Mtch2)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10018854 : Additionally, the cleaved form of IL-1b, produced from pro IL-1b by the action of activated caspase-1, was increased in the cell lysates and culture medium of Map1lc3b-/- macrophages (Fig. 1a).\n",
      "act(p(MGI:Casp1)) -> tloc(p(MGI:Il1b))\n",
      "p(MGI:Map1lc3b) -| tloc(p(MGI:Il1b))\n",
      "----------------------\n",
      "10018856 : we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3beta inhibitors lithium chloride and SB216763, and by GSK-3beta knockdown using short interfering RNA.\n",
      "act(p(MGI:Casp2)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Gsk3b)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Gsk3b)) -> act(p(MGI:Casp2))\n",
      "----------------------\n",
      "10018860 : The anti-caspase-3 effect of A1AT was further tested in vivo in the mouse lung...intramuscular administration of hA1AT-AAV serotype 5, which leads to persistent hA1AT expression,(27) inhibited apoptotic airspace destruction and oxidative stress (measured by catalase activity assay) caused by subsequent direct instillation of active caspase-3 into the mouse lung28 (Figure 7, a? d).\n",
      "act(p(MGI:Casp3)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Casp3)) -> act(p(MGI:Cat))\n",
      "act(p(HGNC:CASP3)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10018862 : Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice.\n",
      "act(p(MGI:Casp3)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Casp3)) -> path(MESHD:Emphysema)\n",
      "----------------------\n",
      "10000056 : TXBP151 was indeed found to be specifically cleaved in vitro by members of the caspase-3-like subfamily, viz. caspase-3, caspase-6 and caspase-7\n",
      "act(p(MGI:Casp3)) -> deg(p(MGI:Tax1bp1))\n",
      "act(p(MGI:Casp6)) -> deg(p(MGI:Tax1bp1))\n",
      "act(p(MGI:Casp7)) -> deg(p(MGI:Tax1bp1))\n",
      "----------------------\n",
      "10018868 : Two potential sites of caspase cleavage, resembling the prototypical caspase-3 cleavage sequence DEVD, are situated in this region in both human and mouse ROCK I, at positions 1110-1113 (DETD) and 1155-1158 (DEQD), respectively.\n",
      "act(p(MGI:Casp3)) -> act(p(MGI:Rock1))\n",
      "act(p(HGNC:CASP3)) -> act(p(HGNC:ROCK1))\n",
      "----------------------\n",
      "10018874 : caspase-8 is relocated into the nucleus of apoptotic neurons, where it cleaves PARP-2 Activity assays confirm that cleavage of PARP-2 results in inactivation of its poly(ADP-ribosylation) property, proportional to the efficiency of the cleavage.\n",
      "act(p(MGI:Casp8)) -| act(p(MGI:Parp2))\n",
      "act(p(MGI:Casp8)) -> deg(p(MGI:Parp2))\n",
      "----------------------\n",
      "10018894 : peritoneal CXCL10, CCL6, and CCL17 expression in CCR1-/- mice was significantly increased over WT expression\n",
      "act(p(MGI:Ccr1)) -| r(MGI:Ccl17)\n",
      "act(p(MGI:Ccr1)) -| r(MGI:Ccl6)\n",
      "act(p(MGI:Ccr1)) -| r(MGI:Cxcl10)\n",
      "----------------------\n",
      "10018896 : At days 8, 11, 20, 23, and 26 after disease induction, splenocytes from CCR2-deficient mice also proliferated less robustly to Ag and secreted lower levels of IFN-{gamma} and IL-6 than splenocytes from wild-type controls\n",
      "act(p(MGI:Ccr2)) -> p(MGI:Ifng)\n",
      "act(p(MGI:Ccr2)) -> p(MGI:Il6)\n",
      "p(MGI:Ccr2) -> p(MGI:Ifng)\n",
      "p(MGI:Ccr2) -> p(MGI:Il6)\n",
      "----------------------\n",
      "10018912 : CTLA-4 delivers signals that inhibit selection, indicating that CTLA-4 and CD28 have opposing functions in thymic development.\n",
      "act(p(MGI:Cd28)) -| act(p(MGI:Ctla4))\n",
      "act(p(MGI:Ctla4)) -| act(p(MGI:Cd28))\n",
      "----------------------\n",
      "10018914 : Notably, a CD36 peptide blocked oxLDL-induced foam cell formation and macrophage activation. However, the activating mCD36 mAb induced macrophage activation was not inhibited by CD36 peptide. Further, activating mCD36 mAb enhanced oxLDL- or TLR2- or TLR4-mediated inflammatory responses.\n",
      "act(p(MGI:Cd36)) -> act(p(MGI:Tlr2))\n",
      "act(p(MGI:Cd36)) -> act(p(MGI:Tlr4))\n",
      "----------------------\n",
      "10004664 : mitochondrial protein, CCOI, is significantly decreased in the setting of OPN stimulation. This effect is blocked by the CD44 competitive ligand,\n",
      "act(p(MGI:Cd44)) -| r(MGI:\"mt-Co1\")\n",
      "p(MGI:Spp1) -| r(MGI:\"mt-Co1\")\n",
      "----------------------\n",
      "10018952 : whereas regulation of the expression of alpha6 integrins and NE occur via different adhesive mechanisms, these molecules might act in a cooperative manner in mediating neutrophil migration through venular walls, in particular the perivascular basement membrane.\n",
      "act(p(MGI:Cela2a)) -> bp(GOBP:\"neutrophil extravasation\")\n",
      "p(MGI:Itga6) -> bp(GOBP:\"neutrophil extravasation\")\n",
      "----------------------\n",
      "10018956 : Increased Mitochondrial Fatty Acid Oxidation in Mice with Disruptions in SCD1. A fall in malonyl-CoA would be expected to result in increased activities of CPT1 and CPT2, enzymes responsible for activated fatty acid transport into mitochondria for b-oxidation. CPT1 activity was 63% higher in SCD1-/- mice relative to wild-type controls. CPT2 activity was also higher in SCD1-/- mice relative to wild-type controls.\n",
      "act(p(MGI:Cpt1a)) -> bp(GOBP:\"fatty acid beta-oxidation\")\n",
      "act(p(MGI:Cpt2)) -> bp(GOBP:\"fatty acid beta-oxidation\")\n",
      "p(MGI:Scd1) -| act(p(MGI:Cpt1a))\n",
      "p(MGI:Scd1) -| act(p(MGI:Cpt2))\n",
      "----------------------\n",
      "10018960 : Histone acetyltransferases (HATs) p300 and CREB-binding protein (CBP) function as co-activators for a variety of sequence-specific transcription factors, including AML1.\n",
      "act(p(MGI:Crebbp)) -> act(p(MGI:Runx1))\n",
      "act(p(MGI:Ep300)) -> act(p(MGI:Runx1))\n",
      "----------------------\n",
      "10018962 : FA-CRKL induced cotranslocation of a Rac1 activator, Dock1, to focal adhesions. These results therefore indicate a role for CrkL in mediating Src signaling by activating small G proteins at focal adhesions. Furthermore, MEFs lacking CrkL show impaired integrin-induced migration despite expression of a closely related protein, Crk-II, in these cells.\n",
      "act(p(MGI:Crkl)) -> bp(GOBP:\"integrin-mediated signaling pathway\")\n",
      "act(p(MGI:Dock1)) -> act(p(MGI:Rac1))\n",
      "----------------------\n",
      "10018996 : Furthermore, treatment with anti-CX3CL1 mAb down-regulated the mRNA expression of TNF-alpha, IFN-gamma, and perforin in the muscles.\n",
      "act(p(MGI:Cx3cl1)) -> r(MGI:Ifng)\n",
      "act(p(MGI:Cx3cl1)) -> r(MGI:Prf1)\n",
      "act(p(MGI:Cx3cl1)) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10019018 : The LTD4-ra MK-571 also dose dependently inhibited MUC5AC (Fig. 6, A and B) and mucus accumulation in epithelial cells as verified morphologically (Fig. 7D and Table 1), as did the LTB4-ra PH-163 72 h after challenge with Ova (Figs. 6, A and B, 7E; Table 1).\n",
      "act(p(MGI:Cysltr1)) -> p(MGI:Muc5ac)\n",
      "act(p(MGI:Ltb4r1)) -> p(MGI:Muc5ac)\n",
      "----------------------\n",
      "10019036 : It has been reported that DNA methyltransferase 1-deficient (Dnmt1-/-) embryonic stem (ES) cells are hypomethylated (20% CpG methylation) and die through apoptosis when induced to differentiate. Here, we show that Dnmt[3a-/-,3b-/-] ES cells with just 0.6% of their CpG dinucleotides behave differently: the majority of cells within the culture are partially or completely blocked in their ability to initiate differentiation\n",
      "act(p(MGI:Dnmt1)) -> bp(GOBP:\"cell differentiation\")\n",
      "act(p(MGI:Dnmt3a)) -> bp(GOBP:\"cell differentiation\")\n",
      "act(p(MGI:Dnmt3b)) -> bp(GOBP:\"cell differentiation\")\n",
      "----------------------\n",
      "10019040 : These findings demonstrate that ET-1 activation of ET(A) receptors mediates an increase in ROS that is associated with cardiac hypertrophy in AhR null mice. In addition, the ET-1-mediated increase in ROS appears to be initiated via increased NAD(P)H oxidase activity.\n",
      "act(p(MGI:Ednra)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Ahr)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10019052 : Furthermore, phosphorylation of RelA on serine 276 or serine 536 increased assembly of phospho-RelA with p300, which enhanced acetylation on lysine 310.\n",
      "act(p(MGI:Ep300)) -> p(MGI:Rela,pmod(A,K,310))\n",
      "p(MGI:Rela,pmod(P)) -> complex(p(MGI:Ep300),p(MGI:Rela))\n",
      "p(MGI:Rela,pmod(P)) -> complex(p(MGI:Ep300),p(MGI:Rela))\n",
      "----------------------\n",
      "10019056 : We show here in vitro and in vivo acetylation of RelA/p65 by p300 on lysine 314 and 315, two novel acetylation sites. Additionally, we confirmed the acetylation on lysine 310 shown previously.\n",
      "act(p(MGI:Ep300)) -> p(MGI:Rela,pmod(A,K,310))\n",
      "act(p(MGI:Ep300)) -> p(MGI:Rela,pmod(A,K,314))\n",
      "act(p(MGI:Ep300)) -> p(MGI:Rela,pmod(A,K,315))\n",
      "----------------------\n",
      "10004760 : exogenously applied serine proteases thrombin, plasmin, and tissue plasminogen activator can activate PAR1 signaling in brain tissue\n",
      "act(p(MGI:F2)) -> act(p(MGI:F2r))\n",
      "act(p(MGI:Plg)) -> act(p(MGI:F2r))\n",
      "p(MGI:Plat) -> act(p(MGI:F2r))\n",
      "----------------------\n",
      "10018258 : Wild-type MEFs induced Ifnb, Tnfa, and Il-6 in response to poly(I:C) {an viral mimetic activator of FADD signaling-SE}, whereas the induction was severely impaired in FADD-deficient MEFs as examined by RT-PCR analyses (Fig. 1A).\n",
      "act(p(MGI:Fadd)) -> r(MGI:Ifnb1)\n",
      "act(p(MGI:Fadd)) -> r(MGI:Il6)\n",
      "act(p(MGI:Fadd)) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10019076 : We therefore conclude that FAP enzymatic activity regulates recruitment, proliferation, survival, or differentiation of myofibroblasts\n",
      "act(p(MGI:Fap)) -> bp(GOBP:\"cell differentiation\")\n",
      "act(p(MGI:Fap)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10004766 : These results suggest that IL-1beta suppresses Fas-mediated hepatocyte apoptosis by inducing molecule(s) that suppress the apoptosis control machinery upstream of caspase 3\n",
      "act(p(MGI:Fas)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Fas)) -> act(p(MGI:Casp3))\n",
      "----------------------\n",
      "10019082 : We further found that expression of the Fas gene was repressed, resulting in abrogation of the Fas-mediated induction of apoptosis both in Mssp-knockout mice and primary thymocytes. it was found that cytochrome C was not released in the cytosol and that activations of caspase 8 and caspase 3 occurred in primary fibroblasts from MSSP (+/+) cells but not from MSSP (-/-) cells.\n",
      "act(p(MGI:Fas)) -> act(p(MGI:Casp3))\n",
      "act(p(MGI:Fas)) -> act(p(MGI:Casp8))\n",
      "----------------------\n",
      "10004792 : agonist for Fpr1 and Fpr2 induced cross-desensitization in neutrophils and attenuated neutrophil migration into the airways\n",
      "act(p(MGI:Fpr1)) -| bp(GOBP:\"neutrophil chemotaxis\")\n",
      "act(p(MGI:Fpr2)) -| bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10019116 : Moreover, inhibition of the TGFbeta1 converting enzyme, furin, resulted in increased PHD2 expression, and decreased basal HIF-1alpha and VEGF levels, suggesting that endogenous production of bioactive TGFbeta1 efficiently regulates HIF-1-targeted genes.\n",
      "act(p(MGI:Furin)) -> act(p(MGI:Tgfb1))\n",
      "act(p(MGI:Tgfb1)) -> act(p(MGI:Tgfbr1))\n",
      "act(p(MGI:Tgfb1)) -> act(p(MGI:Tgfbr2))\n",
      "----------------------\n",
      "10004796 : Surprisingly, the expression of certain adipocytokines such as tumor necrosis factor alpha and resistin was increased, whereas that of adiponectin was decreased in G6PD overexpressed adipocytes\n",
      "act(p(MGI:G6pdx)) -| r(MGI:Adipoq)\n",
      "act(p(MGI:G6pdx)) -> r(MGI:Retn)\n",
      "act(p(MGI:G6pdx)) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10019126 : PTP? is required for SCF-induced c-Kit and Fyn activation, and in this way regulates a Fyn-based c-Kit signaling axis (Fyn/Gab2/Shp2/Vav/PAK/Rac/JNK) that mediates mast cell migration.\n",
      "act(p(MGI:Gab2)) -> act(p(MGI:Ptpn11))\n",
      "act(p(MGI:Kit)) -> act(p(MGI:Fyn))\n",
      "p(MGI:Ptpra) -> act(p(MGI:Kit))\n",
      "----------------------\n",
      "10019144 : Three proteins involved in oxidative protection [SH3 domain-binding glutamic acid-rich-like protein, peroxiredoxin 6 (Prdx6), and isocitrate dehydrogenase 1] were also of lower content in the GHR (-/-) lungs (by approximately 88%, 81% and 70%, respectively).\n",
      "act(p(MGI:Ghr)) -> p(MGI:Idh1)\n",
      "act(p(MGI:Ghr)) -> p(MGI:Prdx6)\n",
      "act(p(MGI:Ghr)) -> p(MGI:Sh3bgrl)\n",
      "----------------------\n",
      "10004814 : Mice lacking both connexin37 (Cx37) and connexin40 (Cx40), gap junction proteins expressed in vascular endothelium, die perinatally with pronounced vascular abnormalities.\n",
      "act(p(MGI:Gja1)) -> bp(GOBP:\"blood vessel development\")\n",
      "act(p(MGI:Gja5)) -> bp(GOBP:\"blood vessel development\")\n",
      "----------------------\n",
      "10019152 : Depletion of PYGL, GLUL, and GLUD1 by means of siRNA reduced TNF+zVADâinduced accumulation of ROS (Fig. 4C and fig. S11), which correlated with cell death (Fig. 3F and figs. S7D and S8D).\n",
      "act(p(MGI:Glud1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Glul)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Pygl)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:GLUD1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:GLUL)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:PYGL)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10019154 : Importantly, knockdown of PYGL, GLUL, or GLUD1 partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells\n",
      "act(p(MGI:Glud1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Glul)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Pygl)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10019176 : These results suggest that Bach1 impedes p53-mediated transactivation by binding to a subset of target genes along with p53 and by recruiting Hdac1.\n",
      "act(p(MGI:Hdac1)) -| act(p(MGI:Trp53))\n",
      "act(p(MGI:Bach1)) -> act(p(MGI:Hdac1))\n",
      "----------------------\n",
      "10004858 : Measuring the quantity of specific mRNAs and biosynthetically labelled proteins a down-regulation of the biosynthesis of C2, factor B and C3 via H2 receptor was found.\n",
      "act(p(MGI:Hrh2)) -| r(MGI:C2)\n",
      "act(p(MGI:Hrh2)) -| r(MGI:C3)\n",
      "act(p(MGI:Hrh2)) -| r(MGI:Cfb)\n",
      "----------------------\n",
      "10004860 : The expression of UCP1 in brown adipose tissue and of UCP3 in brown adipose tissue, white adipose tissue, and skeletal muscle is decreased in H3(-/-) mutants, and the anorexigenic activity of thioperamide is not observed.\n",
      "act(p(MGI:Hrh3)) -> r(MGI:Ucp1)\n",
      "act(p(MGI:Hrh3)) -> r(MGI:Ucp3)\n",
      "----------------------\n",
      "10004866 : Overexpression of 11beta-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)alpha overexpression, central obesity, and insulin resistance\n",
      "act(p(MGI:Hsd11b1)) -> path(MESHD:\"Insulin Resistance\")\n",
      "act(p(MGI:Hsd11b1)) -> path(MESHD:Obesity)\n",
      "act(p(MGI:Hsd11b1)) -> r(MGI:Nr3c1)\n",
      "----------------------\n",
      "10004868 : In mice, overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose or liver causes obesity or insulin resistance, respectively\n",
      "act(p(MGI:Hsd11b1)) -> path(MESHD:\"Insulin Resistance\")\n",
      "act(p(MGI:Hsd11b1)) -> path(MESHD:Obesity)\n",
      "----------------------\n",
      "10004878 : In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.\n",
      "act(p(MGI:Icmt)) -> act(p(MGI:Hras))\n",
      "act(p(MGI:Icmt)) -> act(p(MGI:Kras))\n",
      "----------------------\n",
      "10004882 : levels of RhoA were greatly reduced as a consequence of accelerated protein turnover. In addition, there was a large Ras/Erk1/2-dependent increase in p21(Cip1), which was probably a consequence of the reduced levels of RhoA. Deletion of p21(Cip1) restored the ability of K-Ras-Icmt(Delta/Delta) fibroblasts to grow in soft agar.\n",
      "act(p(MGI:Icmt)) -| p(MGI:Cdkn1a)\n",
      "act(p(MGI:Icmt)) -> p(MGI:Rhoa)\n",
      "----------------------\n",
      "10004886 : The lysosomal enzyme iduronate-2-sulfatase (IDS) is expressed in pancreatic islets and is responsible for degradation of proteoglycans, such as perlecan and dermatan sulfate.\n",
      "act(p(MGI:Ids)) -> deg(a(CHEBI:\"dermatan sulfate\"))\n",
      "act(p(MGI:Ids)) -> deg(a(CHEBI:proteoglycan))\n",
      "----------------------\n",
      "10019226 : IGF2R/IGF-II-deficient mice have elevated levels of circulating IGF binding protein (IGFBP)-3 and show a strong IGFBP-6 immunoreactivity in all pancreatic islet cells\n",
      "act(p(MGI:Igf2r)) -| p(MGI:Igfbp3)\n",
      "complex(p(MGI:Igf2r),p(MGI:Igf2)) -> act(p(MGI:Igf2r))\n",
      "----------------------\n",
      "10019228 : Here we show that IL-10 directly affects progenitor myeloid cells by protecting them from death following the removal of growth factors.\n",
      "act(p(MGI:Il10ra)) -| bp(GOBP:\"apoptotic process\")\n",
      "complex(p(MGI:Il10),p(MGI:Il10ra)) -> act(p(MGI:Il10ra))\n",
      "----------------------\n",
      "10004890 : Lung tumor tissues attracted migration of mouse RAW264.7 macrophages and primary peritoneal macrophages through IL-17, which was mediated by IL-17RA and IL-17RC.\n",
      "act(p(MGI:Il17ra)) -> bp(GOBP:\"macrophage chemotaxis\")\n",
      "act(p(MGI:Il17rc)) -> bp(GOBP:\"macrophage chemotaxis\")\n",
      "p(MGI:Il17a) -> act(p(MGI:Il17ra))\n",
      "p(MGI:Il17a) -> act(p(MGI:Il17rc))\n",
      "----------------------\n",
      "10019238 : These results indicate that the endogenous IL-33/ST2 signaling pathway enhances the expression of CCR3 on eosinophils.\n",
      "act(p(MGI:Il1rl1)) -> p(MGI:Ccr3)\n",
      "p(MGI:Il33) -> act(p(MGI:Il1rl1))\n",
      "p(HGNC:IL33) -> act(p(HGNC:IL1RL1))\n",
      "----------------------\n",
      "10019240 : IL-33 triggered the production of IL-13 and IL-6 and strongly increased the production of CCL17 and TGF-b from WT eosinophils, but not ST2-/- eosinophils, in a dosedependent manner (Fig. 5A).\n",
      "act(p(MGI:Il1rl1)) -> tloc(p(MGI:Ccl17))\n",
      "act(p(MGI:Il1rl1)) -> tloc(p(MGI:Il13))\n",
      "act(p(MGI:Il1rl1)) -> tloc(p(MGI:Il6))\n",
      "act(p(MGI:Il1rl1)) -> tloc(p(MGI:Tgfb1))\n",
      "----------------------\n",
      "10019244 : IL-2-mediated hetero-dimerization of its receptor triggers a rapid increase in the recruitment of Jak3 and activation of both Jak1 and Jak3\n",
      "act(p(MGI:Il2rb)) -> act(p(MGI:Jak1))\n",
      "act(p(MGI:Il2rb)) -> act(p(MGI:Jak3))\n",
      "complex(p(MGI:Il2),p(MGI:Il2ra)) -> complex(p(MGI:Il2rb),p(MGI:Il2rb))\n",
      "complex(p(MGI:Il2rb),p(MGI:Il2rb)) -> act(p(MGI:Il2rb))\n",
      "----------------------\n",
      "10019252 : The interleukin-6 (IL6) family of cytokines signals through the common receptor subunit gp130, and subsequently activates Stat3, MAPK, and PI3K.\n",
      "act(p(MGI:Il6st)) -> bp(GOBP:\"MAPK cascade\")\n",
      "act(p(MGI:Il6st)) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10019254 : identification of an acidic domain of gp130 as a binding region for Hck, which mediates proliferative signaling the deletion of this region of gp130 resulted in a significant reduction of Hck kinase activity and cell proliferation upon stimulation of gp130 compared to wild-type gp130\n",
      "act(p(MGI:Il6st)) -> act(p(MGI:Hck))\n",
      "complex(p(MGI:Il6st),p(MGI:Hck)) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Hck) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10019262 : we used an alternative strategy of inhibiting leukocyte recruitment by activating CD11b/CD18 with small-molecule agonists, which we term leukadherins. These compounds increased the extent of CD11b/CD18-dependent cell adhesion of transfected cells and of primary human and mouse neutrophils\n",
      "act(p(MGI:Itgam)) -> bp(GOBP:\"cell adhesion\")\n",
      "act(p(HGNC:ITGAM)) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10004902 : an RGD peptidomimetic compound, designed to block interaction of ligands to the alpha(v) integrin subunit, increases osteocalcin expression and inhibits collagenase-3 expression,\n",
      "act(p(MGI:Itgav)) -| r(EGID:12096)\n",
      "act(p(MGI:Itgav)) -> r(MGI:Mmp13)\n",
      "----------------------\n",
      "10004904 : Mice heterozygous for the annexin A7 (Anx7) gene have a profound reduction in IP3 receptor function in pancreatic islets along with defective insulin secretion.\n",
      "act(p(MGI:Itpr1)) -> bp(GOBP:\"insulin secretion\")\n",
      "p(MGI:Anxa7) -> act(p(MGI:Itpr1))\n",
      "----------------------\n",
      "10019288 : expression of adipose differentiation markers, such as ALBP and perilipin, was suppressed 50-80% (P < 0.01; Fig. 7, A and B). Expression of lipoprotein lipase (LPL) was also suppressed 30-40% (P < 0.05) in WAT of HSL-/- mice (Fig. 7C), with greater reductions observed in male mice.\n",
      "act(p(MGI:Lipe)) -> r(EGID:103968)\n",
      "act(p(MGI:Lipe)) -> r(MGI:Fabp4)\n",
      "act(p(MGI:Lipe)) -> r(MGI:Lpl)\n",
      "----------------------\n",
      "10019290 : in parallel with the suppression of adipogenic transcription factors PPAR{gamma} and C/EBP{alpha} in WAT of HSL-/- mice,\n",
      "act(p(MGI:Lipe)) -> r(MGI:Cebpa)\n",
      "act(p(MGI:Lipe)) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10000284 : Both the mitogenic potential and the nuclear localization of bFGF were markedly inhibited in the Swiss 3T3 cells upon its oxidation by LO.\n",
      "act(p(MGI:Lox)) -| tloc(p(MGI:Fgf2))\n",
      "p(MGI:Fgf2) -> bp(GOBP:mitosis)\n",
      "----------------------\n",
      "10019318 : we found that IL6 effectively inhibited LIF signalling, repressing transcription of the LIF receptor gp190, and strongly inducing axotrophin/MARCH-7, a novel E3 ubitquitin ligase that we discovered to be active in degradation of gp190 protein.\n",
      "act(p(MGI:March7)) -> deg(p(MGI:Lifr))\n",
      "act(p(MGI:March7)) -> p(MGI:Lifr,pmod(U,K))\n",
      "p(MGI:Il6) -| r(MGI:Lifr)\n",
      "p(MGI:Il6) -> r(MGI:March7)\n",
      "----------------------\n",
      "10004928 : PDK1 mediates its effect in part by MT1-MMP induction, which in turn activates MMP-2 and modulates the ECM proteins decorin and collagen\n",
      "act(p(MGI:Mmp14)) -> act(p(MGI:Mmp2))\n",
      "act(p(MGI:Pdpk1)) -> p(MGI:Mmp14)\n",
      "----------------------\n",
      "10001688 : In contrast, enhanced thrombopoietin signaling, conferred by enforced expression of constitutively active JAK2 or c-MPL, induced phosphorylation of STAT3 and STAT5, but not STAT1, and failed to rescue megakaryocyte maturation.\n",
      "act(p(MGI:Mpl)) -> act(p(MGI:Stat3))\n",
      "act(p(MGI:Jak2)) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10004954 : RNA interference-mediated inhibition of TLR2 and MyD88 expression in C2C12 muscle cells resulted in a near complete inhibition of palmitate-induced insulin resistance and IL-6 production.\n",
      "act(p(MGI:Myd88)) -| bp(GOBP:\"insulin receptor signaling pathway\")\n",
      "act(p(MGI:Myd88)) -> path(MESHD:\"Insulin Resistance\")\n",
      "act(p(MGI:Tlr2)) -| bp(GOBP:\"insulin receptor signaling pathway\")\n",
      "act(p(MGI:Tlr2)) -> path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10019374 : Next, the role of IRAK4 in MyD88 signaling was examined by evaluating IRAK4 activity in the PMN. We found that HMGB1 induced a 6-fold increase in IRAK4 activity in TLR4 WT PMN compared with the non-HMGB1-treated WT PMN (p < 0.01; Fig. 5B)....Pretreatment with MyD88 inhibitor decreased IRAK4 activity by 91% in WT PMN (Fig. 5B).\n",
      "act(p(MGI:Myd88)) -> act(p(MGI:Irak4))\n",
      "p(MGI:Hmgb1) -> act(p(MGI:Irak4))\n",
      "----------------------\n",
      "10019378 : TLR9 primarily induces ISRE gene expression through IRF7...TLR9, which exclusively couples to the MyD88-dependent pathway\n",
      "act(p(MGI:Myd88)) -> act(p(MGI:Irf7))\n",
      "act(p(MGI:Tlr9)) -> act(p(MGI:Myd88))\n",
      "act(p(MGI:Tlr9)) -> act(p(MGI:Irf7))\n",
      "act(p(HGNC:TLR9)) -> act(p(HGNC:MYD88))\n",
      "----------------------\n",
      "10019384 : nicotinic acid strongly reduced the relative fluorescence intensity of arginase-2 versus CD68 levels in a GPR109A-dependent manner (Figure 6C), indicating that nicotinic acid induces reduced M1-like differentiation via GPR109A.\n",
      "act(p(MGI:Niacr1)) -| bp(GOBP:\"macrophage differentiation\")\n",
      "act(p(MGI:Niacr1)) -| p(MGI:Arg2)\n",
      "----------------------\n",
      "10003836 : In macrophages from WT mice, but not from GPR109A-deficient animals, nicotinic acid induced expression of the cholesterol transporter ABCG1 and promoted cholesterol efflux.\n",
      "act(p(MGI:Niacr1)) -> r(MGI:Abcg1)\n",
      "act(p(MGI:Abcg1)) -| a(CHEBI:cholesterol)\n",
      "act(p(MGI:Abcg1)) -> tloc(a(CHEBI:cholesterol))\n",
      "----------------------\n",
      "10019386 : Travassos et al. (2010) also found that stimulation with both Nod1 and Nod2 triggers the induction of autophagy in mouse embryonic fibroblasts (MEFs), mouse macrophages, human lymphoblasts, and human cell lines (Fig. 3).\n",
      "act(p(MGI:Nod1)) -> bp(GOBP:autophagy)\n",
      "act(p(MGI:Nod2)) -> bp(GOBP:autophagy)\n",
      "----------------------\n",
      "10019390 : PDGF stimulates nitric oxide synthase activity in NIH3T3 cells, but not in the superoxide dismutase-expressing clones.\n",
      "act(p(MGI:Nos2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Pdgfra)) -> act(p(MGI:Nos2))\n",
      "act(p(MGI:Pdgfrb)) -> act(p(MGI:Nos2))\n",
      "----------------------\n",
      "10004968 : Expression of BNIP3 was also induced in macrophages by LPS/IFN-gamma, and the induction was blocked by a NOS2 inhibitor, S-methyl-isothiourea\n",
      "act(p(MGI:Nos2)) -> r(MGI:Bnip3)\n",
      "p(MGI:Ifng) -> r(MGI:Bnip3)\n",
      "----------------------\n",
      "10019394 : Akt, a serine/threonine kinase that is a major target of phosphatidylinositol 3-kiniase (PI3K), phosphorylates eNOS at Ser1177, and this phosphorylation enhances eNOS activity and increases NO production in vascular endothelial cells.\n",
      "act(p(MGI:Nos3)) -> a(CHEBI:\"nitric oxide\")\n",
      "act(p(MGI:Akt1)) -> p(MGI:Nos3,pmod(P))\n",
      "p(MGI:Nos3,pmod(P)) -> act(p(MGI:Nos3))\n",
      "act(p(HGNC:NOS3)) -> a(CHEBI:\"nitric oxide\")\n",
      "----------------------\n",
      "10019396 : endothelin-1 failed to stimulate NO production by tubules from NOS3â/â mice (?= 0.38 Â± 0.22 fluorescence units/min; p < 0.001 versus wild-type mice; n = 4) (Fig. 1A).\n",
      "act(p(MGI:Nos3)) -> a(CHEBI:\"nitric oxide\")\n",
      "p(MGI:Edn1) -> act(p(MGI:Nos3))\n",
      "----------------------\n",
      "10019400 : NOXO1...is an organizer protein that activates NADPH oxidase (NOX1)...NADPH oxidase is a major source of reactive oxygen species, and oxidative stress is considered to play an important role in the pathogenesis of COPD\n",
      "act(p(MGI:Nox1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Noxo1) -> act(p(MGI:Nox1))\n",
      "act(p(HGNC:NOX1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10019402 : Hyperoxia-dependent ROS production was strongly reduced in lung sections, in isolated epithelial type II cells, and lung endothelial cells from NOX1-deficient mice.\n",
      "act(p(MGI:Nox1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:NOX1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "path(MESHD:Hyperoxia) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10019430 : The activation of PARP-1 also leads to ATP depletion, a condition that is permissive for necrosis (81, 82).\n",
      "act(p(MGI:Parp1)) -| a(CHEBI:ATP)\n",
      "act(p(HGNC:PARP1)) -| a(CHEBI:ATP)\n",
      "----------------------\n",
      "10019444 : Two transgenic mouse lines were designed by targeting PACE4 to the epidermal basal keratinocytes. Transgenic keratinocytes showed increased processing of MT1-MMP and MT2-MMP resulting in collagenase IV activation and collagen type IV degradation.\n",
      "act(p(MGI:Pcsk6)) -> act(p(MGI:Mmp14))\n",
      "act(p(MGI:Pcsk6)) -> act(p(MGI:Mmp15))\n",
      "----------------------\n",
      "10019446 : the association of carnitine palmitoyltransferase, CPT, activity with Grp58 expression of Grp58 led to an increase in assayable and immunoreactive CPT activity\n",
      "act(p(MGI:Pdia3)) -> act(p(MGI:Cpt1a))\n",
      "act(p(MGI:Pdia3)) -> act(p(MGI:Cpt1b))\n",
      "act(p(MGI:Pdia3)) -> act(p(MGI:Cpt1c))\n",
      "act(p(MGI:Pdia3)) -> act(p(MGI:Cpt2))\n",
      "----------------------\n",
      "10019454 : Glycogen content was increased proportionately to the expression of the transgene, reaching a 40% increase in high-expression transgenic mice\n",
      "act(p(MGI:Pgm1)) -> a(CHEBI:glycogen)\n",
      "p(MGI:Hspb8) -> a(CHEBI:glycogen)\n",
      "----------------------\n",
      "10019472 : Pag overexpression promotes a marked increase in cell size and enhances apoptosis, thus mimicking two previously described c-Myc phenotypes.\n",
      "act(p(MGI:Prdx1)) -> bp(GOBP:\"cell growth\")\n",
      "act(p(MGI:Prdx1)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10019474 : Pag, also known as MSP23 and peroxiredoxin-1 Pag, a member of the peroxiredoxin family, has been reported previously to bind to and inhibit the cytostatic properties of the c-Abl oncoprotein.\n",
      "act(p(MGI:Prdx1)) -| act(p(MGI:Abl1))\n",
      "complex(p(MGI:Prdx1),p(MGI:Abl1)) -| act(p(MGI:Abl1))\n",
      "----------------------\n",
      "10005034 : PRDX6-depleted LECs displayed phenotypic alterations and elevated alpha-smooth muscle actin and betaig-h3 expression\n",
      "act(p(MGI:Prdx6)) -| r(MGI:Acta2)\n",
      "act(p(MGI:Prdx6)) -| r(MGI:Tgfbi)\n",
      "----------------------\n",
      "10019486 : Activation of tyrosine kinases Fyn and Lyn, but not Lck, also occurred within 2 min after PAF stimulation in the cells\n",
      "act(p(MGI:Ptafr)) -> act(p(MGI:Fyn))\n",
      "act(p(MGI:Ptafr)) -> act(p(MGI:Lyn))\n",
      "----------------------\n",
      "10019488 : PAFR promoter 2 contained AP-2 and Sp-1 binding sites we demonstrated that PAF activates p44ERK1/p42ERK2 in CHO cells stably expressing PAF receptor\n",
      "act(p(MGI:Ptafr)) -> act(p(MGI:Mapk1))\n",
      "act(p(MGI:Ptafr)) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10000086 : These results are consistent with our previous data showing that PAF is able to translocate PKCa and PKCe from cytosol to plasma membrane\n",
      "act(p(MGI:Ptafr)) -> tloc(p(MGI:Prkca))\n",
      "act(p(MGI:Ptafr)) -> tloc(p(MGI:Prkce))\n",
      "----------------------\n",
      "10005038 : Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNFalpha production, but up-regulation on the IL-10 production\n",
      "act(p(MGI:Ptger2)) -> r(MGI:Il10)\n",
      "act(p(MGI:Ptger2)) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10005050 : On the other hand, the mRNA for cyclooxygenase-2, which produces PGH2 and participates in the production of prostanoids in inflammation, was expressed in both the resident and BCG-elicited macrophages but barely in the casein-elicited cells.\n",
      "act(p(MGI:Ptgs1)) -> a(CHEBI:\"prostaglandin G2\")\n",
      "act(p(MGI:Ptgs1)) -> a(CHEBI:\"prostaglandin H2\")\n",
      "----------------------\n",
      "10019504 : There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.\n",
      "act(p(MGI:Ptgs1)) -| r(MGI:Il13)\n",
      "act(p(MGI:Ptgs1)) -| r(MGI:Il5)\n",
      "act(p(MGI:Ptgs2)) -| r(MGI:Il13)\n",
      "act(p(MGI:Ptgs2)) -| r(MGI:Il5)\n",
      "----------------------\n",
      "10019506 : In conclusion, the results suggest that ROS generation, through COX-2 up-regulation, may contribute to the active oncogenicity of mutant K-ras in the lung as a result of DNA damage\n",
      "act(p(MGI:Ptgs2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:PTGS2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10019522 : proposed a novel role for the Chat-Cas complex in controlling cell adhesion via the activation of Rap1\n",
      "act(p(MGI:Rap1a)) -> bp(GOBP:\"cell adhesion\")\n",
      "complex(p(MGI:Chat),p(MGI:Bcar1)) -> act(p(MGI:Rap1a))\n",
      "----------------------\n",
      "10019526 : The data in Figs. 1 and 2 provide strong evidence that the Epac/Rap/PLCepsilon pathway contributes to betaAR signaling in the heart.\n",
      "act(p(MGI:Rapgef3)) -> act(p(MGI:Rap1a))\n",
      "act(p(MGI:Rap1a)) -> act(p(MGI:Plce1))\n",
      "----------------------\n",
      "10005068 : flk is a novel allele of the stearoyl coenzyme A desaturase 1 gene (Scd1). flake homozygotes show reduced sebum production and are unable to synthesize the monounsaturated fatty acids (MUFA) palmitoleate (C(16:1)) and oleate (C(18:1)),\n",
      "act(p(MGI:Scd1)) -> a(CHEBI:\"oleic acid\")\n",
      "act(p(MGI:Scd1)) -> a(CHEBI:\"palmitoleic acid\")\n",
      "----------------------\n",
      "10019558 : The activity and mRNA levels of carnitine palmitoyltransferase I (CPT I) and the rate of beta-oxidation were increased in oxidative muscles of SCD1-/- mice.\n",
      "act(p(MGI:Scd1)) -| bp(GOBP:\"fatty acid beta-oxidation\")\n",
      "act(p(MGI:Scd1)) -| act(p(MGI:Cpt1b))\n",
      "act(p(MGI:Scd1)) -| r(MGI:Cpt1b)\n",
      "----------------------\n",
      "10019556 : The mRNA levels and activity of serine palmitoyltransferase (SPT), a key enzyme in ceramide synthesis, as well as the incorporation of [14C]palmitate into ceramide were decreased by approximately 50% in red muscles of SCD1-/- mice.\n",
      "act(p(MGI:Scd1)) -> act(p(MGI:Sptlc1))\n",
      "act(p(MGI:Scd1)) -> r(MGI:Sptlc1)\n",
      "----------------------\n",
      "10005078 : The most upregulated gene identified encodes plasminogen activator inhibitor 1 (PAI-1, Serpine 1), a protease inhibitor that blocks urokinase plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) activity.\n",
      "act(p(MGI:Serpine1)) -| act(p(MGI:Plat))\n",
      "act(p(MGI:Serpine1)) -| act(p(MGI:Plau))\n",
      "----------------------\n",
      "10005090 : Treatment with the plant polyphenol resveratrol as well as isonicotinamide, both of which activate Sirt1, blocked adipocyte development and increased the expression of osteoblast markers.\n",
      "act(p(MGI:Sirt1)) -| bp(GOBP:\"fat cell differentiation\")\n",
      "act(p(MGI:Sirt1)) -> bp(GOBP:\"osteoblast differentiation\")\n",
      "----------------------\n",
      "10019572 : In addition, the same compounds have anti-inflammatory properties, as became evident by the reduction of the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha)\n",
      "act(p(MGI:Sirt1)) -| bp(GOBP:\"inflammatory response\")\n",
      "act(p(MGI:Sirt1)) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10005100 : expression of exogenous human (h) SIRT1 in the brain of hSIRT1 transgenics also resulted in decreased ROCK1 expression and elevated alpha-secretase activity in vivo\n",
      "act(p(MGI:Sirt1)) -> act(p(MGI:Ctsb))\n",
      "act(p(MGI:Sirt1)) -| r(MGI:Rock1)\n",
      "----------------------\n",
      "10019574 : SIRT1 increases adiponectin transcription in adipocytes by activating Foxo1 and enhancing Foxo1 and C/EBPa interaction.\n",
      "act(p(MGI:Sirt1)) -> complex(p(MGI:Foxo1),p(MGI:Cebpa))\n",
      "act(p(MGI:Sirt1)) -> act(p(MGI:Cebpa))\n",
      "act(p(MGI:Sirt1)) -> act(p(MGI:Foxo1))\n",
      "----------------------\n",
      "10019584 : from full text - As expected, fasting induced gene expression of fatty acid oxidation enzymes medium chain acyl-CoA deyhydrogenase (MCAD) and carnitine palmitoyltransferase- 1a (CPT-1a) (Fig. 4A). Notably, mice with hepatic SIRT1 knockdown displayed lower expression of these enzymes compared with control mice.\n",
      "act(p(MGI:Sirt1)) -> r(MGI:Acadm)\n",
      "act(p(MGI:Sirt1)) -> r(MGI:Cpt1a)\n",
      "----------------------\n",
      "10019590 : from full text - As shown in Fig. 2A, infection with SIRT1 shRNA resulted in reduced expression of the gluconeogenic G6Pase and Pepck\n",
      "act(p(MGI:Sirt1)) -> r(MGI:G6pc)\n",
      "act(p(MGI:Sirt1)) -> r(MGI:Pck1)\n",
      "----------------------\n",
      "10019592 : from full text - SIRT1 knockdown caused a slight yet highly significant decrease in LXRalpha expression in both fed and fasted livers. However, SIRT1 knockdown decreased expression of PGC-1beta only the fasted state\n",
      "act(p(MGI:Sirt1)) -> r(MGI:Nr1h3)\n",
      "act(p(MGI:Sirt1)) -> r(MGI:Ppargc1b)\n",
      "----------------------\n",
      "10019568 : beta cell-specific Sirt1-overexpressing (BESTO) transgenic mice. Microarray analyses of beta cell lines reveal that Sirt1 regulates genes involved in insulin secretion, including uncoupling protein 2 (Ucp2). Isolated BESTO islets also have reduced Ucp2, increased ATP production, and enhanced insulin secretion during glucose and KCl stimulation.\n",
      "act(p(MGI:Sirt1)) -| r(MGI:Ucp2)\n",
      "act(p(MGI:Sirt1)) -> tloc(p(HGNC:INS))\n",
      "----------------------\n",
      "10019600 : specifically deacetylated by mitochondrial SIRT3 AceCS2 was completely inactivated upon acetylation and was rapidly reactivated by SIRT3 deacetylation\n",
      "act(p(MGI:Sirt3)) -> act(p(MGI:Acss1))\n",
      "act(p(MGI:Sirt3)) -| p(MGI:Acss1,pmod(A,K,635))\n",
      "p(MGI:Acss1,pmod(A,K,635)) -| act(p(MGI:Acss1))\n",
      "----------------------\n",
      "10019610 : Thus overexpression of Smurf1 specifically promotes Smad1 and Smad5 ubiquitination and degradation in embryonic lung epithelium, thereby modulating the effects of BMP4 on embryonic lung growth.\n",
      "act(p(MGI:Smurf1)) -> deg(p(MGI:Smad1))\n",
      "act(p(MGI:Smurf1)) -> deg(p(MGI:Smad5))\n",
      "----------------------\n",
      "10005128 : These results indicate that superoxide dismutase overexpression blocks the PDGF-induced release of PGE2 by blocking induction of nitric oxide synthase.\n",
      "act(p(MGI:Sod1)) -| act(p(MGI:Nos2))\n",
      "p(MGI:Sod1) -| act(p(MGI:Nos2))\n",
      "----------------------\n",
      "10000028 : These results indicate that the increase in mitochondrial reactive oxygen species from knockout of SOD2 activity can result in biochemical aberrations with features reminiscent of mitochondrial myopathy\n",
      "act(p(MGI:Sod2)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:SOD2)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10019622 : Analysis showed that, compared with WT mice, Sptlc1(+/-) and Sptlc2(+/-) mice had: decreased liver SPT activity by 45% and 60% (P<0.01, respectively); decreased liver ceramide (22% and 39%, P<0.05 and P<0.01, respectively) and sphingosine levels (22% and 31%, P<0.05 and P<0.01, respectively);\n",
      "act(p(MGI:Sptlc1)) -> a(CHEBI:ceramide)\n",
      "act(p(MGI:Sptlc1)) -> a(CHEBI:sphingosine)\n",
      "act(p(MGI:Sptlc2)) -> a(CHEBI:ceramide)\n",
      "act(p(MGI:Sptlc2)) -> a(CHEBI:sphingosine)\n",
      "----------------------\n",
      "10019634 : Mice lacking telomerase activity develop hypertension in the first and third generations as a result of an increased plasma endothelin-1 level due to the overexpression of endothelin-converting enzyme (99).\n",
      "act(p(MGI:Tert)) -| path(MESHD:Hypertension)\n",
      "act(p(MGI:Tert)) -| p(MGI:Ece1)\n",
      "act(p(MGI:Tert)) -| p(MGI:Edn1)\n",
      "----------------------\n",
      "10019636 : Protein analysis of TRalpha1-/-beta-/- soleus muscles showed a marked increase in expression of the slow isoform of the sarcoplasmic reticulum Ca2+ pump (SERCa2), whilst expression of the fast type (SERCa1) was decreased\n",
      "act(p(MGI:Thra)) -> r(MGI:Atp2a1)\n",
      "act(p(MGI:Thra)) -| r(MGI:Atp2a2)\n",
      "act(p(MGI:Thrb)) -> r(MGI:Atp2a1)\n",
      "act(p(MGI:Thrb)) -| r(MGI:Atp2a2)\n",
      "----------------------\n",
      "10019638 : These results indicate that LPS induces autophagy through a TRIF-dependent TLR4 signaling pathway.\n",
      "act(p(MGI:Ticam1)) -> bp(GOBP:autophagy)\n",
      "act(p(MGI:Tlr4)) -> act(p(MGI:Ticam1))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:TICAM1))\n",
      "----------------------\n",
      "10019646 : Interestingly, signaling through TLR1 or TLR3 induced similar responses, despite their use of different adaptor proteins, MydD88 for TLR1 and Trif for TLR3.\n",
      "act(p(MGI:Tlr1)) -> act(p(MGI:Myd88))\n",
      "act(p(MGI:Tlr3)) -> act(p(MGI:Ticam1))\n",
      "act(p(HGNC:TLR1)) -> act(p(HGNC:MYD88))\n",
      "act(p(HGNC:TLR3)) -> act(p(HGNC:TICAM1))\n",
      "----------------------\n",
      "10019648 : Furthermore, activation of TLRs 2, 3 and 7 also induced priming of the NLRP3 inflammasome and macrophages lacking TLRs for the respective stimuli failed to activate caspase-1 after activation via ATP (Fig. 2B).\n",
      "act(p(MGI:Tlr2)) -> act(p(MGI:Nlrp3))\n",
      "act(p(MGI:Tlr3)) -> act(p(MGI:Nlrp3))\n",
      "act(p(MGI:Tlr7)) -> act(p(MGI:Nlrp3))\n",
      "----------------------\n",
      "10019656 : Similar findings were observed with other agonists of TLR2 including the synthetic lipoprotein FSL-1 and lipoteichoic acid (LTA) (data not shown). The TLR5 agonist flagellin reduced PPARgamma mRNA abundance to a lesser extent\n",
      "act(p(MGI:Tlr2)) -| r(MGI:Pparg)\n",
      "act(p(MGI:Tlr5)) -| r(MGI:Pparg)\n",
      "----------------------\n",
      "10019662 : exposure to the TLR4 ligand LPS triggered both MyD88 and Trif to recruit Beclin 1, whereas exposure to the TLR3 ligand poly(I:C) led to an increased association between Trif and Beclin 1 (Fig. 4A).\n",
      "act(p(MGI:Tlr3)) -> complex(p(MGI:Ticam1),p(MGI:Becn1))\n",
      "act(p(MGI:Tlr4)) -> complex(p(MGI:Myd88),p(MGI:Becn1))\n",
      "act(p(MGI:Tlr4)) -> complex(p(MGI:Ticam1),p(MGI:Becn1))\n",
      "----------------------\n",
      "10019670 : The TLR3 agonist poly (I:C) significantly increased bidirectional secretion of CCL2, IL6, TNFA and CSF2 and basolateral secretion of CSF3.\n",
      "act(p(MGI:Tlr3)) -> tloc(p(MGI:Ccl2))\n",
      "act(p(MGI:Tlr3)) -> tloc(p(MGI:Csf2))\n",
      "act(p(MGI:Tlr3)) -> tloc(p(MGI:Il6))\n",
      "act(p(MGI:Tlr3)) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10019684 : Moreover, mice lacking TLR4 are substantially protected from the ability of systemic lipid infusion to (a) suppress insulin signaling in muscle and (b) reduce insulin-mediated changes in systemic glucose metabolism.\n",
      "act(p(MGI:Tlr4)) -| bp(GOBP:\"insulin receptor signaling pathway\")\n",
      "act(p(MGI:Tlr4)) -> path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10019686 : To obtain direct evidence of TLR activation upon THP engagement, we isolated bone marrowâderived macrophages from MyD88 and TLR2, TLR4, and TLR9 KO mice as well as from WT mice. While THP potently stimulated TNF-? production in APCs obtained from WT, TLR2â/â, and TLR9â/â mice, cells from TLR4â/â and MyD88â/â mice were completely resistant to THP or LPS stimulation (Figure ?(Figure6A).6A)\n",
      "act(p(MGI:Tlr4)) -> bp(GOBP:\"macrophage activation\")\n",
      "p(MGI:Tlr4) -> bp(GOBP:\"macrophage activation\")\n",
      "----------------------\n",
      "10019692 : The authors demonstrate that HMGB1 binds to TLR4 and that HMGB1, which is released by chemotherapy-induced cell death, can activate TLR4 and induce anti-tumour T-cell immunity79.\n",
      "act(p(MGI:Tlr4)) -> bp(GOBP:\"T cell activation\")\n",
      "p(MGI:Hmgb1) -> act(p(MGI:Tlr4))\n",
      "----------------------\n",
      "10017306 : Figure 6 and p 3018: lipid infusion markedly inhibited insulin-stimulated insulin receptor substrate-1 (IRS-1) phosphorylation in skeletal muscle of WT mice...This was substantially attenuated in TLR4 -/- mice.\n",
      "act(p(MGI:Tlr4)) -| act(p(MGI:Irs1))\n",
      "act(p(MGI:Tlr4)) -| p(MGI:Irs1,pmod(P))\n",
      "----------------------\n",
      "10019700 : An impaired IRAK4 activation was observed with TLR4 mutant PMN, in which the HMGB1-induced IRAK4 activity was attenuated by 64% compared with that in TLR4 WT PMN (Fig. 5B).\n",
      "act(p(MGI:Tlr4)) -> act(p(MGI:Myd88))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:MYD88))\n",
      "----------------------\n",
      "10019702 : TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4).\n",
      "act(p(MGI:Tlr4)) -> act(p(MGI:Myd88))\n",
      "act(p(MGI:Tlr4)) -> act(p(MGI:Ticam1))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:MYD88))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:TICAM1))\n",
      "----------------------\n",
      "10019676 : from full ext - The marked suppression of CHOP by LPS in wild-type macrophage was almost completely absent in Tlr4?/? and Trif?/? macrophages, but not in Myd88?/? macrophages (Fig. 2a?c).\n",
      "act(p(MGI:Tlr4)) -| r(MGI:Ddit3)\n",
      "p(MGI:Ticam1) -| r(MGI:Ddit3)\n",
      "----------------------\n",
      "10019722 : Treatment of control cells with LPS substantially increased the mRNA of p62 along with that of NAD(P)H:quinone oxidoreductase (NQO1) and peroxiredoxin 1 (Prdx1), known Nrf2 target genes (Fig. 4F and Fig. S4G) (25, 26), demonstrating activation of Nrf2 in LPSstimulated cells.\n",
      "act(p(MGI:Tlr4)) -> r(MGI:Nqo1)\n",
      "act(p(MGI:Tlr4)) -> r(MGI:Prdx1)\n",
      "act(p(MGI:Tlr4)) -> r(MGI:Sqstm1)\n",
      "----------------------\n",
      "10019736 : A cytokine release assay using antibodies to Tumor Necrosis Factor-alfa (TNF) was performed (Fig. 3D). TNF- release in response to HSP70 and (to a lesser extent) following ssPolyU treatment was blunted in SiRNA-TLR7 transfected RAW264.7 cells versus the parental cells or mocktransfected cells\n",
      "act(p(MGI:Tlr7)) -> tloc(p(MGI:Tnf))\n",
      "p(MGI:Hspa1b) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10000600 : TLR9 activation of Raw264.7 cells or mouse primary peritoneal macrophages by CpG ODN treatment enhanced Lox-1 gene and protein expression.\n",
      "act(p(MGI:Tlr9)) -> p(MGI:Olr1)\n",
      "act(p(MGI:Tlr9)) -> r(MGI:Olr1)\n",
      "----------------------\n",
      "10019742 : Herein we show that TNF-related apoptosis-inducing ligand receptor (TRAIL-R), the only proapoptotic death-signaling receptor for TRAIL in the mouse, suppresses inflammation and tumorigenesis.\n",
      "act(p(MGI:Tnfrsf10b)) -| bp(GOBP:\"inflammatory response\")\n",
      "act(p(MGI:Tnfrsf10b)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Tnfrsf10b)) -| path(MESHD:Neoplasms)\n",
      "----------------------\n",
      "10019760 : These responses to TNFalpha were absent in TNFR2-/- and TNFR1/2-/- myofibroblasts, whereas TNFR1-/- cells showed similar responses to WT.\n",
      "act(p(MGI:Tnfrsf1b)) -| act(p(MGI:Mmp2))\n",
      "act(p(MGI:Tnfrsf1b)) -> p(MGI:Mapk1,pmod(P))\n",
      "act(p(MGI:Tnfrsf1b)) -> r(MGI:Timp1)\n",
      "----------------------\n",
      "10019764 : TNF (1ng/ml, 15min) stimulated SRC phosphorylation (Tyr 416) and activation through TNFR2 in Young adult mouse colon cells (YAMC) and Mouse colon epithelial (MCER1-/-) cells (lacking TNFR1). Src specific inhibitors PD-161430, PP1 or PP2 blocked TNF induced cell migration. Loss of TNFR2 (MCER2-/- cells) inhibited SRC activation.\n",
      "act(p(MGI:Tnfrsf1b)) -> p(MGI:Src,pmod(P))\n",
      "complex(p(MGI:Tnf),p(MGI:Tnfrsf1b)) -> act(p(MGI:Tnfrsf1b))\n",
      "p(MGI:Src,pmod(P)) -> act(p(MGI:Src))\n",
      "----------------------\n",
      "10019774 : As demonstrated in Fig. 3A, blockade of the OX40/OX40L interaction significantly reduced the Th1-specific transcription factor T-bet to 30.8% compared with controls (p=0.007). On the other hand, expression of IL-10, a cytokine that was shown to be protective in chronic DSS-induced colitis [29], increased 3.6-fold (p=0.008).\n",
      "act(p(MGI:Tnfrsf4)) -| r(MGI:Il10)\n",
      "act(p(MGI:Tnfrsf4)) -> r(MGI:Tbx21)\n",
      "----------------------\n",
      "10019776 : IL- 10 secretion increased 20-fold (p X 0.0001). This was accompanied by a significant, 18-fold, increase of IL-5 secretion. IFNG levels were not altered, but IL-6 secretion was reduced to 60% compared with controls.\n",
      "act(p(MGI:Tnfrsf4)) -| tloc(p(MGI:Il10))\n",
      "act(p(MGI:Tnfrsf4)) -| tloc(p(MGI:Il5))\n",
      "act(p(MGI:Tnfrsf4)) -> tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10019804 : Stimulation of UNC5B-expressing neovessels with an agonist (Netrin-1) inhibits sprouting angiogenesis. Genetic loss of function of unc5b reduces Netrin-1-mediated angiogenesis inhibition.\n",
      "act(p(MGI:Unc5b)) -| bp(GOBP:angiogenesis)\n",
      "act(p(MGI:Unc5b)) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "p(MGI:Ntn1) -> act(p(MGI:Unc5b))\n",
      "act(p(HGNC:UNC5B)) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10019806 : Thus, the pair netrin-1/UNC5H2 may regulate cell fate by controlling the proapoptotic kinase activity of DAP-kinase.\n",
      "act(p(MGI:Unc5b)) -> complex(p(MGI:Dapk1),p(MGI:Unc5b))\n",
      "complex(p(MGI:Dapk1),p(MGI:Unc5b)) -> act(p(MGI:Dapk1))\n",
      "----------------------\n",
      "10005204 : We found that Wwp2 specifically interacted with mouse Rpb1 and targeted it for ubiquitination both in vitro and in vivo\n",
      "act(p(MGI:Wwp2)) -> deg(p(MGI:Polr2a))\n",
      "complex(p(MGI:Polr2a),p(MGI:Wwp2)) -> deg(p(MGI:Polr2a))\n",
      "----------------------\n",
      "10000346 : We describe here a novel murine ubiquitin ligase, Wwp2, that specifically interacts with Oct-4 and promotes its ubiquitination both in vivo and in vitro.\n",
      "act(p(MGI:Wwp2)) -> deg(p(MGI:Pou5f1))\n",
      "complex(p(MGI:Wwp2),p(MGI:Pou5f1)) -> deg(p(MGI:Pou5f1))\n",
      "----------------------\n",
      "10019816 : To determine if XIAP enhanced proinflammatory gene expression in vivo, we performed qRT-PCR analysis on splenic RNA from WT and XIAP knockout mice. RNA was isolated from splenocytes harvested from uninfected animals or animals infected with L. monocytogenes for 48 h (Figure 6) {to activate XIAP}. The expression of il6 and ifng mRNAs were significantly enhanced in the presence of XIAP during infection.\n",
      "act(p(MGI:Xiap)) -> r(MGI:Ifng)\n",
      "act(p(MGI:Xiap)) -> r(MGI:Il6)\n",
      "----------------------\n",
      "10019822 : Tristetraprolin (TTP) is an mRNA-destabilizing protein that negatively regulates the expression of proinflammatory mediators such as tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor, and cyclooxygenase 2\n",
      "act(p(MGI:Zfp36)) -| r(MGI:Csf2)\n",
      "act(p(MGI:Zfp36)) -| r(MGI:Ptgs2)\n",
      "act(p(MGI:Zfp36)) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10005220 : Calmegin is a putative testis-specific molecular chaperone required for the heterodimerization of fertilin alpha/beta and the appearance of fertilin beta on the sperm surface.\n",
      "act(p(MGI:Clgn)) -> complex(p(MGI:Adam1a),p(MGI:Adam2))\n",
      "p(MGI:Clgn) -> act(p(MGI:Clgn))\n",
      "----------------------\n",
      "10019852 : oestrogenic conditions SRC-1 preferentially binds to the ER which effectively sequesters it thereby reducing enhancer activity\n",
      "complex(a(CHEBI:estradiol),p(HGNC:ESR1)) -> complex(p(HGNC:NCOA1),p(HGNC:ESR1))\n",
      "complex(p(HGNC:NCOA1),p(HGNC:ESR1)) -| r(HGNC:ERBB2)\n",
      "----------------------\n",
      "10019856 : Estrogen rapidly activates the mitogen-activated protein kinases, Erk-1 and Erk-2, via an as yet unknown mechanism. requires the expression of the G protein-coupled receptor homolog, GPR30. We show that 17beta-estradiol activates Erk-1/-2 not only in MCF-7 cells, which express both estrogen receptor alpha (ER alpha) and ER beta, but\n",
      "complex(a(CHEBI:estradiol),p(HGNC:GPER1)) -> act(p(HGNC:MAPK1))\n",
      "complex(a(CHEBI:estradiol),p(HGNC:GPER1)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10019924 : beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex.\n",
      "complex(p(HGNC:AXIN1),p(HGNC:GSK3B)) -> act(p(HGNC:GSK3B))\n",
      "act(p(HGNC:GSK3B)) -> p(HGNC:CTNNB1,pmod(P))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10019936 : We further show that Btg1 and Btg2 enhance Hoxb9-mediated transcription in transfected cells, and we report the formation of a Hoxb9.Btg2 complex on a Hoxb9-responsive target, and the fact that this interaction facilitates the binding of Hoxb9 to DNA.\n",
      "complex(p(HGNC:BTG2),p(HGNC:HOXB9)) -> act(p(HGNC:HOXB9))\n",
      "p(HGNC:BTG1) -> act(p(HGNC:HOXB9))\n",
      "p(HGNC:BTG2) -> act(p(HGNC:HOXB9))\n",
      "----------------------\n",
      "10005268 : FWD1 facilitated ubiquitination and promoted degradation of beta-catenin, resulting in reduced cytoplasmic beta-catenin levels.\n",
      "complex(p(HGNC:BTRC),p(HGNC:CTNNB1)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:BTRC) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10019942 : <s10> Cyclin A:Cdk2 and Cyclin A:Cdc2 phosphorylate RPA2; the major site for Cdc2 has been mapped to Ser29 (Niu et al.,1997).\n",
      "complex(p(HGNC:CCNA2),p(HGNC:CDK1)) -> p(HGNC:RPA2,pmod(P))\n",
      "complex(p(HGNC:CDK2),p(HGNC:CCNA2)) -> p(HGNC:RPA2,pmod(P))\n",
      "----------------------\n",
      "10019950 : <C13> Cyclin E has a half-life of ~30 min. It is degraded by way of the ubiquitin?proteasome pathway subsequent to phosphorylation (possibly autophosphorylation) at threonine-380 (Clurman et al., 1996; Won and Reed, 1996). However, it can be stabilized by binding to Cdk2.\n",
      "complex(p(HGNC:CCNE1),p(HGNC:CDK2)) -| deg(p(HGNC:CCNE1))\n",
      "p(HGNC:CCNE1,pmod(P)) -> deg(p(HGNC:CCNE1))\n",
      "----------------------\n",
      "10019948 : <r2> DPase a-primase may be regulated by phosphorylation of its p68 subunit by Cyclin A:Cdk2, which reduces and Cyclin E:Cdk2 which increases its DNA initiation activity (Voitenleitner et al., 1999).\n",
      "complex(p(HGNC:CCNE1),p(HGNC:CDK2)) -> p(HGNC:POLD3,pmod(P))\n",
      "complex(p(HGNC:CDK2),p(HGNC:CCNA2)) -> p(HGNC:POLD3,pmod(P))\n",
      "----------------------\n",
      "10019952 : <C40> Ser216-phosphorylated Cdc25C is recognized and bound by 14-3-3 protein family members (Peng et al., 1997, 1998). Ser216 phosphorylation and 14-3-3 binding probably sequester Cdc25C and thus prevent it from interacting with Cdk1 in vivo (Peng et al., 1997). 14-3-3s is localized to the cytoplasm and may be the means by which Cdc25C is sequestered outside of the nucleus (Hermeking et al., 1997).\n",
      "complex(p(HGNC:CDC25C),p(HGNC:SFN)) -| p(HGNC:CDC25C,pmod(P))\n",
      "act(complex(p(HGNC:CDK1),p(HGNC:CCNB1))) -> p(HGNC:CDC25C,pmod(P))\n",
      "p(HGNC:CDC25C,pmod(P)) -> complex(p(HGNC:CDC25C),p(HGNC:SFN))\n",
      "----------------------\n",
      "10005286 : We find that Cdk10 binds full length Ets2 in vitro and in vivo and inhibits Ets2 transactivation in mammalian cells.\n",
      "complex(p(HGNC:CDK10),p(HGNC:ETS2)) -| act(p(HGNC:ETS2))\n",
      "p(HGNC:CDK10) -| act(p(HGNC:ETS2))\n",
      "----------------------\n",
      "10005288 : Gadd45 was also able to physically interact with Cdc2, but not Cyclin B1. Addition of Gadd45 to immunoprecipitated Cdc2/Cyclin B1 in vitro led to a dissociation of this complex, and thus may represent a new checkpoint mechanism whereby Cdc2/Cyclin B1 can be inhibited.\n",
      "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) -> bp(GOBP:\"cell cycle\")\n",
      "p(HGNC:GADD45A) -| complex(p(HGNC:CDK1),p(HGNC:CCNB1))\n",
      "p(HGNC:GADD45A) -| act(p(HGNC:CDK1))\n",
      "----------------------\n",
      "10019958 : <C36> Cdc25C is activated by hyperphosphorylation of the Nterminal domain (Gabrielli et al., 1997), which can be phosphorylated by Cyclin B:Cdk1 (Hoffman et al., 1993).\n",
      "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) -> p(HGNC:CDC25C,pmod(P))\n",
      "p(HGNC:CDC25C,pmod(P)) -> act(p(HGNC:CDC25C))\n",
      "----------------------\n",
      "10019964 : a peptide corresponding to the third intracellular loop of the m3-muscarinic receptor (Ser(345)-Leu(463)) is an inhibitor of CK1alpha due to its ability to both act as a pseudo-substrate for CK1alpha and form a high affinity complex with CK1alpha\n",
      "complex(p(HGNC:CHRM3),p(HGNC:CSNK1A1)) -| r(HGNC:CSNK1A1)\n",
      "act(p(HGNC:CSNK1A1)) -> p(HGNC:CHRM3,pmod(P))\n",
      "----------------------\n",
      "10019968 : Csk has been reported to associate with IRS-1 through its SH2 domain and promote dephosphorylation of the focal adhesion kinase (FAK) in an insulin-dependent manner (56).\n",
      "complex(p(HGNC:CSK),p(HGNC:IRS1)) -| p(HGNC:PTK2,pmod(P))\n",
      "act(p(HGNC:CSK)) -| p(HGNC:PTK2,pmod(P))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:CSK),p(HGNC:IRS1))\n",
      "----------------------\n",
      "10019976 : Dlk can induce apoptosis. In search for interaction partners that might serve as regulators or targets of this kinase we identified apoptosis antagonizing transcription factor (AATF) Interestingly, AATF interfered with Dlk-induced apoptosis.\n",
      "complex(p(HGNC:DAPK3),p(HGNC:AATF)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:DAPK3)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10005296 : Strikingly, coexpression of Dlk and Par-4 lead to relocation of Dlk from the nucleus to the cytoplasm, particularly to actin filaments. These interactions provoked a dramatic reorganization of the cytoskeleton and morphological symptoms of apoptosis, thus suggesting a functional relationship between Dlk and Par-4 in the control of apoptosis.\n",
      "complex(p(HGNC:DAPK3),p(HGNC:PAWR)) -> tloc(p(HGNC:DAPK3))\n",
      "tloc(p(HGNC:DAPK3)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10019986 : This is consistent with our finding that EGF, an upstream activator of MAPK, enhances the effect of SRC-1 on PR-dependent gene transcription (50).\n",
      "complex(p(HGNC:EGF),p(HGNC:EGFR)) -> act(p(HGNC:EGFR))\n",
      "act(p(HGNC:NCOA1)) -> act(p(HGNC:PGR))\n",
      "----------------------\n",
      "10019990 : 4E-BP1 is a translation inhibitor that is phosphorylated and inactivated in response to a growth signal. Phosphorylated 4E-BP1 dissociates from eIF4E, the translation initiation factor that binds the cap structure (m7G(5')ppp(5')N) present at the 5' termini of mRNAs, thereby allowing cap-dependent translation.\n",
      "complex(p(HGNC:EIF4EBP1),p(HGNC:EIF4E)) -| act(p(HGNC:EIF4E))\n",
      "p(HGNC:EIF4EBP1,pmod(P)) -| complex(p(HGNC:EIF4EBP1),p(HGNC:EIF4E))\n",
      "----------------------\n",
      "10019996 : The BRCA1 protein was found to associate with ER-alpha in vivo and to bind to ER-alpha in vitro, by an estrogen-independent interaction that mapped to the amino-terminal region of BRCA1 (ca. amino acid 1-300) and the conserved carboxyl-terminal activation function [AF-2] domain of ER-alpha\n",
      "complex(p(HGNC:ESR1),p(HGNC:BRCA1)) -| act(p(HGNC:ESR1))\n",
      "p(HGNC:BRCA1) -| act(p(HGNC:ESR1))\n",
      "----------------------\n",
      "10019998 : LPS-induced monocyte TF expression is regulated through a 56-bp promoter region (2227 through 2172 bp) containing 2 activator protein-1 (AP-1) binding sites and a nuclear factor (NF)-kB binding site, elements that bind c-fos/c-jun and c-Rel/p65 heterodimers, respectively.8,9 LPS-induced TF expression in cells of the monocyte lineage requires functional interaction between these transcription factors.10\n",
      "complex(p(HGNC:FOS),p(HGNC:JUN)) -> r(HGNC:F3)\n",
      "complex(p(HGNC:REL),p(HGNC:RELA)) -> r(HGNC:F3)\n",
      "----------------------\n",
      "10020010 : <E14> The interaction with HDAC1 enhances transcriptional repression by pocket proteins (Brehm et al., 1998; Ferreira et al., 1998; Luo et al., 1998). HDAC1:RB1^taof(RB1) HDAC1:NOLC1^taof(RB1) HDAC1:RBL1^taof(RB1)\n",
      "complex(p(HGNC:HDAC1),p(HGNC:NOLC1)) -> act(p(HGNC:NOLC1))\n",
      "complex(p(HGNC:HDAC1),p(HGNC:RB1)) -> act(p(HGNC:RB1))\n",
      "complex(p(HGNC:HDAC1),p(HGNC:RBL1)) -> act(p(HGNC:RBL1))\n",
      "----------------------\n",
      "10020014 : <B10> HMG1 or 2 competes with Ku for binding to DNA-PK and stimulates DNA-dependent kinase activity in vitro in the absence of Ku (Yumoto et al., 1998).\n",
      "complex(p(HGNC:HMGB1),p(HGNC:PRKDC)) -> act(p(HGNC:PRKDC))\n",
      "complex(p(HGNC:HMGB2),p(HGNC:PRKDC)) -> act(p(HGNC:PRKDC))\n",
      "complex(p(HGNC:PRKDC),a(CHEBI:\"double-stranded DNA\")) -> act(p(HGNC:PRKDC))\n",
      "----------------------\n",
      "10005306 : In contrast, ICAM-2 and ICAM-3 induced a much stronger secretion of the Th1 cytokine TNF-alpha compared to LFA-1/ICAM-1 induced co-stimulation, despite the lower proliferation rate.\n",
      "complex(p(HGNC:ICAM3),p(HGNC:ITGAL),p(HGNC:ITGB2)) -> tloc(p(HGNC:TNF))\n",
      "complex(p(HGNC:ITGAL),p(HGNC:ITGB2),p(HGNC:ICAM2)) -> tloc(p(HGNC:TNF))\n",
      "----------------------\n",
      "10020016 : We found that STAT3, but not STAT5, was activated in response to IGF-I in 293T cells cotransfected with IGF-IR and STAT expression vectors. Moreover, tyrosine phosphorylation of STAT3, JAK1, and JAK2 was increased upon IGF-I stimulation of endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK expression vector.\n",
      "complex(p(HGNC:IGF1),p(HGNC:IGF1R)) -> p(HGNC:JAK1,pmod(P))\n",
      "complex(p(HGNC:IGF1),p(HGNC:IGF1R)) -> p(HGNC:JAK2,pmod(P))\n",
      "complex(p(HGNC:IGF1),p(HGNC:IGF1R)) -> p(HGNC:STAT3,pmod(P))\n",
      "----------------------\n",
      "10005308 : The IGF-II gene is overexpressed in malignant adrenocortical tumors and its proliferative effects are mediated by the type-1 IGF receptor (IGF1R).\n",
      "complex(p(HGNC:IGF2),p(HGNC:IGF1R)) -> act(p(HGNC:IGF1R))\n",
      "act(p(HGNC:IGF1R)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10020028 : The phosphorylated residue is essential for efficient association with IRF-1 and thus for the repressor activity of ICSBP exerted on IRF-1.\n",
      "complex(p(HGNC:IRF8),p(HGNC:IRF1)) -| act(p(HGNC:IRF1))\n",
      "p(HGNC:IRF8,pmod(P)) -> complex(p(HGNC:IRF8),p(HGNC:IRF1))\n",
      "p(HGNC:IRF8) -| act(p(HGNC:IRF1))\n",
      "----------------------\n",
      "10020042 : SIRP is a transmembrane protein that is now known to bind to integrin-associated protein. It appears to bind directly to JAK2 by a process that does not require tyrosyl phosphorylation, although is itself highly phosphorylated on tyrosines in response to GH. The phosphorylated SIRP recruits one or more molecules of the tyrosine phosphatase SHP2 that, in turn, de-phosphorylates SIRP and most likely JAK2.\n",
      "complex(p(HGNC:JAK2),p(HGNC:SIRPA)) -> complex(p(HGNC:SIRPA),p(HGNC:JAK2),p(HGNC:PTPN11))\n",
      "complex(p(HGNC:SIRPA),p(HGNC:JAK2),p(HGNC:PTPN11)) -| p(HGNC:JAK2,pmod(P))\n",
      "complex(p(HGNC:SIRPA),p(HGNC:JAK2),p(HGNC:PTPN11)) -| p(HGNC:SIRPA,pmod(P))\n",
      "----------------------\n",
      "10020044 : This hypothesis is strongly supported by the result that VEGFA165- stimulated, tyrosine phosphorylated VEGFR-2 was associated with b3 integrin. The specificity of the model was restricted to avb3 integrin.\n",
      "complex(p(HGNC:KDR),p(HGNC:ITGAV),p(HGNC:ITGB3)) -> act(p(HGNC:KDR))\n",
      "p(HGNC:KDR,pmod(P)) -> complex(p(HGNC:KDR),p(HGNC:ITGAV),p(HGNC:ITGB3))\n",
      "----------------------\n",
      "10020048 : % In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail.\n",
      "complex(p(HGNC:KIT),p(HGNC:KIT)) -> act(p(HGNC:KIT))\n",
      "act(p(HGNC:KIT)) -> p(HGNC:KIT,pmod(P))\n",
      "act(p(HGNC:KIT)) -> p(HGNC:KIT,pmod(P))\n",
      "----------------------\n",
      "10005314 : We show that CD7 is required for galectin-1-mediated death. This demonstrates a novel function for CD7 as a death trigger and identifies galectin-1/CD7 as a new biologic death signaling pair.\n",
      "complex(p(HGNC:LGALS1),p(HGNC:CD7)) -> bp(GOBP:\"cell death\")\n",
      "complex(p(HGNC:LGALS1),p(HGNC:CD7)) -> act(p(HGNC:CD7))\n",
      "complex(p(HGNC:LGALS1),p(HGNC:CD7)) -> act(p(HGNC:CD7))\n",
      "----------------------\n",
      "10020058 : We have shown that the c-Maf and c-Myb transcription factors physically interact in myeloid cells to form inhibitory complexes that hinder transactivation of c-Myb target genes through direct binding to Myb consensus sites.\n",
      "complex(p(HGNC:MAF),p(HGNC:MYB)) -| act(p(HGNC:MYB))\n",
      "p(HGNC:MAF) -| act(p(HGNC:MYB))\n",
      "act(p(HGNC:MYB)) -| bp(GOBP:\"cell differentiation\")\n",
      "----------------------\n",
      "10020064 : In the yeast two-hybrid system and in transfected COS cells, MIR interacts with myosin regulatory light chain B, which in turn regulates the activity of the actomyosin complex.\n",
      "complex(p(HGNC:MYLIP),p(HGNC:MYL5)) -> bp(GOBP:\"cell migration\")\n",
      "complex(p(HGNC:MYLIP),p(HGNC:MYL9)) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10020066 : Nck associates with IRS-1 (45), many different tyrosine kinases, several serine/threonine kinases through its SH2 domain, as well as Sos through its SH3 domains\n",
      "complex(p(HGNC:NCK1),p(HGNC:IRS1)) -> complex(p(HGNC:HRAS),p(HGNC:SOS1))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:NCK1),p(HGNC:IRS1))\n",
      "----------------------\n",
      "10020072 : Furthermore, Nrf2.ATF4 dimers bound to an StRE sequence from the ho-1 gene. CdCl(2), a potent inducer of HO-1, increased expression of ATF4 in mouse hepatoma cells, and detectable induction of ATF4 protein preceded that of HO-1\n",
      "complex(p(HGNC:NFE2L2),p(HGNC:ATF4)) -> act(p(HGNC:NFE2L2))\n",
      "act(p(HGNC:NFE2L2)) -> r(HGNC:HMOX1)\n",
      "----------------------\n",
      "10020088 : However, in specific organs, the effect of PDGF on angiogenesis may be significant. Thus stimulation of PDGF-AB production in cardiac microvascular cells leads to induction of both von Willebrand factor and VEGF and VEGF receptor-2, suggesting an important role of PDGF in cardiac angiogenesis (110).\n",
      "complex(p(HGNC:PDGFA),p(HGNC:PDGFB)) -> p(HGNC:KDR)\n",
      "complex(p(HGNC:PDGFA),p(HGNC:PDGFB)) -> p(HGNC:VEGFA)\n",
      "complex(p(HGNC:PDGFA),p(HGNC:PDGFB)) -> p(HGNC:VWF)\n",
      "----------------------\n",
      "10018124 : VEGF endogenous production may be upregulated in vascular smooth muscle cells by hypoxia, growth factors (bFGF and PDGF-BB), and cytokines\n",
      "complex(p(HGNC:PDGFB),p(HGNC:PDGFB)) -> p(HGNC:VEGFA)\n",
      "p(HGNC:FGF2) -> p(HGNC:VEGFA)\n",
      "p(HGNC:PDGFB) -> p(HGNC:VEGFA)\n",
      "bp(GOBP:\"response to hypoxia\") -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10020096 : Moreover, activation of the beta -receptor stimulates chemotaxis; in contrast, activation of the alpha -receptors inhibits chemotaxis of certain cell types including fibroblasts and smooth muscle cells (255, 429, 513), whereas chemotaxis of certain other cell types is stimulated (201, 334, 428, 515).\n",
      "complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA)) -> bp(GOBP:chemotaxis)\n",
      "complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA)) -| bp(GOBP:chemotaxis)\n",
      "complex(p(HGNC:PDGFRB),p(HGNC:PDGFRB)) -> bp(GOBP:chemotaxis)\n",
      "----------------------\n",
      "10020100 : Crk, which is the only SH2 protein known that binds with significantly higher affinity to the alpha -receptor than to the beta -receptor (511), forms a complex with the docking protein Cas and the nucleotide exchange protein C3G, which has been linked to the activation of JNK/SAPK (462).\n",
      "complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA),p(HGNC:CRK)) -> complex(p(HGNC:CRK),p(HGNC:RAPGEF1),p(HGNC:BCAR1))\n",
      "complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA),p(HGNC:CRK)) -> p(HGNC:CRK)\n",
      "----------------------\n",
      "10020108 : VEGFR1 does appear to mediate VEGF- and PIGF-induced tissue factor expression and chemotaxis in monocytes, a cell type that expresses only VEGFR1\n",
      "complex(p(HGNC:PGF),p(HGNC:VEGFA)) -> act(p(HGNC:FLT1))\n",
      "complex(p(HGNC:VEGFA),p(HGNC:FLT1)) -> act(p(HGNC:FLT1))\n",
      "act(p(HGNC:FLT1)) -> bp(GOBP:chemotaxis)\n",
      "act(p(HGNC:FLT1)) -> r(HGNC:F3)\n",
      "----------------------\n",
      "10001352 : Inducible overexpression of PS1 led to increased association of beta-catenin with glycogen synthase kinase-3beta (GSK-3beta), a negative regulator of beta-catenin, and accelerated the turnover of endogenous beta-catenin.\n",
      "complex(p(HGNC:PSEN1),p(HGNC:CTNNB1)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:GSK3B) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:PSEN1) -> complex(p(HGNC:CTNNB1),p(HGNC:GSK3B))\n",
      "p(HGNC:PSEN1) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10018178 : <N12> Rad51 binds to c-Abl directly (Yuan et al., 1998). c-Abl phosphorylates Rad51 Tyr54, as a consequence of which the binding of Rad51 to ssDNA is inhibited (Yuan et al., 1998). IR induces c-Abl-dependent phosphorylation of Rad51 (Yuan et al., 1998).\n",
      "complex(p(HGNC:RAD51),p(HGNC:ABL1)) -| complex(p(HGNC:RAD51),a(CHEBI:\"single-stranded DNA\"))\n",
      "act(p(HGNC:ABL1)) -> p(HGNC:RAD51,pmod(P))\n",
      "----------------------\n",
      "10020132 : <s7> The binding of RPA to p53 inhibits the binding of RPA to ssDNA (Dutta et al., 1993) and the binding of p53 to its promoter sites (Miller et al., 1997).\n",
      "complex(p(HGNC:RPA1),p(HGNC:TP53)) -| complex(p(HGNC:RPA2),p(HGNC:RPA3),p(HGNC:RPA1),a(CHEBI:\"single-stranded DNA\"))\n",
      "complex(p(HGNC:RPA1),p(HGNC:TP53)) -| act(p(HGNC:TP53))\n",
      "----------------------\n",
      "10020136 : Phosphorylation of Shc produces its binding to the adaptor protein Grb2, causing activation of the protooncogene ras, which is also upstream of the MAP kinase pathway.\n",
      "complex(p(HGNC:SHC1),p(HGNC:GRB2)) -> act(p(HGNC:HRAS))\n",
      "p(HGNC:SHC1,pmod(P)) -> complex(p(HGNC:SHC1),p(HGNC:GRB2))\n",
      "----------------------\n",
      "10020138 : Mutations at the signal-induced phosphorylation site of beta-catenin inhibited its association with FWD1.\n",
      "complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:FBXO5),p(HGNC:BTRC)) -> complex(p(HGNC:BTRC),p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> complex(p(HGNC:BTRC),p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10020140 : Consistent with this, these reagents also eliminate the ability of the Skp1-CUL1-HOS-ROC1 E3 ligase complex to support the ubiquitination of IkappaBalpha.\n",
      "complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:FBXW11),p(HGNC:RBX1)) -> deg(p(HGNC:NFKBIA))\n",
      "complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:FBXW11),p(HGNC:RBX1)) -> p(HGNC:NFKBIA,pmod(U))\n",
      "----------------------\n",
      "10005360 : In the nucleoprotein complex, Smad2 interacted through its C-domain with Sp1 and enhanced the DNA binding and transcriptional activity of Sp1\n",
      "complex(p(HGNC:SP1),p(HGNC:SMAD2)) -> act(p(HGNC:SP1))\n",
      "p(HGNC:SMAD2) -> act(p(HGNC:SP1))\n",
      "----------------------\n",
      "10020166 : <p17> Ser392 phosphorylation of P53 increases 10-fold the association constant for tetramerization, but this effect is reversed by Ser315 phosphorylation. The tetramerization activates P53 for specific DNA binding and transcription\n",
      "complex(p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53)) -> act(p(HGNC:TP53))\n",
      "p(HGNC:TP53,pmod(P)) -> complex(p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53))\n",
      "p(HGNC:TP53,pmod(P)) -> act(p(HGNC:TP53))\n",
      "----------------------\n",
      "10005378 : These results indicate that 14-3-3 proteins negatively regulate HDAC4 by preventing its nuclear localization and thereby uncover a novel regulatory mechanism for HDACs.\n",
      "complex(p(HGNC:YWHAB),p(HGNC:HDAC4)) -| act(p(HGNC:HDAC4))\n",
      "p(HGNC:YWHAB) -| act(p(HGNC:HDAC4))\n",
      "----------------------\n",
      "10020186 : regulation at the level of elongation a profound decrease in apoB synthesis with no change in apoB mRNA abundance decreased synthesis could be explained by a prolonged elongation rate for apoB the elongation of apoB mRNA in HepG2 cells slows when translocation of nascent apoB across the endoplasmic reticulum is inhibited by preventing Mttp-associated transfer of lipids to the nascent polypeptide\n",
      "complex(p(MGI:Apob),a(CHEBI:lipid)) -> tloc(p(MGI:Apob))\n",
      "p(MGI:Mttp) -> tloc(p(MGI:Apob))\n",
      "tloc(p(MGI:Apob)) -> tloc(p(MGI:Apob))\n",
      "----------------------\n",
      "10005380 : We conclude that beta-arrestin2 can bind to and enhance endocytosis of the LDLR, both in vitro and in vivo, and may thereby influence lipoprotein metabolism\n",
      "complex(p(MGI:Arrb2),p(MGI:Ldlr)) -> act(p(MGI:Ldlr))\n",
      "p(MGI:Arrb2) -> act(p(MGI:Ldlr))\n",
      "----------------------\n",
      "10005384 : Systematic binding assays showed that the C-terminal nuclear receptor box (LVMQLL) of ASXL1 and the activation function-2 activation domain (AF-2 AD) core of the RAR are critical for ligand-dependent interaction\n",
      "complex(p(MGI:Asxl1),p(MGI:Rara)) -> act(p(MGI:Rara))\n",
      "p(MGI:Asxl1) -> act(p(MGI:Rara))\n",
      "----------------------\n",
      "10005398 : hus, the CCND1-CDK6 complex is like to negatively regulate Wnt signaling by mediating beta-catenin phosphorylation and its subsequent degradation in Wnt-stimulated cells.\n",
      "complex(p(MGI:Ccnd1),p(MGI:Cdk6)) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "act(complex(p(MGI:Ccnd1),p(MGI:Cdk6))) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "act(p(MGI:Cdk6)) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "----------------------\n",
      "10020208 : We further show that cyclin E-CDK2-dependent phosphorylation of p27 results in elimination of p27 from the cell, allowing cells to transit from G1 to S phase.\n",
      "complex(p(MGI:Ccne1),p(MGI:Cdk2)) -> bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "act(p(MGI:Cdk2)) -> deg(p(MGI:Cdkn1b))\n",
      "p(MGI:Cdkn1b,pmod(P)) -> deg(p(MGI:Cdkn1b))\n",
      "----------------------\n",
      "10020210 : TGF-beta inhibits Cdk2-cyclin E kinase activity by promoting the binding of cell cycle inhibitor Kip1 protein to the kinase complexes.\n",
      "complex(p(MGI:Ccne1),p(MGI:Cdk2)) -> act(p(MGI:Cdk2))\n",
      "act(p(MGI:Tgfbr1)) -| act(p(MGI:Cdk2))\n",
      "p(MGI:Cdkn1b) -| act(p(MGI:Cdk2))\n",
      "p(HGNC:CDKN1B) -| act(p(HGNC:CDK2))\n",
      "----------------------\n",
      "10020214 : Furthermore, 2B4/CD48 interactions between NK cells also enhanced proliferation of NK cells in response to IL-2\n",
      "complex(p(MGI:Cd244),p(MGI:Cd48)) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Cd244) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Cd48) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10005410 : Furthermore, blocking CD40/CD40L interactions with blocking Ab decreased BAL production of Th1-mediators (IL-12 and TNF-alpha).\n",
      "complex(p(MGI:Cd40lg),p(MGI:Cd40)) -> complex(p(MGI:Il12a),p(MGI:Il12b))\n",
      "complex(p(MGI:Cd40lg),p(MGI:Cd40)) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10020222 : After receptor binding, the intracellular signalling cascade is activated via the ERK-MAP kinase pathway, resulting in increased cell proliferation via cyclin D1 transcription and subsequent phosphorylation of the Rb gene [16] .\n",
      "complex(p(MGI:Cd74),p(MGI:Mif)) -> p(MGI:Rb1,pmod(P))\n",
      "complex(p(MGI:Cd74),p(MGI:Mif)) -> r(MGI:Ccnd1)\n",
      "----------------------\n",
      "10020230 : We show that p27 interacts with cyclin E-CDK2 in at least two distinct ways: one resulting in p27 phosphorylation and release, the other in tight binding and cyclin E-CDK2 inhibition.\n",
      "complex(p(MGI:Cdkn1b),p(MGI:Ccne1),p(MGI:Cdk2)) -| act(p(MGI:Cdk2))\n",
      "p(MGI:Cdkn1b) -| act(p(MGI:Cdk2))\n",
      "----------------------\n",
      "10020234 : C/EBPbeta-PThr(217) and the phosphorylation mimic C/EBPbeta-Glu(217), but not C/EBPbeta-Ala(217), were associated with procaspases 1 and 8 in vivo and in vitro and inhibited their activation.\n",
      "complex(p(MGI:Cebpb),p(MGI:Casp1)) -| act(p(MGI:Casp1))\n",
      "complex(p(MGI:Cebpb),p(MGI:Casp8)) -| act(p(MGI:Casp8))\n",
      "p(MGI:Cebpb,pmod(P)) -> complex(p(MGI:Cebpb),p(MGI:Casp1))\n",
      "p(MGI:Cebpb,pmod(P)) -> complex(p(MGI:Cebpb),p(MGI:Casp8))\n",
      "----------------------\n",
      "10020236 : Nrf1 has also been reported to function as a repressor of transcription. The dentin sialophosphoprotein (DSPP) gene encodes DSP and DPP, which are expressed in terminally differentiated odontoblast. In undifferentiated odontoblast, Nrf1 interacts with C/EBP-? to repress DSPP expression.\n",
      "complex(p(MGI:Cebpb),p(MGI:Nfe2l1)) -| r(MGI:Dspp)\n",
      "act(p(MGI:Cebpb)) -| r(MGI:Dspp)\n",
      "act(p(MGI:Nfe2l1)) -| r(MGI:Dspp)\n",
      "----------------------\n",
      "10020244 : E1A acting to partition CBP p300 from Mitf and thereby reduce its ability to activate transcription.\n",
      "complex(p(MGI:Crebbp),p(MGI:Mitf)) -> act(p(MGI:Mitf))\n",
      "complex(p(MGI:Ep300),p(MGI:Mitf)) -> act(p(MGI:Mitf))\n",
      "----------------------\n",
      "10020246 : when CRY and PER proteins accumulate to a critical threshold, they act as transcriptional repressors of their own genes by attenuating activity of clock and bmal1\n",
      "complex(p(MGI:Cry1),p(MGI:Per1)) -| act(complex(p(MGI:Clock),p(MGI:Arntl)))\n",
      "complex(p(MGI:Cry2),p(MGI:Per2)) -| act(complex(p(MGI:Clock),p(MGI:Arntl)))\n",
      "----------------------\n",
      "10005438 : EGF strongly inhibited the expression of WDNM1 and SGP-2 genes. Our recent results are reviewed and discussed.\n",
      "complex(p(MGI:Egf),p(MGI:Egfr)) -> act(p(MGI:Egfr))\n",
      "act(p(MGI:Egfr)) -| r(MGI:Clu)\n",
      "act(p(MGI:Egfr)) -| r(MGI:Wfdc18)\n",
      "----------------------\n",
      "10020254 : The delayed lung maturation characterized by abnormal branching and poor alveolization in EGFR(-/-) is accompanied by aberrant expression of MMP's. Inhibition of MMP's in developing lungs in vivo or in vitro severely retarded morphogenesis.\n",
      "complex(p(MGI:Egf),p(MGI:Egfr)) -> r(MGI:Mmp14)\n",
      "p(MGI:Mmp14) -> act(p(MGI:Mmp2))\n",
      "----------------------\n",
      "10005442 : As a consequence, the degradation of HIF-1alpha was inhibited as determined by impaired degradation of a reporter protein containing the HIF-1alpha oxygen-dependent degradation domain encompassing the PHD-targeted prolines.\n",
      "complex(p(MGI:Egln1),p(MGI:Hif1a)) -> deg(p(MGI:Hif1a))\n",
      "p(MGI:Egln1) -| act(p(MGI:Hif1a))\n",
      "----------------------\n",
      "10005448 : PCAF and p300 have also been demonstrated to function as critical coactivators for the muscle-specific basic helix-loop-helix (bHLH) protein MyoD during myogenic commitment.\n",
      "complex(p(MGI:Ep300),p(MGI:Myod1)) -> act(p(MGI:Myod1))\n",
      "complex(p(MGI:Kat2b),p(MGI:Myod1)) -> act(p(MGI:Myod1))\n",
      "----------------------\n",
      "10020258 : As discussed earlier, S1P is rapidly generated and secreted by mast cells following FcepsilonRI aggregation81,100.\n",
      "complex(p(MGI:Fcer1a),p(MGI:Fcer1g)) -> a(CHEBI:\"sphingosine 1-phosphate\")\n",
      "complex(p(MGI:Fcer1a),p(MGI:Fcer1g)) -> tloc(a(CHEBI:\"sphingosine 1-phosphate\"))\n",
      "----------------------\n",
      "10005462 : Moreover, BDNF-mediated enhancement of glutamate release from presynaptic terminals depended not only upon TrkB but also upon Myo6 and GIPC1.\n",
      "complex(p(MGI:Gipc1),p(MGI:Myo6),p(MGI:Ntrk2)) -> act(p(MGI:Ntrk2))\n",
      "act(p(MGI:Ntrk2)) -> tloc(a(CHEBI:\"L-glutamic acid\"))\n",
      "----------------------\n",
      "10020268 : Specific binding of Ins II to Qa-1b was confirmed by a CTL peptide-blocking assay. Demonstration of IFN-gamma-regulated Qa-1 expression in beta cells and identification of a Qa-1-binding peptide in the preproinsulin leader sequence invoke further consideration of possible roles of Qa-1 in the progression of islet inflammation.\n",
      "complex(p(MGI:\"H2-T23\"),p(MGI:Ins2)) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Ifng) -> r(MGI:\"H2-T23\")\n",
      "----------------------\n",
      "10005468 : To test the biochemical relevance of this interaction, PGM activity was measured in the heart from wild type and transgenic mice, showing a 20% increase of Vmax in the transgenic group, without change in KM.\n",
      "complex(p(MGI:Hspb8),p(MGI:Pgm1)) -> act(p(MGI:Pgm1))\n",
      "p(MGI:Hspb8) -> act(p(MGI:Pgm1))\n",
      "----------------------\n",
      "10005472 : Thus, IGFBP-4.7A results in greater growth inhibition than equivalent levels of native IGFBP-4 in vivo, demonstrating a role for IGFBP-4 proteolysis in the regulation of IGF-I action.\n",
      "complex(p(MGI:Igf1),p(MGI:Igf1r)) -> act(p(MGI:Igf1r))\n",
      "deg(p(MGI:Igfbp4)) -> p(MGI:Igf1)\n",
      "p(MGI:Igfbp4) -| p(MGI:Igf1)\n",
      "----------------------\n",
      "10000214 : The anti-IL-12 antibody treatment decreased the number of apoptotic cells and the degree of inflammation and fibrosis in lung tissue\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> bp(GOBP:\"inflammatory response\")\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10020288 : CyCAP is a widely expressed secreted glycoprotein that modulates the host response to endotoxin gene-targeted CyCAP-deficient mice are more sensitive to the lethal effects of endotoxin in response to endotoxin, CyCAP-deficient mice overproduce interleukin 12 and interferon-gamma systemically and tumor necrosis factor alpha locally, these are proinflammatory molecules that also promote T helper 1 responses\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> bp(GOBP:\"T-helper 1 type immune response\")\n",
      "p(MGI:Ifng) -> bp(GOBP:\"T-helper 1 type immune response\")\n",
      "p(MGI:Tnf) -> bp(GOBP:\"T-helper 1 type immune response\")\n",
      "p(HGNC:IFNG) -> bp(GOBP:\"T-helper 1 type immune response\")\n",
      "----------------------\n",
      "10020292 : To determine whether activation of p38 MAPK by IL-12 occurred via characterized MAPK kinases, we analyzed the ability of IL-12 to induce phosphorylation of MAPK kinases known to phosphorylate p38 MAPK, including MKK3, MKK6, and MKK4 (24, 25, 26, 27). Using an Ab that detects phosphorylation of MKK3 and MKK6, activation of MKK3/6 was detected following IL-12 stimulation (Fig. 5).\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> act(p(MGI:Map2k3))\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> act(p(MGI:Map2k6))\n",
      "----------------------\n",
      "10020294 : In this report we demonstrate that IL-12 activates mitogen-activated protein kinase kinase 3/6 (MKK) and p38 mitogen-activated protein kinase (MAPK), but not p44/42 (ERK) or stress-activated protein kinase/c-Jun N-terminal kinase MAPK. The activation of p38 MAPK is required for normal induction of IFN-gamma mRNA and IFN-gamma secretion by IL-12 in activated T cells and Th1 cells.\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> act(p(MGI:Mapk14))\n",
      "act(p(MGI:Mapk14)) -> r(MGI:Ifng)\n",
      "----------------------\n",
      "10020296 : the injection of IFNG, or the IFNG-releasing factors IL12 and -18 enhances the extent of the disease in apoE-/- mice (36, 39, 40)\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> path(MESHD:Atherosclerosis)\n",
      "p(MGI:Ifng) -> path(MESHD:Atherosclerosis)\n",
      "p(MGI:Il18) -> path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10005482 : Mice treated with i.p. injection of recombinant murine IL-18 or IL-12 expressed significantly higher pulmonary mRNA levels of the matrix degrading enzymes metalloproteinase (MMP) 12 and cathepsin S\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Ctss)\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Mmp12)\n",
      "p(MGI:Il18) -> r(MGI:Ctss)\n",
      "p(MGI:Il18) -> r(MGI:Mmp12)\n",
      "----------------------\n",
      "10005484 : The upregulation of FasL, IL-12Rbeta2, and tumor necrosis factor-alpha mRNA expression in lung tissue was suppressed by anti-IL-12 antibody treatment\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Fasl)\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Il12rb2)\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10020304 : IL-12 drives high expression of IL-12RÃ2, but little IL-23R, consistent with the ability of these cells to respond to IL-12 (Fig. 4 A).IFN-{gamma} and granzyme G expression was also significantly increased.\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Gzmg)\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Ifng)\n",
      "complex(p(MGI:Il12a),p(MGI:Il12b)) -> r(MGI:Il12rb2)\n",
      "----------------------\n",
      "10005494 : IL-17 and IL-17F were found to be derived mainly from lung CD4+ T cells, and were increased upon IL-23 stimulation in vitro....In vivo blocking of IL-23p19 alone or in combination with IL-23/IL-12p40 resulted in a significant reduction of Mp-induced IL-17 protein and IL-17/IL-17F mRNA expression,\n",
      "complex(p(MGI:Il12b),p(MGI:Il23a)) -> p(MGI:Il17a)\n",
      "complex(p(MGI:Il12b),p(MGI:Il23a)) -> p(MGI:Il17f)\n",
      "complex(p(MGI:Il12b),p(MGI:Il23a)) -> r(MGI:Il17a)\n",
      "complex(p(MGI:Il12b),p(MGI:Il23a)) -> r(MGI:Il17f)\n",
      "----------------------\n",
      "10020312 : However, in CD4+ T cells from naive mice, IL-23 significantly increased the TGFbeta1/IL-6-induced Th17 polarization, including elevated levels of IL-17A and IL-17F and decreased expression of T-bet and FoxP3. Of note, the IL-23-induced increase in IL-17A and IL-17F levels was prevented in T-bet-deficient mice.\n",
      "complex(p(MGI:Il12b),p(MGI:Il23a)) -| r(MGI:Foxp3)\n",
      "complex(p(MGI:Il12b),p(MGI:Il23a)) -> r(MGI:Il17a)\n",
      "complex(p(MGI:Il12b),p(MGI:Il23a)) -> r(MGI:Il17f)\n",
      "----------------------\n",
      "10005502 : Upon stimulation of cells with interleukin-1 (IL-1) the IL-1 receptor type I (IL-1RI) associated kinase-1 (IRAK-1) transiently associates to and dissociates from the IL-1RI and thereafter translocates into the nucleus.\n",
      "complex(p(MGI:Il1r1),p(MGI:Irak1)) -> tloc(p(MGI:Irak1))\n",
      "p(MGI:Il1a) -> complex(p(MGI:Il1r1),p(MGI:Irak1))\n",
      "----------------------\n",
      "10020324 : Interleukin 2 (IL-2)- and IL-4-mediated stimulation of survival and growth, reflected by the induction of bcl2 and c-myc, respectively, depends on the integrity of the membrane-proximal region (S-region) in the IL-2 receptor beta-chain (IL-2R beta) and the haematopoietin homology box1-containing region of the IL-4 receptor alpha-chain (IL-4R alpha).\n",
      "complex(p(MGI:Il2),p(MGI:Il2rb)) -> p(MGI:Bcl2)\n",
      "complex(p(MGI:Il4),p(MGI:Il4ra)) -> p(MGI:Myc)\n",
      "----------------------\n",
      "10020326 : IL-2 induces the expression of c-fos and c-jun family genes, mediated by the acidic region (A-region) within the cytoplasmic domain of IL-2R beta.\n",
      "complex(p(MGI:Il2),p(MGI:Il2rb)) -> r(MGI:Fos)\n",
      "complex(p(MGI:Il2),p(MGI:Il2rb)) -> r(MGI:Jun)\n",
      "----------------------\n",
      "10020336 : Il6 plus Il6R enhanced the expression of RANKL and OPG in calvarial bones, but decreased RANK expression\n",
      "complex(p(MGI:Il6),p(MGI:Il6ra)) -| r(MGI:Tnfrsf11a)\n",
      "complex(p(MGI:Il6),p(MGI:Il6ra)) -> r(MGI:Tnfrsf11b)\n",
      "complex(p(MGI:Il6),p(MGI:Il6ra)) -> r(MGI:Tnfsf11)\n",
      "----------------------\n",
      "10020340 : in Il6 signal cascade, the SHP2 interaction site of gp130 has also been shown to be a Socs3 contact site so that Socs3 may compete for the SHP2-gp130 interaction site\n",
      "complex(p(MGI:Il6st),p(MGI:Socs3)) -| p(MGI:Ptpn11,pmod(P))\n",
      "p(MGI:Il6st) -> p(MGI:Ptpn11,pmod(P))\n",
      "p(MGI:Il6st) -> p(MGI:Socs3,pmod(P))\n",
      "----------------------\n",
      "10005512 : Expression of the FSHbeta subunit and GnRH receptor (GnRHR) genes in gonadotropes is stimulated by activin.\n",
      "complex(p(MGI:Inhba),p(MGI:Inhba)) -> r(MGI:Fshb)\n",
      "complex(p(MGI:Inhba),p(MGI:Inhba)) -> r(MGI:Gnrhr)\n",
      "----------------------\n",
      "10019628 : Direct addition of GM3 ganglioside to 3T3-L1 adipocytes was shown to suppress insulin-stimulated phosphorylation of the insulin receptor (6).\n",
      "complex(p(MGI:Ins1),p(MGI:Insr)) -> act(p(MGI:Insr))\n",
      "act(p(MGI:Insr)) -> p(MGI:Insr,pmod(P))\n",
      "p(MGI:Insr,pmod(P)) -> act(p(MGI:Insr))\n",
      "----------------------\n",
      "10020342 : Others are themselves enzymes, including the phosphotyrosine phosphatase SHP2 and the cytoplasmic tyrosine kinase Fyn.\n",
      "complex(p(MGI:Irs3),p(MGI:Ptpn11)) -> bp(GOBP:\"MAPK cascade\")\n",
      "complex(p(MGI:Irs3),p(MGI:Ptpn11)) -> act(p(MGI:Ptpn11))\n",
      "----------------------\n",
      "10020350 : We have shown previously that the epithelial-restricted integrin alpha(v)beta6 has another critical function; that is, it binds and activates latent transforming growth factor-beta (TGF-beta).\n",
      "complex(p(MGI:Itgb6),p(MGI:Tgfb1)) -> p(MGI:Tgfb1)\n",
      "p(MGI:Itgb6) -> p(MGI:Tgfb1)\n",
      "----------------------\n",
      "10005520 : The binding of +-MITF to c-Jun enhanced the transactivation of MMCP-7 gene, and that of mi-MITF suppressed the transactivation.\n",
      "complex(p(MGI:Jun),p(MGI:Mitf)) -> act(p(MGI:Jun))\n",
      "complex(p(MGI:Jun),p(MGI:Mitf)) -> act(p(MGI:Mitf))\n",
      "act(p(MGI:Mitf)) -> r(MGI:Tpsab1)\n",
      "----------------------\n",
      "10020356 : LPL, which acts as a homodimeric enzyme requires apoCII as a cofactor and is produced in a large number of tissues.\n",
      "complex(p(MGI:Lpl),p(MGI:Apoc2)) -> act(p(MGI:Lpl))\n",
      "complex(p(MGI:Lpl),p(MGI:Lpl)) -> act(p(MGI:Lpl))\n",
      "----------------------\n",
      "10020358 : In vitro assays reveal that the MMP-9.TIMP-1 complex binds to LRP with high affinity and that the binding determinant for LRP appears to reside on MMP-9.\n",
      "complex(p(MGI:Lrp1),p(MGI:Mmp9),p(MGI:Timp1)) -| act(p(MGI:Mmp9))\n",
      "complex(p(MGI:Lrp1),p(MGI:Mmp9),p(MGI:Timp1)) -| p(MGI:Mmp9)\n",
      "----------------------\n",
      "10020362 : mutations in the ERK5 docking site that prevent Map2k5/ERK5 interaction also abrogate the ability of Map3k2 to bind and activate Map2k5.\n",
      "complex(p(MGI:Map2k5),p(MGI:Mapk7)) -> complex(p(MGI:Map3k2),p(MGI:Map2k5))\n",
      "complex(p(MGI:Map2k5),p(MGI:Mapk7)) -> act(p(MGI:Map2k5))\n",
      "----------------------\n",
      "10020364 : We show here that for the mouse Egr1 gene, controlled largely by MAP kinase phosphorylation of the ELK1 transcription factor, the MED23 Mediator subunit that interacts with phospho-ELK1 is also required to stimulate Pol II initiation at a step subsequent to preinitiation complex assembly.\n",
      "complex(p(MGI:Med23),p(MGI:Elk1)) -> act(p(MGI:Elk1))\n",
      "act(p(MGI:Elk1)) -> r(MGI:Egr1)\n",
      "----------------------\n",
      "10020386 : title := \\\"Identification of an interaction between the m-band protein skelemin and beta-integrin subunits. Colocalization of a skelemin-like protein with beta1- and beta3-integrins in non-muscle cells.\\\"\n",
      "complex(p(MGI:Myom1),p(MGI:Itgb1)) -> bp(GOBP:\"cell adhesion\")\n",
      "complex(p(MGI:Myom1),p(MGI:Itgb3)) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10005544 : Human MafG heterodimerizes with p45 NF-E2 and binds DNA with specificity identical to that of purified NF-E2 DNA binding activity. A tethered heterodimer of p45 and MafG is fully functional in supporting expression of alpha- and beta-globin, and in promoting erythroid differentiation in CB3, a p45-deficient mouse erythroleukemia cell line\n",
      "complex(p(MGI:Nfe2l1),p(MGI:Mafg)) -> r(MGI:\"Hba-a1\")\n",
      "complex(p(MGI:Nfe2l1),p(MGI:Mafg)) -> r(MGI:\"Hbb-b1\")\n",
      "act(p(MGI:Mafg)) -> r(MGI:\"Hba-a1\")\n",
      "act(p(MGI:Mafg)) -> r(MGI:\"Hbb-b1\")\n",
      "----------------------\n",
      "10020396 : In this study, we found that retinoids inhibit this LPS-stimulated production of IL-12 in a dose-dependent manner. The NFkappaB components p50 and p65 bound retinoid X receptor (RXR) in a ligand-independent manner in vitro, and the interaction interfaces involved the p50 residues 1-245, the p65 residues 194-441, and the N-terminal A/B/C domains of RXR.\n",
      "complex(p(MGI:Nfkb1),p(MGI:Rxra)) -| act(p(MGI:Nfkb1))\n",
      "complex(p(MGI:Nfkb1),p(MGI:Rxrb)) -| act(p(MGI:Nfkb1))\n",
      "complex(p(MGI:Nfkb2),p(MGI:Rxra)) -| act(p(MGI:Nfkb2))\n",
      "complex(p(MGI:Nfkb2),p(MGI:Rxrb)) -| act(p(MGI:Nfkb2))\n",
      "----------------------\n",
      "10005548 : Mesangial cells from nonobese diabetic (NOD) mice (D-NOD) that develop diabetes at 2-4 mo express an increased density of atrial natriuretic peptide (ANP) clearance receptors [natriuretic peptide C receptor (NPR-C)] and produce less GMP in response to ANP than their nondiabetic counterparts (ND-NOD).\n",
      "complex(p(MGI:Nppa),p(MGI:Npr3)) -| p(MGI:Nppa)\n",
      "p(MGI:Npr3) -| p(MGI:Nppa)\n",
      "----------------------\n",
      "10020398 : recombinant Fxr and Rxr bind to 2 Fxr response elements that are contained within 2 important distal enhancer elements that are upstream of the transcription start site of the apoC2 gene\n",
      "complex(p(MGI:Nr1h4),p(MGI:Rxra)) -> r(MGI:Apoc2)\n",
      "complex(p(MGI:Nr1h4),p(MGI:Rxrb)) -> r(MGI:Apoc2)\n",
      "complex(p(MGI:Nr1h4),p(MGI:Rxrg)) -> r(MGI:Apoc2)\n",
      "----------------------\n",
      "10020402 : In contrast, activated glucocorticoid receptor (GR) preferentially associated with SRC-2 (TIF-2/GRIP-1), which subsequently recruited pCAF and led to specific modification of histone H3, suggesting that specific coactivators recruit distinct histone acetyltransferases to modulate the transcription of steroid-responsive genes.\n",
      "complex(p(MGI:Nr3c1),p(MGI:Ncoa2)) -> act(p(MGI:Nr3c1))\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Kat2b)\n",
      "----------------------\n",
      "10005552 : The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation\n",
      "complex(p(MGI:Nr3c1),p(MGI:Rela)) -| complex(p(MGI:Irf3),p(MGI:Rela))\n",
      "complex(p(MGI:Nr3c1),p(MGI:Rela)) -| complex(p(MGI:Irf7),p(MGI:Rela))\n",
      "act(p(MGI:Nr3c1)) -| act(p(MGI:Irf3))\n",
      "act(p(MGI:Nr3c1)) -| act(p(MGI:Irf7))\n",
      "----------------------\n",
      "10005554 : Co-expression of PIASgamma with Nurr1 results in a potent repression of Nurr1-dependent transcriptional activation of an artificial NGFI-B response element (NBRE) reporter as well as of a reporter driven by the native tyrosine hydroxylase promoter.\n",
      "complex(p(MGI:Nr4a2),p(MGI:Pias4)) -| p(MGI:Th)\n",
      "complex(p(MGI:Nr4a2),p(MGI:Pias4)) -| act(p(MGI:Nr4a2))\n",
      "act(p(MGI:Nr4a2)) -> p(MGI:Th)\n",
      "----------------------\n",
      "10020406 : From introduction Az1 binds the ODC monomer, dissociating the enzymatically active ODC homodimer and thereby inhibiting its activity\n",
      "complex(p(MGI:Odc1),p(MGI:Odc1)) -> act(p(MGI:Odc1))\n",
      "p(MGI:Oaz1) -| act(p(MGI:Odc1))\n",
      "----------------------\n",
      "10020414 : Upon ligand treatment, progesterone receptor (PR) interacted preferentially with SRC-1, which recruited CBP and significantly enhanced acetylation at K5 of histone H4.\n",
      "complex(p(MGI:Pgr),p(MGI:Src)) -> p(MGI:Crebbp)\n",
      "complex(p(MGI:Pgr),p(MGI:Src)) -> p(MGI:Hist4h4,pmod(A,K,5))\n",
      "----------------------\n",
      "10005564 : We have identified genes both induced and repressed by BOB.1/OBF.1. Using different genetic systems, we demonstrate regulation of a selection of these genes. Identified targets included genes encoding Ahd2-like, AKR1C13, Rbp1, Sdh, Idh2, protocadherin gamma, alpha-catenin, Ptprs, Id3, and Creg.\n",
      "complex(p(MGI:Pou2af1),p(MGI:Pou2f1)) -> act(p(MGI:Pou2f1))\n",
      "complex(p(MGI:Pou2f2),p(MGI:Pou2af1)) -> act(p(MGI:Pou2f2))\n",
      "act(p(MGI:Pou2af1)) -| r(MGI:Idh2)\n",
      "----------------------\n",
      "10020422 : The gel mobility shift assay showed the direct binding of PPARgamma-retinoid Xreceptor alpha complex to the PPRE.\n",
      "complex(p(MGI:Pparg),p(MGI:Rxra)) -> r(MGI:Aqp7)\n",
      "p(MGI:Rxra) -> act(p(MGI:Pparg))\n",
      "act(p(MGI:Pparg)) -> r(MGI:Aqp7)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Aqp7)\n",
      "----------------------\n",
      "10020428 : Angiopoietin-1 stimulates association of SHP-2 to the phosphorylated Tie-2 receptor (47), which in turn inhibits PI3 kinase-dependent signaling pathways leading to EC migration.\n",
      "complex(p(MGI:Ptpn11),p(MGI:Tek)) -| bp(GOBP:\"cell migration\")\n",
      "p(MGI:Angpt1) -> complex(p(MGI:Ptpn11),p(MGI:Tek))\n",
      "----------------------\n",
      "10000308 : The repressive effect of Hr is observed on both synthetic and naturally-occurring VDR-responsive promoters, and also when VDR-mediated transactivation is augmented by overexpression of its heterodimeric partner, retinoid X\n",
      "complex(p(MGI:Rxrb),p(MGI:Vdr)) -> act(p(MGI:Vdr))\n",
      "complex(p(MGI:Vdr),p(MGI:Rxra)) -> act(p(MGI:Vdr))\n",
      "----------------------\n",
      "10020458 : Upon incubation with serine proteases, EIA formed inhibitory covalent complexes with pancreatic and neutrophil elastases, cathepsin G, proteinase-3, and chymotrypsin, as previously shown for MNEI, whereas EIB was only able to do so with cathepsin G.\n",
      "complex(p(MGI:Serpinb1a),p(MGI:Ctsg)) -| act(p(MGI:Ctsg))\n",
      "complex(p(MGI:Serpinb1a),p(MGI:Prtn3)) -| act(p(MGI:Prtn3))\n",
      "complex(p(MGI:Serpinb1b),p(MGI:Ctsg)) -| act(p(MGI:Ctsg))\n",
      "----------------------\n",
      "10005588 : The results demonstrate that sortilin is a multifunctional receptor that binds lipoprotein lipase and, when expressed on the cell surface, mediates its endocytosis and degradation.\n",
      "complex(p(MGI:Sort1),p(MGI:Lpl)) -> deg(p(MGI:Lpl))\n",
      "surf(p(MGI:Sort1)) -> complex(p(MGI:Sort1),p(MGI:Lpl))\n",
      "surf(p(MGI:Sort1)) -> deg(p(MGI:Lpl))\n",
      "----------------------\n",
      "10020470 : TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts.\n",
      "complex(p(MGI:Taf9),p(MGI:Trp53)) -> act(p(MGI:Trp53))\n",
      "p(MGI:Taf9) -> act(p(MGI:Trp53))\n",
      "act(p(MGI:Trp53)) -| bp(GOBP:\"cell cycle\")\n",
      "act(p(MGI:Trp53)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10020472 : Interestingly, binding of ARF to DP1 results in an inhibition of the interaction between DP1 and E2F1.\n",
      "complex(p(MGI:Tfdp1),p(MGI:Cdkn2a)) -| complex(p(MGI:Tfdp1),p(MGI:E2f1))\n",
      "p(MGI:Cdkn2a) -| act(p(MGI:Tfdp1))\n",
      "p(HGNC:CDKN2A) -| act(p(HGNC:TFDP1))\n",
      "----------------------\n",
      "10020476 : Further work revealed that TGF-R signaling (Massague and Wotton, 2000) was required for EMT, invasion in vitro, and metastasis in vivo,\n",
      "complex(p(MGI:Tgfb1),p(MGI:Tgfbr1)) -> complex(p(MGI:Tgfb1),p(MGI:Tgfbr1),p(MGI:Tgfbr2))\n",
      "complex(p(MGI:Tgfb1),p(MGI:Tgfbr1),p(MGI:Tgfbr2)) -> act(p(MGI:Tgfbr1))\n",
      "act(p(MGI:Tgfbr1)) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Tgfbr1))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:TGFBR1))\n",
      "----------------------\n",
      "10005606 : Moreover, TGF-beta 1 significantly increased endogenous Elk-3 mRNA levels that had been down-regulated by LPS in macrophages. This increase in Elk-3 correlated with a TGF-beta 1-induced down-regulation of NOS2.\n",
      "complex(p(MGI:Tgfb1),p(MGI:Tgfbr1)) -> p(MGI:Elk3)\n",
      "complex(p(MGI:Tgfb1),p(MGI:Tgfbr1)) -| p(MGI:Nos2)\n",
      "----------------------\n",
      "10020478 : We also found that TGF-beta can stimulate the expression of Foxa1 in Hnf6(+/+) cells and that inhibition of TGF-beta signaling in Hnf6(-/-) cells down-regulates the expression of Foxa1.\n",
      "complex(p(MGI:Tgfb1),p(MGI:Tgfbr2)) -> act(p(MGI:Tgfbr2))\n",
      "p(MGI:Tgfb1) -> r(MGI:Foxa1)\n",
      "----------------------\n",
      "10020480 : this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM.\n",
      "complex(p(MGI:Tnfsf13),p(MGI:Fas)) -> bp(GOBP:\"apoptotic process\")\n",
      "complex(p(MGI:Tnfsf13),p(MGI:Tnfrsf14)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10005624 : These observations suggest that the interaction of YY1 with hypophosphorylated Rb in resting B cells prevents interaction of YY1 with DNA. After stimulation with class-switching activators, such as LPS, Rb becomes hyperphosphorylated and YY1 is released and can then bind to the hs3 enhancer and E mu.\n",
      "complex(p(MGI:Yy1),p(MGI:Rb1)) -| act(p(MGI:Yy1))\n",
      "p(MGI:Rb1) -| act(p(MGI:Yy1))\n",
      "----------------------\n",
      "10020506 : JAZ associates with p53 to stimulate its transcriptional activity in p53-expressing cells, but not in p53-null cells unless complemented with p53. JAZ functions to mediate G1 cell-cycle arrest followed by apoptosis in a p53-dependent mechanism\n",
      "complex(p(MGI:Zfp346),p(MGI:Trp53)) -> act(p(MGI:Trp53))\n",
      "act(p(MGI:Zfp346)) -| bp(GOBP:\"cell cycle\")\n",
      "act(p(MGI:Zfp346)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Zfp346)) -> act(p(MGI:Trp53))\n",
      "----------------------\n",
      "10001308 : TNF-alpha-induced apoptosis in LNCaP cells was accompanied by caspase-dependent proteolysis of p21/WAF1 and Rb, which was significantly attenuated in LN-56.\n",
      "deg(p(HGNC:CDKN1A)) -| p(HGNC:CDKN1A)\n",
      "deg(p(HGNC:RB1)) -| p(HGNC:RB1)\n",
      "----------------------\n",
      "10018984 : The increase in IL-6 in septic DPPI(-/-) mice, which appears to protect these mice from death, may be related to reduced DPPI-mediated activation of mast cell tryptase and other peptidases, which we show cleave IL-6 in vitro.\n",
      "deg(p(MGI:Il6)) -| p(MGI:Il6)\n",
      "path(MESHD:Sepsis) -> tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10020830 : In contrast, the secretion of adipsin, a serine protease specifically expressed in adipocytes, was increased by the expression of wild-type ARF6 and was inhibited by the expression of D125N. These results indicate a requirement for ARF6 in basal and insulin-regulated adipsin secretion but not in glucose transport.\n",
      "act(p(HGNC:ARF6)) -> tloc(p(HGNC:CFD))\n",
      "p(HGNC:INS) -> tloc(p(HGNC:CFD))\n",
      "----------------------\n",
      "10005738 : The activity of N-WASp is enhanced by the binding of effectors like Cdc42-guanosine 5'-3-O-(thio)triphosphate, phosphatidylinositol bisphosphate, or the Shigella IcsA protein. Here we show that the SH3-SH2-SH3 adaptor Grb2 is another activator of N-WASp that stimulates actin polymerization by increasing the amount of N-WASp. Arp2/3 complex.\n",
      "act(p(HGNC:CDC42)) -> act(p(HGNC:WAS))\n",
      "p(HGNC:GRB2) -> act(p(HGNC:WAS))\n",
      "----------------------\n",
      "10005740 : We show that in Jurkat cells, activated forms of Rac1 or Cdc42, but not Rho, stimulate an increase in Akt/PKB activity.\n",
      "act(p(HGNC:CDC42)) -> act(p(HGNC:AKT1))\n",
      "act(p(HGNC:RAC1)) -> act(p(HGNC:AKT1))\n",
      "----------------------\n",
      "10005742 : Expression of activated G(q) increased RGS2 association with the plasma membrane and decreased accumulation in the nucleus, suggesting that signal-induced redistribution may regulate RGS2 function\n",
      "act(p(HGNC:GNAQ)) -| tloc(p(HGNC:RGS2))\n",
      "act(p(HGNC:GNAQ)) -> tloc(p(HGNC:RGS2))\n",
      "----------------------\n",
      "10005746 : We found that TPO stimulation or Ha-Ras G12V expression led to up-regulation of cyclin D1, cyclin D2, and cyclin D3 expression.\n",
      "act(p(HGNC:HRAS)) -> r(HGNC:CCND1)\n",
      "act(p(HGNC:HRAS)) -> r(HGNC:CCND2)\n",
      "act(p(HGNC:HRAS)) -> r(HGNC:CCND3)\n",
      "p(HGNC:THPO) -> r(HGNC:CCND3)\n",
      "----------------------\n",
      "10020862 : We have previously reported that the drs gene, whose mRNA expression is downregulated by retroviral oncogenes such as v-src and v-K-ras, has the ability to suppress transformation by v-src in a rat cell line F2408.\n",
      "act(p(HGNC:KRAS)) -| r(HGNC:SRPX)\n",
      "act(p(HGNC:SRC)) -| r(HGNC:SRPX)\n",
      "p(HGNC:SRPX) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10020870 : Rac promotes cell cycle progression, an effect that correlates with its ability to organize the cytoskeleton and promote spreading, rather than with its ability to activate MAP kinases (63).\n",
      "act(p(HGNC:RAC1)) -> bp(GOBP:\"cell adhesion\")\n",
      "act(p(HGNC:RAC1)) -> bp(GOBP:\"cell cycle\")\n",
      "----------------------\n",
      "10020878 : Correspondingly, in vitro kinase assays showed that N17Rac1 inhibited the kinase activities of MEK1/2 and ERK1/2 stimulated by target signals (Fig. 4b).\n",
      "act(p(HGNC:RAC1)) -> act(p(HGNC:MAP2K1))\n",
      "act(p(HGNC:RAC1)) -> act(p(HGNC:MAP2K2))\n",
      "act(p(HGNC:RAC1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:RAC1)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10020884 : Rac3V12 expression significantly increased the incorporation of BrdUrd into nascent DNA (Fig. 3), emphasizing that transfection of active Rac3 drives epithelial cell proliferation.\n",
      "act(p(HGNC:RAC3)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:RAC3)) -> bp(GOBP:\"DNA replication\")\n",
      "----------------------\n",
      "10020886 : Expression of either dominant-negative Rac3N17 or PBD F107 almost completely blocked Pak and JNK activities, demonstrating that Rac3 is upstream of these proteins (Fig. 4B).\n",
      "act(p(HGNC:RAC3)) -> act(p(HGNC:MAPK8))\n",
      "act(p(HGNC:RAC3)) -> act(p(HGNC:MAPK9))\n",
      "act(p(HGNC:RAC3)) -> act(p(HGNC:PAK1))\n",
      "act(p(HGNC:RAC3)) -> act(p(HGNC:PAK2))\n",
      "----------------------\n",
      "10020900 : In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS.\n",
      "act(p(MGI:Hras)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Jund)) -| bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10005770 : The accumulation of the ST6Gal I transcript in response to activated Ras was accompanied by an increase of alpha2,6-sialyltransferase activity and of Neu5Acalpha2,6Gal at the cell surface.\n",
      "act(p(MGI:Hras)) -> act(p(MGI:St6gal1))\n",
      "act(p(MGI:Kras)) -> act(p(MGI:St6gal1))\n",
      "----------------------\n",
      "10020904 : Following depletion of both serum and Epo for 2 hours, p44/42 ERK (Phospho ERK1 (Thr202/Tyr204); phospho-ERK2 (Thr185/Tyr187)) remained active in H-ras.V12-transduced cells but not in the control cells. No difference was seen in the expression of total p44/42 ERK in the 2 populations of cells\n",
      "act(p(MGI:Hras)) -> p(MGI:Mapk1,pmod(P))\n",
      "act(p(MGI:Hras)) -> p(MGI:Mapk1,pmod(P))\n",
      "act(p(MGI:Hras)) -> p(MGI:Mapk3,pmod(P))\n",
      "act(p(MGI:Hras)) -> p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10005778 : Stable transfection of activated Ha-ras into a number of murine cells correlated with a down-regulation of the expression of the NF1 genes NF1/CTF and NF1/X.\n",
      "act(p(MGI:Hras)) -| r(MGI:Nfix)\n",
      "p(MGI:Hras) -| r(MGI:Nf1)\n",
      "----------------------\n",
      "10020912 : Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.\n",
      "act(p(MGI:Hras)) -> r(MGI:Plau)\n",
      "act(p(MGI:Map2k1)) -> r(MGI:Plau)\n",
      "act(p(MGI:Mapk1)) -> r(MGI:Plau)\n",
      "act(p(MGI:Raf1)) -> r(MGI:Plau)\n",
      "----------------------\n",
      "10020914 : Transformation by human K-Ras or H-Ras (S12 and V12 point mutations, respectively) results in a 10-fold increase in ST6Gal I mRNA, but no alteration in the expression of related sialyltransferases.\n",
      "act(p(MGI:Hras)) -> r(MGI:St6gal1)\n",
      "act(p(MGI:Kras)) -> r(MGI:St6gal1)\n",
      "----------------------\n",
      "10020916 : When c-H-ras expression was induced with heavy metal ions there was a marked reduction in the expression of two glycosylphosphatidylinositol (GPI) anchored proteins, TAP/Ly-6A.2 and Thy-1, on the plasma membrane of the transformed cells.\n",
      "act(p(MGI:Hras)) -| surf(p(MGI:Thy1))\n",
      "surf(p(MGI:Thy1)) -> act(p(MGI:Thy1))\n",
      "----------------------\n",
      "10020942 : We observed in primary mouse embryonic fibroblasts that deletion of rac1 by gene targeting, as well as expression of the constitutively active Rac1 mutant L61Rac1, led to decreased cell growth that was associated with altered cell cycle progression at both G(1)/S and G(2)/M phases, increased apoptosis, and premature senescence.\n",
      "act(p(MGI:Rac1)) -> bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "act(p(MGI:Rac1)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10020950 : Rac GTPases regulate cytoskeletal structure, gene expression, and reactive oxygen species (ROS) production. Rac2-deficient neutrophils cannot chemotax, produce ROS, or degranulate upon G protein-coupled receptor (GPCR) activation.\n",
      "act(p(MGI:Rac2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Rac2)) -> bp(GOBP:chemotaxis)\n",
      "act(p(MGI:Rac2)) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "act(p(HGNC:RAC2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:RAC2)) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10020966 : Consequently, dominant-negative RhoA and RhoB mutants blocked TGF-beta1-induced actin reorganization. Because Rho GTPases are known to regulate the activity of LIM-kinases (LIMK), we found that TGF-beta1 induced LIMK2 phosphorylation with similar kinetics to Rho activation.\n",
      "act(p(MGI:Rhoa)) -> act(p(MGI:Limk2))\n",
      "act(p(MGI:Rhob)) -> act(p(MGI:Limk2))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Limk2))\n",
      "----------------------\n",
      "10021014 : <p10> PKC phosphorylates P53 at Serine378 <p11> The Cdk7:CycH:p36 (CAK) component of TFIIH phosphorylates p53 at sites which may include 372,376, 378, 392 [serine residues]\n",
      "act(complex(p(HGNC:CCNH),p(HGNC:CDK7),p(HGNC:MNAT1))) -> p(HGNC:TP53,pmod(P))\n",
      "act(complex(p(HGNC:CCNH),p(HGNC:CDK7),p(HGNC:MNAT1))) -> p(HGNC:TP53,pmod(P))\n",
      "----------------------\n",
      "10021016 : Stimulation of quiescent cultures with EGF resulted in the rapid recruitment of both enzymes to a phosphotyrosine signaling complex that contained the EGF receptor and Erb-B2.\n",
      "act(complex(p(HGNC:EGFR),p(HGNC:ERBB2))) -> act(p(HGNC:PIK3C2A))\n",
      "act(complex(p(HGNC:EGFR),p(HGNC:ERBB2))) -> act(p(HGNC:PIK3C2B))\n",
      "----------------------\n",
      "10021018 : A third component of the large IkBalpha kinase complex has also been cloned and is referred to as NEMO (NF-kB essential modulator) ( [47]), IKKgamma ( [39]), IKKAP ( [31]), or FIP-3 ( [27]).\n",
      "act(complex(p(HGNC:IKBKG),p(HGNC:CHUK),p(HGNC:IKBKB))) -> p(HGNC:NFKBIA,pmod(P))\n",
      "act(complex(p(HGNC:IKBKG),p(HGNC:CHUK),p(HGNC:IKBKB))) -> p(HGNC:NFKBIA,pmod(P))\n",
      "p(HGNC:IKBKG) -> p(HGNC:NFKBIA,pmod(P))\n",
      "p(HGNC:IKBKG) -> p(HGNC:NFKBIA,pmod(P))\n",
      "----------------------\n",
      "10021020 : Phosphorylation of Ser780 in pRb protein is mediated by the cyclin D1/cdk4 complex (30). A significant increase in endogenous Rb phosphorylation at Ser780 was observed in islets from caAktTg mice, suggesting that cdk4 activity is augmented (Fig. 4B) (P 0.05).\n",
      "act(complex(p(MGI:Ccnd1),p(MGI:Cdk4))) -> p(MGI:Rb1,pmod(P))\n",
      "act(p(MGI:Akt1)) -> p(MGI:Rb1,pmod(P))\n",
      "----------------------\n",
      "10021022 : Here we show that mouse PDK-1 (mPDK-1) undergoes autophosphorylation in vitro on both serine and threonine residues. In addition, we have identified Ser(399) and Thr(516) as the major mPDK-1 autophosphorylation sites in vitro\n",
      "act(complex(p(MGI:Pdpk1),p(MGI:Pdpk1))) -> p(MGI:Pdpk1,pmod(P))\n",
      "act(p(MGI:Pdpk1)) -> p(MGI:Pdpk1,pmod(P))\n",
      "----------------------\n",
      "10021090 : Results indicated that c-Jun phosphorylation at Ser63 and Ser73 was induced by co-transfection of pHA-Cdk3 (Fig. 2B, lane1), but not by Cdk3-DN (Fig. 2B, lane 2); and the mutant His-c-Jun M63/73 could not be phosphorylated by pHA-Cdk3 (Fig. 2B, lane 4).\n",
      "act(p(EGID:1018)) -> p(MGI:Jun,pmod(P))\n",
      "act(p(EGID:1018)) -> p(MGI:Jun,pmod(P))\n",
      "----------------------\n",
      "10021092 : We report that phosphorylation-induced turnover of endogenous N-myc protein in CGNPs increases during mitosis, due to increased priming phosphorylation of N-myc for GSK-3beta. The priming phosphorylation requires the Cdk1 complex, whose cyclin subunits are indirect Sonic hedgehog targets\n",
      "act(p(EGID:12534)) -> p(MGI:Mycn,pmod(P))\n",
      "act(p(MGI:Gsk3b)) -> p(MGI:Mycn,pmod(P))\n",
      "p(MGI:Mycn,pmod(P)) -| deg(p(MGI:Mycn))\n",
      "p(MGI:Mycn,pmod(P)) -> deg(p(MGI:Mycn))\n",
      "----------------------\n",
      "10021104 : Akt decreased ASK1 kinase activity stimulated by both oxidative stress and overexpression in 293 cells by phosphorylating a consensus Akt site at serine 83 of ASK1.\n",
      "act(p(HGNC:AKT1)) -| act(p(HGNC:MAP3K5))\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:MAP3K5,pmod(P))\n",
      "p(HGNC:MAP3K5,pmod(P)) -| act(p(HGNC:MAP3K5))\n",
      "----------------------\n",
      "10021108 : the mutation S256A greatly reduced the rate of phosphorylation of Thr-24 and Ser-319 by PKB in ?itro,\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:FOXO1,pmod(P))\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:FOXO1,pmod(P))\n",
      "----------------------\n",
      "10021118 : The downstream targets of Src that lead to the up-regulation of IGF-IR expression were previously unknown. We demonstrate here that AKT regulates IGF-IR expression in PANC-1\n",
      "act(p(HGNC:AKT1)) -> r(HGNC:IGF1R)\n",
      "act(p(HGNC:AKT2)) -> r(HGNC:IGF1R)\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:AKT1))\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:AKT2))\n",
      "----------------------\n",
      "10021124 : <A2> ATM phosphorylates c-Abl on Ser465 and thereby activates the kinase (Baskaran et al., 1997b). <A3> Phosphorylation by ATM activates c-Abl (Baskaran et al., 1997b). c-Abl tyrosine kinase activity is stimulated in response to ionizing radiation (IR), 1-b-d-arabinofuransylcytosine, camptothecin, or etoposide (Yuan et al., 1996, 1998).\n",
      "act(p(HGNC:ATM)) -> p(HGNC:ABL1,pmod(P))\n",
      "p(HGNC:ABL1,pmod(P)) -> act(p(HGNC:ABL1))\n",
      "----------------------\n",
      "10021146 : Furthermore, the Etk-PTPD1 interaction stimulated the kinase activity of Etk, resulting in an increased phosphotyrosine content in both factors. The Etk-PTPD1 interaction also increased Stat3 activation. In addition, Tec (but not Btk) kinase can also be activated by PTPD1.\n",
      "act(p(HGNC:BMX)) -> act(p(HGNC:STAT3))\n",
      "act(p(HGNC:PTPN21)) -> act(p(HGNC:BMX))\n",
      "act(p(HGNC:PTPN21)) -> act(p(HGNC:TEC))\n",
      "act(p(HGNC:PTPN21)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10021148 : A second autoinhibitory mechanism unique to CaMKIV is relaxed by the autophosphorylation of Ser-12 and Ser-13 (4).\n",
      "act(p(HGNC:CAMK4)) -> p(HGNC:CAMK4,pmod(P))\n",
      "act(p(HGNC:CAMK4)) -> p(HGNC:CAMK4,pmod(P))\n",
      "p(HGNC:CAMK4,pmod(P)) -> act(p(HGNC:CAMK4))\n",
      "p(HGNC:CAMK4,pmod(P)) -> act(p(HGNC:CAMK4))\n",
      "----------------------\n",
      "10021162 : In this study, we examined the cell cycle-dependent phosphorylation of PP1alpha in vivo using three different antibodies. PP1alpha was phosphorylated at Thr-320 during M-phase and again in late G(1)- through early S-phase. Inhibition of Cdk2 led to a small increase in PP1 activity and also prevented PP1alpha phosphorylation. In vitro, PP1alpha was a substrate for Cdk2 but not Cdk4.\n",
      "act(p(HGNC:CDK2)) -> p(HGNC:PPP1CA,pmod(P))\n",
      "act(p(HGNC:CDK2)) -> p(HGNC:PPP1CA,pmod(P))\n",
      "act(p(HGNC:CDK2)) -> act(p(HGNC:PPP1CA))\n",
      "----------------------\n",
      "10021164 : In resting neostriatal slices, cyclin-dependent kinase 5 (Cdk5) phosphorylates DARPP-32 at Thr-75, thereby reducing the efficacy of dopaminergic signaling.\n",
      "act(p(HGNC:CDK5)) -> p(HGNC:PPP1R1B,pmod(P))\n",
      "p(HGNC:PPP1R1B,pmod(P)) -| act(p(HGNC:PPP1R1B))\n",
      "----------------------\n",
      "10021168 : Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (18â21).\n",
      "act(p(HGNC:CHEK1)) -> p(HGNC:CDC25C,pmod(P))\n",
      "act(p(HGNC:CHEK2)) -> p(HGNC:CDC25C,pmod(P))\n",
      "----------------------\n",
      "10021172 : Two related kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta, phosphorylate the IkappaB proteins, leading to their degradation and the subsequent activation of gene expression by NF-kappaB\n",
      "act(p(HGNC:CHUK)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "act(p(HGNC:IKBKB)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "p(HGNC:NFKBIA,pmod(P)) -> deg(p(HGNC:NFKBIA))\n",
      "----------------------\n",
      "10021174 : Characterization of purified recombinant IKKalpha and IKKbeta revealed that both kinases directly phosphorylate S32 and S36 in IkBalpha ( [22 and 49]).\n",
      "act(p(HGNC:CHUK)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "act(p(HGNC:CHUK)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "act(p(HGNC:IKBKB)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "act(p(HGNC:IKBKB)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "----------------------\n",
      "10021182 : In this study, we demonstrate that PI3K-C2alpha and PI3K-C2beta represent two downstream targets of the activated epidermal growth factor (EGF) receptor in human carcinoma-derived A431 cells.\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:PIK3C2A))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:PIK3C2B))\n",
      "----------------------\n",
      "10021190 : In ezrin, two tyrosine residues, corresponding to amino acids 145 and 353, are phosphorylated by the epidermal growth factor receptor\n",
      "act(p(HGNC:EGFR)) -> p(HGNC:EZR,pmod(P))\n",
      "act(p(HGNC:EGFR)) -> p(HGNC:EZR,pmod(P))\n",
      "----------------------\n",
      "10021192 : Gab-1 is heavily phosphorylated by the epidermal growth factor receptor, but poorly by the insulin receptor\n",
      "act(p(HGNC:EGFR)) -> p(HGNC:GAB1,pmod(P))\n",
      "act(p(HGNC:INSR)) -> p(HGNC:GAB1,pmod(P))\n",
      "----------------------\n",
      "10021196 : EGF-R activation was significantly blocked by therapy with PKI166 and was associated with significant reduction in tumor cell production of VEGF and IL-8, which in turn correlated with a significant decrease in microvessel density and an increase in apoptotic endothelial cells.\n",
      "act(p(HGNC:EGFR)) -> p(HGNC:IL8)\n",
      "act(p(HGNC:EGFR)) -> p(HGNC:VEGFA)\n",
      "p(HGNC:IL8) -> bp(GOBP:angiogenesis)\n",
      "p(HGNC:VEGFA) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10005884 : Both EGF and heregulin-beta1 induced expression of hnRNP K mRNA and protein in human breast cancer cells. This growth factor-mediated hnRNP K expression was effectively blocked by pretreatment of cultures with humanized anti-EGF receptor (EGFR) antibody C225, or anti-human epidermal growth factor receptor-2 (HER2) antibody.\n",
      "act(p(HGNC:EGFR)) -> r(HGNC:HNRNPK)\n",
      "act(p(HGNC:ERBB2)) -> r(HGNC:HNRNPK)\n",
      "p(HGNC:EGF) -> r(HGNC:HNRNPK)\n",
      "----------------------\n",
      "10021200 : N-terminal to the kinase domain, in the juxtamembrane region, lie two invariant tyrosine residues (tyrosines 596 and 602 of EphA4; tyrosines 604 and 610 of EphB2) which are embedded in a characteristic and highly conserved ;10-aminoacid sequence motif. These tyrosine residues are major sites for autophosphorylation (9, 15, 27, 54)\n",
      "act(p(HGNC:EPHA4)) -> p(HGNC:EPHA4,pmod(P))\n",
      "act(p(HGNC:EPHA4)) -> p(HGNC:EPHA4,pmod(P))\n",
      "act(p(HGNC:EPHB2)) -> p(HGNC:EPHB2,pmod(P))\n",
      "act(p(HGNC:EPHB2)) -> p(HGNC:EPHB2,pmod(P))\n",
      "----------------------\n",
      "10021214 : Addition of a single tyrosine residue, Y724, restored its [Fgfr3] ability to stimulate cellular transformation, phosphatidylinositol 3-kinase activation, and phosphorylation of Shp2, MAPK, Stat1, and Stat3.\n",
      "act(p(HGNC:FGFR3)) -> p(HGNC:PTPN11,pmod(P))\n",
      "act(p(HGNC:FGFR3)) -> act(p(HGNC:STAT1))\n",
      "act(p(HGNC:FGFR3)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10021218 : B9 clones expressing either wild-type FGFR3 at high levels or mutant FGFR3 displayed increased phosphorylation of STAT3 and higher levels of bcl-x(L) expression than did parental B9 cells after cytokine withdrawal.\n",
      "act(p(HGNC:FGFR3)) -> p(HGNC:STAT3,pmod(P))\n",
      "act(p(HGNC:FGFR3)) -> r(HGNC:BCL2L1)\n",
      "act(p(HGNC:FGFR3)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10021220 : VEGFR1 is also implicated in VEGF stimulation of urokinase and plasminogen activator inhibitor 1 and of metalloproteinase expression in SMCs\n",
      "act(p(HGNC:FLT1)) -> r(HGNC:PLAU)\n",
      "act(p(HGNC:FLT1)) -> r(HGNC:SERPINE1)\n",
      "----------------------\n",
      "10021226 : Recently, it was shown that Fyn is one of the kinases responsible for the phosphorylation of caveolin\n",
      "act(p(HGNC:FYN)) -> p(HGNC:CAV1,pmod(P))\n",
      "act(p(HGNC:FYN)) -> p(HGNC:CAV2,pmod(P))\n",
      "----------------------\n",
      "10021236 : tyrosine phosphorylation of STAT3, JAK1, and JAK2 was increased upon IGF-I stimulation of endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK expression vector.\n",
      "act(p(HGNC:IGF1R)) -> act(p(HGNC:JAK1))\n",
      "act(p(HGNC:IGF1R)) -> act(p(HGNC:JAK2))\n",
      "----------------------\n",
      "10003950 : Na+-salicylate and cyclopentenone PGs, direct inhibitors of IKK beta, interfered in the activation of the Bcl-xL promoter and induced apoptosis in CD28-costimulated CD4+ T cells.\n",
      "act(p(HGNC:IKBKB)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:IKBKB)) -> r(HGNC:BCL2L1)\n",
      "----------------------\n",
      "10021248 : Phosphorylation of full-length IkBalpha by IKK epsilon was also examined using the recombinant kinase. The wild-type IkBalpha was efficiently phosphorylated by IKK epsilon, while substitution of serines 32 and 36 with alanine decreased the level of phosphorylation 5-fold (Figure 2C).\n",
      "act(p(HGNC:IKBKE)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "act(p(HGNC:IKBKE)) -> p(HGNC:NFKBIA,pmod(P))\n",
      "----------------------\n",
      "10021252 : We show here that ILK overexpression elevates cyclin D1 protein levels and directly induces the cyclin D1 gene in mammary epithelial cells. I\n",
      "act(p(HGNC:ILK)) -> p(HGNC:CCND1)\n",
      "act(p(HGNC:ILK)) -> r(HGNC:CCND1)\n",
      "----------------------\n",
      "10021262 : Dominant-negative JAK1 or JAK2 was able to block the IGF-IR-mediated tyrosine phosphorylation of STAT3 in 293T cells.\n",
      "act(p(HGNC:JAK1)) -> act(p(HGNC:STAT3))\n",
      "act(p(HGNC:JAK2)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10021268 : Our results indicate that autocrine secretion of PRL stimulates tyrosine phosphorylation of ErbB-2 by Jak2, provides docking sites for Grb2 and stimulates Ras-MAP kinase cascade, thereby causing unrestricted cellular proliferation.\n",
      "act(p(HGNC:JAK2)) -> p(HGNC:ERBB2,pmod(P))\n",
      "p(HGNC:PRL) -> p(HGNC:ERBB2,pmod(P))\n",
      "----------------------\n",
      "10021276 : Sixth, based upon the activity of different forms of VEGF ligands, VEGFR2 but not VEGFR1 ligation was capable of activating integrins, and this conclusion was confirmed by overexpression of VEGFR2 in cells.\n",
      "act(p(HGNC:KDR)) -> act(complex(p(HGNC:ITGA2),p(HGNC:ITGB1)))\n",
      "act(p(HGNC:KDR)) -> act(complex(p(HGNC:ITGA5),p(HGNC:ITGB1)))\n",
      "act(p(HGNC:KDR)) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))\n",
      "act(p(HGNC:KDR)) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB5)))\n",
      "----------------------\n",
      "10002636 : Stem cell factor (SCF) or c-Kit ligand is a cytokine associated with the differentiation, survival, and activation of mast cells.\n",
      "act(p(HGNC:KIT)) -> bp(GOBP:\"cell differentiation\")\n",
      "act(p(HGNC:KIT)) -> bp(GOBP:\"mast cell activation\")\n",
      "p(HGNC:KITLG) -> act(p(HGNC:KIT))\n",
      "----------------------\n",
      "10021280 : Using purified wild-type and mutant c-Raf-1 proteins, we demonstrate that Thr(269) is the major c-Raf-1 site phosphorylated by KSR in vitro and that phosphorylation of this site is essential for c-Raf-1 activation by KSR.\n",
      "act(p(HGNC:KSR1)) -> act(p(HGNC:RAF1))\n",
      "act(p(HGNC:KSR1)) -> p(HGNC:RAF1,pmod(P))\n",
      "p(HGNC:RAF1,pmod(P)) -> act(p(HGNC:RAF1))\n",
      "----------------------\n",
      "10021282 : Yes and Lck are known to be enriched in rafts and may mediate the activation of Shc when Fyn is not expressed.\n",
      "act(p(HGNC:LCK)) -> complex(p(HGNC:FYN),p(HGNC:SHC1))\n",
      "act(p(HGNC:LCK)) -> p(HGNC:SHC1,pmod(P))\n",
      "act(p(HGNC:YES1)) -> complex(p(HGNC:FYN),p(HGNC:SHC1))\n",
      "act(p(HGNC:YES1)) -> p(HGNC:SHC1,pmod(P))\n",
      "----------------------\n",
      "10021288 : Y-27632, a specific inhibitor of ROCK, inhibited LIM-kinase-induced cofilin phosphorylation but did not affect fibronectin-induced or TESK1-induced cofilin phosphorylation in HeLa cells.\n",
      "act(p(HGNC:LIMK1)) -> p(HGNC:CFL1,pmod(P))\n",
      "p(HGNC:ROCK1) -> act(p(HGNC:LIMK1))\n",
      "p(HGNC:ROCK1) -| p(HGNC:CFL1,pmod(P))\n",
      "----------------------\n",
      "10021290 : We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3\n",
      "act(p(HGNC:LIMK1)) -> p(HGNC:DSTN,pmod(P))\n",
      "act(p(HGNC:LIMK2)) -> p(HGNC:CFL1,pmod(P))\n",
      "act(p(HGNC:LIMK2)) -> p(HGNC:DSTN,pmod(P))\n",
      "----------------------\n",
      "10021292 : FIG. 7. Lyn induces SAPK activation by an MKK7- and MEKK1-dependent, SEK1-independent mechanism.\n",
      "act(p(HGNC:LYN)) -> act(p(HGNC:MAP2K7))\n",
      "act(p(HGNC:LYN)) -> act(p(HGNC:MAP3K1))\n",
      "----------------------\n",
      "10021296 : The results show that Lyn phosphorylates SHPTP1 at the C-terminal Tyr-564 site. Lyn-mediated phosphorylation of SHPTP1 stimulates SHPTP1 tyrosine phosphatase activity.\n",
      "act(p(HGNC:LYN)) -> p(HGNC:PTPN6,pmod(P))\n",
      "act(p(HGNC:LYN)) -> act(p(HGNC:PTPN6))\n",
      "p(HGNC:PTPN6,pmod(P)) -> act(p(HGNC:PTPN6))\n",
      "----------------------\n",
      "10005928 : Inhibition of MEK1 also led to reduced expression of alpha-enolase, phosphoglycerate kinase, elongation factor 2 and heterogeneous nuclear ribonucleoprotein A3, the latter two being detected as truncated proteins.\n",
      "act(p(HGNC:MAP2K1)) -> p(HGNC:EEF2)\n",
      "act(p(HGNC:MAP2K1)) -> p(HGNC:HNRNPA3)\n",
      "----------------------\n",
      "10005930 : constitutively active kinases within the ERK1/2 pathway (MEKK1, MEK1) or the p38 pathway (ASK1, MEKK1, MKK3) are potent activators of the MMP-1 promoter\n",
      "act(p(HGNC:MAP2K1)) -> r(HGNC:MMP1)\n",
      "act(p(HGNC:MAP2K3)) -> r(HGNC:MMP1)\n",
      "act(p(HGNC:MAP3K1)) -> r(HGNC:MMP1)\n",
      "act(p(HGNC:MAP3K5)) -> r(HGNC:MMP1)\n",
      "----------------------\n",
      "10005934 : Ectopic expression of PP2Cbeta-1 inhibited the TAK1-mediated mitogen-activated protein kinase kinase 4-c-Jun amino-terminal kinase and mitogen-activated protein kinase kinase 6-p38 signaling pathways.\n",
      "act(p(HGNC:MAP2K6)) -> act(p(HGNC:MAPK14))\n",
      "act(p(HGNC:MAP3K7)) -> act(p(HGNC:MAP2K4))\n",
      "----------------------\n",
      "10021304 : We further demonstrate that JNK1, activated by its upstream kinase MKK7, negatively regulated the tyrosine phosphorylation and DNA binding and transcriptional activities of Stat3 stimulated by EGF.\n",
      "act(p(HGNC:MAP2K7)) -| p(HGNC:STAT3,pmod(P))\n",
      "act(p(HGNC:MAP2K7)) -| act(p(HGNC:STAT3))\n",
      "act(p(HGNC:MAPK8)) -| p(HGNC:STAT3,pmod(P))\n",
      "----------------------\n",
      "10021320 : These results suggest that Fas-mediated inactivation of Rb is mediated via the p38 kinase, independent of cdks\n",
      "act(p(HGNC:MAPK14)) -> p(HGNC:RB1,pmod(P))\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "act(p(HGNC:MAPK14)) -| act(p(HGNC:RB1))\n",
      "----------------------\n",
      "10005948 : Optimal induction of cyclin D1 by pp60(v-src) involved the extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase members of the mitogen-activated protein kinase family.\n",
      "act(p(HGNC:MAPK14)) -> r(HGNC:CCND1)\n",
      "act(p(HGNC:MAPK8)) -> r(HGNC:CCND1)\n",
      "act(p(HGNC:MAPK9)) -> r(HGNC:CCND1)\n",
      "----------------------\n",
      "10021330 : Its (RSK2) activation requires phosphorylation of the linker region at Ser(369), catalyzed by extracellular signal-regulated kinase (ERK)\n",
      "act(p(HGNC:MAPK1)) -> act(p(HGNC:RPS6KA3))\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:RPS6KA3,pmod(P))\n",
      "p(HGNC:RPS6KA3,pmod(P)) -> act(p(HGNC:RPS6KA3))\n",
      "----------------------\n",
      "10021334 : Furthermore, Erk-2 phosphorylated threonine 1179 and serine 1185 (and to a lesser extent, serine 395) in vitro, suggesting the importance of this pathway for SRC-1 regulation.\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:NCOA1,pmod(P))\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:NCOA1,pmod(P))\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:NCOA1,pmod(P))\n",
      "----------------------\n",
      "10021342 : Integrin signaling may be needed for the transcription of cyclin D1, because the cyclin D1 promoter is coordinately regulated by JNK and ERK (37) (Fig. 4).\n",
      "act(p(HGNC:MAPK1)) -> r(HGNC:CCND1)\n",
      "act(p(HGNC:MAPK3)) -> r(HGNC:CCND1)\n",
      "act(p(HGNC:MAPK8)) -> r(HGNC:CCND1)\n",
      "----------------------\n",
      "10021360 : JNK1 phosphorylates E2F1 in vitro, and co-transfection of JNK1 reduces the DNA binding activity of E2F1;\n",
      "act(p(HGNC:MAPK8)) -> p(HGNC:E2F1,pmod(P))\n",
      "act(p(HGNC:MAPK8)) -| act(p(HGNC:E2F1))\n",
      "----------------------\n",
      "10021362 : Here, we report that Ser-727 phosphorylation of Stat3 can also be induced by JNK and activated either by stress or by its upstream kinase and that various stress treatments induce serine phosphorylation of Stat3 in the absence of tyrosine phosphorylation\n",
      "act(p(HGNC:MAPK8)) -> p(HGNC:STAT3,pmod(P))\n",
      "act(p(HGNC:MAPK8)) -| act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10021366 : At least two p38-dependent 5-LO kinase activities were found. Based on migration properties in in-gel kinase assays and immunoreactivity, one of these was identified as mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP kinase 2). The other appeared to be MAPKAP kinase 3\n",
      "act(p(HGNC:MAPKAPK2)) -> act(p(HGNC:ALOX5))\n",
      "act(p(HGNC:MAPKAPK3)) -> act(p(HGNC:ALOX5))\n",
      "----------------------\n",
      "10021370 : We have shown that MAP/microtubule affinity regulating kinases (MARK) can phosphorylate the microtubule-associated-proteins MAP4, MAP2c, and tau on their microtubule-binding domain in vitro. This leads to their detachment from microtubules (MT) and an increased dynamic instability of MT. In CHO cells expressing MARK1 or MARK2 under control of an inducible promoter, MARK2 phosphorylates an endogenous MAP4-related protein.\n",
      "act(p(HGNC:MARK2)) -> p(HGNC:MAP2,pmod(P))\n",
      "act(p(HGNC:MARK2)) -> p(HGNC:MAP4,pmod(P))\n",
      "act(p(HGNC:MARK2)) -> p(HGNC:MAPT,pmod(P))\n",
      "----------------------\n",
      "10021374 : Rapamycin blocks both 4E-BP1 phosphorylation and cap-dependent translation ( [6]), and mTOR has been demonstrated to phosphorylate 4E-BP1 directly (discussed in further detail below) ( [14]).\n",
      "act(p(HGNC:MTOR)) -> act(p(HGNC:EIF4E))\n",
      "act(p(HGNC:MTOR)) -> p(HGNC:EIF4EBP1,pmod(P))\n",
      "----------------------\n",
      "10021380 : Here, we show that IRS-1 and IRS-2 are phosphorylated on tyrosine in presence of both TRK-T1 and the activated TrkA receptor.\n",
      "act(p(HGNC:NTRK1)) -> p(HGNC:IRS1,pmod(P))\n",
      "act(p(HGNC:NTRK1)) -> p(HGNC:IRS2,pmod(P))\n",
      "----------------------\n",
      "10021384 : Consistent with the earlier results, p42/44 MAPK and its upstream kinase MEK1/2 were activated in a time-dependent manner by the induction of Pak1 (Fig. 3C).\n",
      "act(p(HGNC:PAK1)) -> act(p(HGNC:MAP2K1))\n",
      "act(p(HGNC:PAK1)) -> act(p(HGNC:MAP2K2))\n",
      "act(p(HGNC:PAK1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:PAK1)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10021386 : Examination of whole cell lysates from the same NK92 cells showed that kinase-deficient (KD) PAK1, unlike control CD56, also effectively suppressed MEK and ERK activation by target ligation (Fig. 7b). Thus, PAK1 is upstream of both MEK and ERK in the NK lytic process.\n",
      "act(p(HGNC:PAK1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:PAK1)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10021012 : These include PRK1 and PRK2, whose interaction with Rho-GTP through their N-terminal Rho-binding domains results in a conformational change that enables PDK1 to interact with these kinases and phosphorylate their T-loop #[JL] PRK1 and 2 are PKN1 and 2\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:PKN1))\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:PKN2))\n",
      "----------------------\n",
      "10005988 : Similarly, two other members of the RSK family, RSK1 and RSK3, were partially activated by PDK1 in COS7 cells\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:RPS6KA1))\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:RPS6KA2))\n",
      "----------------------\n",
      "10021398 : Here, we show that the isolated N-terminal kinase of RSK2 (amino acids 1-360) is phosphorylated at Ser(227) by PDK1, a constitutively active kinase, leading to 100-fold stimulation of kinase activity\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:RPS6KA3))\n",
      "act(p(HGNC:PDPK1)) -> p(HGNC:RPS6KA3,pmod(P))\n",
      "----------------------\n",
      "10021400 : The N-terminal kinase is activated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) through phosphorylation of Ser227, and phosphorylates the substrates of RSK.\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:RPS6KA3))\n",
      "act(p(HGNC:PDPK1)) -> p(HGNC:RPS6KA3,pmod(P))\n",
      "p(HGNC:RPS6KA3,pmod(P)) -> act(p(HGNC:RPS6KA3))\n",
      "----------------------\n",
      "10021402 : PDK1 has now been shown to play a central role in activating many of the AGC subfamily members (reviewed in [150,151]). Apart from phosphorylating PKB on Thr308, PDK1 phosphorylates the equivalent residues on PKC isoforms [48,152,153], p70-S6K [32,154], the three isoforms of SGK [27,28,155] and PKA [156] (Figure 6).\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:RPS6KB1))\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:SGK1))\n",
      "----------------------\n",
      "10021406 : Both enzymes are characterized by the presence of a C2 domain at the carboxy terminus and, in vitro, preferentially utilize phosphatidylinositol and phosphatidylinositol 4-monophosphate as lipid substrates.\n",
      "act(p(HGNC:PIK3C2A)) -> a(CHEBI:\"1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate\")\n",
      "act(p(HGNC:PIK3C2A)) -> a(CHEBI:\"phosphatidylinositol 3-phosphate\")\n",
      "act(p(HGNC:PIK3C2B)) -> a(CHEBI:\"1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate\")\n",
      "act(p(HGNC:PIK3C2B)) -> a(CHEBI:\"phosphatidylinositol 3-phosphate\")\n",
      "----------------------\n",
      "10021412 : <C41> Cyclin B is degraded late in mitosis through the ubiquitin-protein ligase (E3) activity of the anaphase-promoting complex, which is probably activated by phosphorylation by Plk1 (Glover et al., 1998).\n",
      "act(p(HGNC:PLK1)) -> p(HGNC:CCNB1,pmod(P))\n",
      "p(HGNC:CCNB1,pmod(P)) -> deg(p(HGNC:CCNB1))\n",
      "----------------------\n",
      "10021418 : In vitro, PKC directly phosphorylated platelet syntaxin 4 and recombinant syntaxin 4. PKC phosphorylation in vitro inhibited (71 +/- 8%) the binding of syntaxin 4 to SNAP-23.\n",
      "act(p(HGNC:PRKCA)) -| complex(p(HGNC:STX4),p(HGNC:SNAP23))\n",
      "act(p(HGNC:PRKCA)) -> p(HGNC:STX4,pmod(P))\n",
      "p(HGNC:STX4,pmod(P)) -| complex(p(HGNC:STX4),p(HGNC:SNAP23))\n",
      "----------------------\n",
      "10021422 : Consistent with this in vivo activity, PKAc enzyme efficiently phosphorylated GSK-3a and -b at serine 21 and 9 in vitro (Fig. 4B), which was blocked by addition of the PKA peptide inhibitor (PKI) (26).\n",
      "act(p(HGNC:PRKCA)) -> p(HGNC:GSK3A,pmod(P))\n",
      "act(p(HGNC:PRKCA)) -> p(HGNC:GSK3B,pmod(P))\n",
      "----------------------\n",
      "10021428 : Protein kinase C (PKC) seems to be involved in negative regulation of the alpha -receptor, since overexpression of PKC-alpha suppressed the expression of the alpha -receptor but not the beta -receptor (125).\n",
      "act(p(HGNC:PRKCA)) -| p(HGNC:PDGFRA)\n",
      "act(p(HGNC:PRKCA)) -| r(HGNC:PDGFRA)\n",
      "p(HGNC:PRKCA) -| p(HGNC:PDGFRA)\n",
      "p(HGNC:PRKCA) -| r(HGNC:PDGFRA)\n",
      "----------------------\n",
      "10021436 : PKC, a serine kinase, can phosphorylate and inhibit tyrosine kinase activity of the insulin receptor as well as tyrosine phosphorylation of insulin receptor substrate (IRS)-1\n",
      "act(p(HGNC:PRKCE)) -> p(HGNC:INSR,pmod(P))\n",
      "act(p(HGNC:PRKCQ)) -> p(HGNC:INSR,pmod(P))\n",
      "p(HGNC:INSR,pmod(P)) -| act(p(HGNC:INSR))\n",
      "p(HGNC:INSR,pmod(P)) -> act(p(HGNC:INSR))\n",
      "----------------------\n",
      "10006004 : It has been shown through electrophoretic mobility shift assay that Ras promoted the PKCzeta-induced binding of Sp1 to the VPF/VEGF promoter.\n",
      "act(p(HGNC:PRKCZ)) -> act(p(HGNC:SP1))\n",
      "act(p(HGNC:SP1)) -> r(HGNC:VEGFA)\n",
      "----------------------\n",
      "10021442 : First, we generated site-specific CADTK mutants. Mutation of Tyr402 eliminated autophosphorylation and significantly decreased kinase activity.\n",
      "act(p(HGNC:PTK2B)) -> p(HGNC:PTK2B,pmod(P))\n",
      "p(HGNC:PTK2B,pmod(P)) -> act(p(HGNC:PTK2B))\n",
      "----------------------\n",
      "10021444 : A downstream target of FAK is paxillin, a phosphoprotein that also can localize to focal adhesion complexes (9).\n",
      "act(p(HGNC:PTK2)) -> act(p(HGNC:PXN))\n",
      "act(p(HGNC:PTK2)) -> p(HGNC:PXN,pmod(P))\n",
      "p(HGNC:PXN,pmod(P)) -> act(p(HGNC:PXN))\n",
      "----------------------\n",
      "10021454 : RIP2 is a serine-threonine kinase associated with the tumor necrosis factor (TNF) receptor complex and is implicated in the activation of NF-kappaB and cell death in mammalian cells.\n",
      "act(p(HGNC:RIPK2)) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:TNF) -> act(p(HGNC:RIPK2))\n",
      "----------------------\n",
      "10006012 : Here we show that RIP2 activates the extracellular signal-regulated kinase (ERK) pathway and that the kinase activity of RIP2 appears to be important in this process.\n",
      "act(p(HGNC:RIPK2)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:RIPK2)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10021468 : we showed that HSF 1 is phosphorylated by the protein kinase RSK2 in vitro we demonstrate that RSK2 slightly represses activation of HSF1 in vivo\n",
      "act(p(HGNC:RPS6KA3)) -> p(HGNC:HSF1,pmod(P))\n",
      "act(p(HGNC:RPS6KA3)) -| act(p(HGNC:HSF1))\n",
      "p(HGNC:HSF1,pmod(P)) -| act(p(HGNC:HSF1))\n",
      "----------------------\n",
      "10021480 : Inhibiting Src tyrosine kinases with herbimycin A reduced MMP-2 and MMP-9 production with no effect on cell attachment.\n",
      "act(p(HGNC:SRC)) -> r(HGNC:MMP2)\n",
      "act(p(HGNC:SRC)) -> r(HGNC:MMP9)\n",
      "----------------------\n",
      "10021482 : A dominant negative inhibitor of c-Src effectively inhibited RalA-dependent uPAR transcription identifying it as a downstream effector in the RalA signalling pathway.\n",
      "act(p(HGNC:SRC)) -> r(HGNC:PLAUR)\n",
      "p(HGNC:RALA) -> r(HGNC:PLAUR)\n",
      "----------------------\n",
      "10016480 : treatment of platelets with thromboxane A1 analog, STA2, led to an activation of this protein kinase and phosphorylation of PAR1\n",
      "act(p(HGNC:STK33)) -> act(p(HGNC:F2R))\n",
      "act(p(HGNC:STK33)) -> p(HGNC:F2R,pmod(P))\n",
      "----------------------\n",
      "10021484 : Moreover, Smad2 and Smad3 interacted with P/CAF upon TGF-beta type I receptor activation in cultured mammalian cells.\n",
      "act(p(HGNC:TGFBR1)) -> complex(p(HGNC:KAT2B),p(HGNC:SMAD3))\n",
      "act(p(HGNC:TGFBR1)) -> complex(p(HGNC:SMAD2),p(HGNC:KAT2B))\n",
      "----------------------\n",
      "10021486 : Each of three Ki-ras(G12V) transfectants responded to TGF-beta1 by an increase in proliferation and by decreasing the abundance of the Cdk inhibitor p21 and the tumor suppressor PTEN, whereas each of three wild-type Ki-ras transfectants remained unresponsive to TGF-beta1.\n",
      "act(p(HGNC:TGFBR3)) -| p(HGNC:CDKN1A)\n",
      "act(p(HGNC:TGFBR3)) -| p(HGNC:PTEN)\n",
      "----------------------\n",
      "10021490 : We show here that activated ACK1, a nonreceptor tyrosine kinase that belongs to the focal adhesion kinase family, causes tyrosine phosphorylation of Ras-GRF1.\n",
      "act(p(HGNC:TNK2)) -> act(p(HGNC:RASGRF1))\n",
      "act(p(HGNC:TNK2)) -> p(HGNC:RASGRF1,pmod(P))\n",
      "p(HGNC:RASGRF1,pmod(P)) -> act(p(HGNC:RASGRF1))\n",
      "----------------------\n",
      "10021494 : <C27> p45Skp2 inhibits Cdk2 kinase activity and blocks phosphorylation of Cdk2 by Wee1 or CAK (Yam et al., 1999). Similarly to p21Cip1, two molecules of p45Skp2 seem to be required to inhibit Cdk2. Binding to p45Skp2 is mutually exclusive with p21cip1.\n",
      "act(p(HGNC:WEE1)) -> p(HGNC:CDK2,pmod(P))\n",
      "p(HGNC:SKP2) -| act(p(HGNC:CDK2))\n",
      "----------------------\n",
      "10006056 : The kinase-inactive SrcK295M induced a G(1) block that was overcome by the constitutively active Abl-PP (AblP242E/P249E). Conversely, the inhibitory effect of Abl-PP-K(-) was not compensated by Src.\n",
      "act(p(MGI:Abl1)) -> bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "act(p(MGI:Src)) -> bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "----------------------\n",
      "10006060 : we identify two previously unknown targets of v-Abl signaling: (1) cyclin D1 and D2 mRNAs are induced upon v-Abl activation; and (2) the CDK inhibitor p27 is decreased upon v-Abl activation.\n",
      "act(p(MGI:Abl1)) -> p(MGI:Cdkn1b)\n",
      "act(p(MGI:Abl1)) -> r(MGI:Ccnd1)\n",
      "act(p(MGI:Abl1)) -> r(MGI:Ccnd2)\n",
      "----------------------\n",
      "10021504 : Combined blockade of Alk1 and Notch signaling further exacerbates hypervascularization, whereas activation of Alk1 by its high-affinity ligand BMP9 rescues hypersprouting induced by Notch inhibition\n",
      "act(p(MGI:Acvrl1)) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "p(MGI:Gdf2) -> act(p(MGI:Acvrl1))\n",
      "p(HGNC:GDF2) -> act(p(HGNC:ACVRL1))\n",
      "----------------------\n",
      "10021506 : BMP9 also activates the Id1 promoter-derived BMP response element (BRE) in a dose-dependent manner (EC50 = 45 +/-; 27 pg/ml) and this activation is abolished by silencing ALK1 expression\n",
      "act(p(MGI:Acvrl1)) -> r(MGI:Id1)\n",
      "p(MGI:Gdf2) -> act(p(MGI:Acvrl1))\n",
      "p(MGI:Gdf2) -> r(MGI:Id1)\n",
      "----------------------\n",
      "10021508 : We identified this kinase to be the G protein-coupled receptor kinase 2 (Grk2), and we showed that it acts on S633 in the C terminus of ?-ENaC. The kinase increases the activity of the channels and renders them insensitive to the ubiquitin protein ligase Nedd4-2.\n",
      "act(p(MGI:Adrbk1)) -> p(MGI:Scnn1b,pmod(P))\n",
      "act(p(MGI:Adrbk1)) -> act(p(MGI:Scnn1b))\n",
      "----------------------\n",
      "10006064 : genetic disruption of AK1-catalyzed ss-phosphoryl transfer in mice decreases the potential of myofibers to sustain nucleotide ratios despite up-regulation of high-energy phosphoryl flux through glycolytic, guanylate and creatine kinase phosphotransfer pathways\n",
      "act(p(MGI:Ak1)) -| bp(GOBP:glycolysis)\n",
      "act(p(MGI:Ak1)) -| act(p(MGI:Ckm))\n",
      "----------------------\n",
      "10006066 : Mechanistically, the loss of Akt1 reduces the basal phosphorylation of several Akt substrates, the migration of fibroblasts and ECs, and NO release.\n",
      "act(p(MGI:Akt1)) -> a(CHEBI:\"nitric oxide\")\n",
      "act(p(MGI:Akt1)) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10021512 : ROS production with ischemia was significantly reduced in lungs with knockout of Akt1 while the response of Akt2 null lungs to ischemia was similar to wild type (Fig. 4A and B). Thus, Akt1 is required for activation of endothelial ROS production with ischemia.\n",
      "act(p(MGI:Akt1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:AKT1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "path(MESHD:Ischemia) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10021054 : PI3K activation, however, results in the recruitment of the serine/threonine kinase PDK1 (3-phosphoinositidedependent protein kinase 1) to the plasma membrane, where PDK1 subsequently phosphorylates and activates another serine/threonine kinase, AKT 86. AKT positively regulates the function of the transcription factor NF-kB by phosphorylating inhibitor of NF-kB (IkB), which is a key regulator of NF-kB 87.\n",
      "act(p(MGI:Akt1)) -> act(p(MGI:Nfkbib))\n",
      "act(p(MGI:Pdk1)) -> act(p(MGI:Akt1))\n",
      "----------------------\n",
      "10021518 : Cyclins D1 and D2 but not D3 protein levels were markedly increased in caAktTg/cdk4/ mice (4.1 1 and 1.9 0.1, respectively, P 0.05) (Fig. 1CâE).\n",
      "act(p(MGI:Akt1)) -> p(MGI:Ccnd1)\n",
      "act(p(MGI:Akt1)) -> p(MGI:Ccnd2)\n",
      "----------------------\n",
      "10021520 : Levels of p21 were significantly increased in caAktTg mice when compared with those of nontransgenic cdk4/ (Fig. 2C). Analysis of p57 expression showed decreased levels in caAktTg mice (Fig. 2C).\n",
      "act(p(MGI:Akt1)) -> p(MGI:Cdkn1a)\n",
      "act(p(MGI:Akt1)) -| p(MGI:Cdkn1c)\n",
      "----------------------\n",
      "10021528 : We first investigated whether hyperactive mTOR could cause abnormal Notch signaling by monitoring the levels of Hes1, a direct target of Notch. We found that Hes1 protein expression was dramatically elevated in cells with constitutively active mTOR caused by loss of the Tsc2 or Pten tumor suppressor gene or oncogenic myristoylation of AKT1 (myrAKT1) (34) (Figure 2A).\n",
      "act(p(MGI:Akt1)) -> p(MGI:Hes1)\n",
      "p(MGI:Pten) -| p(MGI:Hes1)\n",
      "p(MGI:Tsc2) -| p(MGI:Hes1)\n",
      "----------------------\n",
      "10021532 : The reduced level of p53 protein in myr-Akt1 salivary glands corresponds with an increase in MDM2 phosphorylation in vivo, suggesting that the Akt/MDM2/p53 pathway is responsible for suppression of apoptosis. Dominant-negative Akt blocked phosphorylation of MDM2 in salivary acinar cells from myr-Akt1 transgenic mice.\n",
      "act(p(MGI:Akt1)) -> p(MGI:Mdm2,pmod(P))\n",
      "p(MGI:Mdm2,pmod(P)) -| p(MGI:Trp53)\n",
      "p(MGI:Trp53) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10021534 : Both TA-p63 and deltaN-p63 were overexpressed in cells with mTOR activation because of either a lack of Tsc2 or Pten or expression of AKT1-E17K, and were repressed by rapamycin\n",
      "act(p(MGI:Akt1)) -> p(MGI:Trp63)\n",
      "p(MGI:Akt1,sub(E,17,K)) -> p(MGI:Trp63)\n",
      "p(MGI:Pten) -| p(MGI:Trp63)\n",
      "p(MGI:Tsc2) -| p(MGI:Trp63)\n",
      "----------------------\n",
      "10021536 : Heterologous expression of Akt1/PKB(alpha) potently suppressed MCK gene transcription without affecting myogenin gene transcription, whereas heterologous expression of Akt2 increased myogenin and MCK gene transcription.\n",
      "act(p(MGI:Akt1)) -| r(MGI:Ckm)\n",
      "act(p(MGI:Akt2)) -> r(MGI:Ckm)\n",
      "act(p(MGI:Akt2)) -> r(MGI:Myog)\n",
      "----------------------\n",
      "10021538 : upregulation of Jagged1 by mTOR was due, at least in part, to higher levels of Jagged1 mRNA in the Tsc2-null and mutant AKT-expressing cell lines (Figure 3B) and appeared to be directly responsible for Notch activation and Hes1 expression, as these were blocked by decreased Jagged1 expression using siRNA (Figure 3C).\n",
      "act(p(MGI:Akt1)) -> r(MGI:Jag1)\n",
      "p(MGI:Tsc2) -| r(MGI:Jag1)\n",
      "----------------------\n",
      "10021546 : we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.\n",
      "act(p(MGI:Akt1)) -| act(p(MGI:Foxo3))\n",
      "p(MGI:Fbxo32) -> act(p(MGI:Fbxo32))\n",
      "r(MGI:Fbxo32) -> p(MGI:Fbxo32)\n",
      "act(p(MGI:Foxo3)) -> r(MGI:Fbxo32)\n",
      "----------------------\n",
      "10021552 : Furthermore, inhibition of ATM/ATR kinases abolishes both induction of Rad51 and phosphorylation of p53 and reduced the level of apoptosis induced by coexpression of oncogenes and ARF (Pauklin et al., 2005).\n",
      "act(p(MGI:Atm)) -> p(MGI:Rad51)\n",
      "act(p(MGI:Atm)) -> p(MGI:Trp53,pmod(P))\n",
      "----------------------\n",
      "10021564 : Overexpression of wild-type Bcr kinase did not inhibit ligand-mediated PPARgamma1 S82A mutant transcriptional activity, indicating that Bcr regulates PPARgamma activity via S82 phosphorylation.\n",
      "act(p(MGI:Bcr)) -| act(p(MGI:Pparg))\n",
      "p(MGI:Pparg,pmod(P)) -| act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10021570 : Similar observation that immunoprecipitated B-Raf from EGF-stimulated Swiss3T3 cells could activate both MEK1 and MEK2 was also obtained (data not shown).\n",
      "act(p(MGI:Braf)) -> act(p(MGI:Map2k1))\n",
      "act(p(MGI:Braf)) -> act(p(MGI:Map2k2))\n",
      "p(MGI:Egf) -> act(p(MGI:Braf))\n",
      "----------------------\n",
      "10006084 : CaMKIV activates PGC-1alpha largely through the binding of cAMP response element-binding protein to the PGC-1alpha promoter.\n",
      "act(p(MGI:Camk4)) -> act(p(MGI:Creb1))\n",
      "act(p(MGI:Creb1)) -> r(MGI:Ppargc1a)\n",
      "----------------------\n",
      "10021588 : We show that expression of cyclin E-CDK2 in murine fibroblasts causes phosphorylation of the CDK inhibitor p27Kip1 on T187, and that cyclin E-CDK2 can directly phosphorylate p27 T187 in vitro.\n",
      "act(p(MGI:Cdk2)) -> p(MGI:Cdkn1b,pmod(P))\n",
      "p(MGI:Ccne1) -> act(p(MGI:Cdk2))\n",
      "p(HGNC:CCNE1) -> act(p(HGNC:CDK2))\n",
      "----------------------\n",
      "10021594 : In contrast, ectopic expression of cyclin A or cyclin E inhibits MCK expression only when they are co-expressed with their catalytic partner cyclin-dependent kinase 2 (Cdk2).\n",
      "act(p(MGI:Cdk2)) -| r(MGI:Ckm)\n",
      "p(MGI:Ccna1) -| r(MGI:Ckm)\n",
      "p(MGI:Ccna2) -| r(MGI:Ckm)\n",
      "----------------------\n",
      "10021608 : Pctaire1 can be phosphorylated by the Cdk5/p25 complex, and serine 95 is the major phosphorylation site. In brain and muscle of Cdk5 null mice, Pctaire1 activity is significantly reduced Pctaire1 interacts with p35, both in vitro and in vivo, and that phosphorylation of Pctaire1 by Cdk5 enhances its kinase activity.\n",
      "act(p(MGI:Cdk5)) -> act(p(EGID:18555))\n",
      "act(p(MGI:Cdk5)) -> p(EGID:18555,pmod(P))\n",
      "----------------------\n",
      "10021614 : This finding agrees with previous studies that showed that IkBa is a better substrate for the IKKs than IkBb (17). The kinetics of IkBa and IkBb phosphorylation were coincident with the degradation of endogenous IkBa as well as the appearance of DNA-binding NF-kB complexes in the nucleus at approximately 15â30 min (Fig. 1B, bottom three panels).\n",
      "act(p(MGI:Chuk)) -> deg(p(MGI:Nfkbia))\n",
      "act(p(MGI:Chuk)) -> deg(p(MGI:Nfkbib))\n",
      "act(p(MGI:Chuk)) -| p(MGI:Nfkbia)\n",
      "act(p(HGNC:CHUK)) -| p(HGNC:NFKBIA)\n",
      "----------------------\n",
      "10006102 : The IkappaB kinases, IKK1 and IKK2, have been implicated in both IkappaB degradation and subsequent modifications of NFkappaB.\n",
      "act(p(MGI:Chuk)) -> deg(p(MGI:Nfkbia))\n",
      "act(p(MGI:Ikbkb)) -> deg(p(MGI:Nfkbia))\n",
      "----------------------\n",
      "10021624 : CK1 phosphorylation of E-cadherin increased the binding affinity to beta-catenin from approximately 230 to 4 nM.\n",
      "act(p(MGI:Csnk1a1)) -> p(MGI:Cdh1,pmod(P))\n",
      "p(MGI:Cdh1,pmod(P)) -> complex(p(MGI:Ctnnb1),p(MGI:Cdh1))\n",
      "----------------------\n",
      "10006112 : we demonstrate that overexpression of CKII increases the transcriptional activities of MRF4 and MyoD in vivo.\n",
      "act(p(MGI:Csnk2a1)) -> act(p(MGI:Myf6))\n",
      "act(p(MGI:Csnk2a1)) -> act(p(MGI:Myod1))\n",
      "----------------------\n",
      "10021628 : A similar increase in affinity, from 260 to 4 nM, was obtained with CK2 phosphorylation of E-cadherin.\n",
      "act(p(MGI:Csnk2a2)) -> p(MGI:Cdh1,pmod(P))\n",
      "p(MGI:Cdh1,pmod(P)) -> complex(p(MGI:Ctnnb1),p(MGI:Cdh1))\n",
      "----------------------\n",
      "10021630 : These studies demonstrate that exogenous CK II and a ribosome-bound, CK II-like enzyme phosphorylate the ribosomal P proteins in vitro and localize the target site for phosphorylation to the COOH terminus.\n",
      "act(p(MGI:Csnk2a2)) -> p(MGI:Rplp0,pmod(P))\n",
      "act(p(MGI:Nucks1)) -> p(MGI:Rplp0,pmod(P))\n",
      "----------------------\n",
      "10021644 : EGF-R causes disassembly of hemidesmosomes by activating Fyn, which in turn phosphorylates the beta4 cytoplasmic domain. Neoplastic cells expressing dominant negative Fyn display increased hemidesmosomes and migrate poorly in vitro in response to EGF.\n",
      "act(p(MGI:Egfr)) -> act(p(MGI:Fyn))\n",
      "act(p(MGI:Fyn)) -> p(MGI:Itgb4,pmod(P))\n",
      "----------------------\n",
      "10021652 : The EGF effect depended on activation of its receptor tyrosine kinase but not on that of protein kinase C, mitogen-activated protein kinases, or phosphoinositide-3 kinase.\n",
      "act(p(MGI:Egfr)) -| p(MGI:Npr3)\n",
      "act(p(MGI:Egfr)) -| r(MGI:Npr3)\n",
      "p(MGI:Egf) -> act(p(MGI:Egfr))\n",
      "----------------------\n",
      "10017208 : Here, using rat pheochromocytoma PC12 cells transiently transfected with a plasmid expressing a chimera of green fluorescent protein fused to GAP1(m) (GFP-GAP1(m)), we show that epidermal growth factor (EGF) induces a rapid (less than 60 seconds) recruitment of GFP-GAP1(m) from the cytosol to the plasma membrane.\n",
      "act(p(MGI:Egfr)) -> tloc(p(MGI:Rasa2))\n",
      "p(MGI:Egf) -> tloc(p(MGI:Rasa2))\n",
      "----------------------\n",
      "10021658 : Experiments in primary mammary epithelial cells and transfected COS-7 cells revealed a p44/42 MAPK and EGFR-dependent Stat3 activation.\n",
      "act(p(MGI:Egfr)) -> act(p(MGI:Stat3))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10021660 : In vivo, b4-integrin amplifies proproliferative signals in basal epidermal keratinocytes (Nikolopoulos et al., 2005), where STAT3 is expressed and can be activated by EGF/EGF-R (Nishio et al., 2001; Chan et al., 2004; Li et al., 2007)\n",
      "act(p(MGI:Egfr)) -> act(p(MGI:Stat3))\n",
      "p(MGI:Egf) -> act(p(MGI:Stat3))\n",
      "p(MGI:Itgb4) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10021662 : since in PKR-null MEFs there is a marked defect in Erk1 and Erk2 activation by PDGF (Figure1D), it appears that PKR is involved in serine phosphorylation of Stat3 through the activation of Erks.\n",
      "act(p(MGI:Eif2ak2)) -> act(p(MGI:Mapk1))\n",
      "act(p(MGI:Eif2ak2)) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10021664 : Whereas PKR+/+ cells exhibited a clear induction in phospho-Ser727 Stat3, PKR-null cells were defective in this process (Figure1B)\n",
      "act(p(MGI:Eif2ak2)) -> p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Pdgfb) -> p(MGI:Stat3,pmod(P))\n",
      "----------------------\n",
      "10006122 : Our studies demonstrated that activation of PKR induces the expression of members of the tumor necrosis factor receptor (TNFR) family, including Fas (CD95/Apo-1) and pro-apopotic Bax\n",
      "act(p(MGI:Eif2ak2)) -> r(MGI:Bax)\n",
      "act(p(MGI:Eif2ak2)) -> r(MGI:Fas)\n",
      "----------------------\n",
      "10021666 : Accordingly, nuclear extracts prepared from PDGF-treated PKR- null cells were severely deficient in Stat3 containing DNA-binding complexes compared with wild-type MEFs (data not shown). Taken together, we conclude that PDGF-induced activation of Stat3 DNA binding is PKR dependent.\n",
      "act(p(MGI:Eif2ak2)) -> act(p(MGI:Stat3))\n",
      "p(MGI:Pdgfb) -> act(p(MGI:Eif2ak2))\n",
      "----------------------\n",
      "10021676 : Phosphorylation of eIF2alpha results in inhibition of general protein synthesis ( ) and selective activation of ATF4 transcription that up-regulates CHOP gene expression, which in turn causes islet beta-cell apoptosis.\n",
      "act(p(MGI:Eif2ak3)) -> r(MGI:Atf4)\n",
      "p(MGI:Ddit3) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10021680 : Mammalian cells respond to endoplasmic reticulum (ER) stress by attenuation of protein translation The disruption of PERK function or the blocking of eIF2alpha Ser51 phosphorylation fails to attenuate translation after ER stress and also results in substantial impairment of Grp78/BiP induction by ER stress.\n",
      "act(p(MGI:Eif2ak3)) -> r(MGI:Hspa5)\n",
      "p(MGI:Eif2s1,pmod(P)) -> r(MGI:Hspa5)\n",
      "p(MGI:Eif2s1,pmod(P)) -> r(MGI:Hspa5)\n",
      "----------------------\n",
      "10021688 : The ErbB-2 interacting protein receptor-associated late transducer (RALT) was previously identified as a feedback inhibitor of ErbB-2 mitogenic signals.\n",
      "act(p(MGI:Erbb2)) -> p(MGI:Errfi1)\n",
      "p(MGI:Errfi1) -| act(p(MGI:Erbb2))\n",
      "----------------------\n",
      "10021692 : FGF-2 (>/=10(-12) m) also increased cathepsin K and MMP-9 mRNA levels in mouse and rabbit osteoclasts. Among FGF receptors (FGFR1 to 4) only FGFR1 was detected on isolated mouse osteoclasts, whereas all FGFRs were identified on mouse osteoblasts.\n",
      "act(p(MGI:Fgfr1)) -> r(MGI:Ctsk)\n",
      "act(p(MGI:Fgfr1)) -> r(MGI:Mmp9)\n",
      "----------------------\n",
      "10006144 : FGFs activate the endogenous FGFRs leading to the formation of a Grb2/FRS2/Shp2 complex and activation of MAP kinase.\n",
      "act(p(MGI:Fgfr2)) -> bp(GOBP:\"MAPK cascade\")\n",
      "act(p(MGI:Fgfr2)) -> complex(p(MGI:Frs2),p(MGI:Grb2),p(MGI:Ptpn11))\n",
      "p(MGI:Fgf1) -> act(p(MGI:Fgfr2))\n",
      "p(MGI:Fgf2) -> act(p(MGI:Fgfr2))\n",
      "----------------------\n",
      "10021696 : Immunolocalization of FGFR2 and FGFR3 revealed overlap with Dach1 expression during skeletal patterning and chondrocyte maturation. We conclude that Dach1 is a target gene of FGF signaling during limb skeletal development, and Dach1 may function as an intermediary in the FGF signaling pathway regulating cell proliferation or differentiation.\n",
      "act(p(MGI:Fgfr2)) -> r(MGI:Dach1)\n",
      "act(p(MGI:Fgfr3)) -> r(MGI:Dach1)\n",
      "----------------------\n",
      "10021698 : On the other hand, FRS2 expression seemed to be up-regulated slightly in the FGF8-stimulated cells\n",
      "act(p(MGI:Fgfr2)) -> r(MGI:Frs2)\n",
      "act(p(MGI:Fgfr3)) -> r(MGI:Frs2)\n",
      "act(p(MGI:Fgfr4)) -> r(MGI:Frs2)\n",
      "p(MGI:Fgf8) -> r(MGI:Frs2)\n",
      "----------------------\n",
      "10019124 : Both Fyn and Hck phosphorylate the adaptor protein Gab2 to activate PI3K signaling and promote microtubule formation that is important for granule translocation to the plasma membrane (9, 11).\n",
      "act(p(MGI:Fyn)) -> act(p(MGI:Gab2))\n",
      "act(p(MGI:Hck)) -> act(p(MGI:Gab2))\n",
      "----------------------\n",
      "10021720 : Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues.\n",
      "act(p(MGI:Fyn)) -> p(MGI:Agap2,pmod(P))\n",
      "act(p(MGI:Fyn)) -> p(MGI:Agap2,pmod(P))\n",
      "----------------------\n",
      "10021722 : However, purified EGFR did not phosphorylate recombinant PKC delta in vitro, whereas members of the Src family (c-Src, c-Fyn) and membrane preparations from keratinocytes did.\n",
      "act(p(MGI:Fyn)) -> p(MGI:Prkcd,pmod(P))\n",
      "act(p(MGI:Src)) -> p(MGI:Prkcd,pmod(P))\n",
      "----------------------\n",
      "10006158 : acute stimulation by glucose of l-pyruvate kinase (l-PK), fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and Spot 14 genes requires GK expression.\n",
      "act(p(MGI:Gck)) -> r(MGI:Acaca)\n",
      "act(p(MGI:Gck)) -> r(MGI:Fasn)\n",
      "act(p(MGI:Gck)) -> r(MGI:Pklr)\n",
      "act(p(MGI:Gck)) -> r(MGI:Thrsp)\n",
      "----------------------\n",
      "10021734 : We show here that the BCR/ABL SH3 and SH2 domains interact with hematopoietic cell kinase (Hck), leading to the stimulation of Hck catalytic activity. Active Hck phosphorylated STAT5B on Tyr699, which represents an essential step in STAT5B stimulation.\n",
      "act(p(MGI:Hck)) -> p(MGI:Stat5b,pmod(P))\n",
      "p(MGI:Abl1) -> act(p(MGI:Hck))\n",
      "----------------------\n",
      "10006180 : Insulin resistance was improved by systemic neutralization of IL-6 or salicylate inhibition of IKK-beta.\n",
      "act(p(MGI:Ikbkb)) -> path(MESHD:\"Insulin Resistance\")\n",
      "p(MGI:Ikbkb) -> path(MESHD:\"Insulin Resistance\")\n",
      "p(MGI:Il6) -> path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10021758 : While kinase-inactive IKKa had a minor effect, kinase-inactive IKKb was a potent (76% decrease) inhibitor of IL-2 Luc activity (Fig. 5). The effect of kinase-inactive IKKb was comparable to the effect of kinase-inactive MEKK1, which acts as a MAP3K in the JNK cascade (Fig. 5).\n",
      "act(p(MGI:Ikbkb)) -> r(MGI:Il2)\n",
      "act(p(MGI:Map3k1)) -> r(MGI:Il2)\n",
      "----------------------\n",
      "10021760 : By contrast, array (Affymetrix, Santa Clara, CA) analysis of RNA from pooled primary lung samples revealed a subset of ISGs, including Ifit3, Ifi203, and the double-stranded RNA (dsRNA)-activated adenosine deaminase gene (Adar1), that were poorly induced in the absence of IKKe as corroborated by RT-PCR analyses (Fig. 2B and fig. S4B).\n",
      "act(p(MGI:Ikbke)) -> r(MGI:Adar)\n",
      "act(p(MGI:Ikbke)) -> r(MGI:Ifi203)\n",
      "act(p(MGI:Ikbke)) -> r(MGI:Ifit3)\n",
      "----------------------\n",
      "10021762 : RT-PCR analyses from the WT and Ikbke-/- samples showed comparable induction of IFNb but revealed a decrease in the expression of a subset of ISGs (Fig. 2E).\n",
      "act(p(MGI:Ikbke)) -> r(MGI:Adar)\n",
      "act(p(MGI:Ikbke)) -> r(MGI:Ifi203)\n",
      "----------------------\n",
      "10021766 : This pathway begins with the phosphorylation of the adaptor protein Cbl by the insulin receptor, and results in the activation of a small GTP binding protein, TC10\n",
      "act(p(MGI:Insr)) -> p(MGI:Cbl,pmod(P))\n",
      "p(MGI:Cbl,pmod(P)) -> act(p(MGI:Rhoq))\n",
      "p(MGI:Insr,pmod(P)) -> act(p(MGI:Insr))\n",
      "----------------------\n",
      "10001666 : The role of IRAK in IL-18-induced responses was studied in IRAK-deficient mice. Significant defects in JNK induction and partial impairment in NF-kappaB activation were found in IRAK-deficient Th1 cells, resulting in a dramatic decrease in interferon (IFN)-gamma mRNA expression.\n",
      "act(p(MGI:Irak1)) -> act(p(MGI:Mapk8))\n",
      "act(p(MGI:Irak1)) -> r(MGI:Ifng)\n",
      "p(MGI:Il18) -> act(p(MGI:Irak1))\n",
      "----------------------\n",
      "10021774 : IRAK1 can directly use Stat3 as a substrate and cause Stat3 serine 727 phosphorylation. Splenocytes from IRAK1-deficient mice fail to exhibit LPS-induced Stat3 serine phosphorylation and IL-10 gene expression\n",
      "act(p(MGI:Irak1)) -> p(MGI:Stat3,pmod(P))\n",
      "act(p(MGI:Irak1)) -> r(MGI:Il10)\n",
      "act(p(MGI:Irak1)) -> act(p(MGI:Stat3))\n",
      "p(MGI:Stat3,pmod(P)) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10006204 : Furthermore, the absence of IRAK4 kinase activity blocked induction of IL-23R expression, STAT3 activation by IL-23\n",
      "act(p(MGI:Irak4)) -> r(MGI:Il23r)\n",
      "act(p(MGI:Irak4)) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10021788 : Following ligand binding to the IL-10R, Jak1 and Tyk2, which are constitutively associated with IL-10R1 and IL-10R2, respectively (3, 14), are phosphorylated on tyrosine The phosphorylated IL-10R/Jak1/Tyk2 complex serves as a docking site for the transcription factors Stat-1 and Stat-3 Jak1, which is required for the biological activity of IL-10 (20), also tyrosine phosphorylates the insulin receptor substrate-1 (IRS-1)\n",
      "act(p(MGI:Jak1)) -> p(MGI:Irs1,pmod(P))\n",
      "p(MGI:Irs1,pmod(P)) -> act(p(MGI:Irs1))\n",
      "----------------------\n",
      "10021794 : Tyk2, along with JAK2, does appear to regulate TPO receptor localization at the plasma membrane by stimulating recycling and enhancing the stability of the receptor in Ba/F3 cells\n",
      "act(p(MGI:Jak2)) -> surf(p(MGI:Mpl))\n",
      "act(p(MGI:Tyk2)) -> surf(p(MGI:Mpl))\n",
      "----------------------\n",
      "10021796 : when we analyzed the migration of Jak3(-/-) and Jak3(+/+) mature DCs in response to CCL19 and CCL21 chemokines, we found that the absence of Jak3 results in impaired chemotactic responses both in vitro and in vivo.\n",
      "act(p(MGI:Jak3)) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Ccl19) -> act(p(MGI:Jak3))\n",
      "p(MGI:Ccl21a) -> act(p(MGI:Jak3))\n",
      "----------------------\n",
      "10021798 : (WHI-P97) is a rationally designed potent inhibitor of Janus kinase (JAK)-3. Treatment of mast cells with WHI-P97 inhibited the translocation of 5-lipoxygenase (5-LO) from the nucleoplasm to the nuclear membrane and consequently 5-LO-dependent leukotriene (LT) synthesis\n",
      "act(p(MGI:Jak3)) -> act(p(MGI:Alox5))\n",
      "act(p(MGI:Jak3)) -> tloc(p(MGI:Alox5))\n",
      "tloc(p(MGI:Alox5)) -> act(p(MGI:Alox5))\n",
      "----------------------\n",
      "10021818 : Cofilin and LIMK2 co-precipitated and cofilin became phosphorylated in response to TGF-beta1, whereas RNA interference against LIMK2 blocked formation of new stress fibers by TGF-beta1.\n",
      "act(p(MGI:Limk2)) -> p(MGI:Cfl1,pmod(P))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Limk2))\n",
      "----------------------\n",
      "10021828 : Subsequent to its association with Fc?RI, Syk is phosphorylated and activated by Lyn. Syk phosphorylates the adaptor proteins LAT and NTAL/LAB/LAT2\n",
      "act(p(MGI:Lyn)) -> act(p(MGI:Syk))\n",
      "act(p(MGI:Syk)) -> act(p(MGI:Lat2))\n",
      "act(p(MGI:Syk)) -> act(p(MGI:Lat))\n",
      "----------------------\n",
      "10006216 : In this study, we show that J2E erythroid cells lacking Lyn have impaired signaling and reduced levels of transcription factors STAT5a, EKLF and GATA-1.\n",
      "act(p(MGI:Lyn)) -> act(p(MGI:Gata1))\n",
      "act(p(MGI:Lyn)) -> act(p(MGI:Klf1))\n",
      "act(p(MGI:Lyn)) -> act(p(MGI:Stat5a))\n",
      "----------------------\n",
      "10021840 : activated MEK1 increased Elk-1- and c-Jun-dependent gene expression but not ATF2-dependent gene expression (Fig. 4).\n",
      "act(p(MGI:Map2k1)) -> act(p(MGI:Elk1))\n",
      "act(p(MGI:Map2k1)) -> act(p(MGI:Jun))\n",
      "----------------------\n",
      "10021842 : A loss of both MKK6 and MKK3 resulted in cells with increased proliferation and susceptibility to tumorigenic conversion (Brancho et al., 2003).\n",
      "act(p(MGI:Map2k3)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Map2k6)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10021846 : TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation.\n",
      "act(p(MGI:Map2k3)) -> act(p(MGI:Mapk14))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Mapk14))\n",
      "----------------------\n",
      "10021850 : Constitutively active MKK6/3 mutants up-regulated GLUT1 expression and down-regulated GLUT4 expression, thereby significantly increasing basal glucose transport but diminishing transport induced by insulin.\n",
      "act(p(MGI:Map2k3)) -> r(MGI:Slc2a1)\n",
      "act(p(MGI:Map2k3)) -| r(MGI:Slc2a4)\n",
      "act(p(MGI:Map2k6)) -> r(MGI:Slc2a1)\n",
      "act(p(MGI:Map2k6)) -| r(MGI:Slc2a4)\n",
      "----------------------\n",
      "10021852 : MKK3(Glu) increased ATF2- and Elk-1-dependent reporter gene expression but caused only a small increase in Jun-dependent gene expression (Fig. 4).\n",
      "act(p(MGI:Map2k3)) -> act(p(MGI:Atf2))\n",
      "act(p(MGI:Map2k3)) -> act(p(MGI:Elk1))\n",
      "----------------------\n",
      "10021858 : In contrast, the effect of MKK6(Glu) was markedly reduced in experiments using phosphorylation-defective (Ala-69, Ala-71) ATF2.\n",
      "act(p(MGI:Map2k6)) -> p(MGI:Atf2,pmod(P))\n",
      "act(p(MGI:Map2k6)) -> p(MGI:Atf2,pmod(P))\n",
      "p(MGI:Atf2,pmod(P)) -> act(p(MGI:Atf2))\n",
      "p(MGI:Atf2,pmod(P)) -> act(p(MGI:Atf2))\n",
      "----------------------\n",
      "10021866 : This kinase (Map3k11) preferentially activates MAPK8/JNK kinase, and functions as a positive regulator of JNK signaling pathway.\n",
      "act(p(MGI:Map3k11)) -> act(p(MGI:Mapk8))\n",
      "act(p(MGI:Map3k11)) -> act(p(MGI:Mapk9))\n",
      "----------------------\n",
      "10006234 : In T cells, overexpression of SPRK/MLK3, an activator of JNK/SAPK, strongly induces DSE-dependent transcription and dominant negative kinases of SEK and SAPK impair TPA/ionomycin-induced DSE activity.\n",
      "act(p(MGI:Map3k11)) -> act(p(MGI:Gabpa))\n",
      "act(p(MGI:Map3k11)) -> act(p(MGI:Gabpb1))\n",
      "p(MGI:Map3k11) -> act(p(MGI:Gabpa))\n",
      "p(MGI:Map3k11) -> act(p(MGI:Gabpb1))\n",
      "----------------------\n",
      "10021890 : Among the three MAPK inhibitors, SB203580 (the p38 MAPK inhibitor) had the strongest effects on Lox-1 and Nox1 expression (Fig. 7BâD). Furthermore, the production of ROS induced by CpG ODN was attenuated by the inhibition of p38 MAPK activity (data not shown).\n",
      "act(p(MGI:Mapk14)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Mapk14)) -> r(MGI:Nox1)\n",
      "----------------------\n",
      "10021894 : The association between HBP1 and p38 MAPK was initially defined by a two-hybrid interaction. Like the p21 results, the apparent mechanism was that p38 MAPK-mediated phosphorylation of the HBP1 led to increased protein stability and a G1 arrest.\n",
      "act(p(MGI:Mapk14)) -| bp(GOBP:\"cell cycle\")\n",
      "act(p(MGI:Mapk14)) -| deg(p(MGI:Hbp1))\n",
      "----------------------\n",
      "10021904 : cross-talk and activation between the PI 3-kinase/Akt and p38 MAPK pathways that is essential for efficient myoblast differentiation. During myoblast differentiation, Akt kinase activity correlated with S473 but not T308 phosphorylation and occurred 24 h after p38 activation Akt2 promoter activity and protein levels were regulated by p38 activation, thus providing a mechanism for communication.\n",
      "act(p(MGI:Mapk14)) -> act(p(MGI:Akt2))\n",
      "act(p(MGI:Mapk14)) -> p(MGI:Akt2)\n",
      "act(p(MGI:Mapk14)) -> p(MGI:Akt2,pmod(P))\n",
      "----------------------\n",
      "10021918 : A specific p38 MAPK-docking site (aa 81 125) and a p38 MAPK phosphorylation site (serine 401) were identified in the HBP1 protein. No other MAPK appeared to specifically bind and phosphorylate HBP1. In defining the role of p38 MAPK regulation, the inhibition of p38 MAPK activity was shown to decrease HBP1 protein levels by triggering protein instability that is manifested by a decrease in protein half-life.\n",
      "act(p(MGI:Mapk14)) -> p(MGI:Hbp1)\n",
      "act(p(MGI:Mapk14)) -> p(MGI:Hbp1,pmod(P))\n",
      "p(MGI:Hbp1,pmod(P)) -| deg(p(MGI:Hbp1))\n",
      "----------------------\n",
      "10006264 : TNF-alpha represses the promoter activity of the 250-bp region, and the repression is mediated by p38 MAP kinase independent of NF-kappaB\n",
      "act(p(MGI:Mapk14)) -| r(MGI:Rxrb)\n",
      "act(p(MGI:Mapk14)) -| r(MGI:Slc39a7)\n",
      "p(MGI:Tnf) -> act(p(MGI:Mapk14))\n",
      "----------------------\n",
      "10006266 : SB203580, a specific p38 MAPK inhibitor, attenuated these effects, further confirming that both MMK6 and MMK3 act via p38 MAPK, whereas they had no effect on the increase in glucose transport induced by a constitutively active MAPK kinase 1 (MEK1) mutant or by myristoylated Akt.\n",
      "act(p(MGI:Mapk14)) -> r(MGI:Slc2a1)\n",
      "act(p(MGI:Mapk14)) -| r(MGI:Slc2a4)\n",
      "----------------------\n",
      "10021950 : By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.\n",
      "act(p(MGI:Mapk1)) -> act(p(MGI:Sgk1))\n",
      "act(p(MGI:Mapk3)) -> act(p(MGI:Sgk1))\n",
      "act(p(MGI:Trp53)) -> r(MGI:Mapk1)\n",
      "act(p(MGI:Trp53)) -> r(MGI:Mapk3)\n",
      "----------------------\n",
      "10021952 : p44MAPK/extracellular signal-regulated kinase 1 (ERK1) and p42 MAPK/ERK2 are activated by IL-3, colocalize with mitochondrial Bcl2, and can directly phosphorylate Bcl2 on Ser-70 in a stauro-resistant manner both in vitro and in vivo\n",
      "act(p(MGI:Mapk1)) -> p(MGI:Bcl2,pmod(P))\n",
      "act(p(MGI:Mapk3)) -> p(MGI:Bcl2,pmod(P))\n",
      "p(MGI:Il3) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Il3) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10006280 : The MAPK kinase inhibitors did not affect Nur77 and Nurr1 mRNA induction but blocked CRH or cAMP-stimulated Nur transcriptional activity.\n",
      "act(p(MGI:Mapk1)) -> act(p(MGI:Nr4a1))\n",
      "act(p(MGI:Mapk1)) -> act(p(MGI:Nr4a2))\n",
      "----------------------\n",
      "10021968 : p38 MAPK has been reported to activate PPAR-a through increased phosphorylation of PPAR-a and increased co-activation specifically by PGC-1 (refs 22, 23), thereby stimulating fatty-acid oxidation.\n",
      "act(p(MGI:Mapk1)) -> act(p(MGI:Ppargc1a))\n",
      "p(MGI:Ppara,pmod(P)) -> act(p(MGI:Ppara))\n",
      "act(p(MGI:Ppara)) -> bp(GOBP:\"fatty acid oxidation\")\n",
      "----------------------\n",
      "10021972 : In asbestos-associated transformation of rodent mesothelial cells, the use of dominant negative ERK1 or Fra-1 constructs reverses the phenotype of mesothelioma cells to that of normal mesothelial cells (12). Moreover, Fra-1 expression is increased in human mesotheliomas and in other tumor types.\n",
      "act(p(MGI:Mapk3)) -> path(MESHD:Mesothelioma)\n",
      "act(p(MGI:Fosl1)) -> path(MESHD:Mesothelioma)\n",
      "----------------------\n",
      "10000380 : Collectively, these results indicate that ERK-1 regulates hyperoxia-stimulated Nrf2 phosphorylation and the subsequent ARE-driven transcriptional response.\n",
      "act(p(MGI:Mapk3)) -> p(MGI:Nfe2l2,pmod(P))\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Mapk3))\n",
      "p(MGI:Nfe2l2,pmod(P)) -> act(p(MGI:Nfe2l2))\n",
      "----------------------\n",
      "10021974 : TNF-a strongly stimulated FRA-1 promoter activity in WT MEFs as compared with the erk1-/- MEFs (Fig. 9B).\n",
      "act(p(MGI:Mapk3)) -> r(MGI:Fosl1)\n",
      "p(MGI:Tnf) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10021978 : the recruitment of c-Jun was strongly enhanced following TNF-a treatment (Fig. 10B, lanes 3 and 4). In contrast, the binding of c-Jun to the fra-1 promoter was significantly diminished in MEFS lacking the erk1-/- signaling (cf lanes 7 and 8 with lanes 3 and 4).\n",
      "act(p(MGI:Mapk3)) -> act(p(MGI:Jun))\n",
      "p(MGI:Tnf) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10021982 : Figure 3b shows that activated SAPKs isolated from cells stimulate the formation of a ternary complex by Elk-1 (Fig. 3b, lanes 8 and 10).\n",
      "act(p(MGI:Mapk8)) -> complex(p(MGI:Srf),p(MGI:Elk1))\n",
      "act(p(MGI:Mapk9)) -> complex(p(MGI:Srf),p(MGI:Elk1))\n",
      "----------------------\n",
      "10021984 : JNK (c-Jun kinase), another stress-activated protein kinase, phosphorylates FoxO4 at Thr447 and Thr451 and triggers the relocalization of FoxO family members from the cytoplasm to the nucleus (Essers et al., 2004; Oh et al., 2005) (Figure 2).\n",
      "act(p(MGI:Mapk8)) -> p(MGI:Foxo4,pmod(P))\n",
      "act(p(MGI:Mapk8)) -> p(MGI:Foxo4,pmod(P))\n",
      "p(MGI:Foxo4,pmod(P)) -> tloc(p(MGI:Foxo4))\n",
      "p(MGI:Foxo4,pmod(P)) -> tloc(p(MGI:Foxo4))\n",
      "----------------------\n",
      "10021990 : PDGF or serum treatment both activate c-Jun N-terminal kinase (JNK), the mitogen-activated protein kinase responsible for phosphorylation and activation of c-Jun.\n",
      "act(p(MGI:Mapk8)) -> p(MGI:Jun,pmod(P))\n",
      "act(p(MGI:Mapk8)) -> act(p(MGI:Jun))\n",
      "p(MGI:Jun,pmod(P)) -> act(p(MGI:Jun))\n",
      "----------------------\n",
      "10022000 : As shown in Figure 6e, expression of MEKK1 fails to activate either ERK1 or ERK2, whereas both p46 SAPK and p54SAPK are activated at expression levels that result in reporter gene expression.\n",
      "act(p(MGI:Mapk8)) -> act(p(MGI:Elk1))\n",
      "act(p(MGI:Mapk9)) -> act(p(MGI:Elk1))\n",
      "p(MGI:Map3k1) -> act(p(MGI:Mapk8))\n",
      "p(MGI:Map3k1) -> act(p(MGI:Mapk9))\n",
      "----------------------\n",
      "10006300 : Using differential display polymerase chain reaction, we cloned a novel gene, designated mimp (Met-Induced Mitochondrial Protein), which is upregulated in NIH-3T3 cells cotransfected with both HGF/SF and Met (HMH cells).\n",
      "act(p(MGI:Met)) -> r(MGI:Mtch2)\n",
      "p(MGI:Hgf) -> r(MGI:Mtch2)\n",
      "----------------------\n",
      "10006302 : Studies using bone marrow-derived macrophages (BMDM) isolated from a spontaneous mouse model of Crohn's disease-like ileitis (SAMP1/YitFc strain) revealed significant inhibition by CGP57380 of the proinflammatory cytokines TNF, IL-6, and monocyte chemoattractant protein-1 at 4 and 24 h after LPS stimulation\n",
      "act(p(MGI:Mknk1)) -> p(MGI:Ccl2)\n",
      "act(p(MGI:Mknk1)) -> p(MGI:Il6)\n",
      "act(p(MGI:Mknk1)) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10022008 : Mnk1 was also activated at lower levels in Mapk14-null mice (Fig. 3b). This p38a-activated protein kinase phosphorylates and stabilizes Sprouty2 (ref. 26), which in turn can negatively regulate tyrosine kinase receptor signaling in lung cells27.\n",
      "act(p(MGI:Mknk1)) -> p(MGI:Spry2)\n",
      "p(MGI:Mapk14) -> act(p(MGI:Mknk1))\n",
      "----------------------\n",
      "10022012 : Adipocyte differentiation is impaired in fld/fld mice and inhibiting mTOR with rapamycin blocks fat cell differentiation in vivo\n",
      "act(p(MGI:Mtor)) -> bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Lpin1) -> bp(GOBP:\"fat cell differentiation\")\n",
      "----------------------\n",
      "10022014 : Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways.\n",
      "act(p(MGI:Mtor)) -> act(p(MGI:Rps6kb1))\n",
      "act(p(MGI:Mtor)) -> act(p(MGI:Rps6kb2))\n",
      "act(p(MGI:Pdpk1)) -> act(p(MGI:Rps6kb1))\n",
      "act(p(MGI:Pdpk1)) -> act(p(MGI:Rps6kb2))\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:RPS6KB1))\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:RPS6KB2))\n",
      "----------------------\n",
      "10022018 : MYC has been shown to transactivate the CD95L gene (Amanullah et al., 2002; Brunner et al., 2000; Kasibhatla et al., 2000), as well as to downregulate FLIP (Ricci et al., 2004).\n",
      "act(p(MGI:Myc)) -| r(MGI:Cflar)\n",
      "act(p(MGI:Myc)) -> r(MGI:Fasl)\n",
      "----------------------\n",
      "10022022 : The proteins galectin-1, sorcin and vimentin were found to be induced 9-, 9- and 25-fold, respectively, in the PKD proteome\n",
      "act(p(MGI:Nek9)) -| p(MGI:Lgals1)\n",
      "act(p(MGI:Nek9)) -| p(MGI:Sri)\n",
      "act(p(MGI:Nek9)) -| p(MGI:Vim)\n",
      "----------------------\n",
      "10006310 : a series of protein isoforms observed only in the ARPKD kidney was identified as the major urinary protein (MUP).\n",
      "act(p(MGI:Nek9)) -| p(MGI:Mup1)\n",
      "act(p(MGI:Nek9)) -| p(MGI:Mup2)\n",
      "----------------------\n",
      "10022028 : To examine the role of TrkA in NGF's effects, we used K252a, which inhibits the tyrosine kinase activity of this receptor. Pretreatment of the cells with K252a (50 ng/mL) inhibited the production of TNF-a by NGF\n",
      "act(p(MGI:Ntrk1)) -> p(MGI:Tnf)\n",
      "p(MGI:Ngf) -> act(p(MGI:Ntrk1))\n",
      "----------------------\n",
      "10022036 : the platelet-derived growth factor receptor-alpha (PDGFRalpha)-p70S6K signal transduction pathway in mesenchymal cells, which is required for functional angiogenesis induced by fibroblast growth factor-2\n",
      "act(p(MGI:Pdgfra)) -> act(p(MGI:Rps6kb1))\n",
      "p(MGI:Fgf2) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10022040 : Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].\n",
      "act(p(MGI:Pdgfrb)) -> act(p(MGI:Mapk1))\n",
      "act(p(MGI:Pdgfrb)) -> act(p(MGI:Mapk3))\n",
      "act(p(HGNC:PDGFRB)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:PDGFRB)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10022060 : P-Rex1, a guanine-nucleotide exchange factor (GEF) for Rac, is believed to link GPCRs and PI3Kgamma to Rac-dependent neutrophil responses.\n",
      "act(p(MGI:Pik3cg)) -> act(p(MGI:Rac2))\n",
      "act(p(HGNC:PIK3CG)) -> act(p(HGNC:RAC2))\n",
      "----------------------\n",
      "10022066 : Increased PRK2 expression induces catenin tyrosine phosphorylation and Fyn activation Tyrosine phosphorylation of beta and gamma catenin and p120ctn was also induced by PRK2 overexpression\n",
      "act(p(MGI:Pkn2)) -> act(p(MGI:Fyn))\n",
      "act(p(MGI:Pkn2)) -> p(MGI:Ctnnb1,pmod(P))\n",
      "act(p(MGI:Pkn2)) -> p(MGI:Ctnnd1,pmod(P))\n",
      "act(p(MGI:Pkn2)) -> p(MGI:Jup,pmod(P))\n",
      "----------------------\n",
      "10022070 : We further show that SAF-1 is phosphorylated in vitro by PKA-Calpha and that addition of cAMP markedly induces in vivo phosphorylation of SAF-1 and transcription of SAF-regulated reporter genes.\n",
      "act(p(MGI:Prkaca)) -> p(MGI:Maz,pmod(P))\n",
      "p(MGI:Maz,pmod(P)) -> act(p(MGI:Maz))\n",
      "----------------------\n",
      "10022072 : We demonstrated that suppression of both PKC {alpha} and {theta}, using the antisense oligonucleotides, arrests cells in the G1 phase of the cell cycle.\n",
      "act(p(MGI:Prkca)) -> bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "act(p(MGI:Prkcq)) -> bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "----------------------\n",
      "10022074 : Suppression of the PAF effects by calphostin C, a PKC inhibitor, suggests that PKC is an upstream activator of FAK\n",
      "act(p(MGI:Prkca)) -> act(p(MGI:Ptk2))\n",
      "act(p(MGI:Prkce)) -> act(p(MGI:Ptk2))\n",
      "----------------------\n",
      "10022076 : These results indicate that cell cycle arrest mediated by PKC {alpha} and {theta} antisense oligonucleotides is probably through eliciting p21WAF1/CIP1 expression/function.\n",
      "act(p(MGI:Prkca)) -| r(MGI:Cdkn1a)\n",
      "act(p(MGI:Prkcq)) -| r(MGI:Cdkn1a)\n",
      "----------------------\n",
      "10022082 : In murine colon cancer models, elevated expression of PKCBII elevates cyclooxygenase-2 expression and represses TBRII expression to increase susceptibility to colon cancer.130\n",
      "act(p(MGI:Prkcb)) -> r(MGI:Ptgs2)\n",
      "act(p(MGI:Prkcb)) -| r(MGI:Tgfbr2)\n",
      "----------------------\n",
      "10022084 : Consistent with the ability of PKCbI to activate the JNK pathway, production of TNF-a and IL-2 in FcÂ«RI-stimulated mast cells was sensitive not only to a general PKC inhibitor, RO31-8425, and a cPKC-selective inhibitor, Go 6976, but also to a PKCb-selective inhibitor, LY379196 (Fig. 4A).\n",
      "act(p(MGI:Prkcb)) -> tloc(p(MGI:Il2))\n",
      "act(p(MGI:Prkcb)) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10006338 : Instead, a novel protein kinase C, PKCdelta, was activated by AsIII to induce VEGF and stabilize HIF-1alpha.\n",
      "act(p(MGI:Prkcd)) -> p(MGI:Hif1a)\n",
      "act(p(MGI:Prkcd)) -> p(MGI:Vegfa)\n",
      "----------------------\n",
      "10006344 : Elevated expression and activation of PKCzeta increased cell survival, whereas expression of PAR-4 promoted apoptosis.\n",
      "act(p(MGI:Prkcz)) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Pawr) -| act(p(MGI:Prkcz))\n",
      "----------------------\n",
      "10022102 : Although both cGK-Ialpha and -Ibeta, but not cAMP-dependent protein kinase, phosphorylated GKAP42 in vitro, GKAP42 was a good substrate only for cGK-Ialpha in intact cells\n",
      "act(p(MGI:Prkg1)) -> complex(p(MGI:Gkap1),p(MGI:Prkg1))\n",
      "act(p(MGI:Prkg1)) -> p(MGI:Gkap1,pmod(P))\n",
      "p(MGI:Gkap1,pmod(P)) -> complex(p(MGI:Gkap1),p(MGI:Prkg1))\n",
      "----------------------\n",
      "10022108 : These results appear to be relevant in vivo because Prx1 and TN-C expression levels were reduced in FAK-null embryos.\n",
      "act(p(MGI:Ptk2)) -> r(MGI:Tnc)\n",
      "r(MGI:Prrx1) -> p(MGI:Prrx1)\n",
      "----------------------\n",
      "10020998 : We show that JNK- but not p38-activating pathways regulate the DSE activity. Furthermore, the JNK/SAPK signaling pathway cooperates with the Raf-MEK-ERK cascade in TPA/ionomycin-induced DSE activity.\n",
      "act(p(MGI:Raf1)) -> act(p(MGI:Mapk8))\n",
      "act(p(MGI:Raf1)) -> act(p(MGI:Mapk9))\n",
      "----------------------\n",
      "10022124 : Overexpression of both MEN2A-RET and STAT3 strongly enhanced reporter activation, indicating that MEN2A-RET induces cyclin-D1 gene expression via STAT3 (Figure 4a).\n",
      "act(p(MGI:Ret)) -> act(p(MGI:Stat3))\n",
      "act(p(MGI:Stat3)) -> r(MGI:Ccnd1)\n",
      "----------------------\n",
      "10022126 : These data indicate that MEN2A-RET enhances proliferation via STAT3, and that a full length STAT3 is required to mediate the MEN2A-RET induced proliferation.\n",
      "act(p(MGI:Ret)) -> act(p(MGI:Stat3))\n",
      "act(p(MGI:Stat3)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:STAT3)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10022130 : Moreover, it has been reported that H2O2-induced necrosis is also reduced in RIP1-deficient mouse embryonic fibroblasts (MEF).21\n",
      "act(p(MGI:Ripk1)) -> bp(GOBP:\"necrotic cell death\")\n",
      "act(p(HGNC:RIPK1)) -> bp(GOBP:\"necrotic cell death\")\n",
      "----------------------\n",
      "10022134 : Moreover, overexpression of catalytically active RIP3 can trigger necroptosis irrespective of the presence of RIP1 (Ref. 12)\n",
      "act(p(MGI:Ripk3)) -> bp(GOBP:\"necrotic cell death\")\n",
      "act(p(HGNC:RIPK3)) -> bp(GOBP:\"necrotic cell death\")\n",
      "----------------------\n",
      "10022138 : Zhang et al. identify seven metabolic enzymes in the RIP3 complex immunoprecipitated from N-type NIH 3T3 cells that are treated with TNF/zVAD. Of these enzymes, RIP3 directly interacts with glycogen phosphorylase (PYGL), glutamate ammonia ligase (GLUL), and glutamate dehydrogenase 1 (GLUD1). RIP kinase activity is required to enhance the activities of all three enzymes both in vivo and in vitro.\n",
      "act(p(MGI:Ripk3)) -> act(p(MGI:Glud1))\n",
      "act(p(MGI:Ripk3)) -> act(p(MGI:Glul))\n",
      "act(p(MGI:Ripk3)) -> act(p(MGI:Pygl))\n",
      "----------------------\n",
      "10022140 : Wild-type, but not kinase-dead, RIP3 enhances the activity of PYGL, GLUL, and GLUD1 in vitro and in cells (55), which suggests that these metabolic enzymes could be direct substrates of RIP3.\n",
      "act(p(MGI:Ripk3)) -> act(p(MGI:Glul))\n",
      "act(p(MGI:Ripk3)) -> act(p(MGI:Pygl))\n",
      "act(p(HGNC:RIPK3)) -> act(p(HGNC:GLUL))\n",
      "act(p(HGNC:RIPK3)) -> act(p(HGNC:PYGL))\n",
      "----------------------\n",
      "10022148 : In contrast, inhibition of ROCK activity using the small-molecule inhibitor Y-27632 (ref. 19) resulted in a marked reduction in formation of membrane blebs (Fig. 1a)\n",
      "act(p(MGI:Rock1)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:ROCK1)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10006372 : Cyclin D1 promotes cellular motility through inhibiting ROCK signaling and repressing the metastasis suppressor TSP-1\n",
      "act(p(MGI:Rock2)) -| bp(GOBP:\"cell migration\")\n",
      "p(MGI:Ccnd1) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Thbs1) -| bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10022162 : S6K1-deficient mice develop hyperglycemia in response to glucose challenge because of impaired insulin secretion and decreased insulin content in the beta-cells\n",
      "act(p(MGI:Rps6kb1)) -> p(HGNC:INS)\n",
      "act(p(MGI:Rps6kb1)) -> bp(GOBP:\"insulin secretion\")\n",
      "----------------------\n",
      "10022166 : Harrington et al. (2004) showed in the same study that a downstream target of mTORC1, S6K1 was able to phosphorylate and inhibit IRS-1 in Ser302.\n",
      "act(p(MGI:Rps6kb1)) -| act(p(MGI:Irs1))\n",
      "act(p(MGI:Rps6kb1)) -> p(MGI:Irs1,pmod(P))\n",
      "p(MGI:Irs1,pmod(P)) -| act(p(MGI:Irs1))\n",
      "----------------------\n",
      "10022168 : bC also downregulated the expression of the pro-apoptotic gene Fan, and induced expression of the anti-apoptotic Sphk1a.\n",
      "act(p(MGI:Sphk1)) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Nsmaf) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10022170 : Mutant src(-/-) mice have osteopetrosis resulting from defective osteoclasts (increased apoptosis). Expression of a truncated Src mutant lacking the kinase domain induced osteopetrosis in wildtype and Src +/- mice and worsened osteopetrosis in Src -/- mice by increased osteoclast apoptosis.\n",
      "act(p(MGI:Src)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Src)) -| path(MESHD:Osteopetrosis)\n",
      "----------------------\n",
      "10022174 : site-directed mutagenesis directly show that tyrosine 14 is the principal substrate for Src kinase. Only alpha-caveolin underwent tyrosine phosphorylation in v-Src transformed NIH 3T3 cells, although beta-caveolin is well expressed in these cells.\n",
      "act(p(MGI:Src)) -> p(MGI:Cav1,pmod(P))\n",
      "p(MGI:Cav1,pmod(P)) -> act(p(MGI:Cav1))\n",
      "----------------------\n",
      "10022176 : Src-family kinases then phosphorylate the plaque proteins b-catenin, plakoglobin, p120cnt, and acatenin, which is required for their association with the E-cadherin tail (Calautti et al., 1998, 2005).\n",
      "act(p(MGI:Src)) -> p(MGI:Ctnna1,pmod(P))\n",
      "act(p(MGI:Src)) -> p(MGI:Ctnnb1,pmod(P))\n",
      "act(p(MGI:Src)) -> p(MGI:Ctnnd1,pmod(P))\n",
      "act(p(MGI:Src)) -> p(MGI:Jup,pmod(P))\n",
      "----------------------\n",
      "10022186 : b1-integrin phosphorylation by Src results in EGF-R activation (Miranti and Brugge, 2002), and b1-integrin expression is required for the initiation of mouse mammary tumors expressing the polyoma virus middle T antigen (White et al., 2004).\n",
      "act(p(MGI:Src)) -> p(MGI:Itgb1,pmod(P))\n",
      "p(MGI:Itgb1,pmod(P)) -> act(p(MGI:Egfr))\n",
      "----------------------\n",
      "10022188 : Using PDGFR mutants, we have shown that the phosphorylation is exerted via a PDGFR-src pathway. Furthermore, src kinase phosphorylates and coimmunoprecipitates with S6K in vivo.\n",
      "act(p(MGI:Src)) -> p(MGI:Rps6kb1,pmod(P))\n",
      "act(p(MGI:Src)) -> p(MGI:Rps6kb2,pmod(P))\n",
      "----------------------\n",
      "10022190 : In addition, we mapped the sites of tyrosine phosphorylation in S6K1 and S6K2 to Y39 and Y45, respectively.\n",
      "act(p(MGI:Src)) -> p(MGI:Rps6kb1,pmod(P))\n",
      "act(p(MGI:Src)) -> p(MGI:Rps6kb2,pmod(P))\n",
      "----------------------\n",
      "10022194 : 9 cDNAs whose abundance in NIH3T3 fibroblasts is decreased 3-15-fold following transformation by the activated oncogene, v-src. The remaining 6 cDNAs are indentical or highly similar to rat helix-destabilizing protein gene (hnRNP A1), mouse CTLA-2 alpha cysteine protease, rat cytochrome c oxidase (COX) VIc subunit, mouse Type I collagen, human gravin\n",
      "act(p(MGI:Src)) -| r(EGID:665646)\n",
      "act(p(MGI:Src)) -| r(MGI:Akap12)\n",
      "act(p(MGI:Src)) -| r(MGI:Cox6c)\n",
      "----------------------\n",
      "10022198 : In addition, KLF2(-/-) MEFs exhibit a significant growth defect, indicating that KLF2 is required to maintain the viability of MEF cells. The PDGF signal is mediated through the Src signaling pathway, and a downstream target of KLF2 is sphingosine 1-phosphate receptor 1.\n",
      "act(p(MGI:Src)) -> act(p(MGI:Klf2))\n",
      "act(p(MGI:Klf2)) -> r(MGI:S1pr1)\n",
      "----------------------\n",
      "10022204 : MLKB1KO mice had increased insulin-stimulated Akt phosphorylation and a 80% decrease in muscle expression of TRB3, a recently identified Akt inhibitor\n",
      "act(p(MGI:Stk11)) -| act(p(MGI:Akt1))\n",
      "act(p(MGI:Stk11)) -> r(MGI:Trib3)\n",
      "p(MGI:Trib3) -| act(p(MGI:Akt1))\n",
      "----------------------\n",
      "10022206 : LKB1-deficient tumors are shown here to exhibit elevated levels of S6K1 activity and phospho-4EBP1, indicative of hyperactivation of mTOR signaling\n",
      "act(p(MGI:Stk11)) -| act(p(MGI:Mtor))\n",
      "act(p(MGI:Stk11)) -| act(p(MGI:Rps6kb1))\n",
      "act(p(MGI:Stk11)) -| p(MGI:Eif4ebp1)\n",
      "----------------------\n",
      "10022208 : We show that LKB1 directly phosphorylates Thr-172 of AMPKalpha in vitro and activates its kinase activity.\n",
      "act(p(MGI:Stk11)) -> act(p(MGI:Prkaa1))\n",
      "act(p(MGI:Stk11)) -> p(MGI:Prkaa1,pmod(P))\n",
      "act(p(MGI:Stk11)) -> p(MGI:Prkaa2,pmod(P))\n",
      "p(MGI:Prkaa2,pmod(P)) -> act(p(MGI:Prkaa2))\n",
      "----------------------\n",
      "10022232 : As expected from Btk regulation by Syk, two Syk-selective inhibitors, piceatannol and ER-27319, suppressed Fc epsilon RI-induced transcriptional activation of the TNF-a gene promoter and cytokine secretion (Fig. 4C).\n",
      "act(p(MGI:Syk)) -> r(MGI:Tnf)\n",
      "act(p(MGI:Syk)) -> tloc(p(MGI:Il2))\n",
      "----------------------\n",
      "10022236 : Furthermore, exposure of aortic rings from p47(phox-/-) mice to Ang-1 demonstrated fewer vessel sprouts than WT mice. Inhibition of the Tie-2 receptor inhibited Ang-1-induced endothelial migration and vessel sprouting\n",
      "act(p(MGI:Tek)) -> bp(GOBP:\"cell migration\")\n",
      "act(p(MGI:Tek)) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "p(MGI:Angpt1) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "p(MGI:Ncf1) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "act(p(HGNC:TEK)) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10022238 : In agreement with this possibility, we observed that TGFbeta1 inhibited cell adhesion, and transfection of TbetaRI further enhanced this inhibition (Figure 8C, D).\n",
      "act(p(MGI:Tgfbr1)) -| bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Tgfb1) -| bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10019528 : We found that TGFbeta1 enhanced Mv1Lu cell migration, which was strongly increased upon expression of TÃ¢RI (Figure 8A, B). Coexpression of Epac1 with TbetaRI significantly decreased cell migration, as compared to cells transfected with TbetaRI only.\n",
      "act(p(MGI:Tgfbr1)) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Tgfb1) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10006402 : TGF-beta inhibited myogenic differentiation by 98% and stimulated mac25/IGFBP-7 mRNA expression 2-fold.\n",
      "act(p(MGI:Tgfbr1)) -| bp(GOBP:\"myoblast differentiation\")\n",
      "act(p(MGI:Tgfbr1)) -> r(MGI:Igfbp7)\n",
      "p(MGI:Igfbp7) -| bp(GOBP:\"myoblast differentiation\")\n",
      "----------------------\n",
      "10006406 : we demonstrate that TGFbeta acts on HIF-1alpha accumulation and activity by increasing HIF-1alpha protein stability\n",
      "act(p(MGI:Tgfbr1)) -> p(MGI:Hif1a)\n",
      "act(p(MGI:Tgfbr2)) -> p(MGI:Hif1a)\n",
      "p(MGI:Tgfb1) -> p(MGI:Hif1a)\n",
      "----------------------\n",
      "10022398 : In hyperoxic lungs, there was a significant increase in the amount of cleaved caspase-3 (17 kD) and cleaved PARP-1 (85 kD) in WT mice, whereas in NOX1-deficient mice only small increases were observed (Figures 6A26C).\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Casp3))\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Parp1))\n",
      "----------------------\n",
      "10022402 : hyperoxia stimulated ERK-1 and ERK-2 phosphorylation {SE: Canonical ERK phosphorylation leading directly to activation}\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Mapk1))\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Mapk3))\n",
      "path(MESHD:Hyperoxia) -> act(p(HGNC:MAPK1))\n",
      "path(MESHD:Hyperoxia) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10022408 : Hyperoxia was associated with increased lung IKK-alpha and IKK-beta but not increased IKK-gamma, whereas adults showed no increase in IKK-alpha, loss of IKK-gamma, and a modest increase in IKK-beta (Figure 4).\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Chuk)\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Ikbkb)\n",
      "path(MESHD:Hyperoxia) -| p(MGI:Ikbkg)\n",
      "----------------------\n",
      "10022412 : Interestingly, basal and hyperoxia-inducible HO-1 levels were dramatically higher in cav-1-/- mice than in corresponding wild-type mice (Figure 4A).\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Hmox1)\n",
      "p(MGI:Cav1) -| p(MGI:Hmox1)\n",
      "----------------------\n",
      "10022414 : eonatal lung showed an increase in pI-kappaBalpha protein levels after only 30 minutes of hyperoxia and a decrease in total I-kappaBalpha by 4 hours of hyperoxic exposure (Figure 3). In contrast, adults had barely detectable pI-kappaBalpha and had increased total lung I-kappaBalpha protein levels at all time points after hyperoxic exposure (Figure 3).\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Nfkbia)\n",
      "path(MESHD:Hyperoxia) -| p(MGI:Nfkbia)\n",
      "path(MESHD:Hyperoxia) -> p(MGI:Nfkbia,pmod(P))\n",
      "----------------------\n",
      "10000388 : hyperoxia caused the translocation of Nrf2 from the cytoplasm to the nucleus within 30-60 min of exposure\n",
      "path(MESHD:Hyperoxia) -> tloc(p(MGI:Nfe2l2))\n",
      "path(MESHD:Hyperoxia) -> act(p(MGI:Nfe2l2))\n",
      "----------------------\n",
      "10022422 : As shown in Figure 4d, Ero1-La was also strongly induced by hypoglycemia under normoxic conditions. Furthermore, this response was abrogated in the absence of a functional HIF-1.\n",
      "path(MESHD:Hypoglycemia) -> act(p(MGI:Hif1a))\n",
      "act(p(MGI:Hif1a)) -> r(MGI:Ero1l)\n",
      "----------------------\n",
      "10022426 : Ischemia also activated the expression and binding of p53 to an adjacent enhancer site (RE-1) and increased expression and binding of nuclear factor of activated T-cells-c2 to consensus sequences within the first intron. Deletion of either the 5' AP-1/RE-1 region of the promoter or substitution of the first intron abolished ischemia-induced MMP-2 transcription in vivo.\n",
      "path(MESHD:Ischemia) -> p(MGI:Nfatc2)\n",
      "act(p(MGI:Nfatc2)) -> r(MGI:Mmp2)\n",
      "----------------------\n",
      "10022516 : IL-10 inhibits IFN-alpha-activated STAT1 in the liver, at least in part, by inducing SOCS2, SOCS3, and CIS expression\n",
      "p(MGI:Ifna1) -> act(p(MGI:Stat1))\n",
      "p(MGI:Il10) -| act(p(MGI:Stat1))\n",
      "----------------------\n",
      "10022524 : ELISA analysis of whole lung levels of IP-10/CXCL10 and MIG/CXCL9 in both groups of mice revealed that both non-ELR CXC chemokines were significantly elevated in CXCR2-/- mice compared with those in CXCR2+/+ mice (Fig. 8Go).\n",
      "p(EGID:12765) -> p(MGI:Cxcl10)\n",
      "p(EGID:12765) -> p(MGI:Cxcl9)\n",
      "----------------------\n",
      "10022538 : Assessments of bioactivity of the apoptotic markers active caspase 3 (Casp3) and Casp3/7 revealed that the apoptosis signals in the lungs of Raet1a Tg mice were increased (Figure 3, A and B).\n",
      "p(EGID:19368) -> act(p(MGI:Casp3))\n",
      "p(EGID:19368) -> act(p(MGI:Casp7))\n",
      "----------------------\n",
      "10022542 : <C17> Phosphorylation of Thr14 or Tyr15 in Cdk1 reduces kinase activity 10-fold; phosphorylation of both sites reduces activity 100-fold (Liu et al., 1997).\n",
      "p(EGID:5424,pmod(P)) -| act(p(HGNC:CDK1))\n",
      "p(EGID:5424,pmod(P)) -| act(p(HGNC:CDK1))\n",
      "----------------------\n",
      "10002158 : In combination with cell proliferative activities of c-myc and cyclin D1, MDR1 may initiate colorectal tumorigenesis by suppressing cell death pathways programmed in intestinal epithelial cells.\n",
      "p(HGNC:ABCB1) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:CCND1) -> bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:MYC) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10006544 : the cellular level of unesterified arachidonic acid is a general mechanism by which apoptosis is regulated and that COX-2 and FACL4 promote carcinogenesis by lowering this level.\n",
      "p(HGNC:ACSL4) -| a(CHEBI:\"arachidonic acid\")\n",
      "p(HGNC:PTGS2) -| a(CHEBI:\"arachidonic acid\")\n",
      "----------------------\n",
      "10022546 : both proteins. The ion channels and alpha-actinin-2 co-localize at the membrane in HEK cells, where disruption of the actin cytoskeleton and antisense constructs to alpha-actinin-2 modulate the ion and gating current density.\n",
      "p(HGNC:ACTN2) -> act(p(HGNC:KCNA5))\n",
      "p(HGNC:ACTN2) -| act(p(HGNC:KCNA5))\n",
      "----------------------\n",
      "10022566 : In contrast, costimulation with VEGF and Ang-2 induced sprouting angiogenesis originating from coculture spheroids consistent with a model of Ang-2-mediated vessel destabilization resulting in VEGF responsiveness. Ang-2 on its own was able to stimulate endothelial cells in the absence of Ang-1 producing SMC, inducing lateral sheet migration as well as in gel sprouting angiogenesis.\n",
      "p(HGNC:ANGPT2) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "p(HGNC:VEGFA) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10022590 : A beta not only activates but also respresses genes: (i) the gene encoding \\\"hinge\\\" protein, a subunit of the mitochondrial cytochrome-c reductase and\n",
      "p(HGNC:APP) -| r(HGNC:UQCRC2)\n",
      "p(HGNC:APP) -| r(HGNC:UQCRH)\n",
      "----------------------\n",
      "10022612 : Hef1, p130Cas, and Efs define a family of multidomain docking proteins which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion\n",
      "p(HGNC:BCAR1) -> bp(GOBP:\"cell adhesion\")\n",
      "p(HGNC:EFS) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10022614 : Crk has been reported to associate with tyrosine-phosphorylated proteins, such as p130Cas and paxillin (42, 43), involved in the rearrangement of cytoskeletal components, through its SH2 domain.\n",
      "p(HGNC:BCAR1,pmod(P)) -> complex(p(HGNC:BCAR1),p(HGNC:CRK))\n",
      "p(HGNC:PXN,pmod(P)) -> complex(p(HGNC:PXN),p(HGNC:CRK))\n",
      "----------------------\n",
      "10022616 : The over-expression of LAR in tissue culture cells specifically decreased the steady state protein level of p130Cas, a multifunctional signal assembly protein in signal transduction, by reducing the tyrosine phosphorylation and protein stability of p130Cas.\n",
      "p(HGNC:BCAR1,pmod(P)) -> p(HGNC:BCAR1)\n",
      "act(p(HGNC:PTPRF)) -| p(HGNC:BCAR1)\n",
      "act(p(HGNC:PTPRF)) -| p(HGNC:BCAR1,pmod(P))\n",
      "----------------------\n",
      "10022618 : The restoration of A1 in NF-kappaB null cells diminished TNF-induced apoptosis by inhibiting the release of cytochrome c and by blocking caspase 3 activation.\n",
      "p(HGNC:BCL2A1) -| act(p(HGNC:CASP3))\n",
      "p(HGNC:TNF) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10022620 : Transduction of proliferating CD4+ T cells with a tetracycline-regulated retrovirus encoding for a dominant-interfering, degradation-resistant I-kappaBalpha (inhibitor of kappa B alpha factor) mutant induced apoptosis. Bcl-xL features as a prominent anti-apoptotic member among a number of early CD28-inducible genes.\n",
      "p(HGNC:BCL2L1) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:CD28) -> r(HGNC:BCL2L1)\n",
      "----------------------\n",
      "10022630 : In this study, we show that Bin1 engages a caspase-independent cell death process similar to type II apoptosis,\n",
      "p(HGNC:BIN1) -> bp(GOBP:\"cell death\")\n",
      "p(HGNC:BIN1) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10006624 : We showed that BMP-2 caused cell-cycle arrest in the G1 phase and the subsequent apoptosis of myeloma cells.\n",
      "p(HGNC:BMP2) -| bp(GOBP:\"cell cycle\")\n",
      "p(HGNC:BMP2) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10022636 : BMP-2 up-regulated the expression of cyclin-dependent kinase inhibitors (p21(CIP1/WAF1) and p27(KIP1)) and caused hypophosphorylation of retinoblastoma (Rb) protein.\n",
      "p(HGNC:BMP2) -| p(HGNC:RB1,pmod(P))\n",
      "p(HGNC:BMP2) -> r(HGNC:CDKN1A)\n",
      "p(HGNC:BMP2) -> r(HGNC:CDKN1B)\n",
      "----------------------\n",
      "10022646 : However, TGF-beta remained the most potent of these cytokines, inducing TIEG mRNA steady-state levels at 0.1 ng/ml, with a maximum induction of 24-fold at 2.0 ng/ml. The BMP-2 (16-fold), BMP-4 (4-fold), and activin (1-3-fold) also induced TIEG mRNA levels\n",
      "p(HGNC:BMP2) -> r(HGNC:KLF10)\n",
      "p(HGNC:BMP4) -> r(HGNC:KLF10)\n",
      "----------------------\n",
      "10022666 : In this study, we show that the BRCA1 tumor suppressor acts in concert with STAT1 to differentially activate transcription of a subset of IFN-gamma target genes and mediates growth inhibition by this cytokine After IFN-gamma treatment, induction of the cyclin-dependent kinase inhibitor, p21WAF1, was synergistically activated by BRCA1\n",
      "p(HGNC:BRCA1) -> r(HGNC:CDKN1A)\n",
      "p(HGNC:IFNG) -> r(HGNC:CDKN1A)\n",
      "----------------------\n",
      "10022686 : In addition to deinhibition, CaMKI and CaMIV are activated 10-50-fold by trans phosphorylation on a single Thr residue in the activation loop. Once activated, CaMKIV acquires Ca2+/CaM independence, whereas CaMKI remains Ca2+/CaM-dependent (5).\n",
      "p(HGNC:CAMK1,pmod(P)) -> act(p(HGNC:CAMK1))\n",
      "p(HGNC:CAMK4,pmod(P)) -> act(p(HGNC:CAMK4))\n",
      "----------------------\n",
      "10006662 : CART induced gene expression of uncoupling protein 1 (UCP1), UCP2, and UCP3 in brown and white adipose tissue and biceps femoris muscle respectively.\n",
      "p(HGNC:CARTPT) -> r(HGNC:UCP1)\n",
      "p(HGNC:CARTPT) -> r(HGNC:UCP2)\n",
      "p(HGNC:CARTPT) -> r(HGNC:UCP3)\n",
      "----------------------\n",
      "10022704 : However, a mutant at site 371 completely lost the ability to enhance receptor ubiquitination and degradation in living cells ( Figure 6D).\n",
      "p(HGNC:CBL,pmod(P)) -> act(p(HGNC:CBL))\n",
      "p(HGNC:CBL,pmod(P)) -> deg(p(HGNC:EGFR))\n",
      "p(HGNC:CBL,pmod(P)) -> p(HGNC:EGFR,pmod(U,K))\n",
      "----------------------\n",
      "10022714 : MCP-1, a CC-chemokine, enhances tissue factor production by macrophages and increases ICAM-1 expression on endothelial cells.\n",
      "p(HGNC:CCL2) -> p(HGNC:ICAM1)\n",
      "p(HGNC:CCL2) -> r(HGNC:F3)\n",
      "----------------------\n",
      "10022718 : Furthermore, IL-8, MCP-1, and GRO-1 are known to promote expression of CD11b/CD18 (CR3) on the surface of neutrophils and monocytes ( 32 , 33 ).\n",
      "p(HGNC:CCL2) -> r(HGNC:ITGAM)\n",
      "p(HGNC:CXCL1) -> surf(p(HGNC:ITGAM))\n",
      "----------------------\n",
      "10006680 : The chemokine macrophage inflammatory protein-1 alpha (MIP-1alpha) stimulates migration of B cells\n",
      "p(HGNC:CCL3) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:CCL3) -> bp(GOBP:chemotaxis)\n",
      "----------------------\n",
      "10001426 : MIP-1alpha treatment stimulated the degradation of IkappaBalpha, a cytoplasmic inhibitor of NF-kappaB\n",
      "p(HGNC:CCL3) -> deg(p(HGNC:NFKBIA))\n",
      "p(HGNC:NFKBIA) -| act(p(HGNC:NFKB1))\n",
      "----------------------\n",
      "10022720 : <C21> p27Kip1 can be phosphorylated by Cyclin E- or Cyclin A-dependent kinases and thereby may be targeted for degradation (Sheaff et al., 1997).\n",
      "p(HGNC:CCNA2) -> p(HGNC:CDKN1B,pmod(P))\n",
      "p(HGNC:CCNE1) -> p(HGNC:CDKN1B,pmod(P))\n",
      "p(HGNC:CDKN1B,pmod(P)) -> deg(p(HGNC:CDKN1B))\n",
      "----------------------\n",
      "10022732 : GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity.\n",
      "p(HGNC:CCNDBP1) -| p(HGNC:RB1,pmod(P))\n",
      "p(HGNC:CCNDBP1) -| act(p(HGNC:E2F1))\n",
      "p(HGNC:CCNDBP1) -| act(p(HGNC:RB1))\n",
      "p(HGNC:RB1,pmod(P)) -| act(p(HGNC:RB1))\n",
      "----------------------\n",
      "10002162 : total p27KiP1 levels and cyclin E-associated p27Kip1 increased as cells arrested and the amount of the CAK activated cdk2 bound to cyclin E decreased\n",
      "p(HGNC:CCNE1) -> act(p(HGNC:CDK2))\n",
      "p(HGNC:CDKN1B) -| act(p(HGNC:CDK2))\n",
      "----------------------\n",
      "10022742 : Following co-stimulation through accessory receptors (e.g. CD2 or CD28) - however, not following TCR/CD3 stimulation alone - cofilin undergoes dephosphorylation the dephosphorylated form of cofilin associates with the actin cytoskeleton and possesses the capability to translocate into the nucleus.\n",
      "p(HGNC:CD28) -| p(HGNC:CFL1)\n",
      "p(HGNC:CD28) -| p(HGNC:CFL1,pmod(P))\n",
      "p(HGNC:CD2) -| p(HGNC:CFL1)\n",
      "p(HGNC:CD2) -| p(HGNC:CFL1,pmod(P))\n",
      "----------------------\n",
      "10022748 : Furthermore, the anti-CD38 agonist antibody expectedly inhibited bone resorption in the pit assay and elevated interleukin-6 (IL-6) secretion. IL-6, in turn, enhanced CD38 mRNA expression\n",
      "p(HGNC:CD38) -> tloc(p(HGNC:IL6))\n",
      "p(HGNC:IL6) -> r(HGNC:CD38)\n",
      "----------------------\n",
      "10022752 : The results reported in Figure 1 demonstrated that although they were activated, as shown by the expression of the IL-2R a-chain and CD40L (data not shown), peripheral T lymphocytes did not express IL-3.\n",
      "p(HGNC:CD40LG) -> bp(GOBP:\"T cell activation\")\n",
      "p(HGNC:IL2RA) -> bp(GOBP:\"T cell activation\")\n",
      "----------------------\n",
      "10022772 : Recently, knockout studies in mice demonstrated that a deficiency or truncation of VE-cadherin induces endothelial apoptosis and inhibits transmission of the endothelial survival signal by VEGF, leading to lethality at 9.5 days of gestation (36).\n",
      "p(HGNC:CDH5) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:VEGFA) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10006714 : Several genes including the cyclin-dependent kinase inhibitor p21(waf1/cip1) and the homeobox gene transcription factor HOXA10 are induced at the onset of differentiation. Ectopic expression of either gene results in U937 differentiation.\n",
      "p(HGNC:CDKN1A) -> bp(GOBP:\"cell differentiation\")\n",
      "p(HGNC:HOXA10) -> bp(GOBP:\"cell differentiation\")\n",
      "----------------------\n",
      "10000206 : Thus, our results indicate that p21(WAF1/CIP1) mediates TPA-induced growth arrest and differentiation of TSU-Pr1 cells.\n",
      "p(HGNC:CDKN1A) -> bp(GOBP:\"cell differentiation\")\n",
      "p(HGNC:CDKN1A) -| bp(GOBP:\"cell growth\")\n",
      "----------------------\n",
      "10019944 : Titration of unbound p27Kip1 and p21Cip1 molecules into higher order complexes with assembling cyclin D-dependent kinases relieves cyclin E-CDK2 from Cip/Kip constraint, thereby facilitating cyclin E-CDK2 activation later in G1 phase.\n",
      "p(HGNC:CDKN1A) -| act(p(HGNC:CDK2))\n",
      "p(HGNC:CDKN1B) -| act(p(HGNC:CDK2))\n",
      "----------------------\n",
      "10022788 : Assembly and activity of the proto-oncogenic cyclin D/CDK4(6) complexes, the major driving force of G1 phase progression, is negatively regulated by a family of INK4 CDK inhibitors p16INK4a, p15INK4b, p18INK4c, and p19INK4d.\n",
      "p(HGNC:CDKN2B) -| act(p(HGNC:CDK4))\n",
      "p(HGNC:CDKN2C) -| act(p(HGNC:CDK4))\n",
      "p(HGNC:CDKN2D) -| act(p(HGNC:CDK4))\n",
      "----------------------\n",
      "10022816 : Activation of the GFAP gene promoter by IL-11 and related cytokines Previous studies have shown that stimulation of gp130 molecules on neuroepithelial cells by LIF, CNTF, or the IL-6/sIL-6R complex induces activation of the GFAP gene promoter (Bonni et al., 1997 ; Nakashima et al., 1999 b ).\n",
      "p(HGNC:CNTF) -> r(HGNC:GFAP)\n",
      "p(HGNC:IL6) -> r(HGNC:GFAP)\n",
      "p(HGNC:LIF) -> r(HGNC:GFAP)\n",
      "----------------------\n",
      "10006760 : TTF-1 protein synergistically stimulated the hSP-B promoter with RARalpha, CBP, and nuclear receptor coactivators in H441 cells.\n",
      "p(HGNC:CREBBP) -> r(HGNC:SFTPB)\n",
      "p(HGNC:\"NKX2-1\") -> r(HGNC:SFTPB)\n",
      "p(HGNC:RARA) -> r(HGNC:SFTPB)\n",
      "----------------------\n",
      "10022824 : Although phosphorylation at Thr-1179 and Ser-1185 did not directly regulate physical interaction between SRC-1 and CBP, it was required for functional cooperation.\n",
      "p(HGNC:CREBBP) -> act(p(HGNC:NCOA1))\n",
      "p(HGNC:NCOA1) -> act(p(HGNC:CREBBP))\n",
      "----------------------\n",
      "10022832 : The Src tyrosine kinases c-Src, c-Yes, c-Fyn, and c-Hck were tyrosine phosphorylated in the M1/WT cells in response to CSF-1 and bound to the WT CSF-1R through their SH2 domains.\n",
      "p(HGNC:CSF1) -> p(HGNC:FYN,pmod(P))\n",
      "p(HGNC:CSF1) -> p(HGNC:HCK,pmod(P))\n",
      "p(HGNC:CSF1) -> p(HGNC:SRC,pmod(P))\n",
      "p(HGNC:CSF1) -> p(HGNC:YES1,pmod(P))\n",
      "----------------------\n",
      "10022836 : We show that CSF-1 stimulation of BAC1.2F5 macrophages results in the upregulation of expression of ets2 and bcl-xL with similar kinetics of induction.\n",
      "p(HGNC:CSF1) -> r(HGNC:BCL2L1)\n",
      "p(HGNC:CSF1) -> r(HGNC:ETS2)\n",
      "p(MGI:Csf1) -> r(MGI:Bcl2)\n",
      "p(MGI:Csf1) -> r(MGI:Ets2)\n",
      "----------------------\n",
      "10006762 : We found that macrophage colony-stimulating factor caused the greatest up-regulation of both CCR5 and CXCR4 on macrophage maturation\n",
      "p(HGNC:CSF1) -> r(HGNC:CCR5)\n",
      "p(HGNC:CSF1) -> r(HGNC:CXCR4)\n",
      "----------------------\n",
      "10022850 : whereas granulocyte-macrophage colony-stimulating factor caused a marked decrease of CXCR4 (from approximately 5,000 ABS to <500) while up-regulating CCR5 expression\n",
      "p(HGNC:CSF2) -> r(HGNC:CCR5)\n",
      "p(HGNC:CSF2) -| r(HGNC:CXCR4)\n",
      "----------------------\n",
      "10022858 : ResnetDB sentence: Gadd45gamma expression is induced by several cytokines, including IL-3, IL-6, and GM-CSF (20).\n",
      "p(HGNC:CSF2) -> r(HGNC:GADD45G)\n",
      "p(HGNC:IL3) -> r(HGNC:GADD45G)\n",
      "p(HGNC:IL6) -> r(HGNC:GADD45G)\n",
      "----------------------\n",
      "10006782 : At day 3 to day 5 following the onset of G-CSF administration, a strong decrease of CD44 and CD31 expression was observed on mobilized CD34(+) cells compared to controls: the relative fluorescence intensity of CD44 and CD31 was, respectively, 50%-70% and 40%-90% lower than that of controls.\n",
      "p(HGNC:CSF3) -| r(HGNC:CD44)\n",
      "p(HGNC:CSF3) -| r(HGNC:PECAM1)\n",
      "----------------------\n",
      "10006798 : SDF-1alpha treatment induced expression of the chemokines monocyte chemoattractant protein-1, IL-8, and IFN-gamma-inducible protein-10.\n",
      "p(HGNC:CXCL12) -> p(HGNC:CCL2)\n",
      "p(HGNC:CXCL12) -> p(HGNC:CXCL10)\n",
      "p(HGNC:CXCL12) -> p(HGNC:IL8)\n",
      "----------------------\n",
      "10022908 : <C11b> DMTF1 activates transcription from the p19ARF promoter and induces cell cycle arrest and p21Cip1 accumulation in a p19ARF- and p53-dependent manner (Inoue et al., 1999). Another DMTF1-regulated gene is CD13/aminopeptidase N, which is activated cooperatively by DMTF1 and c-Myb; its activation by DMTF1 is inhibited by cyclin D independent of Cdk4/6.\n",
      "p(HGNC:DMTF1) -| bp(GOBP:\"cell cycle\")\n",
      "act(p(HGNC:DMTF1)) -> r(HGNC:ANPEP)\n",
      "----------------------\n",
      "10022928 : Expression of either E2F1 or E2F2 was sufficient to induce the transcription of cyclins (A2, B1, and E), as well as p53 and Bax in the lens fibercells.\n",
      "p(HGNC:E2F2) -> r(HGNC:BAX)\n",
      "p(HGNC:E2F2) -> r(HGNC:TP53)\n",
      "----------------------\n",
      "10022368 : (ii) EDF-1 is phosphorylated in vitro and in vivo by protein kinase C;...In addition, 12-O-tetradecanoylphorbol-13-acetate treatment of human umbilical vein endothelial cell stimulates the nuclear translocation of EDF-1. and (iii) EDF-1-CaM interaction is modulated by the concentrations of Ca(2+) and by the phosphorylation of EDF-1 by protein kinase C both in vitro and in vivo.\n",
      "p(HGNC:EDF1,pmod(P)) -| complex(p(HGNC:CALM1),p(HGNC:EDF1))\n",
      "p(HGNC:EDF1,pmod(P)) -> act(p(HGNC:EDF1))\n",
      "----------------------\n",
      "10019988 : Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt.\n",
      "p(HGNC:EGF) -> complex(p(HGNC:EGFR),p(HGNC:ERBB2))\n",
      "p(HGNC:NRG1) -> complex(p(HGNC:ERBB3),p(HGNC:ERBB2))\n",
      "----------------------\n",
      "10022954 : In contrast, LAR selectively inhibited the epidermal growth factor (EGF)-induced phosphorylation of p130CAS and the formation of the complex between p130CAS and GRB2 but this effect did not influence the activation of MAPK by EGF.\n",
      "p(HGNC:EGF) -> p(HGNC:BCAR1,pmod(P))\n",
      "act(p(HGNC:PTPRF)) -| complex(p(HGNC:BCAR1),p(HGNC:GRB2))\n",
      "----------------------\n",
      "10006858 : Also at the mRNA level, TGF-beta1 counteracted at one point or another the decrease in C/EBPalpha, C/EBPbeta, HNF1beta, and HNF4 expression\n",
      "p(HGNC:EGF) -| r(HGNC:HNF1B)\n",
      "p(HGNC:HGF) -| r(HGNC:HNF1B)\n",
      "----------------------\n",
      "10022968 : By contrast, epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha), respectively, strongly decreased IL-18 mRNA expression in HaCaT keratinocytes in the absence of IL-18 protein release from the cells.\n",
      "p(HGNC:EGF) -| r(HGNC:IL18)\n",
      "p(HGNC:TGFA) -| r(HGNC:IL18)\n",
      "----------------------\n",
      "10022978 : These findings identify (p)Y992 as an important binding site on the EGFR, while (p)Y1068 and (p)Y1173 also contribute to its interaction with PI3K-C2beta . Sequence alignment of these three sites revealed the putative consensus binding site for PI3K-C2beta to be E(p)YL/I.\n",
      "p(HGNC:EGFR,pmod(P)) -> complex(p(HGNC:EGFR),p(HGNC:PIK3C2B))\n",
      "p(HGNC:EGFR,pmod(P)) -> complex(p(HGNC:PIK3CB),p(HGNC:EGFR))\n",
      "p(HGNC:EGFR,pmod(P)) -> complex(p(HGNC:EGFR),p(HGNC:PIK3C2B))\n",
      "----------------------\n",
      "10022992 : Guanylate cyclase b1 subunit (3.3) Proteases/protease inhibitors ----------------------------------------- Cystatin M/CST6 (216)\n",
      "p(HGNC:EGR1) -> r(HGNC:CST6)\n",
      "act(p(HGNC:EGR1)) -> r(HGNC:CST6)\n",
      "----------------------\n",
      "10022996 : Membrane-associated proteins ----------------------------------------- Epithelial membrane protein 2/XMP (16.9)\n",
      "p(HGNC:EGR1) -> r(HGNC:EMP2)\n",
      "act(p(HGNC:EGR1)) -> r(HGNC:EMP2)\n",
      "----------------------\n",
      "10006870 : Furthermore, an inhibitor of the hypusine modification, GC7 (N(1)-guanyl-1, 7-diaminoheptane), prevents CD83 surface expression by apparently interfering with nucleocytoplasmic translocation of the CD83 mRNA and, importantly, significantly inhibits DC-mediated T lymphocyte activation.\n",
      "p(HGNC:EIF5A) -> bp(GOBP:\"T cell activation\")\n",
      "p(HGNC:EIF5A) -> surf(p(HGNC:CD83))\n",
      "----------------------\n",
      "10023010 : NE (22 h) increased MUC5AC protein and glycoprotein levels in A549 cell lysates compared with control cell lysates (Fig. 8, lanes 1 and 2).\n",
      "p(HGNC:ELANE) -> p(HGNC:MUC5AC)\n",
      "p(HGNC:ELANE) -> p(HGNC:MUC5AC,pmod(G))\n",
      "----------------------\n",
      "10023018 : Our results indicate that HuR may play a critical role in cell proliferation, at least in part by mediating cell cycle-dependent stabilization of mRNAs encoding cyclins A and B1.\n",
      "p(HGNC:ELAVL1) -> r(HGNC:CCNA1)\n",
      "p(HGNC:ELAVL1) -> r(HGNC:CCNB1)\n",
      "----------------------\n",
      "10006880 : The gC1q domain of EMILIN-1 can form relatively stable and compact homotrimers and this association is then followed by a multimeric assembly of disulfide-bonded protomers. Recombinant EMILIN-1 purified from the supernatant of 293 cells represents a very efficient ligand for cell adhesion of several cell types.\n",
      "p(HGNC:EMILIN1) -> bp(GOBP:\"cell adhesion\")\n",
      "p(HGNC:EMILIN2) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10006884 : The process also involves the subsequent recruitment of p300/CBP and PCAF to a complex that synergistically regulates transcription and remodels the chromatin. PCAF and p300 have also been demonstrated to function as critical coactivators for the muscle-specific basic helix-loop-helix (bHLH) protein MyoD during myogenic commitment.\n",
      "p(HGNC:EP300) -> act(p(HGNC:MYOD1))\n",
      "p(HGNC:KAT2B) -> act(p(HGNC:MYOD1))\n",
      "----------------------\n",
      "10023034 : In the case of insulin, it is unclear whether SHIP associates with IRS proteins or the insulin receptor, although a recent report has demonstrated SHIP association with IRS-2 in response to erythropoietin\n",
      "p(HGNC:EPO) -> complex(p(HGNC:INPP5D),p(HGNC:IRS2))\n",
      "p(HGNC:INPP5D,pmod(P)) -> complex(p(HGNC:INPP5D),p(HGNC:IRS2))\n",
      "p(HGNC:IRS2,pmod(P)) -> complex(p(HGNC:INPP5D),p(HGNC:IRS2))\n",
      "----------------------\n",
      "10006890 : Expression of Erbin increases the amount of ErbB2 labeled by biotin in transfected cells, suggesting that Erbin is able to increase ErbB2 surface expression.\n",
      "p(HGNC:ERBB2IP) -> p(HGNC:ERBB2)\n",
      "p(HGNC:ERBB2IP) -> surf(p(HGNC:ERBB2))\n",
      "----------------------\n",
      "10023054 : We have previously reported that in thrombin-stimulated human platelets, cytosolic phospholipase A(2) (cPLA2) is phosphorylated on Ser-505 by p38 protein kinase and on Ser-727 by an unknown kinase.\n",
      "p(HGNC:F2) -> p(HGNC:PLA2G4A,pmod(P))\n",
      "p(HGNC:F2) -> p(HGNC:PLA2G4A,pmod(P))\n",
      "----------------------\n",
      "10023056 : The levels of IL6 and of G-CSF mRNAs showed a time dependent increase during two to eight hours after thrombin stimulation....Cytokines were measured by enzyme linked immunosorbent assay (ELISA) in the supernatants of cultured rheumatoid synovial fibroblasts stimulated by thrombin\n",
      "p(HGNC:F2) -> tloc(p(HGNC:CSF3))\n",
      "p(HGNC:F2) -> tloc(p(HGNC:IL6))\n",
      "----------------------\n",
      "10000040 : Acidic fibroblast growth factor (FGF-1), a prototype member of the heparin-binding growth factor family, influences proliferation, differentiation, and protein synthesis in different cell types\n",
      "p(HGNC:FGF1) -> bp(GOBP:\"cell differentiation\")\n",
      "p(HGNC:FGF1) -> bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:FGF1) -> bp(GOBP:\"protein metabolic process\")\n",
      "----------------------\n",
      "10015734 : Our results show that FGF-1 induced collagenase mRNA expression, which was strongly enhanced when FGF-1 was used with heparin. Likewise, both FGF-1 and FGF-1 plus heparin reduced by 70 to 80% the expression of type I collagen transcript, in part through effect on pro-alpha1(I) collagen mRNA stability. A downregulation of HSP47 gene expression was also observed\n",
      "p(HGNC:FGF1) -| r(HGNC:COL1A1)\n",
      "p(HGNC:FGF1) -> r(HGNC:MMP1)\n",
      "p(HGNC:FGF1) -| r(HGNC:SERPINH1)\n",
      "----------------------\n",
      "10023082 : Both low and high MW FGF-2 isoforms show angiogenic activity in vivo and induce cell proliferation, chemotaxis, and uPA production in cultured endothelial cells (188). Also, FGF-2 was found to induce tube formation in collagen gels and to modulate integrin expression, gap junction intercellular communication and VEGF, Flk-1 and uPAR upregulation in vitro (31, 100).\n",
      "p(HGNC:FGF2) -> bp(GOBP:\"blood vessel development\")\n",
      "p(HGNC:FGF2) -> p(HGNC:KDR)\n",
      "p(HGNC:FGF2) -> p(HGNC:PLAU)\n",
      "----------------------\n",
      "10023084 : insulin-like growth factor-1 and basic fibroblast growth factor (bFGF) activate MAPK/Erk, and both growth factors promote myoblast proliferation\n",
      "p(HGNC:FGF2) -> bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:FGF2) -> bp(GOBP:\"MAPK cascade\")\n",
      "p(HGNC:IGF1) -> bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:IGF1) -> bp(GOBP:\"MAPK cascade\")\n",
      "----------------------\n",
      "10006916 : Vascular endothelial growth factor and basic fibroblast growth factor, which were overexpressed in involved psoriasis skin, enhanced angiopoietin 2 and Tie2 expression in dermal microvascular endothelial cell cultures.\n",
      "p(HGNC:FGF2) -> r(HGNC:ANGPT2)\n",
      "p(HGNC:FGF2) -> r(HGNC:TEK)\n",
      "p(HGNC:VEGFA) -> r(HGNC:TEK)\n",
      "----------------------\n",
      "10023112 : insulin-like growth factor-1 enhances muscle cell differentiation, whereas bFGF inhibits the expression of the muscle-specific transcription factors MyoD and myogenin.\n",
      "p(HGNC:FGF2) -| r(HGNC:MYOD1)\n",
      "p(HGNC:FGF2) -| r(HGNC:MYOG)\n",
      "p(HGNC:IGF1) -> bp(GOBP:\"cell differentiation\")\n",
      "----------------------\n",
      "10023130 : VEGF-D enhancedHUVEC migration at concentration,,, In contrast, PlGF induced minimal stimulation HUVEC migration at concentrations, which stimulated proliferative response.\n",
      "p(HGNC:FIGF) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:FIGF) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))\n",
      "p(HGNC:FIGF) -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10020538 : avb3 is a receptor for a number of proteins with an exposed Arg-Gly-Asp (RGD) sequence, including fibronectin, vitronectin, laminin, von Willebrand factor (vWF), fibrinogen and denatured collagen.\n",
      "p(HGNC:FN1) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))\n",
      "p(HGNC:VWF) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))\n",
      "----------------------\n",
      "10023136 : we show that transient adherence to fibronectin induces the production of activated forms of matrix metalloproteinase-2 (MMP-2) and MMP-9, as well as downregulation of tissue inhibitor of metalloproteinase-2 (TIMP-2) by T-cell lines.\n",
      "p(HGNC:FN1) -> r(HGNC:MMP2)\n",
      "p(HGNC:FN1) -> r(HGNC:MMP9)\n",
      "p(HGNC:FN1) -| r(HGNC:TIMP2)\n",
      "----------------------\n",
      "10023138 : Overexpression of c-Jun, JunB, Fra2, or FosB in activated HSCs repressed TIMP-1 promoter activity, whereas c-Fos and Fra1 had little effect.\n",
      "p(HGNC:FOSB) -| r(HGNC:TIMP1)\n",
      "p(HGNC:FOSL2) -| r(HGNC:TIMP1)\n",
      "p(HGNC:JUNB) -| r(HGNC:TIMP1)\n",
      "----------------------\n",
      "10023146 : the mutation S256A completely prevented phosphorylation at Thr- 24 and Ser-319 (Figure 1A, lanes 7 and 8, numbering from the left)\n",
      "p(HGNC:FOXO1,sub(S,256,A)) -| p(HGNC:FOXO1,pmod(P))\n",
      "p(HGNC:FOXO1,sub(S,256,A)) -| p(HGNC:FOXO1,pmod(P))\n",
      "----------------------\n",
      "10023158 : GADD45 beta, which activates mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase kinase 4 (MEKK4), was induced by IL-18 and augmented by IL-12.\n",
      "p(HGNC:GADD45B) -> act(p(HGNC:MAP3K4))\n",
      "p(HGNC:IL18) -> r(HGNC:GADD45B)\n",
      "----------------------\n",
      "10006974 : Expression of the prolactin receptor (PRLR) gene is increased in pancreatic islets during pregnancy and in vitro in insulin-producing cells by growth hormone (GH) and prolactin (PRL).\n",
      "p(HGNC:GH1) -> r(HGNC:PRLR)\n",
      "p(HGNC:PRL) -> r(HGNC:PRLR)\n",
      "----------------------\n",
      "10023186 : Mutagenesis of the GBS inhibited TTF-1-dependent activation of the SP-A promoter, and the activity of the GBS was influenced by mutations in any of three distinct TTF-1 regulatory elements located within the 5'-flanking region of the SP-A gene.\n",
      "p(HGNC:GNB5) -| r(HGNC:SFTPA1)\n",
      "p(HGNC:\"NKX2-1\") -> r(HGNC:SFTPA1)\n",
      "----------------------\n",
      "10023202 : The SH2 domain of the adaptor protein Grb- 2 and the SH2 domain of the phosphotyrosine phosphatase SHP-2 bind other sequences, including pYVNI, pYIDL, and pYASI sequences (1).\n",
      "p(HGNC:GRB2,pmod(P)) -> complex(p(HGNC:IRS1),p(HGNC:GRB2))\n",
      "p(HGNC:PTPN11,pmod(P)) -> complex(p(HGNC:PTPN11),p(HGNC:IRS1))\n",
      "----------------------\n",
      "10006988 : HCR-1 appears to have a dominant effect on apoE and apoCI and HCR-2 has a dominant effect on apoCIV and apoCII gene expressio\n",
      "p(HGNC:HCRT) -> r(HGNC:APOC1)\n",
      "p(HGNC:HCRT) -> r(HGNC:APOC2)\n",
      "p(HGNC:HCRT) -> r(HGNC:APOC4)\n",
      "p(HGNC:HCRT) -> r(HGNC:APOE)\n",
      "----------------------\n",
      "10006992 : During the first 24 h after HGF treatment, enhanced expression of the pro-apoptotic genes bax and c-Myc was observed at level of mRNA and protein.\n",
      "p(HGNC:HGF) -> r(HGNC:BAX)\n",
      "p(HGNC:HGF) -> r(HGNC:MYC)\n",
      "----------------------\n",
      "10007000 : in human keratinocytes HGF/SF but not the related cytokine macrophage stimulating protein (MSP) significantly increases expression of VEGF and plasminogen activator inhibitor-1 (PAI-1) on the level of protein and mRNA.\n",
      "p(HGNC:HGF) -> r(HGNC:SERPINE1)\n",
      "p(HGNC:HGF) -> r(HGNC:VEGFA)\n",
      "----------------------\n",
      "10023250 : Similarly HNF1 stimulates the expression of CYP1A2 (Chung and Bresnick, 1995 ), UGT1A1 (Bernard et al., 1999 ), UGT1A7 ( Metz et al., 2000 ), and UGT2B1 (Hansen et al., 1997 ), whereas C/EBP regulates UGT2B1 (Hansen et al., 1998 ) and GST Ya (Pimental et al., 1993 ; Chen and Ramos, 2000 ).\n",
      "p(HGNC:HNF1A) -> r(HGNC:CYP1A2)\n",
      "p(HGNC:HNF1A) -> r(HGNC:SLC35A2)\n",
      "p(HGNC:HNF1A) -> r(HGNC:UGT1A1)\n",
      "p(HGNC:HNF1A) -> r(HGNC:UGT1A7)\n",
      "----------------------\n",
      "10000148 : Finally, overexpression of hnRNP K in breast cancer cells significantly increased target c-myc promoter activity and c-Myc protein, hnRNP K protein levels, and enhanced breast cancer cell proliferation and growth in an anchorage-independent manner.\n",
      "p(HGNC:HNRNPK) -> bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:HNRNPK) -> r(HGNC:MYC)\n",
      "----------------------\n",
      "10023270 : though V12Ras was able to stimulate ERK phosphorylation and induce cyclin D1 expression in the absence of androgen\n",
      "p(HGNC:HRAS) -> p(HGNC:CCND1)\n",
      "p(HGNC:HRAS) -> p(HGNC:MAPK1,pmod(P))\n",
      "----------------------\n",
      "10023290 : These EC adhesion molecules include vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin, and P-selectin.6,7\n",
      "p(HGNC:ICAM1) -> bp(GOBP:\"cell adhesion\")\n",
      "p(HGNC:SELE) -> bp(GOBP:\"cell adhesion\")\n",
      "p(HGNC:SELP) -> bp(GOBP:\"cell adhesion\")\n",
      "p(HGNC:VCAM1) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10023296 : IFN-alpha induces the expression of ubiquitin cross-reactive protein (ISG15) and two ubiquitin-conjugating enzymes, UbcH5 and UbcH8.\n",
      "p(HGNC:IFNA1) -> p(HGNC:ISG15)\n",
      "p(HGNC:IFNA1) -> p(HGNC:UBE2D1)\n",
      "p(HGNC:IFNA1) -> p(HGNC:UBE2L6)\n",
      "----------------------\n",
      "10023314 : Northern-blot analysis showed that IFN-alpha rapidly enhances mRNA expression of UbcH5, UbcH6 and UbcH8 in T cells.\n",
      "p(HGNC:IFNA1) -> r(HGNC:UBE2D1)\n",
      "p(HGNC:IFNA1) -> r(HGNC:UBE2E1)\n",
      "p(HGNC:IFNA1) -> r(HGNC:UBE2L6)\n",
      "----------------------\n",
      "10023316 : in contrast to the direct recruitment of Stat4 by the IL-12 receptor, Stat4 activation by the human IFN-alpha receptor occurs through indirect recruitment by intermediates involving Stat2\n",
      "p(HGNC:IFNA1) -> act(p(HGNC:STAT4))\n",
      "p(HGNC:IL12RB1) -> act(p(HGNC:STAT4))\n",
      "act(p(HGNC:STAT2)) -> act(p(HGNC:STAT4))\n",
      "----------------------\n",
      "10023324 : Western blot analysis for IP-10, Mig, and I-TAC extended Northern blot results to detection of all 3 proteins after IFN-g stimulation in ECs (Figure 7b).\n",
      "p(HGNC:IFNG) -> p(HGNC:CXCL10)\n",
      "p(HGNC:IFNG) -> p(HGNC:CXCL11)\n",
      "p(HGNC:IFNG) -> p(HGNC:CXCL9)\n",
      "----------------------\n",
      "10007056 : We found that tumor-necrosis factor alpha (TNF-alpha) and interferon-gamma (IFN-gamma) synergistically enhance the expression of fractalkine.\n",
      "p(HGNC:IFNG) -> r(HGNC:CX3CL1)\n",
      "p(HGNC:TNF) -> p(HGNC:CX3CL1)\n",
      "----------------------\n",
      "10007066 : Fas is constitutively expressed by primary murine microglia at a low level and significantly up-regulated by TNF-alpha or IFN-gamma stimulation\n",
      "p(HGNC:IFNG) -> r(HGNC:FAS)\n",
      "p(HGNC:TNF) -> r(HGNC:FAS)\n",
      "----------------------\n",
      "10023344 : Fc gamma RIIb2, is expressed on circulating human monocytes, and when co-cross-linked with stimulatory Fc gamma R it down-regulates effector function. Fc gamma RIIb2 expression is increased by IL-4 and decreased by IFN-gamma\n",
      "p(HGNC:IFNG) -| r(HGNC:FCGR2B)\n",
      "p(HGNC:IL4) -> r(HGNC:FCGR2B)\n",
      "----------------------\n",
      "10007092 : The neurotrophin, nerve growth factor (NGF), and insulin-like growth factor 1 induce the migration but not the proliferation of smooth muscle cells, whereas PDGF-BB stimulates both responses.\n",
      "p(HGNC:IGF1) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:NGF) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:PDGFB) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:PDGFB) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10007098 : Our results showed that after 6-days in culture; treatment with insulin, IGF-I and IGF-II increased the synthesis of amelogenin and ameloblastin.\n",
      "p(HGNC:IGF1) -> p(HGNC:AMBN)\n",
      "p(MGI:Igf1) -> r(MGI:Amelx)\n",
      "----------------------\n",
      "10023388 : there was little phosphorylation of wild-type GSTÂ±FKHR in unstimulated cells and, as expected, all three sites became maximally phosphorylated in 15Â±30 min when transfected cells were stimulated with IGF-1 (Figure 1A). at Thr-24, Ser-256 and Ser-319\n",
      "p(HGNC:IGF1) -> p(HGNC:FOXO1,pmod(P))\n",
      "p(HGNC:IGF1) -> p(HGNC:FOXO1,pmod(P))\n",
      "p(HGNC:IGF1) -> p(HGNC:FOXO1,pmod(P))\n",
      "----------------------\n",
      "10020030 : In smooth muscle cells, blocking ligand occupancy of aVb3 integrin reduces IGF-1-induced IRS-1 phosphorylation\n",
      "p(HGNC:IGF1) -> p(HGNC:IRS1,pmod(P))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:IRS1),p(HGNC:ITGAV))\n",
      "----------------------\n",
      "10017346 : Insulin and IGF-1 stimulation also promote association between IRS-1 and aVb3 integrin (vitronectin receptor)\n",
      "p(HGNC:IGF1) -> p(HGNC:IRS1,pmod(P))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:IRS1),p(HGNC:ITGAV))\n",
      "----------------------\n",
      "10023438 : Phosphorylation of two closely spaced serine residues in this domain, at positions 176 and 180 in IKK? and positions 177 and 181 in IKK?, has been shown to be important for IKK kinase activity (22).\n",
      "p(HGNC:IKBKB,pmod(P)) -> act(p(HGNC:IKBKB))\n",
      "p(HGNC:IKBKB,pmod(P)) -> act(p(HGNC:IKBKB))\n",
      "----------------------\n",
      "10007128 : IL-10 induction of FS secretion (and FS binding of activin A) restores the normal growth capabilities of HGPIN cultures\n",
      "p(HGNC:IL10) -> complex(p(HGNC:FST),p(HGNC:INHBA),p(HGNC:INHBA))\n",
      "p(HGNC:IL10) -> tloc(p(HGNC:FST))\n",
      "----------------------\n",
      "10020616 : Thus, RANTES produced by human airway muscle cells is stimulated by TNF-a plus IFN-g but inhibited by IL-4, IL-10, and IL-13 (12).\n",
      "p(HGNC:IL10) -| p(HGNC:CCL5)\n",
      "p(HGNC:IL13) -| p(HGNC:CCL5)\n",
      "p(HGNC:IL4) -| p(HGNC:CCL5)\n",
      "----------------------\n",
      "10023444 : IL-10 also reduces the expression of major histocompatibility complex class II, B7.1/B7.2 antigens and clonal designator (CD)23 by these cells, thereby decreasing their accessory cell function (30). In contrast, IL-10 upregulates the release of another antiinflammatory cytokine, IL-1 receptor antagonist (30).\n",
      "p(HGNC:IL10) -| p(HGNC:CD80)\n",
      "p(HGNC:IL10) -| p(HGNC:CD86)\n",
      "p(HGNC:IL10) -| p(HGNC:FCER2)\n",
      "p(HGNC:IL10) -> p(HGNC:IL1RN)\n",
      "----------------------\n",
      "10023454 : IL-10 induced a dose-dependent increase in the level of TIMP-1 released by AM without affecting the release of MMP-9 by these cells (Figure 5). This cytokine also significantly reduced the production of TNF-alpha in a dose-dependent manner (Figure 5).\n",
      "p(HGNC:IL10) -> tloc(p(HGNC:TIMP1))\n",
      "p(HGNC:IL10) -| tloc(p(HGNC:TNF))\n",
      "----------------------\n",
      "10023468 : Tyrosine phosphorylation of JAK1 was detected at a very low concentration of IL-4 (1 ng/ml), while IL-13 induced phosphorylation only at concentrations of 50 ng/ml and above, both in normal (Figure 2a,b, upper blots) and tumor lung myoÂ®broblasts (Figure 2c,d, upper blots).\n",
      "p(HGNC:IL13) -> p(HGNC:JAK1,pmod(P))\n",
      "p(HGNC:IL4) -> p(HGNC:JAK1,pmod(P))\n",
      "----------------------\n",
      "10023470 : the constitutive phosphorylation of STAT3 was observed repeatedly in tumor myoÂ®bro- blasts (Figure 6f), but only occasionally in normal Â®broblasts (Figure 6e). In the latter cells, IL-4 and IL- 13 induced (Figure 6d) or increased (Figure 6e) the tyrosine phosphorylation of STAT3, whereas in tumor myoÂ®broblasts the two cytokines only caused an increase in the phosphorylation of STAT3 (Figure 6f).\n",
      "p(HGNC:IL13) -> p(HGNC:STAT3,pmod(P))\n",
      "p(HGNC:IL4) -> p(HGNC:STAT3,pmod(P))\n",
      "----------------------\n",
      "10023472 : In normal lung Â®broblasts and in tumor myoÂ®broblasts, STAT6 was indeed phosphorylated on tyrosine residues in response to IL-4 and IL-13 (Figure 4a,b, upper blots).\n",
      "p(HGNC:IL13) -> p(HGNC:STAT6,pmod(P))\n",
      "p(HGNC:IL4) -> p(HGNC:STAT6,pmod(P))\n",
      "----------------------\n",
      "10023474 : Finally, Tyk2, the fourth member of the JAK family, was found to be constitutively tyrosine-phosphorylated in these cells. However, IL-4 and IL-13 increased its phosphorylation level in lung myoÂ®broblasts (Figure 2j), but not in normal cells, where both cytokines appear to slightly decrease its extent of phosphoryla- tion (Figure 2i).\n",
      "p(HGNC:IL13) -> p(HGNC:TYK2,pmod(P))\n",
      "p(HGNC:IL4) -> p(HGNC:TYK2,pmod(P))\n",
      "----------------------\n",
      "10023486 : IL-4 and IL-13 induced tyrosine phosphorylation of STAT6 (green cytoplasmic staining) but probably also nuclear translocation of some phosphorylated STAT6 mole- cules, accounting for the yellow signal detected. Similar results were obtained with normal lung Â®broblasts.\n",
      "p(HGNC:IL13) -> tloc(p(HGNC:STAT6))\n",
      "p(HGNC:IL4) -> tloc(p(HGNC:STAT6))\n",
      "----------------------\n",
      "10023504 : Therapy for 14 days with recombinant human IL-16 significantly inhibited the production of IFN-gamma, IL-1beta, and TNF-alpha in the synovium.\n",
      "p(HGNC:IL16) -| tloc(p(HGNC:IFNG))\n",
      "p(HGNC:IL16) -| tloc(p(HGNC:IL1B))\n",
      "p(HGNC:IL16) -| tloc(p(HGNC:TNF))\n",
      "----------------------\n",
      "10007142 : Recombinant IL-16 was found to up-regulate CD25 and CD80 but to down-regulate CD4 and CD86 surface expression in MDM cultures.\n",
      "p(HGNC:IL16) -| surf(p(HGNC:CD4))\n",
      "p(HGNC:IL16) -> surf(p(HGNC:CD80))\n",
      "p(HGNC:IL16) -> surf(p(HGNC:IL2RA))\n",
      "----------------------\n",
      "10023506 : interleukin-17 induces time-dependent stimulation of tyrosine phosphorylation of JAK 1, 2 and 3, Tyk 2 and STAT 1, 2, 3 and 4 within 0.5 to 30 min\n",
      "p(HGNC:IL17A) -> act(p(HGNC:JAK1))\n",
      "p(HGNC:IL17A) -> act(p(HGNC:JAK2))\n",
      "p(HGNC:IL17A) -> act(p(HGNC:JAK3))\n",
      "----------------------\n",
      "10002472 : Stimulation by IL-18 strongly enhanced tyrosine phosphorylation of STAT3 and of the mitogen-activated protein kinases (MAPK) p44erk-1and p42erk-2.\n",
      "p(HGNC:IL18) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:IL18) -> act(p(HGNC:MAPK3))\n",
      "p(HGNC:IL18) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10023518 : Moreover, interleukin (IL)-1alpha and tumor necrosis factor (TNF)-alpha induce the alpha -receptor in osteoblast cultures from fetal rat bone (75, 468).\n",
      "p(HGNC:IL1A) -> complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA))\n",
      "p(HGNC:TNF) -> complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA))\n",
      "----------------------\n",
      "10023520 : Apoptosis signal-regulating kinase 1 (ASK 1) is a mitogen-activated protein (MAP) kinase kinase kinase (MAPKKK) that is activated by TNF and IL-1\n",
      "p(HGNC:IL1A) -> act(p(HGNC:MAP3K5))\n",
      "p(HGNC:TNF) -> act(p(HGNC:MAP3K5))\n",
      "----------------------\n",
      "10018224 : In this study, we determined the role of PP2Cbeta-1, a major isoform of mammalian PP2C, in the TAK1 signaling pathway, a stress-activated protein kinase cascade that is activated by interleukin-1, transforming growth factor-beta, or stress.\n",
      "p(HGNC:IL1A) -> act(p(HGNC:MAP3K7))\n",
      "p(HGNC:IL1B) -> act(p(HGNC:MAP3K7))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:MAP3K7))\n",
      "----------------------\n",
      "10007158 : It was first identified as a membrane protein in endothelial cells activated with IL-1 or TNF-alpha.\n",
      "p(HGNC:IL1A) -> p(HGNC:CX3CL1)\n",
      "p(HGNC:TNF) -> p(HGNC:CX3CL1)\n",
      "----------------------\n",
      "10023522 : Pro-inflammatory cytokines such as TNF-alpha and IL-1 repress, and TGF-beta stimulates the apoCIII promoter activity\n",
      "p(HGNC:IL1A) -| r(HGNC:APOC3)\n",
      "p(HGNC:TGFB1) -> r(HGNC:APOC3)\n",
      "p(HGNC:TNF) -| r(HGNC:APOC3)\n",
      "----------------------\n",
      "10023530 : Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA (Figs. 1â4).\n",
      "p(HGNC:IL1A) -> r(HGNC:MMP14)\n",
      "p(HGNC:IL1B) -> r(HGNC:MMP14)\n",
      "p(HGNC:TNF) -> r(HGNC:MMP14)\n",
      "----------------------\n",
      "10007166 : Tumor necrosis factor-alpha (TNF-alpha ), interleukin-1alpha, or interleukin-1beta caused a time-dependent increase in the steady-state MT1-MMP mRNA levels within 4 h of exposure, peaking about 4-fold by 6 h, and remaining elevated for 12 h.\n",
      "p(HGNC:IL1A) -> r(HGNC:MMP14)\n",
      "p(HGNC:IL1B) -> r(HGNC:MMP14)\n",
      "p(HGNC:TNF) -> r(HGNC:MMP14)\n",
      "----------------------\n",
      "10007176 : CXCR4 protein expression was also enhanced upon treatment with TNF-alpha and IL-1beta (2- to 3-fold).\n",
      "p(HGNC:IL1B) -> p(HGNC:CXCR4)\n",
      "p(HGNC:TNF) -> p(HGNC:CXCR4)\n",
      "----------------------\n",
      "10016854 : Tissue factor (TF) can be induced in monocytes by external signals such as growth factors, inflammatory cytokines (interleukin [IL]-1b and tumor necrosis factor [TNF]-a), oxidized LDLs, and endotoxin. 2\n",
      "p(HGNC:IL1B) -> p(HGNC:F3)\n",
      "p(HGNC:TNF) -> p(HGNC:F3)\n",
      "----------------------\n",
      "10023540 : VEGF production induced by IL-1beta, TNF-alpha, and TGF-beta was further increased when CD40L+ L cells were coincubated, by factors of 5.9, 5.5, and 9.6, respectively, which indicated that these cytokines had an additive effect on VEGF production driven by CD40L.\n",
      "p(HGNC:IL1B) -> p(HGNC:VEGFA)\n",
      "p(HGNC:TGFB1) -> p(HGNC:VEGFA)\n",
      "p(HGNC:TNF) -> tloc(p(HGNC:VEGFA))\n",
      "p(HGNC:CD40) -> p(HGNC:VEGFA)\n",
      "p(HGNC:TNF) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10007186 : Interleukin-1beta increased the levels of C/EBPdelta mRNA as soon as 2 h and up to 24 h without affecting those of C/EBPbeta. Higher amounts of C/EBPdelta proteins correlate with the stimulation of C/EBPdelta mRNA.\n",
      "p(HGNC:IL1B) -> r(HGNC:CEBPD)\n",
      "act(p(HGNC:CEBPD)) -> r(HGNC:PLA2G2A)\n",
      "----------------------\n",
      "10007194 : Enhancement of CXC chemokine receptor 4 (CXCR4) mRNA expression was observed upon treatment with the cytokines TNF-alpha and IL-1beta.\n",
      "p(HGNC:IL1B) -> r(HGNC:CXCR4)\n",
      "p(HGNC:TNF) -> r(HGNC:CXCR4)\n",
      "----------------------\n",
      "10007196 : Both the ATX mRNA amount and the 5'-nucleotide phosphodiesterase (PDE) activity of SFC lysate were reduced after treatment of SFC with the cytokines IL-1beta or IL-4.\n",
      "p(HGNC:IL1B) -| r(HGNC:ENPP2)\n",
      "p(HGNC:IL4) -| r(HGNC:ENPP2)\n",
      "----------------------\n",
      "10007198 : IL-1beta increased PGHS-2 mRNA and PGE2 output from villous and chorion trophoblasts and decreased PGDH mRNA\n",
      "p(HGNC:IL1B) -| r(HGNC:HPGD)\n",
      "p(HGNC:IL1B) -> r(HGNC:PTGS2)\n",
      "----------------------\n",
      "10023574 : Using a naturally occurring compound found in the colon of vertebrates, butyrate, we provide evidence in an intestinal cell line that alteration of IkappaB-beta expression can modulate the transcriptional activation of the interleukin-8 (IL-8) gene by preventing the nuclear translocation of NF-kappaB proteins......Expression of IkB-b in Caco-2 cells inhibits transcriptional activation of the IL-8 promoter by IL-1b\n",
      "p(HGNC:IL1B) -> r(HGNC:IL8)\n",
      "p(HGNC:NFKBIB) -| r(HGNC:IL8)\n",
      "----------------------\n",
      "10023582 : Contrary to the hypothesis, both IL-1beta and IL-6 treatment resulted in a significant decrease in OT receptor messenger RNA measured by ribonuclease protection analysis.\n",
      "p(HGNC:IL1B) -| r(HGNC:OXTR)\n",
      "act(p(HGNC:CEBPB)) -| r(HGNC:OXTR)\n",
      "----------------------\n",
      "10007214 : Proinflammatory cytokines, including IL-1beta and tumor necrosis factor-alpha (TNF-alpha), promote cancer cell adhesion and liver metastases by up-regulating the expression of vascular cell adhesion molecule-1 (VCAM-1)\n",
      "p(HGNC:IL1B) -> r(HGNC:VCAM1)\n",
      "p(HGNC:TNF) -> r(HGNC:VCAM1)\n",
      "p(HGNC:VCAM1) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10007216 : The addition of interleukin (IL)-1beta or tumor necrosis factor (TNF)-alpha induced a dose- and time-dependent increase in C3 and factor B secretion.\n",
      "p(HGNC:IL1B) -> tloc(p(HGNC:C3))\n",
      "p(HGNC:IL1B) -> tloc(p(HGNC:CFB))\n",
      "p(HGNC:TNF) -> tloc(p(HGNC:C3))\n",
      "p(HGNC:TNF) -> tloc(p(HGNC:CFB))\n",
      "----------------------\n",
      "10007226 : We have observed a novel phenomenon that IL-2 and IL-4 induce the expression of CCR3 on T lymphocytes\n",
      "p(HGNC:IL2) -> r(HGNC:CCR3)\n",
      "p(HGNC:IL4) -> r(HGNC:CCR3)\n",
      "----------------------\n",
      "10007228 : We have observed a novel phenomenon that IL-2 and IL-4 induce the expression of CCR3 on T lymphocytes.\n",
      "p(HGNC:IL2) -> r(HGNC:CCR3)\n",
      "p(HGNC:IL4) -> r(HGNC:CCR3)\n",
      "----------------------\n",
      "10007244 : Interleukin (IL)-4 specifically induces 12/15-lipoxygenase messenger RNA, protein, and enzymatic activity in primary cultures of human monocytes and airway epithelial cells\n",
      "p(HGNC:IL4) -> r(HGNC:ALOX12)\n",
      "p(HGNC:IL4) -> r(HGNC:ALOX15)\n",
      "----------------------\n",
      "10023644 : IL-4 inhibited the BCG-mediated MIP-1alpha and MCP-1 expression in a concentration-dependent manner.\n",
      "p(HGNC:IL4) -| r(HGNC:CCL2)\n",
      "p(HGNC:IL4) -| r(HGNC:CCL3)\n",
      "----------------------\n",
      "10023646 : In vivo exposure to GM-CSF and IL-4 down-regulates the expression of CD14 and up-regulates the expression of HLA-DR and CD11c in a dose-responsive manner.\n",
      "p(HGNC:IL4) -| r(HGNC:CD14)\n",
      "p(HGNC:IL4) -> r(HGNC:ITGAX)\n",
      "----------------------\n",
      "10007252 : IL-4 strongly enhanced the generation of CD1a(+) LC/DC and also up-regulated the expression of the skin-homing structures E-cadherin and cutaneous lymphocyte antigen.\n",
      "p(HGNC:IL4) -> r(HGNC:CDH1)\n",
      "p(HGNC:IL4) -> r(HGNC:\"HLA-DOA\")\n",
      "----------------------\n",
      "10023652 : Transforming growth factor-beta1 increased dermatopontin mRNA and protein levels, while interleukin-4 reduced dermatopontin expression.\n",
      "p(HGNC:IL4) -| r(HGNC:DPT)\n",
      "p(HGNC:TGFB1) -> p(HGNC:DPT)\n",
      "p(HGNC:TGFB1) -> r(HGNC:DPT)\n",
      "----------------------\n",
      "10023672 : The IL-6-type cytokines, IL-6 and oncostatin M, simultaneously inhibited cell proliferation and increased cell migration\n",
      "p(HGNC:IL6) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:IL6) -| bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:OSM) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:OSM) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10002576 : In T47D cells, IL-6 stimulated the activation of Janus-activated kinase 1 tyrosine kinase and signal transducers and activators of transcription (STAT) 1 and STAT3 transcription factors. Expression of dominant negative STAT3 in the cells strongly reduced IL-6-mediated growth inhibition but did not prevent IL-6-induced cell migration.\n",
      "p(HGNC:IL6) -> act(p(HGNC:JAK1))\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT1))\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10007276 : Moreover, in human lymphoid cell lines of B- and T-cell origin (Raji, Jurkat, and NC-37), IL-6 stimulated production of MMP-9 and MMP-2 but not TIMP-1. In the Matrigel invasion assay IL-6 significantly upregulated transmigration of Raji and Jurkat cells, which in turn was inhibited by recombinant human TIMP-1 and anti-MMP-9 and MMP-2 antibodies.\n",
      "p(HGNC:IL6) -> p(HGNC:MMP2)\n",
      "p(HGNC:IL6) -> p(HGNC:MMP9)\n",
      "----------------------\n",
      "10023694 : Northern blot analysis documented that two transcription factor genes chosen for further study, c-myc promoter-binding protein (MBP-1) and X-box binding protein 1 (XBP-1), were up-regulated in U266 cells about 3-fold relative to the cell cycle-dependent beta-actin gene 12 h after IL-6 treatment.\n",
      "p(HGNC:IL6) -> r(HGNC:ENO1)\n",
      "p(HGNC:IL6) -> r(HGNC:XBP1)\n",
      "----------------------\n",
      "10023710 : The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. #[JL] IL6ST is gp130\n",
      "p(HGNC:IL6ST) -> act(p(HGNC:STAT3))\n",
      "act(p(HGNC:STAT3)) -> bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "act(p(HGNC:STAT3)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10007310 : In BW5147 T-cell lymphoma, IL-9 induced the rapid expression of CIS, SOCS-2 and SOCS-3 with a peak after 2 h of stimulation\n",
      "p(HGNC:IL9) -> r(HGNC:CISH)\n",
      "p(HGNC:IL9) -> r(HGNC:SOCS2)\n",
      "p(HGNC:IL9) -> r(HGNC:SOCS3)\n",
      "----------------------\n",
      "10007312 : In vitro, our studies showed that IL-9 also induces expression of MUC2 and MUC5AC in human primary lung cultures and in the human muccoepidermoid NCI-H292 cell line, indicating a direct effect of IL-9 on inducing mucin expression in these cells.\n",
      "p(HGNC:IL9) -> r(HGNC:MUC2)\n",
      "p(HGNC:IL9) -> r(HGNC:MUC5AC)\n",
      "----------------------\n",
      "10023724 : ILK overexpression can also inhibit GSK-3 activity (Delcommenne et al., 1998; Troussard et al., 1999) and also results in nuclear accumulation of beta-catenin (Novak et al., 1998).\n",
      "p(HGNC:ILK) -| act(p(HGNC:GSK3B))\n",
      "p(HGNC:ILK) -> tloc(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10023744 : Insulin (+/-1,000 pmol/l) induced a two- to threefold increase (P hexokinase II, p85alphaPI3K, and SREBP-1c mRNA levels in muscle and in adipose tissue in control subjects, in insulin-resistant nondiabetic obese patients, and in hyperglycemic type 1 diabetic subjects.\n",
      "p(HGNC:INS) -> r(HGNC:HK2)\n",
      "p(HGNC:INS) -> r(HGNC:PIK3R1)\n",
      "p(HGNC:INS) -> r(HGNC:SREBF1)\n",
      "----------------------\n",
      "10023748 : this negative regulation likely results from competition between SOCS3 and Stat5B binding to the same insulin receptor motif SOCS3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds\n",
      "p(HGNC:INSR,pmod(P)) -> complex(p(HGNC:INSR),p(HGNC:STAT5B))\n",
      "p(HGNC:INSR,pmod(P)) -> complex(p(HGNC:SOCS3),p(HGNC:INSR))\n",
      "p(HGNC:SOCS3) -| complex(p(HGNC:INSR),p(HGNC:STAT5B))\n",
      "p(HGNC:STAT5B) -| complex(p(HGNC:SOCS3),p(HGNC:INSR))\n",
      "----------------------\n",
      "10007332 : IFN-beta expression can be activated by interferon regulatory factor-1 (IRF-1) and interferon-stimulated gene factor 3gamma (ISGF3gamma).\n",
      "p(HGNC:IRF1) -> r(HGNC:IFNB1)\n",
      "p(HGNC:IRF9) -> r(HGNC:IFNB1)\n",
      "----------------------\n",
      "10023758 : Substitution of Ser-477 and Ser-479 with the phosphomimetic Asp resulted in a form of IRF-7 that activated the IFNA promoter up to 200-fold (Fig. 2 B).\n",
      "p(HGNC:IRF7,pmod(P)) -> act(p(HGNC:IRF7))\n",
      "p(HGNC:IRF7,pmod(P)) -> act(p(HGNC:IRF7))\n",
      "----------------------\n",
      "10023766 : The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:YWHAB),p(HGNC:IRS1))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:YWHAE),p(HGNC:IRS1))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:YWHAZ),p(HGNC:IRS1))\n",
      "----------------------\n",
      "10023768 : TNF-a appears to impair insulin signaling by increasing serine phosphorylation of IRS-1. Serine-phosphorylated IRS-1 inhibits insulin receptor tyrosine kinase activity, which leads to impaired downstream signaling\n",
      "p(HGNC:IRS1,pmod(P)) -| act(p(HGNC:INSR))\n",
      "p(HGNC:TNF) -> p(HGNC:IRS1,pmod(P))\n",
      "----------------------\n",
      "10023770 : other SH2 proteins, such as Crk (adaptor), Nck (adaptor), Fyn (tyrosine kinase), and Csk (tyrosine kinase), bind to tyrosine residues on IRS proteins through their specific SH2 domains.\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:CRK),p(HGNC:IRS1))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:CSK),p(HGNC:IRS1))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:FYN),p(HGNC:IRS1))\n",
      "p(HGNC:IRS1,pmod(P)) -> complex(p(HGNC:NCK1),p(HGNC:IRS1))\n",
      "----------------------\n",
      "10007340 : Blocking monoclonal antibodies against alpha4, alpha5, and alphav integrins strongly reduced MMP-2 and MMP-9 production induced by fibronectin.\n",
      "p(HGNC:ITGA4) -> r(HGNC:MMP2)\n",
      "p(HGNC:ITGA4) -> r(HGNC:MMP9)\n",
      "p(HGNC:ITGA5) -> r(HGNC:MMP2)\n",
      "p(HGNC:ITGA5) -> r(HGNC:MMP9)\n",
      "----------------------\n",
      "10023782 : We found that incubation of monocytes with anti-CD11b or anti-CD11c mAbs led rapidly to a marked induction of MIP-1alpha, MIP-1beta, and IL-8 mRNAs.\n",
      "p(HGNC:ITGAM) -> r(HGNC:CCL3)\n",
      "p(HGNC:ITGAM) -> r(HGNC:CCL4)\n",
      "p(HGNC:ITGAM) -> r(HGNC:IL8)\n",
      "----------------------\n",
      "10023806 : Socs1 suppresses the mitogenic potential of Kit while maintaining Steel factor-dependent cell survival signals.\n",
      "p(HGNC:KIT) -> bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:KITLG) -| bp(GOBP:\"cell death\")\n",
      "----------------------\n",
      "10023834 : Specifically, we demonstrate that the ectopic expression of K10 inhibits the proliferation of human keratinocytes in culture while K16 expression appears to promote the proliferation of these cells\n",
      "p(HGNC:KRT10) -| bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:KRT16) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10023872 : <r8> PCNA binds DNA ligase I; the complex may function to join Okazaki fragments during DNA replication (Levin et al.,1997).\n",
      "p(HGNC:LIG1) -> bp(GOBP:\"DNA replication\")\n",
      "p(HGNC:PCNA) -> act(p(HGNC:LIG1))\n",
      "----------------------\n",
      "10023884 : Activation of MEK1 and MEK2 involves phosphorylation upon conserved serine residues (Ser-218 and Ser-222 on MEK1, Ser-222 and Ser-226 on MEK2\n",
      "p(HGNC:MAP2K1,pmod(P)) -> act(p(HGNC:MAP2K1))\n",
      "p(HGNC:MAP2K1,pmod(P)) -> act(p(HGNC:MAP2K1))\n",
      "p(HGNC:MAP2K2,pmod(P)) -> act(p(HGNC:MAP2K2))\n",
      "p(HGNC:MAP2K2,pmod(P)) -> act(p(HGNC:MAP2K2))\n",
      "----------------------\n",
      "10023888 : In addition, constitutive activation of the pathway via expression of the constitutively active mutants of MAPKK1 or MAPKK2 induced the expression of the platelet/megakaryocytic-specific genes alpha IIb and eta 3 .\n",
      "p(HGNC:MAP2K1) -> r(HGNC:ITGA2B)\n",
      "p(HGNC:MAP2K2) -> r(HGNC:ITGA2B)\n",
      "----------------------\n",
      "10023894 : Wild type, but not KD, MLK3 was able to phosphorylate His-MEK1 (Fig. 5A) ? and GST-SEK1 (Fig. 5B) ? in vitro.\n",
      "p(HGNC:MAP3K11) -> act(p(HGNC:MAP2K1))\n",
      "p(HGNC:MAP3K11) -> act(p(HGNC:MAP2K4))\n",
      "----------------------\n",
      "10007374 : PKC-theta activation of NF-kappaB is mediated through the selective induction of IKKbeta, while the Cot- and NIK-dependent pathway involves induction of both IKKalpha and IKKbeta.\n",
      "p(HGNC:MAP3K14) -> act(p(HGNC:CHUK))\n",
      "p(HGNC:MAP3K14) -> act(p(HGNC:IKBKB))\n",
      "p(HGNC:MAP3K8) -> act(p(HGNC:CHUK))\n",
      "p(HGNC:MAP3K8) -> act(p(HGNC:IKBKB))\n",
      "----------------------\n",
      "10007382 : CD146 engagement initiates an outside-in signaling pathway involving the protein tyrosine kinases FYN and FAK as well as paxillin.\n",
      "p(HGNC:MCAM) -> act(p(HGNC:FYN))\n",
      "p(HGNC:MCAM) -> act(p(HGNC:PTK2))\n",
      "----------------------\n",
      "10007386 : MDMX can inhibit the transcriptional activity of ectopically expressed SMAD1, SMAD2, SMAD3, and SMAD4\n",
      "p(HGNC:MDM4) -| act(p(HGNC:SMAD1))\n",
      "p(HGNC:MDM4) -| act(p(HGNC:SMAD3))\n",
      "p(HGNC:MDM4) -| act(p(HGNC:SMAD4))\n",
      "----------------------\n",
      "10023942 : phosphorylation sites in Myc, Thr 58 and Ser 62 Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc\n",
      "p(HGNC:MYC,pmod(P)) -> p(HGNC:MYC,pmod(P))\n",
      "p(HGNC:MYC,pmod(P)) -> deg(p(HGNC:MYC))\n",
      "----------------------\n",
      "10023952 : RAR coactivators ACTR, SRC-1, and transcriptional intermediary factor 2 (TIF2) stimulated human (h) SP-B promoter activity in a dose-dependent fashion in pulmonary adenocarcinoma H441 cells.\n",
      "p(HGNC:NCOA1) -> r(HGNC:SFTPB)\n",
      "p(HGNC:NCOA2) -> r(HGNC:SFTPB)\n",
      "p(HGNC:NCOA3) -> r(HGNC:SFTPB)\n",
      "----------------------\n",
      "10023954 : title := \\\"The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.\\\"\n",
      "p(HGNC:NCOA2) -> bp(GOBP:\"myoblast differentiation\")\n",
      "p(HGNC:NCOA2) -> act(p(HGNC:MEF2C))\n",
      "----------------------\n",
      "10023976 : Inhibition of IFN-beta expression directly correlated with a reduction in the binding of NF-kappaB (p50-RelA) complex to PRDII after Sendai virus infection in IkappaBalpha-expressing cells, whereas IFN-beta expression and NF-kappaB binding were only slightly reduced in IkappaBbeta-expressing cells.\n",
      "p(HGNC:NFKBIA) -| r(HGNC:IFNB1)\n",
      "p(HGNC:NFKBIB) -| r(HGNC:IFNB1)\n",
      "----------------------\n",
      "10023978 : NGF induces prolonged activation of the Shc/MAP kinase pathway and phospholipase Cgamma compared with PDGF-BB.\n",
      "p(HGNC:NGF) -> bp(GOBP:\"MAPK cascade\")\n",
      "p(HGNC:NGF) -> act(p(HGNC:PLCG1))\n",
      "----------------------\n",
      "10023988 : Both bak and bag-1 were expressed in undifferentiated PC12 cells, and their levels increased slightly with NGF treatment (data not shown).\n",
      "p(HGNC:NGF) -> r(HGNC:BAG1)\n",
      "p(HGNC:NGF) -> r(HGNC:BAK1)\n",
      "----------------------\n",
      "10007420 : In PC12 cells, nerve growth factor induces neuronal differentiation and repressed expression of nrg-1.\n",
      "p(HGNC:NGF) -> r(HGNC:NRG1)\n",
      "p(HGNC:NGF) -| r(HGNC:NRG1)\n",
      "----------------------\n",
      "10007432 : ANP significantly attenuated production of TNF-alpha and IL-1beta without affecting production of IL-10 and IL-1ra.\n",
      "p(HGNC:NPPA) -| r(HGNC:IL1B)\n",
      "p(HGNC:NPPA) -| r(HGNC:IL1R1)\n",
      "----------------------\n",
      "10024054 : In MDA-MB-453 cells, NRG1beta acting through an ErbB2/ErbB3 heterodimer stimulated prolonged signaling of all pathways examined relative to NRG2beta acting through the same heterodimeric receptor species. Surprisingly, NRG1beta and NRG2beta also regulated partially overlapping but distinct sets of genes in these cells.\n",
      "p(HGNC:NRG1) -> complex(p(HGNC:ERBB3),p(HGNC:ERBB2))\n",
      "p(HGNC:NRG2) -> complex(p(HGNC:ERBB3),p(HGNC:ERBB2))\n",
      "----------------------\n",
      "10024056 : As expected, EGF preferentially stimulated the recruitment of the adaptor protein Grb2 to EGF receptor whereas NRG1beta preferentially stimulated the recruitment of this protein to ErbB3. NRG1beta also preferentially stimulated the association of p85, the 85-kDa subunit of PI3K, with ErbB3, as demonstrated previously (40).\n",
      "p(HGNC:NRG1) -> complex(p(HGNC:GRB2),p(HGNC:ERBB3))\n",
      "p(HGNC:NRG1) -> complex(p(HGNC:GRB2),p(HGNC:PIK3R1))\n",
      "----------------------\n",
      "10024076 : At least for the interaction between VEGF-A165 and VEGFR-2, it has been demonstrated that neuropilin-1 acts as a co-receptor which enhances the affinity of the receptor for the ligand (Soker et al., 1998).\n",
      "p(HGNC:NRP1) -> act(p(HGNC:KDR))\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10024080 : NT-3 Enhances Expression of the Neuronal Differentiation Marker Genes GAP-43 and NPY in SH-SY5Y/ trkC Cells.\n",
      "p(HGNC:NTF3) -> r(HGNC:GAP43)\n",
      "p(HGNC:NTF3) -> r(HGNC:NPY)\n",
      "----------------------\n",
      "10024098 : Another PDGF binding protein was isolated from a rat neural retina cell line and called PDGF-associated protein (PAP) (124). PAP binds PDGF with low affinity and was found to enhance the activity of PDGF-AA but depress the activity of PDGF-BB.\n",
      "p(HGNC:PDAP1) -> complex(p(HGNC:PDGFA),p(HGNC:PDGFA))\n",
      "p(HGNC:PDAP1) -| complex(p(HGNC:PDGFB),p(HGNC:PDGFB))\n",
      "----------------------\n",
      "10007464 : The withdrawal of the mitogen platelet-derived growth factor (PDGF), but not TH or RA treatment, causes a rapid decrease in c-fos, NGFI-A/Krox-24, and cyclin D2 mRNA\n",
      "p(HGNC:PDGFA) -> r(HGNC:CCND2)\n",
      "p(HGNC:PDGFA) -> r(HGNC:EGR1)\n",
      "p(HGNC:PDGFA) -> r(HGNC:FOS)\n",
      "----------------------\n",
      "10007474 : Furthermore, we found that NBPhox can also enhance second messenger-mediated activation of the c-fos promoter and several enhancers, including cyclic AMP-response element, the binding site for activator protein 1, and serum-response element.\n",
      "p(HGNC:PHOX2B) -> r(HGNC:CREB1)\n",
      "p(HGNC:PHOX2B) -> r(HGNC:FOS)\n",
      "p(HGNC:PHOX2B) -> r(HGNC:SRF)\n",
      "----------------------\n",
      "10024134 : we show that phosphorylation of cPLA2 at both Ser-505 and Ser-727 and elevation of Ca(2+) leads to its activation in agonist-stimulated cells.\n",
      "p(HGNC:PLA2G4A,pmod(P)) -> act(p(HGNC:PLA2G4A))\n",
      "p(HGNC:PLA2G4A,pmod(P)) -> act(p(HGNC:PLA2G4A))\n",
      "----------------------\n",
      "10024148 : In human aortic smooth muscle cells, fibrates inhibit the IL-1b?induced expression of cyclooxygenase (COX)-2 and IL-6 by inhibiting the NF-kB and AP-1 signaling pathway.9,10\n",
      "p(HGNC:PPARA) -| p(HGNC:IL6)\n",
      "p(HGNC:PPARA) -| p(HGNC:JUN)\n",
      "p(HGNC:PPARA) -| p(HGNC:PTGS2)\n",
      "----------------------\n",
      "10024188 : Additionally, several studies have shown that antioxidant enzymes and mimics also block NF-kB activation by various stimuli. For example, overexpression of peroxiredoxin [247] or thioredoxin [111] blocks NF-kB activation by H2O2.\n",
      "p(HGNC:PRDX6) -| a(CHEBI:\"reactive oxygen species\")\n",
      "p(HGNC:PRDX6) -| bp(GOBP:\"response to oxidative stress\")\n",
      "p(HGNC:TXN) -| a(CHEBI:\"reactive oxygen species\")\n",
      "p(HGNC:TXN) -| bp(GOBP:\"response to oxidative stress\")\n",
      "----------------------\n",
      "10024192 : Transfection of PKAc, but not empty vector, enhanced phosphorylation of cotransfected GSK-3a and -b at serine 21 and 9 in HEK293 cells (Fig. 4A).\n",
      "p(HGNC:PRKACA) -> p(HGNC:GSK3A,pmod(P))\n",
      "p(HGNC:PRKACA) -> p(HGNC:GSK3B,pmod(P))\n",
      "----------------------\n",
      "10024196 : Here we demonstrate that the aPKCs interact in an EGF-inducible manner with MEK5 and that this interaction is required and sufficient for the activation of MEK5 in response to EGF.\n",
      "p(HGNC:PRKCI) -> act(p(HGNC:MAP2K5))\n",
      "p(HGNC:PRKCZ) -> act(p(HGNC:MAP2K5))\n",
      "----------------------\n",
      "10007488 : SOCS-3 and SOCS-1 genes were transiently expressed in response to PRL, both in vivo and in vitro, whereas the expression of SOCS-2 and CIS genes was still elevated 24 h after hormonal stimulation\n",
      "p(HGNC:PRL) -> r(HGNC:CISH)\n",
      "p(HGNC:PRL) -> r(HGNC:SOCS2)\n",
      "----------------------\n",
      "10007490 : Following prolactin activation, both STAT5A and STAT5B were rapidly translocated into the nucleus and displayed a detergent-resistant, punctate nuclear staining pattern.\n",
      "p(HGNC:PRL) -> tloc(p(HGNC:STAT5A))\n",
      "p(HGNC:PRL) -> tloc(p(HGNC:STAT5B))\n",
      "----------------------\n",
      "10024216 : In support of this finding, the beta-catenin half-life was dramatically longer in fibroblasts deficient in PS1, and this phenotype was completely rescued by replacement of PS1, demonstrating that PS1 normally stimulates the degradation of beta-catenin.\n",
      "p(HGNC:PSEN1) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:PSEN1) -| p(HGNC:CTNNB1)\n",
      "----------------------\n",
      "10024232 : To determine which receptors were stimulated by PGE2 to promote wound closure, wounded monolayers of 16HBE14o2 cells were treated with agonists and antagonists of EP1, EP3, and EP4 receptors. Figure 5 shows that both the EP1 receptor antagonist AH-6809 and the EP4 receptor antagonist AH-23848B significantly inhibited wound repair compared with that in untreated control monolayers.\n",
      "p(HGNC:PTGER1) -> bp(GOBP:\"wound healing\")\n",
      "p(HGNC:PTGER4) -> bp(GOBP:\"wound healing\")\n",
      "----------------------\n",
      "10007514 : In MCF-7 breast cancer cells that express wild type p53, PTTG overexpression caused apoptosis. p53 was translocated to the nuclei in cells expressing PTTG .\n",
      "p(HGNC:PTTG1) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:PTTG1) -> tloc(p(HGNC:TP53))\n",
      "----------------------\n",
      "10024268 : <E21> The p107 promoter contains E2F recognition elements and can be repressed by pRb or p107 (Zhu et al., 1995).\n",
      "p(HGNC:RB1) -| r(HGNC:RBL1)\n",
      "p(HGNC:RBL1) -| r(HGNC:RBL1)\n",
      "----------------------\n",
      "10007526 : MSSP possesses versatile functions, including stimulation of DNA replication, transcriptional regulation, apoptosis induction, and cell transformation coordinated by c-Myc.\n",
      "p(HGNC:RBMS1) -> bp(GOBP:\"DNA replication\")\n",
      "p(HGNC:RBMS1) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:RBMS1) -> act(p(HGNC:MYC))\n",
      "----------------------\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10024302 : <s16> DNA-PK can bind to RPA (Shao et al., 1999). <s17> Phosphorylation of RPA2 by DNA-PK impairs the binding of RPA to DNA-PK (Shao et al., 1999).\n",
      "p(HGNC:RPA2,pmod(P)) -| complex(p(HGNC:RPA2),p(HGNC:RPA3),p(HGNC:RPA1),p(HGNC:PRKDC))\n",
      "p(HGNC:RPA2,pmod(P)) -| complex(p(HGNC:RPA2),p(HGNC:RPA3),p(HGNC:RPA1),p(HGNC:PRKDC))\n",
      "----------------------\n",
      "10024304 : Here, we identify Ser386 in the hydrophobic motif of RSK2 as a phosphorylation-dependent docking site and activator of PDK1.\n",
      "p(HGNC:RPS6KA3,pmod(P)) -> complex(p(HGNC:RPS6KA3),p(HGNC:PDPK1))\n",
      "p(HGNC:RPS6KA3,pmod(P)) -> act(p(HGNC:PDPK1))\n",
      "p(HGNC:RPS6KA3,pmod(P)) -> act(p(HGNC:RPS6KA3))\n",
      "----------------------\n",
      "10024312 : Human peripheral blood monocytes stimulated with sE-selectin showed a time-dependent increase in the tyrosine phosphorylation of a broad range of cellular proteins, predominantly in the molecular size range of Src family kinases (50-60 kDa) and mitogen-activated protein kinases (MAPKs). Western blot analysis of Src family kinases showed a time-dependent increase in Src, Hck, and Lyn phosphorylation.\n",
      "p(HGNC:SELE) -> p(HGNC:HCK,pmod(P))\n",
      "p(HGNC:SELE) -> p(HGNC:LYN,pmod(P))\n",
      "p(HGNC:SELE) -> p(HGNC:SRC,pmod(P))\n",
      "----------------------\n",
      "10024322 : Overexpression of 14-3-3 sigma obstructs cell cycle entry by inhibiting cyclin -CDK activity in many breast cancer cell lines.\n",
      "p(HGNC:SFN) -| bp(GOBP:\"cell cycle\")\n",
      "p(HGNC:SFN) -| act(p(HGNC:CDK4))\n",
      "----------------------\n",
      "10024346 : These findings explain the tumor suppressor roles of Smad2 and Smad4 in growth arrest signaling by TGF-beta.\n",
      "p(HGNC:SMAD2) -| bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:SMAD2) -| path(MESHD:Carcinoma)\n",
      "----------------------\n",
      "10024352 : Supernatants of monocytes stimulated with the F(ab')2 preparation of anti-U1-RNP antibodies enhanced the amounts of both Il-1 alpha and IL-6 associated with HPAECs almost as effectively as those stimulated with intact autoantibody molecules.\n",
      "p(HGNC:SNRNP70) -> r(HGNC:IL1A)\n",
      "p(HGNC:SNRNP70) -> r(HGNC:IL6)\n",
      "----------------------\n",
      "10007590 : Unlike SOCS-2, both SOCS-1 and SOCS-3 abolished the ability of the PRLR to induce beta-casein gene promoter activation.\n",
      "p(HGNC:SOCS1) -| r(HGNC:CSN2)\n",
      "p(HGNC:SOCS3) -| r(HGNC:CSN2)\n",
      "----------------------\n",
      "10024358 : Furthermore, SOCS-1 and SOCS-3 were shown to inhibit GH stimulated transcription of the GH-responsive serine protease inhibitor 2.1 gene promoter.\n",
      "p(HGNC:SOCS1) -| r(HGNC:SERPINA3)\n",
      "p(HGNC:SOCS3) -| r(HGNC:SERPINA3)\n",
      "----------------------\n",
      "10024360 : SOD (250 U/ml) significantly suppressed the IL-6 production and IL-6 mRNA expression induced by XO, whereas catalase (500 U/ml) did not modulate the IL-6 response to XO (Fig. 4).\n",
      "p(HGNC:SOD1) -| p(HGNC:IL6)\n",
      "p(HGNC:SOD1) -| r(HGNC:IL6)\n",
      "----------------------\n",
      "10024364 : In support of this hypothesis, the gelatinolytic activity of MMP-2 and the mRNA levels of MMP-3 and MMP-7 were increased in the Sod2 overexpressors compared with control cell lines (Fig. 5C, left panel).\n",
      "p(HGNC:SOD2) -> act(p(HGNC:MMP2))\n",
      "p(HGNC:SOD2) -> r(HGNC:MMP3)\n",
      "p(HGNC:SOD2) -> r(HGNC:MMP7)\n",
      "----------------------\n",
      "10022688 : Immunoblot analysis of extracts from control and HT15 cells showed an increase in the activated forms of ERK1/2 in the Sod2-overexpressing cells that was reversed upon coexpression of catalase (Fig. 5A).\n",
      "p(HGNC:SOD2) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:SOD2) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10024384 : We also found that the G1-S progression of the cell cycle and expression of cyclin A mRNA were significantly suppressed in T24 cells expressing the drs gene under non-adhesion culture conditions.\n",
      "p(HGNC:SRPX) -| bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "p(HGNC:SRPX) -| r(HGNC:CCNA1)\n",
      "----------------------\n",
      "10024394 : Tyrosine phosphorylation is essential for Stat dimerization, nuclear translocation, DNA binding, and transcriptional activation.\n",
      "p(HGNC:STAT5A,pmod(P)) -> complex(p(HGNC:STAT5A),p(HGNC:STAT5A))\n",
      "p(HGNC:STAT5A,pmod(P)) -> tloc(p(HGNC:STAT5A))\n",
      "p(HGNC:STAT5A,pmod(P)) -> act(p(HGNC:STAT5A))\n",
      "----------------------\n",
      "10007628 : Finally, stable expression of AP-2 in hepatoma cells significantly reduced the expression of endogenous SAA, albumin, and alpha-fetoprotein genes.\n",
      "p(HGNC:TFAP2A) -| r(HGNC:AFP)\n",
      "p(HGNC:TFAP2A) -| r(HGNC:ALB)\n",
      "----------------------\n",
      "10024430 : TGF-b1 also stimulates H2O2 production in bovine pulmonary artery endothelial cells (22), vascular endothelial cells (23), mouse osteoblastic cells (24), and human lung fibroblast (HLF) cells (25, 26).\n",
      "p(HGNC:TGFB1) -> a(CHEBI:\"hydrogen peroxide\")\n",
      "p(MGI:Tgfb1) -> a(CHEBI:\"hydrogen peroxide\")\n",
      "----------------------\n",
      "10024436 : TGF-beta increased cell adhesion to vitronectin and up-regulated the surface level of alpha(v)beta(5) via increasing beta(5) protein synthesis by a transcriptional mechanism.\n",
      "p(HGNC:TGFB1) -> bp(GOBP:\"cell adhesion\")\n",
      "p(HGNC:TGFB1) -> complex(p(HGNC:ITGAV),p(HGNC:ITGB5),p(HGNC:VTN))\n",
      "p(HGNC:TGFB1) -> r(HGNC:ITGB5)\n",
      "p(HGNC:TGFB1) -> surf(complex(p(HGNC:ITGAV),p(HGNC:ITGB5),p(HGNC:VTN)))\n",
      "----------------------\n",
      "10024442 : Endogenous Miz-1 is present in HaCaT cells as two species of relative molecular mass 85,000 (Mr 85K) and 100K, respectively, the latter species forming a complex with Myc (Fig. 2a). TGFbeta had no effect on levels of Miz-1 but caused a rapid reduction in levels of Myc. This was accompanied by a marked reduction in levels of the MycâMiz-1 complex (Fig. 2a).\n",
      "p(HGNC:TGFB1) -| complex(p(HGNC:ZBTB17),p(HGNC:MYC))\n",
      "p(HGNC:TGFB1) -| p(HGNC:MYC)\n",
      "----------------------\n",
      "10007666 : TSP-1 and TGF-beta1 promoted a dose-dependent upregulation of ASPC-1 and COLO-357 PAI-1 expression.\n",
      "p(HGNC:TGFB1) -> r(HGNC:SERPINE1)\n",
      "p(HGNC:THBS1) -> r(HGNC:SERPINE1)\n",
      "----------------------\n",
      "10024480 : Furthermore, expression of dominant negative Smad3 or Smad4 in cells decreased or abolished the stimulation of beta(5) promoter activity by TGF-beta. Smad4 mutant also inhibited the up-regulation of surface beta(5) level by TGF-beta. Thus, TGF-beta increases expression of the integrin beta(5) gene by mechanisms involving Sp1/Sp3 and Smad transcription factors.\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD4))\n",
      "act(p(HGNC:SMAD3)) -> r(HGNC:ITGB5)\n",
      "act(p(HGNC:SMAD4)) -> r(HGNC:ITGB5)\n",
      "----------------------\n",
      "10024496 : By using a refined model of megakaryocytic differentiation, we found that either TPO stimulation or Ha-Ras G12V expression could up-regulate the expression of cyclin D1 and cyclin D2 in addition to cyclin D3, and that, when cdc2 activity was suppressed, each of cyclin D1, cyclin D2, and cyclin D3 expression was able to induce megakaryocytic differentiation with a similar efficiency.\n",
      "p(HGNC:THPO) -> r(HGNC:CCND1)\n",
      "p(HGNC:THPO) -> r(HGNC:CCND2)\n",
      "----------------------\n",
      "10024498 : The TIMPs bind with high affinity in a 1:1 molar ratio to the catalytic site of active MMPs resulting in loss of proteolytic activity. Moreover, TIMP-1 and TIMP-2 can form a specific complex with the zymogens of MMP-9 and MMP-2, respectively.\n",
      "p(HGNC:TIMP1) -| act(p(HGNC:MMP9))\n",
      "p(HGNC:TIMP2) -| act(p(HGNC:MMP2))\n",
      "----------------------\n",
      "10024510 : Tumor necrosis factor-alpha (TNF) inhibits fat cell differentiation and may also mediate insulin resistance in adipocytes\n",
      "p(HGNC:TNF) -| bp(GOBP:\"fat cell differentiation\")\n",
      "p(HGNC:TNF) -> path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10007486 : TNF caused a rapid activation of caspase-8 and -7 in cells transfected with a vector. The activation of these caspases was potentiated by the PKC inhibitor bisindolylmaleimide (BIM) which downregulates PKC eta and sensitizes cells to TNF.\n",
      "p(HGNC:TNF) -> act(p(HGNC:CASP7))\n",
      "p(HGNC:TNF) -> act(p(HGNC:CASP8))\n",
      "----------------------\n",
      "10024516 : c-Raf-1 kinase was identified as an intracellular target of a signal transduction cascade initiated by binding of TNF-alpha to TNFR-I.\n",
      "p(HGNC:TNF) -> act(p(HGNC:TNFRSF1A))\n",
      "p(HGNC:TNFRSF1A) -> act(p(HGNC:RAF1))\n",
      "----------------------\n",
      "10024520 : Mercurio et al. have recently shown that HeLa cells contain two distinct IKK complexes, one consisting of IKKa/IKKb heterodimers, and the other containing IKKb homodimers (23). Moreover, both complex types could be activated by TNF-a, with heterodimeric complexes showing more abundant IKK activity than homodimeric complexes (23).\n",
      "p(HGNC:TNF) -> act(complex(p(HGNC:CHUK),p(HGNC:IKBKB)))\n",
      "p(HGNC:TNF) -> act(complex(p(HGNC:IKBKB),p(HGNC:IKBKB)))\n",
      "----------------------\n",
      "10024522 : Exposure of human umbilical vein endothelial cells (HUVECs) to TNF-alpha elicited the rapid phosphorylation of Akt/PKB.\n",
      "p(HGNC:TNF) -> act(p(HGNC:AKT1))\n",
      "p(HGNC:TNF) -> p(HGNC:AKT1,pmod(P))\n",
      "----------------------\n",
      "10024524 : TNF-a induced minimal activation of MAPKerk after brief periods of exposure (5â15 min); however, phosphoactivation of MAPKerk was observed by 60 min.\n",
      "p(HGNC:TNF) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:TNF) -> act(p(HGNC:MAPK3))\n",
      "p(HGNC:TNF) -> p(HGNC:MAPK1,pmod(P))\n",
      "p(HGNC:TNF) -> p(HGNC:MAPK3,pmod(P))\n",
      "----------------------\n",
      "10024536 : TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts\n",
      "p(HGNC:TNF) -> p(HGNC:IL6)\n",
      "p(HGNC:TNF) -> r(HGNC:IL6)\n",
      "----------------------\n",
      "10024538 : TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).\n",
      "p(HGNC:TNF) -> p(HGNC:IL6)\n",
      "p(HGNC:TNF) -> tloc(p(HGNC:IL6))\n",
      "----------------------\n",
      "10024564 : The transcript level of Caspase-8, Fas, FADD, DR3, TNFR1 and FRDD were increased by the TNF-alpha signaling pathway.\n",
      "p(HGNC:TNF) -> r(HGNC:FADD)\n",
      "p(HGNC:TNF) -> r(HGNC:FAS)\n",
      "p(HGNC:TNF) -> r(HGNC:TNFRSF1A)\n",
      "p(HGNC:TNF) -> r(HGNC:TNFRSF25)\n",
      "----------------------\n",
      "10007700 : Following TNF alpha up-regulation, there was increased expression of Fas (CD95) and Fas-ligand (Fas-L)\n",
      "p(HGNC:TNF) -> r(HGNC:FAS)\n",
      "p(HGNC:TNF) -> r(HGNC:FASLG)\n",
      "----------------------\n",
      "10024572 : Tumor necrosis factor-alpha (TNF-alpha) mediated a large decrease in IL-18 mRNA levels in the human keratinocyte cell line HaCaT, which was accompanied by a subsequent accumulation of IL-18 protein in the cell culture supernatants, which was shown to be biologically active.\n",
      "p(HGNC:TNF) -| r(HGNC:IL18)\n",
      "p(HGNC:TNF) -> tloc(p(HGNC:IL18))\n",
      "----------------------\n",
      "10007726 : p60-TNFR-mediated inhibition increased continuously during 6 h of treatment and was associated with a down-regulation of glucose transporter-4 (GLUT4) mRNA and GLUT4 protein, whereas the p80-TNFR-specific mutein caused a transient increase in GLUT4 mRNA, but did not alter GLUT4 protein expression after a 24-h incubation\n",
      "p(HGNC:TNFRSF1A) -| r(HGNC:SLC2A4)\n",
      "p(HGNC:TNFRSF1B) -> r(HGNC:SLC2A4)\n",
      "----------------------\n",
      "10024610 : HPV-16 E6 expression suppresses CD437-induced CPP32 activation (A), PARP cleavage (B), and cytochrome c (C) in H460 cells.\n",
      "p(HGNC:TP53) -> act(p(HGNC:CASP3))\n",
      "act(p(HGNC:TP53)) -> r(HGNC:TNFRSF10B)\n",
      "----------------------\n",
      "10024618 : It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)\n",
      "p(HGNC:TPO) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:TPO) -> act(p(HGNC:STAT5A))\n",
      "p(HGNC:TPO) -> act(p(HGNC:STAT5B))\n",
      "----------------------\n",
      "10024636 : Cells that overexpressed TWIST exhibited a spindle shaped morphology, reduced levels of alkaline phosphatase, a reduced proliferation rate, and failed to respond to basic fibroblast growth factor (bFGF).\n",
      "p(HGNC:TWIST1) -| bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:TWIST1) -| p(HGNC:ALPL)\n",
      "----------------------\n",
      "10024638 : TWIST antisense cells exhibited increased levels of alkaline phosphatase and type I collagen mRNA, initiated osteopontin mRNA expression, and had a reduced proliferation rate.\n",
      "p(HGNC:TWIST1) -| r(HGNC:ALPL)\n",
      "p(HGNC:TWIST1) -| r(HGNC:COL1A1)\n",
      "p(HGNC:TWIST1) -| r(HGNC:SPP1)\n",
      "----------------------\n",
      "10024654 : Furthermore, VCAM-1 can induce chemotaxis in endothelial cells in vitro and angiogenesis in vivo (134).\n",
      "p(HGNC:VCAM1) -> bp(GOBP:angiogenesis)\n",
      "p(HGNC:VCAM1) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10024658 : Moreover, induction of wild type PTPH1 resulted in specific dephosphorylation of VCP without changing the overall phosphotyrosine profile of the cells.\n",
      "p(HGNC:VCP,pmod(P)) -> act(p(HGNC:VCP))\n",
      "act(p(HGNC:PTPN3)) -| act(p(HGNC:VCP))\n",
      "act(p(HGNC:PTPN3)) -| p(HGNC:VCP,pmod(P))\n",
      "----------------------\n",
      "10007762 : VEGF-induced enhancement of endothelial functions that mediate the inhibition of vascular smooth muscle cell proliferation, enhanced endothelial cell survival, suppression of thrombosis, and anti-inflammatory effects\n",
      "p(HGNC:VEGFA) -| bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:VEGFA) -| bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:VEGFA) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10024660 : VEGF may also cause an impairment of leukocyte interactions with the endothelium via the ability of endogenous NO synthesis to inhibit leukocyte rolling and adhesion and upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1\n",
      "p(HGNC:VEGFA) -> p(HGNC:ICAM1)\n",
      "p(HGNC:VEGFA) -> p(HGNC:VCAM1)\n",
      "----------------------\n",
      "10007770 : VEGF increased VCAM-1 and ICAM-1 protein levels and increased leukocyte adhesiveness in a NF-kappaB-dependent manner. These results suggest that VEGF-stimulated expression of ICAM-1, VCAM-1, and E-selectin mRNAs was mainly through NF-kappaB activation\n",
      "p(HGNC:VEGFA) -> r(HGNC:ICAM1)\n",
      "p(HGNC:VEGFA) -> r(HGNC:SELE)\n",
      "p(HGNC:VEGFA) -> r(HGNC:VCAM1)\n",
      "----------------------\n",
      "10018362 : The ubiquitous homolog of WASp, N-WASp, is a multidomain protein that interacts with the Arp2/3 complex and G-actin via its C-terminal WA domain to stimulate actin polymerization.\n",
      "p(HGNC:WASL) -> complex(p(HGNC:ACTG1),p(HGNC:ACTG1))\n",
      "p(HGNC:WASL) -> complex(p(HGNC:ACTR2),p(HGNC:ACTR3))\n",
      "----------------------\n",
      "10007774 : Wnt-1 overexpression in mammary epithelial cells induced cyclin D1 mRNA and targeted overexpression of Wnt-1 in the mammary gland of transgenic mice increased both ILK activity and cyclin D1 levels.\n",
      "p(HGNC:WNT1) -> r(HGNC:CCND1)\n",
      "p(MGI:Wnt1) -> act(p(MGI:Ilk))\n",
      "----------------------\n",
      "10024690 : As shown in Fig. 3A, stimulation with XO resulted in a significant increase in the levels of IL-6 at 12 and 24 h compared with those with 0.7 mM X alone (P , 0.0001). Consistent with these protein data, stimulation of HS-24 cells with XO caused the maximum elevation in IL-6 mRNAlevels at 6 h, whereas XO did not modulate control GAPDH transcript levels (Fig. 3B).\n",
      "p(HGNC:XDH) -> p(HGNC:IL6)\n",
      "p(HGNC:XDH) -> r(HGNC:IL6)\n",
      "----------------------\n",
      "10024714 : <C18> Dephosphorylation of Cdk1 Thr14 and Tyr15 sites is carried out by Cdc25C, which must itself be activated by phosphorylation in its N-terminal domain (Jackman and Pines, 1997). Cdc25C activity is high in mitosis during mitosis and low during interphase.\n",
      "act(p(HGNC:CDC25C)) -| p(EGID:5424,pmod(P))\n",
      "act(p(HGNC:CDC25C)) -| p(EGID:5424,pmod(P))\n",
      "----------------------\n",
      "10007816 : We have shown previously that PTEN negatively controls the G1/S cell cycle transition and regulates the levels of p27(KIP1), a CDK inhibitor\n",
      "act(p(HGNC:PTEN)) -| bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "act(p(HGNC:PTEN)) -> p(HGNC:CDKN1B)\n",
      "----------------------\n",
      "10007810 : Here we report that PTEN and the PI 3-kinase pathway regulate p27 protein stability. PTEN-deficiency in mouse embryonic stem (ES) cells causes a decrease of p27 levels with concomitant increase of SKP2, a key component of the SCF(SKP2) complex. Conversely, in human glioblastoma cells, ectopic PTEN expression leads to p27 accumulation, which is accompanied by a reduction of SKP2.\n",
      "act(p(HGNC:PTEN)) -> p(HGNC:CDKN1B)\n",
      "act(p(HGNC:PTEN)) -| p(HGNC:SKP2)\n",
      "----------------------\n",
      "10024730 : The FAK and Shc pathways are regulated both positively and negatively by tyrosine phosphatases. Integrin-mediated activation of ERK is suppressed in cells that lack the re- ceptor-type protein tyrosine phosphatase a or the cytosolic phosphatase SHP-2 (19). These enzymes dephosphorylate the negative regulatory site in Src-family kinases and thus, presumably, amplify both FAK and Shc signaling.\n",
      "act(p(HGNC:PTPN11)) -> act(p(HGNC:FYN))\n",
      "act(p(HGNC:PTPN11)) -> act(p(HGNC:LCK))\n",
      "act(p(HGNC:PTPN11)) -> act(p(HGNC:YES1))\n",
      "----------------------\n",
      "10007830 : The haematopoietic protein tyrosine phosphatase (HePTP) is a negative regulator of the MAP kinases Erk1, Erk2 and p38.\n",
      "act(p(HGNC:PTPN7)) -| act(p(HGNC:MAP2K1))\n",
      "act(p(HGNC:PTPN7)) -| act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:PTPN7)) -| act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10007832 : reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKCdelta activation.\n",
      "act(p(HGNC:PTPRC)) -| act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:PTPRC)) -| act(p(HGNC:MAPK3))\n",
      "act(p(HGNC:PTPRC)) -| act(p(HGNC:PRKCD))\n",
      "r(HGNC:PTPRC) -> p(HGNC:PTPRC)\n",
      "----------------------\n",
      "10024752 : stress-induced activation of p54 SAPKbeta, p46 SAPKgamma (JNK1) or p38 MAP kinases is abolished upon co-transfection with increasing amounts of M3/6\n",
      "act(p(MGI:Dusp8)) -| act(p(MGI:Mapk1))\n",
      "act(p(MGI:Dusp8)) -| act(p(MGI:Mapk9))\n",
      "----------------------\n",
      "10024756 : in 3T3-L1 adipocytes Insulin-induced phosphorylation of Akt, one of the molecules downstream of PI3-kinase, was inhibited by xpression of wild-type SHIP2 expression of SHIP2 appeared to affect the myr-p110-induced phosphorylation, and not the translocation, of Akt2.\n",
      "act(p(MGI:Inppl1)) -| act(p(MGI:Akt2))\n",
      "act(p(MGI:Inppl1)) -| p(MGI:Akt2,pmod(P))\n",
      "----------------------\n",
      "10003706 : This activation is completely abolished by calyculin A and cyclosporine A, inhibitors of protein phosphatase 1 and 2B, respectively.\n",
      "act(p(MGI:Ppp1cb)) -> act(p(MGI:Slc12a4))\n",
      "act(p(MGI:Ppp3cb)) -> act(p(MGI:Slc12a4))\n",
      "----------------------\n",
      "10007858 : Our results demonstrate that in vivo PTEN is a potent negative regulator of insulin signaling and insulin sensitivity in adipose tissue.\n",
      "act(p(MGI:Pten)) -| bp(GOBP:\"insulin receptor signaling pathway\")\n",
      "p(MGI:Pten) -> path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10024772 : Jak1 phosphorylation was reduced in wildtype indivduals after Il13 treatement, implying that SHP-2 is responsible for this effect.\n",
      "act(p(MGI:Ptpn11)) -| p(MGI:Jak1,pmod(P))\n",
      "p(MGI:Jak1,pmod(P)) -> act(p(MGI:Jak1))\n",
      "----------------------\n",
      "10024784 : Cotransfection of JAK1 or JAK3 with TCPTP-WT resulted in substantial dephosphorylation of the kinases\n",
      "act(p(MGI:Ptpn2)) -| act(p(MGI:Jak1))\n",
      "act(p(MGI:Ptpn2)) -| act(p(MGI:Jak3))\n",
      "act(p(MGI:Ptpn2)) -| p(MGI:Jak1,pmod(P))\n",
      "act(p(MGI:Ptpn2)) -| p(MGI:Jak3,pmod(P))\n",
      "----------------------\n",
      "10024786 : In addition, SHP-1 and its mutants showed similar association and dephosphorylation of the other Jak family members (JAK1, Tyk2, and JAK3) but not c-fes when coexpressed in Cos-7 cells (data not shown).\n",
      "act(p(MGI:Ptpn6)) -| p(MGI:Jak1,pmod(P))\n",
      "act(p(MGI:Ptpn6)) -| p(MGI:Jak3,pmod(P))\n",
      "act(p(MGI:Ptpn6)) -| p(MGI:Tyk2,pmod(P))\n",
      "----------------------\n",
      "10024788 : Tyrosine phosphorylation of the NMDAR NR2A and NR2B subunits was reduced upon PTPalpha ablation, indicating a positive effect of this phosphatase on NMDAR phosphorylation via intermediate molecules.\n",
      "act(p(MGI:Ptpra)) -> p(MGI:Grin2a)\n",
      "act(p(MGI:Ptpra)) -> p(MGI:Grin2b)\n",
      "----------------------\n",
      "10024790 : Defects in TCR-mediated signals underlying these abnormalities have now been investigated using CD45-null T cells. No T cell proliferation was detected in response to a CD3 mAb. In thymocytes the p56(lck) and p59(fyn) tyrosine kinases were hyperphosphorylated, and p56(lck) was in its inactive conformation.\n",
      "act(p(MGI:Ptprc)) -> act(p(MGI:Lck))\n",
      "act(p(MGI:Ptprc)) -| p(MGI:Fyn,pmod(P))\n",
      "act(p(MGI:Ptprc)) -| p(MGI:Lck,pmod(P))\n",
      "----------------------\n",
      "10024812 : Inactivation of the ABCA1 gene in ABCA1-knockout mice resulted in a decrease in plasma cholesterol and phospholipids and the virtual absence of plasma HDL.16,19,20\n",
      "p(MGI:Abca1) -> a(CHEBI:cholesterol)\n",
      "p(MGI:Abca1) -> a(CHEBI:phospholipid)\n",
      "----------------------\n",
      "10024834 : Abcg1/ macrophages accumulate sterols, notably 7-ketocholesterol and desmosterol after feeding of a high-cholesterol diet (Table) as well as 27-OH cholesterol (0.260.04 versus 0.440.04 ng/mg protein in macrophages from WT and Abcg1/ mice fed a chow diet, respectively; P0.05).\n",
      "p(MGI:Abcg1) -| a(CHEBI:cholesterol)\n",
      "p(MGI:Abcg1) -| a(CHEBI:desmosterol)\n",
      "----------------------\n",
      "10024842 : Consistent with the altered histology and increased cytokine expression, we found elevated expression of Mmp-8 and Mmp-12 mRNAs in the lungs of Abcg1-/- mice, compared with wild-type controls (Fig. 5)... We also noted a small but significant increase in Timp-1, but not Timp-2 and Timp-3, mRNA levels in the lungs of Abcg1-/- mice (Fig. 5). p? 0.01\n",
      "p(MGI:Abcg1) -| r(MGI:Mmp12)\n",
      "p(MGI:Abcg1) -| r(MGI:Mmp8)\n",
      "p(MGI:Abcg1) -| r(MGI:Timp1)\n",
      "----------------------\n",
      "10024844 : mutations in the Abca1 gene have little or no plasma HDL mutations in Abcg5 or Abcg8 result in elevated levels of cholesterol and plant sterols, especially sitosterol, in both blood and tissues, and show evidence of premature coronary atherosclerosis\n",
      "p(MGI:Abcg5) -| a(CHEBI:sitosterol)\n",
      "p(MGI:Abcg8) -| a(CHEBI:sitosterol)\n",
      "----------------------\n",
      "10007892 : c-Abl function was dispensable in cells deficient in active p53 and inhibition of c-Abl reduced mitogen-induced c-myc expression. These data identify a novel function of cytoplasmic c-Abl in the signalling pathways regulating growth factor-induced c-myc expression and we propose the existence of a tyrosine kinase signalling cascade (PDGFR/c-Src/c-Abl) important for mitogenesis.\n",
      "p(MGI:Abl1) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Abl1) -> r(MGI:Myc)\n",
      "p(MGI:Src) -> p(MGI:Abl1)\n",
      "----------------------\n",
      "10024846 : These results support a model where c-Abl is inhibited in part through an intramolecular Src homology 3-linker interaction and stimulated to full catalytic activity by sequential phosphorylation at Tyr-412 and Tyr-245.\n",
      "p(MGI:Abl1,pmod(P)) -> act(p(MGI:Abl1))\n",
      "p(MGI:Abl1,pmod(P)) -> act(p(MGI:Abl1))\n",
      "----------------------\n",
      "10007896 : Acylcarnitines in SkM predominantly accumulated during exercise with a concomitant decrease of free carnitine.\n",
      "p(MGI:Acadvl) -| a(CHEBI:carnitine)\n",
      "p(MGI:Acadvl) -> a(CHEBI:\"O-acylcarnitine\")\n",
      "----------------------\n",
      "10007898 : Fasting combined with a cold challenge for 8 h significantly induced liver long-chain acylcarnitine and free carnitine production.\n",
      "p(MGI:Acadvl) -| a(CHEBI:carnitine)\n",
      "p(MGI:Acadvl) -| a(CHEBI:\"O-acylcarnitine\")\n",
      "----------------------\n",
      "10024856 : N-KO, but not C-KO mice, have a marked resistance to bleomycin lung injury as assessed by lung histology and hydroxyproline content.\n",
      "p(MGI:Ace) -> a(CHEBI:hydroxyproline)\n",
      "p(MGI:Ace) -> path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10024868 : We further demonstrated that mACTN2 could enhance two transactivation activities of GRIP1, which in turn could enhance the homodimerization of mACTN2.\n",
      "p(MGI:Actn2) -> p(MGI:Grip1)\n",
      "p(MGI:Grip1) -> complex(p(MGI:Actn2),p(MGI:Actn2))\n",
      "----------------------\n",
      "10024878 : In addition, ADAM10 can release soluble EGFR ligands that also occur in tumours, such as ?-cellulin and EGF32,47.\n",
      "p(MGI:Adam10) -> tloc(p(MGI:Btc))\n",
      "p(MGI:Adam10) -> tloc(p(MGI:Egf))\n",
      "----------------------\n",
      "10024886 : This complemented other data showing that overexpression of ADAM17 in MCF-7 breast cancer cells increased invasion and proliferation in vitro, whereas the same was true when ADAM17 expression was downregulated in MDA-Mb-435 cells26\n",
      "p(MGI:Adam17) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Adam17) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10024892 : Cytokine determination within BAL fluid revealed that LPS challenged Tie2-adam17 -/- mice showed reduced release of IL-6 (Fig 7A, 3.9-fold) and TNF-a (Fig 7B, 1.6-fold), whereas no effect was observed in PBS-challenged mice.\n",
      "p(MGI:Adam17) -> tloc(p(MGI:Il6))\n",
      "p(MGI:Adam17) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10024898 : overexpression of ADAM9 causes shedding of EGF and fibroblast growth factor receptor, FGFR2iiib (a murine splice variant of FGFR2), both of which have pivotal functions in the pathogenesis of this disease.\n",
      "p(MGI:Adam9) -> tloc(p(MGI:Egf))\n",
      "p(MGI:Adam9) -> tloc(p(MGI:Fgfr2))\n",
      "----------------------\n",
      "10024904 : Four adenosine receptors have been identified: A1R, A2AR, A2BR, and A3R (20, 28)....As previously noted (10), there were increases in transcript levels for all of the adenosine receptors except the A2AR in the lungs of ADA-/-A2AR+/+ mice.\n",
      "p(MGI:Ada) -| r(MGI:Adora1)\n",
      "p(MGI:Ada) -| r(MGI:Adora2a)\n",
      "p(MGI:Ada) -| r(MGI:Adora2b)\n",
      "p(MGI:Ada) -| r(MGI:Adora3)\n",
      "----------------------\n",
      "10024910 : Other cytokines that were elevated in the lungs of ADA-/-A2AR+/+ mice but were not altered following the removal of the A2AR included IL-4, IL-5, IL-13, and IL-9 (data not shown).\n",
      "p(MGI:Ada) -| r(MGI:Il13)\n",
      "p(MGI:Ada) -| r(MGI:Il19)\n",
      "p(MGI:Ada) -| r(MGI:Il4)\n",
      "p(MGI:Ada) -| r(MGI:Il5)\n",
      "----------------------\n",
      "10007916 : We reported previously that VIP/PACAP protect T cells from activation-induced cell death through down-regulation of Fas ligand (FasL).\n",
      "p(MGI:Adcyap1) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Adcyap1) -| r(MGI:Fasl)\n",
      "p(MGI:Vip) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Vip) -| r(MGI:Fasl)\n",
      "----------------------\n",
      "10007922 : In this work we show that deficiency of beta-adducin produces an 80% decrease of alpha-adducin and a fourfold up-regulation of gamma-adducin in erythrocytes.\n",
      "p(MGI:Add2) -> r(MGI:Add1)\n",
      "p(MGI:Add2) -| r(MGI:Add3)\n",
      "----------------------\n",
      "10024926 : gAd induced the phosphorylation of MEK1/2 and ERK1/2 in RAW264 cells. In addition, the gAd-induced phosphorylation of MEK1/2 and ERK1/2 was dramatically reduced by PD98059 and U0126, respectively.\n",
      "p(MGI:Adipoq) -> act(p(MGI:Map2k1))\n",
      "p(MGI:Adipoq) -> act(p(MGI:Map2k2))\n",
      "p(MGI:Adipoq) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Adipoq) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10007926 : expressions of vascular endothelial growth factor receptor-2 and platelet endothelial cell adhesion molecule-1 on endothelial cells were decreased in the adiponectin-knockout mice.\n",
      "p(MGI:Adipoq) -> p(MGI:Kdr)\n",
      "p(MGI:Adipoq) -> p(MGI:Pecam1)\n",
      "----------------------\n",
      "10024928 : the APN KO lung showed enhanced endothelial dysfunction, reflected as an increase in endothelial apoptosis, which resulted from a decrease in VEGFR-2 and PECAM-1 expression\n",
      "p(MGI:Adipoq) -> p(MGI:Kdr)\n",
      "p(MGI:Adipoq) -> p(MGI:Pecam1)\n",
      "p(MGI:Kdr) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Pecam1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10007928 : We investigated whether globular adiponectin (gAd) affects the expression of inflammation-related genes in murine macrophages (RAW264 cells). DNA microarray analysis indicated that granulocyte colony-stimulating factor (G-CSF) showed the largest increase in expression in gAd-stimulated RAW264 cells. The gAd-induced secretion of G-CSF increased in a time- and dose-dependent manner.\n",
      "p(MGI:Adipoq) -> r(MGI:Csf3)\n",
      "p(MGI:Adipoq) -> tloc(p(MGI:Csf3))\n",
      "----------------------\n",
      "10024934 : L1-R is the main subtype of ADM receptor in both keratinocytes and fibroblasts ADM concentration-dependently raised the proliferation rate and lowered the apoptotic rate of both keratinocytes and fibroblasts\n",
      "p(MGI:Adm) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Adm) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10024964 : In comparison to wild-type (WT) mice, wound healing and wound-induced angiogenesis were significantly suppressed in AT1a(-/-) mice, and these mice exhibited reduced expression of CD31 in wound granulation tissues.\n",
      "p(MGI:Agtr1a) -> bp(GOBP:\"wound healing\")\n",
      "p(MGI:Agtr1a) -> p(MGI:Pecam1)\n",
      "----------------------\n",
      "10024976 : We detected two-fold higher catecholamine plasma levels in Ahr-/- mice than in wild type animals (Fig. 3A,B). These levels were, however, significantly lower than those found in the plasma of Vav3-deficient mice (Fig. 3A,B).\n",
      "p(MGI:Ahr) -| a(CHEBI:catecholamine)\n",
      "p(MGI:Vav3) -| a(CHEBI:catecholamine)\n",
      "----------------------\n",
      "10007938 : Using wild-type (Ahr+/+) and AhR-null (Ahr-/-) mouse primary keratinocyte cultures and tissue explants, we show that lack of AhR increases keratinocyte migration and accelerates skin re-epithelialization without affecting cell proliferation or recruitment of inflammatory cells.\n",
      "p(MGI:Ahr) -| bp(GOBP:\"cell migration\")\n",
      "p(MGI:Ahr) -| bp(GOBP:\"wound healing\")\n",
      "----------------------\n",
      "10024996 : In agreement with our hypothesis, we observed that Ahrâ/â animals displayed tachypnea, showing inspiratory/expiratory cycles very similar to those observed in Vav3-deficient mice (Fig. 1A,B). Likewise, as in the case of the latter mouse strain (38,40), we detected high blood pressure (Fig. 1C,E) and tachycardia (Fig. 1D,F) in Ahrâ/â animals both under sentient (Fig. 1C,D) and unconscious (Fig. 1E,F) conditions.\n",
      "p(MGI:Ahr) -| path(MESHD:Tachycardia)\n",
      "p(MGI:Vav3) -| path(MESHD:Tachycardia)\n",
      "----------------------\n",
      "10025006 : Immunohistochemical analyses of serial sections also revealed that, similar to what happens in Vav3-/- animals (40), neurons located in the RVLM of Ahr-/- mice contained higher levels of tyrosine hydroxylase than those present in the RVLM of wild type mice (Fig. 5C,D).\n",
      "p(MGI:Ahr) -> p(MGI:Th)\n",
      "p(MGI:Vav3) -> p(MGI:Th)\n",
      "----------------------\n",
      "10007946 : we introduced Iba1 into Swiss 3T3 fibroblasts and demonstrated the enhancement of platelet-derived growth factor (PDGF)-induced membrane ruffling and chemotaxis\n",
      "p(MGI:Aif1) -> bp(GOBP:chemotaxis)\n",
      "p(MGI:Pdgfa) -> bp(GOBP:chemotaxis)\n",
      "----------------------\n",
      "10007950 : the transfectants that overexpressed AIF-1 showed marked morphological changes and produced significantly large amounts of interleukin (IL)-6, IL-10 and IL-12p40\n",
      "p(MGI:Aif1) -> r(MGI:Il10)\n",
      "p(MGI:Aif1) -> r(MGI:Il12b)\n",
      "p(MGI:Aif1) -> r(MGI:Il6)\n",
      "----------------------\n",
      "10025042 : AK1 knockouts we observed lower mRNA levels for long chain acyl-CoA dehydrogenase and glutamate dehydrogenase (35 and 54% reduction),\n",
      "p(MGI:Ak1) -| r(MGI:Acadl)\n",
      "p(MGI:Ak1) -| r(MGI:Glud1)\n",
      "----------------------\n",
      "10025046 : Similarly, the levels of mRNAs for PK-M, GAPDH, and GPDH were ~1.5-fold increased in mutant gastrocnemius compared with wild type\n",
      "p(MGI:Ak1) -| r(MGI:Gapdh)\n",
      "p(MGI:Ak1) -| r(MGI:Gpd1)\n",
      "p(MGI:Ak1) -| r(MGI:Pkm)\n",
      "----------------------\n",
      "10025064 : Furthermore, the loss of MnSOD dramatically altered several markers involved in cell proliferation and growth, including decreased growth stimulatory function of mTOR signaling and enhanced growth inhibitory function of GSK-3B signaling... We first detected significantly reduced phosphorylation of Akt (Ser473) in Sod2-/- MEFs.\n",
      "p(MGI:Akt1,pmod(P)) -> act(p(MGI:Akt1))\n",
      "p(MGI:Sod2) -> p(MGI:Akt1,pmod(P))\n",
      "p(MGI:Sod2) -> p(MGI:Gsk3b,pmod(P))\n",
      "----------------------\n",
      "10025076 : Figure 2. Effects of albumin. (A) Alveolar macrophage supernatant TNF- and (B) MMP-12 after in vitro exposure to smoke-conditioned medium and A1AT or albumin (Alb).\n",
      "p(MGI:Alb) -> tloc(p(MGI:Mmp12))\n",
      "p(MGI:Alb) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10025080 : Similar to AlkB, ABH2 and ABH3 have the ability to repair 1meA and 3meC residues. However, whereas ABH2 prefers double-stranded DNA, ABH3 and AlkB favour single-stranded DNA and RNA (Aas et al, 2003; Falnes et al, 2004).\n",
      "p(MGI:Alkbh2) -> bp(GOBP:\"double-strand break repair\")\n",
      "p(MGI:Alkbh3) -> bp(GOBP:\"single strand break repair\")\n",
      "----------------------\n",
      "10025088 : Cys-LT production was reduced by zileuton 15 min after challenge with Ova, and at 6 h, all the LT were reduced (Fig. 2B, other time points not shown).\n",
      "p(MGI:Alox5) -> a(CHEBI:\"leukotriene B4\")\n",
      "p(MGI:Alox5) -> a(CHEBI:\"leukotriene C4\")\n",
      "p(MGI:Alox5) -> a(CHEBI:\"leukotriene D4\")\n",
      "p(MGI:Alox5) -> a(CHEBI:\"leukotriene E4\")\n",
      "----------------------\n",
      "10025090 : We demonstrate that IL-10 suppresses the production of LTB(4) from DC by inhibiting FLAP protein expression without any effect on 5-LO and cytosolic phospholipase A(2).\n",
      "p(MGI:Alox5ap) -> r(MGI:Ltb)\n",
      "p(MGI:Il10) -| r(MGI:Ltb)\n",
      "----------------------\n",
      "10025102 : Zileuton dose dependently inhibited mucus accumulation in the lungs after Ova challenge and completely so at 50 mg/kg three times a day for 3 days (39, 47), as evaluated by RT-PCR for MUC5AC mRNAs (Fig. 6A), by ELISA for MUC5AC proteins (Fig. 6B)\n",
      "p(MGI:Alox5) -> p(MGI:Muc5ac)\n",
      "p(MGI:Alox5) -> r(MGI:Muc5ac)\n",
      "----------------------\n",
      "10007970 : MMP3 is similarly expressed while a 40% increase in MMP2 and a 50% decrease in MMP9 message levels in Alx4-deficient mice relative to their wild-type littermates is observed.\n",
      "p(MGI:Alx4) -| r(MGI:Mmp2)\n",
      "p(MGI:Alx4) -> r(MGI:Mmp9)\n",
      "----------------------\n",
      "10007998 : Plasma corticosterone and aldosterone concentrations were significantly enhanced in apc(Min/+) mice.\n",
      "p(MGI:Apc) -| a(CHEBI:aldosterone)\n",
      "p(MGI:Apc) -| a(CHEBI:corticosterone)\n",
      "----------------------\n",
      "10025144 : Although PAR2 was upregulated in cytokine-stimulated endothelial cells, APC signaling remained PAR1-dependent. Large-scale gene expression profiling documented marked differences in both up- and downregulated genes between APC and thrombin signaling in cytokine-stimulated cells. APC downregulated IIa upregulated\n",
      "p(MGI:Apc) -| r(MGI:Dtna)\n",
      "p(MGI:F2) -> r(MGI:Dtna)\n",
      "----------------------\n",
      "10025150 : human SAP also significantly reduced the histopathological extent of bleomycin-induced collagen deposition (Fig. 3 A) and the generation of collagen at the protein (Fig. 3 B) and gene level (Fig. 3 C).\n",
      "p(MGI:Apcs) -| p(MGI:Col1a1)\n",
      "p(MGI:Apcs) -| r(MGI:Col1a1)\n",
      "p(HGNC:APCS) -| p(HGNC:COL1A1)\n",
      "----------------------\n",
      "10025152 : Moreover, SAP treatment increased the level of the M1 macrophage-associated chemokine IP10/CXCL10, in the circulation of mice treated with SAP, in comparison to control treated bleomycin-challenged animals (Fig. 3 G).\n",
      "p(MGI:Apcs) -> p(MGI:Cxcl10)\n",
      "p(HGNC:APCS) -> p(HGNC:CXCL10)\n",
      "----------------------\n",
      "10025154 : Analysis of a wider panel of M2-associated genes using branched DNA technology in the lungs of bleomycin challenged mice treated with SAP indicated that SAP also reduced the expression of the M2-associated proteins MARCO (Fig. 3 E), ST2 and FIZZ- 1 (Fig. 3 F); as well as attenuating the bleomycin-induced profibrotic mediators CCL2 (MCP1/JE) [14], and oncostatin M (OSM) (OSM) [15] (Fig. 3 E).\n",
      "p(MGI:Apcs) -| r(MGI:Ccl2)\n",
      "p(MGI:Apcs) -| r(MGI:Marco)\n",
      "p(MGI:Apcs) -| r(MGI:Osm)\n",
      "p(MGI:Apcs) -| r(MGI:Retnlb)\n",
      "----------------------\n",
      "10025198 : In diabetic apolipoprotein E (apo E) deficient mice, RAGE signaling mediates prolonged vascular inflammation, and enhances the expression of vascular cell adhesion molecule (VCAM)-1 and tissue factor, leading to an exacerbation of the inflammatory state (82).\n",
      "p(MGI:Apoe) -| r(MGI:F3)\n",
      "p(MGI:Apoe) -| r(MGI:Vcam1)\n",
      "----------------------\n",
      "10025204 : qRT-PCR revealed that the aorta of ApoE KO mice had markedly decreased constitutive levels of miR-143 and miR-145, and that expression was further reduced (to less than 75% of WT levels) when fed on a high-fat diet (HFD) (Figure 2b).\n",
      "p(MGI:Apoe) -> r(MGI:Mir143)\n",
      "p(MGI:Apoe) -> r(MGI:Mir145)\n",
      "----------------------\n",
      "10025208 : level of both TLR-2 and TLR-4 mRNA is increased with time in arterial tissue obtained from Apo E-deficient mice, and TLR-2 and TLR-4 expression on circulating monocytes is increased at 40 weeks in Apo E-deficient mice compared with controls [96].\n",
      "p(MGI:Apoe) -| r(MGI:Tlr2)\n",
      "p(MGI:Apoe) -| r(MGI:Tlr4)\n",
      "----------------------\n",
      "10025214 : We also observed that the hepatic mRNA levels of cistathionine {beta}-synthase and the modifier subunit of {gamma}-glutamylcysteine synthetase, two enzymes that are induced under oxidative stress, were up-regulated in AR null mice.\n",
      "p(MGI:Areg) -| r(MGI:Cbs)\n",
      "p(MGI:Areg) -| r(MGI:Gclm)\n",
      "----------------------\n",
      "10025216 : As shown in Figure 4a and b, HIF-1anull cells totally failed to upregulate Ero1-La under hypoxia. Likewise, HIF-1b-null cells were incapable of inducing Ero1-La under hypoxia.\n",
      "p(MGI:Arnt) -> r(MGI:Ero1l)\n",
      "p(MGI:Hif1a) -> r(MGI:Ero1l)\n",
      "----------------------\n",
      "10025218 : Furthermore, this defect is associated with decreased cell surface expression of integrin alphavbeta3 and significantly decreased expression of this integrin in focal adhesions.\n",
      "p(MGI:Arnt) -> surf(complex(p(MGI:Itgav),p(MGI:Itgb3)))\n",
      "act(p(MGI:Epas1)) -> surf(complex(p(MGI:Itgav),p(MGI:Itgb3)))\n",
      "----------------------\n",
      "10025224 : Both beta arr1-KO and beta arr2-KO cells showed similar impairment in agonist-stimulated beta(2)-AR and AT(1A)-R desensitization, when compared with their WT control cells\n",
      "p(MGI:Arrb1) -| act(p(MGI:Adrb2))\n",
      "p(MGI:Arrb1) -| act(p(MGI:Agtr1a))\n",
      "p(MGI:Arrb2) -| act(p(MGI:Adrb2))\n",
      "p(MGI:Arrb2) -| act(p(MGI:Agtr1a))\n",
      "----------------------\n",
      "10025242 : The apparent increase in the differentiation of the cells overexpressing hARX was accompanied by increased levels of MLC1/3F and Myogenin, as determined by PCR and western blot (Figure 4l and m)\n",
      "p(MGI:Arx) -> r(MGI:Myl1)\n",
      "p(MGI:Arx) -> r(MGI:Myog)\n",
      "----------------------\n",
      "10025246 : ATF-2 or SMAD-3, but not IRF-3, short-hairpin RNA reduced p19 promoter activity and protein expression in RAW264.7 cells responding to TMEV.\n",
      "p(MGI:Atf2) -> p(MGI:Il23a)\n",
      "p(MGI:Atf2) -> r(MGI:Il23a)\n",
      "p(MGI:Smad3) -> p(MGI:Il23a)\n",
      "p(MGI:Smad3) -> r(MGI:Il23a)\n",
      "----------------------\n",
      "10025250 : To evaluate the functional role of CREB and ATF2 in the induction of CRP2, we cotransfected ?795Csrp2-luc construct with expression plasmids in transient transfection assays. CREB did not increase Csrp2 promoter activity (Fig. 8A). In contrast, ATF2 expression increased Csrp2 promoter activity by ?3-fold (Fig. 8A), and TGF? further enhanced the transcriptional activation by ATF2 7-fold (Fig. 8A).\n",
      "p(MGI:Atf2) -> r(MGI:Csrp2)\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Csrp2))\n",
      "----------------------\n",
      "10025264 : Whereas c-Jun resulted in a twofold activation of the MLC2a promoter, both ATF3 and JDP2 expression resulted in a marked suppression of the MLC2a-dependent luciferase activity (Fig. 4B).\n",
      "p(MGI:Atf3) -| r(MGI:Myl7)\n",
      "p(MGI:Jun) -> r(MGI:Myl7)\n",
      "----------------------\n",
      "10025310 : Furthermore, primary cells derived from the Atm-/- mice displayed cellular defects characteristic of A-T, including hypersensitivity to ?-irradiation and defective cell cycle G1/S and S-phase checkpoint control following ?-irradiation (3, 33).\n",
      "p(MGI:Atm) -| bp(GOBP:\"DNA replication\")\n",
      "p(MGI:Atm) -| bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "----------------------\n",
      "10020654 : it has been recently shown that ATM is critical for p53 activation and the induction of apoptosis in response to c-MYC, suggesting that, in at least some cases, the ARF and ATM pathways cooperate with c-MYC to activate p53 and promote apoptosis (Figure 1a; Pusapati et al., 2006).\n",
      "p(MGI:Atm) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Atm) -> act(p(MGI:Trp53))\n",
      "----------------------\n",
      "10025312 : Atm-/- cells show an impaired p53 upregulation in response to gamma-irradiation and an increased level of p21, either or both of which could be responsible for their cellular defects and increased tumorigenesis.\n",
      "p(MGI:Atm) -| p(MGI:Cdkn1a)\n",
      "p(MGI:Atm) -> p(MGI:Trp53)\n",
      "----------------------\n",
      "10025356 : Further support for the importance of Bax, but not Bak, inMYC-mediated apoptosis was obtained using a switchable mouse model of MYC-induced apoptosis in pancreatic beta cells, where it was shown that c-MYC induces apoptosis in vivo exclusively through Bax (Dansen et al., 2006).\n",
      "p(MGI:Bax) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Myc) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Myc) -> p(MGI:Bax)\n",
      "p(HGNC:BAX) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10008070 : Reversibly, overexpression of NOXA or PUMA induces apoptosis as evidenced by the activation of BAK and caspase-7.\n",
      "p(MGI:Bbc3) -> act(p(MGI:Bak1))\n",
      "p(MGI:Bbc3) -> act(p(MGI:Casp7))\n",
      "p(MGI:Pmaip1) -> act(p(MGI:Bak1))\n",
      "p(MGI:Pmaip1) -> act(p(MGI:Casp7))\n",
      "----------------------\n",
      "10025366 : it is likely that Chat-induced Rap1 activation was mediated by upregulation of the Cas-Crk-C3G signaling pathway rather than direct guanine nucleotide exchange factor activity of Chat\n",
      "p(MGI:Bcar1) -> p(MGI:Crk)\n",
      "p(MGI:Chat) -> p(MGI:Bcar1)\n",
      "p(MGI:Crk) -> p(MGI:Rapgef1)\n",
      "p(MGI:Rapgef1) -> act(p(MGI:Rap1a))\n",
      "----------------------\n",
      "10025368 : And34 overexpression augments both autophosphorylation and kinase activity of the Cdc42/Rac-responsive serine/threonine kinase PAK1\n",
      "p(MGI:Bcar3) -> act(p(MGI:Pak1))\n",
      "p(MGI:Bcar3) -> p(MGI:Pak1,pmod(P))\n",
      "----------------------\n",
      "10008074 : Astrocytes overexpressing bcl-2 had elevated glutathione levels (130-200%), increased superoxide dismutase (170%) and glutathione peroxidase (140%) activities\n",
      "p(MGI:Bcl2) -> a(CHEBI:glutathione)\n",
      "p(MGI:Bcl2) -> act(p(MGI:Gpx1))\n",
      "p(MGI:Bcl2) -> act(p(MGI:Sod1))\n",
      "----------------------\n",
      "10025372 : Bcl-2 inhibits MYC-mediated apoptosis in some but not all cell systems, although having no effect on the proliferative function of c-MYC (Hoffman and Liebermann, 1998; Nilsson and Cleveland, 2003).\n",
      "p(MGI:Bcl2) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BCL2) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10025374 : c-MYC overexpression accelerated apoptosis when these cells were deprived of IL-3 (Eischen et al., 2001b). Furthermore, c-MYC overexpression suppresses Bcl-2 protein and RNA levels, and restoration of Bcl-2 protein blocks this accelerated apoptosis.\n",
      "p(MGI:Bcl2) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Myc) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Myc) -| p(MGI:Bcl2)\n",
      "p(MGI:Myc) -| r(MGI:Bcl2)\n",
      "p(HGNC:BCL2) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10008082 : Cystic kidneys from postnatal day 20 bcl-2 -/- mice demonstrate a reduced expression, sixfold decrease in activity, and altered distribution of SHP-2 and PTP 1B\n",
      "p(MGI:Bcl2) -> r(MGI:Ptpn11)\n",
      "p(MGI:Bcl2) -> r(MGI:Sirpa)\n",
      "----------------------\n",
      "10008088 : We found that in primary mouse B cells, BCL-6 repressed expression of the Blimp-1, p27kip1, and cyclin D2 target genes.\n",
      "p(MGI:Bcl6) -| r(MGI:Ccnd2)\n",
      "p(MGI:Bcl6) -| r(MGI:Cdkn1b)\n",
      "----------------------\n",
      "10025398 : Thus, BDNF stimulates calbindin expression in cultured hippocampal and cortical neurons (Ip et al., 1993 ; Widmer and Hefti, 1994 ).\n",
      "p(MGI:Bdnf) -> p(MGI:Calb1)\n",
      "p(MGI:Bdnf) -> r(MGI:Calb1)\n",
      "----------------------\n",
      "10025402 : alpha chimaerin which has 91% homology to human alpha2 chimaerin, was also up-regulated following exposure to BDNF figure shows NGF also induces\n",
      "p(MGI:Bdnf) -> r(MGI:Chn1)\n",
      "p(MGI:Klk1b4) -> r(MGI:Chn1)\n",
      "p(MGI:Ngf) -> r(MGI:Chn1)\n",
      "----------------------\n",
      "10025404 : An increase in the expression of beta chimaerin mRNA by the BDNF treatment was found during the observation period, Expression of beta chimaerin mRNA is induced transiently by NGF as well as BDNF\n",
      "p(MGI:Bdnf) -> r(MGI:Chn2)\n",
      "p(MGI:Klk1b4) -> r(MGI:Chn2)\n",
      "p(MGI:Ngf) -> r(MGI:Chn2)\n",
      "----------------------\n",
      "10025412 : A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy.\n",
      "p(MGI:Becn1) -> bp(GOBP:autophagy)\n",
      "p(MGI:Bnip3) -> bp(GOBP:autophagy)\n",
      "p(MGI:Gabarap) -> bp(GOBP:autophagy)\n",
      "----------------------\n",
      "10025416 : Becn1+/- macrophages displayed greater caspase-1 activation and cleaved IL-1b after LPS and ATP treatment (Fig. 1a).\n",
      "p(MGI:Becn1) -| act(p(MGI:Casp1))\n",
      "p(MGI:Becn1) -| tloc(p(MGI:Il1b))\n",
      "----------------------\n",
      "10025420 : IL-1b and IL-18 secretion into the medium was also increased in Map1lc3b-/- and Becn1+/- macrophages compared to corresponding wild-type macrophages (Fig. 1b).\n",
      "p(MGI:Becn1) -| tloc(p(MGI:Il18))\n",
      "p(MGI:Map1lc3b) -| tloc(p(MGI:Il18))\n",
      "----------------------\n",
      "10008094 : the combination of biglycan overexpression and Ang II infusion resulted in marked increases in vascular smooth muscle cell proliferation and migration in the coronary arteries, as well as increases in fibrosis surrounding the vessels. In vitro, biglycan caused an increase in thymidine incorporation and migration of vascular smooth muscle cells, whereas these parameters were unchanged or reduced in endothelial cells.\n",
      "p(MGI:Bgn) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Bgn) -> bp(GOBP:\"DNA replication\")\n",
      "----------------------\n",
      "10025422 : Biglycan deficiency resulted in a reduction of pro-Il1B (Figure7A) and Nlrp3 (Figure7B) mRNA expression as well as in decreased levels of active caspase-1 (Figure 7, C and E) and mature IL-1B (Figure7F) over the whole experimental period.\n",
      "p(MGI:Bgn) -> p(MGI:Casp1)\n",
      "p(MGI:Bgn) -> r(MGI:Il1b)\n",
      "p(MGI:Bgn) -> r(MGI:Nlrp3)\n",
      "----------------------\n",
      "10008096 : addition of biglycan resulted in an increase in cdk2 expression and decrease in p27 levels in the vascular smooth muscle cells.\n",
      "p(MGI:Bgn) -> p(MGI:Cdk2)\n",
      "p(MGI:Bgn) -| p(MGI:Cdkn1b)\n",
      "----------------------\n",
      "10025424 : mRNA levels of several osteoblast-specific marker genes were tested to determine the effect of Bgn on MC3T3-E1 differentiation. ocn transcript levels markedly increased in Bgn-treated cells. Higher levels of runx2 and bmp2 mRNA were also observed in Bgn-treated cells.\n",
      "p(MGI:Bgn) -> r(EGID:12096)\n",
      "p(MGI:Bgn) -> r(MGI:Bmp2)\n",
      "p(MGI:Bgn) -> r(MGI:Runx2)\n",
      "----------------------\n",
      "10025442 : Protein interaction studies confirm that SHARP1 interacts with and inhibits the transcriptional activity of both C/EBPbeta and C/EBPalpha, and enhances the association of C/EBPbeta with histone deacetylase 1 (HDAC1).\n",
      "p(MGI:Bhlhe41) -> complex(p(MGI:Cebpb),p(MGI:Hdac1))\n",
      "p(MGI:Bhlhe41) -| act(p(MGI:Cebpa))\n",
      "p(MGI:Bhlhe41) -| act(p(MGI:Cebpb))\n",
      "----------------------\n",
      "10008104 : Survivin disruption by DN T34A Survivin blocked CA-Ras-induced IL-3-independent cell survival and proliferation; however, it did not affect CA-Ras-mediated enhancement of S-phase, indicating that the anti-apoptotic activity of CA-Ras is Survivin dependent while its S-phase enhancing effect is not.\n",
      "p(MGI:Birc5) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Hras) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10025456 : Here we identified BLNK as a direct target of the transcription factor Pax5 (BSAP). Restoration of BLNK expression in Ig(mu) transgenic Pax5(--) pro-B cells resulted in constitutive pre-BCR signaling and increased cell proliferation without inducing progression to the pre-B cell stage.....Pax5 Activates BLNK by Binding to the Transcription Initiation Region\n",
      "p(MGI:Blnk) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Pax5)) -> r(MGI:Blnk)\n",
      "----------------------\n",
      "10025462 : Indeed, mouse embryonic fibroblasts deficient for the polycomb group protein BMI1 underwent premature cellular senescence, due to the derepression of both the INK4A and ARF genes (Jacobs et al., 1999).\n",
      "p(MGI:Bmi1) -| bp(GOBP:\"cell aging\")\n",
      "p(MGI:Bmi1) -| r(MGI:Cdkn2a)\n",
      "----------------------\n",
      "10008114 : Bone morphogenetic protein 1 (BMP-1) and mammalian Tolloid (mTLD), two proteinases encoded by Bmp1, provide procollagen C-proteinase (pCP) activity that converts procollagens I to III into the major fibrous components of mammalian extracellular matrix (ECM)\n",
      "p(MGI:Bmp1) -> p(MGI:Col1a1)\n",
      "p(MGI:Bmp1) -> p(MGI:Col1a2)\n",
      "p(MGI:Bmp1) -> p(MGI:Col2a1)\n",
      "p(MGI:Bmp1) -> p(MGI:Col3a1)\n",
      "----------------------\n",
      "10025486 : Following confluence, BMP-2was added tomedium at 200 ng/mL for 2-3 weeks, causing a 6-fold induction of ALP activity in wild-type MEFs. In RB/ MEFs, we observed a reduction in both basal and BMP-2-induced ALP activity as compared to that in wild-type MEFs, although BMP-2 still stimulated activity 3-fold in these cells (Figure 2A).\n",
      "p(MGI:Bmp2) -> act(p(MGI:Alpl))\n",
      "act(p(MGI:Rb1)) -> act(p(MGI:Alpl))\n",
      "----------------------\n",
      "10025488 : Cells cultured in the presence of BMP4, -7 or ?2 showed increased expression of alpha-SMA in AECs by immunofluorescence and Western blotting\n",
      "p(MGI:Bmp2) -> p(MGI:Acta2)\n",
      "p(MGI:Bmp4) -> p(MGI:Acta2)\n",
      "p(MGI:Bmp7) -> p(MGI:Acta2)\n",
      "----------------------\n",
      "10025492 : Consistent with a requirement for pRb in osteocalcin expression, weobserved using RT-PCR that osteocalcin mRNA was induced by BMP-2 in wild-type but not RB/ MEFs (Figure 2C, inset).\n",
      "p(MGI:Bmp2) -> r(EGID:12096)\n",
      "p(MGI:Bmp2) -> r(MGI:Bglap2)\n",
      "act(p(MGI:Rb1)) -> r(EGID:12096)\n",
      "act(p(MGI:Rb1)) -> r(MGI:Bglap2)\n",
      "----------------------\n",
      "10025494 : Moreover, the knockdown of Sam68 using short hairpin RNA in the embryonic mesenchymal multipotential progenitor C3H10T1/2 cells resulted in more pronounced expression of the mature osteoblast marker osteocalcin when differentiation was induced with bone morphogenetic protein-2.\n",
      "p(MGI:Bmp2) -| r(EGID:12096)\n",
      "p(MGI:Bmp2) -| r(MGI:Bglap2)\n",
      "p(MGI:Khdrbs1) -| r(EGID:12096)\n",
      "p(MGI:Khdrbs1) -| r(MGI:Bglap2)\n",
      "----------------------\n",
      "10008120 : BMP-2 induces expression of molecular markers characteristic of pre- and hypertrophic chondrocytes, such as Indian hedgehog, parathyroid hormone/parathyroid hormone-related peptide receptor, type X collagen, and alkaline phosphatase\n",
      "p(MGI:Bmp2) -> r(MGI:Alpl)\n",
      "p(MGI:Bmp2) -> r(MGI:Col10a1)\n",
      "p(MGI:Bmp2) -> r(MGI:Ihh)\n",
      "p(MGI:Bmp2) -> r(MGI:Pth1r)\n",
      "----------------------\n",
      "10008122 : After BMP-2 implantation into the back muscles of 198 mice, expression of BMPR-1A, -2, and Noggin was increased during the early phase of the reaction\n",
      "p(MGI:Bmp2) -> r(MGI:Bmpr1a)\n",
      "p(MGI:Bmp2) -> r(MGI:Bmpr2)\n",
      "p(MGI:Bmp2) -> r(MGI:Nog)\n",
      "----------------------\n",
      "10025508 : Loss of either p107 or p130 resulted in a consistently greater increase in ALP due to BMP-2 than was observed in wild-type cells. Furthermore, CBFA1 mRNA levels were increased by BMP-2 treatment in both wild-type and RB/ MEFs\n",
      "p(MGI:Bmp2) -> r(MGI:Runx2)\n",
      "act(p(MGI:Rbl1)) -| act(p(MGI:Alpl))\n",
      "act(p(MGI:Rbl2)) -| act(p(MGI:Alpl))\n",
      "----------------------\n",
      "10025510 : Using reverse transcriptase-real time PCR to measure mRNA expression we found that ZNF450, Runx2/Cbfa-1, and Sp7/osterix were induced by BMP-2 after 4 h in C2C12 myoblast cells.\n",
      "p(MGI:Bmp2) -> r(MGI:Runx2)\n",
      "p(MGI:Bmp2) -> r(MGI:Sp7)\n",
      "p(MGI:Bmp2) -> r(MGI:Zbtb24)\n",
      "----------------------\n",
      "10025514 : blastic differentiation induced by BMP-2. In contrast, secretion of the late marker osteocalcin was undetect( able in RB/ MEFs, while clearly induced in wild-type MEFs as well as in p107/ and p130/ MEFs (Figure 2C).\n",
      "p(MGI:Bmp2) -> tloc(p(EGID:12096))\n",
      "p(MGI:Bmp2) -> tloc(p(MGI:Bglap2))\n",
      "act(p(MGI:Rb1)) -> tloc(p(EGID:12096))\n",
      "act(p(MGI:Rb1)) -> tloc(p(MGI:Bglap2))\n",
      "----------------------\n",
      "10008132 : RBP-Jkappa binding to its target sequence is important not only for Notch signaling, but also for BMP2 signaling, to activate the Hes-5 gene promoter\n",
      "p(MGI:Bmp2) -> act(p(MGI:Rbpj))\n",
      "act(p(MGI:Rbpj)) -> r(MGI:Hes5)\n",
      "----------------------\n",
      "10008134 : Sp1-mediated transcription is one of the mechanisms, which is responsible for BMP2-induced up-regulation of Erk2 expression.\n",
      "p(MGI:Bmp2) -> act(p(MGI:Sp1))\n",
      "act(p(MGI:Sp1)) -> r(MGI:Mapk1)\n",
      "----------------------\n",
      "10008138 : We also found that two members of the BMP family that are crucial for chondrogenesis, GDF5 and BMP4, regulate the pattern of Barx2 expression\n",
      "p(MGI:Bmp4) -> r(MGI:Barx2)\n",
      "p(MGI:Gdf5) -> r(MGI:Barx2)\n",
      "----------------------\n",
      "10025520 : Bead implantation experiments demonstrate that ectopic expression of Fgf8 can induce/maintain the expression of both Pitx1 and Pitx2 at E9.5. In contrast, Bmp4-expressing tissues and BMP4-soaked beads were able to repress Pitx1 expression in mandibular mesenchyme and Pitx2 expression\n",
      "p(MGI:Bmp4) -| r(MGI:Pitx1)\n",
      "p(MGI:Bmp4) -| r(MGI:Pitx2)\n",
      "p(MGI:Fgf8) -> r(MGI:Pitx1)\n",
      "p(MGI:Fgf8) -> r(MGI:Pitx2)\n",
      "----------------------\n",
      "10025526 : TGF-beta reduces the activity of MMPs through increasing plasminogen activator inhibitor (PAI)-1, we tested whether BMP7 interferes with this TGF-beta effect. BMP7 reduces, by about two-thirds, the activation of a PAI-1\n",
      "p(MGI:Bmp7) -| act(p(MGI:Serpine1))\n",
      "p(MGI:Serpine1) -| act(p(MGI:Mmp2))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Serpine1))\n",
      "----------------------\n",
      "10008144 : BMP-7 suppressed the expression of mRNAs for COL1A2 and tissue inhibitor of metalloproteinase-2 while increasing those of inhibitors of differentiation (Id) 2 and 3.\n",
      "p(MGI:Bmp7) -| r(MGI:Col1a2)\n",
      "p(MGI:Bmp7) -> r(MGI:Id2)\n",
      "p(MGI:Bmp7) -> r(MGI:Id3)\n",
      "p(MGI:Bmp7) -| r(MGI:Timp2)\n",
      "----------------------\n",
      "10025570 : Consistent with the increases in inflammatory cells in the BAL fluids from btk-/- mice, BAL fluids from these mice contained increased levels of IL-4, IL-5, and IL-13 (Fig. 7C). Interestingly, btk -/- BAL fluids also had higher levels of IFN-G, in line with the increased IgG2a levels in these mice (Fig. 7A).\n",
      "p(MGI:Btk) -| p(MGI:Ifng)\n",
      "p(MGI:Btk) -| p(MGI:Il13)\n",
      "p(MGI:Btk) -| p(MGI:Il4)\n",
      "p(MGI:Btk) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10025572 : Production of both Th1 (IFN-G) and Th2 (IL-4, IL-5, and IL-13) cytokines was antigen-dependent and more abundant in cultures with btk -/- DCs than in those with WT DCs (Fig. 4B ).\n",
      "p(MGI:Btk) -| p(MGI:Ifng)\n",
      "p(MGI:Btk) -| p(MGI:Il13)\n",
      "p(MGI:Btk) -| p(MGI:Il4)\n",
      "p(MGI:Btk) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10025574 : Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls.\n",
      "p(MGI:C1qa) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:C1qa) -| path(MESHD:Glomerulonephritis)\n",
      "----------------------\n",
      "10025580 : In WT mice CH induced an approximate 2-fold increase in IL-6 mRNA at three weeks that was abrogated in C3 -/- mice... We observed increases in lung intracellular adhesion molecule 1 (ICAM-1)...the increase in ICAM-1 was abrogated in C3 -/- mice (Fig. 7).\n",
      "p(MGI:C3) -> p(MGI:Icam1)\n",
      "p(MGI:C3) -> r(MGI:Il6)\n",
      "p(HGNC:C3) -> p(HGNC:ICAM1)\n",
      "----------------------\n",
      "10008168 : The in vivo administration of KN-93 to mice xenografted with human osteosarcoma cells significantly decreased intratibial and subcutaneous tumor growth. Mechanistically, KN-93 and alpha-CaMKII siRNA increased p21((CIP/KIP)) gene expression, protein levels, and decreased the phosphorylation of retinoblastoma protein and E2F transactivation\n",
      "p(MGI:Camk2a) -| p(MGI:Cdkn1a)\n",
      "p(MGI:Camk2a) -| r(MGI:Cdkn1a)\n",
      "----------------------\n",
      "10008172 : The absence of both mu- and m-calpain activity, caused by disruption of the capn4 gene in mice, retarded migration, and disrupted the cytoskeleton, both in primary capn4(-/-) embryonic fibroblasts (mEF) and in capn4(-/-) mEF immortalized with SV40 large T-antigen (TAg).\n",
      "p(MGI:Capn1) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Capn2) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Capns1) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10025606 : mRNA levels for cathepsin L, the 14-kDa ubiquitin-conjugating enzyme E2, and the C2 subunit of the 20S proteasome decreased by approximately 47% (P<0.005) in the gastrocnemius muscle from calpain-3 deficient mice.\n",
      "p(MGI:Capn3) -> r(MGI:Ctsl)\n",
      "p(MGI:Capn3) -> r(MGI:Psma1)\n",
      "----------------------\n",
      "10008182 : Importantly, apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema.\n",
      "p(MGI:Casp3) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Casp3) -> path(MESHD:Emphysema)\n",
      "----------------------\n",
      "10025620 : Figure 5 Runx2/Cbfa1 expression in preosteoblasts by Western blot analysis. Caspase-3âdeficient (Casp3â/â and Casp3+/â) preosteoblasts showed decreased Runx2/Cbfa1 expression and altered expression pattern of Runx2/Cbfa1 in response to TGF-? treatment when compared with WT preosteoblasts. (Western Blot)\n",
      "p(MGI:Casp3) -| p(MGI:Runx2)\n",
      "p(MGI:Tgfb1) -| p(MGI:Runx2)\n",
      "----------------------\n",
      "10025628 : the induction of Tnfa and Il-6 was severely impaired after 2 h of poly(I:C) stimulation and reduced after 6 h of stimulation in caspase-8-deficient cells (Fig. 4B).\n",
      "p(MGI:Casp8) -> r(MGI:Il6)\n",
      "p(MGI:Casp8) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10025638 : Several genes are downregulated at 13 weeks, including SR Ca2+-ATPase (SERCA2) and adenine nucleotide translocase 1 (Ant1) genes.\n",
      "p(MGI:Casq1) -| r(MGI:Atp2a2)\n",
      "p(MGI:Casq1) -| r(MGI:Slc25a4)\n",
      "----------------------\n",
      "10025640 : Cardiac ankyrin repeat protein (CARP), glutathione peroxidase (Gpx1), and genes which participate in the formation of extracellular matrix including decorin, TSC-36, Magp2, Osf2, and SPARC are upregulated in CSQ mouse hearts at 7 and 13 weeks of age compared to those of non-transgenic littermates.\n",
      "p(MGI:Casq1) -> r(MGI:Dcn)\n",
      "p(MGI:Casq1) -> r(MGI:Fstl1)\n",
      "p(MGI:Casq1) -> r(MGI:Mfap5)\n",
      "p(MGI:Casq1) -> r(MGI:Sparc)\n",
      "----------------------\n",
      "10025678 : In support of this notion, we identify several SH2 domain containing proteins, namely c-Src, NCK, and Ras-GAP, that interact with caveolin-2 in a phosphorylation-dependent manner.\n",
      "p(MGI:Cav2,pmod(P)) -> complex(p(MGI:Cav2),p(MGI:Nck1))\n",
      "p(MGI:Cav2,pmod(P)) -> complex(p(MGI:Cav2),p(MGI:Src))\n",
      "p(MGI:Cav2,pmod(P)) -> complex(p(MGI:Cav2),p(MGI:Syngap1))\n",
      "----------------------\n",
      "10008196 : Because the presenilins also form a physical complex with caveolin-3, caveolin-3 may provide a common platform for APP and the presenilins to associate in astrocytes\n",
      "p(MGI:Cav3) -> complex(p(MGI:Psen1),p(MGI:App))\n",
      "p(MGI:Cav3) -> complex(p(MGI:Psen2),p(MGI:App))\n",
      "----------------------\n",
      "10008198 : Immunoreactivities of APP and presenilins were concomitantly increased in caveolin-3-positive astrocytes\n",
      "p(MGI:Cav3) -> p(MGI:Psen1)\n",
      "p(MGI:Cav3) -> p(MGI:Psen2)\n",
      "----------------------\n",
      "10025680 : Analysis of skeletal muscle tissue from caveolin-3- overexpressing transgenic mice reveals: (i) a dramatic increase in the number of sarcolemmal muscle cell caveolae; (ii) a preponderance of hypertrophic, necrotic, and immature/regenerating skeletal muscle fibers with characteristic central nuclei; and (iii) down-regulation of dystrophin and beta-dystroglycan protein expression.\n",
      "p(MGI:Cav3) -| r(MGI:Dag1)\n",
      "p(MGI:Cav3) -| r(MGI:Dmd)\n",
      "----------------------\n",
      "10025704 : More interestingly, CCL19 and CCL21 have recently been involved in DC maturation, by enhancing the up-regulation of CD86 and CD40 expression markers, whereas CCL19 stimulation also led to increased secretion of IL-12, IL-1? and TNF? from DCs.\n",
      "p(MGI:Ccl19) -> r(MGI:Cd40)\n",
      "p(MGI:Ccl19) -> r(MGI:Cd86)\n",
      "----------------------\n",
      "10025714 : Peritoneal macrophages pre-attached to Transwell membranes were exposed to media, fMLP, GM-CSF, or MCP-1. After 21 h incubation, the concentration of migrated CD44-deficient macrophages was significantly less than that of migrated C57BL/6 macrophages under all conditions\n",
      "p(MGI:Ccl2) -> bp(GOBP:\"macrophage chemotaxis\")\n",
      "p(MGI:Cd44) -> bp(GOBP:\"macrophage chemotaxis\")\n",
      "p(MGI:Csf2) -> bp(GOBP:\"macrophage chemotaxis\")\n",
      "----------------------\n",
      "10000330 : knockout of MCP1 or its receptor CCR-2 also attenuates atherosclerosis in murine models,40,41 and knockout of macrophage colony-stimulation factor (MCSF), which converts monocytes to macrophages, similarly attenuates atherosclerosis.42\n",
      "p(MGI:Ccl2) -> path(MESHD:Atherosclerosis)\n",
      "p(MGI:Ccr2) -> path(MESHD:Atherosclerosis)\n",
      "p(MGI:Csf1) -> path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10025734 : Wounds of mice treated with anti-MIP-1alpha antiserum had significantly fewer macrophages than control (41% decrease, P < 0. 01). This decrease in wound macrophages was paralleled by decreased angiogenic activity and collagen synthesis.\n",
      "p(MGI:Ccl3) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Ccl3) -> bp(GOBP:\"macrophage activation\")\n",
      "----------------------\n",
      "10008230 : During skeletal myogenesis, cell cycle withdrawal accompanies the expression of the contractile phenotype. Here we show that ectopic expression of each D-type cyclin is sufficient to inhibit the transcriptional activation of the muscle-specific creatine kinase (MCK) gene.\n",
      "p(MGI:Ccnd1) -| r(MGI:Ckm)\n",
      "p(MGI:Ccnd2) -| r(MGI:Ckm)\n",
      "p(MGI:Ccnd3) -| r(MGI:Ckm)\n",
      "----------------------\n",
      "10025750 : In these cells, cyclin D3 is increased during differentiation and phosphorylates C/EBPalpha at Ser193, leading to the formation of growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.\n",
      "p(MGI:Ccnd3) -> p(MGI:Cebpa,pmod(P))\n",
      "p(MGI:Cebpa,pmod(P)) -> complex(p(MGI:Cebpa),p(MGI:Cdk2))\n",
      "p(MGI:Cebpa,pmod(P)) -> complex(p(MGI:Cebpa),p(MGI:Smarca2))\n",
      "----------------------\n",
      "10025752 : Pharmacological and genetic studies provide evidence that the expression of cyclin G1, not cyclin G2, is regulated by progesterone via its nuclear receptor. Furthermore, the expression of these genes is aberrantly up-regulated in homeo box A-10 mutant uteri, suggesting that cyclin G1 and cyclin G2 genes act as downstream targets of homeobox A-10 and negatively impact uterine cell proliferation.\n",
      "p(MGI:Ccng1) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Ccng2) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Hoxa10)) -> r(MGI:Ccng1)\n",
      "act(p(MGI:Hoxa10)) -> r(MGI:Ccng2)\n",
      "----------------------\n",
      "10008234 : The results suggest that cyclin G1 is primarily associated with epithelial cell differentiation before implantation and stromal cell proliferation and differentiation during decidualization, whereas cyclin G2 is associated with terminal differentiation and apoptosis of the luminal epithelial and stromal cells at the site of blastocyst after implantation.\n",
      "p(MGI:Ccng2) -> bp(GOBP:\"cell differentiation\")\n",
      "p(MGI:Ccng2) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10008236 : Additionally, T cells from CCR2(-/)- immunized mice showed decreased antigen-induced proliferation and production of IFN-gamma compared with wild-type immunized controls, suggesting that CCR2 enhances the T helper cell type 1 immune response in EAE.\n",
      "p(MGI:Ccr2) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Ccr2) -> p(MGI:Ifng)\n",
      "----------------------\n",
      "10025764 : levels of mRNA encoding ...C were evaluated in lungs from IL-13 transgene and transgene mice...Interestingly, the levels of expression of TIMP-1 and TIMP-4 were increased in CCR2/ animals (Fig. 7B).\n",
      "p(MGI:Ccr2) -| r(MGI:Timp1)\n",
      "p(MGI:Ccr2) -| r(MGI:Timp4)\n",
      "----------------------\n",
      "10025766 : However, those CCR2-deficient mice also showed defects in IL-4 and IL-5 secretion as well as IFN-gamma secretion, similar to our mice.\n",
      "p(MGI:Ccr2) -> tloc(p(MGI:Ifng))\n",
      "p(MGI:Ccr2) -> tloc(p(MGI:Il4))\n",
      "p(MGI:Ccr2) -> tloc(p(MGI:Il5))\n",
      "----------------------\n",
      "10025776 : . The concentration of IL-6, IL-13 and IL-17 was significantly higher in KO mice relative to wild-type mice, while that of IL-12 was significantly higher in wild-type mice relative to KO mice.\n",
      "p(MGI:Ccr5) -> complex(p(MGI:Il12a),p(MGI:Il12b))\n",
      "p(MGI:Ccr5) -| p(MGI:Il13)\n",
      "p(MGI:Ccr5) -| p(MGI:Il17a)\n",
      "p(MGI:Ccr5) -| p(MGI:Il6)\n",
      "----------------------\n",
      "10025784 : the expression of tissue damage-related proteins, TGF-? and mesothelin was more markedly increased in the lungs of KO mice relative to wild-type mice.\n",
      "p(MGI:Ccr5) -| p(MGI:Msln)\n",
      "p(MGI:Ccr5) -| p(MGI:Tgfb1)\n",
      "----------------------\n",
      "10008246 : stimulation with OKT3 resulted in greatly increased quantities of the group VI calcium-independent phospholipase A2\n",
      "p(MGI:Cd247) -> r(MGI:Pla2g6)\n",
      "p(MGI:Cd3d) -> r(MGI:Pla2g6)\n",
      "p(MGI:Cd3e) -> r(MGI:Pla2g6)\n",
      "p(MGI:Cd3g) -> r(MGI:Pla2g6)\n",
      "----------------------\n",
      "10025802 : increased transforming growth factor-beta1 (TGF-beta1) expression and apoptosis were present in podocytes at the onset of albuminuria and were followed by depletion of podocytes associated with progressive focal-segmental glomerulosclerosis in CD2AP-/- mice\n",
      "p(MGI:Cd2ap) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Cd2ap) -| p(MGI:Tgfb1)\n",
      "----------------------\n",
      "10025814 : acLDL-mediated induction of these four inflammatory genes was substantially reduced in CD36-deficient macrophages (MCP-1, TNF-alpha, KC, and IL-1beta)\n",
      "p(MGI:Cd36) -> r(MGI:Ccl2)\n",
      "p(MGI:Cd36) -> r(MGI:Cxcl1)\n",
      "p(MGI:Cd36) -> r(MGI:Il1b)\n",
      "p(MGI:Cd36) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10025818 : Analysis of CD28 KO T cells also revealed a strong defect in Survivin expression; however, this was accompanied by many defects, such as reduced levels of cyclin D, cyclin E, CDK2, and Aurora B (see Figure S1 in the Supplemental Data available with this article online).\n",
      "p(MGI:Cd38) -> r(MGI:Aurkb)\n",
      "p(MGI:Cd38) -> r(MGI:Birc5)\n",
      "p(MGI:Cd38) -> r(MGI:Cdk2)\n",
      "----------------------\n",
      "10025836 : In addition, the anti-CD154 mAb treatment suppressed the up-regulated expression of COL1A1, RANTES, and MCP-1 mRNA (Figure 5g).\n",
      "p(MGI:Cd40lg) -> r(MGI:Ccl2)\n",
      "p(MGI:Cd40lg) -> r(MGI:Ccl5)\n",
      "p(MGI:Cd40lg) -> r(MGI:Col1a1)\n",
      "----------------------\n",
      "10025838 : Exposure of CD40L enhanced the constitutive production of IL-6 and MCP-1 protein (Figure 4A and 4B).\n",
      "p(MGI:Cd40lg) -> tloc(p(MGI:Ccl2))\n",
      "p(MGI:Cd40lg) -> tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10025856 : In the absence of stimulation, CD44-deficient macrophages had significantly attenuated adhesion to endothelial cells (Figure 5). This difference was accentuated in the presence of TNF-alpha stimulation\n",
      "p(MGI:Cd44) -> bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Tnf) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10025858 : Examination of the inflammatory response to intratracheal LPS revealed a significant increase in total inflammatory cell numbers in the BAL fluid from CD44-/- mice...an increase in the cell numbers of macrophage, neutrophils, and lymphocytes\n",
      "p(MGI:Cd44) -| bp(GOBP:\"macrophage chemotaxis\")\n",
      "p(MGI:Cd44) -| bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10025862 : IL-1beta release was inhibited in peritoneal macrophages derived from CD44-deficient mice, in an MH-S macrophage cell line treated with antibodies to CD44, or by inhibitors of lysosome function.\n",
      "p(MGI:Cd44) -> p(MGI:Il1b)\n",
      "p(HGNC:CD44) -> p(HGNC:IL1B)\n",
      "----------------------\n",
      "10025872 : Anti-CD4 was found to perturb proximal signalling events upon TCR/CD3 ligation, resulting in reduced tyrosine phosphorylation of Zap-70 and LAT (linker for activation of T cells) and reduced association of tyrosine-phosphorylated LAT with lck. This ultimately resulted in severely reduced proliferation of the responding CD4+ T cells\n",
      "p(MGI:Cd4) -> bp(GOBP:\"T cell proliferation\")\n",
      "p(MGI:Cd4) -> complex(p(MGI:Lat),p(MGI:Lck))\n",
      "p(MGI:Cd4) -> p(MGI:Lat,pmod(P))\n",
      "p(MGI:Cd4) -> p(MGI:Zap70,pmod(P))\n",
      "----------------------\n",
      "10025878 : At the gene transcriptional level, Api6 overexpression stimulated mRNA expression of Stat3 and its upstream stimuli IL-6 in whole lung cells, AT II epithelial cells, and alveolar macrophages (Fig. 4A).\n",
      "p(MGI:Cd5l) -> r(MGI:Il6)\n",
      "p(MGI:Cd5l) -> r(MGI:Stat3)\n",
      "----------------------\n",
      "10008262 : Cdca4 (Hepp) was originally identified as a gene expressed specifically in hematopoietic progenitor cells as opposed to hematopoietic stem cells. More recently, it has been shown to stimulate p53 activity and also lead to p53-independent growth inhibition when overexpressed.\n",
      "p(MGI:Cdca4) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Cdca4) -> act(p(MGI:Trp53))\n",
      "----------------------\n",
      "10025890 : E-cadherinknockout epidermis displays some hyperproliferation, which however appears to be limited due to compensatory upregulation of P-cadherin (Young et al., 2003; Tinkle et al., 2004; Tunggal et al., 2005)\n",
      "p(MGI:Cdh1) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Cdh1) -| p(MGI:Cdh3)\n",
      "----------------------\n",
      "10025912 : When Notch-IC is present, however, it competes with the inhibitory proteins to bind to CSL. Notch1-IC also directly stimulates expression of the cell-cycle regulator Waf1 (also known as Cip1 and p21) in primary mouse keratinocytes25. The increase in Waf1 concentration causes proliferating keratinocytes to withdraw from the cell cycle and helps to initiate terminal differentiation.\n",
      "p(MGI:Cdkn1a) -| bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Cdkn1a) -| bp(GOBP:\"cell differentiation\")\n",
      "p(MGI:Cdkn1a) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10025916 : Molecular analysis indicated that myostatin down-regulated the protein levels of Cdk2 and up-regulated the levels of its inhibitor p21, thereby rendering Cdk2 inactive.\n",
      "p(MGI:Cdkn1a) -| act(p(MGI:Cdk2))\n",
      "p(MGI:Mstn) -| act(p(MGI:Cdk2))\n",
      "p(MGI:Mstn) -| p(MGI:Cdk2)\n",
      "p(MGI:Mstn) -> p(MGI:Cdkn1a)\n",
      "----------------------\n",
      "10025918 : For each of these conditions, myogenic transcriptional inhibition is reversed by the ectopic co-expression of the general Cdk inhibitor p21.\n",
      "p(MGI:Cdkn1a) -| act(p(MGI:Cdk2))\n",
      "p(MGI:Cdkn1a) -> r(MGI:Ckm)\n",
      "----------------------\n",
      "10025926 : peritoneal macrophages from p21-/- mice exhibit a higher phagocytotic capacity and lower expression of cytokines such as IL-1b, macrophage inflammatory protein (MIP)-1, and MIP-2 than do their wild-type (WT) counterparts (24).\n",
      "p(MGI:Cdkn1a) -> p(MGI:Cxcl2)\n",
      "p(MGI:Cdkn1a) -> p(MGI:Il1b)\n",
      "----------------------\n",
      "10025928 : LPC markedly increased mRNA levels of VCAM-1 (2.7-fold) and MCP-1 (3.7-fold) in WT-EC 24 hours after addition of LPC, whereas, interestingly, this effect was blocked by pretreatment with anti-TNFalpha antibody (1 ug/mL in final concentration) or p21Cip1 small interfering RNA (siRNA)\n",
      "p(MGI:Cdkn1a) -> r(MGI:Ccl2)\n",
      "p(MGI:Cdkn1a) -> r(MGI:Vcam1)\n",
      "p(MGI:Tnf) -> r(MGI:Ccl2)\n",
      "p(MGI:Tnf) -> r(MGI:Vcam1)\n",
      "----------------------\n",
      "10025934 : Taken together, these data indicate that PYK2-induced p21Cip1 activates p300, which promotes Ets-1 binding to the MCP-1 promoter, leading to enhancement of MCP-1 transcription.\n",
      "p(MGI:Cdkn1a) -> act(p(MGI:Ep300))\n",
      "act(p(MGI:Ep300)) -> act(p(MGI:Ets1))\n",
      "act(p(MGI:Ets1)) -> r(MGI:Ccl2)\n",
      "----------------------\n",
      "10025936 : Furthermore, siRNA knockdown of p21Cip1 (88+/-3% inhibition in p21Cip1 protein levels, n=4, P,0.05) attenuated TNFa-mediated Ets-1 binding to MCP-1 promoter in WT-EC (Figure 5D). Thus, TNFa actually induced the transcription of MCP-1 gene by activating Ets-1 binding to the promoter region.\n",
      "p(MGI:Cdkn1a) -> act(p(MGI:Ets1))\n",
      "act(p(MGI:Ets1)) -> r(MGI:Ccl2)\n",
      "----------------------\n",
      "10025952 : Sustained Myc signaling induces Arf expression, resulting in apoptosis through the inhibition of Mdm2 and stabilization of the p53 tumor suppressor protein (37, 38).\n",
      "p(MGI:Cdkn2a) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Cdkn2a) -| p(MGI:Mdm2)\n",
      "act(p(MGI:Myc)) -> r(MGI:Cdkn2a)\n",
      "----------------------\n",
      "10025954 : There are several ways to achieve de-regulation of the RB network and the activation of E2F. There are clear loss-of-function RB mutations that are deficient in E2F binding, and p16 mutations that are defective in Cyclin D/CDK4 inhibition (Sherr, 2001).\n",
      "p(MGI:Cdkn2a) -| act(p(MGI:Cdk4))\n",
      "p(HGNC:CDKN2A) -| act(p(HGNC:CDK4))\n",
      "----------------------\n",
      "10025964 : ARF negatively regulates the transcriptional activity of MYC by associating with and relocating MYC from the nucleoplasm to the nucleolus (Amente et al., 2006; Meyer et al., 2006; Sarker and Fisher, 2006),\n",
      "p(MGI:Cdkn2a) -> tloc(p(MGI:Myc))\n",
      "p(MGI:Cdkn2a) -| act(p(MGI:Myc))\n",
      "----------------------\n",
      "10025974 : Our results indicated that the p38a-deficient lungs had hyperproliferative alveolar tissue with loss of differentiation markers. A similar but more marked lung phenotype, with hyperproliferation and defective cell maturation, has been described previously in CCAAT/ enhancer-binding protein (C/EBP)a knockout mice, which die shortly after birth because of respiratory failure16â18.\n",
      "p(MGI:Cebpa) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Mapk14) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10025978 : Fig. 1a?d Immunohistochemical stainings for surfactant proteins SP-A (a, b) and SP-C (c, d) in the lungs of control (a, c) and CCAAT/enhancer-binding protein (C/EBP)-A-deficient (b, d) mice. Note the stronger immunoreactive products of SP-A (b) and SP-C (d) over the alveolar cells in the hyperplastic alveolar wall and over materials in the alveolar spaces\n",
      "p(MGI:Cebpa) -| p(MGI:Sftpa1)\n",
      "p(MGI:Cebpa) -| p(MGI:Sftpc)\n",
      "----------------------\n",
      "10025980 : Collectively, these results show that C/EBPalpha and C/EBPbeta trans-acting factors can promote transcription of the mouse p8 gene (i) by direct binding to the C/EBP consensus site, and (ii) by enhancing the activity of other trans-acting factors interacting with the p8 promoter.\n",
      "p(MGI:Cebpa) -> r(MGI:Nupr1)\n",
      "p(MGI:Cebpb) -> r(MGI:Nupr1)\n",
      "----------------------\n",
      "10025984 : Accumulation of b-actin mRNA was essentially identical in both wild-type (+/+) and knockout (-/-) lungs. The ratios of the calculated dot areas for SP-A, SP-B, and SP-C mRNAs divided by those for the b-actin mRNAs in the wild-type (+/+) and knockout (-/-) lungs were 0.16Â±0.04 and 0.24Â±0.04 (n=4, P<0.05), 0.52Â±0.12 and 0.79Â±0.09 (n=4, P<0.05), and 1.98Â±0.24 and 2.49Â±0.31 (n=4), respectively (Fig. 5).\n",
      "p(MGI:Cebpa) -| r(MGI:Sftpa1)\n",
      "p(MGI:Cebpa) -| r(MGI:Sftpb)\n",
      "p(MGI:Cebpa) -| r(MGI:Sftpc)\n",
      "----------------------\n",
      "10025986 : the amount of Tgfb1 (TGFb) mRNA was higher in p38a-deficient lungs compared with Mapk14D/+ lungs (Fig. 3e). TGFb has been found to be overexpressed in C/EBPa knockout lungs17, so the reduced C/EBPa levels in the Mapk14-null lungs could account for the higher TGFb expression.\n",
      "p(MGI:Cebpa) -| r(MGI:Tgfb1)\n",
      "p(MGI:Mapk14) -| r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10025988 : To further confirm the effect of C/EBPbeta on Xbp1 induction, we generated 3T3-L1 cells stably expressing C/EBP? shRNA with over 80% knockdown efficacy (Figures 2F?2G). Loss of C/EBP? significantly blocked differentiation as expected (Figure S2C). Indeed, Xbp1 mRNA levels were reduced by nearly 60% in differentiating C/EBP?i 3T3-L1 cells compared with CONi cells at 8 hr postinduction (Figure 2G).\n",
      "p(MGI:Cebpb) -> bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Cebpb) -> r(MGI:Xbp1)\n",
      "----------------------\n",
      "10025992 : deletion of two CREB-binding sites from the Cebpb promoter abrogates Cebpb induction upon macrophage activation. This blocks the downstream induction of M2-specific Msr1, Il10, II13ra, and Arg-1 genes, whereas the inflammatory (M1) genes Il1, Il6, Tnfa, and Il12 are not affected\n",
      "p(MGI:Cebpb) -> r(MGI:Arg1)\n",
      "p(MGI:Cebpb) -> r(MGI:Il10)\n",
      "p(MGI:Cebpb) -> r(MGI:Il13ra1)\n",
      "p(MGI:Cebpb) -> r(MGI:Msr1)\n",
      "----------------------\n",
      "10008280 : C/EBPbeta knockdown increases levels of KLF4 and Krox20, suggesting that C/EBPbeta normally suppresses Krox20 and KLF4 expression via a tightly controlled negative feedback loop\n",
      "p(MGI:Cebpb) -| r(MGI:Egr2)\n",
      "p(MGI:Cebpb) -| r(MGI:Klf4)\n",
      "----------------------\n",
      "10026002 : Male Balb/c mice showed MUC5AC mRNA and protein expression, and goblet cell metaplasia after 8 days of intratracheal instillation of pancreatic elastase. These changes were mediated by elastase proteolytic activity and subsequent initiation of an inflammatory process documented by increases in Gro-{alpha}/KC and IL-5 (338).\n",
      "p(MGI:Cela1) -> p(MGI:Cxcl1)\n",
      "p(MGI:Cela1) -> p(MGI:Il5)\n",
      "p(MGI:Cela1) -> p(MGI:Muc5ac)\n",
      "----------------------\n",
      "10026004 : we isolated total RNA from these mice at 20 days after an intratracheal instillation of either saline or PPE and analyzed by Northern blot (Fig. 1)....Fibulin-5 mRNA is induced 3.8 0.4-fold over baseline (P 0.009, n 3) in the elastase-treated lung at day 20. Elastin mRNA is elevated only 2.4 0.5-fold (P 0.23, n 3) over baseline.\n",
      "p(MGI:Cela1) -> r(MGI:Eln)\n",
      "p(MGI:Cela1) -> r(MGI:Fbln5)\n",
      "----------------------\n",
      "10026036 : Osteocalcin (OCN) mRNA levels decrease following both Tsg and Chd treatment. Tsg and Chd also inhibit alkaline phosphatase (ALP) activity in a dose-dependent manner\n",
      "p(MGI:Chrd) -| act(p(EGID:109899))\n",
      "p(MGI:Chrd) -| r(MGI:Bglap2)\n",
      "p(MGI:Twsg1) -| act(p(EGID:109899))\n",
      "p(MGI:Twsg1) -| r(MGI:Bglap2)\n",
      "----------------------\n",
      "10026064 : from full text - Fig. 6. Signal through MDL-1 up-regulated RANTES, IP-10, and MDC mRNA expression in G-CSF-pretreated 32Dcl3 cells\n",
      "p(MGI:Clec5a) -> r(MGI:Ccl22)\n",
      "p(MGI:Clec5a) -> r(MGI:Ccl5)\n",
      "p(MGI:Clec5a) -> r(MGI:Cxcl10)\n",
      "----------------------\n",
      "10008352 : ciliary neurotrophic factor, CNTF, activation of gp130 in NSCs rapidly increased Notch1 expression\n",
      "p(MGI:Cntf) -> act(p(MGI:Il6st))\n",
      "p(MGI:Il6st) -> r(MGI:Notch1)\n",
      "----------------------\n",
      "10026086 : infusion of EGF and CNTF into adult forebrain lateral ventricles increased periventricular NOTCH1 compared with EGF alone\n",
      "p(MGI:Cntf) -> r(MGI:Notch1)\n",
      "p(MGI:Egf) -> r(MGI:Notch1)\n",
      "----------------------\n",
      "10026094 : Furthermore, Csn2(-/-) embryos contained elevated levels of p53 and p21, which may contribute to premature cell cycle arrest of the mutant.\n",
      "p(MGI:Cops2) -| p(MGI:Cdkn1a)\n",
      "p(MGI:Cops2) -| p(MGI:Trp53)\n",
      "----------------------\n",
      "10008370 : Interestingly, Cpt1c deletion caused a specific elevation of hypothalamic CPT1a and CPT1b isoform expression and activity.\n",
      "p(MGI:Cpt1c) -| act(p(MGI:Cpt1a))\n",
      "p(MGI:Cpt1c) -| act(p(MGI:Cpt1b))\n",
      "p(MGI:Cpt1c) -| p(MGI:Cpt1a)\n",
      "p(MGI:Cpt1c) -| p(MGI:Cpt1b)\n",
      "----------------------\n",
      "10026102 : mRNA levels of hepatic glucoregulatory genes G6pc and Pck1 were significantly increased in WT mice on HFD and to an even greater degree in Cpt1c KO mice (Fig. 3b).\n",
      "p(MGI:Cpt1c) -| r(MGI:G6pc)\n",
      "p(MGI:Cpt1c) -| r(MGI:Pck1)\n",
      "----------------------\n",
      "10026106 : CR2 activation induced, within a brief span of 2 min, tyrosine phosphorylation of nucleolin and its interaction with Src homology 2 domains of the p85 subunit of PI 3 kinase and of 3BP2 and Grb2\n",
      "p(MGI:Cr2) -> p(MGI:Grb2,pmod(P))\n",
      "p(MGI:Cr2) -> p(MGI:Ncl,pmod(P))\n",
      "p(MGI:Cr2) -> p(MGI:Sh3bp2,pmod(P))\n",
      "p(MGI:Ncl,pmod(P)) -> complex(p(MGI:Ncl),p(MGI:Pik3cb))\n",
      "----------------------\n",
      "10015452 : apigenin, a selective casein kinase 2 (CK2) inhibitor, was found to inhibit response% IFN-gamma stimulated CK2 activity and the level of phosphorylated cAMP response element-binding protein, which is known to induce ICER gene transcription, and this response was inhibited in the presence of apigenin.\n",
      "p(MGI:Creb1,pmod(P)) -> r(MGI:Crem)\n",
      "p(MGI:Ifng) -> act(p(MGI:Csnk2a2))\n",
      "----------------------\n",
      "10008380 : both CBP and p300 are indispensable for the full activation of PPARgamma and adipocyte differentiation and that CBP and p300 do not mutually complement in the process.\n",
      "p(MGI:Crebbp) -> bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Crebbp) -> act(p(MGI:Pparg))\n",
      "p(MGI:Ep300) -> bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Ep300) -> act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10026116 : CRH and cAMP induce Nur77 and Nurr1 expression and transcription at the NurRE site by protein kinase A (PKA) and calcium-dependent and -independent mechanisms.\n",
      "p(MGI:Crh) -> r(MGI:Nr4a1)\n",
      "p(MGI:Crh) -> r(MGI:Nr4a2)\n",
      "----------------------\n",
      "10026132 : from full text - Furthermore, Cdc2 kinase activity was reduced (Figs. 2B and 1C). Therefore, the cell cycle progression from S to M phase was impaired during liver regeneration in Cry-deficient mice\n",
      "p(MGI:Cry1) -> bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Cry1) -> act(p(EGID:12534))\n",
      "p(HGNC:CRY1) -> bp(GOBP:\"cell cycle\")\n",
      "----------------------\n",
      "10026134 : from full text - The expression profiles of cyclin D1 and wee1 transcripts were markedly different between Cry-deficient and wildtype mice throughout the liver regeneration process: cyclin D1 expression decreased up to 86% and wee1 expression increased up to 4.6-fold\n",
      "p(MGI:Cry1) -> r(MGI:Ccnd1)\n",
      "p(MGI:Cry1) -| r(MGI:Wee1)\n",
      "----------------------\n",
      "10026144 : As shown in Figures 2D and 2E, lungs from M-CSF-/- mice had reduced CTGF expression compared with lungs from M-CSF+/+ mice treated with bleomycin, as shown by mRNAand protein analysis.\n",
      "p(MGI:Csf1) -> p(MGI:Ctgf)\n",
      "p(MGI:Csf1) -> r(MGI:Ctgf)\n",
      "----------------------\n",
      "10008400 : In addition, the Leydig cells from csfm(op)/ csfm(op) males have diminished amounts of the steroidogenic enzyme proteins P450 side chain cleavage, 3beta-hydroxysteroid dehydrogenase, and P450 17alpha-hydroxylase-lyase, with associated reductions in the activity of all these steroidogenic enzymes, as well as in 17beta-hydroxysteroid dehydrogenase.\n",
      "p(MGI:Csf1) -> r(EGID:111785)\n",
      "p(MGI:Csf1) -> r(MGI:Cyp11a1)\n",
      "p(MGI:Csf1) -> r(MGI:Cyp17a1)\n",
      "----------------------\n",
      "10026152 : Insight into the regulatoin of Pparg expression in activated macrophages has recently been provided by Ricote et al, who demonstrated an induction of Pparg expression in these cells by colony-stimulating factor, granulocyte/macrophage colony stumulating factor, and oxidized LDL.\n",
      "p(MGI:Csf1) -> r(MGI:Pparg)\n",
      "p(MGI:Csf2) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10008416 : In addition, western blot assays revealed that exposure of FSDC to GM-CSF induces the phosphorylation and degradation of the inhibitor of NF-kappaB (IkB), with subsequent translocation of the p50, p52 and RelB subunits of the transcription nuclear factor kappa B (NF-kappaB) from the cytosol to the nucleus.\n",
      "p(MGI:Csf2) -> deg(p(MGI:Nfkbia))\n",
      "p(MGI:Csf2) -> act(p(MGI:Nfkbia))\n",
      "----------------------\n",
      "10026168 : In addition, we also observed increased levels of chemokines MIP-1a and MCP-1 in the BAL in the AdGM-CSF group, particularly at early time points (data not shown).\n",
      "p(MGI:Csf2) -> p(MGI:Ccl2)\n",
      "p(MGI:Csf2) -> p(MGI:Ccl3)\n",
      "----------------------\n",
      "10026170 : In sharp contrast, there was a significant induction of IFNg in the lung of the GM-CSF group, which peaked at day 7 and remained high at day 12 and markedly declined by day 19 (Figure 8).\n",
      "p(MGI:Csf2) -> p(MGI:Ifng)\n",
      "p(HGNC:CSF2) -> p(HGNC:IFNG)\n",
      "----------------------\n",
      "10008422 : However, when these cells are transferred to medium containing G-CSF, the cell number increases 4-5-fold and after 12 days the entire population is differentiated into granulocytes followed by apoptotic death.\n",
      "p(MGI:Csf3) -> bp(GOBP:\"cell differentiation\")\n",
      "p(MGI:Csf3) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10026192 : Here we show that implantation of tumour cells in mice resulted in upregulation of Bv8 (PROK2) in CD11b1Gr11 myeloid cells. We identified granulocyte colony-stimulating factor as a major positive regulator of Bv8 (mRNA) expression. Anti-Bv8 antibodies reduced CD11b1Gr11 cell mobilization elicited by granulocyte colony-stimulating factor.\n",
      "p(MGI:Csf3) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Csf3) -> r(MGI:Prok2)\n",
      "----------------------\n",
      "10008428 : In our search for genes that are induced during apoptosis and/or terminal differentiation of 32Dcl3 cells, we identified a novel gene termed AATYK (Apoptosis Associated Tyrosine Kinase), whose expression is dramatically upregulated during IL-3 deprivation as well as G-CSF-induced terminal differentiation.\n",
      "p(MGI:Csf3) -> r(MGI:Aatk)\n",
      "p(MGI:Il3) -| r(MGI:Aatk)\n",
      "----------------------\n",
      "10026200 : cytoplasmic ??catenin is recruited into a destruction complex, in which it interacts with APC and the axins, and is N?terminally phosphorylated by casein kinase 1? (CK1a) and GSK3?84?88\n",
      "p(MGI:Csnk1a1) -> p(MGI:Ctnnb1,pmod(P))\n",
      "p(MGI:Gsk3b) -> p(MGI:Ctnnb1,pmod(P))\n",
      "----------------------\n",
      "10026202 : In the presence of canonical Wnt ligands (FIG. 1b), LRP5âLRP6 is phosphorylated by CK1? and GSK3?96,97 (and possibly other protein kinases yet to be identified), and Dishevelled is recruited to the plasma membrane, where it interacts with Frizzled receptors and polymerizes with other Dishevelled molecules98,99\n",
      "p(MGI:Csnk1a1) -> p(MGI:Lrp5,pmod(P))\n",
      "p(MGI:Csnk1a1) -> p(MGI:Lrp6,pmod(P))\n",
      "----------------------\n",
      "10026204 : Interestingly, compared with untreated controls, TGFbeta treatment reduced wild type VSMC migration by ?50%, whereas Csrp2-/- VSMC migration was not affected (Fig. 1C), indicating that up-regulation of CRP2 correlated with a blunted VSMC motility\n",
      "p(MGI:Csrp2) -| bp(GOBP:\"cell migration\")\n",
      "p(MGI:Tgfb1) -| bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10026214 : These data indicate that epithelial overexpression of CTGF results in excessive pulmonary vascular remodeling.\n",
      "p(MGI:Ctgf) -> path(MESHD:Fibrosis)\n",
      "p(HGNC:CTGF) -> path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10008442 : We found, indeed, that CTLA-4 engagement inhibits STAT6 activation leaving unaffected the STAT6 protein level. Moreover, CTLA-4 engagement drastically inhibits IL-4Ralpha mRNA and protein up-regulation under Th2-polarizing conditions.\n",
      "p(MGI:Ctla4) -| r(MGI:Il4ra)\n",
      "p(MGI:Ctla4) -| act(p(MGI:Stat6))\n",
      "----------------------\n",
      "10026226 : Hepatocyte growth factor (HGF) and beta-catenin both play a crucial role in stimulating hepatocyte proliferation,\n",
      "p(MGI:Ctnnb1) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Hgf) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10026228 : COX-2 protein and activity clearly decreased in cells transfected with -catenin after treatment compared to cells transfected with non-specific siRNA (Fig. 4A, B).\n",
      "p(MGI:Ctnnb1) -> act(p(MGI:Ptgs2))\n",
      "p(MGI:Ctnnb1) -> p(MGI:Ptgs2)\n",
      "----------------------\n",
      "10026244 : In mouse keratinocytes, Src kinase-mediated phosphorylation was found to generate a docking site for PI3K (p85) on plakoglobin in an EGF-R-dependent manner, to a minor extent on p120cnt, but not on b-catenin, which apparently lacks a PI3K (p85)-docking motive (Calautti et al., 2005).\n",
      "p(MGI:Ctnnd1,pmod(P)) -> complex(p(MGI:Ctnnd1),p(MGI:Pik3r1))\n",
      "p(MGI:Jup,pmod(P)) -> complex(p(MGI:Jup),p(MGI:Pik3r1))\n",
      "----------------------\n",
      "10026254 : a targeted null mutation or chemical inhibition of Cat S ameliorates IFN--induced DNA injury, apoptosis, and emphysema.\n",
      "p(MGI:Ctss) -> bp(GOBP:\"cellular response to DNA damage stimulus\")\n",
      "p(MGI:Ctss) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Ctss) -> path(MESHD:Emphysema)\n",
      "----------------------\n",
      "10026260 : Furthermore, expression of VACM-1 but not S730AVACM-1 protein retarded cytokinesis and prevented MAPK phosphorylation.\n",
      "p(MGI:Cul5) -| act(p(MGI:Mapk1))\n",
      "p(MGI:Cul5) -| act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10026274 : IFN-gamma-inducible protein 10/CXCL10 and IFN-inducible T cell alpha chemoattractant/CXCL11 had similar effects on T lymphocyte proliferation,\n",
      "p(MGI:Cxcl10) -> bp(GOBP:\"T cell proliferation\")\n",
      "p(MGI:Cxcl11) -> bp(GOBP:\"T cell proliferation\")\n",
      "----------------------\n",
      "10026304 : Gro I is a member of the CâXâC chemokine family and is associated with inflammation, angiogenesis, chemotaxis, and growth or survival of tumor cells\n",
      "p(MGI:Cxcl1) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Cxcl1) -> bp(GOBP:chemotaxis)\n",
      "p(HGNC:CXCL1) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10026308 : they do express the GROa homologue KC, and the GROb,g homologue MIP-2, which are known to bind and activate mIL-8RH (43, 44).\n",
      "p(MGI:Cxcl1) -> act(p(EGID:12765))\n",
      "p(MGI:Cxcl2) -> act(p(EGID:12765))\n",
      "p(HGNC:CXCL2) -> act(p(EGID:3579))\n",
      "----------------------\n",
      "10026312 : We confirmed the ability of CXCL2 to induce neutrophil chemotaxis through CXCR2, using antibodies to CXCR2 and the CXCR2 antagonist RPX (Fig. 4B). The decreased surface expression of CXCR2 by LTA was accompanied by reduced F-actin polymerization in response to CXCL2 (Fig. 4D).\n",
      "p(MGI:Cxcl2) -> act(p(EGID:12765))\n",
      "p(HGNC:CXCL2) -> act(p(EGID:3579))\n",
      "----------------------\n",
      "10026358 : the hepatic enzyme cholesterol 7alpha-hydroxylase catalyzes the rate limiting reaction in the conversion of cholesterol to bile acids in the classic pathway, and consequently plays a critical role in cholesterol and bile acid homeostasis, enzyme encoded by Cyp7a1\n",
      "p(MGI:Cyp7a1) -> a(CHEBI:\"bile salt\")\n",
      "p(MGI:Cyp7a1) -| a(CHEBI:cholesterol)\n",
      "----------------------\n",
      "10026360 : bile acids function as end product inhibitors and repress the synthesis of both chenodeoxycholic acid and cholic acid as a result of the decreased expression of Cyp7a1 and Cyp8b1, respectively\n",
      "p(MGI:Cyp7a1) -> a(CHEBI:chenodeoxycholate)\n",
      "p(MGI:Cyp8b1) -> a(CHEBI:\"cholic acid\")\n",
      "----------------------\n",
      "10026364 : Hepatic Abcg5/g8 protein levels were higher in Cyp7a1-tg mice than their wild-type littermates, whereas intestine Abcg5/g8 protein expression showed no difference (Fig. 4A).\n",
      "p(MGI:Cyp7a1) -> p(MGI:Abcg5)\n",
      "p(MGI:Cyp7a1) -> p(MGI:Abcg8)\n",
      "----------------------\n",
      "10026368 : Cyp7a1-tg mice had significantly higher Abcg5 (2.7-fold) and Abcg8 (1.7-fold) mRNA expression in the liver, but not in the intestine (Table 1)\n",
      "p(MGI:Cyp7a1) -> r(MGI:Abcg5)\n",
      "p(MGI:Cyp7a1) -> r(MGI:Abcg8)\n",
      "----------------------\n",
      "10026374 : an alternative pathway has been described that involves the hydroxylation of oxysterols by oxysterol 7alpha-hydroxylase [Cyp7b] prior to their conversion to primary bile acids\n",
      "p(MGI:Cyp7b1) -> a(CHEBI:\"bile salt\")\n",
      "p(MGI:Cyp7b1) -| a(CHEBI:oxysterol)\n",
      "----------------------\n",
      "10008470 : Ectopic expression of Dab2 in NIH-3T3 mouse fibroblasts attenuates canonical Wnt/beta-catenin-mediated signaling, including accumulation of beta-catenin, activation of beta-catenin/T-cell-specific factor/lymphoid enhancer-binding factor 1-dependent reporter constructs, and endogenous cyclin D1 induction.\n",
      "p(MGI:Dab2) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Dab2) -> r(MGI:Ccnd1)\n",
      "----------------------\n",
      "10026380 : Cells in which DG expression was suppressed were growth inhibited, accumulated in the S-phase of the cell cycle, failed to undergo lactogenic differentiation, and displayed an increase in the percentage of apoptotic cells.\n",
      "p(MGI:Dag1) -> bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Dag1) -> bp(GOBP:\"cell differentiation\")\n",
      "p(MGI:Dag1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10026404 : To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.\n",
      "p(MGI:Ddit3) -> p(MGI:Bax)\n",
      "p(MGI:Ddit3) -> p(MGI:Bbc3)\n",
      "p(MGI:Ddit3) -> p(MGI:Bcl2l11)\n",
      "p(HGNC:DDIT3) -> p(HGNC:BAX)\n",
      "p(HGNC:DDIT3) -> p(HGNC:BBC3)\n",
      "p(HGNC:DDIT3) -> p(HGNC:BCL2L11)\n",
      "----------------------\n",
      "10026392 : In Chop-/- macrophages, the increase in Ero1a mRNA and both basal and ER stressâinduced ERO1-alpha protein were diminished.\n",
      "p(MGI:Ddit3) -> p(MGI:Ero1l)\n",
      "p(MGI:Ddit3) -> r(MGI:Ero1l)\n",
      "p(HGNC:DDIT3) -> p(HGNC:ERO1L)\n",
      "----------------------\n",
      "10026408 : In contrast to energy depletion, mTOR inhibition by hypoxia does not require AMPK or LKB1. Down-regulation of mTOR activity by hypoxia requires de novo mRNA synthesis and correlates with increased expression of the hypoxia-inducible REDD1 gene.\n",
      "p(MGI:Ddit4) -> act(complex(p(MGI:Tsc1),p(MGI:Tsc2)))\n",
      "p(MGI:Ddit4) -| act(p(MGI:Mtor))\n",
      "p(HGNC:DDIT4) -| act(p(EGID:2475))\n",
      "----------------------\n",
      "10026436 : A severe block in peripheral CD8(+) T cell development was observed upon dcr-1 deletion in the thymus. These cells were defective in microRNA processing, and upon stimulation they proliferated poorly and underwent increased apoptosis.\n",
      "p(MGI:Dicer1) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Dicer1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10026456 : Furthermore, Dicer loss resulted in increased expression of p53 target genes associated with p53-mediated cell senescence, including p21 , PAI-1 , PAl-2 , and CylinD2 ( Fig. 3 E ).\n",
      "p(MGI:Dicer1) -| r(MGI:Ccnd2)\n",
      "p(MGI:Dicer1) -| r(MGI:Cdkn1a)\n",
      "p(MGI:Dicer1) -| r(MGI:Serpinb2)\n",
      "p(MGI:Dicer1) -| r(MGI:Serpine1)\n",
      "----------------------\n",
      "10026460 : Overexpression of Dkk-1 prevented the profibrotic effects of Wnt-10b on dermal thickening and normalized both hydroxyproline content and myofibroblast counts at 12 weeks to the levels of wild-type control mice\n",
      "p(MGI:Dkk1) -| a(CHEBI:hydroxyproline)\n",
      "p(HGNC:DKK1) -| a(CHEBI:hydroxyproline)\n",
      "----------------------\n",
      "10026462 : we generated retroviruses that express either Dkk1, a secreted antagonist that prevents Wnt ligands from binding to the LRP5/6 co-receptor (Mao et al., 2001aGo), or a dominant-negative form of Tcf4\n",
      "p(MGI:Dkk1) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Dkk1) -| act(p(MGI:Lrp5))\n",
      "p(MGI:Dkk1) -| act(p(MGI:Lrp6))\n",
      "p(HGNC:DKK1) -| act(p(HGNC:LRP5))\n",
      "p(HGNC:DKK1) -| act(p(HGNC:LRP6))\n",
      "----------------------\n",
      "10026464 : DKK1 antagonizes Wnt signalling during head formation in mice77. An additional DKK-receptor, Kremen, was shown to inhibit the Wnt signalling pathway by internalization of LRP78.\n",
      "p(MGI:Dkk1) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Kremen1) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "----------------------\n",
      "10026466 : In recent years, other mechanisms of activation of the canonical Wnt pathway in tumours have been discovered; for example, silencing of the genes that encode the inhibitory Wnt ligands SFRPs and DKKs by hypermethylation, or by overexpression of Wnt proteins (WNT2B for example), Frizzleds (FZD10 for example) or Dishevelled142â149\n",
      "p(MGI:Dkk1) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Dvl1) -> bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Fzd10) -> bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Wnt2b) -> bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "----------------------\n",
      "10008502 : DLK1 overexpression strongly inhibited angiotube formation, whereas lung endothelial cells from Dlk1-null mice were highly angiogenic. In vivo studies demonstrated DLK1-mediated inhibition of neovessel formation and revealed an altered pattern of angiogenesis in the retinas of Dlk1-null mice.\n",
      "p(MGI:Dlk1) -| bp(GOBP:angiogenesis)\n",
      "p(MGI:Dlk1) -| bp(GOBP:\"blood vessel development\")\n",
      "----------------------\n",
      "10008506 : In a model of ischemic retinopathy, Dll4 blockade also enhanced angiogenic sprouting and regrowth of lost retinal vessels while suppressing ectopic pathological neovascularization\n",
      "p(MGI:Dll4) -| bp(GOBP:angiogenesis)\n",
      "p(MGI:Dll4) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10008512 : Here we show that BMP2 induces DLX3, a homeodomain protein that activates Runx2 gene transcription. Small interfering RNA knockdown studies in osteoblasts validate that DLX3 is a potent regulator of Runx2.Furthermore in Runx2 null cells, DLX3 forced expression suffices to induce transcription of Runx2, osteocalcin, and alkaline phosphatase genes, thus defining DLX3 as an osteogenic regulator independent of RUNX2.\n",
      "p(MGI:Dlx3) -> r(EGID:109899)\n",
      "p(MGI:Dlx3) -> r(MGI:Bglap2)\n",
      "p(MGI:Dlx3) -> r(MGI:Runx2)\n",
      "----------------------\n",
      "10026490 : In Sertoli cells of DjA1(-/-) mice, the androgen receptor markedly accumulated with enhanced transcription of several androgen-responsive genes, including Pem and testin\n",
      "p(MGI:Dnaja1) -| r(EGID:18617)\n",
      "p(MGI:Dnaja1) -| r(EGID:21753)\n",
      "p(MGI:Dnaja1) -| r(MGI:Ar)\n",
      "----------------------\n",
      "10026504 : IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group. po0.05, po0.01 as determined by unpaired, two-tailed Studentâs t-test. Results shown are representative of three independent experiments.\n",
      "p(MGI:Dpp4) -| p(MGI:Il13)\n",
      "p(MGI:Dpp4) -| p(MGI:Il4)\n",
      "p(MGI:Dpp4) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10026518 : Furthermore, we find that basal arginase 1 expression and associated arginase activity is markedly increased in MKP-2 deletion mice, a response which would also mediate a reduction in NO formation, this is again different to the findings in MKP-1?/? macrophages .\n",
      "p(MGI:Dusp4) -| act(p(MGI:Arg1))\n",
      "p(MGI:Dusp4) -| r(MGI:Arg1)\n",
      "----------------------\n",
      "10026520 : MKP-2 negatively regulated IL-12, IL-6 and TNF-a expression and positively regulates IL-10 confirming this hypothesis.\n",
      "p(MGI:Dusp4) -> r(MGI:Il10)\n",
      "p(MGI:Dusp4) -| r(MGI:Il12a)\n",
      "p(MGI:Dusp4) -| r(MGI:Il6)\n",
      "p(MGI:Dusp4) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10008544 : Dvl binds to the intracellular domain of the frizzled transmembrane receptors, and also to axin to block its activity, which results in the activation of beta-catenin and, consequently, in a transcriptional switch.\n",
      "p(MGI:Dvl2) -> bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Dvl2) -> act(p(MGI:Ctnnb1))\n",
      "----------------------\n",
      "10026524 : overexpression of either E2F1 or E2F2 in lens fiber cells was sufficient to cause cell cycle entry and subsequent apoptosis\n",
      "p(MGI:E2f1) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:E2f2) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10026540 : Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B.\n",
      "p(MGI:Edn1) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Edn1) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10026554 : Upon stimulation with EGF (0.3 ng/ml) or bFGF (0.3 ng/ml) about 20% of uninjected EGFR/ErbB-2 cells entered S phase (data not shown). We observed a similar rate of entrance into S phase when counting cells microinjected with a control antiserum (RAM, Figure 1e). Cells micro- injected with anti-RALT antibodies and stimulated with EGF progressed to S phase at a frequency which was 2.8-fold higher than control cells.\n",
      "p(MGI:Egf) -> bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Errfi1) -| bp(GOBP:\"cell cycle\")\n",
      "----------------------\n",
      "10026560 : Epidermal growth factor (EGF) and heparin-binding (HB)-EGF, but not platelet-derived growth factor or insulin-like growth factor I, inhibited (125)I-ANP binding to ND-NOD and D-NOD mesangial cells, particularly in the latter.\n",
      "p(MGI:Egf) -| complex(p(MGI:Nppa),p(MGI:Npr3))\n",
      "p(MGI:Hbegf) -| complex(p(MGI:Nppa),p(MGI:Npr3))\n",
      "----------------------\n",
      "10026576 : Treatment of the cells with EGF or serum induces the rapid phosphorylation of an -60 kDa protein that is not detected in untransfected or quiescent cells.....Elk- I phosphopeptides can be detected that are also phosphorylated by purified ERKI in .vitro. Most of the radioactivity is contained in the set of partially overlapping peptides encompassing serines 383 and 389 (peptides 1- 4, 8 and 9).\n",
      "p(MGI:Egf) -> p(MGI:Elk1,pmod(P))\n",
      "p(MGI:Egf) -> p(MGI:Elk1,pmod(P))\n",
      "----------------------\n",
      "10026580 : NPR-C density decreased with no change in the apparent dissociation constant, and there was also a decrease in NPR-C mRNA expression.\n",
      "p(MGI:Egf) -| p(MGI:Npr3)\n",
      "p(MGI:Egf) -| r(MGI:Npr3)\n",
      "p(MGI:Hbegf) -| p(MGI:Npr3)\n",
      "p(MGI:Hbegf) -| r(MGI:Npr3)\n",
      "----------------------\n",
      "10008578 : Results demonstrate that EGF inhibits expression of WDNM1 and SGP-2 genes in mammary epithelial cells.\n",
      "p(MGI:Egf) -| r(EGID:104191)\n",
      "p(MGI:Egf) -| r(MGI:Wfdc18)\n",
      "----------------------\n",
      "10026590 : In NIH3T3HERc cells treated with EGF, activation of the corresponding reporter construct (el2CAT) - reporter containing c-fos SRE - is dependent on co-transfection of Gal-Elk.\n",
      "p(MGI:Egf) -> r(MGI:Fos)\n",
      "p(MGI:Egf) -> act(p(MGI:Elk1))\n",
      "act(p(MGI:Elk1)) -> r(MGI:Fos)\n",
      "----------------------\n",
      "10026600 : In egfr (-/-) MEF cells, UV radiation did not induce HIF-1alpha and VEGF expression, in contrast, in egfr (+/+) MEF cells, UV radiation strongly induced HIF-1alpha and VEGF expression.\n",
      "p(MGI:Egfr) -> r(MGI:Hif1a)\n",
      "p(MGI:Egfr) -> r(MGI:Vegfa)\n",
      "----------------------\n",
      "10026622 : Reynolds et al. (137) investigated the expression of Egr-1 (early growth response gene 1) in NZW and AKR mice. Egr-1 gene induces IL-1b and TNFa, cytokines that contribute to the recruitment of inflammatory cells after smoke exposure.\n",
      "p(MGI:Egr1) -> p(MGI:Il1b)\n",
      "p(MGI:Egr1) -> p(MGI:Tnf)\n",
      "p(HGNC:EGR1) -> p(HGNC:TNF)\n",
      "----------------------\n",
      "10026624 : Egr-1 did, however, play a critical role in the activation of TGF-B1 because the ability of IL-13 to activate TGF-B1 was markedly diminished in comparisons of BAL fluids from Tg (+) mice with wild type and null mutant Egr-1 loci (Fig. 8B).\n",
      "p(MGI:Egr1) -> p(MGI:Tgfb1)\n",
      "p(MGI:Il13) -> p(MGI:Tgfb1)\n",
      "----------------------\n",
      "10016976 : Egr-1/MGRE binding was induced by GnRH in an ERK-dependent manner. Transcriptional activity of Egr-1 protein was enhanced by GnRH treatment.\n",
      "p(MGI:Egr1) -> r(EGID:319520)\n",
      "p(MGI:Egr1) -> r(MGI:Dusp4)\n",
      "----------------------\n",
      "10026626 : EGR target genes include bFGF, TGFbeta1, tissue factor, several Hox genes, platelet-derived growth factor A and B, Fas ligand and LHbeta\n",
      "p(MGI:Egr1) -> r(MGI:F3)\n",
      "p(MGI:Egr3) -> r(MGI:Fasl)\n",
      "----------------------\n",
      "10026618 : Erg1 transcription factor directly activates the luteinizing hormone beta LHbeta subuit promoter, and female mice lacking Egr1 are infertile due to LHbeta deficiency\n",
      "p(MGI:Egr1) -> r(MGI:Lhb)\n",
      "act(p(MGI:Egr1)) -> r(MGI:Lhb)\n",
      "----------------------\n",
      "10026636 : loss of EGR4 results in male infertility due to increased germ cell apoptosis and defective spermiogenesis\n",
      "p(MGI:Egr4) -> bp(GOBP:spermatogenesis)\n",
      "p(MGI:Egr4) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10026650 : The results (Figure4A and B) showed a 16-fold induction in PKR wild-type cells in contrast to a 0.8-fold induction in c-fos message in PKR-null cells at 15 min of PDGF treatment\n",
      "p(MGI:Eif2ak2) -> r(MGI:Fos)\n",
      "p(MGI:Pdgfb) -> r(MGI:Fos)\n",
      "----------------------\n",
      "10026658 : The promoter activity of a p53 downstream gene, Bax, was also upregulated more in MEFGCN2-/- andMEFPERK-/-cells than in MEF WT and MEF A/A cells (Figure 3D).\n",
      "p(MGI:Eif2ak3) -| r(MGI:Bax)\n",
      "p(MGI:Eif2ak4) -| r(MGI:Bax)\n",
      "----------------------\n",
      "10026662 : Our data showed that p53 transcriptional activity was up to 4.0 Â± 0.5- and 4.4 Â± 0.8-folds in MEF PERK-/- and MEF GCN2-/- cells, whereas the activity was only up to 1.4 Â± 0.1- and 1.7 Â± 0.1-folds in MEF WT and MEFA/A cells, respectively, in hypoxia (Figure 3C).\n",
      "p(MGI:Eif2ak3) -| act(p(MGI:Trp53))\n",
      "p(MGI:Eif2ak4) -| act(p(MGI:Trp53))\n",
      "----------------------\n",
      "10019222 : Transfection with the Thr37,46-->Ala37,46 mutant of 4E-BP1 showed that phosphorylation of Thr37,46 residues was required for IGF-I induction of protein synthesis in MCT cells\n",
      "p(MGI:Eif4ebp1,pmod(P)) -> bp(GOBP:\"protein metabolic process\")\n",
      "p(MGI:Eif4ebp1,pmod(P)) -> bp(GOBP:\"protein metabolic process\")\n",
      "----------------------\n",
      "10008608 : In this paper, we demonstrate a regulatory mechanism by which JunB transcriptionally controls the expression of DMP1 during osteoblast differentiation. The cooperative interaction of JunB with p300 has been shown to dramatically modulate the DMP1 promoter activity during mineralization.\n",
      "p(MGI:Ep300) -> act(p(MGI:Jun))\n",
      "act(p(MGI:Jun)) -> r(MGI:Dmp1)\n",
      "----------------------\n",
      "10026706 : To identify the modified residue, the relevant tryptic peptides from each sample were further analyzed by tandem mass spectrometry. Comparison of the fragment patterns revealed that Asn 851 contained the additional oxygen atom (Fig. 4B). Together these data show that FIH-1 is an asparaginyl hydroxylase that inhibits HIF transcriptional activity by preventing CAD association with the coactivator p300.\n",
      "p(MGI:Epas1,pmod(H,N,851)) -| complex(p(MGI:Epas1),p(MGI:Ep300))\n",
      "p(MGI:Epas1,pmod(H,N,851)) -| act(p(MGI:Epas1))\n",
      "----------------------\n",
      "10026710 : EphB1/Fc induced endothelial ephrin-B1 tyrosine phosphorylation, migration and integrin-mediated (alpha(v)beta(3) and alpha(5)beta(1)) attachment and promoted neovascularization, in vivo, in a mouse corneal micropocket assay.\n",
      "p(MGI:Ephb1) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Ephb1) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Ephb1) -> p(MGI:Efnb1,pmod(P))\n",
      "----------------------\n",
      "10026714 : Ephrin-B1-induced tyrosine phosphorylation of both EphB2 and p62dok was abrogated in cells expressing the double juxtamembrane mutant or EphB2KDIIM (23) (data not shown).\n",
      "p(MGI:Ephb2,pmod(P)) -> p(MGI:Dok1,pmod(P))\n",
      "p(MGI:Ephb2,pmod(P)) -> p(MGI:Dok1,pmod(P))\n",
      "----------------------\n",
      "10026720 : We demonstrate that Eps15 is constitutively associated with both alpha-adaptin and clathrin. Upon EGF stimulation, Eps15 and alpha-adaptin are recruited to the EGF receptor.\n",
      "p(MGI:Eps15,pmod(P)) -| complex(p(MGI:Eps15),p(MGI:Ap2a2))\n",
      "p(MGI:Eps15,pmod(P)) -> complex(p(MGI:Eps15),p(MGI:Egfr))\n",
      "----------------------\n",
      "10026734 : Figure 3. (C and D) Down-regulation of IL-18 mRNA expression by IL-1{alpha} (C) and EP (D) in primary keratinocytes.\n",
      "p(MGI:Ereg) -| r(MGI:Il18)\n",
      "p(MGI:Il1a) -| r(MGI:Il18)\n",
      "----------------------\n",
      "10026738 : We have shown previously that ERF is phosphorylated in vitro and in vivo by Erks at multiple sites. This phosphorylation determines its cytoplasmic localization and inactivation.....ERF nuclear export is dependent on extensive phosphorylation and is a CRM1-dependent process.\n",
      "p(MGI:Erf,pmod(P)) -> tloc(p(MGI:Erf))\n",
      "tloc(p(MGI:Erf)) -| act(p(MGI:Erf))\n",
      "----------------------\n",
      "10018230 : Here we demonstrate that the IRE1alpha-XBP1 pathway, the most conserved branch of the unfolded protein response (UPR), is indispensable for adipogenesis. Indeed, XBP1-deficient mouse embryonic fibroblasts and 3T3-L1 cells with XBP1 or IRE1alpha knockdown exhibit profound defects in adipogenesis\n",
      "p(MGI:Ern1) -> act(p(MGI:Xbp1))\n",
      "p(HGNC:ERN1) -> act(p(HGNC:XBP1))\n",
      "----------------------\n",
      "10008634 : We now report that RALT binds to ligand-activated epidermal growth factor receptor (EGFR), ErbB-4 and ErbB-2.ErbB-3 dimers. When ectopically expressed in 32D cells reconstituted with the above ErbB receptor tyrosine kinases (RTKs) RALT behaved as a pan-ErbB inhibitor.\n",
      "p(MGI:Errfi1) -| complex(p(MGI:Erbb3),p(MGI:Erbb2))\n",
      "p(MGI:Errfi1) -| act(p(MGI:Egfr))\n",
      "p(MGI:Errfi1) -| act(p(MGI:Erbb4))\n",
      "----------------------\n",
      "10026772 : \\\"Estrogen increases coagulation factor V mRNA levels via both estrogen receptor-alpha and -beta in murine bone marrow/bone.\\\"\n",
      "p(MGI:Esr1) -> r(MGI:F5)\n",
      "p(MGI:Esr2) -> r(MGI:F5)\n",
      "----------------------\n",
      "10008640 : Arterial wall thickening, perivascular fibrosis, and cardiac hypertrophy are significantly diminished in Ets1-/- mice compared with control mice in response to Ang II.\n",
      "p(MGI:Ets1) -> path(MESHD:Fibrosis)\n",
      "p(MGI:Ets1) -> path(MESHD:Hypertrophy)\n",
      "----------------------\n",
      "10026782 : Knockdown of Ets-1 in WT-EC (70+/-3% reduction at Ets-1 protein level, n=4, P<0.05) abolished LPC- and TNFa-mediated VCAM-1 and MCP-1 mRNA expression (Figure 5B), suggesting that Ets-1 plays an important role in LPC/TNFa-mediated synthesis of VCAM-1 and MCP-1 downstream of PYK2.\n",
      "p(MGI:Ets1) -> r(MGI:Ccl2)\n",
      "p(MGI:Ets1) -> r(MGI:Vcam1)\n",
      "----------------------\n",
      "10008642 : The Zta, Ets, and Hes1 transcription factors were all shown to mediate alterations in reporter gene activity driven by LXRalpha promoter deletion constructs\n",
      "p(MGI:Ets1) -> r(MGI:Nr1h3)\n",
      "p(MGI:Hes1) -> r(MGI:Nr1h3)\n",
      "----------------------\n",
      "10026784 : As shown in Fig. 7A, most cells undergoing Ets2 overexpression induced apoptosis (as judged from the condensed and fragmented appearance of the nuclei (Fig. 7B)) display activation of caspase-3.\n",
      "p(MGI:Ets2) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Ets2) -> act(p(MGI:Casp3))\n",
      "----------------------\n",
      "10026804 : Concentrations of tumour necrosis factor-alpha (TNF-alpha) were elevated in BAL fluid from thrombin-treated mice, and a TNF-alpha-neutralising antibody inhibited the influx of neutrophils in response to thrombin.\n",
      "p(MGI:F2) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(HGNC:F2) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10008662 : However, when bleomycin-treated animals concurrently received a continuous infusion of a direct thrombin inhibitor at an anticoagulant dose, lung collagen accumulation in response to bleomycin was attenuated by up to 40%. Furthermore, alpha(1)(I) procollagen and CTGF mRNA levels were also significantly reduced in these animals.\n",
      "p(MGI:F2) -> r(MGI:Col1a1)\n",
      "p(MGI:F2) -> r(MGI:Ctgf)\n",
      "----------------------\n",
      "10026812 : mice embryos deficient in tissue factor have an impaired pattern of extraembryonic angiogenesis and VWF increases endothelial cell activation\n",
      "p(MGI:F3) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Vwf) -> bp(GOBP:\"endothelial cell activation\")\n",
      "----------------------\n",
      "10008666 : The brain total phospholipid mass was reduced 17% by gene ablation, ascribed to a 27% and 32% reduction in the masses of ChoGpl and sphingomyelin\n",
      "p(MGI:Fabp3) -> a(CHEBI:phospholipid)\n",
      "p(MGI:Fabp3) -> a(CHEBI:sphingomyelin)\n",
      "----------------------\n",
      "10026820 : PPAR-gamma activity was elevated in A-FABP-/- macrophages with stimulation of downstream targets including LXR-alpha and ABCA1, resulting in enhanced efflux of cholesterol\n",
      "p(MGI:Fabp4) -| r(MGI:Abca1)\n",
      "p(MGI:Fabp4) -| r(MGI:Nr1h3)\n",
      "p(MGI:Fabp4) -| act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10026840 : FADD-/- fibroblasts are defective in type I IFN induction that is independent of IFN signaling [57].\n",
      "p(MGI:Fadd) -> r(MGI:Ifna2)\n",
      "p(MGI:Fadd) -> r(MGI:Ifna4)\n",
      "p(MGI:Fadd) -> r(MGI:Ifna5)\n",
      "p(MGI:Fadd) -> r(MGI:Irf7)\n",
      "----------------------\n",
      "10026850 : Fas ligand-deficient generalized lymphoproliferative disease mutant (gld) mice did not develop silicosis. The gld mice had markedly reduced neutrophil extravasation into bronchoalveolar space, and did not show increased TNF-alpha production, nor pulmonary inflammation\n",
      "p(MGI:Fasl) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Fasl) -> bp(GOBP:\"neutrophil extravasation\")\n",
      "p(MGI:Fasl) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10000074 : it was found that a 6-fold increase in Fdft1 activity compared with that of the wild-type did not cause significant changes in HmgCoA reductase activity, while the amounts of synthesized dolichols and ergosterols increased by 80 and 32 percent respectively Fdft1 is the enzyme that regulates the flow rate of synthesized mevalonic acid pathway products independent of HmgCoA reductase\n",
      "p(MGI:Fdft1) -> a(CHEBI:dolichol)\n",
      "p(MGI:Fdft1) -> a(CHEBI:ergosterol)\n",
      "----------------------\n",
      "10008684 : Fibrinogen (Fgb), the tissue activator of plasminogen (t-PA) and its inhibitor (PAI-1) are described as so-called cardiovascular risk factors.\n",
      "p(MGI:Fgb) -> p(MGI:Plg)\n",
      "p(MGI:Serpine1) -| act(p(MGI:Fgb))\n",
      "----------------------\n",
      "10026880 : In addition to oncogenic Ras (Oft et al., 1996), hepatocyte growth factor (HGF)/scatter factor (SF), fibroblast growth factor (FGF), and TGF alone induce mesenchymal features in diverse epithelial cell systems (Brinkmann et al., 1995; Piek et al., 1999; Thiery and Chopin, 1999).\n",
      "p(MGI:Fgf1) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "p(MGI:Hgf) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "p(MGI:Tgfa) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "----------------------\n",
      "10008692 : However, immature osteoblasts respond to FGF treatment with increased proliferation, whereas in differentiating cells FGF does not induce DNA synthesis but causes apoptosis.\n",
      "p(MGI:Fgf1) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Fgf2) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10008694 : When either primary or OB1 osteoblasts are induced to differentiate, FGF signaling inhibits expression of alkaline phosphatase, and blocks mineralization.\n",
      "p(MGI:Fgf1) -| r(MGI:Alpl)\n",
      "p(MGI:Fgf2) -| r(MGI:Alpl)\n",
      "----------------------\n",
      "10008698 : The level of FAS and SERCA2 mRNA expression is increased rapidly after FGF-1 addition; in contrast, PFK mRNA is induced with kinetics more typical of delayed-early genes. These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation\n",
      "p(MGI:Fgf1) -> r(MGI:Atp2a2)\n",
      "p(MGI:Fgf1) -> r(MGI:Fasn)\n",
      "p(MGI:Fgf1) -> r(MGI:Pfkl)\n",
      "----------------------\n",
      "10008700 : These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation.\n",
      "p(MGI:Fgf1) -> r(MGI:Atp2a2)\n",
      "p(MGI:Fgf1) -> r(MGI:Fasn)\n",
      "p(MGI:Fgf1) -> r(MGI:Pfkl)\n",
      "----------------------\n",
      "10000274 : Here we provide evidence that both the mitogenic effect of bFGF and the differentiation-promoting effect of NT3 are linked with modifications of cell cycle kinetics in mouse cortical precursor cells\n",
      "p(MGI:Fgf2) -> bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Ntf3) -> bp(GOBP:\"cell differentiation\")\n",
      "----------------------\n",
      "10026890 : IL-18 is a novel inhibitor of angiogenesis, sufficiently potent to supress tumor growth by directly inhibiting fibroblast growth factor 2 induced endothelial cell proliferation\n",
      "p(MGI:Fgf2) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Il18) -| bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10008708 : bFGF downregulates p27(kip1) and upregulates cyclin D2 expression. This contrasts with NT3, which upregulates p27(kip1) and downregulates cyclin D2 expression\n",
      "p(MGI:Fgf2) -| act(p(MGI:Cdkn1b))\n",
      "p(MGI:Fgf2) -> r(MGI:Ccnd2)\n",
      "p(MGI:Ntf3) -> act(p(MGI:Cdkn1b))\n",
      "p(MGI:Ntf3) -| r(MGI:Ccnd2)\n",
      "----------------------\n",
      "10026898 : FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.\n",
      "p(MGI:Fgf2) -> act(p(MGI:Fgfr1))\n",
      "p(MGI:Fgf2) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Fgf2) -> act(p(MGI:Mapk3))\n",
      "p(HGNC:FGF2) -> act(p(HGNC:FGFR1))\n",
      "p(HGNC:FGF2) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:FGF2) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10026900 : These data indicate that adenovirus-mediated expression of mSef reduced FGF-induced tyrosine phosphorylation of FGFR without affecting the overall level of FGFR expression (Fig.4 A).\n",
      "p(MGI:Fgf2) -> act(p(MGI:Fgfr1))\n",
      "p(MGI:Fgf2) -> p(MGI:Fgfr1,pmod(P))\n",
      "----------------------\n",
      "10008716 : We observed that certain cytokine and growth factors [such as TNF alpha, basic fibroblast growth factor, transforming growth factor beta, and protein kinase C-activating agents plus calcium ionophore], when added to differentiated adipocytes, cause rapid down-regulation of PPARgamma mRNA expression\n",
      "p(MGI:Fgf2) -| r(MGI:Pparg)\n",
      "p(MGI:Tgfb1) -| r(MGI:Pparg)\n",
      "p(MGI:Tnf) -| r(MGI:Pparg)\n",
      "----------------------\n",
      "10008722 : In the absence of FGF8 signaling, nephron formation is initiated, but the nascent nephrons do not express Wnt4 or Lim1, and nephrogenesis does not progress to the S-shaped body stage.\n",
      "p(MGI:Fgf8) -> r(MGI:Lhx1)\n",
      "p(MGI:Fgf8) -> r(MGI:Wnt4)\n",
      "----------------------\n",
      "10026918 : We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.\n",
      "p(MGI:Fhit) -| act(p(MGI:Atr))\n",
      "p(MGI:Fhit) -| act(p(MGI:Chek1))\n",
      "p(HGNC:FHIT) -| act(p(HGNC:ATR))\n",
      "----------------------\n",
      "10026928 : We further confirmed FKBP mediated up-regulation of Sdc1 mRNA levels (Table 2) and down-regulation of MMP9 by stably overexpressing Fkbp1a or Fkbp8 in B16-F10 cells\n",
      "p(MGI:Fkbp1a) -| r(MGI:Mmp9)\n",
      "p(MGI:Fkbp8) -| r(MGI:Mmp9)\n",
      "----------------------\n",
      "10008738 : We then used gene expression profiling to identify syndecan 1 (Sdc1) and matrix metalloproteinase 9 (MMP9) as genes directly regulated by Fkbp1a and Fkbp8.\n",
      "p(MGI:Fkbp1a) -| r(MGI:Mmp9)\n",
      "p(MGI:Fkbp1a) -> r(MGI:Sdc1)\n",
      "----------------------\n",
      "10026930 : Syndecan 1 (Sdc1) mRNA was consistently up-regulated 4-5 fold in B16-F10 cells by either Fkbp8 or Fkbp1a gene expression,\n",
      "p(MGI:Fkbp1a) -> r(MGI:Sdc1)\n",
      "p(MGI:Fkbp8) -> r(MGI:Sdc1)\n",
      "----------------------\n",
      "10026936 : Unexpectedly, FLI-1 enhances the stimulating activity of GATA-1 on a GATA-1-responsive promoter but represses that of EKLF on beta-globin and an EKLF-responsive artificial promoters.\n",
      "p(MGI:Fli1) -> act(p(MGI:Gata1))\n",
      "p(MGI:Fli1) -| act(p(MGI:Klf1))\n",
      "----------------------\n",
      "10026962 : We have used siRNA approaches to show that Fra-1 expression is critical to the expression of genes, such as cd44 and c-met, that are critical to migration and autocrine growth factor production in transformation and invasion of mesotheliomas (13).\n",
      "p(MGI:Fosl1) -> r(MGI:Cd44)\n",
      "p(MGI:Fosl1) -> r(MGI:Met)\n",
      "----------------------\n",
      "10026970 : Both mRNA and protein levels of Mrp2 and Mrp4 were decreased in the livers of Foxa2-mutant mice on both standard chow and cholic acidâenriched feed (Fig. 3a,b).\n",
      "p(MGI:Foxa2) -> p(MGI:Abcc2)\n",
      "p(MGI:Foxa2) -> p(MGI:Abcc4)\n",
      "p(MGI:Foxa2) -> r(MGI:Abcc2)\n",
      "p(MGI:Foxa2) -> r(MGI:Abcc4)\n",
      "----------------------\n",
      "10026972 : Furthermore, the induction of Mrp3 normally seen in livers of mice fed a cholic acidâsupplemented diet was blunted in the absence of Foxa2 (Fig. 3a,b).\n",
      "p(MGI:Foxa2) -> p(MGI:Abcc3)\n",
      "p(MGI:Foxa2) -> r(MGI:Abcc3)\n",
      "----------------------\n",
      "10008752 : Finally, ex vivo aortic ring assay to test the sprouting and microvessel formation revealed enhanced microvessel outgrowth by Foxc2 overexpression\n",
      "p(MGI:Foxc2) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Foxc2) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10027000 : By cDNA expression array analysis and RNase protection assay, the Tbx family of transcription factors such as Tbx2, 3, 4, and 5 which, like Foxf1, are expressed in the lung mesenchyme (Chapman et al., 1996) were found to be diminished in Foxf1+/- mutant background (Kalinichenko et al., 2001b), implicating the potential role of Foxf1 in the transcriptional regulation of Tbx genes.\n",
      "p(MGI:Foxf1) -> r(MGI:Tbx2)\n",
      "p(MGI:Foxf1) -> r(MGI:Tbx3)\n",
      "p(MGI:Foxf1) -> r(MGI:Tbx4)\n",
      "p(MGI:Foxf1) -> r(MGI:Tbx5)\n",
      "----------------------\n",
      "10008758 : This alteration is shown to be due to the delayed formation of Peyer's patches organizing centers as revealed by the expressions of VCAM1 and IL-7 receptor alpha-chain at 17.5 days postcoitus.\n",
      "p(MGI:Foxl1) -> r(MGI:Il7r)\n",
      "p(MGI:Foxl1) -> r(MGI:Vcam1)\n",
      "----------------------\n",
      "10027030 : Consistent with diminished numbers of squamous type I cells in epFoxm1-/- lungs, mRNA levels of T1-alpha and aquaporin 5 were significantly decreased as demonstrated by quantitative real-time (RT-PCR) (qRT-PCR) analysis (Fig. 3B).\n",
      "p(MGI:Foxm1) -> r(MGI:Aqp5)\n",
      "p(MGI:Foxm1) -> r(MGI:Pdpn)\n",
      "----------------------\n",
      "10008766 : Partial knockout of Foxo1 in Foxo1(+/-) mice throughout the body led to accelerated skin wound healing with enhanced keratinocyte migration\n",
      "p(MGI:Foxo1) -| bp(GOBP:\"cell migration\")\n",
      "p(MGI:Foxo1) -| bp(GOBP:\"wound healing\")\n",
      "----------------------\n",
      "10008774 : In electrophoretic mobility-shift assays, FoxO1 binds to the FoxO concensus site of the KATP channel subunit KIR6.1 promoter. In primary atrial culture, targeting FoxO1 and FoxO3 with siRNA specifically reduces mRNA expression of FoxO1 and -O3 and KIR6.1.\n",
      "p(MGI:Foxo1) -> p(MGI:Kcnj8)\n",
      "p(MGI:Tppp2) -> p(MGI:Kcnj8)\n",
      "----------------------\n",
      "10008780 : Fibroblast growth factor 2, adiponectin, and notch1 genes were significantly increased at wound sites in Foxo1+/? mice\n",
      "p(MGI:Foxo1) -| r(MGI:Adipoq)\n",
      "p(MGI:Foxo1) -| r(MGI:Fgf2)\n",
      "p(MGI:Foxo1) -| r(MGI:Notch1)\n",
      "----------------------\n",
      "10027046 : Using antibodies specific for cleaved caspase-3 and -7, their activation was analyzed after cytokine withdrawal (and FKHR-L1 activation). Caspase-3 (Fig. 4 A, top) and -7 (Fig. 4 A, middle) were both cleaved after cytokine withdrawal.\n",
      "p(MGI:Foxo3) -> act(p(MGI:Casp3))\n",
      "p(MGI:Foxo3) -> act(p(MGI:Casp7))\n",
      "----------------------\n",
      "10027052 : Both cytokine withdrawal and FKHR-L1 activation resulted in an upregulation of p27KIP1 and Bim. (Western Blot).\n",
      "p(MGI:Foxo3) -> p(MGI:Bcl2l11)\n",
      "p(MGI:Foxo3) -> p(MGI:Cdkn1b)\n",
      "----------------------\n",
      "10027068 : Compared with wild-type mice, Fpr1 knockout mice displayed marked decreases in the lung migration of neutrophils and macrophages after CS exposure.\n",
      "p(MGI:Fpr1) -> bp(GOBP:\"macrophage chemotaxis\")\n",
      "p(MGI:Fpr1) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10027070 : We have previously demonstrated that complex formation between the SH2 domain of Grb2 and FRS2a is mediated via Y196-, Y306-, Y349-, and Y392-designated Grb2 binding sites (4, 5).\n",
      "p(MGI:Frs2,pmod(P)) -> complex(p(MGI:Frs2),p(MGI:Grb2))\n",
      "p(MGI:Frs2,pmod(P)) -> complex(p(MGI:Frs2),p(MGI:Grb2))\n",
      "p(MGI:Frs2,pmod(P)) -> complex(p(MGI:Frs2),p(MGI:Grb2))\n",
      "p(MGI:Frs2,pmod(P)) -> complex(p(MGI:Frs2),p(MGI:Grb2))\n",
      "----------------------\n",
      "10027072 : In addition, FRS2a recruits Grb2 indirectly by means of two binding sites for the SH2 domains of the protein tyrosine phosphatase Shp2 at Y436- and Y471-designated Shp2 binding sites (5).\n",
      "p(MGI:Frs2,pmod(P)) -> complex(p(MGI:Frs2),p(MGI:Ptpn11))\n",
      "p(MGI:Frs2,pmod(P)) -> complex(p(MGI:Frs2),p(MGI:Ptpn11))\n",
      "----------------------\n",
      "10027084 : It is thought that ADAM17 maturation (activation by the cleavage of the propeptide by proprotein convertases, such as furin and PC7) occurs during transit or on arrival at the cell surface (FIG. 4a), and this may be similar for other ADAMs.\n",
      "p(MGI:Furin) -> act(p(MGI:Adam17))\n",
      "p(MGI:Pcsk7) -> act(p(MGI:Adam17))\n",
      "----------------------\n",
      "10027092 : Administration of 1.99.25 inhibited physiological and pathologic sprouting angiogenesis within the retina\n",
      "p(MGI:Fzd4) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Fzd4) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "p(HGNC:FZD4) -> bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10027096 : The deficiency of Cks1 in TGF-beta-treated cells likely contributes to the stabilization of Kip1 protein and destabilization of Skp2, because in the absence of Cks1, SCFSkp2 cannot ubiquitinate Kip1 protein; instead, self-ubiquitination of Skp2 occurs.\n",
      "p(MGI:Fzr1) -| deg(p(MGI:Skp2))\n",
      "p(MGI:Fzr1) -| p(MGI:Cdkn1b)\n",
      "p(MGI:Fzr1) -> p(MGI:Skp2)\n",
      "----------------------\n",
      "10027098 : Inhibition of G6PD with siRNA led to increased ROS and apoptosis, decreased proliferation, and impaired insulin secretion.\n",
      "p(MGI:G6pdx) -| a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:G6pdx) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:G6pdx) -> bp(GOBP:\"insulin secretion\")\n",
      "----------------------\n",
      "10027106 : Furthermore Gadd45a was demonstrated to strongly inhibit Aurora-A kinase activity and to antagonize Aurora-A-induced centrosome amplification.\n",
      "p(MGI:Gadd45a) -| act(p(MGI:Aurka))\n",
      "p(HGNC:GADD45A) -| act(p(HGNC:AURKA))\n",
      "----------------------\n",
      "10027112 : While most beta-catenin protein is localized to the cell membrane and is involved in cell-cell adhesion, accumulation of free cytoplasmic beta-catenin will translocate into the nucleus where it functions in a bipartite transcription factor complex, whose targets include invasion and metastasis promoting endopeptidases, matrix metalloproteinases (MMP).\n",
      "p(MGI:Gadd45a) -| act(p(MGI:Ctnnb1))\n",
      "tloc(p(MGI:Ctnnb1)) -> act(p(MGI:Ctnnb1))\n",
      "----------------------\n",
      "10027130 : Other notable genes downregulated with GATA-1 knockdown are the p45 subunit of nuclear factor erythroid-derived 2 (NF- E2), JAK2, and beta1-tubulin.\n",
      "p(MGI:Gata1) -> r(MGI:Jak2)\n",
      "p(MGI:Gata1) -> r(MGI:Nfe2)\n",
      "p(MGI:Gata1) -> r(MGI:Tubb1)\n",
      "----------------------\n",
      "10027132 : Figure 5. Synergistic Activation of Transcription by FOG and GATA-1 from p45 NF-E2 Regulatory Sequences\n",
      "p(MGI:Gata1) -> r(MGI:Nfe2)\n",
      "p(MGI:Zfpm1) -> r(MGI:Nfe2)\n",
      "----------------------\n",
      "10027138 : early studies have indicated that Stat6 (8, 9, 10), a cytosolic latent transcription factor that is rapidly activated after cellular exposure to IL-4 and IL-13, is essential for Th2 cell differentiation through the induction of GATA3 (5, 6, 7),\n",
      "p(MGI:Gata3) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "act(p(MGI:Stat6)) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "act(p(MGI:Stat6)) -> r(MGI:Gata3)\n",
      "act(p(HGNC:STAT6)) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "----------------------\n",
      "10027144 : Gfi1b mRNA was decreased approximately 3-fold 48 hours after infection of lymphomas with Gata3siRNA virus (Figure 7A). To further test the ability of Gata3 to promote Gfi1b mRNA expression we used a Gata3-producing retrovirus to ectopically express Gata3 protein (Figure 7C). Gata3 induced Gfi1b mRNA by 12- or 6-fold over control virus-infected cells in 1.F9 or 0531 lymphomas, respectively (Figure 7D).\n",
      "p(MGI:Gata3) -> r(MGI:Gfi1b)\n",
      "act(p(MGI:Gata3)) -> r(MGI:Gfi1b)\n",
      "----------------------\n",
      "10027148 : In contrast to Sox7, exogenous expression of Gata-4 or Gata-6 induced the expression of laminin alpha1 and Hnf1b in undifferentiated F9 and F9H1Sox7 cells without RA/Bt2cAMP treatment (Fig. 5 and 6 ).\n",
      "p(MGI:Gata4) -> r(MGI:Hnf1b)\n",
      "p(MGI:Gata6) -> r(MGI:Hnf1b)\n",
      "----------------------\n",
      "10027152 : Within the proximal A1AR promoter, putative binding sites for cardiac transcription factors GATA and Nkx2.5 were identified. Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression\n",
      "p(MGI:Gata4) -> act(p(MGI:\"Nkx2-5\"))\n",
      "p(MGI:\"Nkx2-5\") -> act(p(MGI:Gata4))\n",
      "act(p(MGI:Gata4)) -> r(MGI:Adora1)\n",
      "act(p(MGI:\"Nkx2-5\")) -> r(MGI:Adora1)\n",
      "----------------------\n",
      "10027160 : Previously described targets of canonical Wnt signaling such as Fgfr2, Mycn (N-myc) and Bmp4 were also upregulated in Gata6 flox/flox:Sftpc-cre mutants (Supplementary Fig. 2 online).\n",
      "p(MGI:Gata6) -| r(MGI:Bmp4)\n",
      "p(MGI:Gata6) -| r(MGI:Fgfr2)\n",
      "p(MGI:Gata6) -| r(MGI:Mycn)\n",
      "----------------------\n",
      "10027164 : The laminin alpha1 expression levels were significantly reduced in cells silenced for Sox7, Gata-6, or Gata-4/6 compared to those in control cells, indicating that either Sox7 or Gata-6 is indispensable for the induction of laminin alpha1 expression in F9 cells treated with RA/Bt2cAMP (Fig. 2 ).\n",
      "p(MGI:Gata6) -> r(MGI:Lama1)\n",
      "p(MGI:Sox7) -> r(MGI:Lama1)\n",
      "----------------------\n",
      "10008810 : We find that mutant GFAP, as well as excess wild type GFAP, promotes formation of cytoplasmic inclusions, disrupts the cytoskeleton, decreases cell proliferation, increases cell death, reduces proteasomal function, and compromises astrocyte resistance to stress.\n",
      "p(MGI:Gfap) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Gfap) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10027196 : At 36 weeks of age, significant increases in AST, CK, and LDH values were observed in the transgenic mice c\n",
      "p(MGI:Gh) -> p(MGI:Ckm)\n",
      "p(MGI:Gh) -> p(MGI:Got1)\n",
      "----------------------\n",
      "10027198 : The isoform SH2-Bbeta modulates JAK2 activity by binding to the phosphorylated enzyme, further increasing its activity. in an animal model of GH excess in which JAK2 is not phosphorylated, although it is increased in the membrane-fraction, both the level of SH2-Bbeta, and especially its association to membranes, are augmented.\n",
      "p(MGI:Gh) -> p(MGI:Jak2)\n",
      "p(MGI:Gh) -> p(MGI:Sh2b1)\n",
      "----------------------\n",
      "10008836 : Administration of IGF-I or GH to Ghrhrlit/Ghrhrlit mice suppressed MDGI mRNA levels in a dose-dependent manner.\n",
      "p(MGI:Gh) -| r(MGI:Fabp3)\n",
      "p(MGI:Igf1) -| r(MGI:Fabp3)\n",
      "----------------------\n",
      "10027204 : In this study, we demonstrate that GH and PRL decrease the mRNA and protein levels of FAS in 3T3-L1 adipocytes.\n",
      "p(MGI:Gh) -| r(MGI:Fasn)\n",
      "p(MGI:Prl) -| r(MGI:Fasn)\n",
      "----------------------\n",
      "10027210 : Previous in vitro studies have shown that growth hormone (GH) can inhibit PPARalpha-dependent gene expression by down-regulation of PPARalpha expression and by a novel inhibitory cross-talk involving the GH-activated transcription factor STAT5b. ...A corresponding increase in mRNA, was observed in the STAT5b-deficient mice, suggesting a transcriptional mechanism for the observed increases.\n",
      "p(MGI:Gh) -| r(MGI:Ppara)\n",
      "p(MGI:Gh) -> act(p(MGI:Stat5b))\n",
      "act(p(MGI:Stat5b)) -| r(MGI:Ppara)\n",
      "----------------------\n",
      "10008844 : GAGA box of the rat serine protease inhibitor 2 (spi 2) genes not only acts as a basal promoter element, but also mediates transcriptional activation by growth hormone and interleukin-6.\n",
      "p(MGI:Gh) -> r(MGI:Serpina3k)\n",
      "p(MGI:Il6) -> r(MGI:Serpina3k)\n",
      "----------------------\n",
      "10008846 : Interestingly, 500 ng/ml GH and 30 ng/ml IL-6 increased PAI-1 secretion five-fold and 3.6-fold, respectively. Furthermore, GH and IL-6 induced PAI-1 mRNA by up to 7.3-fold, and 3.6-fold, respectively, in a time-dependent fashion with significant stimulation seen at concentrations as low as 5 ng/ml GH and 10 ng/ml IL-6.\n",
      "p(MGI:Gh) -> r(MGI:Serpine1)\n",
      "p(MGI:Gh) -> tloc(p(MGI:Serpine1))\n",
      "p(MGI:Il6) -> r(MGI:Serpine1)\n",
      "p(MGI:Il6) -> tloc(p(MGI:Serpine1))\n",
      "----------------------\n",
      "10008850 : Remarkably, retroviral expression of either Gja1 or Tll1 in 3T3-L1 preadipocytes also inhibited adipocyte differentiation\n",
      "p(MGI:Gja1) -| bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Tll1) -| bp(GOBP:\"fat cell differentiation\")\n",
      "----------------------\n",
      "10027230 : Interestingly, we found that the level of endothelial cell differentiation in the E15.5 Shh-/- lung mesenchyme is reduced, based on PECAM-1 and Flk-1 staining, while Shh-/-;Gli3-/- lung mesenchyme displays a relatively increased distribution of PECAM-1- and Flk-1-positive cells (Figs. 6A-bâc,hâi).\n",
      "p(MGI:Gli3) -| p(MGI:Kdr)\n",
      "p(MGI:Gli3) -| p(MGI:Pecam1)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "p(MGI:Shh) -> p(MGI:Kdr)\n",
      "p(MGI:Shh) -> p(MGI:Pecam1)\n",
      "----------------------\n",
      "10027236 : In contrast, Tbx2 and Tbx3 expressions are significantly repressed in Shh-/- and enhanced in Shh-/-;Gli3-/- lungs (Figs. 5B-e,h,f,i).\n",
      "p(MGI:Gli3) -| r(MGI:Tbx2)\n",
      "p(MGI:Gli3) -| r(MGI:Tbx3)\n",
      "p(MGI:Shh) -> r(MGI:Tbx2)\n",
      "p(MGI:Shh) -> r(MGI:Tbx3)\n",
      "----------------------\n",
      "10008860 : In contrast, Glp1r-/- thymocytes exhibited a hypoproliferative response, whilst peripheral Glp1r-/- lymphocytes were hyperproliferative in response to mitogenic stimulation\n",
      "p(MGI:Glp1r) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Glp1r) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10027240 : In the Grx1 KO, the cigarette smoke-induced upregulation of these cytokines was significantly impaired, compared to the wild type controls. Moreover, the baseline levels of IL12(p40), GCSF, RANTES, MIP-1a, TNFa (data not shown) and IFNg (data not shown) were found to be lower in the BAL fluid of Grx1 KO mice compared to wild type mice\n",
      "p(MGI:Glrx) -> p(MGI:Ccl3)\n",
      "p(MGI:Glrx) -> p(MGI:Ccl5)\n",
      "p(MGI:Glrx) -> p(MGI:Csf3)\n",
      "p(MGI:Glrx) -> p(MGI:Il12b)\n",
      "----------------------\n",
      "10027244 : Knockdown of PYGL, GLUL, or GLUD1 partially reduced the degree of TNF- and zVAD-fmkâmediated ROS production and necrosis.\n",
      "p(MGI:Glul) -> a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Pygl) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10016716 : intracellular interaction of PKA, GMF, and p38 is supported by the phosphorylation of GMF upon cellular stimulation by forskolin (blocked by PKA inhibitor) and by the co-immunoprecipitation of p38 with GMF from cell lysates. Withdrawal of nerve growth factor from PC12 leads to increased GMF phosphorylation with a time course similar to that reported for p38 activation.\n",
      "p(MGI:Gmfb,pmod(P)) -> act(p(MGI:Mapk14))\n",
      "p(MGI:Ngf) -| p(MGI:Gmfb,pmod(P))\n",
      "----------------------\n",
      "10008864 : The expression and activity of the protein-tyrosine phosphatase 1B (PTP1B), but not protein-tyrosine phosphatases SHP-1, SHP-2, and LAR, were constitutively decreased in tissues expressing the Q205L Galpha(i2).\n",
      "p(MGI:Gnai2) -| act(p(MGI:Ptpn1))\n",
      "p(MGI:Gnai2) -| r(MGI:Ptpn1)\n",
      "----------------------\n",
      "10027248 : As shown in Fig. 1B, single-cell microinjection of Galpha q/11 antibody or RGS2 protein into 3T3-L1 adipocytes markedly inhibited (70 and 81%, respectively) insulin induced-GLUT4 translocation.\n",
      "p(MGI:Gnaq) -> act(p(MGI:Slc2a4))\n",
      "p(MGI:Rgs2) -> act(p(MGI:Slc2a4))\n",
      "----------------------\n",
      "10008866 : when overexpressed, GOPC, which is thought to influence traffic in the endocytic/secretory pathway, causes a large reduction in the amounts of both channels, probably by leading them to the degradative end of this pathway.\n",
      "p(MGI:Gopc) -| p(MGI:Cftr)\n",
      "p(MGI:Gopc) -| p(MGI:Clcn3)\n",
      "----------------------\n",
      "10008870 : These were manifested by up-regulation of cyclin D1 expression and cyclin-dependent kinase activity and down-regulation of the cyclin-dependent kinase inhibitor p27Kip1.\n",
      "p(MGI:Gpi1) -> p(MGI:Ccnd1)\n",
      "p(MGI:Gpi1) -| p(MGI:Cdkn1b)\n",
      "----------------------\n",
      "10027252 : Moreover, our results show a decrease in both the number of neuronal markers and the number of differentiating neuronal cells (cholinergic, catecholaminergic, and GABAergic neurons) from NSC in D3m-shM6A cells (tubb3, MAP2, DCX, nestin)\n",
      "p(MGI:Gpm6a) -> p(MGI:Dcx)\n",
      "p(MGI:Gpm6a) -> p(MGI:Tubb3)\n",
      "----------------------\n",
      "10027278 : Mice with haploinsufficiency of the Grb2 gene (Grb2(+/-) mice) appear normal at birth but have defective T cell signaling. In response to pressure overload, cardiac p38 MAPK and JNK activation was inhibited and cardiac hypertrophy and fibrosis was blocked in Grb2(+/-) mice.\n",
      "p(MGI:Grb2) -> path(MESHD:Fibrosis)\n",
      "p(MGI:Grb2) -> path(MESHD:Hypertrophy)\n",
      "----------------------\n",
      "10008888 : Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.\n",
      "p(MGI:Grb2) -> r(MGI:Plau)\n",
      "p(MGI:Hgf) -> r(MGI:Plau)\n",
      "p(MGI:Sos1) -> r(MGI:Plau)\n",
      "----------------------\n",
      "10027282 : Significant reductions in brain levels of early cytokines, including IL-1beta and IL-6 mRNA expression, and late cytokine high mobility group box-1 protein (HMGB1), were found in the gelsolin-treated group compared to the placebo group at all time points (Figure 4).\n",
      "p(MGI:Gsn) -| r(MGI:Il1b)\n",
      "p(MGI:Gsn) -| r(MGI:Il6)\n",
      "----------------------\n",
      "10027352 : n addition, Hes6 suppresses Hes1 from inhibiting Mash1-E47 heterodimer and thereby enables Mash1 and E47 to upregulate transcription in the presence of Hes1.\n",
      "p(MGI:Hes1) -| complex(p(MGI:Ascl1),p(MGI:Tcf3))\n",
      "p(MGI:Hes6) -> act(p(MGI:Ascl1))\n",
      "p(MGI:Hes6) -> act(p(MGI:Tcf3))\n",
      "----------------------\n",
      "10027358 : Expression of either Hes1 or Hes5 significantly activated the STAT reporter gene construct in both E13 neuroepithelial cells and MNS-70 cells,\n",
      "p(MGI:Hes1) -> act(p(MGI:Stat3))\n",
      "p(MGI:Hes5) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10027362 : siRNA-mediated knockdown of HEY1 and HEY2 (Figure S4E) suppressed BMP9-mediated inhibition of tube formation and effects on downstream gene expression (Figures 4A, 4D, 4E, and 4G)\n",
      "p(MGI:Hey1) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "p(MGI:Hey2) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10008934 : In 129SvJ mice with targeted disruption of the hemojuvelin (Hfe2) gene, which display very low expression of liver hepcidin, Cybrd1 mRNA content increased to 1040 %, Dmt1 mRNA content to 200 % and Fpn1 mRNA to 150 % when compared to wild-type mice\n",
      "p(MGI:Hfe2) -| r(MGI:Cybrd1)\n",
      "p(MGI:Hfe2) -| r(MGI:Slc11a2)\n",
      "p(MGI:Hfe2) -| r(MGI:Slc40a1)\n",
      "----------------------\n",
      "10027370 : We found unexpected alterations in the expression of Slc39a1 (mouse ortholog of SLC11A3) and Cybrd1, which encode key iron transport proteins, and Hamp (hepcidin antimicrobial peptide), a hepatic regulator of iron transport.\n",
      "p(MGI:Hfe) -| r(MGI:Cybrd1)\n",
      "p(MGI:Hfe) -> r(MGI:Hamp)\n",
      "p(MGI:Hfe) -> r(MGI:Slc40a1)\n",
      "----------------------\n",
      "10008950 : Additionally, HGF induced increased transcription of c-fos, c-jun, junB, junD, and c-myc early response genes in both cell lines.\n",
      "p(MGI:Hgf) -> r(MGI:Junb)\n",
      "p(MGI:Hgf) -> r(MGI:Myc)\n",
      "----------------------\n",
      "10027382 : Here we report that delivery of the human HGF gene delivery in mice led to hepatomegaly via beta-catenin activation in the liver in 1- and 4-week studies. The mechanisms of beta-catenin activation in the 1-week study included loss of c-Met-beta-catenin association as well as canonical beta-catenin activation, leading to its nuclear translocation.\n",
      "p(MGI:Hgf) -> tloc(p(MGI:Ctnnb1))\n",
      "tloc(p(MGI:Ctnnb1)) -> act(p(MGI:Ctnnb1))\n",
      "----------------------\n",
      "10027396 : All four surfactants displayed a substantial reduction in protein levels in the HIF1alpha -/- mice as compared with control pups (Fig. 5B).\n",
      "p(MGI:Hif1a) -> p(MGI:Sftpa1)\n",
      "p(MGI:Hif1a) -> p(MGI:Sftpb)\n",
      "p(MGI:Hif1a) -> p(MGI:Sftpc)\n",
      "p(MGI:Hif1a) -> p(MGI:Sftpd)\n",
      "----------------------\n",
      "10027398 : These experiments document that BNip3 and NIX expression is HIF1alpha-dependent, and cobalt induces their expression in a time and dose dependent manner.\n",
      "p(MGI:Hif1a) -> r(MGI:Bnip3)\n",
      "p(MGI:Hif1a) -> r(MGI:Bnip3l)\n",
      "----------------------\n",
      "10027400 : However, lower levels of beta-catenin, CCSP, HIMF, VEGF, and HIF2alpha mRNA in neonatal HIF1alpha-/- pups compared with control littermates suggest that HIF1alpha plays a role in controlling their expression during maturation of the lung (7, 15).\n",
      "p(MGI:Hif1a) -> r(MGI:Ctnnb1)\n",
      "p(MGI:Hif1a) -> r(MGI:Epas1)\n",
      "p(MGI:Hif1a) -> r(MGI:Retnla)\n",
      "p(MGI:Hif1a) -> r(MGI:Scgb1a1)\n",
      "----------------------\n",
      "10027404 : qRT-PCR analysis of the genes for surfactant proteins show a decreased expression of SP-A, SP-B, and SP-C in the HIF1alpha-/- mice compared with control pups (Fig. 5A).\n",
      "p(MGI:Hif1a) -> r(MGI:Sftpa1)\n",
      "p(MGI:Hif1a) -> r(MGI:Sftpb)\n",
      "p(MGI:Hif1a) -> r(MGI:Sftpc)\n",
      "----------------------\n",
      "10027406 : The expression of endothelin 1 and platelet-derived growth factor beta was increased in the lung endothelial cells of NEPAS/HIF-3alpha-null mice.\n",
      "p(MGI:Hif3a) -| r(MGI:Edn1)\n",
      "p(MGI:Hif3a) -| r(MGI:Pdgfb)\n",
      "----------------------\n",
      "10008960 : NEPAS mRNA is derived from the HIF-3alpha gene by alternative splicing, replacing the first exon of HIF-3alpha with that of inhibitory PAS. NEPAS can dimerize with Arnt and exhibits only low levels of transcriptional activity, similar to that of HIF-3alpha. NEPAS suppressed reporter gene expression driven by HIF-1alpha and HIF-2alpha\n",
      "p(MGI:Hif3a) -| act(p(MGI:Epas1))\n",
      "p(MGI:Hif3a) -| act(p(MGI:Hif1a))\n",
      "----------------------\n",
      "10027416 : Increased expression of FasL was observed in most of the Shn-2â/â cultured cells tested. Increased expression of Fas and Bim was observed only in Shn-2â/â effector Th2 cells.\n",
      "p(MGI:Hivep2) -| r(MGI:Bcl2l11)\n",
      "p(MGI:Hivep2) -| r(MGI:Fas)\n",
      "p(MGI:Hivep2) -| r(MGI:Fasl)\n",
      "----------------------\n",
      "10027444 : HMG-CoA reductase inhibition results in the activation of protein kinase Akt and the posttranslational phosphorylation of the eNOS protein.82,83\n",
      "p(MGI:Hmgcr) -| act(p(MGI:Akt1))\n",
      "p(MGI:Hmgcr) -| p(MGI:Nos3,pmod(P))\n",
      "----------------------\n",
      "10027446 : Q-RT-PCR (Fig.4F) and Western blot analyses (Fig.4G) revealed that loss of HMGN3 leads to an 80% reduction in the amount of Glut2 transcripts and a 50% reduction in the amount of GLUT2 protein.\n",
      "p(MGI:Hmgn3) -> p(MGI:Slc2a2)\n",
      "p(MGI:Hmgn3) -> r(MGI:Slc2a2)\n",
      "----------------------\n",
      "10027462 : Loss of TCF-1Â expressionÂ impaired the capacity of theseÂ ILCÂ subsets to produce IL-5, IL-13, and IL-22 and resulted in crippled responses to intestinal infection with Citrobacter rodentium.\n",
      "p(MGI:Hnf1a) -> p(MGI:Il13)\n",
      "p(MGI:Hnf1a) -> p(MGI:Il22)\n",
      "p(MGI:Hnf1a) -> p(MGI:Il5)\n",
      "----------------------\n",
      "10026362 : the Tcf1 protein [aka Hnf-1lapha] also regulates transcription of the gene Nr1h4 encoding Fxr, thereby leading to reduced expression of small heterodimer partner-1 [Shp-1] and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway\n",
      "p(MGI:Hnf1a) -> r(MGI:Cyp7a1)\n",
      "p(MGI:Hnf1a) -> r(MGI:Nr0b2)\n",
      "p(MGI:Hnf1a) -> r(MGI:Nr1h4)\n",
      "----------------------\n",
      "10008976 : Here we identify hnRNP A1 as an IRES trans-acting factor that regulates cyclin D1 and c-myc IRES activity, depending on the Akt status of the cell. hnRNP A1 binds both IRESs in vitro and in intact cells and enhances in vitro IRES-dependent reporter expression.\n",
      "p(MGI:Hnrnpa1) -> p(MGI:Ccnd1)\n",
      "p(MGI:Hnrnpa1) -> p(MGI:Myc)\n",
      "----------------------\n",
      "10008978 : Functional pathway analysis showed that HNRPAB augments mRNA and protein levels of COX-2 and subsequent prostaglandin E(2) (PGE(2)) production by suppressing degradation of COX-2 mRNA\n",
      "p(MGI:Hnrnpab) -> p(MGI:Ptgs2)\n",
      "p(MGI:Hnrnpab) -> r(MGI:Ptgs2)\n",
      "----------------------\n",
      "10027478 : Microarray analysis of Hop transgenic hearts, however, indicates repression of c-fos, a classic SRF transcriptional target (41), consistent with previous data indicating that Hop can repress SRF-dependent transcription (19, 20). Interestingly, we also identified an RNA helicase, Dby, that is consistently downregulated in Hop transgenic hearts.\n",
      "p(MGI:Hopx) -| r(MGI:Ddx3y)\n",
      "p(MGI:Hopx) -| r(MGI:Fos)\n",
      "----------------------\n",
      "10027482 : TABLE 2. Loss of HOXA13 function causes increased sinusoidal and lymphatic endothelial gene expression.\n",
      "p(MGI:Hoxa13) -| r(MGI:Igfbp3)\n",
      "p(MGI:Hoxa13) -| r(MGI:Lyve1)\n",
      "p(MGI:Hoxa13) -| r(MGI:Selenbp1)\n",
      "----------------------\n",
      "10027492 : Finally we show that HoxA5 increases Akt1 mRNA, protein expression and further enhances Akt activity via a coordinate down regulation of PTEN....Figure 7...HoxA5 induces Akt mRNA and protein expression and increases Akt activity in endothelial cells.\n",
      "p(MGI:Hoxa5) -> act(p(MGI:Akt1))\n",
      "p(MGI:Hoxa5) -> p(MGI:Akt1)\n",
      "p(MGI:Hoxa5) -> r(MGI:Akt1)\n",
      "----------------------\n",
      "10027504 : sults showed that overexpression of HOXB7 increased proliferation 3.5-fold, and induced an SMC-like cell morphology. In addition, expression of the early SMC markers calponin and SM22 increased 4-fold and 3-fold respectively by semi-quantitative RT-PCR.\n",
      "p(MGI:Hoxb7) -> r(MGI:Cnn1)\n",
      "p(MGI:Hoxb7) -> r(MGI:Tagln)\n",
      "----------------------\n",
      "10008996 : These data suggest that Hp plays a pivotal role in reducing renal oxidative damage during haemolysis\n",
      "p(MGI:Hp) -| a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Hp) -| bp(GOBP:\"response to oxidative stress\")\n",
      "----------------------\n",
      "10027510 : TGF? can also suppress gastrointestinal inflammatory activity by stimulating the expression of the prostaglandin-degrading enzyme 15-PGDH, which antagonizes the proinflammatory action of COX2 (Yan et al., 2004).\n",
      "p(MGI:Hpgd) -| act(p(MGI:Ptgs2))\n",
      "p(MGI:Tgfb1) -| bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Tgfb1) -> p(MGI:Hpgd)\n",
      "----------------------\n",
      "10027514 : Ha-Ras cooperates with transforming growth factor beta (TGFbeta) to cause epithelial mesenchymal transition (EMT) characterized by spindle-like cell morphology, loss of epithelial markers, and induction of mesenchymal markers.\n",
      "p(MGI:Hras) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "p(MGI:Tgfb1) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "----------------------\n",
      "10027516 : Over-expression of constitutively activated H-Ras (CA-Ras) in Ba/F3 cells blocked down-modulation of Survivin expression, G0/G1 arrest, and apoptosis induced by IL-3 withdrawal, while dominant-negative (DN) H-Ras down-regulated Survivin.\n",
      "p(MGI:Hras) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Hras) -> p(MGI:Birc5)\n",
      "p(MGI:Il3) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10009010 : Histidine-rich glycoprotein (HRGP) is an abundant heparin-binding plasma protein that efficiently arrests growth and vascularization of mouse tumor models.\n",
      "p(MGI:Hrg) -| bp(GOBP:angiogenesis)\n",
      "p(MGI:Hrg) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10027524 : In contrast, OVA-exposed H1R-/- tissues consistently displayed only modest increases in gene expression with statistically significant reductions in transcripts for IL-5, IL-13, and IL-10 compared with WT levels (P < 0.005, P < 0.005, and P < 0.05 respectively).\n",
      "p(MGI:Hrh1) -> r(MGI:Il10)\n",
      "p(MGI:Hrh1) -> r(MGI:Il13)\n",
      "p(MGI:Hrh1) -> r(MGI:Il5)\n",
      "----------------------\n",
      "10009014 : 11beta-HSD-1(-/-) mice also have increased HDL cholesterol, with elevated liver mRNA and serum levels of apolipoprotein AI. % Conversely, liver Aalpha-fibrinogen mRNA levels are decreased.\n",
      "p(MGI:Hsd11b1) -| r(MGI:Apoa1)\n",
      "p(MGI:Hsd11b1) -> r(MGI:Fga)\n",
      "----------------------\n",
      "10027534 : Taken together with the increased expression of Tgf-b and Sdf1 in WT MEFs compared to Hsf1 null MEFs (Figure 4A), these results suggest that TGF-b and SDF1 are produced and secreted by fibroblasts in an HSF1-dependent manner.\n",
      "p(MGI:Hsf1) -> p(MGI:Cxcl12)\n",
      "p(MGI:Hsf1) -> p(MGI:Tgfb1)\n",
      "----------------------\n",
      "10009022 : Here we report that, in mice, HSF1 deficiency reduces cardiac expression of Hsp25, alphaB-crystallin and Hsp70\n",
      "p(MGI:Hsf1) -> r(MGI:Cryab)\n",
      "p(MGI:Hsf1) -> r(MGI:Hspb1)\n",
      "----------------------\n",
      "10027536 : This confirmed that expression levels of Sdf1, Tgf-b1, and Tgf-b2 were significantly lower in Hsf1 null MEFs than in WT MEFs, even without coculture with cancer cells (Figures 4A and S4A).\n",
      "p(MGI:Hsf1) -> r(MGI:Cxcl12)\n",
      "p(MGI:Hsf1) -> r(MGI:Tgfb1)\n",
      "p(MGI:Hsf1) -> r(MGI:Tgfb2)\n",
      "----------------------\n",
      "10009030 : These alterations can be attributed to the absence of Hsp70 because viral expression of Hsp70 in KO cultured cardiomyocytes restored these parameters\n",
      "p(MGI:Hspa1a) -| path(MESHD:Hypertrophy)\n",
      "p(MGI:Hspa1b) -| path(MESHD:Hypertrophy)\n",
      "----------------------\n",
      "10027568 : Gene expression profiles of Htt KO mice and Flx-treated mice in six regions of the brain and their regulator candidates. Fold changes detected with RT-PCR in the two experimental conditions (Htt KO/WT and treated with Flx/Sal for 3 days) are calculated in the 30 genes listed in the Table 1\n",
      "p(MGI:Htt) -> r(EGID:15127)\n",
      "p(MGI:Htt) -| r(MGI:Pid1)\n",
      "p(MGI:Htt) -> r(MGI:Pitpna)\n",
      "p(MGI:Htt) -| r(MGI:Tuba1a)\n",
      "----------------------\n",
      "10006530 : Transfection experiments indicate that over-expression of Id inhibits the trans-activation of the muscle creatine kinase enhancer by MyoD.\n",
      "p(MGI:Id1) -| act(p(MGI:Myod1))\n",
      "act(p(MGI:Myod1)) -> r(MGI:Ckm)\n",
      "----------------------\n",
      "10009042 : Further, when evaluated in vitro loss of Id2 results in decreased proliferation of neural progenitors and decreased expression of the Hes1 and Ascl1 (Mash1) transcription factors, known mediators of neuronal differentiation.\n",
      "p(MGI:Id2) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Id2) -| r(MGI:Ascl1)\n",
      "p(MGI:Id2) -| r(MGI:Hes1)\n",
      "----------------------\n",
      "10027590 : We found that overexpression of Id2 in EML cells induced the expression of GATA-1 target genes including GATA-1, ELKF, EpoR, and alpha-globin (Figure 6F).\n",
      "p(MGI:Id2) -> r(MGI:Epor)\n",
      "p(MGI:Id2) -> r(MGI:Gata1)\n",
      "p(MGI:Id2) -> r(MGI:\"Hba-a1\")\n",
      "p(MGI:Id2) -> r(MGI:Klf1)\n",
      "----------------------\n",
      "10027594 : FIG. 1. Retroviral transduction of Id3 down-modulates the SRG3 protein expression.FIG. 2. Id3 transcriptionally represses SRG3 gene expression\n",
      "p(MGI:Id3) -| p(MGI:Smarcc1)\n",
      "p(MGI:Id3) -| r(MGI:Smarcc1)\n",
      "----------------------\n",
      "10027610 : as evidenced by the abolition of IFN induction in DC derived from IFNAR KO and IRF-9 KO mice [39, 45].\n",
      "p(MGI:Ifnar1) -> p(MGI:Ifna1)\n",
      "p(MGI:Ifnar1) -> r(MGI:Ifnb1)\n",
      "p(MGI:Irf9) -> p(MGI:Ifna1)\n",
      "----------------------\n",
      "10027614 : Like pDC-depleted mice, IFN-alpha/beta receptor-deficient mice showed a significant delay in wound reepithelization (Fig. 5 E) and displayed a profound deficiency in IL-6, IL-17, and IL-22 expression levels in injured skin, without affecting the expression of IFN-gamma (Fig. 5 F).\n",
      "p(MGI:Ifnb1) -> bp(GOBP:\"wound healing\")\n",
      "p(MGI:Ifnb1) -> p(MGI:Il22)\n",
      "p(MGI:Ifnb1) -> p(MGI:Il6)\n",
      "----------------------\n",
      "10019900 : In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12.\n",
      "p(MGI:Ifnb1) -> act(p(MGI:Irf1))\n",
      "p(MGI:Il2) -> act(p(MGI:Irf1))\n",
      "p(HGNC:IFNB1) -> act(p(HGNC:IRF1))\n",
      "p(HGNC:IL2) -> act(p(HGNC:IRF1))\n",
      "----------------------\n",
      "10026644 : PKR is required for poly IC- and poly IC plus interferon gamma (IFNg)-induced islet cell apoptosis, implicating a role of PKR in the etiology of type 1 diabetes (43).\n",
      "p(MGI:Ifng) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:IFNG) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10027648 : The majority of these cells were airway epithelial cells and type I and type II alveolar epithelial cells on light microscopic evaluations (Fig. 1, B and C)....In accord with these observations, double staining with TUNEL and anti-SP-C Abs revealed a large number of alveolar type II epithelial cells that were TUNEL positive and SP-C positive (Fig. 1, D).\n",
      "p(MGI:Ifng) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:IFNG) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10027650 : dox induction of IFN-? caused a significant increase in TUNEL staining in lungs from Tg+ mice (Figure 8, A and B).\n",
      "p(MGI:Ifng) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:IFNG) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10027652 : The same group demonstrated just recently that mast cells actively participate in the formation of aortic aneurysms by release of IL-6 and IFN?, which induced apoptosis of smooth muscle cells and protease expression [111].\n",
      "p(MGI:Ifng) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Il6) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:IFNG) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10027654 : IFN-? also activated caspase-3, -8, and -9 and Bid, causing readily detectable increases in caspase bioactivities and truncated Bid (tBid) accumulation (Figure 9, F and G).\n",
      "p(MGI:Ifng) -> act(p(MGI:Bid))\n",
      "p(MGI:Ifng) -> act(p(MGI:Casp3))\n",
      "p(MGI:Ifng) -> act(p(MGI:Casp8))\n",
      "p(MGI:Ifng) -> act(p(MGI:Casp9))\n",
      "----------------------\n",
      "10027656 : Caspase-8, an activator caspase that interacts with the death domain of the TNF receptor and CD95 (Fas) receptor, was activated in experimental emphysema caused by lung overexpression of either IFN-{gamma} (370) or IL-13 (196).\n",
      "p(MGI:Ifng) -> act(p(MGI:Casp8))\n",
      "p(MGI:Il13) -> act(p(MGI:Casp8))\n",
      "----------------------\n",
      "10027658 : We and others have shown that activation of IL-4 (23) and IFN-{alpha} receptors stimulates tyrosyl phosphorylation of IRS docking proteins, which depends upon Jak,\n",
      "p(MGI:Ifng) -> act(p(MGI:Irs1))\n",
      "p(MGI:Il4) -> act(p(MGI:Irs1))\n",
      "----------------------\n",
      "10027666 : As expected, we found that IFN-gamma led to a rapid rise in both JAK1 and JAK2 phosphorylation band density above baseline levels, and this IFN-gamma-induced JAK activation was not altered by adenosine treatment at any time point (data not shown).\n",
      "p(MGI:Ifng) -> act(p(MGI:Jak1))\n",
      "p(MGI:Ifng) -> act(p(MGI:Jak2))\n",
      "----------------------\n",
      "10027670 : rIFN-gamma strikingly enhances the secretion of IgG2a by murine splenic B cells stimulated with bacterial LPS in vitro and concomitantly suppresses the production of IgG3, IgG1, IgG2b, and IgE while sparing IgM secretion.\n",
      "p(MGI:Ifng) -| p(MGI:Ighg2b)\n",
      "p(MGI:Ifng) -| p(EGID:16020)\n",
      "p(MGI:Ifng) -> p(EGID:380793)\n",
      "p(MGI:Ifng) -| p(MGI:Ighg1)\n",
      "----------------------\n",
      "10027674 : Recombinant IFN-gamma increased the synthesis of C2 and factor B in primary cultures of human mononuclear phagocytes and in murine fibroblasts transfected with cosmid DNA bearing the human C2 and factor B genes.\n",
      "p(MGI:Ifng) -> p(MGI:C2)\n",
      "p(MGI:Ifng) -> p(MGI:Cfb)\n",
      "----------------------\n",
      "10027678 : the levels of CCR5 mRNA and protein were markedly increased in dox-treated IFN-?â transgenic animals (Figure 2, A and B).\n",
      "p(MGI:Ifng) -> p(MGI:Ccr5)\n",
      "p(MGI:Ifng) -> r(MGI:Ccr5)\n",
      "p(HGNC:IFNG) -> p(HGNC:CCR5)\n",
      "----------------------\n",
      "10027682 : highly sensitive to IFN-g but poorly responsive to TNF-a (references 4, 5, 7, 9, 10, and 12 and unpublished observations). For these experiments, we first verified that this profile of cytokine responsiveness for ICAM-1 gene expression was similar in isolated mTE cells (Fig. 1 A).\n",
      "p(MGI:Ifng) -> p(MGI:Icam1)\n",
      "p(MGI:Ifng) -> r(MGI:Icam1)\n",
      "----------------------\n",
      "10027684 : treatment with both IFN-g and TNF-a resulted in equivalent ICAM-1 induction by immunostaining (Fig. 1, B and C)\n",
      "p(MGI:Ifng) -> p(MGI:Icam1)\n",
      "p(MGI:Tnf) -> p(MGI:Icam1)\n",
      "----------------------\n",
      "10009070 : Specifically, macrophage-activating factor (MAF), interferon-gamma (IFN-gamma), or picogram amounts of endotoxin (LPS) induced LFA-1 on TG-elicited macrophages following overnight incubation.\n",
      "p(MGI:Ifng) -> p(MGI:Itgal)\n",
      "p(MGI:Maf) -> p(MGI:Itgal)\n",
      "----------------------\n",
      "10027694 : Type I (alpha/beta) and type II (gamma) IFN enhance MHC class I gene expression through an IFN-responsive element (IRE) present in the 5' flanking region of the class I-a genes. We have found that cell surface expression of thymus leukemia Ag (TL) was up-regulated by IFN-gamma\n",
      "p(MGI:Ifng) -> r(EGID:15033)\n",
      "p(MGI:Ifng) -> surf(p(EGID:15033))\n",
      "p(MGI:Ifng) -> surf(p(MGI:\"H2-D1\"))\n",
      "p(MGI:Ifng) -> surf(p(MGI:\"H2-K1\"))\n",
      "----------------------\n",
      "10009080 : Mincle mRNA expression was strongly induced in response to several inflammatory stimuli, such as LPS, TNF-alpha, IL-6, and IFN-gamma in wild-type macrophages.\n",
      "p(MGI:Ifng) -> r(MGI:Clec4e)\n",
      "p(MGI:Il6) -> r(MGI:Clec4e)\n",
      "p(MGI:Tnf) -> r(MGI:Clec4e)\n",
      "----------------------\n",
      "10027704 : RT-PCR and Northern blot evaluations demonstrated that IFN-g increased the levels of mRNA encoding cathepsins D, H, S, and B.\n",
      "p(MGI:Ifng) -> r(MGI:Ctsb)\n",
      "p(MGI:Ifng) -> r(MGI:Ctsd)\n",
      "p(MGI:Ifng) -> r(MGI:Ctsh)\n",
      "p(MGI:Ifng) -> r(MGI:Ctss)\n",
      "----------------------\n",
      "10027706 : The levels of EGR1, ZBP-1, GADD45-b, C/EBP-d, and GAPDH expression in control and IFN-c-treated RAW 264.7 macrophage cells were determined by real-time PCR analysis.\n",
      "p(MGI:Ifng) -> r(MGI:Egr1)\n",
      "p(MGI:Ifng) -> r(MGI:Gadd45b)\n",
      "p(MGI:Ifng) -> r(MGI:Gapdh)\n",
      "p(MGI:Ifng) -> r(MGI:Zbp1)\n",
      "----------------------\n",
      "10027710 : In addition to the well-known GBP-2 and IRG- 47, we confirmed two novel members of this groupâthe ATP-dependent interferon-responsive gene (ADIR), and interferon-induced helicase (Ifih, Helicard, and mda-5), that are induced by IFN-c in RAW 264.7 cells (Fig. 2).\n",
      "p(MGI:Ifng) -> r(MGI:Gbp2)\n",
      "p(MGI:Ifng) -> r(MGI:Ifi47)\n",
      "p(MGI:Ifng) -> r(MGI:Ifih1)\n",
      "p(MGI:Ifng) -> r(MGI:Tor3a)\n",
      "----------------------\n",
      "10017840 : STE significantly elevated background and IFNg- induced activity of both the p35 and p40 promoters (Fig. 2)\n",
      "p(MGI:Ifng) -> r(MGI:Il12a)\n",
      "p(MGI:Ifng) -> r(MGI:Il12b)\n",
      "----------------------\n",
      "10027716 : IFN-gamma increased GKLF and interferon regulatory factor-1 mRNA levels in a parallel fashion and these effects were abolished in STAT1 knockout mouse STAT1 mediated IFN-gamma-stimulated GKLF gene expression.\n",
      "p(MGI:Ifng) -> r(MGI:Irf1)\n",
      "p(MGI:Ifng) -> r(MGI:Klf4)\n",
      "----------------------\n",
      "10027722 : Galectin-9 expression can be induced by IFN-gamma or IL-1beta in various tissues such as endothelial cells, fibroblasts and astrocytes26, 27, 28.\n",
      "p(MGI:Ifng) -> r(MGI:Lgals9)\n",
      "p(MGI:Il1b) -> r(MGI:Lgals9)\n",
      "----------------------\n",
      "10009092 : Using RT-PCR, the enhanced TLR2 and TLR4 mRNA expression was shown to be completely dependent on the action of IFN-gamma and TNF-alpha.\n",
      "p(MGI:Ifng) -> r(MGI:Tlr2)\n",
      "p(MGI:Tnf) -> r(MGI:Tlr2)\n",
      "----------------------\n",
      "10009096 : IFN-gamma caused phosphorylation of CREB, and overexpression of CREB increased IFN-gamma-induced BAFF promoter activity.\n",
      "p(MGI:Ifng) -> r(MGI:Tnfsf13b)\n",
      "p(MGI:Ifng) -> act(p(MGI:Creb1))\n",
      "act(p(MGI:Creb1)) -> r(MGI:Tnfsf13b)\n",
      "----------------------\n",
      "10027744 : Similarly, IFN-g induced a significant nuclear localization of p50 and a larger nuclear localization of p65\n",
      "p(MGI:Ifng) -> tloc(p(MGI:Nfkb1))\n",
      "p(MGI:Ifng) -> tloc(p(MGI:Rela))\n",
      "----------------------\n",
      "10009112 : IRS-3 expression in WT cells also caused an increase in IGF-1-induced mitogen-activated protein kinase phosphorylation and egr-1 expression\n",
      "p(MGI:Igf1) -> bp(GOBP:\"MAPK cascade\")\n",
      "p(MGI:Irs3) -> r(MGI:Egr1)\n",
      "----------------------\n",
      "10009114 : However, increased IRS-2 expression augmented glucose/IGF-1 induced beta-cell growth mitogenesis and decreased apoptosis due to glucose-deprivation\n",
      "p(MGI:Igf1) -> bp(GOBP:mitosis)\n",
      "p(MGI:Irs2) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10027774 : from full text - Similarly, we find that both b-arrestin1 and 2 are ubiquitinated in IGF-1-stimulated WT MEF cells.\n",
      "p(MGI:Igf1) -> deg(p(MGI:Arrb1))\n",
      "p(MGI:Igf1) -> deg(p(MGI:Arrb2))\n",
      "p(MGI:Igf1) -> p(MGI:Arrb1,pmod(U,K))\n",
      "p(MGI:Igf1) -> p(MGI:Arrb2,pmod(U,K))\n",
      "----------------------\n",
      "10025228 : from full text - As shown in Fig. 1A, ERK1/2 in wild-type MEFs is phosphorylated after IGF-1 stimulation with a peak at 5â10 min, after which pERK declined substantially. In b-arrestin1 KO MEFs, on the other hand, ERK1/2 remained essentially inactivated upon IGF-1 stimulation (Fig. 1A).\n",
      "p(MGI:Igf1) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Igf1) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10027794 : We found that myelin staining, MBP and PLP expression, and the percentage of oligodendrocytes and their precursors are significantly reduced in all brain regions of developing IGF-I KO mice but are similar to controls in adult IGF-I KO mice.\n",
      "p(MGI:Igf1) -> r(MGI:Mbp)\n",
      "p(MGI:Igf1) -> r(MGI:Plp1)\n",
      "----------------------\n",
      "10009130 : Transgenic overexpression of IGF-1 resulted in marked increases in skeletal muscle DHPR alpha(1S) and RyR1 mRNA in young and old mice and in enhance\n",
      "p(MGI:Igf1) -> r(MGI:Qdpr)\n",
      "p(MGI:Igf1) -> r(MGI:Ryr1)\n",
      "----------------------\n",
      "10027796 : Table 2 The temporal pattern of genes down-regulated with IGF-1 treatment: Genes down-regulated at 1 & 4 hrs\n",
      "p(MGI:Igf1) -| r(MGI:Rbm39)\n",
      "p(MGI:Igf1) -| r(MGI:Txnip)\n",
      "----------------------\n",
      "10027800 : We showed that after 4-nitroquinoline 1-oxide-induced DNA damage, IGF-I induced exclusion of the p53 protein from the nucleus and led to its degradation in the cytoplasm, whereas p53 mRNA was unaffected.\n",
      "p(MGI:Igf1) -> tloc(p(MGI:Trp53))\n",
      "tloc(p(MGI:Trp53)) -> deg(p(MGI:Trp53))\n",
      "----------------------\n",
      "10027802 : Igf2r encodes a trans-membrane receptor that transports mannose-6-phosphate tagged proteins and insulin-like growth factor 2 to lysosomes. Inactivating mutations of Igf2r in mice lead to increased systemic Igf2 levels that cause embryonic overgrowth and perinatal lethality\n",
      "p(MGI:Igf2) -> bp(GOBP:\"cell growth\")\n",
      "p(MGI:Igf2r) -| p(MGI:Igf2)\n",
      "----------------------\n",
      "10009142 : The concentration of the proapoptotic molecule caspase-3 was increased during lactation in ATF4-transgenic animal. Mammary glands from ATF4-transgenic mice also showed significant nuclear translocation of activated STAT3 and up-regulation of one of its target genes, insulin-like growth factor-binding protein-5, which is thought to facilitate apoptosis by sequestering insulin-like growth factor\n",
      "p(MGI:Igfbp5) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Atf4)) -> r(MGI:Igfbp5)\n",
      "act(p(MGI:Atf4)) -> act(p(MGI:Stat3))\n",
      "act(p(MGI:Stat3)) -> r(MGI:Igfbp5)\n",
      "----------------------\n",
      "10027816 : In the Ihh-- littermate, however, no expression was detected in the perichondrium for either Tcf1 or Dkk1\n",
      "p(MGI:Ihh) -> r(MGI:Dkk1)\n",
      "p(MGI:Ihh) -> r(MGI:Hnf1a)\n",
      "----------------------\n",
      "10027836 : Intramuscular injection of AAV5-mIL10 into ApoE-deficient, atherosclerosis-susceptible mice inhibit atherogenesis through both antiinflammatory and cholesterol-lowering effects [85, 86].\n",
      "p(MGI:Il10) -| a(CHEBI:cholesterol)\n",
      "p(MGI:Il10) -| bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10027850 : Thus, while IL-10 can reduce Th2 recall immune responses, its major effect evident during the primary response is to inhibit the development of Th1 responses, thereby favoring Th2 development.\n",
      "p(MGI:Il10) -| bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "p(MGI:Il10) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "p(HGNC:IL10) -| bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "----------------------\n",
      "10027874 : Pretreatment of the cells with IL-10 resulted in a marked reduction of Elk-1 phosphorylation (Figure 6A).\n",
      "p(MGI:Il10) -| p(MGI:Elk1,pmod(P))\n",
      "p(MGI:Il10) -| act(p(MGI:Elk1))\n",
      "----------------------\n",
      "10027876 : In accord with these findings, IL-10 caused a significant increase in TGF-b1 mRNA and latent TGF-b1 protein accumulation in lungs from transgene () mice (Fig. 6).\n",
      "p(MGI:Il10) -> p(MGI:Tgfb1)\n",
      "p(MGI:Il10) -> r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10027884 : We compared CLPMphi gene expression profiles of wild-type mice with IL-10-deficient mice, and identified genes that are selectively expressed in wild-type CLPMphi. These genes included nuclear IkappaB proteins such as Bcl-3 and IkappaBNS.\n",
      "p(MGI:Il10) -> r(MGI:Bcl3)\n",
      "p(MGI:Il10) -> r(MGI:Nfkbid)\n",
      "----------------------\n",
      "10027886 : Expression of all proinflammatory/profibrotic mediators as assessed by reverse transcriptase-PCR and densitometry was less in Lenti-IL-10-injected wounds compared with Lenti-GFP-injected wounds, with the difference in the expression of IL-6, MCP-1, and HSP47 reaching statistical significance (Figure 5).\n",
      "p(MGI:Il10) -| r(MGI:Ccl2)\n",
      "p(MGI:Il10) -| r(MGI:Il6)\n",
      "p(MGI:Il10) -| r(MGI:Serpinh1)\n",
      "----------------------\n",
      "10027892 : In the case of Th2-type cytokines, enhanced production of IL-4 and IL-6 was reduced by treatment with anti-TGF-/3 or anti-IL- IO (Fig. 5B).\n",
      "p(MGI:Il10) -> tloc(p(MGI:Il4))\n",
      "p(MGI:Il10) -> tloc(p(MGI:Il6))\n",
      "p(MGI:Tgfb1) -> tloc(p(MGI:Il4))\n",
      "p(MGI:Tgfb1) -> tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10027896 : Immune-complex kinase reactions using the artificial substrate enolase showed that upon stimulation with IL-11, p62yes and p60src were activated, but p59fyn did not appear to be activated. These results correlate with antiphosphotyrosine (APT) immunoblots.\n",
      "p(MGI:Il11) -> act(p(MGI:Src))\n",
      "p(MGI:Il11) -> act(p(MGI:Yes1))\n",
      "p(MGI:Il11) -> p(MGI:Src,pmod(P))\n",
      "p(MGI:Il11) -> p(MGI:Yes1,pmod(P))\n",
      "----------------------\n",
      "10027898 : tryosine phosphorylation of gp130 was observed in fibroblasts after stimulation with all the cytokines\n",
      "p(MGI:Il11) -> p(MGI:Il6st,pmod(P))\n",
      "p(MGI:Il6) -> p(MGI:Il6st,pmod(P))\n",
      "p(MGI:Lif) -> p(MGI:Il6st,pmod(P))\n",
      "p(MGI:Osm) -> p(MGI:Il6st,pmod(P))\n",
      "----------------------\n",
      "10027912 : IL-13 caused an impressive increase in lung collagen (measured by hydroxyproline content assay) and BAL HA content that could be easily appreciated with the histochemical and biochemical measurement techniques (Fig. 5 and data not shown).\n",
      "p(MGI:Il13) -> a(CHEBI:\"hyaluronic acid\")\n",
      "p(MGI:Il13) -> a(CHEBI:hydroxyproline)\n",
      "----------------------\n",
      "10027916 : In the CC10-IL-13 mice, progressive lung pathology is noted. At 1 mo of age, these animals manifest peribronchial inflammation, mucus metaplasia, alveolar enlargement, and subepithelial fibrosis (10).\n",
      "p(MGI:Il13) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Il13) -> path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10027920 : Zymography also demonstrated IL-13âinduced BAL moieties that comigrated with the unprocessed and/or fully processed forms of MMP-9, -12, and -2 (Figure 8, a and b).\n",
      "p(MGI:Il13) -> act(p(MGI:Mmp12))\n",
      "p(MGI:Il13) -> act(p(MGI:Mmp2))\n",
      "p(MGI:Il13) -> act(p(MGI:Mmp9))\n",
      "----------------------\n",
      "10027924 : In contrast, significant amounts of total and activated TGF-1 were seen in BAL from Tg mice (Fig. 7, A and B).\n",
      "p(MGI:Il13) -> act(p(MGI:Tgfb1))\n",
      "p(MGI:Il13) -> p(MGI:Tgfb1)\n",
      "p(HGNC:IL13) -> p(HGNC:TGFB1)\n",
      "----------------------\n",
      "10027930 : As expected, we found that tg-IL-13+Stat6+/- mice had substantial fibrosis as demonstrated by elevated levels of lung hydroxyproline, a constituent of collagen (Fig. 3b). This increase was dependent on STAT6 expression, but expression of hSTAT6 in epithelial cells did not result in reconstitution of the fibrotic response.\n",
      "p(MGI:Il13) -> path(MESHD:Fibrosis)\n",
      "p(MGI:Stat6) -> path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10027938 : Among the Th2 cytokines tested, IL-13 was by far the most effective cytokine inducing eotaxin in the lung, up-regulating both the eotaxin mRNA expression and protein production (Fig. 2, AâC).\n",
      "p(MGI:Il13) -> p(MGI:Ccl11)\n",
      "p(MGI:Il13) -> r(MGI:Ccl11)\n",
      "----------------------\n",
      "10027940 : naive BALB/c mice were treated with different concentrations of IL-4 and IL-13, and eotaxin in lung tissues or in BAL were measured by ELISA...Compared with IL-13, IL-4 induced much lower levels of eotaxin even at higher doses (Fig. 4).\n",
      "p(MGI:Il13) -> p(MGI:Ccl11)\n",
      "p(MGI:Il4) -> p(MGI:Ccl11)\n",
      "----------------------\n",
      "10027942 : MCP-3, macrophage-derived chemokine (MDC), and C10 have also been demonstrated to be induced in an IL-13-dependent fashion in vivo, and IL-13 stimulates MCP-1, MDC, and eotaxin production in vitro (14, 26, 27).\n",
      "p(MGI:Il13) -> p(MGI:Ccl11)\n",
      "p(MGI:Il13) -> p(MGI:Ccl2)\n",
      "p(MGI:Il13) -> p(MGI:Ccl22)\n",
      "p(MGI:Il13) -> p(MGI:Ccl7)\n",
      "----------------------\n",
      "10027946 : This was done by quantitating the levels of selected chemokines (MCP-1, MIP-1, eotaxin) in BAL...fluids from CC10-rtTA-IL-13 mice at intervals after dox administration. Rapid inductive patterns and delayed inductive patterns were noted.\n",
      "p(MGI:Il13) -> p(MGI:Ccl11)\n",
      "p(MGI:Il13) -> p(MGI:Ccl2)\n",
      "p(MGI:Il13) -> p(MGI:Ccl3)\n",
      "----------------------\n",
      "10017064 : (from text) The increase in intracellular AMCase in these Th2 inflammation/asthma models was paralleled by an increase of total EGFR in lung lysates (Fig. 3a) as well as specific EGFR surface expression on lung epithelial cells as analyzed by immunohistochemistry (Fig. 3b) and flow cytometry (Fig. 3, c and d).\n",
      "p(MGI:Il13) -> p(MGI:Egfr)\n",
      "p(MGI:Il13) -> surf(p(MGI:Egfr))\n",
      "----------------------\n",
      "10027948 : IL-13 increased Egr-1 mRNA levels in a biphasic manner in Stat6/ fibroblasts; early induction of Egr-1 mRNA was observed 30 min following exposure to IL-13 and declined after 3â6 h (Fig. 6A). Egr-1 protein was increased in Stat6/ fibroblasts as compared with Stat6/ fibroblasts from 30 min to 3 h after IL-13 treatment (Fig. 6, B and C).\n",
      "p(MGI:Il13) -> p(MGI:Egr1)\n",
      "p(MGI:Il13) -> r(MGI:Egr1)\n",
      "p(HGNC:IL13) -> p(HGNC:EGR1)\n",
      "----------------------\n",
      "10027950 : as for Jak1, the phosphoryaltions of Tyk2 and IRS-2 were reduced after IL13 stimulaiton in wildtype cells.\n",
      "p(MGI:Il13) -> p(MGI:Irs2,pmod(P))\n",
      "p(MGI:Il13) -> p(MGI:Tyk2,pmod(P))\n",
      "----------------------\n",
      "10027952 : After 24 hours of IL-13 induction, phosphorylation of ERK1 (p44) and ERK2 (p42) but not JNK1/2 or p38 MAPK was observed (Figure 1).\n",
      "p(MGI:Il13) -> p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Il13) -> p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10027962 : Likewise, intratracheal IL-13 treatment caused goblet cell hyperplasia in association with increased SPDEF staining in control but not in Stat-6-/- mice (Figure 11, A and B).\n",
      "p(MGI:Il13) -> p(MGI:Spdef)\n",
      "p(MGI:Stat6) -> p(MGI:Spdef)\n",
      "----------------------\n",
      "10027970 : 4 of these 7 genes (SPRR1a, SPRR2a, SPRR2b, and Ca2T6) were again induced at least 4-fold more by IL-13 than by IL-4\n",
      "p(MGI:Il13) -> r(EGID:20755)\n",
      "p(MGI:Il13) -> r(MGI:Col6a2)\n",
      "p(MGI:Il13) -> r(MGI:Sprr1a)\n",
      "p(MGI:Il13) -> r(MGI:Sprr2b)\n",
      "----------------------\n",
      "10027972 : SPRR1a, SPRR2a, SPRR2b, and Ca2T6...these genes were expressed at a higher level in the lungs of the IL-13 transgenic mice than in the matched wild-type mice\n",
      "p(MGI:Il13) -> r(EGID:20755)\n",
      "p(MGI:Il13) -> r(MGI:Col6a2)\n",
      "p(MGI:Il13) -> r(MGI:Sprr1a)\n",
      "p(MGI:Il13) -> r(MGI:Sprr2b)\n",
      "----------------------\n",
      "10027976 : transcripts for the the A2A adenosine receptor were decreased in the lungs of 3-month-old IL-13 Tg mice, whereas transcripts for the A1, A2B, and A3 adenosine receptors were elevated (Figure 3a).\n",
      "p(MGI:Il13) -> r(MGI:Adora1)\n",
      "p(MGI:Il13) -| r(MGI:Adora2a)\n",
      "p(MGI:Il13) -> r(MGI:Adora2b)\n",
      "p(MGI:Il13) -> r(MGI:Adora3)\n",
      "----------------------\n",
      "10027980 : In addition, as shown in Fig. 1, IL-13 caused a significant increase in the amounts of mRNA encoding cytosolic phospholipase A2 (cPLA2) (Fig. 1A) and lesser increases in LTA4 hydrolase (LTA4H) and 5-LO-activating protein (FLAP) (Fig. 1B). (In Tg IL-13 lung specific overexpression mouse model)\n",
      "p(MGI:Il13) -> r(MGI:Alox5ap)\n",
      "p(MGI:Il13) -> r(MGI:Lta4h)\n",
      "p(MGI:Il13) -> r(MGI:Pla2g4a)\n",
      "----------------------\n",
      "10027982 : we assessed the levels of mRNA encoding CC chemokines that might be expected to contribute to these responses. As shown in Fig. 1A, IL-13 was a potent stimulator of MCP moieties, including MCP-1, MCP-2, MCP-3, and MCP-5 (Fig. 1).\n",
      "p(MGI:Il13) -> r(MGI:Ccl12)\n",
      "p(MGI:Il13) -> r(MGI:Ccl2)\n",
      "p(MGI:Il13) -> r(MGI:Ccl7)\n",
      "p(MGI:Il13) -> r(MGI:Ccl8)\n",
      "----------------------\n",
      "10027986 : As expected (Figure 4), IL-9 induced the expression of mCLCA3, confirming the observation in IL-9 transgenic mice. In addition, IL-4 and IL-13 were also able to induce the expression of mCLCA3 in the lung, whereas no expression was observed in the lungs of mice treated with IFN-gamma (Figure 4).\n",
      "p(MGI:Il13) -> r(MGI:Clca3)\n",
      "p(MGI:Il4) -> r(MGI:Clca3)\n",
      "p(MGI:Il9) -> r(MGI:Clca3)\n",
      "----------------------\n",
      "10027988 : Tg IL-13 caused increases in lung volume, alveolar size, goblet cell number, and Gob-5, Muc-5ac, and Muc-1 gene expression in Tg+ ERK1/2 MAPK-sufficient animals (Figure 8, AâH).\n",
      "p(MGI:Il13) -> r(MGI:Clca3)\n",
      "p(MGI:Il13) -> r(MGI:Muc1)\n",
      "p(MGI:Il13) -> r(MGI:Muc5ac)\n",
      "----------------------\n",
      "10027998 : As previously described by our laboratory, the levels of MMP-9 and 12 mRNA were increased in lungs from Tg IL-13 mice (10, 36).\n",
      "p(MGI:Il13) -> r(MGI:Mmp12)\n",
      "p(MGI:Il13) -> r(MGI:Mmp9)\n",
      "----------------------\n",
      "10028000 : These studies demonstrated that in vivo administration of either IL-4 or IL-13 intranasally could induce significant expression of ORMDL3 mRNA in WT bronchial epithelium as assessed by qPCR (Fig. S3A)\n",
      "p(MGI:Il13) -> r(MGI:Ormdl3)\n",
      "p(MGI:Il4) -> r(MGI:Ormdl3)\n",
      "----------------------\n",
      "10028002 : IL-13-induced PDGF-A and PDGF-C mRNA levels were significantly reduced in fibroblasts isolated from the lungs of Stat6/ mice compared with fibroblasts isolated from the lungs of the wild-type Stat6/ mice (Fig. 2, A and B).\n",
      "p(MGI:Il13) -> r(MGI:Pdgfa)\n",
      "p(MGI:Il13) -> r(MGI:Pdgfc)\n",
      "----------------------\n",
      "10028004 : FIZZ2 gene expression was significantly upregulated by IL-4 at 4-h and 8-h time points and by IL-13 at the 4-h time point (p < 0.05).\n",
      "p(MGI:Il13) -> r(MGI:Retnlb)\n",
      "p(MGI:Il4) -> r(MGI:Retnlb)\n",
      "----------------------\n",
      "10028006 : In this study we demonstrate that IL-4 and IL-13 enhance Ugrp2 gene expression in the mouse transformed Clara cell line, mtCC, in a time- and dose-dependent manner.\n",
      "p(MGI:Il13) -> r(MGI:Scgb3a1)\n",
      "p(MGI:Il4) -> r(MGI:Scgb3a1)\n",
      "----------------------\n",
      "10028008 : Interestingly, IL-13 did cause an approximately 80% decrease in pulmonary a1-AT expression (Figure 13). It also caused a significant increase in TIMP-1 expression that was seen after as little as 1 day and was readily apparent with longer periods of dox administration (Figure 13, and data not shown) (P < 0.05 for all comparisons).\n",
      "p(MGI:Il13) -| r(MGI:Serpina1a)\n",
      "p(MGI:Il13) -> r(MGI:Timp1)\n",
      "----------------------\n",
      "10028010 : As previously reported (13), IL-13 was a potent inducer of TIMP-1 and had lesser stimulatory effects on TIMP-2 and TIMP-4 while inhibiting 1-AT in wild-type animals (Fig. 7B). (RT-PCR analysis)\n",
      "p(MGI:Il13) -| r(MGI:Serpina1a)\n",
      "p(MGI:Il13) -> r(MGI:Timp1)\n",
      "p(MGI:Il13) -> r(MGI:Timp2)\n",
      "p(MGI:Il13) -> r(MGI:Timp4)\n",
      "----------------------\n",
      "10028012 : Numbers of cells expressing high levels of Ag-presentation molecules were increased in mice given IL-13 and IFN-g relative to all other groups of mice (Fig. 6). These cells were detected using anti-CD11c (a molecule expressed by dendritic cells), MHC class II, and CD86 (B7-2) Abs.\n",
      "p(MGI:Il13) -> surf(p(MGI:Cd86))\n",
      "p(MGI:Il13) -> surf(p(MGI:Itgax))\n",
      "----------------------\n",
      "10028044 : Consistently, IL-17A and IL-17F treatment of 3T3-L1 pre-adipocytes inhibited adipogenesis, leading to reduced production of leptin.\n",
      "p(MGI:Il17a) -| p(MGI:Lep)\n",
      "p(MGI:Il17f) -| p(MGI:Lep)\n",
      "----------------------\n",
      "10028050 : The hepatic mRNA expression of TNF-alpha, TGF-beta1, and collagen 1 alpha 1, which increased in the WT mice, also significantly decreased in the KO mice.\n",
      "p(MGI:Il17a) -> r(MGI:Col1a1)\n",
      "p(MGI:Il17a) -> r(MGI:Tgfb1)\n",
      "p(MGI:Il17a) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10009182 : In CIA synoviocytes, IL-17 increased the expression of TLR-2, 4, and 9, and this effect was significantly alleviated by neutralizing antibodies to IL-17, IL-1beta, and IL-6.\n",
      "p(MGI:Il17a) -> r(MGI:Tlr2)\n",
      "p(MGI:Il17a) -> r(MGI:Tlr4)\n",
      "p(MGI:Il17a) -> r(MGI:Tlr9)\n",
      "----------------------\n",
      "10028056 : At day 7 following infection, lung tissue from mice given hIL-17F Ad showed substantial increases in the mRNA for inflammatory cytokines and chemokines, including IL-6, IFN-g, inflammatory protein 10, and monokine induced by IFN-g (Fig. 3).\n",
      "p(MGI:Il17f) -> r(MGI:Cxcl10)\n",
      "p(MGI:Il17f) -> r(MGI:Cxcl9)\n",
      "p(MGI:Il17f) -> r(MGI:Ifng)\n",
      "p(MGI:Il17f) -> r(MGI:Il6)\n",
      "----------------------\n",
      "10028060 : Adenovirus-mediated expression of mSef but not GFP resulted in a reduction in the levels of activated ERK1/2, whereas overall levels of ERK1/2 were unaffected (Fig. 2 A).\n",
      "p(MGI:Il17rd) -| act(p(MGI:Mapk1))\n",
      "p(MGI:Il17rd) -| act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10009186 : Finally, we showed that IL-18-activated human peripheral blood neutrophils produced significant amounts of LTB(4) that were effectively blocked by the MK.\n",
      "p(MGI:Il18) -> a(CHEBI:\"leukotriene B4\")\n",
      "p(MGI:Il18) -> tloc(a(CHEBI:\"leukotriene B4\"))\n",
      "----------------------\n",
      "10028068 : In addition, IL-18 also upregulates the production of proinflammatory cytokines such as IL-1 and tumor necrosis factor-alpha.\n",
      "p(MGI:Il18) -> tloc(p(MGI:Il1a))\n",
      "p(MGI:Il18) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10028070 : We cultured sorted mast cells and basophils with IL-25, IL-18, or IL-25 IL-18 and detected both IL-5 and IL-13 from IL-18 cultured cell supernatants\n",
      "p(MGI:Il18) -> tloc(p(MGI:Il13))\n",
      "p(MGI:Il18) -> tloc(p(MGI:Il5))\n",
      "----------------------\n",
      "10028076 : IL-19 is anti-proliferative for cultured human coronary artery VSMC. This may be due to the observation that IL-19 transiently reduces HuR expression, which is known to play a role in VSMC proliferation [71].\n",
      "p(MGI:Il19) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Il19) -| p(MGI:Elavl1)\n",
      "----------------------\n",
      "10028080 : It has also been shown that IL-1a may be implicated in early stages of carcinogenesis, as it induces growth factors and stimulates the production of reactive oxygen species in vitro\n",
      "p(MGI:Il1a) -> a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Il1a) -> path(MESHD:Neoplasms)\n",
      "----------------------\n",
      "10028090 : RT-PCR analysis was performed to assess the degree of activation of the cytokines IL-1b, MIP-1a, MIP-2, and TNF-a. The results showed a significant increase in the mRNA level for MIP-1 and MIP-2 at 6 h after intratracheal IL-1a administration, with a significant attenuation in the transgenic mice (Figure 4)\n",
      "p(MGI:Il1a) -> r(MGI:Ccl3)\n",
      "p(MGI:Il1a) -> r(MGI:Cxcl2)\n",
      "----------------------\n",
      "10028092 : Anti-IL-1a, but not anti-IL-1b intervention significantly attenuated expression of CXCL-1 RNA transcripts and protein in smoke-exposed mice...Furthermore, CXCL-2 and CXCL-5 gene expression, while increased following smoke-exposure, were attenuated by anti-IL-1a\n",
      "p(MGI:Il1a) -> r(MGI:Cxcl1)\n",
      "p(MGI:Il1a) -> r(MGI:Cxcl2)\n",
      "p(MGI:Il1a) -> r(MGI:Cxcl5)\n",
      "----------------------\n",
      "10009208 : Furthermore, after treatment with IL-1beta for 1 h, cytoplasmic IkappaBalpha degradation occurred simultaneously with translocation of p65 into the nucleus.\n",
      "p(MGI:Il1b) -> deg(p(MGI:Ikbkb))\n",
      "p(MGI:Il1b) -> tloc(p(MGI:Rela))\n",
      "----------------------\n",
      "10028112 : animal models, with reduced atherosclerosis observed in IL-1b [41] and IL-1 receptor-deficient mice [11], while IL-1ra-deficient mice exhibit increased neointima formation [42]. IL-1Ra administration to Apo E-deficient mice or porcine arterial injury models reduced neointima formation significantly [11,43] as well as reducing vascular remodelling following acute myocardial infarction in the rat [44].\n",
      "p(MGI:Il1b) -> path(MESHD:Atherosclerosis)\n",
      "p(MGI:Il1r1) -> path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10028124 : IL-1b increased the production of neutrophil chemoattractants such as Gro-alpha (CXCL1) and MIP-2 (CXCL2) in lungs.\n",
      "p(MGI:Il1b) -> p(MGI:Cxcl1)\n",
      "p(MGI:Il1b) -> p(MGI:Cxcl2)\n",
      "p(HGNC:IL1B) -> p(HGNC:CXCL2)\n",
      "----------------------\n",
      "10028128 : Elevated levels of IL-17 were found in lung tumors in IL-1Ra KO mice, compared with tumors in WT mice, whereas significantly lower levels of IL-17 were detected in IL-1b KO mice, indicating that these cytokines possibly mutually interact in the lung tumor microenvironment\n",
      "p(MGI:Il1b) -> p(MGI:Il17a)\n",
      "p(MGI:Il1r1) -| p(MGI:Il17a)\n",
      "----------------------\n",
      "10028136 : iNOS protein was undetectable at 1 h but was increased after 2, 4, and 24 h of incubation with IL-6. The iNOS expression induced by a 2-h incubation with 10 ng/ml IL-1beta, a well known inducer of iNOS in cardiac myocytes (38), was used as a positive control in these experiments.\n",
      "p(MGI:Il1b) -> p(MGI:Nos2)\n",
      "p(MGI:Il6) -> p(MGI:Nos2)\n",
      "----------------------\n",
      "10028154 : Because STAP-2 expression is induced by proinflammatory cytokines such as IL-6 or IL-1beta, STAP-2 may play a role in the regulation of inflammation.\n",
      "p(MGI:Il1b) -> r(MGI:Stap2)\n",
      "p(MGI:Il6) -> r(MGI:Stap2)\n",
      "----------------------\n",
      "10028156 : Real-time RT-PCR revealed that IL-1beta induced SYN expression at the transcriptional level, because the mRNA level of SYN was upregulated by IL-1?. TNF-? had a weaker effect on SYN transcription, whereas IL-6 had no effect\n",
      "p(MGI:Il1b) -> r(MGI:Syvn1)\n",
      "p(MGI:Tnf) -> r(MGI:Syvn1)\n",
      "----------------------\n",
      "10028174 : We also investigated the expression of various genes, including, CXCL-1, GM-CSF, and MMP-12 (Figure 5 EâG, respectively), all of which were significantly attenuated in IL-1R1 deficient animals reconstituted with IL-1R1 deficient bone marrow cells (KO into KO)\n",
      "p(MGI:Il1r1) -> r(MGI:Csf2)\n",
      "p(MGI:Il1r1) -> r(MGI:Cxcl1)\n",
      "p(MGI:Il1r1) -> r(MGI:Mmp12)\n",
      "----------------------\n",
      "10027060 : Forced expression of wild-type mouse Foxp3 inhibited IL-6/IL-21-induced Il23r expression, whereas Foxp3DeltaEx2 had less inhibitory activity (Fig. 4a)\n",
      "p(MGI:Il21) -> r(MGI:Il23r)\n",
      "p(MGI:Il6) -> r(MGI:Il23r)\n",
      "----------------------\n",
      "10028190 : IL-22 but not saline induced keratinocyte hyperplasia in mouse ears (Figure ?(Figure6B)6Figure 6B) as well as increased defensin ?1, S100A8, and S100A9 transcripts (data not shown). IL-22 also significantly induced IL-1? gene expression,\n",
      "p(MGI:Il22) -> path(MESHD:Hyperplasia)\n",
      "p(MGI:Il22) -> r(MGI:Il1b)\n",
      "----------------------\n",
      "10028196 : As demonstrated in Figure ?Figure6A,6Figure 6A, IL-22 but not saline induced a significant increase in S100A8, S100A9, and defensin ?1\n",
      "p(MGI:Il22) -> r(MGI:Defb1)\n",
      "p(MGI:Il22) -> r(MGI:S100a8)\n",
      "p(MGI:Il22) -> r(MGI:S100a9)\n",
      "----------------------\n",
      "10028204 : The increased enzymatic activity of gelatinases in the ileum of infected WT but not IL-23p19?/? mice was paralleled by increased mRNA and protein levels of either gelatinase at day 8 after infection compared with naive WT mice (Fig. 2, C and D). These results indicate that IL-23 is required for the up-regulation of both MMP-2 and MMP-9 in T. gondiiâinduced ileitis.\n",
      "p(MGI:Il23a) -> r(MGI:Mmp2)\n",
      "p(MGI:Il23a) -> r(MGI:Mmp9)\n",
      "----------------------\n",
      "10028214 : As has been reported previously, the intratracheal administration of IL-25 induced a type 2 type inflammatory response, characterized by airway hyperreactivity, eosinophil infiltrates, mucus production, and the upregulation of inflammatory genes including Il25 and Il17rb (see Supplemental Fig. 5).\n",
      "p(MGI:Il25) -> r(MGI:Il13)\n",
      "p(MGI:Il25) -> r(MGI:Il17rb)\n",
      "p(MGI:Il25) -> r(MGI:Il25)\n",
      "p(MGI:Il25) -> r(MGI:Il5)\n",
      "----------------------\n",
      "10009248 : In vitro, IL-33 amplified IL-13-induced polarization of alveolar- and bone marrow-derived macrophage toward an AAM phenotype by increasing the expression of arginase I, Ym1, as well as the production of CCL24 and CCL17\n",
      "p(MGI:Il33) -> p(MGI:Ccl17)\n",
      "p(MGI:Il33) -> p(MGI:Ccl24)\n",
      "p(MGI:Il33) -> r(MGI:Arg1)\n",
      "p(MGI:Il33) -> r(MGI:Chil3)\n",
      "----------------------\n",
      "10028234 : IL-33-treated mice exhibited substantially increased expression of related components of the ECM such as fibronectin and collagen IIIa, in comparison with that of untreated mice\n",
      "p(MGI:Il33) -> r(MGI:Col3a1)\n",
      "p(MGI:Il33) -> r(MGI:Fn1)\n",
      "----------------------\n",
      "10028236 : In bone marrow cultures, IL-33 induced mRNA expression of granulocyte macrophage colony-stimulating factor, IL-4, IL-13, and IL-10;\n",
      "p(MGI:Il33) -> r(MGI:Csf2)\n",
      "p(MGI:Il33) -> r(MGI:Il10)\n",
      "p(MGI:Il33) -> r(MGI:Il13)\n",
      "p(MGI:Il33) -> r(MGI:Il4)\n",
      "----------------------\n",
      "10028238 : Sclerostin is produced solely by osteocytes, and sclerostin mRNA was both readily detectable and suppressed by IL-33 treatment in both culture systems...IL-33 transiently enhanced DMP-1 steady-state mRNA levels (Fig. 5E), but there was no significant effect on MEPE steady-state mRNA levels.\n",
      "p(MGI:Il33) -> r(MGI:Dmp1)\n",
      "p(MGI:Il33) -| r(MGI:Sost)\n",
      "----------------------\n",
      "10009250 : the 32Dcl3 cell line, which is derived from normal mouse bone marrow, is non-tumorigenic and diploid. These cells are strictly dependent on IL-3 for growth and apoptose when deprived of IL-3.\n",
      "p(MGI:Il3) -> bp(GOBP:\"cell growth\")\n",
      "p(MGI:Il3) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10028244 : Following IL-3 withdrawal, c-MYC is downregulated and cells become growth arrested, accumulating in the G0/G1 phase of the cell cycle, and rapidly undergo apoptosis. Enforced c-MYC expression accelerates the apoptotic response in the absence of IL-3 (Askew et al., 1991).\n",
      "p(MGI:Il3) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Il3) -> p(MGI:Myc)\n",
      "----------------------\n",
      "10000100 : Further, IL-4 inhibits the synthesis of nitric oxide from a murine macrophage cell line stimulated with interferong by the inhibition of inducible nitric oxide synthase mRNA formation\n",
      "p(MGI:Il4) -| a(CHEBI:\"nitric oxide\")\n",
      "p(MGI:Il4) -| r(MGI:Nos2)\n",
      "----------------------\n",
      "10028258 : In addition to their positive effects on TH2 and TH1 development, IL-4 (Fig. 1) and IL-12 (7, 30), acting via STAT proteins, potently suppress induction of T-bet and Gata-3, thereby limiting differentiation of TH1 and TH2 subsets, respectively.\n",
      "p(MGI:Il4) -| bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "p(MGI:Il4) -| r(MGI:Tbx21)\n",
      "p(HGNC:IL4) -| bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "----------------------\n",
      "10028260 : IL-4 increases mRNA turnover of IL-1 b and TNFa in human monocytes and mouse macrophages, respectively (23, 24).\n",
      "p(MGI:Il4) -> deg(p(MGI:Il1b))\n",
      "p(MGI:Il4) -> deg(p(MGI:Tnf))\n",
      "----------------------\n",
      "10028266 : In addition to its effects on human cells, IL-4 reduced C5a receptors in murine bone marrow-derived DC and impaired recruitment of labeled bone marrow-derived DC in syngeneic BALB/c mice to i.p. injected C5a. Overall, these data suggest that inhibition of a rapid anaphylatoxin-induced mobilization of monocytes and DC to inflamed tissues represents an important anti-inflammatory activity of the Th2 cytokine IL-4.\n",
      "p(MGI:Il4) -| p(MGI:C3ar1)\n",
      "p(MGI:Il4) -| p(MGI:C5ar1)\n",
      "p(HGNC:IL4) -| p(HGNC:C3AR1)\n",
      "p(HGNC:IL4) -| p(HGNC:C5AR1)\n",
      "----------------------\n",
      "10028280 : Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6.\n",
      "p(MGI:Il4) -| p(MGI:Tbx21)\n",
      "p(MGI:Il4) -> act(p(MGI:Stat6))\n",
      "act(p(MGI:Stat6)) -| r(MGI:Tbx21)\n",
      "act(p(MGI:Tbx21)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "----------------------\n",
      "10028284 : We found that the induction of AMCase and Clca3 transcripts was markedly reduced in mice with Clara cell-specific disruption of Il4ra (Fig. 8, c and d).\n",
      "p(MGI:Il4ra) -> r(MGI:Chia1)\n",
      "p(MGI:Il4ra) -> r(MGI:Clca3)\n",
      "----------------------\n",
      "10028288 : Muc5ac and Muc5b were both highly induced by allergen treatment of control mice, but induction of these transcripts was markedly impaired in mice with Clara cell-specific disruption of Il4ra (Fig. 8, a and b).\n",
      "p(MGI:Il4ra) -> r(MGI:Muc5ac)\n",
      "p(MGI:Il4ra) -> r(MGI:Muc5b)\n",
      "----------------------\n",
      "10028290 : IL-4C inhalation failed to induce Ca2T6 or SPRR1a gene expression at any time point studied, it initially induced SPRR2a and SPRR2b gene expression...In addition, an observation that IL-4, but not IL-13, induced IFN- gene expression (Fig. 4)\n",
      "p(MGI:Il4) -> r(EGID:20755)\n",
      "p(MGI:Il4) -> r(MGI:Ifng)\n",
      "p(MGI:Il4) -> r(MGI:Sprr2b)\n",
      "----------------------\n",
      "10028292 : Both IL-4 and IL-9 can increase the expression of BCL3, a protein with close homology to I??B, thus contributing to NF-??B inhibition [59].\n",
      "p(MGI:Il4) -> r(MGI:Bcl3)\n",
      "p(MGI:Il9) -> r(MGI:Bcl3)\n",
      "----------------------\n",
      "10028294 : Twenty-four hour stimulation with 25.0 ng/ml mOSM induced detectable increases in eotaxin-1 expression at the mRNA and protein level in both wt and STAT6-/- MLF (Fig. 5, A and C). Stimulation of wt MLF using 10.0 ng/ml mIL-4 induced eotaxin mRNA expression and protein production that was nondetectable in STAT6-/- MLF (Fig. 5, A and C)\n",
      "p(MGI:Il4) -> r(MGI:Ccl11)\n",
      "p(MGI:Osm) -> r(MGI:Ccl11)\n",
      "p(MGI:Stat6) -> r(MGI:Ccl11)\n",
      "----------------------\n",
      "10009264 : c-Maf-null macrophages exhibit strongly impaired IL-10 protein production and mRNA expression upon LPS stimulation.\n",
      "p(MGI:Il4) -> r(MGI:Maf)\n",
      "act(p(MGI:Maf)) -> r(MGI:Il10)\n",
      "----------------------\n",
      "10020328 : This unconventional interaction of SOCS5 protein with the IL-4R resulted in the inhibition of IL-4-mediated signal transducer and activator of transcription-6 activation.\n",
      "p(MGI:Il4) -> act(p(MGI:Stat6))\n",
      "p(HGNC:IL4) -> act(p(HGNC:STAT6))\n",
      "----------------------\n",
      "10028310 : Fig. 4. IL-4 induces STAT6 binding to a site in the 5' upstream regulatory region of the AID gene.\n",
      "p(MGI:Il4) -> act(p(MGI:Stat6))\n",
      "p(HGNC:IL4) -> act(p(HGNC:STAT6))\n",
      "----------------------\n",
      "10028276 : To verify the absence of the STAT6-signaling cascade in STAT6-/- MLF, we assessed mOSM and mIL-4 induced responses with respect to STAT3 and STAT6 activation. Fig. 6 confirms the absence of STAT6 protein and STAT6 induction in STAT6-/- MLF but equivalent activation of STAT3 in both wt and STAT6-/- MLF.\n",
      "p(MGI:Il4) -> act(p(MGI:Stat6))\n",
      "p(MGI:Osm) -> act(p(MGI:Stat3))\n",
      "p(MGI:Osm) -> act(p(MGI:Stat6))\n",
      "----------------------\n",
      "10009272 : Furthermore, anti-IL-5 antibody caused significant reduction in lung eosinophilia, cytokine expression, and fibrosis. These findings taken together suggest an important role for IL-5 in pulmonary fibrosis via its ability to regulate eosinophilic inflammation, and thus eosinophil-dependent fibrogenic cytokine production\n",
      "p(MGI:Il5) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Il5) -> path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10028320 : Immunostaining with anti-TGF-b and anti-MCP-1 antibodies revealed similar results. As previously reported [8, 9, 16], there was a substantial increase in the number of cells expressing these cytokines in bleomycin-injured lungs, which was also inhibited by treatment with anti-IL-5 antibody as confirmed by morphometric counting of cytokine-positive cells (Fig. 7, B and C, respectively).\n",
      "p(MGI:Il5) -> p(MGI:Ccl2)\n",
      "p(MGI:Il5) -> p(MGI:Tgfb1)\n",
      "p(HGNC:IL5) -> p(HGNC:CCL2)\n",
      "p(HGNC:IL5) -> p(HGNC:TGFB1)\n",
      "----------------------\n",
      "10028314 : Indeed at each time point examined, levels of lung hydroxyproline, soluble collagen, fibronectin, and TGF-? were higher in blm-treated IL-5TG relative to IL-5WT mice (Fig. 2?, AâD).\n",
      "p(MGI:Il5) -> p(MGI:Fn1)\n",
      "p(MGI:Il5) -> p(MGI:Tgfb1)\n",
      "p(HGNC:IL5) -> p(HGNC:TGFB1)\n",
      "----------------------\n",
      "10028322 : TNF-alpha, IL-1beta, and IFN-gamma expression were slightly decreased in cultures from blm-treated IL-5-/- mice relative to cultures from blm-treated IL-5+/+ mice (Table IV?), whereas TGF-beta levels were significantly increased. Anti-CD3-induced expression of IL-4 and IL-13 were dramatically diminished in IL-5?/? T cells in comparison to IL-5+/+ T cells.\n",
      "p(MGI:Il5) -> p(MGI:Il13)\n",
      "p(MGI:Il5) -> p(MGI:Il4)\n",
      "----------------------\n",
      "10028334 : Several pro-inflammatory mediators up-regulate SAA transcription, including Il1, Il6, TNFalpha, and Lif.\n",
      "p(MGI:Il6) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Lif) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Tnf) -> bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:IL6) -> bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:TNF) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10028336 : Il6 can elicit proinflammatory or anti-inflammatory effects, depending on the in vivo environmental circumstances\n",
      "p(MGI:Il6) -> bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:IL6) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10028338 : More importantly, persistent activation of IL-6 downstream Stat3 in AT II epithelial cellsdirec tly induced lung inflammation and bronchioalveolar adenocarcinoma (22).\n",
      "p(MGI:Il6) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Il6) -> path(MESHD:Adenocarcinoma)\n",
      "p(HGNC:IL6) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10028344 : Il6, leukemia inhibitory factor [LIF}, and oncostatin M [OSM] are Il6-type cytokines that stimulate osteoclast formation and function\n",
      "p(MGI:Il6) -> bp(GOBP:\"osteoclast differentiation\")\n",
      "p(MGI:Lif) -> bp(GOBP:\"osteoclast differentiation\")\n",
      "p(MGI:Osm) -> bp(GOBP:\"osteoclast differentiation\")\n",
      "----------------------\n",
      "10028346 : GFAP-IL-6 mice showed faster tissue repair and decreased oxidative stress and apoptosis compared with control litter-mate mice.\n",
      "p(MGI:Il6) -| bp(GOBP:\"response to oxidative stress\")\n",
      "p(MGI:Il6) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10028352 : Fig.3 A shows that an increase in phosphorylation of ERK2 at Tyr204 was detected after 5 min of exposure to 10 ng/ml IL-6; this effect peaked at 30 min and was followed by a decline to basal levels by 2 h.\n",
      "p(MGI:Il6) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Il6) -> p(MGI:Mapk1,pmod(P))\n",
      "----------------------\n",
      "10028356 : alpha 2-macroglobulin, alpha 1-antichymotrypsin ( = contrapsin), cysteine protease inhibitor ( = thiostatin), alpha 1-antitrypsin, ceruloplasmin and fibrinogens are predominantly regulated by the keratinocyte-derived HSF-III/-II or IL-6\n",
      "p(MGI:Il6) -> p(MGI:A2m)\n",
      "p(MGI:Il6) -> p(MGI:Cp)\n",
      "p(MGI:Il6) -> p(MGI:Fga)\n",
      "p(MGI:Il6) -> p(MGI:Kng1)\n",
      "----------------------\n",
      "10009278 : recombinant IL-6 to IL-6 KO animals before LPS or TNF-alpha challenge, replenished ANXA1 liver synthesis to that of WT animals.\n",
      "p(MGI:Il6) -> p(MGI:Anxa1)\n",
      "p(MGI:Il6) -> r(MGI:Anxa1)\n",
      "----------------------\n",
      "10028358 : Immunoblots using antibodies to BATF detected an increase in BATF protein in response to LIF/IL-6 stimulation.\n",
      "p(MGI:Il6) -> p(MGI:Batf)\n",
      "p(MGI:Il6ra) -> p(MGI:Batf)\n",
      "p(MGI:Lif) -> p(MGI:Batf)\n",
      "p(MGI:Lifr) -> p(MGI:Batf)\n",
      "----------------------\n",
      "10028368 : Fig. 1 Ashows that phosphorylation of STAT3 at Tyr705 was detected after 5 min of exposure to 10 ng/ml IL-6, reached a maximum at 15 min, and then declined within 1 h. These results demonstrate that IL-6 activates a STAT3 signaling in adult rat ventricular myocytes.\n",
      "p(MGI:Il6) -> p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Il6) -> act(p(MGI:Stat3))\n",
      "p(MGI:Stat3,pmod(P)) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10028372 : nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck are activated through the Il6R receptor\n",
      "p(MGI:Il6ra) -> act(p(MGI:Btk))\n",
      "p(MGI:Il6ra) -> act(p(MGI:Fes))\n",
      "p(MGI:Il6ra) -> act(p(MGI:Hck))\n",
      "p(MGI:Il6ra) -> act(p(MGI:Tec))\n",
      "----------------------\n",
      "10028380 : from full text - anti-IL-6 receptor monoclonal antibody to a murine colitis model and found that the treatment with this antibody reduced IFN-gamma, TNF-alpha, and IL-1beta mRNA, and suppressed expression of several intracellular adhesion molecules in the colonic vascular endothelium.\n",
      "p(MGI:Il6) -> r(MGI:Ifng)\n",
      "p(MGI:Il6) -> r(MGI:Il1b)\n",
      "p(MGI:Il6) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10028390 : interleukin-6 (IL-6) or leukemia inhibitory factor (LIF)-induced differentiation of the myeloid cell line M1 was associated with a rapid increase in the level of mRNA encoding the signaling adaptor protein, SKAP55R\n",
      "p(MGI:Il6) -> r(MGI:Skap2)\n",
      "p(MGI:Lif) -> r(MGI:Skap2)\n",
      "----------------------\n",
      "10028396 : this acidic domain of gp130 is responsible for the activation of Hck, Erk, Pyk2 and signals cell proliferation upon growth factor stimulation\n",
      "p(MGI:Il6st) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Il6st) -> act(p(MGI:Hck))\n",
      "p(MGI:Il6st) -> act(p(MGI:Ptk2b))\n",
      "----------------------\n",
      "10028406 : functions of the 2 major signaling pathways, the signal transducers and activators of transcription 1 and 3 [STAT1/3] and the Src-homology tyrosine phosphatase 2 [SHP2]-Ras-ERK [Ptpn11], emanating from the common signal transducer, gp130, in the gastrointestinal tract\n",
      "p(MGI:Il6st) -> act(p(MGI:Ptpn11))\n",
      "p(MGI:Il6st) -> act(p(MGI:Stat1))\n",
      "----------------------\n",
      "10028408 : NOTCH1 activation, indicated by tumor necrosis factor alpha-converting enzyme, TACE [Adam17], and presenilin-mediated processing, also increased\n",
      "p(MGI:Il6st) -> p(MGI:Notch1)\n",
      "p(MGI:Notch1) -> r(MGI:Adam17)\n",
      "----------------------\n",
      "10028412 : tyrosine phosphorylation of SHP2, a phosphotyrosine phosphatase, and that of STAT3 depend on the second tyrosine residue Y2 from the membrane in gp130\n",
      "p(MGI:Il6st,pmod(P)) -> p(MGI:Ptpn11,pmod(P))\n",
      "p(MGI:Il6st,pmod(P)) -> p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Stat3,pmod(P)) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10028424 : Although STAT3 is essential for IL-6-induced macrophage differentiation of M1 cells, GATA-1 had little or no effect on tyrosine phosphorylation, DNA binding, and transcriptional activities of STAT3 in Western blot analysis, electropholic mobility shift assay (EMSA), and luciferase assays.\n",
      "p(MGI:Il6) -> act(p(MGI:Stat3))\n",
      "act(p(MGI:Stat3)) -> bp(GOBP:\"macrophage differentiation\")\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "act(p(HGNC:STAT3)) -> bp(GOBP:\"macrophage differentiation\")\n",
      "----------------------\n",
      "10016526 : IL-6 induced STAT3 transactivation was reduced from sixfold to 2.5-fold when cells were pre- treated with the JAK2 inhibitor (Figure 2b).\n",
      "p(MGI:Il6) -> act(p(MGI:Stat3))\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10028426 : Stat3 controls cell death and tissue remodeling in the mouse mammary gland during involution, which is partially induced by IL6 and LIF.\n",
      "p(MGI:Il6) -> act(p(MGI:Stat3))\n",
      "p(MGI:Lif) -> act(p(MGI:Stat3))\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10028436 : Although recognized as a T cell growth factor, IL-9 exerts a Th2 inflammatory response in these cells, and suppresses expression of TNF??, IFN??, with a concurrent up regulation of IL-10 [15].\n",
      "p(MGI:Il9) -| p(MGI:Ifng)\n",
      "p(MGI:Il9) -> p(MGI:Il10)\n",
      "p(MGI:Il9) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10028440 : IL-9 induced MUC2 and MUC5AC expression in IL-9 transgenic mice (Tg5) and in IL-9 treated C57BL/6 mice. Protein level of MUC2 and MUC5AC was confirmed by dot blot analysis.\n",
      "p(MGI:Il9) -> p(MGI:Muc2)\n",
      "p(MGI:Il9) -> p(MGI:Muc5ac)\n",
      "----------------------\n",
      "10028442 : Transcripts for the Th2 cytokines IL-5, IL-13, and IL-9 could be detected in lung tissue from transgene-positive mice after transgene induction (Fig. 6).\n",
      "p(MGI:Il9) -> r(MGI:Il13)\n",
      "p(MGI:Il9) -> r(MGI:Il5)\n",
      "----------------------\n",
      "10028448 : In vivo, the constitutive expression of IL-9 in transgenic mice results in elevated MUC2 and MUC5AC gene expression in airway epithelial cells and periodic acid-Schiff-positive staining (reflecting mucous glycogenates).\n",
      "p(MGI:Il9) -> r(MGI:Muc2)\n",
      "p(MGI:Il9) -> r(MGI:Muc5ac)\n",
      "----------------------\n",
      "10009306 : overexpression of the antisense ING1 stimulated expression of 14 genes, which included cyclin B1, 12-O-tetradecanoylphorbol-13-acetate-inducible sequence 11, proto-oncogene DEK, and osteopontin,\n",
      "p(MGI:Ing1) -| r(MGI:Ccnb1)\n",
      "p(MGI:Ing1) -| r(MGI:Dek)\n",
      "p(MGI:Ing1) -| r(MGI:Spp1)\n",
      "----------------------\n",
      "10028472 : INSIG1 expression restricts lipogenesis in mature adipocytes and blocks differentiation in preadipocytes.\n",
      "p(MGI:Insig1) -| bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Insig1) -| bp(GOBP:\"lipid biosynthetic process\")\n",
      "----------------------\n",
      "10009312 : In this report, we show that IRAK1 is mainly involved in Stat3 activation and subsequent interleukin-10 (IL-10) gene expression.\n",
      "p(MGI:Irak1) -> r(MGI:Il10)\n",
      "p(MGI:Irak1) -> act(p(MGI:Stat3))\n",
      "----------------------\n",
      "10028492 : We show that ectopic expression of STAT1 or its downstream transcriptional target IRF-1 promotes features of megakaryocytic differentiation of G1ME cells, a Gata1-null erythromegakaryocytic cell line (25),\n",
      "p(MGI:Irf1) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "p(MGI:Stat1) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "----------------------\n",
      "10009324 : In TNBS colitis, no differences were found in interleukin (IL)-18 and tumor necrosis factor (TNF)-alpha expression between IRF4 knockout and wild-type mice. However, significant differences were detected in IL-6 and IL-17 production.\n",
      "p(MGI:Irf4) -> p(MGI:Il17a)\n",
      "p(MGI:Irf4) -> p(MGI:Il6)\n",
      "----------------------\n",
      "10028502 : In contrast, over- expression of either IRF4 or ICSBP in both macrophages and NIH-3T3 fibroblasts suppressed transcription of the PU.1-independent H-2L d MHC class I promoter.\n",
      "p(MGI:Irf4) -| r(EGID:14980)\n",
      "p(MGI:Irf8) -| r(EGID:14980)\n",
      "----------------------\n",
      "10009328 : Furthermore, both IRF4 and ICSBP activated transcription of the IL-1beta promoter in both cell types.\n",
      "p(MGI:Irf4) -> r(MGI:Il1b)\n",
      "p(MGI:Irf8) -> r(MGI:Il1b)\n",
      "----------------------\n",
      "10028518 : Indeed, pDC from IRF-7 KO mice are almost completely devoid of IFNalpha and IFNbeta induction in response to viral infection and stimulation by TLR7 and 9 ligands [39].\n",
      "p(MGI:Irf7) -> r(MGI:Ifna1)\n",
      "p(MGI:Irf7) -> r(MGI:Ifnb1)\n",
      "----------------------\n",
      "10028522 : Caspase 9 is activated by FasL in both CMS4 and CMS4.Vector cells but not in CMS4.K79E cells. Consistent with caspase 9 activation, caspase 3 activation and PARP cleavage are also inhibited in CMS4.K79E cells (Fig. 1B).\n",
      "p(MGI:Irf8) -> act(p(MGI:Casp3))\n",
      "p(MGI:Irf8) -> act(p(MGI:Casp9))\n",
      "----------------------\n",
      "10009330 : Small interfering RNA-induced repression of IRF8 in a GC-derived B cell line resulted in decreased expression of MDM2 at the protein level but increased expression of p53 and p21.\n",
      "p(MGI:Irf8) -| p(MGI:Cdkn1a)\n",
      "p(MGI:Irf8) -> p(MGI:Mdm2)\n",
      "p(MGI:Irf8) -| p(MGI:Trp53)\n",
      "----------------------\n",
      "10009340 : Insulin receptor substrates (IRS-1 and IRS-2) are essential for intracellular signaling by insulin and insulin-like growth factor-I (IGF-I), anabolic regulators of bone metabolism\n",
      "p(MGI:Irs1) -> bp(GOBP:\"insulin receptor signaling pathway\")\n",
      "p(MGI:Irs2) -> bp(GOBP:\"insulin receptor signaling pathway\")\n",
      "----------------------\n",
      "10028538 : S6K can phosphorylate IRS-1 on a different residue, Ser1101, thus reducing its function and leading to insulin resistance in vivo in skeletal muscle (Tremblay et al., 2007).\n",
      "p(MGI:Irs1,pmod(P)) -| act(p(MGI:Irs1))\n",
      "p(MGI:Rps6kb1) -| act(p(MGI:Irs1))\n",
      "p(MGI:Rps6kb1) -> p(MGI:Irs1,pmod(P))\n",
      "----------------------\n",
      "10028542 : Semiquantitative RT-PCR showed a dramatically reduced islet expression of sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA)-2b and -3 in the mutants. These data provide evidence that IRS-1 modulation of insulin secretion is associated with Ca(2+) signaling and expression of SERCA-2b and -3 genes in pancreatic islets and provides a direct link between insulin resistance and defective insulin secretion.\n",
      "p(MGI:Irs1) -> r(MGI:Atp2a2)\n",
      "p(MGI:Irs1) -> r(MGI:Atp2a3)\n",
      "----------------------\n",
      "10009348 : they showed increased receptor activator of nuclear factor kappaB ligand (RANKL) expression and osteoclastogenesis in the coculture with bone marrow cells\n",
      "p(MGI:Irs2) -| bp(GOBP:\"osteoclast differentiation\")\n",
      "p(MGI:Irs2) -| p(MGI:Tnfsf11)\n",
      "----------------------\n",
      "10009352 : In contrast, increased IRS-3 expression significantly inhibited mitogenesis and increased apoptosis\n",
      "p(MGI:Irs3) -| bp(GOBP:mitosis)\n",
      "p(MGI:Irs3) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10028550 : Following transduction of IRS-3 or IRS-4, the cells showed a significant decrease in IRS-2 mRNA and protein levels without any change in the IRS-1 protein level.\n",
      "p(MGI:Irs3) -| r(MGI:Irs2)\n",
      "p(MGI:Irs4) -| r(MGI:Irs2)\n",
      "----------------------\n",
      "10028556 : We found that {ITGA5 sh-RNA} transfected LLC cells showed decreased expression of the alpha5 gene, which was associated with decreased adhesion to fibronectin and reduced cell migration, proliferation and colony formation when compared to control cells and cells stably transfected with alpha2 integrin subunit in vitro.\n",
      "p(MGI:Itga5) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Itga5) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10009360 : Overexpression of alpha5 in preadipocytes results in enhanced proliferation and attenuated differentiation.\n",
      "p(MGI:Itga5) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Itga5) -| bp(GOBP:\"fat cell differentiation\")\n",
      "----------------------\n",
      "10009370 : We also present data showing that beta(6)(-/-) mice are seriously compromised in their ability to mount a mucosal mast cell response after infection, and there is a significant reduction in the expression and systemic release of the granule chymase, mouse mast cell protease-1.\n",
      "p(MGI:Itgav) -> bp(GOBP:\"mast cell activation\")\n",
      "p(MGI:Itgav) -> r(MGI:Mcpt1)\n",
      "p(MGI:Itgav) -> tloc(p(MGI:Mcpt1))\n",
      "----------------------\n",
      "10009372 : The expression of Tcf-4, a transcription factor known to be required for intestinal epithelial stem cell proliferation, was increased and mislocalized in the intestinal epithelia of the beta1 integrin-deleted mice\n",
      "p(MGI:Itgb1) -| p(MGI:Tcf4)\n",
      "p(MGI:Tcf4) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10028568 : beta1 integrins were found to drive the expression of Hedgehogs in intestinal epithelial cells in an HNF-3beta (Foxa2)-dependent fashion.\n",
      "p(MGI:Itgb1) -> act(p(MGI:Foxa2))\n",
      "act(p(MGI:Foxa2)) -> r(MGI:Shh)\n",
      "----------------------\n",
      "10028586 : In parallel to JNK, two other MAPKs, ERK1 and ERK2, were also found to be targeted to the nucleus in a b4-integrindependent manner in keratinocytes (Nikolopoulos et al., 2005).\n",
      "p(MGI:Itgb4) -> tloc(p(MGI:Mapk1))\n",
      "p(MGI:Itgb4) -> tloc(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10028598 : Erk1 and Erk2 were found to be much less phosphorylated in Itpkb ?/? E?-2?22-BCL-2 B cells than in control B cells after BCR activation (Fig. 3 b).\n",
      "p(MGI:Itpkb) -| p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Itpkb) -| p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10028610 : Endogenous expression of JDP2 was induced in both C2C12 myoblast and rhabdomyosarcoma (RD) cells programmed to differentiate. Ectopic expression of JDP2 in C2C12 myoblast cells inhibited cell cycle progression and induced spontaneous muscle cell differentiation.\n",
      "p(MGI:Jdp2) -| bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Jdp2) -> bp(GOBP:\"myoblast differentiation\")\n",
      "----------------------\n",
      "10028612 : The mechanism of tumor suppressor action of JDP2 can be partially explained by the generation of inhibitory AP-1 complexes via the increase of JunB, JunD, and Fra2 expression and decrease of c-Jun expression.\n",
      "p(MGI:Jdp2) -> p(MGI:Fosl2)\n",
      "p(MGI:Jdp2) -> p(MGI:Junb)\n",
      "p(MGI:Jdp2) -> p(MGI:Jund)\n",
      "p(MGI:Jdp2) -| r(MGI:Jun)\n",
      "----------------------\n",
      "10028618 : Transient transfection experiments revealed that overexpression of JDP2 leads to activation of both tartrate-resistant acid phosphatase (TRAP) and cathepsin K gene promoters in RAW264.7 cells.\n",
      "p(MGI:Jdp2) -> r(MGI:Acp5)\n",
      "p(MGI:Jdp2) -> r(MGI:Ctsk)\n",
      "----------------------\n",
      "10028622 : ression analysis showed down-regulation of Cx40 and Cx43, but not Cx45 message in JDP2-transgenics (Fig. 4A). Thus we\n",
      "p(MGI:Jdp2) -| r(MGI:Gja1)\n",
      "p(MGI:Jdp2) -| r(MGI:Gja5)\n",
      "----------------------\n",
      "10028658 : Interestingly, c-Jun Re cells had dramatically lower Grp78 and Gadd153 expression in response to TG treatment compared to c-junâ/â cells (Fig. 2C).\n",
      "p(MGI:Jun) -| p(MGI:Ddit3)\n",
      "p(MGI:Jun) -| p(MGI:Hspa5)\n",
      "p(HGNC:JUN) -| p(HGNC:DDIT3)\n",
      "p(HGNC:JUN) -| p(HGNC:HSPA5)\n",
      "----------------------\n",
      "10028660 : Interestingly, overexpression of exogenous c-Jun in the c-jun?/? cells caused both an autophosphorylation of c-Jun in the target cells (Fig. 7A) and induced up-regulation of Adapt78 expression (Fig. 7B).\n",
      "p(MGI:Jun) -> p(MGI:Jun,pmod(P))\n",
      "p(MGI:Jun) -> p(MGI:Rcan1)\n",
      "----------------------\n",
      "10028662 : Intriguingly, Adapt78 expression was up-regulated in response to TG treatment in c-Jun Re cells but not in c-junâ/â cells (Fig. 2C).\n",
      "p(MGI:Jun) -> p(MGI:Rcan1)\n",
      "p(HGNC:JUN) -> p(HGNC:RCAN1)\n",
      "----------------------\n",
      "10009404 : Finally, REN enhances caspase-3 activation and terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling apoptotic GCP numbers;\n",
      "p(MGI:Kctd11) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Kctd11) -> act(p(MGI:Casp3))\n",
      "----------------------\n",
      "10009406 : REN also impairs both Gli2-dependent gene transcription and Shh-enhanced expression of the target Gli1 mRNA, thus antagonizing the Shh-induced effects on the proliferation and differentiation of cultured GCPs.\n",
      "p(MGI:Kctd11) -| r(MGI:Gli2)\n",
      "p(MGI:Shh) -> r(MGI:Gli2)\n",
      "----------------------\n",
      "10028690 : Among the enriched gene sets (Excel S6), the Nrf2/Keap1 transcription factors were significantly up-regulated in Keap1-/- esophagi (Nfe2, Nrf2, Srebp1), as well as Nrf2-relevant metabolism GO gene sets (GO_666, GO_1221, GO_1333, GO_1374, GO_1408, GO_1418) and canonical pathway gene sets (CP_29, CP_67, CP_68, CP_71, CP_429, CP_530, CP_625, CP_626).\n",
      "p(MGI:Keap1) -| p(MGI:Nfe2)\n",
      "p(MGI:Keap1) -| p(MGI:Nfe2l2)\n",
      "p(MGI:Keap1) -| p(MGI:Srebf1)\n",
      "----------------------\n",
      "10028692 : Real-time PCR showed that Ppard was up-regulated and Pten down-regulated in Keap1?/? esophagus, while keratinization-associated genes (Calm4 and Sbsn) were up-regulated\n",
      "p(MGI:Keap1) -| p(MGI:Ppard)\n",
      "p(MGI:Keap1) -> p(MGI:Pten)\n",
      "p(MGI:Keap1) -> p(MGI:Sbsn)\n",
      "----------------------\n",
      "10028694 : In the oesophagus of Keap1-/- mice, the expression of keratin 6 is greatly increased in an NRF2-dependent manner (44).\n",
      "p(MGI:Keap1) -| r(EGID:110309)\n",
      "act(p(MGI:Nfe2l2)) -> r(EGID:110309)\n",
      "----------------------\n",
      "10028696 : Both NQO1 and GCLm were significantly up-regulated compared to control cells transfected with a Page 21 of 52 nontargeting siRNA (SS siRNA), 3.8 and 1.75 fold increase respectively (P < 0.05)\n",
      "p(MGI:Keap1) -| r(MGI:Gclm)\n",
      "p(MGI:Keap1) -| r(MGI:Nqo1)\n",
      "----------------------\n",
      "10028698 : Expression levels of Nqo1 and Gclm mRNA were significantly up-regulated in the lungs of Keap1?2-3/?2-3;CctCre+ mice compared to Keap1flox/flox mice,\n",
      "p(MGI:Keap1) -| r(MGI:Gclm)\n",
      "p(MGI:Keap1) -| r(MGI:Nqo1)\n",
      "----------------------\n",
      "10009412 : Our findings identify endogenous Sam68 as a positive regulator of adipocyte differentiation and a negative regulator of osteoblast differentiation, which is consistent with Sam68 being a modulator of bone marrow mesenchymal cell differentiation, and hence bone metabolism, in aged mice.\n",
      "p(MGI:Khdrbs1) -> bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Khdrbs1) -| bp(GOBP:\"osteoblast differentiation\")\n",
      "----------------------\n",
      "10009426 : Knockdown of KLF4 inhibits adipogenesis and downregulates C/EBPbeta levels. KLF4 binds directly to the C/EBPbeta (Cebpb) promoter as shown by chromatin immunoprecipitation and gel shift assays and, together with Krox20, cooperatively transactivates a C/EBPbeta reporter.\n",
      "p(MGI:Klf4) -> bp(GOBP:\"fat cell differentiation\")\n",
      "act(p(MGI:Egr2)) -> r(MGI:Cebpb)\n",
      "act(p(MGI:Klf4)) -> r(MGI:Cebpb)\n",
      "----------------------\n",
      "10028740 : Two genes overexpressed in SP3 cells are those encoding DPT, dermatopontin (accession number NM_001937), and ABCA5\n",
      "p(MGI:Kmt2d) -| r(MGI:Abca5)\n",
      "p(MGI:Kmt2d) -| r(MGI:Dpt)\n",
      "----------------------\n",
      "10028766 : Expression of KrasG12V induced also a loss of epithelial markers (as assessed by E-cadherin staining, which was similar in Mapk14D/+ and Mapk14D/D alveoli; Fig. 6c) and an increase in SP-C+ cells (Fig. 6d).\n",
      "p(MGI:Kras,sub(G,12,V)) -| p(MGI:Cdh1)\n",
      "p(MGI:Kras,sub(G,12,V)) -> p(MGI:Sftpc)\n",
      "----------------------\n",
      "10028794 : FcepsilonRI-dependent phosphorylation of PLCg1 and PLCg2 is almost abolished and the calcium signal is reduced in Lat -/- BMMCs26.\n",
      "p(MGI:Lat) -> p(MGI:Plcg1)\n",
      "p(MGI:Lat) -> p(MGI:Plcg2)\n",
      "----------------------\n",
      "10028806 : An approximately 2.5-fold increase of Smad2 phosphorylation at Ser 465/467 was also detected in LDLR expressing, LRP1-deficient SMCs (Figure 6B, C).\n",
      "p(MGI:Ldlr) -> act(p(MGI:Smad2))\n",
      "p(MGI:Lrp1) -| act(p(MGI:Smad2))\n",
      "----------------------\n",
      "10028814 : Further studies confirmed that leptin decreases the levels of SREBP-1/ADD1 RNA and transcriptionally active SREBP-1/ADD1 protein in white adipose tissue.(Figure7)\n",
      "p(MGI:Lep) -| r(MGI:Add1)\n",
      "p(MGI:Lep) -| r(MGI:Srebf1)\n",
      "p(MGI:Lep) -| act(p(MGI:Srebf1))\n",
      "----------------------\n",
      "10028820 : mRNA expressions of OPN, TNF-alpha, TGF-beta, and short-form leptin receptors (Ob-Ra) were significantly increased in db-db mice compared with db-m or ob-ob mice.\n",
      "p(MGI:Lep) -> r(MGI:Spp1)\n",
      "p(MGI:Lep) -> r(MGI:Tgfb1)\n",
      "p(MGI:Lep) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10028838 : Immunofluorescence staining for ?-smooth muscle actin (?-SMA) (green) and collagen-1 (red) showing reduced ?-SMA and collagen-1 expression in galectin-3?/? fibroblasts after TGF-?1\n",
      "p(MGI:Lgals3) -> p(MGI:Acta2)\n",
      "p(HGNC:LGALS3) -> p(HGNC:ACTA2)\n",
      "----------------------\n",
      "10028842 : As shown in Figure 6A, IL-4 levels in BAL fluid from gal3-/- mice were significantly lower than those from gal3+/+ mice. In contrast, the opposite results were observed for IFN-g (Figure 6B).\n",
      "p(MGI:Lgals3) -| p(MGI:Ifng)\n",
      "p(MGI:Lgals3) -> p(MGI:Il4)\n",
      "----------------------\n",
      "10028836 : In addition, we obtained cells from the lungs and the spleen from the OVA-challenged mice and cultured them in the presence of OVA. We noted that cells from gal3-/- mice produced significantly higher amounts of IFN-g (a Th1 cytokine) and lower amounts of IL-4 (a Th2 cytokine), compared to gal3+/+ mice (data not shown). The results suggest that gal3-/- mice have lower Th2 but higher Th1 responses compared to gal3+/+ mice.\n",
      "p(MGI:Lgals3) -| p(MGI:Ifng)\n",
      "p(MGI:Lgals3) -> p(MGI:Il4)\n",
      "----------------------\n",
      "10028854 : cell adhesion to immobilized galectin-8 is mediated by sugar-protein interactions with integrins galectin-8 triggers integrin-mediated signaling cascades including Tyr phosphoylation of focal adhesion kinase and paxillin\n",
      "p(MGI:Lgals8) -> p(MGI:Ptk2,pmod(P))\n",
      "p(MGI:Lgals8) -> p(MGI:Pxn,pmod(P))\n",
      "----------------------\n",
      "10028858 : According to our confocal image data, there were apoptotic bodies and necrotic-like cells present during galectin-9-induced cell death, suggesting the possible involvement of apoptotic and necrotic cell death. Similarly, galectin-2 can induce both necrosis and apoptosis23.\n",
      "p(MGI:Lgals9) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Lgals9) -> bp(GOBP:\"necrotic cell death\")\n",
      "----------------------\n",
      "10009468 : The expression of SSI-1, SSI-2, and SSI-3 mRNAs was significantly augmented in TG hearts after LIF stimulation\n",
      "p(MGI:Lif) -> r(MGI:Socs1)\n",
      "p(MGI:Lif) -> r(MGI:Socs2)\n",
      "p(MGI:Lif) -> r(MGI:Socs3)\n",
      "----------------------\n",
      "10028866 : The death of mutants such as Xrcc1/, LigIII/ and Polb/ was preceded by elevated levels of apoptosis (Gu et al, 1994; Tebbs et al, 1999; Sugo et al, 2000; Puebla-Osorio et al, 2006).\n",
      "p(MGI:Lig3) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Polb) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Xrcc1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10009472 : White adipose tissue of HSL null mice was characterized by reduced mass and reduced protein expression of PPARgamma, a key transcription factor in adipogenesis, and stearoyl-CoA desaturase 1, the expression of which is known to be positively correlated to the differentiation state of the adipocyte.\n",
      "p(MGI:Lipe) -> p(MGI:Pparg)\n",
      "p(MGI:Lipe) -> p(MGI:Scd1)\n",
      "----------------------\n",
      "10009474 : The mRNA expression of pRb and RIP140 was decreased in isolated white adipocytes, while the expression of UCP-1 and CPT1 was increased in HSL null mice compared to wildtype littermates.\n",
      "p(MGI:Lipe) -| r(MGI:Cpt1b)\n",
      "p(MGI:Lipe) -> r(MGI:Nrip1)\n",
      "p(MGI:Lipe) -> r(MGI:Rb1)\n",
      "p(MGI:Lipe) -| r(MGI:Ucp1)\n",
      "----------------------\n",
      "10009476 : LPL and endothelial lipase (EL) are associated with macrophages in human atherosclerotic lesions, and overexpression of LPL in mouse macrophages is associated with a greater extent of atherosclerosis\n",
      "p(MGI:Lipg) -> path(MESHD:Atherosclerosis)\n",
      "p(MGI:Lpl) -> path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10009484 : LO potently downregulated the PI3K and Akt kinases, while partially inhibiting MEK kinase activity.\n",
      "p(MGI:Lox) -| act(p(MGI:Akt1))\n",
      "p(MGI:Lox) -| act(p(MGI:Map3k1))\n",
      "----------------------\n",
      "10028888 : Consistent with this hypothesis, LO expression decreased both the rate of I kappa B alpha turnover and the activities of IKK alpha and IKK beta. Moreover, the ectopic expression of a constitutively active version of either kinase reversed the negative effects of LO.\n",
      "p(MGI:Lox) -| act(p(MGI:Chuk))\n",
      "p(MGI:Lox) -| act(p(MGI:Ikbkb))\n",
      "----------------------\n",
      "10009490 : Lipin-1 deficiency in the mouse causes generalized lipodystrophy, characterized by impaired adipose tissue development and insulin resistance.\n",
      "p(MGI:Lpin1) -> bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Lpin1) -| path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10009492 : lipin deficiency prevents normal lipid accumulation and induction of key adipogenic genes, including peroxisome proliferator-activated receptor (PPAR)gamma and CCAAT enhancer-binding protein (C/EBP)alpha.\n",
      "p(MGI:Lpin1) -> bp(GOBP:\"lipid biosynthetic process\")\n",
      "p(MGI:Lpin1) -> r(MGI:Cebpa)\n",
      "p(MGI:Lpin1) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10028904 : Preliminary studies to examine levels of apolipoproteins A-I, A-II, A-IV and E revealed slightly higher apo A-I and apo A-II levels in plasma of fld mice\n",
      "p(MGI:Lpin1) -| r(MGI:Apoa1)\n",
      "p(MGI:Lpin1) -| r(MGI:Apoa2)\n",
      "----------------------\n",
      "10028906 : fld mice exhibited 2 fold reductions in expression of ... PPARG and CEBPA and in ... aP2. The expression of DGAT was reduced 3 fold in fld tissue\n",
      "p(MGI:Lpin1) -> r(MGI:Cebpa)\n",
      "p(MGI:Lpin1) -> r(MGI:Dgat1)\n",
      "p(MGI:Lpin1) -> r(MGI:Fabp4)\n",
      "p(MGI:Lpin1) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10028908 : As expected, mRNA levels for LPL were reduced in fld white adipose tissue, as were those of adipsin. We also found that uncoupling protein 1 mRNA in brown adipose tissue from fld mice was reduced.\n",
      "p(MGI:Lpin1) -> r(MGI:Cfd)\n",
      "p(MGI:Lpin1) -> r(MGI:Ucp1)\n",
      "----------------------\n",
      "10028914 : About a two-fold increase of PDGFRb expression was detected in smLRP1-/- mice regardless of LDLR genotype (Figure 2A, C). Increased Erk1/2 phosphorylation was also observed in these aortas (Figure 2A). These data suggest that the expression and activation of PDGFRb is only regulated by LRP1, not LDLR.\n",
      "p(MGI:Lrp1) -| act(p(MGI:Mapk1))\n",
      "p(MGI:Lrp1) -| act(p(MGI:Mapk3))\n",
      "p(MGI:Lrp1) -| r(MGI:Pdgfrb)\n",
      "----------------------\n",
      "10028918 : Studies from our laboratory have shown that LRP1 suppresses PDGF receptor b (PDGFRb) activation and protects against atherosclerosis.\n",
      "p(MGI:Lrp1) -| act(p(MGI:Pdgfrb))\n",
      "p(MGI:Lrp1) -| path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10009506 : sLRP1 induced expression of regulatory cytokines by RAW 264.7 cells, including TNF-a, MCP-1/CCL2, and IL-10.\n",
      "p(MGI:Lrp1) -> p(MGI:Ccl2)\n",
      "p(MGI:Lrp1) -> p(MGI:Il10)\n",
      "p(MGI:Lrp1) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10028942 : The supernatants from cultured LN cells were also collected and the production of various cytokines (TNF-alpha, IFN-gamma, IL-6, and IL-17) was measured (Fig. 3B). The cytokine levels in BLT1-/- cells were significantly lower than those in BLT1+/+ cells\n",
      "p(MGI:Ltb4r1) -> r(MGI:Ifng)\n",
      "p(MGI:Ltb4r1) -> r(MGI:Il17a)\n",
      "p(MGI:Ltb4r1) -> r(MGI:Il6)\n",
      "p(MGI:Ltb4r1) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10009514 : Disruption of latent TGF-beta binding protein (LTBP)-4 expression in the mouse leads to abnormal lung development and colorectal cancer. Lung fibroblasts from these mice produced decreased amounts of active TGF-beta, whereas secretion of latent TGF-beta was significantly increased. Expression and secretion of TGF-beta2 and -beta3 increased considerably.\n",
      "p(MGI:Ltbp4) -| tloc(p(MGI:Tgfb1))\n",
      "p(MGI:Ltbp4) -| tloc(p(MGI:Tgfb2))\n",
      "p(MGI:Ltbp4) -| tloc(p(MGI:Tgfb3))\n",
      "----------------------\n",
      "10028952 : alpha-LTbetaR also induced RelA translocation to the nucleus, albeit to a lesser extent, but predominantly induced nuclear translocation of RelB at late time points (Figure 1B, right).\n",
      "p(MGI:Ltbr) -> tloc(p(MGI:Rela))\n",
      "p(MGI:Ltbr) -> tloc(p(MGI:Relb))\n",
      "----------------------\n",
      "10028954 : Electrophoretic mobility shift assay supershift analysis confirmed TNF-induced RelA but not RelB NF-bB binding within 30 minutes (Figure 1C, left). In contrast, a-LTbR induced both RelA and RelB complexes, although with slower kinetics (Figure 1C, right).\n",
      "p(MGI:Ltbr) -> act(p(MGI:Rela))\n",
      "p(MGI:Ltbr) -> act(p(MGI:Relb))\n",
      "p(MGI:Tnf) -> act(p(MGI:Rela))\n",
      "----------------------\n",
      "10028958 : Mammalian two-hybrid analysis and luciferase assay suggested that excess LYL1 blocked the dimerization of E2A and thus inhibited the regulatory activity of E2A on the CD4 promoter.\n",
      "p(MGI:Lyl1) -| r(MGI:Cd4)\n",
      "p(MGI:Tcf3) -> r(MGI:Cd4)\n",
      "----------------------\n",
      "10028962 : Among the cytokines expressed after 4 h of Ag stimulation in BMMCs, our data show that levels of mRNA and protein for IL-4, IL-6, and for IL-13 are all significantly higher in Lyn-/- than in WT BMMCs.\n",
      "p(MGI:Lyn) -| r(MGI:Il13)\n",
      "p(MGI:Lyn) -| r(MGI:Il4)\n",
      "p(MGI:Lyn) -| r(MGI:Il6)\n",
      "----------------------\n",
      "10028980 : Given our observation that overexpression of MafB inhibits RANKL-mediated osteoclast differentiation, we examined the expression levels of NFATc1 and OSCAR, which are known to be important modulators of osteoclastogenesis.11,32 As compared to control, exogenous overexpression of MafB attenuated the expression of NFATc1 as well as OSCAR during RANKL-mediated osteoclastogenesis (Figure 3A).\n",
      "p(MGI:Mafb) -| r(MGI:Nfatc1)\n",
      "p(MGI:Mafb) -| r(MGI:Oscar)\n",
      "----------------------\n",
      "10009530 : Furthermore, the expression of Bach 2, which can form a heterodimer with mafG protein, was found to be greatly reduced, while Notch 1 expression was increased in mafG deficient mice.\n",
      "p(MGI:Mafg) -> r(MGI:Bach2)\n",
      "p(MGI:Mafg) -| r(MGI:Notch1)\n",
      "----------------------\n",
      "10028984 : With respect to vasculature, MAO-A-mediated ROS production has been shown to induce mitogenic signaling in smooth muscle cells by a process that may involve the activation of the metalloproteinase MMP-2, which likely contributes to vascular wall remodeling [21].\n",
      "p(MGI:Maoa) -> a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Maoa) -> act(p(MGI:Mmp2))\n",
      "----------------------\n",
      "10028990 : LC3-II was increased in FoxO3MyHC cardiomyocytes after ex vivo transgene activation (Figure 4F; see Supplementary material online, Figure S6C). Treatment with lysosomal inhibitors revealed that LC3-II levels could still be stimulated in FoxO3MyHC cardiomyocytes, indicating an activation of autophagy rather than a disturbance in autophagic flux.\n",
      "p(MGI:Map1lc3b) -> bp(GOBP:autophagy)\n",
      "act(p(MGI:Foxo3)) -> bp(GOBP:autophagy)\n",
      "act(p(MGI:Foxo3)) -> p(MGI:Map1lc3b)\n",
      "p(HGNC:MAP1LC3B) -> bp(GOBP:autophagy)\n",
      "act(p(HGNC:FOXO3)) -> p(HGNC:MAP1LC3B)\n",
      "----------------------\n",
      "10029026 : BMMCs from mice lacking Map3k2 showed reduced production (50-60%) of IL-6, IL-13, and TNF-alpha after stimulation\n",
      "p(MGI:Map3k2) -> p(MGI:Il13)\n",
      "p(MGI:Map3k2) -> p(MGI:Il6)\n",
      "p(MGI:Map3k2) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10029044 : Figure 5. Inability of TGFbeta to induce expression of mRNA for various tissue remodeling molecules in tak-/- fibroblasts.\n",
      "p(MGI:Map3k7) -> r(MGI:Lox)\n",
      "p(MGI:Map3k7) -> r(MGI:Thbs1)\n",
      "p(MGI:Map3k7) -> r(MGI:Timp3)\n",
      "p(MGI:Map3k7) -> r(MGI:Vcl)\n",
      "----------------------\n",
      "10029050 : from full text - Gene expression of TLR2 and TLR4 was upregulated with obesity in WT mice, and this increase was diminished in obese TPL2KO mice (Fig. 2).\n",
      "p(MGI:Map3k8) -> r(MGI:Tlr2)\n",
      "p(MGI:Map3k8) -> r(MGI:Tlr4)\n",
      "----------------------\n",
      "10029060 : However, the SP-C+ cells were more numerous in the Mapk14-/- lungs (with almost twice as many as in Mapk14-/+ lungs; Fig. 2c). Notably, immunohistological staining showed reduced levels of the epithelial marker E-cadherin in the alveolar cells (Fig. 2c), indicating defective differentiation of these cells.\n",
      "p(MGI:Mapk14) -> p(MGI:Cdh1)\n",
      "p(MGI:Mapk14) -| p(MGI:Sftpc)\n",
      "----------------------\n",
      "10029062 : Notably, we found that p38a-deficient lungs contained lower levels of C/EBPa and HNF3b, another transcription factor involved in lung differentiation whose expression is controlled by C/EBPa (ref. 19) (Fig. 3a and Supplementary Fig. 1a online).\n",
      "p(MGI:Mapk14) -> p(MGI:Cebpa)\n",
      "p(MGI:Mapk14) -> p(MGI:Foxa2)\n",
      "----------------------\n",
      "10029064 : As demonstrated in Fig. 8A, ERK was strongly phosphorylated in p38â/â MEF, but not in p38+/+ MEF.\n",
      "p(MGI:Mapk14) -| p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Mapk14) -| p(MGI:Mapk1,pmod(P))\n",
      "----------------------\n",
      "10029068 : We also detected a reduction in STAT3 protein in Mapk14D/D lungs (Fig. 3a) that correlated with the reduction in Il6 mRNA (Fig. 3).\n",
      "p(MGI:Mapk14) -> p(MGI:Stat3)\n",
      "p(MGI:Mapk14) -> r(MGI:Il6)\n",
      "----------------------\n",
      "10029070 : ...phosphorylation of both T180 and Y182 within the TGY motif of p38 MAPK is necessary for activation of the enzyme...\n",
      "p(MGI:Mapk14,pmod(P)) -> act(p(MGI:Mapk14))\n",
      "p(MGI:Mapk14,pmod(P)) -> act(p(MGI:Mapk14))\n",
      "----------------------\n",
      "10029076 : Nox1 and Nox4 mRNAs were upregulated in H-RasV12-transformed p38??/? MEFs, suggesting that these two NOX family members may be involved in H-RasV12-induced ROS production in fibroblasts (Figure S5B).\n",
      "p(MGI:Mapk14) -| r(MGI:Nox1)\n",
      "p(MGI:Mapk14) -| r(MGI:Nox4)\n",
      "----------------------\n",
      "10029098 : These results are consistent with previous data showing that loss of JNK1/JNK2 in MEFs results in reduced proliferation17 and that inactivation of c-Jun in MEFs results in premature senescence and impaired proliferation19.\n",
      "p(MGI:Mapk8) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Mapk9) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Jun)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10029100 : the absence of JNK1 resulted in decreased accumulation of the cells, whereas JNK2-deficient cells exhibited an increase in the number of cells as compared to wildtype cells (Fig. 5A, left panel), consistent with previous studies (28, 32).\n",
      "p(MGI:Mapk8) -> bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Mapk9) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10029106 : The total phosphorylation state of Elk-1 was significantly decreased in JNK1-deficient MEFs but increased in JNK2-deficient MEFs compared to wild-type cells (Fig. 4B).\n",
      "p(MGI:Mapk8) -> p(MGI:Elk1,pmod(P))\n",
      "p(MGI:Mapk9) -| p(MGI:Elk1,pmod(P))\n",
      "----------------------\n",
      "10029108 : Jnk1-/- cells express reduced amounts of c-Jun, whereas Jnk2-/- cells express increased amounts of c-Jun, compared to wild-type cells (Fig. 5A, right panel).\n",
      "p(MGI:Mapk8) -> p(MGI:Jun)\n",
      "p(MGI:Mapk9) -| p(MGI:Jun)\n",
      "----------------------\n",
      "10029110 : Compared to nonstimulated wild-type cells, TBP mRNA expression was decreased in Jnk1-/- cells, whereas TBP mRNA levels were increased in Jnk2-/- cells (Fig. 1B).\n",
      "p(MGI:Mapk8) -> r(MGI:Tbp)\n",
      "p(MGI:Mapk9) -| r(MGI:Tbp)\n",
      "----------------------\n",
      "10029116 : Macrophages lacking JNK2 displayed suppressed foam cell formation caused by defective uptake and degradation of modified lipoproteins and showed increased amounts of the modified lipoprotein-binding and -internalizing scavenger receptor A (SR-A), whose phosphorylation was markedly decreased\n",
      "p(MGI:Mapk9) -> act(p(MGI:Msr1))\n",
      "p(MGI:Mapk9) -> p(MGI:Msr1,pmod(P))\n",
      "----------------------\n",
      "10029126 : to examine the influence of Mat1a on hepatic growth, we studied the effects of targeted disruption of the murine Mat1a gene in the absence of Mat1a, plasma methionine levels were increased hepatic S-adenosylmethionine and glutathione levels were reduced\n",
      "p(MGI:Mat1a) -> a(CHEBI:glutathione)\n",
      "p(MGI:Mat1a) -| a(CHEBI:methionine)\n",
      "----------------------\n",
      "10009564 : The RNA-mediated pathogenesis model for the myotonic dystrophies DM1 and DM2 proposes that mutant transcripts from the affected genes sequester a family of double-stranded RNA-binding factors, the muscleblind proteins MBNL1, MBNL2 and MBNL3, in the nucleus. These proteins are homologues of the Drosophila muscleblind proteins that are required for the terminal differentiation of muscle and photoreceptor tissues,\n",
      "p(MGI:Mbnl1) -> bp(GOBP:\"myoblast differentiation\")\n",
      "p(MGI:Mbnl2) -> bp(GOBP:\"myoblast differentiation\")\n",
      "p(MGI:Mbnl3) -> bp(GOBP:\"myoblast differentiation\")\n",
      "----------------------\n",
      "10029156 : Mesp1 induced the paraxial mesoderm genes Pax3 and Tcf15 on day 4, but this was not sustained at day 6 (Figures S3A and S3B).\n",
      "p(MGI:Mesp1) -> r(MGI:Pax3)\n",
      "p(MGI:Mesp1) -> r(MGI:Tcf15)\n",
      "----------------------\n",
      "10029188 : In MIF?/? mice, endotoxin-treated macrophages showed decreased viability, reduced proinflammatory function, and increased apoptosis [37].\n",
      "p(MGI:Mif) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Mif) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10029204 : Use of antisense MIF led to decreased MIF concentrations in treated macrophages while higher amounts of mitogen-activated protein kinase phosphatase and lower concentrations of cytokines such as TNF were observed. This study thus demonstrated the proinflammatory potential of MIF and stressed the importance of an autocrine action of MIF to override steroid-induced MKP-1 and to inhibit cytokine production [29] .\n",
      "p(MGI:Mif) -| p(MGI:Dusp1)\n",
      "p(MGI:Mif) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10029214 : Possible transcriptional regulators of plaque development and inflammation, such as P-c-jun and CEBP- b, were down-regulated in MIF antibody-treated mice [36]\n",
      "p(MGI:Mif) -> act(p(MGI:Cebpb))\n",
      "p(MGI:Mif) -> act(p(MGI:Jun))\n",
      "----------------------\n",
      "10029250 : In addition, Stat3-induced downstream developmental gene HNF4a wasup-regulated to 78.6-fold, Foxa3 to 9.3-fold, and SHH to 3.3-fold (Fig. 4D).\n",
      "p(MGI:Mmp12) -> p(MGI:Foxa3)\n",
      "p(MGI:Mmp12) -> p(MGI:Hnf4a)\n",
      "p(MGI:Mmp12) -> p(MGI:Shh)\n",
      "----------------------\n",
      "10029252 : As shown in Fig. 4A, IL-6 concentration in BALF of doxycycline-treated mice was steadily increased compared with those in untreated bitransgenic mice in a time-dependent fashion,\n",
      "p(MGI:Mmp12) -> p(MGI:Il6)\n",
      "p(HGNC:MMP12) -> p(HGNC:IL6)\n",
      "----------------------\n",
      "10029260 : increased expression of several other MMPs was also observed in doxycycline-treated bitransgenic mice compared with untreated mice. (Fig 4D)\n",
      "p(MGI:Mmp12) -> r(MGI:Mmp2)\n",
      "p(MGI:Mmp12) -> r(MGI:Mmp7)\n",
      "p(MGI:Mmp12) -> r(MGI:Mmp8)\n",
      "p(MGI:Mmp12) -> r(MGI:Mmp9)\n",
      "----------------------\n",
      "10029290 : Interestingly, the mRNA levels of MMP-3 and MMP-12 (but not MMP-2, MMP-10, TIMP-2, or TIMP-3) were found to be significantly reduced in heart of mdx/Mmp9-/- mice compared to mdx/Mmp9+/+ mice (Figure 6).\n",
      "p(MGI:Mmp9) -> r(MGI:Mmp12)\n",
      "p(MGI:Mmp9) -> r(MGI:Mmp3)\n",
      "----------------------\n",
      "10029294 : Myostatin appears to function by controlling myoblast cell cycle progression (35). Recombinant myostatin, when added to actively growing myoblasts, inhibited the progression of G1 myoblasts into S phase.\n",
      "p(MGI:Mstn) -| bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Mstn) -| bp(GOBP:\"G1/S transition of mitotic cell cycle\")\n",
      "----------------------\n",
      "10029300 : INTRO Myostatin is a newly identified member of the transforming growth factor beta superfamily, and myostatin-null mice have been found to show a two- to threefold increase in skeletal muscle mass due to an increase in the number of muscle fibers (hyperplasia) and the size of the fibers (hypertrophy) (21).\n",
      "p(MGI:Mstn) -| path(MESHD:Hyperplasia)\n",
      "p(MGI:Mstn) -| path(MESHD:Hypertrophy)\n",
      "----------------------\n",
      "10009602 : The sequences of the other cDNA fragments were identical to those of contrapsin, transketolase, and vanin-3. The latter two were up-regulated, whereas contrapsin was down-regulated in neonatal MT-null mice.\n",
      "p(MGI:Mt1) -> r(MGI:Serpina3k)\n",
      "p(MGI:Mt1) -| r(MGI:Tkt)\n",
      "p(MGI:Mt1) -| r(MGI:Vnn3)\n",
      "----------------------\n",
      "10009604 : Here we show that expression of MTA3 inhibits ductal branching in virgin and pregnant murine transgenic mammary glands. MTA3 also suppresses the Wnt4 pathway and, thus, these findings parallel phenotypic changes in Wnt4-null mice. MTA3 represses Wnt4 transcription and Wnt4 secretion, inhibiting Wnt-target genes in mammary epithelial cells\n",
      "p(MGI:Mta3) -| tloc(p(MGI:Wnt4))\n",
      "act(p(MGI:Mta3)) -| r(MGI:Wnt4)\n",
      "----------------------\n",
      "10029316 : While the reduction of mTOR markedly abolished STAT3, p63, and Notch signaling (Figure 9A), decreased expression of rictor did not affect the STAT3/p63/Notch signaling cascade (Figure 9B).\n",
      "p(MGI:Mtor) -> p(MGI:Hes1)\n",
      "p(MGI:Mtor) -> p(MGI:Notch1)\n",
      "p(MGI:Mtor) -> p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Mtor) -> p(MGI:Trp63)\n",
      "----------------------\n",
      "10029334 : NIH3T3/MUC4 cells also showed an increased phosphorylation of ERKs (p42/44 MAPK) as compared to the control NIH3T3/ pSecTag cells.\n",
      "p(MGI:Muc4) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Muc4) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10029338 : Our results clearly show that NIH3T3/ MUC4 cells have increased levels of total and phosphorylated ErbB2 protein as compared to the control NIH3T3/pSecTag cells (Figure 4).\n",
      "p(MGI:Muc4) -> p(MGI:Erbb2)\n",
      "p(MGI:Muc4) -> p(MGI:Erbb2,pmod(P))\n",
      "----------------------\n",
      "10029352 : BrdU incorporation showed that although there was increased proliferation in c-MYC overexpressing cells compared with control cells\n",
      "p(MGI:Myc) -> bp(GOBP:\"cell proliferation\")\n",
      "p(HGNC:MYC) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10029372 : Myd88(-/-) and Tlr4(-/-)Tlr2(-/-) mice showed impaired transepithelial migration of inflammatory cells but decreased survival and enhanced epithelial cell apoptosis after lung injury\n",
      "p(MGI:Myd88) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Myd88) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10029382 : This was the first direct evidence of an atheroprotective effect of TLR deficiency. These mice had a reduction in plasma monocyte chemotactic protein-1 (MCP-1), an important mediator of tissue macrophage infiltration, as well as a reduction in plaque lipid content and macrophage infiltration. The same changes were found in MyD88â/âapoEâ/â mice, in accordance with Bjorkbacka et al. (42).\n",
      "p(MGI:Myd88) -> p(MGI:Ccl2)\n",
      "p(MGI:Tlr4) -> p(MGI:Ccl2)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------\n",
      "10029384 : By using neutralizing antibody against TLR4, the releases of CCL3 and CXCL2 was decreased (Fig. 3A and B). MyD88 is a critical adapter molecule for the transduction of TLRs signals. Therefore, cDCs lacking MyD88 were investigated. CSE did not induce the release of CCL3 and CXCL2 from cDCs obtained from MyD88 knockout mice (Fig. 3C and D).\n",
      "p(MGI:Myd88) -> p(MGI:Ccl3)\n",
      "p(MGI:Myd88) -> p(MGI:Cxcl2)\n",
      "----------------------\n",
      "10029386 : In response to hepatocyte cell death, MyD88 signalling was responsible for the activation of NF-?B and for the production of factors such as IL-6 (ReF. 122).\n",
      "p(MGI:Myd88) -> p(MGI:Il6)\n",
      "p(HGNC:MYD88) -> p(HGNC:IL6)\n",
      "----------------------\n",
      "10029392 : Deficiency of MyD88, a downstream signaling molecule of TLR4, also abolished the lipopolysaccharide response in WT and Abcg1-deficient macrophages (Figure IA and IB in the online-only Data Supplement).\n",
      "p(MGI:Myd88) -> r(MGI:Ccl3)\n",
      "p(MGI:Myd88) -> r(MGI:Cxcl2)\n",
      "p(MGI:Myd88) -> r(MGI:Il1b)\n",
      "p(MGI:Myd88) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10029394 : Thus, the hyperplasia condition observed in the absence of myostatin could be due to increased proliferation of myoblasts because of a deregulated G1/S checkpoint (35). MyoD and Myf5 are expressed in myoblasts and myotubes and have been shown to be required for myogenesis.\n",
      "p(MGI:Myf5) -> bp(GOBP:\"skeletal muscle tissue development\")\n",
      "p(MGI:Myod1) -> bp(GOBP:\"skeletal muscle tissue development\")\n",
      "----------------------\n",
      "10029398 : In contrast, dominant inhibitory Myo1c cargo domain expression diminished this interaction and inhibited IRS-1 phosphorylation.\n",
      "p(MGI:Myo1c) -> complex(p(MGI:Ikbkg),p(MGI:Irs1))\n",
      "p(MGI:Myo1c) -> p(MGI:Irs1,pmod(P))\n",
      "----------------------\n",
      "10009622 : These results demonstrate that Myt1b and Ngn3 positively regulate each other's expression to promote endocrine differentiation.\n",
      "p(MGI:Myt1) -> r(MGI:Neurog3)\n",
      "p(MGI:Neurog3) -> r(MGI:Myt1)\n",
      "----------------------\n",
      "10009634 : Exogenous/ectopic expression studies with GRIP-1 sense and antisense vectors in myogenic C2C12 cells demonstrated that this SRC is necessary for (1) induction/activation of myogenin, MEF-2, and the crucial cell cycle regulator, p21, and (2)contractile protein expression and myotube formation\n",
      "p(MGI:Ncoa2) -> r(MGI:Cdkn1a)\n",
      "p(MGI:Ncoa2) -> r(MGI:Myog)\n",
      "----------------------\n",
      "10009640 : These results suggest that necdin is a nuclear factor that governs the permanent arrest of cell growth of postmitotic neurons during development of the nervous systems of vertebrates.\n",
      "p(MGI:Ndn) -| bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Ndn) -| bp(GOBP:\"cell growth\")\n",
      "----------------------\n",
      "10029450 : Knockdown of cPLA2 or a chaperone involved in the assembly of mitochondrial complex I, the NADH dehydrogenase (ubiquinone) 1-? subcomplex assembly factor 1 (NDUFAF1), resulted in a similar inhibition of TNF-induced necroptosis (Supplementary Figure 5c and d),\n",
      "p(MGI:Ndufaf1) -> bp(GOBP:\"necrotic cell death\")\n",
      "p(MGI:Pla2g4a) -> bp(GOBP:\"necrotic cell death\")\n",
      "----------------------\n",
      "10009650 : Transfection of vectors expressing neuroD and neuroD2 into P19 cells shows that both can activate expression through simple E-box-driven reporter constructs and can activate a reporter driven by the neuroD2 promoter region, but the GAP-43 promoter is preferentially activated by neuroD2.\n",
      "p(MGI:Neurod2) -> r(MGI:Gap43)\n",
      "p(MGI:Neurog1) -> r(MGI:Gap43)\n",
      "----------------------\n",
      "10029474 : Fibroblasts derived from Nrf1 null embryos showed reduced expression of GCLM and GSS, and Nrf1 has been shown to bind and activate the GCLM promoter\n",
      "p(MGI:Nfe2l1) -> r(MGI:Gclm)\n",
      "p(MGI:Nfe2l1) -> r(MGI:Gss)\n",
      "act(p(MGI:Nfe2l1)) -> r(MGI:Gclm)\n",
      "----------------------\n",
      "10000634 : Nrf2(-/-) mice exposed to low-dose DEP showed significantly increased airway hyperresponsiveness and counts of lymphocytes and eosinophils, together with increased concentrations of IL-12 and IL-13, and thymus and activation-regulated chemokine (TARC), in BAL fluid than wild-type mice. In contrast, expression of antioxidant enzyme genes was significantly higher in wild-type mice than in Nrf2(-/-) mice.\n",
      "p(MGI:Nfe2l2) -| p(MGI:Ccl17)\n",
      "p(MGI:Nfe2l2) -| p(MGI:Il13)\n",
      "----------------------\n",
      "10029518 : FIGURE 3. Phosphorylation of Nrf2Y568 is essential for interaction with Crm1 and nuclear export of Nrf2\n",
      "p(MGI:Nfe2l2,pmod(P)) -> complex(p(MGI:Nfe2l2),p(MGI:Xpo1))\n",
      "p(MGI:Nfe2l2,pmod(P)) -> tloc(p(MGI:Nfe2l2))\n",
      "----------------------\n",
      "10029522 : The levels of collagen alpha1 (I), alpha1 (III), and fibronectin mRNAs were reduced in 1-day wounds of Nrf2 knockout mice compared to control littermates.\n",
      "p(MGI:Nfe2l2) -> r(MGI:Col1a1)\n",
      "p(MGI:Nfe2l2) -> r(MGI:Fn1)\n",
      "----------------------\n",
      "10029526 : Interestingly, the normally observed induction of IL-1beta and TNF-alpha expression (22) was delayed in the knockout mice. The levels of IL-1beta mRNA were 50% lower in the 1-day wounds of Nrf2-/- mice than for control littermates.\n",
      "p(MGI:Nfe2l2) -> r(MGI:Il1b)\n",
      "p(MGI:Nfe2l2) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10029536 : There are two isoforms of 3beta- HSD expressed in wild-type megakaryocytes (I and VI), but neither are expressed in NF-E2 null megakaryocytes.\n",
      "p(MGI:Nfe2) -> p(MGI:Hsd3b1)\n",
      "p(MGI:Nfe2) -> p(MGI:Hsd3b6)\n",
      "----------------------\n",
      "10029558 : NF-Ya overexpression induced the expression of HOXB4 in HSCs-enriched LinâSca-1+ population in vivo (Fig. 1A ). In parallel, NF-Ya overexpression increased the expression of the HOX4 paralogs HOXC4 and HOXD4, and to a lesser extent HOXA4 (Fig. 1A ).\n",
      "p(MGI:Nfya) -> r(MGI:Hoxb4)\n",
      "p(MGI:Nfya) -> r(MGI:Hoxc4)\n",
      "p(MGI:Nfya) -> r(MGI:Hoxd4)\n",
      "----------------------\n",
      "10029560 : NAB2 overexpression blocked NGF-dependent differentiation and prevented NGF induction of TGF-beta1, MMP3 and p21waf1\n",
      "p(MGI:Ngf) -> bp(GOBP:\"cell differentiation\")\n",
      "p(MGI:Ngf) -> r(MGI:Cdkn1a)\n",
      "p(MGI:Ngf) -> r(MGI:Mmp3)\n",
      "p(MGI:Ngf) -> r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10029562 : NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells... NGF also induced phosphorylation of JNK\n",
      "p(MGI:Ngf) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Ngf) -> act(p(MGI:Mapk3))\n",
      "p(MGI:Ngf) -> act(p(MGI:Mapk8))\n",
      "----------------------\n",
      "10029570 : Increased expression of TTF-1 in alveolar type II cells caused dose-dependent alterations in alveolar morphology, epithelial cell hyperplasia, emphysema, and pulmonary inflammation.\n",
      "p(MGI:\"Nkx2-1\") -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:\"Nkx2-1\") -> path(MESHD:Emphysema)\n",
      "----------------------\n",
      "10029594 : In mouse models, Nod1 or Nod2 deficiency results in enhanced intestinal inflammation upon bacterial infection as a result of the disruption of innate immune responses.\n",
      "p(MGI:Nod1) -| bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Nod2) -| bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10029604 : Comparison of both mouse genotypes showed that basal lung expression of several genes, including some cytoskeletal proteins (e.g., actin, myosin, and keratin) and cell surface proteins (e.g., CD3, CD8, and T cell receptor), was suppressed in NOS2-/- mice compared with wild-type mice (Fig. 6C, Table 3).\n",
      "p(MGI:Nos2) -> r(EGID:20755)\n",
      "p(MGI:Nos2) -> r(MGI:Sprr3)\n",
      "p(MGI:Nos2) -> r(MGI:Thy1)\n",
      "----------------------\n",
      "10009708 : Subpleural fibrotic changes and hydroxyproline content in the eNOS-TG mice were significantly reduced compared with those of the wild-type (WT) mice by day 56\n",
      "p(MGI:Nos3) -| a(CHEBI:hydroxyproline)\n",
      "p(MGI:Nos3) -| path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10029614 : both apoE//prostacyclin receptor/164 and apoE//eNOS/163 mice showed accelerated atherosclerosis compared with apoE/ mice.\n",
      "p(MGI:Nos3) -| path(MESHD:Atherosclerosis)\n",
      "p(MGI:Ptgir) -| path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10009724 : Microarray analysis indicated a significant upregulation of CYP2C29 and retinoid X receptor gamma (RXRgamma) in isolated mesenteric arteries/arterioles of female endothelial nitric oxide synthase-knockout mice, a result that was validated by real-time RT-PCR.\n",
      "p(MGI:Nos3) -| r(MGI:Cyp2c29)\n",
      "p(MGI:Nos3) -| r(MGI:Rxrg)\n",
      "----------------------\n",
      "10029626 : Notch1 can also function as a tumour suppressor in mouse skin by inducing Waf1 and repressing Shh and Wnt signalling.\n",
      "p(MGI:Notch1) -| bp(GOBP:\"Wnt receptor signaling pathway\")\n",
      "p(MGI:Notch1) -| p(MGI:Shh)\n",
      "p(MGI:Notch1) -> r(MGI:Cdkn1a)\n",
      "----------------------\n",
      "10009730 : Taken together, these data strongly suggest that activation of Gata2 expression by Notch1/RBPjkappa is a crucial event for the onset of definitive hematopoiesis in the embryo.\n",
      "p(MGI:Notch1) -> r(MGI:Gata2)\n",
      "p(MGI:Rbpj) -> r(MGI:Gata2)\n",
      "----------------------\n",
      "10009732 : Furthermore, both EC network formation and expression of activated notch 1 or notch 4 induce expression of the bHLH transcription factor HESR-1 and downregulate the known HESR-1 target VEGFR-2 (KDR).\n",
      "p(MGI:Notch1) -> r(MGI:Hey1)\n",
      "p(MGI:Notch4) -> r(MGI:Hey1)\n",
      "act(p(MGI:Hey1)) -| r(MGI:Kdr)\n",
      "----------------------\n",
      "10029638 : ROS were markedly increased in the lungs of hyperoxia-exposed WT mice compared with air-exposed WT mice. This hyperoxiainduced increase in ROS was significantly attenuated in NOX1- deficient mice but not in NOX2-deficient mice (Figure 3A).\n",
      "p(MGI:Nox1) -> a(CHEBI:\"reactive oxygen species\")\n",
      "path(MESHD:Hyperoxia) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10029662 : since Lrh1 is required for transcription of Cyp7a1, one net result of activating Fxr and Shp expression was a decrease in the mRNA, protein and activity of Cyp7a1\n",
      "p(MGI:Nr0b2) -| act(p(MGI:Cyp7a1))\n",
      "p(MGI:Nr0b2) -| p(MGI:Cyp7a1)\n",
      "p(MGI:Nr0b2) -| r(MGI:Cyp7a1)\n",
      "act(p(MGI:Nr5a2)) -> r(MGI:Cyp7a1)\n",
      "----------------------\n",
      "10029674 : In the Enterocyte LXRa and LXRb activity increases the expression of ABCA1 and likely also ABCG5 and ABCG8, while FXR activity positively regulated I-BABP (a cytosolic factor involved in the hepatic/portal reciruclation of bile acids in and out of the gut lumen (see Figure 3C)\n",
      "p(MGI:Nr1h2) -> r(MGI:Abcg5)\n",
      "p(MGI:Nr1h2) -> r(MGI:Abcg8)\n",
      "p(MGI:Nr1h3) -> r(MGI:Abca1)\n",
      "----------------------\n",
      "10029676 : activated Pxr, like activated Fxr, results in repression of Cyp7a1 Cyp7a1 expression is repressed by both bile acid-activated Pxr and Fxr, and induced by oxysterol-activated Lxr\n",
      "p(MGI:Nr1h2) -> r(MGI:Cyp7a1)\n",
      "p(MGI:Nr1h3) -> r(MGI:Cyp7a1)\n",
      "p(MGI:Nr1i2) -| r(MGI:Cyp7a1)\n",
      "----------------------\n",
      "10029688 : identified 1 gene Mrp2 involved in this excretion process that, surprisingly, is activated by Pxr, Fxr and Car [constitutive androstane receptor], emphasizes the overlapping roles of multiple nuclear receptors\n",
      "p(MGI:Nr1h4) -> r(MGI:Abcc2)\n",
      "p(MGI:Nr1i2) -> r(MGI:Abcc2)\n",
      "p(MGI:Nr1i3) -> r(MGI:Abcc2)\n",
      "----------------------\n",
      "10009746 : Mrp2 expression is regulated by the pregnane X receptor [Pxr, Nr1I2] and constitutive androstane receptor [Car, Nr1I3]\n",
      "p(MGI:Nr1i2) -> r(MGI:Abcc2)\n",
      "p(MGI:Nr1i3) -> r(MGI:Abcc2)\n",
      "----------------------\n",
      "10029698 : By using semiquantitative PCR, real-time quantitative PCR, and Western blotting analysis, we found that CD36 mRNA and protein expression in peritoneal macrophages isolated from TR4-/- mice was significantly lower as compared to that from TR4+/+ mice (Fig. 2A).\n",
      "p(MGI:Nr2c2) -> p(MGI:Cd36)\n",
      "p(MGI:Nr2c2) -> r(MGI:Cd36)\n",
      "----------------------\n",
      "10009756 : DEX activates the gene encoding C/EBP delta. Likewise, MIX is a direct inducer of C/EBP beta gene expression\n",
      "p(MGI:Nr3c1) -> r(MGI:Cebpd)\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Cebpd)\n",
      "----------------------\n",
      "10009758 : DEX activates the gene encoding C/EBP delta. Likewise, MIX is a direct inducer of C/EBP beta gene expression.\n",
      "p(MGI:Nr3c1) -> r(MGI:Cebpd)\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Cebpd)\n",
      "----------------------\n",
      "10009770 : This treatment completely suppressed both endogenous plasma corticosterone and hepatic corticosterone-binding globulin (CBG) mRNA\n",
      "p(MGI:Nr3c1) -| r(MGI:Serpina6)\n",
      "act(p(MGI:Nr3c1)) -| r(MGI:Serpina6)\n",
      "----------------------\n",
      "10029716 : Among the apical/canalicular transporters, the expression of Abcg8 and Abcg5, both involved in the biliary excretion of sterols, was decreased in the livers of LRH-1hep-/- mice (Fig. 6C).\n",
      "p(MGI:Nr5a1) -> r(MGI:Abcg5)\n",
      "p(MGI:Nr5a1) -> r(MGI:Abcg8)\n",
      "----------------------\n",
      "10029724 : These observations were extended to HC-11 cells, a murine cell line derived from breast epithelium. In these cells TGF-a, an activator of EGFR, and HRG- 1b, which triggers ErbB-2/ErbB-3 dimers (Marte et al., 1995a,b), are able to induce RALT expression (Fiorentino et al., 2000).\n",
      "p(MGI:Nrg1) -> p(MGI:Errfi1)\n",
      "p(MGI:Tgfa) -> p(MGI:Errfi1)\n",
      "----------------------\n",
      "10029746 : Levels of BAL IL-13 (Fig. 5E) and lung IL-13 (Fig. 5F) were significantly increased in hORMDL3zp3-Cre mice at 8 and 26 wk of age as assessed by ELISA. Levels of BAL IL-5 (Fig. 5G) were significantly increased in hORMDL3zp3-Cre mice at 8 and 26 wk of age, whereas levels of lung IL-5 were only increased at 8 wk (Fig. 5H).\n",
      "p(MGI:Ormdl3) -> p(MGI:Il13)\n",
      "p(MGI:Ormdl3) -> p(MGI:Il5)\n",
      "----------------------\n",
      "10029750 : hORMDL3zp3-Cre mice had significantly increased levels of lung CXC chemokine mRNA, including CXCL10 in bronchial epithelial cells (Fig. 4I), as well as increased levels of CXCL11 mRNA in BAL macrophages (Fig. 4J), whereas levels of lung KC mRNA, the murine equivalent of IL-8, was not increased (data not shown).\n",
      "p(MGI:Ormdl3) -> r(MGI:Cxcl10)\n",
      "p(MGI:Ormdl3) -> r(MGI:Cxcl11)\n",
      "----------------------\n",
      "10029758 : These data demonstrate that OSM induces up-regulation of C/EBPdelta via a Stat3-dependent pathway in mammary epithelial cells and that the growth inhibition induced by OSM depends on the presence of C/EBPdelta.\n",
      "p(MGI:Osm) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Cebpd)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10029764 : Oncostatin M (OSM), an interleukin 6-type cytokine, induces sustained up-regulation of CCAAT/enhancer-binding protein (C/EBP) delta mRNA and protein\n",
      "p(MGI:Osm) -> p(MGI:Cebpd)\n",
      "p(MGI:Osm) -> r(MGI:Cebpd)\n",
      "----------------------\n",
      "10029766 : We also compared the effects of mOSM on IL-6 expression in both wt and STAT6-/- MLF (Fig. 5, B and D) and show that STAT6-/- MLF respond similarly to wt MLF in IL-6 expression at both the mRNA and protein levels.\n",
      "p(MGI:Osm) -> p(MGI:Il6)\n",
      "p(MGI:Osm) -> r(MGI:Il6)\n",
      "----------------------\n",
      "10029768 : mOSM induced STAT1 (Y701), STAT3 (Y705), and STAT5 (Y694) phosphorylation as reported by others (57, 58, 59).\n",
      "p(MGI:Osm) -> p(MGI:Stat1,pmod(P))\n",
      "p(MGI:Osm) -> p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Osm) -> p(MGI:Stat5a,pmod(P))\n",
      "----------------------\n",
      "10029770 : Levels of VCAM-1 in STAT-6-deficient MLF were somewhat reduced compared with those observed in wt MLF, however, the ability of mOSM or mTNF-{alpha} to induce VCAM-1 was maintained (Fig. 7B).\n",
      "p(MGI:Osm) -> p(MGI:Vcam1)\n",
      "p(MGI:Tnf) -> p(MGI:Vcam1)\n",
      "----------------------\n",
      "10029756 : OSM also stimulated Ca release and enhanced the mRNA expression of RANKL and OPG in mouse calcaria, but have no effect on the expression of RANK\n",
      "p(MGI:Osm) -> r(MGI:Tnfrsf11b)\n",
      "p(MGI:Osm) -> r(MGI:Tnfsf11)\n",
      "----------------------\n",
      "10029776 : This up-regulation is dependent on signaling by phospho-Stat3 (signal transducers and activators of transcription).\n",
      "p(MGI:Osm) -> act(p(MGI:Stat3))\n",
      "act(p(MGI:Stat3)) -> r(MGI:Cebpd)\n",
      "----------------------\n",
      "10029778 : At 5 min post-ATP, most of the intracellular pro-IL-1 was processed into mature IL-1 and ?50% of the procaspase-1 was converted to active tetramer ... A similar 5-min lag preceded the extracellular accumulation of cathepsin B, a soluble cysteine protease normally packaged within lysosomes, as well as LAMP-1,\n",
      "p(MGI:P2rx7) -> tloc(p(MGI:Casp1))\n",
      "p(MGI:P2rx7) -> tloc(p(MGI:Ctsb))\n",
      "p(MGI:P2rx7) -> tloc(p(MGI:Il1b))\n",
      "p(MGI:P2rx7) -> tloc(p(MGI:Lamp1))\n",
      "----------------------\n",
      "10029810 : PKCzeta down-regulation is shown to be a critical determinant of cell migration. Transfection of high-motility cells with either wild-type PKCzeta or its regulatory domain suppresses migration.\n",
      "p(MGI:Pawr) -| bp(GOBP:\"cell migration\")\n",
      "p(MGI:Prkcz) -| bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10009834 : Expression of the dominant negative Pax3 resulted in a loss of expression of Six1, Eya2, and endogenous Pax3 as well as a down-regulation in the expression of Mox1.\n",
      "p(MGI:Pax3) -> p(MGI:Eya2)\n",
      "p(MGI:Pax3) -> p(MGI:Meox1)\n",
      "p(MGI:Pax3) -> p(MGI:Six1)\n",
      "----------------------\n",
      "10029824 : We demonstrate that in Pax6-/- brains, cells with early dorsal thalamic projection at the internal capsule are more dispersed. In addition, alterations in the structure of the PSPB were observed, together with the failure of expression of axon attractive molecules Sema3c, Sema5a and netrin 1\n",
      "p(MGI:Pax6) -> r(MGI:Ntn1)\n",
      "p(MGI:Pax6) -> r(MGI:Sema5a)\n",
      "act(p(MGI:Pax6)) -> r(MGI:Sema3c)\n",
      "----------------------\n",
      "10029832 : Pax9 is required for the mesenchymal expression of Bmp4, Msx1, and Lef1 at a critical stage of tooth development\n",
      "p(MGI:Pax9) -> r(MGI:Bmp4)\n",
      "p(MGI:Pax9) -> r(MGI:Lef1)\n",
      "p(MGI:Pax9) -> r(MGI:Msx1)\n",
      "----------------------\n",
      "10029834 : In contrast, the microarray data indicated that three keratin genes involved in the formation of âsoftâ orthokeratin (Krt1-10, Krt2-1, Krt2-17) were up-regulated.\n",
      "p(MGI:Pax9) -| r(MGI:Krt10)\n",
      "p(MGI:Pax9) -| r(MGI:Krt1)\n",
      "p(MGI:Pax9) -| r(MGI:Krt2)\n",
      "----------------------\n",
      "10029838 : the synthesis of phosphatidylcholine by the CDP-choline pathway is under the control of the rate-limiting enzyme CTP-phosphocholine cytidylyltransferase [CCT] Srebps have been proposed to regulate CCT at the transcriptional level, or via the synthesis of lipid activators or substrates of the CDP-choline pathway\n",
      "p(MGI:Pcyt1a) -> a(CHEBI:lecithin)\n",
      "p(MGI:Pcyt1b) -> a(CHEBI:lecithin)\n",
      "----------------------\n",
      "10029844 : Expression of PGC-1?, PEPCK, and glucose-6-phosphatase mRNAs were also significantly increased in fasted KO compared with fasted WT livers (Table 2), consistent with enhanced glucose production in KO livers.\n",
      "p(MGI:Pde3b) -| r(MGI:G6pc)\n",
      "p(MGI:Pde3b) -| r(MGI:Pck1)\n",
      "p(MGI:Pde3b) -| r(MGI:Ppargc1a)\n",
      "----------------------\n",
      "10029846 : As analyzed by real-time RT-PCR, levels of SOCS-3 mRNA and mRNAs of proinflammatory cytokines IL-1, IL-6, TNF-?, and plasminogen activator inhibitorâ1 (PAI-1) were increased in fasted KO liver (Table 2).\n",
      "p(MGI:Pde3b) -| r(MGI:Il6)\n",
      "p(MGI:Pde3b) -| r(MGI:Serpine1)\n",
      "p(MGI:Pde3b) -| r(MGI:Socs3)\n",
      "p(MGI:Pde3b) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10029850 : In a paradigm of mouse lung injury induced by endotoxin inhalation, the number of neutrophils recovered in the bronchoalveolar lavage was markedly decreased in PDE4D(-/-) and PDE4B(-/-) mice 4 and 24 h after exposure to LPS.\n",
      "p(MGI:Pde4b) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(MGI:Pde4d) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10029856 : Stimulation of isolated murine NKT cells with anti-CD3 antibody plus IL-2 induced not only cell proliferation but production of cytokines including IFN-gamma, TNF-alpha, IL-17 and IL-22. ASB16165 significantly inhibited the CD3/IL-2-stimulated cell proliferation and production of all the cytokines examined\n",
      "p(MGI:Pde7a) -> p(MGI:Ifng)\n",
      "p(MGI:Pde7a) -> p(MGI:Il17a)\n",
      "p(MGI:Pde7a) -> p(MGI:Il22)\n",
      "p(MGI:Pde7a) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10029862 : In the present experiments, PDGF-A and -B siRNA completely abrogated the mRNA expression of PDGF-A and -B (Fig. 6, C and D) and inhibited the expression of Fgf7 and -10 (Fig. 6, C and D).\n",
      "p(MGI:Pdgfa) -> r(MGI:Fgf10)\n",
      "p(MGI:Pdgfa) -> r(MGI:Fgf7)\n",
      "p(MGI:Pdgfb) -> r(MGI:Fgf10)\n",
      "p(MGI:Pdgfb) -> r(MGI:Fgf7)\n",
      "----------------------\n",
      "10029872 : Consistent with previously published data (Williams et al, 2000), phosphorylation of S6K T389 and rpS6 S240/244 is abrogated in PDK1 null cells (Figure 3A, lanes 5â8).\n",
      "p(MGI:Pdpk1) -> p(MGI:Rps6kb1,pmod(P))\n",
      "p(MGI:Pdpk1) -> p(MGI:Rps6,pmod(P))\n",
      "p(MGI:Pdpk1) -> p(MGI:Rps6,pmod(P))\n",
      "----------------------\n",
      "10029876 : Substitution of Arg-238, equivalent to conserved Arg in the 14-3-3 binding motif, with Glu (R238E) decreased 14-3-3theta binding to PDK1 (Fig. 3 C, upper panel, lane 4). In contrast, substitution of Val-243 with Pro (V243P), a residue conserved in many 14-3-3 targets, such as Raf-1 and Bad (Fig.3 A), dramatically increased the amount of 14-3-3theta bound to PDK1\n",
      "p(MGI:Pdpk1,sub(R,238,E)) -| complex(p(MGI:Pdpk1),p(MGI:Ywhaq))\n",
      "p(MGI:Pdpk1,sub(V,243,P)) -> complex(p(MGI:Pdpk1),p(MGI:Ywhaq))\n",
      "----------------------\n",
      "10029878 : Co-immunoprecipitation analysis indicated that mutation at Ser-241 impairs the PDK1 binding ability for 14-3-3theta and 14-3-3eta (Fig. 3 B, upper panel, lane 3, and data not shown).\n",
      "p(MGI:Pdpk1,sub(S,241,A)) -| complex(p(MGI:Pdpk1),p(MGI:Ywhah))\n",
      "p(MGI:Pdpk1,sub(S,241,A)) -| complex(p(MGI:Pdpk1),p(MGI:Ywhaq))\n",
      "----------------------\n",
      "10009870 : By a separate pathway, Phox2b represses expression of the inhibitors of neurogenesis Hes5 and Id2. The role of Phox2b in the specification of neuronal subtype identity appears to depend in part on its capacity to act as a patterning gene in the progenitor domain.\n",
      "p(MGI:Phox2b) -| r(MGI:Hes5)\n",
      "p(MGI:Phox2b) -| r(MGI:Id2)\n",
      "----------------------\n",
      "10029906 : Phox2b misexpression represses the Pax6 and Olig2 genes, which should inhibit a branchiomotor fate, and induces Nkx6.1 and Nkx6.2, which are expressed in branchiomotor progenitors.\n",
      "p(MGI:Phox2b) -| r(MGI:\"Nkx6-1\")\n",
      "p(MGI:Phox2b) -| r(MGI:\"Nkx6-2\")\n",
      "p(MGI:Phox2b) -> r(MGI:Olig2)\n",
      "p(MGI:Phox2b) -> r(MGI:Pax6)\n",
      "----------------------\n",
      "10029912 : As assessed by quantitative RT-PCR, the Gfer mRNA was decreased by 2.4-fold in PIASx -/- mice compared with PIASx +/+ mice\n",
      "p(MGI:Pias2) -> r(MGI:Ddx24)\n",
      "act(p(MGI:Pias2)) -> r(MGI:Gfer)\n",
      "----------------------\n",
      "10029920 : Data coming from mice lacking p110a regulatory subunits have shed light on the dual role of p85 in PI3K regulation in response to insulin (Katso et al., 2001). Heterozygous deletion of either p85a or b in mice leads, surprisingly, to increased sensitivity to insulin, whereas compound heterozygous mutants fail to activate PI3K in response to insulin.\n",
      "p(MGI:Pik3r1) -> path(MESHD:\"Insulin Resistance\")\n",
      "p(MGI:Pik3r2) -> path(MESHD:\"Insulin Resistance\")\n",
      "----------------------\n",
      "10029932 : Overexpression of PIM1 increases 4EBP1 and S6K phosphorylation...Overexpression of the 44 kd PIM1 kinase in FDCP1 cells increased 4EBP1 phosphorylation on Thr37/46 a known mTOR phosphorylation site (Fig. 5A)\n",
      "p(MGI:Pim1) -> p(MGI:Eif4ebp1,pmod(P))\n",
      "p(MGI:Pim1) -> p(MGI:Eif4ebp1,pmod(P))\n",
      "p(MGI:Pim1) -> p(MGI:Rps6kb1,pmod(P))\n",
      "----------------------\n",
      "10029934 : Assays of BAL cytokine concentrations demonstrated that IL-4, IL-5, IL-13, and IFN-g were decreased in Pim1 kinase inhibitor (100 mg/kg)âtreated mice that had been sensitized and challenged with OVA (Figure 3C).\n",
      "p(MGI:Pim1) -> p(MGI:Ifng)\n",
      "p(MGI:Pim1) -> p(MGI:Il13)\n",
      "p(MGI:Pim1) -> p(MGI:Il4)\n",
      "p(MGI:Pim1) -> p(MGI:Il5)\n",
      "----------------------\n",
      "10029936 : The Pim-1 and Pim-2 transfectants have lower levels of serine/threonine protein phosphatase 2A (PP2A) activity and the alpha- and beta-subunit B56gamma of the PP2A phosphatase do not coimmunoprecipitate in these cells. Thus, the effects of Pim on PP2A activity may mediate the levels of c-Myc and the phosphorylation of proteins needed for increased protein synthesis.\n",
      "p(MGI:Pim1) -> p(MGI:Myc)\n",
      "p(MGI:Pim2) -> p(MGI:Myc)\n",
      "----------------------\n",
      "10029958 : ApoE-deficient mice overexpressing human plasma PAF-AH develop less atherosclerosis due to reduced lipid accumulation, inhibition of neo-intima formation, and reduced macrophage attraction (108).\n",
      "p(MGI:Pla2g7) -| a(CHEBI:lipid)\n",
      "p(MGI:Pla2g7) -| path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10029960 : The decreased TNF and IL-1 plasma levels in PLA2R knockout mice indicate a potential role for PLA2R in the onset and progression of endotoxic shock (127).\n",
      "p(MGI:Pla2r1) -> p(MGI:Il1b)\n",
      "p(MGI:Pla2r1) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10009886 : The PLAA peptide and melittin increased the expression of genes encoding the proinflammatory cytokine tumor necrosis factor alpha (TNFalpha) and cyclooxygenase-2 (COX-2), which is involved in PGE(2) production.\n",
      "p(MGI:Plaa) -> r(MGI:\"mt-Co2\")\n",
      "p(MGI:Plaa) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10029972 : PLN overexpression was associated with depressed rates of contraction and relaxation, which were not linked to reduced SERCA2a abundance, although the levels of other key Ca2+-handling proteins, including ryanodine receptor, FKBP12, and L-type Ca2+ channel, were significantly decreased.\n",
      "p(MGI:Pln) -| r(MGI:Fkbp1a)\n",
      "p(MGI:Pln) -| r(MGI:Ryr1)\n",
      "----------------------\n",
      "10029984 : Macrophages from PC Tg mice can express high level of human PON2 besides intrinsic mouse PON2 and PON3 ... PC Tg macrophages maintained significantly lower levels of ROS for at least 2 hours than macrophages from Wt mice ... Inflammatory factors such as TNF-alpha and IL-6 are expressed at lower levels in PC Tg MPMs compared with Wt MPMs.\n",
      "p(MGI:Pon2) -| a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Pon2) -| p(MGI:Il6)\n",
      "p(MGI:Pon2) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10029998 : CYP2B, CYP2C, CYP3A and CYP7A1 levels increased profoundly as a function of time and in association with the decrease in POR expression.\n",
      "p(MGI:Por) -| p(MGI:Cyp2b10)\n",
      "p(MGI:Por) -| p(MGI:Cyp2c29)\n",
      "p(MGI:Por) -| p(MGI:Cyp3a11)\n",
      "p(MGI:Por) -| p(MGI:Cyp7a1)\n",
      "----------------------\n",
      "10030000 : the liver is adapting to increases in localized lipid content by inducing both peroxisomal and mitochondrial oxidation pathways. Abcd1 and Abcd2, involved in peroxisomal fatty acid oxidation, are up-regulated 1.3- and 1.6-fold, respectively.\n",
      "p(MGI:Por) -| r(MGI:Abcd1)\n",
      "p(MGI:Por) -| r(MGI:Abcd2)\n",
      "----------------------\n",
      "10030002 : Mitochondrial ?-oxidation is also induced via the induction of several key genes, such as Acox1, Acsl4, and Cpt1a by 1.2-, 1.6-, and 1.7-fold, respectively; however, the 1.5-fold up-regulation of Acc2 may counteract mitochondrial oxidation by leading to increases in cellular content of malonyl-CoA, an allosteric inhibitor of CPT1a.\n",
      "p(MGI:Por) -| r(MGI:Acacb)\n",
      "p(MGI:Por) -| r(MGI:Acox1)\n",
      "p(MGI:Por) -| r(MGI:Acsl4)\n",
      "p(MGI:Por) -| r(MGI:Cpt1a)\n",
      "----------------------\n",
      "10030004 : hese findings are similarly found in the colon, where cholesterol biosynthetic genes are up-regulated: Cyp51a1, Fdft1, Idi1, and Lss were induced 1.4-, 1.8-, 1.9-, and 1.3-fold, respectively. Lldr was induced to a lesser extent, but retained significance (1.4-fold).\n",
      "p(MGI:Por) -| r(MGI:Cyp51)\n",
      "p(MGI:Por) -| r(MGI:Fdft1)\n",
      "p(MGI:Por) -| r(MGI:Idi1)\n",
      "p(MGI:Por) -| r(MGI:Lss)\n",
      "----------------------\n",
      "10030006 : the expression of both Shp and hepatocyte nuclear factor 4 ? (Hnf4?) was decreased 1.8- and 1.4-fold, respectively.\n",
      "p(MGI:Por) -> r(MGI:Hnf4a)\n",
      "p(MGI:Por) -> r(MGI:Nr0b2)\n",
      "----------------------\n",
      "10030008 : The abundance of medium-chain fatty acids would then serve as ideal substrates for Scd1 and Scd2, both of which are increased 2.2- and 1.5-fold respectively.\n",
      "p(MGI:Por) -| r(MGI:Scd1)\n",
      "p(MGI:Por) -| r(MGI:Scd2)\n",
      "----------------------\n",
      "10030010 : Here we show that conditional deletion of Pot1a elicits a DNA damage response at telomeres, resulting in p53-dependent replicative senescence.\n",
      "p(MGI:Pot1a) -| bp(GOBP:\"cellular response to DNA damage stimulus\")\n",
      "p(MGI:Pot1a) -| bp(GOBP:\"replicative cell aging\")\n",
      "p(MGI:Trp53) -> bp(GOBP:\"replicative cell aging\")\n",
      "----------------------\n",
      "10030012 : reconstitution of Rb-defective tumor cells with functional Rb results in hyperphosphorylation of Oct1 and disruption of Oct1 interaction with H2A octamer element Oct1 can be posttranslationally modified by phosphorylation, and this modification has been shown to reduce the binding of Oct1 to DNA\n",
      "p(MGI:Pou2f1,pmod(P)) -| act(p(MGI:Pou2f1))\n",
      "p(MGI:Rb1) -> p(MGI:Pou2f1,pmod(P))\n",
      "----------------------\n",
      "10030028 : Ppara activation can suppress Lxr-Srebf1c pathway through reduction of Lxr/Rxr formation, proposing a novel transcription factor cross-talk between Lxr and Ppara in hepatic lipid homeostasis\n",
      "p(MGI:Ppara) -| complex(p(MGI:Nr1h2),p(MGI:Rxra))\n",
      "p(MGI:Ppara) -| complex(p(MGI:Nr1h3),p(MGI:Rxra))\n",
      "----------------------\n",
      "10030030 : Lung levels of TNF-[alpha] and IL-1[beta] were significantly higher in PPAR-[alpha]-deficient mice in comparison with those of PPAR-[alpha] WT animals (Fig. 3).\n",
      "p(MGI:Ppara) -| p(MGI:Il1b)\n",
      "p(MGI:Ppara) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10030036 : Therefore the profound repression of CYP27 and apoE expressoin by activatoin or overexpression of PPARd might contribute to the lipid accumulation observed in these cells in culture\n",
      "p(MGI:Ppard) -| r(MGI:Apoe)\n",
      "p(MGI:Ppard) -| r(MGI:Cyp27a1)\n",
      "----------------------\n",
      "10030042 : PGC-1 mediates this increased GLUT4 expression, in large part, by binding to and coactivating the muscle-selective transcription factor MEF2C.\n",
      "p(MGI:Ppargc1a) -> act(complex(p(MGI:Ppargc1a),p(MGI:Mef2c)))\n",
      "act(complex(p(MGI:Ppargc1a),p(MGI:Mef2c))) -> r(MGI:Slc2a4)\n",
      "----------------------\n",
      "10030048 : The basal levels of PPARgamma and its target genes CD36 and ABCG1 were dramatically reduced in macrophage-specific PPARgamma knockout mice\n",
      "p(MGI:Pparg) -> r(MGI:Abcg1)\n",
      "p(MGI:Pparg) -> r(MGI:Cd36)\n",
      "----------------------\n",
      "10030050 : Target genes regulated basally by PPARgamma expression greater than twofold are listed in Table 1.\n",
      "p(MGI:Pparg) -| r(MGI:Ccr7)\n",
      "p(MGI:Pparg) -| r(MGI:Il2ra)\n",
      "----------------------\n",
      "10030058 : Moreover, PRDM16-transduced cells expressed several of the important thermogenic genes in a cAMP-dependent manner, similar to what bona fide brown fat cells do in culture and in vivo. The mRNA levels of UCP1, deiodinase-d2 and PGC-1alpha were increased by PRDM16 in unstimulated fat cells and induced to very high levels by PRDM16 in response to cAMP\n",
      "p(MGI:Prdm16) -> r(MGI:Dio2)\n",
      "p(MGI:Prdm16) -> r(MGI:Ppargc1a)\n",
      "p(MGI:Prdm16) -> r(MGI:Ucp1)\n",
      "----------------------\n",
      "10030062 : Interestingly, the mRNA levels of several genes that are preferentially expressed in white relative to brown fat cells were significantly repressed by PRDM16 expression, including psat1, serpin3ak and resistin\n",
      "p(MGI:Prdm16) -| r(MGI:Psat1)\n",
      "p(MGI:Prdm16) -| r(MGI:Retn)\n",
      "p(MGI:Prdm16) -| r(MGI:Serpina3k)\n",
      "----------------------\n",
      "10030068 : TGF-beta1 treatment of NMuMG cells has been shown to lead to EMT, as judged by the upregulation of mesenchymal markers Fibronectin, N-Cadherin and Vimentin (15). Knockdown of Blimp-1 overrode the characteristic upregulation of all three mesenchymal makers by TGF-beta1 (Fig. 1C).\n",
      "p(MGI:Prdm1) -| p(MGI:Cdh2)\n",
      "p(MGI:Prdm1) -| p(MGI:Fn1)\n",
      "p(MGI:Prdm1) -| p(MGI:Vim)\n",
      "----------------------\n",
      "10030090 : Compared to WT MAECs, AMPKalpha2-/- MAECs exhibited elevated expression of p47phox, p67phox, and gp91phox (Figure 3A).\n",
      "p(MGI:Prkaa2) -| p(MGI:Cybb)\n",
      "p(MGI:Prkaa2) -| p(MGI:Ncf1)\n",
      "p(MGI:Prkaa2) -| p(MGI:Ncf2)\n",
      "----------------------\n",
      "10030092 : The proinflammatory cytokines interleukin (IL)-2 and interferon-gamma in serum were significantly increased in LDLr-/-/ AMPKalpha2-/- mice (Online Table II).\n",
      "p(MGI:Prkaa2) -| p(MGI:Ifng)\n",
      "p(MGI:Prkaa2) -| p(MGI:Il2)\n",
      "----------------------\n",
      "10030094 : Interestingly, the antiinflammatory cytokines IL-5 and IL-10 were also significantly increased in LDLr-/-/ AMPKalpha2-/- mice and were downregulated by MG132 treatment (Online Table II).\n",
      "p(MGI:Prkaa2) -| p(MGI:Il10)\n",
      "p(MGI:Prkaa2) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10030100 : Further, nuclear levels of p65 and p50 were significantly higher in AMPKalpha2-/- MAECs than in WT MAECs (Figure 3C).\n",
      "p(MGI:Prkaa2) -| tloc(p(MGI:Nfkb1))\n",
      "p(MGI:Prkaa2) -| tloc(p(MGI:Rela))\n",
      "----------------------\n",
      "10030162 : FROM FULL TEXT: we tested recombinant Bv8 on mouse tumour-associated endothelial cells and found that it induces mitogen-activated protein (MAP) kinase phosphorylation and tube formation (Supplementary Fig. 8a?c).\n",
      "p(MGI:Prok2) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Prok2) -> bp(GOBP:\"MAPK cascade\")\n",
      "----------------------\n",
      "10009928 : We hypothesized that silencing MSS1 gene expression might inhibit microglial inflammation. Using RNA interference (RNAi), we showed significant reduction of IkB? degradation and NF-kB activation. The production of lipopolysaccharides-induced pro-inflammatory mediators such as inducible nitric oxide synthase (iNOS), nitric oxide, cyclooxygenase-2, and prostaglandin E2 were also reduced by MSS1 gene knockdown.\n",
      "p(MGI:Psmc2) -> a(CHEBI:\"nitric oxide\")\n",
      "p(MGI:Psmc2) -> act(p(MGI:Nfkb1))\n",
      "p(MGI:Psmc2) -> p(MGI:Ptgs2)\n",
      "----------------------\n",
      "10030210 : DCs cultured in TSN from COX-2-inhibited cells showed augmentation in the number of proliferating clusters as well as the number of cells staining positively for DEC-205\n",
      "p(MGI:Ptgs2) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Ptgs2) -| p(MGI:Ly75)\n",
      "----------------------\n",
      "10030216 : Interestingly, COX-2?/? mice on atherogenic diet showed more systemic inflammation with higher levels of TNF (Fig. 5B) and IL-6 (Fig. 5D) than wild-type controls. Furthermore, IL-12 was significantly increased by atherogenic diet in wild-type controls, while COX-2 depletion completely abolished this induction (Fig. 5E).\n",
      "p(MGI:Ptgs2) -| p(MGI:Il6)\n",
      "p(MGI:Ptgs2) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10030226 : the presence of Sox4 mRNA in hypertrophic chrondrocytes within the mouse epiphyseal growth plate at sites that overlap or are adjacent to target cells for TPH and PTHrP, and its strong up-regulation via activated PTH/PTHrP receptors in OHS cells, makes it a promising candidate for mediated downstream effects of PTH and PTHrP in bone\n",
      "p(MGI:Pth) -> act(p(MGI:Sox4))\n",
      "p(MGI:Pthlh) -> act(p(MGI:Sox4))\n",
      "----------------------\n",
      "10030232 : TGF? stimulates PTHrP secretion without appearing to increase PTHrP mRNA levels. PTHrP stimulates the production of RANK ligand (RANKL) in osteoblasts, which in turn promotes the differentiation of osteoclast precursors and bone resorption. Administration of anti-PTHrP neutralizing antibodies inhibits TGF?-dependent osteolytic bone metastasis in mice (Kakonen et al., 2002).\n",
      "p(MGI:Pthlh) -> p(MGI:Tnfsf11)\n",
      "p(MGI:Tgfb1) -> tloc(p(MGI:Pthlh))\n",
      "----------------------\n",
      "10030236 : Specifically, PTH and PTHrP rapidly and transiently induce expression of the mRNAs encoding IL-6 and LIF.\n",
      "p(MGI:Pthlh) -> r(MGI:Il6)\n",
      "p(MGI:Pthlh) -> r(MGI:Lif)\n",
      "p(MGI:Pth) -> r(MGI:Il6)\n",
      "p(MGI:Pth) -> r(MGI:Lif)\n",
      "----------------------\n",
      "10030268 : ASC is essential for activation of caspase-1 and production of mature IL-1 in response to all of these inflammatory stimuli\n",
      "p(MGI:Pycard) -> act(p(MGI:Casp1))\n",
      "p(MGI:Pycard) -> p(MGI:Il1b)\n",
      "----------------------\n",
      "10030270 : Fig. 4A shows that ASCâ/â BMDM were completely deficient in ATP-induced activation of inflammasome complexes as well as the coupled release of mature IL-1 and active caspase-1.\n",
      "p(MGI:Pycard) -> tloc(p(MGI:Casp1))\n",
      "p(MGI:Pycard) -> tloc(p(MGI:Il1b))\n",
      "----------------------\n",
      "10030284 : Rac1+/â ECs exhibited decreased proliferation and capillary formation compared to Rac1+/+ ECs (fig. S2A).\n",
      "p(MGI:Rac1) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Rac1) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10030286 : Rac1-deficient cells migrated more slowly (Figure 3A). Rac1-deficient cells also showed a reduction in proliferation (Figure 3B).\n",
      "p(MGI:Rac1) -> bp(GOBP:\"cell migration\")\n",
      "p(MGI:Rac1) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10030298 : rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation\n",
      "p(MGI:Rac2) -> act(p(MGI:Mapk1))\n",
      "p(MGI:Rac2) -> act(p(MGI:Mapk14))\n",
      "p(MGI:Rac2) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10030314 : furthermore, both receptors [RARA and RARG] cause a late upregulation and apparent cleavage of the squamous differentiation marker protein kinase C (PKC)-eta.\n",
      "p(MGI:Rara) -> deg(p(MGI:Prkch))\n",
      "p(MGI:Rara) -> r(MGI:Prkch)\n",
      "p(MGI:Rarg) -> deg(p(MGI:Prkch))\n",
      "p(MGI:Rarg) -> r(MGI:Prkch)\n",
      "----------------------\n",
      "10030322 : Moreover, tumors with conditionally expressed RASSF1A exhibited SAh-gal activity (Fig. 2C), which serves as an indicator for senescence occurring in vivo (8, 9), as well as enhanced p21Cip1/Waf1 expression (Fig. 2D).\n",
      "p(MGI:Rassf1) -> p(MGI:Cdkn1a)\n",
      "p(HGNC:RASSF1) -> p(HGNC:CDKN1A)\n",
      "----------------------\n",
      "10009984 : in addition, both pRb and its relative p107 inhibited transcription from the Htf9-a promoter. These results link the control of Htf9-a/RanBP-1 expression to the cell cycle progression.\n",
      "p(MGI:Rb1) -| r(MGI:Ranbp1)\n",
      "p(MGI:Rbl1) -| r(MGI:Ranbp1)\n",
      "act(p(MGI:Rb1)) -| r(MGI:Ranbp1)\n",
      "----------------------\n",
      "10030344 : In addition, E1A can repress the activity of HBP1 via conserved region 1 sequences in a manner independent of the CBP co-activator.\n",
      "p(MGI:Rb1) -| act(p(MGI:Hbp1))\n",
      "p(MGI:Rbl1) -| act(p(MGI:Hbp1))\n",
      "p(MGI:Rbl2) -| act(p(MGI:Hbp1))\n",
      "----------------------\n",
      "10030362 : These findings indicate that the acetylation of RelA at lysine 310 is importantly regulated by prior phosphorylation of serines 276 and 536. Such phosphorylated and acetylated forms of RelA display enhanced transcriptional activity.\n",
      "p(MGI:Rela,pmod(A,K,310)) -> act(p(MGI:Rela))\n",
      "p(MGI:Rela,pmod(P)) -> act(p(MGI:Rela))\n",
      "p(MGI:Rela,pmod(P)) -> act(p(MGI:Rela))\n",
      "----------------------\n",
      "10030374 : Expression of the cancer-related NF-kappaB target genes cyclin D1, c-myc, and bcl-xl was significantly increased in grossly normal transgenic mammary glands starting the first cycle of pregnancy and increased further in mammary carcinomas compared to mammary glands from wild-type mice or virgin transgenic mice.\n",
      "p(MGI:Rel) -> r(MGI:Bcl2l1)\n",
      "p(MGI:Rel) -> r(MGI:Ccnd1)\n",
      "p(MGI:Rel) -> r(MGI:Myc)\n",
      "----------------------\n",
      "10010002 : HIMF-stimulated RPSM proliferation. Thus, the PI3K/Akt pathway, at least in part, mediates the proliferative effect of HIMF. Further studies showed that HIMF had angiogenic and vasoconstrictive properties. HIMF increased pulmonary arterial pressure and vascular resistance more potently than either endothelin-1 or angiotensin II\n",
      "p(MGI:Retnla) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Retnla) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10030388 : Inhibition of phosphatidylinositol 3-kinase (see {601232}) inhibited Retnlb-activated Akt phosphorylation and also inhibited RPSM proliferation.\n",
      "p(MGI:Retnlb) -> act(p(MGI:Akt1))\n",
      "p(HGNC:RETNLB) -> act(p(HGNC:AKT1))\n",
      "----------------------\n",
      "10010006 : However, RELMbeta stimulated naive bone marrow-derived macrophages to secrete significant amounts of TNF-alpha, IL-6, and RANTES\n",
      "p(MGI:Retnlb) -> tloc(p(MGI:Ccl5))\n",
      "p(MGI:Retnlb) -> tloc(p(MGI:Il6))\n",
      "p(MGI:Retnlb) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10030396 : Over- expression of MEN2A-RET mutants reduced STAT3 ser727 phosphorylation to basal levels, suggesting that STAT3 tyr705 phosphorylation is a prerequisite for maximal MEN2A-RET induced STAT3 ser727 phos- phorylation (Figure 3b).\n",
      "p(MGI:Ret,pmod(P)) -> p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Ret,pmod(P)) -> p(MGI:Stat3,pmod(P))\n",
      "----------------------\n",
      "10030398 : STAT3 tyr705 phosphoryla- tion was reduced when the MEN2A-RET single mutants tyr752phe or tyr928phe were overexpressed, while no STAT3 tyr705 phosphorylation was observed in the presence of the MEN2A-RET double mutant (Figure 3b).\n",
      "p(MGI:Ret,pmod(P)) -> p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Ret,pmod(P)) -> p(MGI:Stat3,pmod(P))\n",
      "----------------------\n",
      "10010010 : RGS1, RGS3, and RGS4 also reduced rapid chemoattractant-triggered adhesion, although the proadhesive response appears quantitatively less sensitive to RGS action than chemotaxis.\n",
      "p(MGI:Rgs1) -| bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Rgs3) -| bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Rgs4) -| bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10030408 : As shown in supplementary Fig 1 online, both TNFR1- and RIP-null MEFs are more resistant than WT MEF cells to ER stress-induced apoptosis.\n",
      "p(MGI:Ripk1) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Tnfrsf1a) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10030412 : This resulted in processing of p100 NF-kB2 to p52, a decrease in levels of cFLIP(L), and activation of caspase-8, culminating in cell death. Therefore, the pro-survival effect of RIPK1 is mediated by stabilization of TRAF2 and cIAP1.\n",
      "p(MGI:Ripk1) -| act(p(MGI:Casp8))\n",
      "p(MGI:Ripk1) -> p(MGI:Cflar)\n",
      "----------------------\n",
      "10030420 : The production of IL-4, IL-5, and IL-13 in the in vitro-generated Ring1B-/- Th2 cells as in Fig. 2A was significantly decreased (Fig. 2C).\n",
      "p(MGI:Rnf2) -> p(MGI:Il13)\n",
      "p(MGI:Rnf2) -> p(MGI:Il4)\n",
      "p(MGI:Rnf2) -> p(MGI:Il5)\n",
      "----------------------\n",
      "10030422 : In addition, mRNA expression of several proapoptotic genes Bim, Noxa, Bax, and Perp were significantly increased in Ring1B-/- Th2 cells, whereas no decrease in the expression of the antiapoptotic genes Mcl1, Bcl2, and Bcl-xL was detected (Fig. 5C).\n",
      "p(MGI:Rnf2) -| r(MGI:Bax)\n",
      "p(MGI:Rnf2) -| r(MGI:Bcl2l11)\n",
      "p(MGI:Rnf2) -| r(MGI:Perp)\n",
      "p(MGI:Rnf2) -| r(MGI:Pmaip1)\n",
      "----------------------\n",
      "10030424 : Figure 2. Rho/ROCK inhibition disrupts vasculogenesis, ex vivo angiogenesis, and in vitro angiogenesis.\n",
      "p(MGI:Rock1) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Rock2) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10010028 : activation of PPARgamma-RXR initiates a potent apoptotic signaling cascade in B cells, potentially through NF-kappaB activation\n",
      "p(MGI:Rxra) -> act(p(MGI:Pparg))\n",
      "p(MGI:Rxrb) -> act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10030462 : Ryk is required for neurite outgrowth induced by Wnt-3a and in the activation of T cell factor (TCF) induced by Wnt-1.\n",
      "p(MGI:Ryk) -> bp(GOBP:\"cell growth\")\n",
      "p(MGI:Ryk) -> bp(GOBP:\"T cell activation\")\n",
      "----------------------\n",
      "10030464 : Finally, injection of S100A8, S100A9, or S100A8/A9 into a murine air pouch model led to rapid, transient accumulation of neutrophils confirming their activities in vivo.\n",
      "p(MGI:S100a8) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(MGI:S100a9) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(HGNC:S100A8) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(HGNC:S100A9) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10030476 : Consistently with increased MVD in tumors grown in S1P2-/- mice, the mRNA levels of CD31, VE-cadherin, VEGFR2, and Notch1, which are expressed in vascular ECs, were elevated in tumors of S1P2-/- mice (Supplementary Fig. S4).\n",
      "p(MGI:S1pr2) -| r(MGI:Cdh5)\n",
      "p(MGI:S1pr2) -| r(MGI:Kdr)\n",
      "p(MGI:S1pr2) -| r(MGI:Notch1)\n",
      "p(MGI:S1pr2) -| r(MGI:Pecam1)\n",
      "----------------------\n",
      "10030500 : The results show that while low levels of SOCS-3 mRNA (Fig. 4A, bar 1) and SOCS-3 protein (Fig. 4B, lane 1) are expressed in the lungs of WT mice, these levels are appreciably higher in their UG-KO littermates (Fig. 4A, bar 3 & 4B, lane 3).\n",
      "p(MGI:Scgb1a1) -| p(MGI:Socs3)\n",
      "p(MGI:Scgb1a1) -| r(MGI:Socs3)\n",
      "----------------------\n",
      "10030502 : The role of Nav1.5 channels in SAN pacemaking has been described in heterozygous Scn5a+/? mice (276). Scn5a+/? mice display major age-dependent dysfunction in atrioventricular conduction and a moderate reduction of the mean heart rate (381). Intact atrial-SAN preparations from Scn5a+/? mice have shown normal pacemaking in the SAN center, but demonstrated slower intranodal SAN conduction and exit block (276) (Fig. 17C).\n",
      "p(MGI:Scn5a) -| path(MESHD:Bradycardia)\n",
      "p(MGI:Scn5a) -| path(MESHD:\"Heart Block\")\n",
      "----------------------\n",
      "10019350 : Conversely, short interfering RNA-mediated suppression of Fkbp1a increases tumor cell invasion and MMP9 levels, while down-regulating Sdc1. anti-Fkbp1a RNAi significantly reduced Sdc1 protein levels Sdc1 blocks tumor cell invasion directly, by increasing cell adhesion to ECM (19, 20), and by inhibiting the expression of matrix metalloproteinase 9 (MMP9), which degrades ECM substrates\n",
      "p(MGI:Sdc1) -> bp(GOBP:\"cell adhesion\")\n",
      "p(MGI:Sdc1) -| r(MGI:Mmp9)\n",
      "----------------------\n",
      "10030540 : We found that P-selectin-treated LCs showed a significant induction of different genes involved in immune tolerance, as TGF-beta, IL-10, and IDO (Fig. 2C).\n",
      "p(MGI:Selp) -> r(MGI:Ido1)\n",
      "p(MGI:Selp) -> r(MGI:Il10)\n",
      "p(MGI:Selp) -> r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10010060 : We generated SePP-knockout mice that were viable, but exhibited reduced growth and developed ataxia.\n",
      "p(MGI:Sepp1) -> bp(GOBP:\"cell growth\")\n",
      "p(MGI:Sepp1) -| path(MESHD:Ataxia)\n",
      "----------------------\n",
      "10030550 : SQN-5 is a mouse serpin that is highly similar to the human serpins SCCA1 (SERPINB3) and SCCA2 (SERPINB4). Previous studies characterizing the biochemical activity of SQN-5 showed that this serpin, like SCCA2, inhibited the chymotrypsin-like enzymes mast cell chymase and cathepsin G.\n",
      "p(MGI:Serpinb3a) -| act(p(MGI:Cma1))\n",
      "p(MGI:Serpinb3a) -| act(p(MGI:Ctsg))\n",
      "----------------------\n",
      "10010064 : Using an expanded panel of papain-like cysteine proteinases, we now show that SQN-5, like SCCA1, inhibited cathepsins K, L, S, and V but not cathepsin B or H.\n",
      "p(MGI:Serpinb3a) -| act(p(MGI:Ctsk))\n",
      "p(MGI:Serpinb3a) -| act(p(MGI:Ctsl))\n",
      "p(MGI:Serpinb3a) -| act(p(MGI:Ctss))\n",
      "----------------------\n",
      "10010068 : Net represses PAI-1 promoter activity and binds to a specific region of the promoter containing Ets binding sites in the absence of SRF. We conclude that Net is a negative regulator of PAI-1 expression and is thereby involved in cell migration.\n",
      "p(MGI:Serpine1) -| bp(GOBP:\"cell migration\")\n",
      "act(p(MGI:Elk3)) -| r(MGI:Serpine1)\n",
      "----------------------\n",
      "10030556 : In line with these findings, expressions of the iNKT cell markers CD3-epsilon and natural killer 1.1 (NK1.1) were also found to be significantly higher in livers of PAI-1?/? mice in comparison with wild-type mice regardless of additional treatments (Figure 5b and c).\n",
      "p(MGI:Serpine1) -| r(MGI:Cd3e)\n",
      "p(MGI:Serpine1) -| r(MGI:Klrb1c)\n",
      "----------------------\n",
      "10030560 : As shown in Figure 4A, exogenous SP-A treatment increased the expression of M1-related genes, such as CCL5, CCL2, TNF-?, and IL-1?, in mouse PMs. The expression of M2 markers did not change significantly. M1-related gene expression on human peripheral blood monocytes was also up-regulated by SP-A (Figure 4B).\n",
      "p(MGI:Sftpa1) -> r(MGI:Ccl2)\n",
      "p(MGI:Sftpa1) -> r(MGI:Ccl5)\n",
      "p(MGI:Sftpa1) -> r(MGI:Il1b)\n",
      "p(MGI:Sftpa1) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10030574 : Emphysema in SP-D2/2 mice was associated with increased production of matrix metalloproteinases (MMP)-2, -9, and -12, hydrogen peroxide, and increased proinflammatory cytokine production after pulmonary infection (4, 5)\n",
      "p(MGI:Sftpd) -| p(MGI:Mmp12)\n",
      "p(MGI:Sftpd) -| p(MGI:Mmp2)\n",
      "p(MGI:Sftpd) -| p(MGI:Mmp9)\n",
      "----------------------\n",
      "10030580 : Immunofluorescence staining analysis with anti-NF-kB p65 Ab demonstrated that the p65 subunit of NF-kB was present in the cytoplasm of AM from both WT and SP-D2/2 mice (Fig. 4A). However, in AMs from SP-D2/2 mice, increased staining for NF-kB p65 was observed; furthermore, nuclear staining was markedly increased in AMs from SP-D2/2 mice and was almost never detected in AMs from WT mice.\n",
      "p(MGI:Sftpd) -> tloc(p(MGI:Rela))\n",
      "p(MGI:Sftpd) -> act(p(MGI:Rela))\n",
      "----------------------\n",
      "10030584 : NF-kB activity was determined in nuclear extracts from SP-D2/2 mice by assessing binding to a consensus NF-kB oligonucleotide in EMSA (Fig. 4B). Increased NF-kB binding was observed in nuclear extracts from AMs of SP-D2/2 mice. (EMSA)...Supershift assay for NF-kB showed that the protein/DNA complex contained both components of NF-kB p50 and p65,\n",
      "p(MGI:Sftpd) -| act(p(MGI:Nfkb1))\n",
      "p(MGI:Sftpd) -| act(p(MGI:Rela))\n",
      "----------------------\n",
      "10010086 : Recombinant VEGF-A increased Hrt-3 mRNA levels while siRNA knockdown abolished rShh stimulated VEGF-A expression while concomitantly inhibiting Shh-induced increases in Hrt-3 mRNA levels, proliferating cell nuclear antigen (PCNA), and Notch 1 IC expression, respectively\n",
      "p(MGI:Shh) -> p(MGI:Notch1)\n",
      "p(MGI:Shh) -> p(MGI:Pcna)\n",
      "p(MGI:Shh) -> r(MGI:Heyl)\n",
      "p(MGI:Vegfa) -> r(MGI:Heyl)\n",
      "----------------------\n",
      "10010088 : Shh upregulates several mesenchymal cell markers, including its target gene Patched (Ptc), intercellular signaling genes Bone Morphogenetic Protein-4 (Bmp4) and Noggin (Nog), and smooth muscle actin and myosin.\n",
      "p(MGI:Shh) -> r(MGI:Bmp4)\n",
      "p(MGI:Shh) -> r(MGI:Nog)\n",
      "p(MGI:Shh) -> r(MGI:Ptch1)\n",
      "----------------------\n",
      "10030618 : Runx2 was only modestly induced by Hh during 3 days of treatment (Fig. 6F), whereas expression of Osx was increased approximately threefold\n",
      "p(MGI:Shh) -> r(MGI:Runx2)\n",
      "p(MGI:Shh) -> r(MGI:Sp7)\n",
      "----------------------\n",
      "10030620 : Wnt5a, Wnt7b and Wnt9a were consistently induced over control levels following 24 or 48 hours of Hh treatment\n",
      "p(MGI:Shh) -> r(MGI:Wnt5a)\n",
      "p(MGI:Shh) -> r(MGI:Wnt7b)\n",
      "p(MGI:Shh) -> r(MGI:Wnt9a)\n",
      "----------------------\n",
      "10010094 : Overexpression of SIK repressed ACTH-mediated expression of CYP11A- and Steroidogenic acute regulatory (StAR)-genes by inhibiting CREB bound to their promoters.\n",
      "p(MGI:Sik1) -| act(p(MGI:Creb1))\n",
      "act(p(MGI:Creb1)) -> r(MGI:Cyp11a1)\n",
      "act(p(MGI:Creb1)) -> r(MGI:Star)\n",
      "----------------------\n",
      "10030632 : Insulin disrupts TORC2 activity by induction of the Ser/Thr kinase SIK2, which we show here undergoes AKT2-mediated phosphorylation at Ser 358.\n",
      "p(MGI:Sik2,pmod(P)) -> act(p(MGI:Sik2))\n",
      "act(p(MGI:Akt2)) -> p(MGI:Sik2,pmod(P))\n",
      "----------------------\n",
      "10010100 : Overexpression of SHP-1 in intestinal epithelial crypt cells significantly inhibited dhfr, c-myc, and cyclin D1 gene expression but did not interfere with c-fos gene expression.\n",
      "p(MGI:Sirpa) -| r(MGI:Ccnd1)\n",
      "p(MGI:Sirpa) -| r(MGI:Dhfr)\n",
      "p(MGI:Sirpa) -| r(MGI:Myc)\n",
      "----------------------\n",
      "10010108 : Suppression of SIRT1 or activation of PPAR gamma enhances Ero1-L alpha expression and stimulates secretion of high-molecular-weight complexes of adiponectin in mature adipocytes.\n",
      "p(MGI:Sirt1) -| r(MGI:Ero1l)\n",
      "p(MGI:Sirt1) -| tloc(p(MGI:Adipoq))\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ero1l)\n",
      "act(p(MGI:Pparg)) -> tloc(p(MGI:Adipoq))\n",
      "----------------------\n",
      "10010120 : Nas1(-/-) mice exhibited reduced intestinal sulfomucin content, enhanced intestinal permeability and DSS-induced colitis, and developed systemic infections when challenged orally with C jejuni. The transcriptional profile of 41 genes was altered in Nas1(-/-) mice, with the most upregulated gene being pancreatic lipase-related protein 2 and the most downregulated gene being carbonic anhydrase 1 (Car1).\n",
      "p(MGI:Slc13a1) -| path(MESHD:Colitis)\n",
      "p(MGI:Slc13a1) -> r(MGI:Car1)\n",
      "p(MGI:Slc13a1) -| r(MGI:Pnliprp2)\n",
      "----------------------\n",
      "10030692 : TGF?1-defective mice and Smad3-deficient mice develop precancerous colon lesions with submucosal inflammation, which frequently progress to colon carcinoma (Engle et al., 2002; Maggio-Price et al., 2006).\n",
      "p(MGI:Smad3) -| bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Tgfb1) -| bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10030696 : Smad3-null mice also developed emphysema at postnatal day 28, associated with increased MMP-9 and -12 expression (22, 41).\n",
      "p(MGI:Smad3) -| p(MGI:Mmp12)\n",
      "p(MGI:Smad3) -| p(MGI:Mmp9)\n",
      "----------------------\n",
      "10030704 : CTGF mRNA expression at basal level was 2-fold lower in Smad3 KO lung fibroblasts than in WT....PAI-1 mRNA expression was also lower in untreated Smad3 KO lung fibroblasts\n",
      "p(MGI:Smad3) -> r(MGI:Ctgf)\n",
      "p(MGI:Smad3) -> r(MGI:Serpine1)\n",
      "----------------------\n",
      "10030708 : Quantitative PCR analysis showed no difference in MMP-2 mRNA expression in total lung RNA between Smad3 KO and WT mice, whereas MMP-9 mRNA expression was significantly higher (2-fold, p 0.05) as was MMP-12 expression (2.5-fold, p 0.05) in Smad3 KO mice compared with WT\n",
      "p(MGI:Smad3) -| r(MGI:Mmp12)\n",
      "p(MGI:Smad3) -| r(MGI:Mmp9)\n",
      "----------------------\n",
      "10010150 : Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos.\n",
      "p(MGI:Smad4) -> r(MGI:Ccnd1)\n",
      "p(MGI:Smad4) -> r(MGI:Ccnd2)\n",
      "p(MGI:Smad4) -> r(MGI:Id2)\n",
      "p(MGI:Smad4) -> r(MGI:Mycn)\n",
      "----------------------\n",
      "10030724 : In accord with the level of Smad7 which accumulated time-dependently, the amount of each of the cyclins (cyclin D1, cyclin E and cyclin A) drastically decreased by 60 h postplating (Fig. 5A).\n",
      "p(MGI:Smad7) -| p(MGI:Ccna1)\n",
      "p(MGI:Smad7) -| p(MGI:Ccnd1)\n",
      "p(MGI:Smad7) -| p(MGI:Ccne1)\n",
      "----------------------\n",
      "10030726 : Intriguingly, we found that the expression levels of SREBP1c as well as the critical lipogenic genes controlled by SREBP1c (including fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl-CoA carboxylase-1) were all upregulated by ethanol treatment and by Smad7 deletion (Figure 7A).\n",
      "p(MGI:Smad7) -| r(MGI:Acaca)\n",
      "p(MGI:Smad7) -| r(MGI:Fasn)\n",
      "p(MGI:Smad7) -| r(MGI:Scd1)\n",
      "p(MGI:Smad7) -| r(MGI:Srebf1)\n",
      "----------------------\n",
      "10010158 : Notch2 and the Notch target gene, HES5, were also significantly elevated in Smoothened-induced tumors showing that Shh pathway activation is sufficient to induce Notch pathway signaling.\n",
      "p(MGI:Smo) -> r(MGI:Hes5)\n",
      "p(MGI:Smo) -> r(MGI:Notch2)\n",
      "----------------------\n",
      "10030762 : Phosphorylation of these sites in Smad1 enables the binding of the E3 ubiquitin ligase Smurf1, which bars Smad1 interaction with nucleoporins and leads to Smad1 polyubiquitination and degradation (Sapkota et al., 2007).\n",
      "p(MGI:Smurf1) -| complex(p(MGI:Smad1),p(MGI:Nup98))\n",
      "p(MGI:Smurf1) -> deg(p(MGI:Smad1))\n",
      "p(MGI:Smurf1) -> p(MGI:Smad1,pmod(U))\n",
      "----------------------\n",
      "10030764 : Taken together, overexpression of SNAI transcription factors is able to induce EMT in ATII cells, even in the absence of TGFb1.\n",
      "p(MGI:Snai1) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "p(MGI:Snai2) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "----------------------\n",
      "10010160 : The reepithelialization component of excisional wound healing was reduced 1.7-fold and expression of the Slug target genes keratin 8 and E-cadherin was increased at wound margins in Slug null compared to wild type mice.\n",
      "p(MGI:Snai2) -> bp(GOBP:\"wound healing\")\n",
      "p(MGI:Snai2) -> r(MGI:Cdh1)\n",
      "p(MGI:Snai2) -> r(MGI:Krt8)\n",
      "----------------------\n",
      "10030770 : FROM FULL TEXT FULL TEXT after suppression of SOCS-3 and a tendency to improvement after reduction of SOCS-1. Furthermore, the high levels of expression of PGC-1ÃÂ± in the livers of db/db mice that contribute to the increased gluconeogenesis in obese diabetic animals (20) were almost normalized by either single antisense treatment or combined therapy SHOWN EXPERIMENTALLY IN FIGURE 3\n",
      "p(MGI:Socs1) -> p(MGI:Ppargc1a)\n",
      "p(MGI:Socs3) -> p(MGI:Ppargc1a)\n",
      "----------------------\n",
      "10030772 : Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.\n",
      "p(MGI:Socs1) -| p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Socs1) -| act(p(MGI:Stat3))\n",
      "p(MGI:Socs3) -| p(MGI:Stat3,pmod(P))\n",
      "p(MGI:Socs3) -| act(p(MGI:Stat3))\n",
      "p(HGNC:SOCS3) -| act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10010172 : Furthermore, overexpression of SOCS2 or SOCS3 inhibited IFN-alpha-induced reporter activity in hepatic cells\n",
      "p(MGI:Socs2) -| p(MGI:Ifna1)\n",
      "p(MGI:Socs3) -| p(MGI:Ifna1)\n",
      "----------------------\n",
      "10030778 : decreased production of major urinary protein, increased local IGF-I production, and collagen accumulation in the dermis, were observed in SOCS-2-deficient mice\n",
      "p(MGI:Socs2) -| r(MGI:Igf1)\n",
      "p(MGI:Socs2) -> r(MGI:Mup1)\n",
      "----------------------\n",
      "10030780 : We show that loss of suppressor of cytokine signaling (SOCS) 3 in T cells increases both interleukin (IL)-17 and IL-10 production, induces an antiinflammatory macrophage phenotype, and leads to unexpected IL-17-dependent reduction in lesion development and vascular inflammation\n",
      "p(MGI:Socs3) -| p(MGI:Il10)\n",
      "p(MGI:Socs3) -| p(MGI:Il17a)\n",
      "p(HGNC:SOCS3) -| p(HGNC:IL17A)\n",
      "----------------------\n",
      "10030784 : The expression of TGF-beta1, a mediator of fibrosis, was enhanced by SOCS3 gene deletion, but suppressed by the overexpression of a dominant-negative STAT3 or SOCS3 both in vivo and in vitro. These data suggest that TGF-beta1 is a target gene of STAT3 and could be one of the mechanisms for enhanced fibrosis in SOCS3-deficient mice.\n",
      "p(MGI:Socs3) -| r(MGI:Tgfb1)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10010186 : The Sod2(-/-) MEFs produced less cellular ATP, had lower O(2) consumption, generated more superoxide, and expressed less Prdx3 protein.\n",
      "p(MGI:Sod2) -> a(CHEBI:ATP)\n",
      "p(MGI:Sod2) -> p(MGI:Prdx3)\n",
      "----------------------\n",
      "10030792 : Homozygous SOD2 -/- mice die within the first 10 days of life with a dilated cardiomyopathy, accumulation of lipid in liver and skeletal muscle, and metabolic acidosis.\n",
      "p(MGI:Sod2) -| a(CHEBI:lipid)\n",
      "p(MGI:Sod2) -| path(MESHD:Acidosis)\n",
      "----------------------\n",
      "10010188 : The Sod2 mutant mice exhibit a tissue-specific inhibition of the respiratory chain enzymes NADH-dehydrogenase (complex I) and succinate dehydrogenase (complex II), inactivation of the tricarboxylic acid cycle enzyme aconitase, development of a urine organic aciduria in conjunction with a partial defect in 3-hydroxy-3-methylglutaryl-CoA lyase, and accumulation of oxidative DNA damage\n",
      "p(MGI:Sod2) -| bp(GOBP:\"cellular response to DNA damage stimulus\")\n",
      "p(MGI:Sod2) -> act(p(MGI:Aco2))\n",
      "----------------------\n",
      "10030796 : Relative to wild-type mice, lung inflammation and damage was attenuated in mice that overexpressed either SOD2 or SOD3 (Ho et al., 1998; Folz et al., 1999).\n",
      "p(MGI:Sod2) -| bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Sod3) -| bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10030802 : Finally, the ratio of microtubule-associated protein light chain 3 (LC3)-II/LC3-I, an index of autophagic activity, was increased in Sod2(-/-) MEFs, consistent with a reduction in mTOR signal transduction.\n",
      "p(MGI:Sod2) -> act(p(MGI:Mtor))\n",
      "p(MGI:Sod2) -| p(MGI:Map1lc3a)\n",
      "----------------------\n",
      "10030810 : Figure 6 - Western blot showing the lack of mature MnSOD protein, a reduced level of HSP70-1, and increased levels of TXNIP and MT1/2 in Sod2-/- brains.\n",
      "p(MGI:Sod2) -> p(MGI:Hspa1a)\n",
      "p(MGI:Sod2) -| p(MGI:Mt1)\n",
      "p(MGI:Sod2) -| p(MGI:Mt2)\n",
      "p(MGI:Sod2) -| p(MGI:Txnip)\n",
      "----------------------\n",
      "10030816 : overexpression of the amino-terminal domain of CAP in 3T3-L1 cells abrogates insulin-stimulated glucose uptake and glycogen and lipid synthesis without affecting PI 3-kinase-dependent signaling events.\n",
      "p(MGI:Sorbs1) -| a(CHEBI:glycogen)\n",
      "p(MGI:Sorbs1) -| bp(GOBP:\"lipid biosynthetic process\")\n",
      "----------------------\n",
      "10010190 : Sclerostin inhibited the BMP6 and BMP7 activity but not the BMP2 and BMP4 activity. Sclerostin bound to BMP6 and BMP7\n",
      "p(MGI:Sost) -| act(p(MGI:Bmp6))\n",
      "p(MGI:Sost) -| act(p(MGI:Bmp7))\n",
      "----------------------\n",
      "10010192 : Ectodin inhibited the activity of BMP2, BMP4, BMP6, and BMP7 for mouse preosteoblastic MC3T3-E1 cells, and bound to these BMPs with high affinity\n",
      "p(MGI:Sostdc1) -| act(p(MGI:Bmp2))\n",
      "p(MGI:Sostdc1) -| act(p(MGI:Bmp4))\n",
      "p(MGI:Sostdc1) -| act(p(MGI:Bmp6))\n",
      "p(MGI:Sostdc1) -| act(p(MGI:Bmp7))\n",
      "----------------------\n",
      "10030820 : However, the expression of Otx2 (37), Ctgf (38), and Ebaf (39) were significantly decreased, whereas Hrc (40) was increased in Sox15-null ES cells.\n",
      "p(MGI:Sox15) -> r(MGI:Ctgf)\n",
      "p(MGI:Sox15) -| r(MGI:Hrc)\n",
      "p(MGI:Sox15) -> r(MGI:Lefty2)\n",
      "p(MGI:Sox15) -> r(MGI:Otx2)\n",
      "----------------------\n",
      "10030824 : To determine whether Sox17 overexpression could directly activate its target genes, we treated Sox17- inducible ES cells with doxycycline, collected RNA, and performed genome-wide transcriptional analysis and quantitative RTâPCR. Following Sox17 induction, we found increased expression of both the Lama1 gene and genes encoding basement membrane components Col4a1 and Col4a2\n",
      "p(MGI:Sox17) -> r(MGI:Col4a1)\n",
      "p(MGI:Sox17) -> r(MGI:Col4a2)\n",
      "p(MGI:Sox17) -> r(MGI:Lama1)\n",
      "----------------------\n",
      "10030828 : In contrast, goblet cells were absent in Sox2-/- bronchiolar epithelium. Neither Spdef (an Ets-like factor required for goblet cell differentiation) nor Muc5AC (a pulmonary mucin) were induced (Fig. 4F,H).\n",
      "p(MGI:Sox2) -> p(MGI:Muc5ac)\n",
      "p(MGI:Sox2) -> p(MGI:Spdef)\n",
      "p(HGNC:SOX2) -> p(HGNC:SPDEF)\n",
      "----------------------\n",
      "10030840 : Compared with the mice of scramble decoy ODNs injected group, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of proteins, resulting in 70% for TGF-beta1, 61% for fibronectin, and 66% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3A).\n",
      "p(MGI:Sp1) -> p(MGI:Fn1)\n",
      "p(MGI:Sp1) -> p(MGI:Mmp13)\n",
      "p(MGI:Sp1) -> p(MGI:Tgfb1)\n",
      "p(HGNC:SP1) -> p(HGNC:FN1)\n",
      "----------------------\n",
      "10030844 : Compared with the mice with treatment of scramble decoy ODNs, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of mRNA, resulting in 47% for TGF-?1, 32% for fibronectin, and 13% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3B).\n",
      "p(MGI:Sp1) -> r(MGI:Fn1)\n",
      "p(MGI:Sp1) -> r(MGI:Mmp13)\n",
      "p(MGI:Sp1) -> r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10030852 : FOXA2 staining was absent at sites of goblet cell hyperplasia induced by SPDEF (Figure 9, C and D).\n",
      "p(MGI:Spdef) -| p(MGI:Foxa2)\n",
      "p(HGNC:SPDEF) -| p(HGNC:FOXA2)\n",
      "----------------------\n",
      "10030874 : OPN stimulates T cell proliferation and induces T cells and macrophages to express other Th1 cytokines...it is involved in macrophage recruitment during inflammation\n",
      "p(MGI:Spp1) -> bp(GOBP:\"macrophage chemotaxis\")\n",
      "p(MGI:Spp1) -> bp(GOBP:\"T cell proliferation\")\n",
      "----------------------\n",
      "10010218 : collagenase-3 gene expression increases in the presence of an anti-osteopontin monoclonal antibody that binds near the RGD motif of this protein, whereas osteocalcin expression is inhibited.\n",
      "p(MGI:Spp1) -| p(MGI:Mmp13)\n",
      "p(MGI:Spp1) -> r(EGID:12096)\n",
      "----------------------\n",
      "10010226 : Co-immunoprecipitation studies with H-Ras-transformed cells revealed that Spry2 and H-Ras interact and that H-Ras interacts with Spry2-binding partners, c-Cbl and CIN85, in a Spry2-dependent manner.\n",
      "p(MGI:Spry2) -> complex(p(MGI:Hras),p(MGI:Cbl))\n",
      "p(MGI:Spry2) -> complex(p(MGI:Hras),p(MGI:Sh3kbp1))\n",
      "----------------------\n",
      "10030896 : both xSpry1Y53F and mSpry2Y55F were unable to inhibit the binding of Grb2 to FRS2 or Shp2 in response to FGF stimulation (Fig. 2a, b) or the recruitment of Grb2âSos complex to FRS2 (Fig. 2c).\n",
      "p(MGI:Spry2,pmod(P)) -| complex(p(MGI:Frs2),p(MGI:Grb2))\n",
      "p(MGI:Spry2,pmod(P)) -| complex(p(MGI:Grb2),p(MGI:Ptpn11))\n",
      "p(MGI:Spry2,pmod(P)) -| complex(p(MGI:Grb2),p(MGI:Sos1),p(MGI:Frs2))\n",
      "----------------------\n",
      "10010230 : we found that heterozygous Sptlc1 (a subunit of SPT) KO mice also absorbed significantly less cholesterol than controls. To understand the mechanism, we measured protein levels of Niemann-Pick C1-like 1 (NPC1L1), ABCG5, and ABCA1, three key factors involved in intestinal cholesterol absorption. We found that NPC1L1 and ABCA1 were decreased, whereas ABCG5 was increased in the SPT deficient small intestine.\n",
      "p(MGI:Sptlc1) -> p(MGI:Abca1)\n",
      "p(MGI:Sptlc1) -| p(MGI:Abcg5)\n",
      "p(MGI:Sptlc1) -> p(MGI:Npc1l1)\n",
      "----------------------\n",
      "10030908 : In addition, IL-13, IL-5 and eotaxin levels in BAL (Figure 6C), which were dramatically increased in OVA-challenged WT mice, were severely reduced in similarly treated p62-/- mice.\n",
      "p(MGI:Sqstm1) -> p(MGI:Ccl11)\n",
      "p(MGI:Sqstm1) -> p(MGI:Il13)\n",
      "p(MGI:Sqstm1) -> p(MGI:Il5)\n",
      "----------------------\n",
      "10030912 : Interestingly, whereas IFN-gamma secretion is not affected (Figure 1A, left panel), IL-4 secretion is significantly reduced in p62-/- cells (Figure 1A, right panel). The synthesis of three other Th2 cytokines such as IL-5, IL-10 and IL-13 was also inhibited in p62-/- Th2 cells (Figure 1B).\n",
      "p(MGI:Sqstm1) -> p(MGI:Il10)\n",
      "p(MGI:Sqstm1) -> p(MGI:Il13)\n",
      "p(MGI:Sqstm1) -> p(MGI:Il5)\n",
      "p(MGI:Sqstm1) -> tloc(p(MGI:Il4))\n",
      "----------------------\n",
      "10010234 : Finally, we found that p53 inactivation and c-myc expression, two cell cycle events regulated by Src during mitogenesis,\n",
      "p(MGI:Src) -| p(MGI:Trp53)\n",
      "p(MGI:Src) -> r(MGI:Myc)\n",
      "----------------------\n",
      "10010236 : However, the absence of SREBP-1 severely impaired the marked induction of hepatic mRNAs of fatty acid synthetic genes, such as acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase,\n",
      "p(MGI:Srebf1) -> r(MGI:Acaca)\n",
      "p(MGI:Srebf1) -> r(MGI:Fasn)\n",
      "p(MGI:Srebf1) -> r(MGI:Scd1)\n",
      "----------------------\n",
      "10030916 : As depicted in Fig. 4, the genes for glycerol-3-phosphate acyltransferase, ATP citrate lyase, glucose-6-phosphate dehydrogenase, and S14 were markedly activated by refeeding in the wild-type mice (Fig. 4 and Table II). In contrast, these refeeding responses were severely reduced inSREBP-1 ?/? mice.\n",
      "p(MGI:Srebf1) -> r(MGI:Acly)\n",
      "p(MGI:Srebf1) -> r(MGI:Gpam)\n",
      "p(MGI:Srebf1) -> r(MGI:H6pd)\n",
      "p(MGI:Srebf1) -> r(MGI:Thrsp)\n",
      "----------------------\n",
      "10030948 : Recently, STAT3-deficient mice were shown to develop emphysema with evidence of apoptosis and caspase-3 expression when infected by adenovirus (209).\n",
      "p(MGI:Stat3) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Stat3) -| p(MGI:Casp3)\n",
      "----------------------\n",
      "10030956 : Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined.\n",
      "p(MGI:Stat3) -> p(MGI:Hes1)\n",
      "p(MGI:Stat3) -> p(MGI:Jag1)\n",
      "p(MGI:Stat3) -> p(MGI:Trp63)\n",
      "----------------------\n",
      "10010272 : These results indicate that Stat5a plays an indispensable role in Stat6-independent Th2 cell differentiation and subsequent Th2 cell-mediated allergic airway inflammation\n",
      "p(MGI:Stat5a) -> bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Stat5a) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "p(MGI:Stat6) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "----------------------\n",
      "10010284 : Previous studies demonstrate that the SUV39-h proteins are preferentially targeted to the pericentric heterochromatin, and mice lacking both Suv39-h genes show cytogenetic abnormalities and an increased incidence of lymphoma.\n",
      "p(MGI:Suv39h1) -| path(MESHD:Lymphoma)\n",
      "p(MGI:Suv39h2) -| path(MESHD:Lymphoma)\n",
      "----------------------\n",
      "10010288 : Airway hyper-reactivity was significantly reduced in the TAC1(-/-) as well as the TAC1(-/-)/NK1(-/-) groups. However, LPS-induced histological inflammatory changes (perivascular/peribronchial oedema, neutrophil infiltration and goblet cell hyperplasia), MPO activity and TNF-alpha concentration were markedly diminished only in TAC1(-/-) mice\n",
      "p(MGI:Tac1) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(MGI:Tac1) -> act(p(MGI:Mpo))\n",
      "p(MGI:Tac1) -> p(MGI:Tnf)\n",
      "----------------------\n",
      "10031032 : Genes involved in meiosis that commences at day 9 in the mouse testes are lower in the Taf4b-null testes at post-natal day 8 including Dmc1, Scp3, and Stag3 (Fig. 6D; Prieto et al. 2001; Hunt and Hassold 2002). Bard1, which has recently been identified as a pro-apoptotic factor in the testes (Feki et al. 2004), is low in day 8 Taf4b-null testes.\n",
      "p(MGI:Taf4b) -> r(MGI:Bard1)\n",
      "p(MGI:Taf4b) -> r(MGI:Dmc1)\n",
      "p(MGI:Taf4b) -> r(MGI:Stag3)\n",
      "p(MGI:Taf4b) -> r(MGI:Sycp3)\n",
      "----------------------\n",
      "10031034 : Bmp8b, which is required for gonocyte proliferation (Zhao et al. 1996), is expressed at lower levels in Taf4b-null testes by RTâPCR at day 8 but not at day 0 or day 3 (Fig. 6E; data not shown). JAGGED2, the ligand for NOTCH1, is also expressed at lower levels in Taf4b-null males.\n",
      "p(MGI:Taf4b) -> r(MGI:Bmp8b)\n",
      "p(MGI:Taf4b) -> r(MGI:Jag2)\n",
      "----------------------\n",
      "10031042 : At birth, testes of Taf4b-null males appear histologically normal; however, at post-natal day 3 gonocyte proliferation is impaired and expression of spermatogonial stem cell markers c-Ret, Plzf, and Stra8 is reduced. {RT-PCR}\n",
      "p(MGI:Taf4b) -> r(MGI:Ret)\n",
      "p(MGI:Taf4b) -> r(MGI:Stra8)\n",
      "p(MGI:Taf4b) -> r(MGI:Zbtb16)\n",
      "----------------------\n",
      "10031068 : T-bet-deficient B lymphocytes demonstrate impaired production of IgG2a, IgG2b, and IgG3 and, most strikingly, are unable to generate germ-line or postswitch IgG2a transcripts in response to IFN-g. (Fig. 4)\n",
      "p(MGI:Tbx21) -> p(MGI:Ighg2b)\n",
      "p(MGI:Tbx21) -> p(EGID:380793)\n",
      "p(MGI:Tbx21) -> r(EGID:380793)\n",
      "----------------------\n",
      "10031070 : T-bet-deficient B cells produced excess amounts of the Th2-related isotypes IgG1 and IgE (Fig. ?4)\n",
      "p(MGI:Tbx21) -| p(EGID:16020)\n",
      "p(MGI:Tbx21) -| p(MGI:Ighg1)\n",
      "----------------------\n",
      "10031076 : By contrast, strong overexpression of T-bet repressed IL-4 production in wild-type TH2 cells10,16, but this repression was completely dependent on Runx3 (Fig. 5c). T-bet-mediated repression of another TH2 cytokine, IL-5, was independent of Runx3 (Fig. 5d),\n",
      "p(MGI:Tbx21) -| p(MGI:Il4)\n",
      "p(MGI:Tbx21) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10031078 : Finally, we also found that ectopic T-bet specifically induced robust transcription of both endogenous (cellular) T-bet and IL-12 receptor beta 2 (IL-12Rbeta 2) (Fig. 2C).\n",
      "p(MGI:Tbx21) -> r(MGI:Il12rb2)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Il12rb2)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Tbx21)\n",
      "----------------------\n",
      "10031084 : Figure 1 TRF2 (myc-tagged) induces telomere dysfunction and cellular senescence in p53 P/P primary mouse embryonic fibroblasts.\n",
      "p(MGI:Terf2) -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "act(p(MGI:Trp53)) -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "----------------------\n",
      "10031086 : overexpression of TRF2 in p53 P/P MEFs resulted in upregulation of p21 (Fig 1D). In addition, reduction of BrdU incorporation, induction of p21 level and increased number of SA-beta-gal-positive senescent cells were also observed when oncogenic H-Ras was overexpressed in p53 P/P MEFs (Fig 1A?C).\n",
      "p(MGI:Terf2) -> p(MGI:Cdkn1a)\n",
      "act(p(MGI:Trp53)) -> p(MGI:Cdkn1a)\n",
      "----------------------\n",
      "10010306 : TGF-alpha repressed the differentiation of the preadipocyte cell line 3T3-F442A in a dose-dependent and reversible manner as judged by morphological conversion and diminished expression of mRNAs encoding the adipocyte-specific markers adipsin and glycerophosphate dehydrogenase.\n",
      "p(MGI:Tgfa) -| bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Tgfa) -| r(MGI:Cfd)\n",
      "p(MGI:Tgfa) -| r(MGI:Gpd1)\n",
      "----------------------\n",
      "10031116 : TGF-B can function either as a proangiogenic or antiangiogenic factor in vitro; however, the preponderance of evidence supports a proangiogenic role for TGF-B in vivo.93 Several lines of evidence support a prominent role for the TGF-B signaling pathway in stimulating angiogenesis. First, targeted deletion of members of this pathway in mice, including TGF-B1, TBRI, and TBRII, all result in aberrant angiogenesis.\n",
      "p(MGI:Tgfb1) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Tgfbr1) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Tgfbr2) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10010324 : Reorganization of the actin cytoskeleton in response to growth factor signaling, such as transforming growth factor beta (TGF-beta), controls cell adhesion, motility, and growth of diverse cell types. In Swiss3T3 fibroblasts, a widely used model for studies of actin reorganization, TGF-beta1 induced rapid actin polymerization into stress fibers and concomitantly activated RhoA and RhoB small GTPases.\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Rhoa))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Rhob))\n",
      "----------------------\n",
      "10010332 : Further, evidence is presented for TGF-beta-stimulated p160ROCK translocation to the nucleus and inhibitory phosphorylation of the cyclin-dependent kinase-activating phosphatase, Cdc25A.\n",
      "p(MGI:Tgfb1) -| act(p(MGI:Cdc25a))\n",
      "p(MGI:Tgfb1) -> tloc(p(MGI:Rock1))\n",
      "----------------------\n",
      "10031146 : These studies demonstrate that TGF-1 is a potent stimulator of Bax mRNA and protein accumulation in lungs from doxycyclinetreated Tg mice (Fig. 1).\n",
      "p(MGI:Tgfb1) -> p(MGI:Bax)\n",
      "p(MGI:Tgfb1) -> r(MGI:Bax)\n",
      "----------------------\n",
      "10031148 : ex vivo studies of macro-phages derived from Smad3â/â mice demonstrated a more activated phenotype with enhanced induction of MCP-1 secretion in response to LPS. Importantly, while TGF-?1 inhibited LPS-stimulated MCP-1 production from Smad3+/+ mice, this TGF-?1 inhibition was completely blocked in macrophages from Smad3â/â mice.79\n",
      "p(MGI:Tgfb1) -| p(MGI:Ccl2)\n",
      "act(p(MGI:Smad3)) -| bp(GOBP:\"macrophage activation\")\n",
      "act(p(MGI:Smad3)) -| tloc(p(MGI:Ccl2))\n",
      "----------------------\n",
      "10031150 : the spindle-like phenotype induced by TGF treatment (Fig. 1 A, inset) persisted after factor removal (Fig. 1 B, inset) and involved loss of E-cadherin/4-integrin, whereas vimentin was strongly induced\n",
      "p(MGI:Tgfb1) -| p(MGI:Cdh1)\n",
      "p(MGI:Tgfb1) -| p(MGI:Itga4)\n",
      "p(MGI:Tgfb1) -> p(MGI:Vim)\n",
      "p(HGNC:TGFB1) -| p(HGNC:CDH1)\n",
      "p(HGNC:TGFB1) -> p(HGNC:VIM)\n",
      "----------------------\n",
      "10031152 : In epithelial cells, TGF? induces expression of p15Ink4b, which inhibits cyclinD-cdk4/6 complexes, and of p21Cip1, which inhibits cyclinE/A-cdk2 complexes...(Gomis et al., 2006b; Seoane et al., 2004).\n",
      "p(MGI:Tgfb1) -> p(MGI:Cdkn1a)\n",
      "p(MGI:Tgfb1) -> p(MGI:Cdkn2b)\n",
      "----------------------\n",
      "10031158 : TGFbeta induced CRP2 protein expression as early as 2 h, and the induction continued at the 4 h time point (Fig. 1A). Similar to the protein results, Northern blot analysis revealed that TGF? induced CRP2 mRNA expression in a time-dependent manner (Fig. 1B).\n",
      "p(MGI:Tgfb1) -> p(MGI:Csrp2)\n",
      "p(MGI:Tgfb1) -> r(MGI:Csrp2)\n",
      "----------------------\n",
      "10031160 : Similarly, TGF-{beta} stimulation regulated Foxp3 expression in anti-CD3/CD28-stimulated human CD4+ T lymphocytes at the mRNA and protein level, suggesting that TGF-{beta} controls expression of this key regulatory protein both in human and murine T cells (Fig. 1, B and C).\n",
      "p(MGI:Tgfb1) -> p(MGI:Foxp3)\n",
      "p(MGI:Tgfb1) -> r(MGI:Foxp3)\n",
      "----------------------\n",
      "10031172 : This was demonstrated for in vitro recombinant MIF in fibroblasts, where growth-factor-induced stimulation of these cells resulted in increased MIF concentrations, activation of the ERK-MAP kinase pathway and subsequent increase in cell proliferation [50] . This was also shown in a colon cancer cell line where the addition of TGF resulted in increased MIF expression [51] .\n",
      "p(MGI:Tgfb1) -> p(MGI:Mif)\n",
      "p(MGI:Tgfb1) -> r(MGI:Mif)\n",
      "----------------------\n",
      "10031180 : In addition, SNAI1 and SNAI2 protein expression was increased by TGFb1 in a time-dependent manner, as assessed by western blot analysis.\n",
      "p(MGI:Tgfb1) -> p(MGI:Snai1)\n",
      "p(MGI:Tgfb1) -> p(MGI:Snai2)\n",
      "----------------------\n",
      "10031186 : In contrast, downregulation of Id expression by TGF-beta generates E2A that is free from Id proteins, thus allowing E2A to become active and induce EMT through repression of E-cadherin expression.\n",
      "p(MGI:Tgfb1) -> p(MGI:Tcf3)\n",
      "act(p(MGI:Tcf3)) -> bp(GOBP:\"epithelial to mesenchymal transition\")\n",
      "----------------------\n",
      "10031188 : in the absence of exogenous TGF-?1, the VSMCs receptor expression profile switched from predominantly type II to type I\n",
      "p(MGI:Tgfb1) -| p(MGI:Tgfbr1)\n",
      "p(MGI:Tgfb1) -> p(MGI:Tgfbr2)\n",
      "----------------------\n",
      "10031190 : Figure 2(C) Real-time PCR analysis indicates that all three miR-29 family members are down-regulated in fibroblasts after exposure to TGF? for 48 h. *, P < 0.05 compared with untreated fibroblasts.\n",
      "p(MGI:Tgfb1) -| r(EGID:387222)\n",
      "p(MGI:Tgfb1) -| r(EGID:387223)\n",
      "p(MGI:Tgfb1) -| r(EGID:387224)\n",
      "----------------------\n",
      "10031192 : Stimulation of primary murine HSC (Fig. 3E) as well as immortalized murine HSC (GRX-HSC; Supporting Fig. S3B) with recombinant TGF-beta led to a significant decrease of miR-29 expression, correlating with an increase in collagen expression in these cells.\n",
      "p(MGI:Tgfb1) -| r(EGID:387222)\n",
      "p(MGI:Tgfb1) -| r(EGID:387223)\n",
      "p(MGI:Tgfb1) -| r(EGID:387224)\n",
      "----------------------\n",
      "10031194 : Moreover, TGF-beta 1 markedly suppressed the expression of antigen peresenting molecule Ia and co-stimulatory molecule CD86 on the surface of cultured Lin- c-kit+ HPCs. Examination of RT-PCR showed that TGF-beta 1 could also inhibit the expression of MHC class II trans-activator (CTIIA) mRNA\n",
      "p(MGI:Tgfb1) -| r(EGID:69717)\n",
      "p(MGI:Tgfb1) -| r(MGI:Cd86)\n",
      "p(MGI:Tgfb1) -| r(MGI:Ciita)\n",
      "----------------------\n",
      "10031198 : Smad3 is an important mediator of the TGF beta signaling pathway Smad3-/- follicles have impaired growth, increased atresia, and altered differentiation in the presence of high FSH levels, normal expression of FSHR, and lower expression of cyclin D2\n",
      "p(MGI:Tgfb1) -> r(MGI:Ccnd2)\n",
      "act(p(MGI:Smad3)) -> r(MGI:Ccnd2)\n",
      "----------------------\n",
      "10010340 : COL1A2 promoter activity was dose dependently induced by TGF-beta1, which was further augmented by adenoviral overexpression of Smad3, but was downregulated by Smad7.\n",
      "p(MGI:Tgfb1) -> r(MGI:Col1a2)\n",
      "act(p(MGI:Smad3)) -> r(MGI:Col1a2)\n",
      "act(p(MGI:Smad7)) -| r(MGI:Col1a2)\n",
      "----------------------\n",
      "10031208 : TGF-?1 can induce IL-10 production (an anti-inflammatory cytokine) in T cells through a Smad4 dependent mechanism by Smad4 DNA-binding to the IL-10 promoter suggesting a unique role for Smad4 in regulating TGF-?1âs antiinflammatory effects in T cells.133\n",
      "p(MGI:Tgfb1) -> r(MGI:Il10)\n",
      "act(p(MGI:Smad4)) -> r(MGI:Il10)\n",
      "----------------------\n",
      "10031224 : However, at 6 h after treatment with rTGF- 1, there was a significant (1.7-fold) increased (TIMP1) expression ( p 0.03) in WT fibroblasts that was not seen in KO fibroblasts. .. whereas there was a significant increase in TGF-1 gene expression in WT fibroblasts at 6 and 24 h ( p 0.03).\n",
      "p(MGI:Tgfb1) -> r(MGI:Tgfb1)\n",
      "p(MGI:Tgfb1) -> r(MGI:Timp1)\n",
      "----------------------\n",
      "10031226 : TGF-{beta}-stimulated CD4+CD25â cells contained TGF-{beta} mRNA but produced low levels of IL-10 and little or no IFN-{gamma} and IL-4.\n",
      "p(MGI:Tgfb1) -| tloc(p(MGI:Ifng))\n",
      "p(MGI:Tgfb1) -| tloc(p(MGI:Il10))\n",
      "p(MGI:Tgfb1) -| tloc(p(MGI:Il4))\n",
      "----------------------\n",
      "10031234 : The transcription factor early growth response-1 (Egr-1) mediates the stimulation of collagen transcription elicited by TGF-beta and is necessary for the development of pulmonary fibrosis in mice.\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Egr1))\n",
      "act(p(MGI:Egr1)) -> path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10031236 : Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Foxo1))\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Foxo3))\n",
      "act(p(MGI:Foxo1)) -> r(MGI:Foxp3)\n",
      "act(p(MGI:Foxo3)) -> r(MGI:Foxp3)\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:FOXO1))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:FOXO3))\n",
      "----------------------\n",
      "10031240 : FIGURE 9. TGF-beta1 induces snail-1 in hepatocytes in EMT state and lack of evidence for Akt/Erk1/2 activation\n",
      "p(MGI:Tgfb1) -> act(p(MGI:Smad3))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10031258 : WtTGFbetaRIII inhibited phosphorylation of Smad 2 and 3 (Fig. 3A) as well as Akt and ERK by TGF-beta (Fig. 3B).\n",
      "p(MGI:Tgfbr3) -| act(p(MGI:Smad2))\n",
      "p(MGI:Tgfbr3) -| act(p(MGI:Smad3))\n",
      "p(HGNC:TGFBR3) -| act(p(HGNC:SMAD2))\n",
      "p(HGNC:TGFBR3) -| act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10031268 : TSP-1, a major constituent of alpha-granules, acts as a potent inhibitor of endothelial cell proliferation and stimulates endothelial cell apoptosis.186\n",
      "p(MGI:Thbs1) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Thbs1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10031292 : TIMP-2 and Ala+TIMP-2 A549 xenografts exhibited reduced tumor growth (70-95% inhibition), decreased angiogenesis and increased apoptosis in both nude and NOD-SCID mice\n",
      "p(MGI:Timp2) -| bp(GOBP:angiogenesis)\n",
      "p(MGI:Timp2) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10031300 : More specifically, when compared to EV tumors, TIMP-2 or Ala+TIMP-2 caused down-regulation of IGF-1 receptor (IGF-1R) expression (4.8 fold) and an increase in IGF binding proteins (including IGFBP-5 (4.0 fold) and -7 (3.5 fold)), proteins that limit the bioavailability of IGF ligands\n",
      "p(MGI:Timp2) -| r(MGI:Igf1r)\n",
      "p(MGI:Timp2) -> r(MGI:Igfbp5)\n",
      "p(MGI:Timp2) -> r(MGI:Igfbp7)\n",
      "----------------------\n",
      "10031312 : Notably, CXCR2 expression and chemotaxis to CXCL2 were significantly higher in neutrophils from TLR2-/- mice compared with those from WT mice subjected to S-CLP (Fig. 2 C and D).\n",
      "p(MGI:Tlr2) -| bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(MGI:Tlr2) -| r(EGID:12765)\n",
      "----------------------\n",
      "10010402 : Wound areas in TLR2(-/-), TLR4(-/-), and TLR2/4(-/-) mice were larger than wild-type mice both at days 3 and 7 after wounding, accompanied by decreased numbers of infiltrating macrophages in the dermis and decreased TGF-beta and CCL5 mRNA expression in the wounded skin\n",
      "p(MGI:Tlr2) -> r(MGI:Ccl5)\n",
      "p(MGI:Tlr2) -> r(MGI:Tgfb1)\n",
      "p(MGI:Tlr4) -> r(MGI:Ccl5)\n",
      "p(MGI:Tlr4) -> r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10031322 : In contrast, the protein level of MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 in TLR3-/- skin wounds was significantly decreased compared with WT mice (Fig. 5BâD).\n",
      "p(MGI:Tlr3) -> p(MGI:Ccl2)\n",
      "p(MGI:Tlr3) -> p(MGI:Ccl3)\n",
      "p(MGI:Tlr3) -> p(MGI:Cxcl2)\n",
      "----------------------\n",
      "10031324 : However, the expression of the genes for MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 was significantly reduced in TLR3-/- mice compared with WT controls (Fig. 5A).\n",
      "p(MGI:Tlr3) -> r(MGI:Ccl2)\n",
      "p(MGI:Tlr3) -> r(MGI:Ccl3)\n",
      "p(MGI:Tlr3) -> r(MGI:Cxcl2)\n",
      "----------------------\n",
      "10031334 : In the mouse, TLR4 has a role for maintaining normal lung architecture by inhibiting oxidant stress.\n",
      "p(MGI:Tlr4) -| bp(GOBP:\"response to oxidative stress\")\n",
      "p(HGNC:TLR4) -| bp(GOBP:\"response to oxidative stress\")\n",
      "----------------------\n",
      "10031338 : The basal and CSE-inducible expression of LC3B and cleaved caspase-3 were elevated in pulmonary alveolar type II (ATII) cells from Tlr4-deficient mice...These findings suggest that TLR exerts an inhibitory effect on the expression of the autophagic protein LC3B, and also on the apoptotic response to CSE\n",
      "p(MGI:Tlr4) -| bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Tlr4) -| p(MGI:Casp3)\n",
      "p(MGI:Tlr4) -| p(MGI:Map1lc3b)\n",
      "p(HGNC:TLR4) -| p(HGNC:CASP3)\n",
      "p(HGNC:TLR4) -| p(HGNC:MAP1LC3B)\n",
      "----------------------\n",
      "10031344 : Furthermore, TLR4 deficiency has been shown to cause age-related pulmonary emphysema by increased oxidant stress and cell death in aged mice, in the absence of smoking\n",
      "p(MGI:Tlr4) -| path(MESHD:Emphysema)\n",
      "p(HGNC:TLR4) -| path(MESHD:Emphysema)\n",
      "----------------------\n",
      "10031348 : The Tlr4-mutated or Tlr4-deficient mice showed higher levels of LC3B under basal conditions and after CS exposure. The expression of cleaved caspase-3 was markedly increased in Tlr4-deficient mice exposed to CS. We describe a protective regulatory function of TLR4 against emphysematous changes of the lung in response to CS\n",
      "p(MGI:Tlr4) -| p(MGI:Casp3)\n",
      "p(MGI:Tlr4) -| p(MGI:Map1lc3b)\n",
      "p(HGNC:TLR4) -| p(HGNC:CASP3)\n",
      "p(HGNC:TLR4) -| p(HGNC:MAP1LC3B)\n",
      "----------------------\n",
      "10031354 : we examined mRNA expression of various Nox proteins in lung lysates from Tlr4â/â and WT mice. Nox3 was present at a very low level in WT lungs, whereas Tlr4â/â lung lysates showed increased expression of Nox3 mRNA and protein (Figure 7, A and B).\n",
      "p(MGI:Tlr4) -| p(MGI:Nox3)\n",
      "p(MGI:Tlr4) -| r(MGI:Nox3)\n",
      "----------------------\n",
      "10031358 : In contrast to the cryopyrin null mice, IL-1beta release and transcription were suppressed in macrophages derived from Tlr4-deficient mice\n",
      "p(MGI:Tlr4) -> r(MGI:Il1b)\n",
      "p(MGI:Tlr4) -> tloc(p(MGI:Il1b))\n",
      "----------------------\n",
      "10010412 : In contrast, LPS from Escherichia coli stimulated mast cells in a TLR4-dependent manner to produce TNF-alpha, IL-1beta, IL-6, and IL-13, but not IL-4 nor IL-5.\n",
      "p(MGI:Tlr4) -> tloc(p(MGI:Il13))\n",
      "p(MGI:Tlr4) -> tloc(p(MGI:Il1b))\n",
      "p(MGI:Tlr4) -> tloc(p(MGI:Il6))\n",
      "p(MGI:Tlr4) -> tloc(p(MGI:Tnf))\n",
      "----------------------\n",
      "10031368 : Expression of both IFN-a2 and IFN-b mRNA was found to be profoundly abrogated in TLR7-deficient mice\n",
      "p(MGI:Tlr7) -> r(MGI:Ifna2)\n",
      "p(MGI:Tlr7) -> r(MGI:Ifnb1)\n",
      "----------------------\n",
      "10016738 : To confirm that TLR9 was involved in the CpG ODN-induced signaling, a siRNA approach was used, and TLR9 siRNA was found to attenuate CpG ODN-induced Lox-1 mRNA and protein expression, Nox1 mRNA and protein expression, and foam cell formation (Fig. 4A-F).\n",
      "p(MGI:Tlr9) -> p(MGI:Nox1)\n",
      "p(MGI:Tlr9) -> r(MGI:Nox1)\n",
      "----------------------\n",
      "10031380 : Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Seven days after transplantation of the A375-GFP, capillary nets became far more abundant in the tumors grown in WT mice than those in TNKO mice. Interestingly, VEGF and TN-C expressions showed antithetical expression patterns between the tumors in WT mice and those in TNKO mice.\n",
      "p(MGI:Tnc) -> bp(GOBP:angiogenesis)\n",
      "p(MGI:Tnc) -> r(MGI:Vegfa)\n",
      "p(MGI:Vegfa) -> bp(GOBP:angiogenesis)\n",
      "p(HGNC:VEGFA) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10010426 : TSG-6 protein up-regulates the expression of inducible cyclooxygenase-2 (COX-2), a key enzyme in inflammation and immune responses. This action of TSG-6 protein was abolished by heat denaturation, trypsin digestion, or anti-TSG-6 antibodies. TSG-6 treatment also resulted in a rapid increase in COX-2 mRNA levels, suggesting that TSG-6 up-regulates COX-2 gene expression\n",
      "p(MGI:Tnfaip6) -> p(MGI:Ptgs2)\n",
      "p(MGI:Tnfaip6) -> r(MGI:Ptgs2)\n",
      "----------------------\n",
      "10010434 : We further demonstrate that inflammatory signals that antagonize differentiation, such as TNFalpha and lipopolysaccharide, acutely induce Nur77 expression both in vitro and in vivo.\n",
      "p(MGI:Tnf) -| bp(GOBP:\"fat cell differentiation\")\n",
      "p(MGI:Tnf) -> r(MGI:Nr4a1)\n",
      "----------------------\n",
      "10010436 : fatty acid beta-oxidation and uncoupling protein (UCP)-2 expression decreased after treatment with VSL#3 or anti-TNF antibodies.\n",
      "p(MGI:Tnf) -> bp(GOBP:\"fatty acid beta-oxidation\")\n",
      "p(MGI:Tnf) -> r(MGI:Ucp2)\n",
      "----------------------\n",
      "10031406 : We recently showed that mice lacking tumor necrosis factor- (TNF-) receptors do not develop smoke-induced inflammation,\n",
      "p(MGI:Tnf) -> bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:TNF) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10031408 : Here we demonstrate that \\\"LDL(-)\\\" increases TNFa-induced inflammatory responses through NFkappaB and AP-1 activation, with corresponding increases in endothelial vascular adhesion molecule-1 (VCAM1) expression. LDL receptor overexpression increases these effects.\n",
      "p(MGI:Tnf) -> bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:TNF) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10031410 : Transgenic overexpression of TNF-{alpha} led to emphysema and exaggerated alveolar inflammation (82)\n",
      "p(MGI:Tnf) -> bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:TNF) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10017728 : Levels of TNF?, a central mediator of inflammation in DSS colitis (Kojouharoff et al., 1997), were elevated in DSS treated XBP1?/? vs XBP1+/+ colonic tissues with intermediate TNF? expression in XBP1+/? mice (Fig. 5E).\n",
      "p(MGI:Tnf) -> bp(GOBP:\"inflammatory response\")\n",
      "p(HGNC:TNF) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10031424 : TNF-alpha-induced desensitization of endothelin-1-stimulated GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes is due, at least in part, to a decreased expression of Galphaq/11,\n",
      "p(MGI:Tnf) -| act(p(MGI:Edn1))\n",
      "p(MGI:Tnf) -| r(MGI:Gnaq)\n",
      "----------------------\n",
      "10031426 : TNF-a also elicited enhanced MMP-9 activity (Fig. 6, middle) and TGF-b release (Fig. 6, bottom) in BALFs.\n",
      "p(MGI:Tnf) -> act(p(MGI:Mmp9))\n",
      "p(MGI:Tnf) -> tloc(p(MGI:Tgfb1))\n",
      "----------------------\n",
      "10031428 : Western blotting of whole-cell lysates prepared from untreated or TNFalpha/CHX-treated NIH 3T3 cells showed no detectable cleavage of ROCK II (Fig. 2a) but significant cleavage of ROCK I, as well as cleavage of the well characterized caspase substrate poly-ADP ribose polymerase (PARP) after treatment with TNFalpha ( Fig. 2b).\n",
      "p(MGI:Tnf) -> act(p(MGI:Parp1))\n",
      "p(MGI:Tnf) -> act(p(MGI:Rock1))\n",
      "----------------------\n",
      "10031430 : Treatment of 3T3-L1 adipocytes with 10 ng/ml TNF-alpha for 24 h produced a maximal (50%) decrease in PDE3B activity, protein and mRNA, which was well correlated with both activation of protein kinase A (PKA) and stimulation of lipolysis, presumably reflecting an increase in intracellular cAMP concentration.\n",
      "p(MGI:Tnf) -| act(p(MGI:Pde3b))\n",
      "p(MGI:Tnf) -| p(MGI:Pde3b)\n",
      "p(MGI:Tnf) -| r(MGI:Pde3b)\n",
      "----------------------\n",
      "10031434 : Fig. 4. Both cIAP1 and 2 are recruited to TNF-R1 upon TNFa treatment and are required for Rip1 polyubiquitination.\n",
      "p(MGI:Tnf) -> act(p(MGI:Tnfrsf1a))\n",
      "p(MGI:Tnf) -> complex(p(MGI:Tnfrsf1a),p(MGI:Birc2))\n",
      "p(MGI:Tnf) -> complex(p(MGI:Tnfrsf1a),p(MGI:Birc3))\n",
      "p(HGNC:TNF) -> act(p(HGNC:TNFRSF1A))\n",
      "----------------------\n",
      "10031468 : antiâTNF-alpha treatment significantly decreased epithelial GM-CSF expression in LPS-treated cocultures, both on mRNA and protein level\n",
      "p(MGI:Tnf) -> p(MGI:Csf2)\n",
      "p(MGI:Tnf) -> r(MGI:Csf2)\n",
      "----------------------\n",
      "10031472 : overexpression of TNF produced an increase in neutrophils, parenchymal B cell nodules, MMP-12, cathepsin K, and emphysema in the absence of smoke (176).\n",
      "p(MGI:Tnf) -> p(MGI:Ctsk)\n",
      "p(MGI:Tnf) -> p(MGI:Mmp12)\n",
      "p(HGNC:TNF) -> p(HGNC:MMP12)\n",
      "----------------------\n",
      "10031476 : In YAMC cells, TNF induced ErbB4 messenger RNA, protein, and phosphorylation; nuclear factor kappaB activation also stimulated ErbB4 accumulation.\n",
      "p(MGI:Tnf) -> p(MGI:Erbb4,pmod(P))\n",
      "p(MGI:Tnf) -> r(MGI:Erbb4)\n",
      "----------------------\n",
      "10031490 : As shown in Fig. 9A, TNF-a strongly stimulated both ERK1 and ERK2 phosphorylation in WT cells (cf lanes 1 and 2).\n",
      "p(MGI:Tnf) -> p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Tnf) -> p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Tnf) -> p(MGI:Mapk3,pmod(P))\n",
      "p(MGI:Tnf) -> p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10031492 : The capacity of TNF to induce MMP expression in chondrocytes was not altered by the deficiency of c-fos, since MMP-3, MMP-9, and MMP-13 were similarly induced in hTNFtg and c-fos-/-hTNFtg mice (Table 3).\n",
      "p(MGI:Tnf) -> p(MGI:Mmp13)\n",
      "p(MGI:Tnf) -> p(MGI:Mmp3)\n",
      "p(MGI:Tnf) -> p(MGI:Mmp9)\n",
      "p(HGNC:TNF) -> p(HGNC:MMP9)\n",
      "----------------------\n",
      "10031494 : The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9\n",
      "p(MGI:Tnf) -> p(MGI:Mmp14)\n",
      "p(MGI:Tnf) -> p(MGI:Mmp3)\n",
      "p(MGI:Tnf) -> p(MGI:Mmp9)\n",
      "p(MGI:Tnf) -> tloc(p(MGI:Mmp14))\n",
      "----------------------\n",
      "10020800 : Whereas TNF treatment (24 hours) markedly increased cytoplasmic p100 and RelB levels without inducing nuclear translocation, combined TNFR-1/LTbR stimulation resulted in p100 degradation and significantly increased nuclear accumulation of p52 and RelB compared to LTbR signaling alone\n",
      "p(MGI:Tnf) -> p(MGI:Nfkb2)\n",
      "p(MGI:Tnf) -> p(MGI:Relb)\n",
      "----------------------\n",
      "10031502 : Genetic complementation of RelA/p65-/- cells with wild type and non-acetylatable mutants of RelA/p65 (K314R and K315R) revealed that neither shuttling, DNA binding nor the induction of anti-apoptotic genes by tumor necrosis factor alpha was affected by acetylation on these residues.\n",
      "p(MGI:Tnf) -> p(MGI:Rela,pmod(A,K,310))\n",
      "p(MGI:Tnf) -> p(MGI:Rela,pmod(A,K,314))\n",
      "p(MGI:Tnf) -> p(MGI:Rela,pmod(A,K,315))\n",
      "----------------------\n",
      "10031504 : Intratracheal instillation of TNF-? elicited a rapid increase in VCAM-1 expression within lung tissue\n",
      "p(MGI:Tnf) -> p(MGI:Vcam1)\n",
      "p(HGNC:TNF) -> p(HGNC:VCAM1)\n",
      "----------------------\n",
      "10031462 : TNF- stimulated the monocyte adhesion (Fig. 11C), which was associated with VCAM-1 expression (Fig. 11B).\n",
      "p(MGI:Tnf) -> p(MGI:Vcam1)\n",
      "p(HGNC:TNF) -> p(HGNC:VCAM1)\n",
      "----------------------\n",
      "10031508 : Expression levels of chemokines such as CCL1 (TCA-3), CCL2 (MCP-1), and CCL6 (C10) have been shown to be dependent on hemopoietically derived TNF-alpha production (40).\n",
      "p(MGI:Tnf) -> r(MGI:Ccl1)\n",
      "p(MGI:Tnf) -> r(MGI:Ccl2)\n",
      "p(MGI:Tnf) -> r(MGI:Ccl6)\n",
      "----------------------\n",
      "10031522 : In addition to FOXc2 and MKP-1, TNF has previously been reported to increase the expression of WNT10A and decorin (DCN) while repressing aquaporin.\n",
      "p(MGI:Tnf) -> r(MGI:Dcn)\n",
      "p(MGI:Tnf) -> r(MGI:Dusp1)\n",
      "p(MGI:Tnf) -> r(MGI:Foxc2)\n",
      "p(MGI:Tnf) -> r(MGI:Wnt10a)\n",
      "----------------------\n",
      "10031538 : genes that are positively regulated by PPARgamma, such as adipocyte lipid-binding protein 2 (aP2) or lipoprotein lipase-(LPL). PPARgamma mRNA levels were also downregulated by tumor necrosis factor alpha (TNFalpha)\n",
      "p(MGI:Tnf) -| r(MGI:Pparg)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Fabp4)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Lpl)\n",
      "----------------------\n",
      "10010488 : The genes expression of 19S regulator's subunits Psmc2, Psmc5, Psmd1, and Psmd2 were examined by the use of reverse-transcription polymerase chain reaction... TNF-alpha and burn can markedly increased the activities and contents of 26S proteasome and 19S regulator in mice skeletal muscle. In addition, the expression levels of the 19S regulator's subunits also were remarkably increased.\n",
      "p(MGI:Tnf) -> r(MGI:Psmc2)\n",
      "p(MGI:Tnf) -> r(MGI:Psmc5)\n",
      "p(MGI:Tnf) -> r(MGI:Psmd1)\n",
      "p(MGI:Tnf) -> r(MGI:Psmd2)\n",
      "----------------------\n",
      "10031544 : a part of the H2-Ke4 genomic region (1.9-kb), as well as the 250-bp promoter, was transcriptionally active as an Rxrb promoter; TNF)-alpha significantly repressed the %activity of the 250-bp promoter\n",
      "p(MGI:Tnf) -| r(MGI:Rxrb)\n",
      "p(MGI:Tnf) -| r(MGI:Slc39a7)\n",
      "----------------------\n",
      "10031566 : We also examined Bip/GRP78 expression and XBP1 protein in TNFR1-/- cells after Tg treatment. Bip/GRP78 messenger RNA level and the level of the spliced form of XBP1 protein are decreased in TNFR1-/- cells (supplementary Fig 2 online).\n",
      "p(MGI:Tnfrsf1a) -> p(MGI:Xbp1)\n",
      "p(MGI:Tnfrsf1a) -> r(MGI:Hspa5)\n",
      "----------------------\n",
      "10010502 : Elevated levels of human TNF-alpha were accompanied by increases in synovial cell expression of murine IL-1beta and IL-6\n",
      "p(MGI:Tnf) -> tloc(p(MGI:Il1b))\n",
      "p(MGI:Tnf) -> tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10010532 : It was found that the mRNA expression levels of type I collagen and collagen fibril-associated molecules other than decorin were decreased and that the expression level of decorin was increased in TNX-null fibroblasts.\n",
      "p(MGI:Tnxb) -> r(MGI:Col1a1)\n",
      "p(MGI:Tnxb) -> r(MGI:Col1a2)\n",
      "p(MGI:Tnxb) -| r(MGI:Dcn)\n",
      "----------------------\n",
      "10010534 : Differential display analysis of wild-type and TNX-null fibroblasts revealed that mRNA expression level of type VI collagen alpha3 is predominantly decreased in TNX-null fibroblasts. Expression levels of mRNAs of other subunits of type VI collagen, alpha2 and alpha3 chains, were also remarkably decreased in TNX-null fibroblasts.\n",
      "p(MGI:Tnxb) -> r(MGI:Col6a2)\n",
      "p(MGI:Tnxb) -> r(MGI:Col6a3)\n",
      "----------------------\n",
      "10031662 : Consistent with our previous findings that TRAF2 and TRAF6 activate ASK1, H(2)O(2)-induced ASK1 activation and cell death were strongly reduced in the cells derived from Traf2-/- and Traf6-/- mice.\n",
      "p(MGI:Traf2) -> act(p(MGI:Map3k5))\n",
      "p(MGI:Traf6) -> act(p(MGI:Map3k5))\n",
      "----------------------\n",
      "10031672 : TRAF3-/- B cells showed vastly prolonged survival ex vivo, markedly increased constitutive activation of NF-?B2 and decreased PKC? nuclear translocation independent of BAFF.\n",
      "p(MGI:Traf3) -> act(p(MGI:Prkcd))\n",
      "p(MGI:Traf3) -| act(p(MGI:Nfkb2))\n",
      "----------------------\n",
      "10031674 : Additional in vivo evidence for the elevated constitutive NF-?B2 activity in TRAF3-/- B cells may be the enhanced expression of CD21 and CD23 on splenic and LN B cells in B-TRAF3-/- mice,\n",
      "p(MGI:Traf3) -| p(MGI:Cr2)\n",
      "p(MGI:Traf3) -| p(MGI:Fcer2a)\n",
      "----------------------\n",
      "10010538 : While TRAP1 has only a small stimulatory effect on TGF-beta signaling in functional assays, deletion constructs of TRAP1 inhibit TGF-beta signaling and diminish the interaction of Smad4 with Smad2.\n",
      "p(MGI:Trap1) -> act(p(MGI:Tgfbr1))\n",
      "p(MGI:Trap1) -> act(p(MGI:Tgfbr2))\n",
      "----------------------\n",
      "10031676 : upregulation of TRB3 through direct transcriptional control by Ppara...TRB3 is an inhibitor of Akt?protein kinase B\n",
      "p(MGI:Trib3) -| act(p(MGI:Akt1))\n",
      "act(p(MGI:Ppara)) -> r(MGI:Trib3)\n",
      "----------------------\n",
      "10031686 : An increase in the level of the tumor suppressor protein p53 can induce cell cycle arrest or cell death\n",
      "p(MGI:Trp53) -| bp(GOBP:\"cell cycle\")\n",
      "p(MGI:Trp53) -> bp(GOBP:\"cell death\")\n",
      "----------------------\n",
      "10031688 : As shown in a number of in vivo studies using atherosclerosis-prone mice, a deficiency in p53, one of the main factors involved in senescence signaling (Fig 1), accelerates atherosclerosis development, possibly by increasing macrophage proliferation in atherosclerotic lesions.86-88\n",
      "p(MGI:Trp53) -| bp(GOBP:\"cell proliferation\")\n",
      "p(MGI:Trp53) -| path(MESHD:Atherosclerosis)\n",
      "----------------------\n",
      "10031712 : reduction of the expression of all the p63 isoforms using pan siRNA for p63 (39, 45, 46) decreased the expression of both Jagged1 and Hes1 in WT MEFs, MEFs without Tsc1 or Tsc2, and WT MEFs expressing myrAKT1 (Figure 6B).\n",
      "p(MGI:Trp63) -> p(MGI:Hes1)\n",
      "p(MGI:Trp63) -> p(MGI:Jag1)\n",
      "----------------------\n",
      "10031718 : These cells also exhibit a marked increase in PERK phosphorylation compared to a littermate-derived wild-type (WT) control cell line (Figure 1A, triplicates shown), indicating the presence of ER stress.\n",
      "p(MGI:Tsc1) -| bp(GOBP:\"response to endoplasmic reticulum stress\")\n",
      "p(MGI:Tsc1) -| act(p(MGI:Eif2ak3))\n",
      "----------------------\n",
      "10031726 : Importantly, whereas phosphorylation of Thr- 389 (RPS6KB1 P@T412) in Tsc1- and Tsc2-null MEFs was inhibited by rapamycin, phosphorylation of this site was strongly resistant to inhibition by wortmannin.\n",
      "p(MGI:Tsc1) -| p(MGI:Rps6kb1,pmod(P))\n",
      "p(MGI:Tsc2) -| p(MGI:Rps6kb1,pmod(P))\n",
      "----------------------\n",
      "10031722 : As shown in Figure 1A, Tsc1-/- mouse embryonic fibroblasts (MEFs) exhibited constitutive mTORC1 activity, as indicated by robust rapamycinsensitive S6K1 (Thr389) and ribosomal protein S6 (Ser235/236) phosphorylation under basal, unstimulated conditions.\n",
      "p(MGI:Tsc1) -| p(MGI:Rps6kb1,pmod(P))\n",
      "p(MGI:Tsc1) -| p(MGI:Rps6,pmod(P))\n",
      "p(MGI:Tsc1) -| p(MGI:Rps6,pmod(P))\n",
      "----------------------\n",
      "10010554 : GILZ appears to play a key role in the anti-inflammatory and immunosuppressive effects of glucocorticoids and IL-10\n",
      "p(MGI:Tsc22d3) -| bp(GOBP:\"inflammatory response\")\n",
      "p(MGI:Tsc22d3) -| bp(GOBP:\"macrophage activation\")\n",
      "----------------------\n",
      "10031730 : Similar to the TSC1 deficiency, Tsc2-/- cells also exhibited increased PERK phosphorylation and XBP-1 splicing as well as increased GRP78 and CHOP expression compared to WT controls (see Figures S1A and S1B available online).\n",
      "p(MGI:Tsc2) -| act(p(MGI:Eif2ak3))\n",
      "p(MGI:Tsc2) -| p(MGI:Xbp1)\n",
      "p(MGI:Tsc2) -| r(MGI:Ddit3)\n",
      "p(MGI:Tsc2) -| r(MGI:Hspa5)\n",
      "----------------------\n",
      "10017424 : Because the enhanced NF-kB signaling in Tsc2-/- MEFs was abolished by rapamycin treatment, NF-kB signaling appeared to be downstream of mTORC1 (Figure 10A).\n",
      "p(MGI:Tsc2) -| p(MGI:Nfkbia,pmod(P))\n",
      "p(MGI:Tsc2) -| p(MGI:Rela,pmod(P))\n",
      "----------------------\n",
      "10031764 : These findings demonstrate that M-Twist interacts with MyoD through the basic domains, thereby inhibiting MyoD.\n",
      "p(MGI:Twist1) -| bp(GOBP:\"skeletal muscle tissue development\")\n",
      "p(MGI:Twist1) -| act(p(MGI:Myod1))\n",
      "----------------------\n",
      "10010566 : Expression of twist1 in Th1 lymphocytes limited the expression of the cytokines interferon-gamma, IL-2, and tumor necrosis factor-alpha, and ameliorated Th1-mediated immunopathology in delayed-type hypersensitivity and antigen-induced arthritis.\n",
      "p(MGI:Twist1) -| r(MGI:Ifng)\n",
      "p(MGI:Twist1) -| r(MGI:Il2)\n",
      "p(MGI:Twist1) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10031770 : Ectopically expressed mouse Twist (Mtwist) was shown to inhibit myogenesis by blocking DNA binding by MyoD, by titrating E proteins, and by inhibiting trans-activation by MEF2\n",
      "p(MGI:Twist1) -| act(p(MGI:Myod1))\n",
      "act(p(MGI:Twist1)) -| act(p(MGI:Mef2a))\n",
      "----------------------\n",
      "10031778 : Table 2 Comparison of expression ratios between microarray and RT-qPCR, lipid and mixed annotated genes ## WT vs Tyk2-/- peritoneal macrophages ##\n",
      "p(MGI:Tyk2) -| r(MGI:Crat)\n",
      "p(MGI:Tyk2) -| r(MGI:Fasn)\n",
      "p(MGI:Tyk2) -| r(MGI:Zbp1)\n",
      "----------------------\n",
      "10031782 : from full text - Reduction of DAP12 mRNA in both liver and splenic DC resulted in significantly increased expression of CD80 and CD86 as well as of the coregulatory molecules B7-H1 (programmed death ligand-1) and B7- H2 (programmed death ligand-2) relative to DC transfected with ctl siRNA (Fig. 2B, 2C)\n",
      "p(MGI:Tyrobp) -| r(MGI:Cd274)\n",
      "p(MGI:Tyrobp) -| r(MGI:Cd80)\n",
      "p(MGI:Tyrobp) -| r(MGI:Cd86)\n",
      "p(MGI:Tyrobp) -| r(MGI:Icosl)\n",
      "----------------------\n",
      "10010580 : We also present evidence that DAP12 is a general macrophage fusion regulator and is involved in modulating the expression of several macrophage-associated genes, including those encoding known mediators of macrophage fusion, such as DC-STAMP and Cadherin 1.\n",
      "p(MGI:Tyrobp) -> r(MGI:Cdh1)\n",
      "p(MGI:Tyrobp) -> r(MGI:Dcstamp)\n",
      "----------------------\n",
      "10010588 : One of the phenotypes of mice with targeted disruption of the uncoupling protein-2 gene (Ucp2-/-) is greater macrophage phagocytic activity and free radical production, resulting in a striking resistance to infectious microorganisms.\n",
      "p(MGI:Ucp2) -| a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Ucp2) -| bp(GOBP:\"macrophage activation\")\n",
      "p(MGI:Ucp2) -> path(MESHD:Infection)\n",
      "----------------------\n",
      "10031798 : B6.Cg-Ay carrying the UCP2/UCP3 transgene from Line 32 were significantly leaner than nontransgenic B6.Cg-Ay mice... Moderate overexpression of UCP2 and 3 reduced fat mass and increased LDL cholesterol in two independent lines of transgenic mice.\n",
      "p(MGI:Ucp2) -| path(MESHD:Obesity)\n",
      "p(MGI:Ucp3) -| path(MESHD:Obesity)\n",
      "----------------------\n",
      "10031804 : nduction of inflammatory cytokines by LPS is increased in Ucp2-/- mice. A, Northern blotting. Spleen total RNA was isolated from mice treated with 4 Âµg/g bw LPS or PBS. RNA for IFNg, IL1b, TNF and IL6 were elevated in Ucp2-/- mice in response to LPS.\n",
      "p(MGI:Ucp2) -| r(MGI:Ifng)\n",
      "p(MGI:Ucp2) -| r(MGI:Il1b)\n",
      "p(MGI:Ucp2) -| r(MGI:Il6)\n",
      "p(MGI:Ucp2) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10031818 : we observed a significant diminution of the L-PK and S14 gene expression 18 h after glucose refeeding, whereas in ad libitum fed mice, no difference was detected. This result, obtained in adult liver of USF2 ?/? mice, was consistent with the 64% reduction in the amount of L-PK protein\n",
      "p(MGI:Usf2) -> p(MGI:Pklr)\n",
      "p(MGI:Usf2) -> r(MGI:Pklr)\n",
      "p(MGI:Usf2) -> r(MGI:Thrsp)\n",
      "----------------------\n",
      "10031824 : down-modulation of Vav3 protein levels by vav3 siRNAs had an effect on these GTPases, and thus RhoA activation was increased, whereas Rac1 activation was decreased in transfected T-FGM AhR+/+ cells (Figure 10C).\n",
      "p(MGI:Vav3) -> act(p(MGI:Rac1))\n",
      "p(MGI:Vav3) -| act(p(MGI:Rhoa))\n",
      "----------------------\n",
      "10010604 : Treatment with vascular endothelial cell growth factor (VEGF) gave rise to endothelial-like cells, expressing Flt-1, Flk-1, von Willebrand Factor (vWF), CD31\n",
      "p(MGI:Vegfa) -> r(MGI:Flt1)\n",
      "p(MGI:Vegfa) -> r(MGI:Kdr)\n",
      "p(MGI:Vegfa) -> r(MGI:Pecam1)\n",
      "p(MGI:Vegfa) -> r(MGI:Vwf)\n",
      "----------------------\n",
      "10031852 : Rt-Pcr analysis of endothelial cell lines from normal and hypoxic EC from wt and vhl-/- and vhl-/-.hif1a-/- mice. Hypoxia treatment .5% for 8 hours.\n",
      "p(MGI:Vhl) -| r(MGI:Nos2)\n",
      "p(MGI:Vhl) -| r(MGI:Pgk1)\n",
      "p(MGI:Vhl) -| r(MGI:Slc2a1)\n",
      "----------------------\n",
      "10031876 : Col1a1, osteopontin (OP; Spp1 - Mouse Genome Informatics) and OC were all significantly induced within 48 hours of Wnt3a stimulation\n",
      "p(MGI:Wnt3a) -> r(EGID:12096)\n",
      "p(MGI:Wnt3a) -> r(MGI:Col1a1)\n",
      "p(MGI:Wnt3a) -> r(MGI:Spp1)\n",
      "----------------------\n",
      "10031884 : Sox9 protein levels were decreased in both Wnt5aâ/â and Col2a1- Wnt5a mice, and no alteration was observed in Col2a1-Wnt5b mice when compared with the wild-type littermate (Fig. 8A).\n",
      "p(MGI:Wnt5a) -> p(MGI:Sox9)\n",
      "p(MGI:Wnt5a) -| p(MGI:Sox9)\n",
      "----------------------\n",
      "10031888 : This was confirmed by our observation that the expression of Pthrpr and Cbfa1 in the prehypertrophic chondrocytes was reduced and delayed and the expression of Col10a1, a hypertrophic chondrocyte marker, was absent in the Wnt5aâ/â limb from 12.5 dpc to 15.5 dpc (Fig. 2B,C).\n",
      "p(MGI:Wnt5a) -> r(MGI:Col10a1)\n",
      "p(MGI:Wnt5a) -> r(MGI:Pthlh)\n",
      "p(MGI:Wnt5a) -> r(MGI:Runx2)\n",
      "----------------------\n",
      "10031892 : Col2a1 expression was increased in the cartilage of the Wnt5aâ/â and Col2a1-Wnt5b mice, but decreased in the Col2a1-Wnt5a mice (Fig. 8B).\n",
      "p(MGI:Wnt5a) -| r(MGI:Col2a1)\n",
      "p(MGI:Wnt5b) -> r(MGI:Col2a1)\n",
      "----------------------\n",
      "10031902 : luciferase assay of the Col2a1 reporter was performed in mouse primary chondrocytes (Fig. 8C). Col2a1-luciferase activity was suppressed by Wnt5a but increased by Wnt5b in a dosedependent manner.\n",
      "p(MGI:Wnt5a) -| act(p(MGI:Col2a1))\n",
      "p(MGI:Wnt5b) -> act(p(MGI:Col2a1))\n",
      "----------------------\n",
      "10031916 : Wrn Delta hel/Delta hel mutant mouse embryonic fibroblasts exhibit increased oxidative stress. This was reflected by increased intracellular reactive oxygen species (ROS), increased oxidative damage in genomic DNA, changes in ATP/ADP ratios, and a disruption of the inner mitochondrial transmembrane potential when compared to wild type mouse embryonic fibroblasts.\n",
      "p(MGI:Wrn) -| a(CHEBI:\"reactive oxygen species\")\n",
      "p(MGI:Wrn) -| bp(GOBP:\"cellular response to DNA damage stimulus\")\n",
      "p(MGI:Wrn) -| bp(GOBP:\"response to oxidative stress\")\n",
      "----------------------\n",
      "10031924 : Elevated basal grp78 levels in XBP1-/- small intestinal epithelia indicated increased ER stress (Fig. 1B) that was confirmed by microarray analysis showing both increased grp78 (Haspa5) and Chop (Ddit3) (P=0.02) (Supplementary Table 1 and Supplementary Fig. 2A).\n",
      "p(MGI:Xbp1) -| bp(GOBP:\"response to endoplasmic reticulum stress\")\n",
      "p(MGI:Xbp1) -| r(MGI:Ddit3)\n",
      "p(MGI:Xbp1) -| r(MGI:Hspa5)\n",
      "----------------------\n",
      "10031930 : JNK phosphorylation was increased in XBP1-/- small intestinal epithelia compared to controls consistent with the described TRAF2-dependent function of IRE1 to activate JNK (Urano et al., 2000) (Fig. 4B).\n",
      "p(MGI:Xbp1) -| act(p(MGI:Mapk8))\n",
      "p(MGI:Xbp1) -| act(p(MGI:Mapk9))\n",
      "----------------------\n",
      "10031932 : In contrast, upon introduction of XBP-1s, Akt phosphorylation was readily detectable in Tsc2-/- cells. There was also an increase in IRS-1 protein levels in XBP-1sexpressing cells.\n",
      "p(MGI:Xbp1) -> p(MGI:Akt1,pmod(P))\n",
      "p(MGI:Xbp1) -> p(MGI:Irs1)\n",
      "----------------------\n",
      "10031936 : XBP1-/- intestine was completely devoid of Paneth cells (Fig. 1DE), compared to XBP1+/+ and XBP1+/- mice (Fig. 1E and Supplementary Fig. 2B). mRNA expression of cryptdins-1, -4, and -5 and lysozyme, but not cathelicidin, were substantially reduced (Fig. 1A).\n",
      "p(MGI:Xbp1) -> r(EGID:13216)\n",
      "p(MGI:Xbp1) -> r(EGID:13238)\n",
      "p(MGI:Xbp1) -> r(EGID:13239)\n",
      "p(MGI:Xbp1) -> r(MGI:Lyz2)\n",
      "----------------------\n",
      "10031938 : Among the genes selectively altered in E-xbp-1s B cells are those with known relevance to human MM pathogenesis, such as Cyclin D1, Cyclin D2, MAF, and MAFB (Figure6A and data not shown)\n",
      "p(MGI:Xbp1) -> r(MGI:Ccnd1)\n",
      "p(MGI:Xbp1) -> r(MGI:Ccnd2)\n",
      "p(MGI:Xbp1) -> r(MGI:Maf)\n",
      "p(MGI:Xbp1) -> r(MGI:Mafb)\n",
      "----------------------\n",
      "10010644 : TTP, TIS11b, and TIS11d each also induce apoptosis through the mitochondrial pathway analogously to certain oncogenes, suggesting that they influence growth or survival signals.\n",
      "p(MGI:Zfp36) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Zfp36l1) -> bp(GOBP:\"apoptotic process\")\n",
      "p(MGI:Zfp36l2) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10031984 : . Importantly, the levels of several genes linked to the control of cancerous transformation in the breast (Esr1, Prg and Foxa1) are significantly reduced upon Fog2 excision\n",
      "p(MGI:Zfpm1) -> r(MGI:Esr1)\n",
      "p(MGI:Zfpm1) -> r(MGI:Foxa1)\n",
      "p(MGI:Zfpm1) -> r(MGI:Srgn)\n",
      "----------------------\n",
      "10031986 : Northern blot analysis was consistent with these results, revealing that 6â24 hr after induction, ?- and ?-globin mRNAs were induced to levels 3- to 4-fold higher in FOG- infected G1ER cells compared to control infected cells ( Figure 6C).\n",
      "p(MGI:Zfpm1) -> r(MGI:\"Hba-a1\")\n",
      "p(MGI:Zfpm1) -> r(MGI:\"Hbb-b1\")\n",
      "----------------------\n",
      "10032044 : Paralleling the trend of mRNA down-regulation, OREBP protein exhibited significant reduction in cells overexpressing either miR-200b or miR-717 (Figure 4C).\n",
      "r(EGID:387243) -| p(MGI:Nfat5)\n",
      "r(EGID:751531) -| p(MGI:Nfat5)\n",
      "----------------------\n",
      "10032046 : overexpression of miR-200b or miR-717 resulted in significant reductions in its (OREBP) transactivation activity (Figure 4D).\n",
      "r(EGID:387243) -| act(p(MGI:Nfat5))\n",
      "r(EGID:751531) -| act(p(MGI:Nfat5))\n",
      "----------------------\n",
      "10032060 : By contrast, increased commitment to the Th2 pathway was evident in bicm2/m2 Th2 cell cultures as higher numbers of IL-4?producing cells were observed (Fig. 3A). In support of this result, enhanced levels of the Th2 cytokines IL-4, IL-5, and IL-10 were generated by bicm2/m2 cells after culture in Th2 polarizing conditions (Fig. 3C).\n",
      "r(MGI:Mir155) -| p(MGI:Il10)\n",
      "r(MGI:Mir155) -| p(MGI:Il4)\n",
      "r(MGI:Mir155) -| p(MGI:Il5)\n",
      "----------------------\n",
      "10032104 : Vascular inflammatory phenotypes such as accelerated expression of VCAM-1, tissue factor, or matrix metalloproteinases in mice are also prevented by sRAGE treatment (95).\n",
      "tloc(p(MGI:Ager)) -| p(MGI:F3)\n",
      "tloc(p(MGI:Ager)) -| p(MGI:Vcam1)\n",
      "----------------------\n",
      "10032108 : These data confirm that sIL-6R-mediated signaling primarily limits neutrophil influx; however, induction of CXCL5 and CXCL6 may regulate other neutrophil responses.\n",
      "tloc(p(MGI:Il6ra)) -| bp(GOBP:\"neutrophil extravasation\")\n",
      "tloc(p(MGI:Il6ra)) -> r(MGI:Cxcl5)\n",
      "----------------------\n",
      "10032146 : Two uptake systems that control the extracellular concentrations of released monoamine neurotransmitters such as noradrenaline and adrenaline have been described. The gene encoding the uptake-2 transporter has recently been identified in humans (EMT), rats (OCT3), and mice (Orct3/Slc22a3).\n",
      "act(p(MGI:Slc22a3)) -| a(CHEBI:dopamine)\n",
      "act(p(MGI:Slc22a3)) -| a(CHEBI:serotonin)\n",
      "----------------------\n",
      "10010726 : The present observations point to a decreased sensitivity of mature erythrocytes from taut-/- mice to osmotic shock and oxidative stress, rendering them more resistant to apoptosis\n",
      "act(p(MGI:Slc6a6)) -> bp(GOBP:\"response to osmotic stress\")\n",
      "act(p(MGI:Slc6a6)) -> bp(GOBP:\"response to oxidative stress\")\n",
      "act(p(MGI:Slc6a6)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10032158 : The minimal XRE bound by AHR-ARNT is 59-TNGCGTG-39, with the specific binding sites for AHR and ARNT being (59)T(C/T)GC and GTG (39), respectively (7). Binding of AHR/ARNT acti-vates the expression of a battery of genes involved in drug and hormone metabolism, e.g., CYP1A1, CYP1B1, GST A2, and NADPH quinone reductase (8).\n",
      "act(complex(p(HGNC:ARNT),p(HGNC:AHR))) -> r(HGNC:CYP1A1)\n",
      "act(complex(p(HGNC:ARNT),p(HGNC:AHR))) -> r(HGNC:CYP1B1)\n",
      "act(complex(p(HGNC:ARNT),p(HGNC:AHR))) -> r(HGNC:GSTA2)\n",
      "----------------------\n",
      "10032162 : Overexpression of Clock and CLIF Induce PAI-1 mRNA Expression. CLOCK and CLIF transactivate the PAI-1 promoter through two E-box sites. (Figure 3D shows that CLOCK by itself, but not CLIF, also induces PAI-1 mRNA expression).\n",
      "act(complex(p(HGNC:CLOCK),p(HGNC:ARNTL2))) -> r(HGNC:SERPINE1)\n",
      "act(p(HGNC:CLOCK)) -> r(HGNC:SERPINE1)\n",
      "----------------------\n",
      "10032170 : heterodimer transcription factors CLOCK and BMAL1 stimulate transcription of CRY1 and CRY2 and PER1 and PER2\n",
      "act(complex(p(MGI:Clock),p(MGI:Arntl))) -> r(MGI:Cry1)\n",
      "act(complex(p(MGI:Clock),p(MGI:Arntl))) -> r(MGI:Cry2)\n",
      "act(complex(p(MGI:Clock),p(MGI:Arntl))) -> r(MGI:Per1)\n",
      "act(complex(p(MGI:Clock),p(MGI:Arntl))) -> r(MGI:Per2)\n",
      "----------------------\n",
      "10032174 : clock and bmal1 also activate transcription of rev-erb-alpha, which in turn represses the transcription of bmal1\n",
      "act(complex(p(MGI:Clock),p(MGI:Arntl))) -> r(MGI:Nr1d1)\n",
      "act(p(MGI:Nr1d1)) -| r(MGI:Arntl)\n",
      "----------------------\n",
      "10032184 : FIG. 3. E2A/HEB complex activates the SRG3 promoter activity through E84 element, which is inhibited by Id proteins.\n",
      "act(complex(p(MGI:Tcf3),p(MGI:Tcf12))) -> r(MGI:Smarcc1)\n",
      "act(p(MGI:Tcf12)) -> r(MGI:Smarcc1)\n",
      "act(p(MGI:Tcf3)) -> r(MGI:Smarcc1)\n",
      "----------------------\n",
      "10032190 : Finally, we found 67 genes, including Igals1, which were induced by TGF-ÃÆ??ÃÆ?ÃâÃÂ¸ in control cells and in cells expressing MycV394D, but not in cells expressing wild-type Myc, arguing that they were repressed by Myc via binding to Miz1 (Fig. 2 A). (Table S1)\n",
      "act(complex(p(MGI:Zbtb17),p(MGI:Myc))) -| r(MGI:Itgb4)\n",
      "act(complex(p(MGI:Zbtb17),p(MGI:Myc))) -| r(MGI:Lgals1)\n",
      "act(complex(p(MGI:Zbtb17),p(MGI:Myc))) -| r(MGI:Mkrn1)\n",
      "----------------------\n",
      "10010770 : Dominant negative mutants of CREB and ATF-2 but not c-Jun inhibited pp60(v-src) induction of cyclin D1.\n",
      "act(p(HGNC:ATF2)) -> r(HGNC:CCND1)\n",
      "act(p(HGNC:CREB1)) -> r(HGNC:CCND1)\n",
      "----------------------\n",
      "10010776 : Important factors for apoE gene regulation appear to be SP1 on the proximal promoter, and possibly HNF-3, C/EBP and hormone nuclear receptors on the enhancers.\n",
      "act(p(HGNC:CEBPA)) -> r(HGNC:APOE)\n",
      "act(p(HGNC:FOXA2)) -> r(HGNC:APOE)\n",
      "act(p(HGNC:SP1)) -> r(HGNC:APOE)\n",
      "----------------------\n",
      "10010778 : the amount of Gadd45gamma transcripts became maximal when both C/EBPbeta and C/EBPdelta levels were high\n",
      "act(p(HGNC:CEBPB)) -> r(HGNC:GADD45G)\n",
      "act(p(HGNC:CEBPD)) -> r(HGNC:GADD45G)\n",
      "----------------------\n",
      "10010782 : The increase in SR-A expression correlates with activation of the redox-sensitive transcription factors activating protein-1 c-Jun and CCAAT enhancer-binding protein beta\n",
      "act(p(HGNC:CEBPB)) -> r(HGNC:MSR1)\n",
      "act(p(HGNC:JUN)) -> r(HGNC:MSR1)\n",
      "----------------------\n",
      "10010790 : We now report that IFN-gamma abrogates TGF-beta-stimulated COL1A2 transcription in fibroblasts by inhibiting Smad activities. IFN-gamma appears to induce competition between activated Stat1alpha and Smad3 for interaction with limiting amounts of cellular p300/CBP.\n",
      "act(p(HGNC:CREBBP)) -> r(HGNC:COL1A2)\n",
      "act(p(HGNC:EP300)) -> r(HGNC:COL1A2)\n",
      "----------------------\n",
      "10032232 : Corresponding to the accumulation of beta-catenin, expression of the MDR1 gene product was steadily up-regulated in adenomas and adenocarcinomas of 10 patients with familial adenomatous polyposis.\n",
      "act(p(HGNC:CTNNB1)) -> r(HGNC:ABCB1)\n",
      "act(p(HGNC:TCF7L2)) -> r(HGNC:ABCB1)\n",
      "----------------------\n",
      "10010796 : The mechanism for the cell cycle downregulation appeared to be a transcriptional downregulation of E2F-1, a transcription factor that regulates genes required for cell cycle progression beyond the G1/S interphase.\n",
      "act(p(HGNC:E2F1)) -> bp(GOBP:\"cell cycle\")\n",
      "act(p(HGNC:NRF1)) -| r(HGNC:E2F1)\n",
      "----------------------\n",
      "10032250 : We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promoter.\n",
      "act(p(HGNC:E2F1)) -> r(HGNC:CDKN1A)\n",
      "act(p(HGNC:E2F3)) -> bp(GOBP:\"cell cycle\")\n",
      "act(p(HGNC:E2F3)) -> r(HGNC:CDKN1A)\n",
      "----------------------\n",
      "10032256 : expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.\n",
      "act(p(HGNC:E2F1)) -> r(HGNC:POLA1)\n",
      "act(p(HGNC:E2F1)) -> r(HGNC:POLA1)\n",
      "act(p(HGNC:E2F1)) -> r(HGNC:TOP2A)\n",
      "act(p(HGNC:E2F1)) -> r(HGNC:TOP2A)\n",
      "----------------------\n",
      "10010802 : In addition, expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.\n",
      "act(p(HGNC:E2F1)) -> r(HGNC:POLA1)\n",
      "act(p(HGNC:E2F1)) -> r(HGNC:TOP2A)\n",
      "----------------------\n",
      "10032274 : Finally ESE-3b and ESE-1 activate the EndoA enhancer Ets site oligo equally well (Fig. 8e)....ESE-3 can also bind to the promoter and the enhancer SPRR2A and EndoA sites respectively, as does ESE-1.\n",
      "act(p(HGNC:EHF)) -> r(HGNC:KRT8)\n",
      "act(p(HGNC:ELF3)) -> r(HGNC:KRT8)\n",
      "----------------------\n",
      "10032278 : both ESE-1 and ESE-3 transactivate the SPRR2A oligo but to a different extent (Fig. 8d)....ESE-3 can also bind to the promoter and the enhancer SPRR2A and EndoA sites respectively, as does ESE-1.\n",
      "act(p(HGNC:EHF)) -> r(HGNC:SPRR2A)\n",
      "act(p(HGNC:ELF3)) -> r(HGNC:SPRR2A)\n",
      "----------------------\n",
      "10010820 : We report here that NFATp synergizes with MEF2D to recruit the coactivator p300 for the transcription of Nur77\n",
      "act(p(HGNC:EP300)) -> r(HGNC:NR4A1)\n",
      "act(p(HGNC:MEF2D)) -> r(HGNC:NR4A1)\n",
      "act(p(HGNC:NFATC2)) -> r(HGNC:NR4A1)\n",
      "----------------------\n",
      "10010822 : EPAS1 shares high homology with hypoxia-inducible factor-1alpha (HIF-1alpha) and, like HIF-1alpha, has been shown to bind to the HIF-1-binding site and to activate its downstream genes such as vascular endothelial growth factor (VEGF) and erythropoietin.\n",
      "act(p(HGNC:EPAS1)) -> r(HGNC:EPO)\n",
      "act(p(HGNC:EPAS1)) -> r(HGNC:VEGFA)\n",
      "----------------------\n",
      "10016314 : This result is consistent with the hypothesis that tamoxifen acts as an antiestrogen in breast tissue and that the pattern of expression resulting from estrogen withdrawal is identical to the pattern of expression induced by tamoxifen treatment...\n",
      "act(p(HGNC:ESR1)) -> r(EGID:9687)\n",
      "act(p(HGNC:ESR1)) -> r(HGNC:PDZK1)\n",
      "----------------------\n",
      "10022676 : In addition, BRCA1 blocked the expression of two endogenous estrogen-regulated gene products in human breast cancer cells: pS2 and cathepsin D\n",
      "act(p(HGNC:ESR1)) -> r(HGNC:CTSD)\n",
      "act(p(HGNC:ESR1)) -> r(HGNC:TFF1)\n",
      "----------------------\n",
      "10032292 : We demonstrate that the expression of collagenous proteins and collagen alpha2(I) (COL1A2) mRNA was inhibited following stable transfection of Fli-1 in dermal fibroblasts..... In contrast, Ets-1 stimulates COL1A2 promoter activity. In vitro binding assays demonstrate that both Fli-1 and Ets-1 form DNA-protein complexes with sequences present in COL1A2 promoter.\n",
      "act(p(HGNC:ETS1)) -> r(HGNC:COL1A2)\n",
      "act(p(HGNC:FLII)) -| r(HGNC:COL1A2)\n",
      "----------------------\n",
      "10032294 : We demonstrate that the expression of collagenous proteins and collagen alpha2(I) (COL1A2) mRNA was inhibited following stable transfection of Fli-1 in dermal fibroblasts. We propose that Fli-1 inhibits COL1A2 promoter activity by competition with Ets-1.\n",
      "act(p(HGNC:ETS1)) -> r(HGNC:COL1A2)\n",
      "act(p(HGNC:FLI1)) -| r(HGNC:COL1A2)\n",
      "----------------------\n",
      "10010828 : We now report that co-transfection into HepG2 or COS-1 cells of either ets-1 or ets-2 expression plasmids together with chimaeric GnT II promoter-chloramphenicol acetyltransferase plasmids results in a 2-4-fold stimulation of promoter activity.\n",
      "act(p(HGNC:ETS1)) -> r(HGNC:MGAT2)\n",
      "act(p(HGNC:ETS2)) -> r(HGNC:MGAT2)\n",
      "----------------------\n",
      "10032298 : In this region the putative cis element binding factor, AML1a \\\"(RUNX1)\\\", was detected [20]. Further deletion of 31 bp from nucleotide positions 3229 to 3199 resulted in increased luciferase activity, indicating the possibility of negative cis element(s) located between 3229 and 3199. Two putative cis element binding factors, STATx [21] and c-Ets-1 [22], were demonstrated in this region.\n",
      "act(p(HGNC:ETS1)) -| r(HGNC:PPP1R12A)\n",
      "act(p(HGNC:RUNX1)) -> r(HGNC:PPP1R12A)\n",
      "----------------------\n",
      "10032302 : Results from transactivation studies with c-Jun and c-Fos expression plasmids confirmed a strong activation of the ET-1 promoter by c-Jun and c-Fos. 16 Cotransfection of PPARs in the presence of c-Jun and c-Fos repressed the strong transactivation of the ET-1 promoter as well as the transactivation of a heterologous AP-1driven promoter.\n",
      "act(p(HGNC:FOS)) -> r(HGNC:EDN1)\n",
      "act(p(HGNC:JUN)) -> r(HGNC:EDN1)\n",
      "----------------------\n",
      "10032318 : To test this possibility we performed cotransfection assays in NIH-3T3 cells and HeLa cells with three different reporter constructs containing either synthetic (M1?, Fig. ?Fig.4A,B4A,B and ?D3; Fig. ?Fig.4C)4C) or natural (p45 NF-E2; Fig. ?Fig.4D)4D) GATA-1-dependent promoters. The p45 NF-E2 promoter requires the synergistic action of GATA-1 and FOG as a cofactor (Tsang et al. 1997).\n",
      "act(p(HGNC:GATA1)) -> r(HGNC:NFE2)\n",
      "act(p(MGI:Gata1)) -> r(MGI:Nfe2)\n",
      "----------------------\n",
      "10010836 : Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression. These observations suggest that embryonic A1AR expression involves activation of the A1AR promoter by GATA-4 and Nkx2.5.\n",
      "act(p(HGNC:GATA4)) -> r(HGNC:ADORA1)\n",
      "act(p(HGNC:\"NKX2-5\")) -> r(HGNC:ADORA1)\n",
      "----------------------\n",
      "10032332 : hepatocyte nuclear factor (HNF)-4a, HNF-1a, insulin promoter factor-1, and HNF-1b in MODY1, -3, -4, and -5, respectively (Yamagata et al., 1996a, 1996b; Stoffers et al., 1997; Horikawa et al., 1997). These transcription factors are expressed in pancreatic b cells, and the mutations are believed to cause insulin deficiency by impairing b cell function.\n",
      "act(p(HGNC:HNF1A)) -> bp(GOBP:\"insulin secretion\")\n",
      "act(p(HGNC:HNF1B)) -> bp(GOBP:\"insulin secretion\")\n",
      "act(p(HGNC:HNF4A)) -> bp(GOBP:\"insulin secretion\")\n",
      "act(p(HGNC:PDX1)) -> bp(GOBP:\"insulin secretion\")\n",
      "----------------------\n",
      "10010846 : In HepG2 cells, HNF1alpha bound to this region and activated the UGT2B17 promoter, as assessed by functional and gel shift assays.\n",
      "act(p(HGNC:HNF1A)) -> p(HGNC:UGT2B17)\n",
      "act(p(HGNC:HNF1A)) -> r(HGNC:UGT2B17)\n",
      "----------------------\n",
      "10010848 : The UGT2B17 promoter could also be activated by exogenous HNF1alpha in LNCaP cells. However, because these cells do not contain HNF1alpha, other transcription factors must regulate the UGT2B17 promoter. Cotransfection experiments showed that HNF1beta, elevates promoter activity in LNCaP cells.\n",
      "act(p(HGNC:HNF1B)) -> p(HGNC:UGT2B17)\n",
      "act(p(HGNC:HNF1B)) -> r(HGNC:UGT2B17)\n",
      "----------------------\n",
      "10032336 : Hepatocyte nuclear factor 4 (HNF4) and chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) synergistically activate transcription of the CYP7A1 promoter\n",
      "act(p(HGNC:HNF4A)) -> r(HGNC:CYP7A1)\n",
      "act(p(HGNC:NR2F2)) -> r(HGNC:CYP7A1)\n",
      "----------------------\n",
      "10010856 : In this paper, we describe a mechanism by which p21 and HOXA10 may act in concert, where HOXA10 can bind directly to the p21 promoter and, together with its trimeric partners PBX1 and MEIS1, activate p21 transcription, resulting in cell cycle arrest and differentiation.\n",
      "act(p(HGNC:HOXA10)) -> r(HGNC:CDKN1A)\n",
      "act(p(HGNC:MEIS1)) -> r(HGNC:CDKN1A)\n",
      "act(p(HGNC:PBX1)) -> r(HGNC:CDKN1A)\n",
      "----------------------\n",
      "10010860 : DNA binding assays and cell transfection experiments revealed that the bipartite core sequence of FPB (5'-ATCAATCA-3') binds the PBX1/2, PREP1, and HOXB1 proteins, and this in turn leads to promoter transactivation.\n",
      "act(p(HGNC:HOXB1)) -> r(HGNC:COL5A2)\n",
      "act(p(HGNC:PBX1)) -> r(HGNC:COL5A2)\n",
      "act(p(HGNC:PBX2)) -> r(HGNC:COL5A2)\n",
      "act(p(HGNC:PKNOX1)) -> r(HGNC:COL5A2)\n",
      "----------------------\n",
      "10032346 : In addition to Nrf2 and c-Jun, other nuclear transcription factors including Nrf1, Jun-B, and Jun-D also bind to the ARE and regulate expression and induction of NQO1 gene.\n",
      "act(p(HGNC:JUNB)) -> r(HGNC:NQO1)\n",
      "act(p(HGNC:JUND)) -> r(HGNC:NQO1)\n",
      "----------------------\n",
      "10032350 : Furthermore, activation of PPARalpha represses both c-Jun- and p65-induced transcription of the human IL-6 promoter.\n",
      "act(p(HGNC:JUN)) -> r(HGNC:IL6)\n",
      "act(p(HGNC:RELA)) -> r(HGNC:IL6)\n",
      "----------------------\n",
      "10010870 : Transcriptional interference between PPARalpha and both c-Jun and p65 occurs reciprocally, since c-Jun and p65 also inhibit PPARalpha-mediated activation of a PPAR response element-driven promoter.\n",
      "act(p(HGNC:JUN)) -| act(p(HGNC:PPARA))\n",
      "act(p(HGNC:PPARA)) -| act(p(HGNC:JUN))\n",
      "act(p(HGNC:PPARA)) -| act(p(HGNC:RELA))\n",
      "act(p(HGNC:RELA)) -| act(p(HGNC:PPARA))\n",
      "----------------------\n",
      "10032352 : indicate a direct physical and functional interplay between two negative regulators of cell proliferation, Smad3 and P/CAF.\n",
      "act(p(HGNC:KAT2B)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:SMAD3)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10032356 : ectopic overexpression of TIEG is sufficient to trigger the apoptotic cell program in these cells, which is preceded by a decrease of Bcl-2 protein levels\n",
      "act(p(HGNC:KLF10)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:KLF10)) -| r(HGNC:BCL2)\n",
      "----------------------\n",
      "10010872 : In luciferase assays, FKLF-2 activates predominantly the gamma, and to a lesser degree, the epsilon and beta globin gene promoters.\n",
      "act(p(HGNC:KLF13)) -> r(HGNC:HBB)\n",
      "act(p(HGNC:KLF13)) -> r(HGNC:HBE1)\n",
      "act(p(HGNC:KLF13)) -> r(HGNC:HBG1)\n",
      "act(p(HGNC:KLF13)) -> r(HGNC:HBG2)\n",
      "----------------------\n",
      "10010880 : Overexpression of an MafK dominant negative mutant decreased Nrf2 binding to GCS EpRE sequences, inhibited the inducible expression of GCS(h) and GCS(l) promoter/reporter transgenes, and reduced endogenous GCS gene induction\n",
      "act(p(HGNC:MAFK)) -> r(HGNC:DLD)\n",
      "act(p(HGNC:MAFK)) -> r(HGNC:GCSH)\n",
      "----------------------\n",
      "10010882 : The transcriptional activation domain of ERK5 is required for maximal MEF2 activity in response to calcium flux in T cells, and it can activate the endogenous Nur77 gene when constitutively recruited to the Nur77 promoter via MEF2 sites.\n",
      "act(p(HGNC:MAP2K5)) -> act(p(HGNC:MEF2D))\n",
      "act(p(HGNC:MEF2D)) -> r(HGNC:NR4A1)\n",
      "----------------------\n",
      "10010896 : These findings suggest that muscle regulatory factors, such as MyoD, Myf4, and Myf6, contribute to the muscle-specific expression of ACCbeta via E-boxes and the novel cis-element GCCTGTCA.\n",
      "act(p(HGNC:MYOD1)) -> r(HGNC:ACACB)\n",
      "act(p(HGNC:MYOG)) -> r(HGNC:ACACB)\n",
      "----------------------\n",
      "10010906 : Increased expression was associated with an increase in the binding of Nrf2 to electrophile response elements (EpRE) in the promoters of these genes. Nrf2 overexpression increased the activity of GCS(h) and GCS(l) promoter/reporter transgenes.\n",
      "act(p(HGNC:NFE2L2)) -> r(HGNC:DLD)\n",
      "act(p(HGNC:NFE2L2)) -> r(HGNC:GCSH)\n",
      "----------------------\n",
      "10010908 : Nrf2 regulates expression of genes encoding enzymes with antioxidant (e.g. heme oxygenase-1 (HO-1)) or xenobiotic detoxification (e.g. NAD(P)H:quinone oxidoreductase, glutathione S-transferase) functions via the stress- or antioxidant-response elements (StRE/ARE)\n",
      "act(p(HGNC:NFE2L2)) -> r(HGNC:GSTA1)\n",
      "act(p(HGNC:NFE2L2)) -> r(HGNC:NQO1)\n",
      "----------------------\n",
      "10020074 : Finally, a direct interaction between PPARgamma and NRF2 was confirmed by glutathione S-transferase pull-down assay. In conclusion, the NRF2-binding site (-98/-88) is the major promoter of 5'FL-TXS which can be suppressed by activated PPARgamma via a protein-protein interaction with NRF2 in macrophages.\n",
      "act(p(HGNC:NFE2)) -> r(HGNC:TBXAS1)\n",
      "act(p(HGNC:PPARG)) -| r(HGNC:TBXAS1)\n",
      "----------------------\n",
      "10032408 : Nkx3-1 facilitated SRF binding to the complex Nkx-binding site (NKE) of SMGA. Expression of mNkx3-1 in heterologous CV-1 fibroblasts was unable to elicit SMGA promoter activity but required the coexpression of serum response factor (SRF) to activate robust SMGA transcription. Thus, SMGA is a novel target for Nkx3-1, and the activity of Nkx3-1 on the SMGA promoter is dependent upon SRF.\n",
      "act(p(HGNC:\"NKX3-1\")) -> r(HGNC:ACTG2)\n",
      "act(p(HGNC:SRF)) -> r(HGNC:ACTG2)\n",
      "----------------------\n",
      "10010920 : Introduction of COUP-TFII to MDA-MB-435 cells resulted in reduced growth and plating efficiency. Interestingly, COUP-TFII increased the expression of cyclin D1 and p21(WAF1/CIP1) in MDA-MB-435 cells\n",
      "act(p(HGNC:NR2F2)) -| bp(GOBP:\"cell growth\")\n",
      "act(p(HGNC:NR2F2)) -> r(HGNC:CCND1)\n",
      "act(p(HGNC:NR2F2)) -> r(HGNC:CDKN1A)\n",
      "----------------------\n",
      "10010930 : We have shown that the inflammatory cytokines, interleukin-6 (IL-6) and heme-induced HO-1 gene expression, were suppressed by dexamethasone (Dex) in a sustained manner.\n",
      "act(p(HGNC:NR3C1)) -| r(HGNC:HMOX1)\n",
      "act(p(HGNC:NR3C1)) -| r(HGNC:IL6)\n",
      "----------------------\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10032432 : The mechanism for the increased protein synthesis and growth appeared to be a transcriptional upregulation of the eIF-2alpha and eIF-2beta genes.\n",
      "act(p(HGNC:NRF1)) -> r(HGNC:EIF2S1)\n",
      "act(p(HGNC:NRF1)) -> r(HGNC:EIF2S2)\n",
      "----------------------\n",
      "10032450 : Transfection of expression plasmids for Brn3a, Brn3b, and Brn3c (Pou4f1, 2, and 3) transactivated the Brn3b promoter by 3- to 10-fold in 293T cells or ND7 cells.\n",
      "act(p(HGNC:POU4F1)) -> r(HGNC:POU3F2)\n",
      "act(p(HGNC:POU4F2)) -> r(HGNC:POU3F2)\n",
      "act(p(HGNC:POU4F3)) -> r(HGNC:POU3F2)\n",
      "----------------------\n",
      "10010946 : PPARalpha activation increases plasma HDL cholesterol via the induction of hepatic apolipoprotein A-I and apolipoprotein A-II expression in humans\n",
      "act(p(HGNC:PPARA)) -> r(HGNC:APOA1)\n",
      "act(p(HGNC:PPARA)) -> r(HGNC:APOA2)\n",
      "----------------------\n",
      "10010948 : PPARalpha down-regulates hepatic apolipoprotein C-III and increases lipoprotein lipase gene expression\n",
      "act(p(HGNC:PPARA)) -| r(HGNC:APOC3)\n",
      "act(p(HGNC:PPARA)) -> r(HGNC:LPL)\n",
      "----------------------\n",
      "10032454 : Furthermore, cotransfection with either a PPAR{alpha} or a PPAR{gamma} expression vector significantly repressed both basal (P=0.002 and P=0.007, respectively) and thrombin-induced ET-1 promoter activity, an effect which was further enhanced in the presence of their respective ligands (P=0.001 and P=0.002, respectively) (Figure 5ADown and 5BDown).\n",
      "act(p(HGNC:PPARA)) -| r(HGNC:EDN1)\n",
      "act(p(HGNC:PPARG)) -| r(HGNC:EDN1)\n",
      "----------------------\n",
      "10032466 : Accumulated observations have shown, however, that activation of PPARgamma can suppress transcription of some genes, including the angiotensin AT 1 receptor ( 43 ) and endothelin-1 ( 17 ) genes\n",
      "act(p(HGNC:PPARG)) -| r(HGNC:AGTR1)\n",
      "act(p(HGNC:PPARG)) -| r(HGNC:EDN1)\n",
      "----------------------\n",
      "10032480 : Treatment of HTBE cells with retinoids that selectively bind and activate the RARalpha, beta, or gamma receptor also increased the level of CYP26 expression (Fig.4A).\n",
      "act(p(HGNC:RARA)) -> r(HGNC:CYP26A1)\n",
      "act(p(HGNC:RARB)) -> r(HGNC:CYP26A1)\n",
      "act(p(HGNC:RARG)) -> r(HGNC:CYP26A1)\n",
      "----------------------\n",
      "10032482 : RAR-, RARalpha- and RARgamma-selective agonists strongly induced mucin mRNAs in a dose-dependent manner, while the RARbeta-selective retinoid only weakly induced mucin gene expression at very high concentrations (1 microM).\n",
      "act(p(HGNC:RARA)) -> r(HGNC:MUC2)\n",
      "act(p(HGNC:RARA)) -> r(HGNC:MUC5AC)\n",
      "act(p(HGNC:RARG)) -> r(HGNC:MUC2)\n",
      "act(p(HGNC:RARG)) -> r(HGNC:MUC5AC)\n",
      "----------------------\n",
      "10032484 : transactivation activity of Nur77 was significantly inhibited by cotransfection of RARalpha or RXRalpha\n",
      "act(p(HGNC:RARA)) -| act(p(HGNC:NR4A1))\n",
      "act(p(HGNC:RXRA)) -| act(p(HGNC:NR4A1))\n",
      "----------------------\n",
      "10032494 : We demonstrated that ROR alpha is expressed in human primary smooth-muscle cells and that ectopic expression of ROR alpha1 inhibits TNFalpha-induced IL-6, IL-8 and COX-2 expression in these cells.\n",
      "act(p(HGNC:RORA)) -| r(HGNC:IL6)\n",
      "act(p(HGNC:RORA)) -| r(HGNC:IL8)\n",
      "act(p(HGNC:RORA)) -| r(HGNC:PTGS2)\n",
      "----------------------\n",
      "10010980 : TSF1 did not directly activate a Smads-dependent promoter from plasminogen activator inhibitor 1 gene, but it showed enhancement in co-operation with Smad3 and Smad4.\n",
      "act(p(HGNC:SMAD3)) -> act(p(HGNC:STK16))\n",
      "act(p(HGNC:SMAD4)) -> act(p(HGNC:STK16))\n",
      "----------------------\n",
      "10011000 : Co-transfection expression experiments in Drosophilia SL2 cells lacking endogenous Sp factors demonstrate that Sp1 and Sp3 function as activators of the MMP-2 promoter and synergize for enhanced MMP-2 activation. Overexpression of AP-2 in AP-2-deficient HepG2 cells enhances MMP-2 promoter activation.\n",
      "act(p(HGNC:SP1)) -> r(HGNC:MMP2)\n",
      "act(p(HGNC:SP3)) -> r(HGNC:MMP2)\n",
      "----------------------\n",
      "10032516 : Supershift assays showed that the transcription factors Sp2 and Sp3 are part of the complexes formed at the Sp1-3 site, and that Sp1 does not appear to be directly involved. The data indicate that complex formation is initiated at site Sp1-3, which appears to be essential for promoter activity. However, other regions of the proximal promoter may also contribute to the regulation of MAT2A gene expression.\n",
      "act(p(HGNC:SP2)) -> r(HGNC:MAT2A)\n",
      "act(p(HGNC:SP3)) -> r(HGNC:MAT2A)\n",
      "----------------------\n",
      "10007314 : CIS and SOCS-2 expression was induced either via STAT1 and/or STAT3 or via STAT5 but only STAT1 and/or STAT3 were involved in SOCS-3 expression.\n",
      "act(p(HGNC:STAT1)) -> r(HGNC:SOCS3)\n",
      "act(p(HGNC:STAT3)) -> r(HGNC:SOCS3)\n",
      "----------------------\n",
      "10019898 : Interleukin 12 (IL-12)-induced T helper 1 (Th1) development requires Stat4 activation. Using subtractive cloning, we identified ERM, an Ets transcription factor, to be a Th1-specific, IL-12-induced gene. IL-12-induction of ERM occurred in wild-type and Stat1-deficient, but not Stat4-deficient, T cells, suggesting ERM is Stat4-inducible.\n",
      "act(p(HGNC:STAT4)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "act(p(HGNC:STAT4)) -> r(HGNC:ETV5)\n",
      "----------------------\n",
      "10011022 : These data indicate that the human 12/15-lipoxygenase gene is induced in airway epithelial cells through Stat6-dependent transcriptional mechanisms mediated by a specific Stat6 response element in the 5'-flanking region\n",
      "act(p(HGNC:STAT6)) -> r(HGNC:ALOX12)\n",
      "act(p(HGNC:STAT6)) -> r(HGNC:ALOX15)\n",
      "----------------------\n",
      "10032542 : Using cotransfection experiments, we find that SPBP enhances the transcriptional activity of various transcription factors such as c-Jun, Ets1, Sp1, and Pax6. Hence, SPBP seems to act as a transcriptional coactivator.\n",
      "act(p(HGNC:TCF20)) -> act(p(HGNC:JUN))\n",
      "act(p(HGNC:TCF20)) -> act(p(HGNC:PAX6))\n",
      "act(p(HGNC:TCF20)) -> act(p(HGNC:SP1))\n",
      "----------------------\n",
      "10032550 : Further characterization of this protein has identified a family of three related genes, AP-2alpha, beta and gamma (Bosher et al., 1996). All three of these proteins, but particularly AP-2alpha and gamma, can activate the ERBB2 promoter and can be found at elevated levels in breast tumour-derived cell lines.\n",
      "act(p(HGNC:TFAP2A)) -> r(HGNC:ERBB2)\n",
      "act(p(HGNC:TFAP2C)) -> r(HGNC:ERBB2)\n",
      "----------------------\n",
      "10011030 : The suppressed genes include mainly cell cycle regulators like cyclin B1, cyclin H and kinases like c-abl, CLK1 and others.\n",
      "act(p(HGNC:TP53)) -| r(HGNC:ABL1)\n",
      "act(p(HGNC:TP53)) -| r(HGNC:CCNB1)\n",
      "act(p(HGNC:TP53)) -| r(HGNC:CCNH)\n",
      "act(p(HGNC:TP53)) -| r(HGNC:CLK1)\n",
      "----------------------\n",
      "10032558 : Endogenous bcl-2 protein level decreased 12 fold and bax increased approximately 4 fold in PC3 vector control cells following Ad-p53 infection.\n",
      "act(p(HGNC:TP53)) -> r(HGNC:BAX)\n",
      "act(p(HGNC:TP53)) -| p(HGNC:BCL2)\n",
      "----------------------\n",
      "10011052 : endogenous p73 alpha and beta proteins are up-regulated in p53-deficient tumor cells in response to overexpressed E2F1, c-Myc, and E1A. E2F1, c-Myc, and E1A-mediated p73 up-regulation leads to activation of the p73 transcription function, as shown by p73-responsive reporter activity and by induction of known endogenous p73 target gene products such as p21 and HDM2.\n",
      "act(p(HGNC:TP73)) -> r(HGNC:CDKN1A)\n",
      "act(p(HGNC:TP73)) -> r(HGNC:MDM2)\n",
      "----------------------\n",
      "10032600 : the induction of 2 other reporter genes, FPPS and LDLR, in response to cellular sterol depletion, was attenuated by coexpressed wild-type Yy1\n",
      "act(p(HGNC:YY1)) -| r(HGNC:FDPS)\n",
      "act(p(HGNC:YY1)) -| r(HGNC:LDLR)\n",
      "----------------------\n",
      "10032602 : Yy1 inhibits the transcription of specific SREBP-dependent genes and that, in the case of the HMG-CoA synthase gene, this involves displacement of nuclear factor Y from the promoter Yy1 plays a regulatory role in the transcriptional regulation of specific SREBP-responsive genes\n",
      "act(p(HGNC:YY1)) -| r(HGNC:FDPS)\n",
      "act(p(HGNC:YY1)) -| r(HGNC:HMGCS1)\n",
      "act(p(HGNC:YY1)) -| r(HGNC:HMGCS2)\n",
      "act(p(HGNC:YY1)) -| r(HGNC:LDLR)\n",
      "----------------------\n",
      "10032604 : induction was attenuated approximately 80 percent when cell were cotransfected with low levels of a plasmid encoding wild-type Yy1\n",
      "act(p(HGNC:YY1)) -| r(HGNC:HMGCS1)\n",
      "act(p(HGNC:YY1)) -| r(HGNC:HMGCS2)\n",
      "----------------------\n",
      "10032608 : Overexpression of ZNF202 m1 in RAW264.7 macrophages prevented the induction of ABCA1 gene expression by 20( S )OH-cholesterol and 9- cis -retinoic acid, further substantiating the interference of ZNF202 in critical elements of transcriptional activation......ZNF202 Binds Specific ABCA1 and ABCG1 Promotor Sequences....ZNF202m1 Represses ABCA1 and ABCG1 Promotors\n",
      "act(p(HGNC:ZNF202)) -| r(HGNC:ABCA1)\n",
      "act(p(HGNC:ZNF202)) -| r(HGNC:ABCG1)\n",
      "----------------------\n",
      "10032610 : Fig. 6. Repression of apoAIV and apoE promoters by ZNF202 m1 in HepG2 cells. ......we used several reporter constructs containing portions of the apoE and apoAIV genes; these fragments all had been shown to bind ZNF202 in gel shift experiments.\n",
      "act(p(HGNC:ZNF202)) -| r(HGNC:APOA4)\n",
      "act(p(HGNC:ZNF202)) -| r(HGNC:APOE)\n",
      "----------------------\n",
      "10032612 : Additional fragments derived from the promoters of phospholipid transfer protein and hepatic nuclear factor-4 (HNF4) and the apoCIII enhancer that had been shown to bind GST.ZF3-8 in vitro were also used in reporter assays. Transcriptional repression in the presence of ZNF202 was similar to the one observed for the apoE and apoAIV promoters (Table I)\n",
      "act(p(HGNC:ZNF202)) -| r(HGNC:APOC3)\n",
      "act(p(HGNC:ZNF202)) -| r(HGNC:HNF4A)\n",
      "act(p(HGNC:ZNF202)) -| r(HGNC:PLTP)\n",
      "----------------------\n",
      "10032616 : Th17 development from wild-type mice is suboptimal in the presence of the AhR antagonist CH-223191, similar to the situation in AhR-deficient mice, which show attenuated IL-17 production and no IL-22 production.\n",
      "act(p(MGI:Ahr)) -> bp(GOBP:\"T-helper 17 cell differentiation\")\n",
      "act(p(MGI:Ahr)) -> p(MGI:Il17a)\n",
      "act(p(MGI:Ahr)) -> p(MGI:Il22)\n",
      "----------------------\n",
      "10032632 : Therefore, testosterone and DHT regulate lineage determination in mesenchymal pluripotent cells by promoting their commitment to the myogenic lineage and inhibiting their differentiation into the adipogenic lineage through an androgen receptor-mediated pathway.\n",
      "act(p(MGI:Ar)) -| bp(GOBP:\"fat cell differentiation\")\n",
      "act(p(MGI:Ar)) -> r(MGI:Ar)\n",
      "act(p(MGI:Ar)) -| r(MGI:Cebpa)\n",
      "act(p(MGI:Ar)) -| r(MGI:Pparg)\n",
      "----------------------\n",
      "10032634 : Further analysis indicated that AR suppressed wound healing by enhancing the inflammatory response through a localized increase in TNF-alpha expression (mRNA and protein).\n",
      "act(p(MGI:Ar)) -> bp(GOBP:\"inflammatory response\")\n",
      "act(p(MGI:Ar)) -| bp(GOBP:\"wound healing\")\n",
      "act(p(MGI:Ar)) -> p(MGI:Tnf)\n",
      "act(p(MGI:Ar)) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10032636 : EPAS1 forms a heterodimeric complex with the aryl hydrocarbon nuclear transporter prior to transcriptional activation of target genes. EPAS1 expression is limited to the endothelium of mouse embryos and, in agreement with its cell type-specific expression pattern, is capable of specifically activating the transcription of the endothelial tyrosine kinase gene Tie-2.\n",
      "act(p(MGI:Arnt)) -> act(p(MGI:Epas1))\n",
      "act(p(MGI:Epas1)) -> r(MGI:Tek)\n",
      "act(p(HGNC:ARNT)) -> act(p(HGNC:EPAS1))\n",
      "----------------------\n",
      "10032638 : AR stimulation on the probasin core promoter could be partially induced with BRG1, but BRM strongly stimulated AR activity\n",
      "act(p(MGI:Ar)) -> r(MGI:Pbsn)\n",
      "act(p(MGI:Smarca2)) -> r(MGI:Pbsn)\n",
      "act(p(MGI:Smarca2)) -> act(p(MGI:Ar))\n",
      "act(p(MGI:Smarca4)) -> r(MGI:Pbsn)\n",
      "----------------------\n",
      "10032640 : Additionally, we found Arx directly repressed three of the identified transcription factors: Lmo1, Ebf3 and Shox2 {Promoter activation, ChIP and EMSA}.\n",
      "act(p(MGI:Arx)) -| r(MGI:Ebf3)\n",
      "act(p(MGI:Arx)) -| r(MGI:Lmo1)\n",
      "act(p(MGI:Arx)) -| r(MGI:Shox2)\n",
      "----------------------\n",
      "10011076 : Unexpectedly, however, MASH1 and MASH2 also activate transcription of both exogenous and endogenous MCK in transfected C3H/10T1/2 fibroblasts.\n",
      "act(p(MGI:Ascl1)) -> r(MGI:Ckm)\n",
      "act(p(MGI:Ascl2)) -> r(MGI:Ckm)\n",
      "----------------------\n",
      "10032644 : These results indicate that CREB and ATF1 act in concert to mediate signals essential for maintaining cell viability during early embryonic development.\n",
      "act(p(MGI:Atf1)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Creb1)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10011082 : Chromosomal DNA immunoprecipitation assays revealed that SMAD-3 and ATF-2 bind to the endogenous p19 promoter in RAW264.7 cells and SJL/J SPM following challenge with TMEV.\n",
      "act(p(MGI:Atf2)) -> r(MGI:Il23a)\n",
      "act(p(MGI:Smad3)) -> r(MGI:Il23a)\n",
      "----------------------\n",
      "10032654 : Activating transcription factor 2 (ATF-2) and p300 cooperate in the activation of transcription of the c-jun gene during the differentiation of F9 cells.\n",
      "act(p(MGI:Atf2)) -> r(MGI:Jun)\n",
      "act(p(MGI:Ep300)) -> r(MGI:Jun)\n",
      "----------------------\n",
      "10011084 : In addition, ATF-2 binds to the -2.4-kb element even without induction and c-Fos to the -6.9-kb element only after induction. Accordingly, overexpression of c-Fos caused induction from the -6.9-kb element, but reduced induction from the -2.4-kb element. The involvement of the Ets-2 transcription factor was shown by using expression plasmids for wild-type and dominant negative Ets-2.\n",
      "act(p(MGI:Atf2)) -> r(MGI:Plau)\n",
      "act(p(MGI:Fos)) -> r(MGI:Plau)\n",
      "----------------------\n",
      "10011092 : SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation\n",
      "act(p(MGI:Atf4)) -> bp(GOBP:\"osteoblast differentiation\")\n",
      "act(p(MGI:Runx2)) -> bp(GOBP:\"osteoblast differentiation\")\n",
      "act(p(MGI:Satb2)) -> act(p(MGI:Atf4))\n",
      "act(p(MGI:Satb2)) -> act(p(MGI:Runx2))\n",
      "----------------------\n",
      "10011094 : ATF4 increased the levels of Ocn mRNA and mOG2 promoter activity in Runx2-containing osteoblasts but not in non-osteoblastic cells that lack detectable Runx2 protein\n",
      "act(p(MGI:Atf4)) -> r(MGI:Bglap2)\n",
      "act(p(MGI:Runx2)) -> r(MGI:Bglap2)\n",
      "----------------------\n",
      "10011096 : Overexpression of ATF4 severely impaired normal development of the mammary gland, which was associated with reduced proliferation and differentiation of mammary alveolar epithelium and up-regulation of p21(WAF1) and p27(Kip1).\n",
      "act(p(MGI:Atf4)) -> r(MGI:Cdkn1a)\n",
      "act(p(MGI:Atf4)) -> r(MGI:Cdkn1a)\n",
      "act(p(MGI:Atf4)) -> r(MGI:Cdkn1b)\n",
      "act(p(MGI:Atf4)) -> r(MGI:Cdkn1b)\n",
      "----------------------\n",
      "10018232 : The UPR-mediated activation of ATF6 (Activation of Transcription Factor 6) induces cytoprotective ER stress proteins, including GRP78 and GRP94\n",
      "act(p(MGI:Atf6)) -> r(MGI:Hsp90b1)\n",
      "act(p(MGI:Atf6)) -> r(MGI:Hspa5)\n",
      "----------------------\n",
      "10032682 : Heterodimers of the small Maf proteins and NF-E2â related factor 2 (Nrf2), which belongs to the basic leucin zipper (bZip) family of transcriptional factors, activate HO-1 through binding to MAREs (16â19). In contrast, heterodimers of small Maf and Bach1 or Bach2 repress MAREdependent transcription (20).\n",
      "act(p(MGI:Bach1)) -| r(MGI:Hmox1)\n",
      "act(p(MGI:Bach2)) -| r(MGI:Hmox1)\n",
      "act(p(MGI:Nfe2l2)) -> r(MGI:Hmox1)\n",
      "----------------------\n",
      "10011110 : We identified three chemokines, MCP-1, MCP-3 and MRP-1, which are negatively regulated by BCL-6 in macrophages.\n",
      "act(p(MGI:Bcl6)) -| r(MGI:Ccl2)\n",
      "act(p(MGI:Bcl6)) -| r(MGI:Ccl6)\n",
      "act(p(MGI:Bcl6)) -| r(MGI:Ccl7)\n",
      "----------------------\n",
      "10011116 : Although expression of the early marker CCAAT/enhancer binding protein beta (C/EBPbeta) is not altered, its crucial downstream targets C/EBPalpha and peroxisome proliferator-activated receptor gamma (PPARgamma) are downregulated by SHARP1.\n",
      "act(p(MGI:Bhlhe41)) -| r(MGI:Cebpa)\n",
      "act(p(MGI:Bhlhe41)) -| r(MGI:Pparg)\n",
      "----------------------\n",
      "10032710 : Experiments designed to uncover the potential role of LXR alpha in adipogenesis revealed that this transcription factor, unlike CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma, is not adipogenic but rather inhibits adipogenesis if inappropriately expressed and activated. However, LXR alpha has several important roles in adipocyte function.\n",
      "act(p(MGI:Cebpa)) -> bp(GOBP:\"fat cell differentiation\")\n",
      "act(p(MGI:Nr1h3)) -| bp(GOBP:\"fat cell differentiation\")\n",
      "act(p(MGI:Pparg)) -> bp(GOBP:\"fat cell differentiation\")\n",
      "----------------------\n",
      "10011132 : Introduction of an inducible C/EBP alpha gene into the line revealed that conditional expression of C/EBP alpha induced the C/EBP family members C/EBP beta and C/EBP epsilon\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Cebpb)\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Cebpe)\n",
      "----------------------\n",
      "10032722 : There was also dramatically reduced expression of some adipocyte genes, such as those encoding leptin and adipsin, while others like Glut4 and Fabp4 were not altered.\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Cfd)\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Lep)\n",
      "----------------------\n",
      "10032726 : The most potent inducer of the HO-1 promoter was C/EBPa (3.4-fold; P 0.05), followed to a lesser extent by C/EBPd (2.0-fold) and no significant induction by C/EBPb (Fig. 7B).\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Hmox1)\n",
      "act(p(MGI:Cebpd)) -> r(MGI:Hmox1)\n",
      "----------------------\n",
      "10011138 : CCAAT/enhancer-binding protein site (C/EBP, -1344 to -1305) which interacts with C/EBPalpha and C/EBPbeta factors. The latter factors control the transcription of the ITIH3 gene positively.\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Itih3)\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Itih3)\n",
      "----------------------\n",
      "10011140 : Furthermore, ectopic expression of ADD1/SREBP1c by adenovirus significantly increased the expression of resistin mRNA in adipocytes. Human resistin promoter was also activated by C/EBP alpha expression\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Retn)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Retn)\n",
      "----------------------\n",
      "10011142 : C/EBPalpha and C/EBPdelta activate the Clara cell secretory protein gene through interaction with two adjacent C/EBP-binding sites\n",
      "act(p(MGI:Cebpa)) -> r(MGI:Scgb1a1)\n",
      "act(p(MGI:Cebpd)) -> r(MGI:Scgb1a1)\n",
      "----------------------\n",
      "10032734 : Our data show a 25% increase in both mRNA levels for PDE3A and PDE3B and a 25% increase in PDE activity in the livers of fasted C/EBPb-/- mice\n",
      "act(p(MGI:Cebpb)) -| act(p(MGI:Pde3a))\n",
      "act(p(MGI:Cebpb)) -| act(p(MGI:Pde3b))\n",
      "act(p(MGI:Cebpb)) -| r(MGI:Pde3a)\n",
      "act(p(MGI:Cebpb)) -| r(MGI:Pde3b)\n",
      "----------------------\n",
      "10032736 : after Bleomycin treatment, C/EBPbwt mice had moderate to severe lung fibrosis (mean score 2.8+/20.4; n: 10) compared to controls , while C/EBPb-Ala217 mice of the same genetic background had mild or moderate lung fibrosis (mean score: 1.5+/20.5; n: 10; P,0.001; Wilcoxon U Test)\n",
      "act(p(MGI:Cebpb)) -> path(MESHD:Fibrosis)\n",
      "act(p(HGNC:CEBPB)) -> path(MESHD:Fibrosis)\n",
      "----------------------\n",
      "10032738 : the protein expression of lung fibrogenic indicators a- SMA, present in activated myofibroblasts (NM_007392.2) and TGF-b1, a fibrogenic cytokine [27] (NM_009370.2) were induced by Bleomycin in C/EBPbwt mice ,5-fold (n: 7 per group; a-SMA: 5.2+/20.3, P,0.0001; TGF-b1: 5.9+/20.3 P,0.0001) but not in C/EBPb-Ala217 mice (n: 6 per group; a-SMA: 1.2+/20.2, P = 0.15; TGF-b1: 0.7+/20.2, P = 0.013)\n",
      "act(p(MGI:Cebpb)) -> p(MGI:Acta2)\n",
      "act(p(MGI:Cebpb)) -> p(MGI:Tgfb1)\n",
      "act(p(HGNC:CEBPB)) -> p(HGNC:TGFB1)\n",
      "----------------------\n",
      "10032742 : These gain-of-function studies have demonstrated the sufficiency of these proteins for adipogenesis, and combined with the temporal sequence of the appearance of these factors already mentioned, suggests a transcriptional cascade whereby C/EBPb and d induce PPARg and C/EBPa, which in turn promote the terminally differentiated state.\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Cebpa)\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Pparg)\n",
      "act(p(MGI:Cebpd)) -> r(MGI:Cebpa)\n",
      "act(p(MGI:Cebpd)) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10032744 : Pointing to a direct regulatory role for XBP1 in vivo, XBP1 was enriched on the Cebpa promoter on d4 (Figure 4D); this binding was comparable with that of C/EBPbeta on d4 and was completely abolished in XBP1i 3T3-L1 cells (Figures 4D and S4B).\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Cebpa)\n",
      "act(p(MGI:Xbp1)) -> r(MGI:Cebpa)\n",
      "----------------------\n",
      "10032746 : presence of type 1 Il6R, which is a binding site for NF-IL-6, IL-6DBP, and CEBPbeta has been confirmed in the genes for CRP, hemoplexin A and haptoglobin binding activity of NF-IL-6 is probably induced by Il6 through the increased expression of the NF-IL-6 gene\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Crp)\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Hp)\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Hpx)\n",
      "----------------------\n",
      "10032748 : Mouse embryo fibroblasts nullizygous for C/EBPbeta had a proliferative advantage over cells with one or two functional copies of this gene. C/EBP inhibition enhanced the expression of the three major components of AP-1 in cycling CEF, namely c-Jun, JunD, and Fra-2, and stimulated AP-1 activity. In contrast, the over-expression of C/EBPbeta caused a dramatic reduction in the levels of AP-1 proteins.\n",
      "act(p(MGI:Cebpb)) -| r(MGI:Fosl2)\n",
      "act(p(MGI:Cebpb)) -| r(MGI:Jun)\n",
      "act(p(MGI:Cebpb)) -| r(MGI:Jund)\n",
      "----------------------\n",
      "10011152 : We here report that the NFkappaB and C/EBP beta controlled gene IL6 is upregulated in DDIT3- and FUS-DDIT3-expressing fibrosarcoma cell lines\n",
      "act(p(MGI:Cebpb)) -> r(MGI:Il6)\n",
      "act(p(MGI:Ddit3)) -> r(MGI:Il6)\n",
      "----------------------\n",
      "10032764 : Interestingly, the anti-apoptotic proteins Bcl-2 and Bcl-x were clearly down-regulated after induction of C/EBPE activity in LG/CEBPE-ER cells even though the cells were being cultured in IL-3.\n",
      "act(p(MGI:Cebpe)) -| p(MGI:Bcl2)\n",
      "act(p(MGI:Cebpe)) -| p(MGI:Bcl2l1)\n",
      "----------------------\n",
      "10032766 : The most striking difference induced by C/EBPE-ER induction is the robust up-regulation of p27. In sharp contrast, cyclin D2, cyclin A, cyclin E, cdk4, and cdk6 were clearly down-regulated after 4 days of 4-HT treatment.\n",
      "act(p(MGI:Cebpe)) -| p(MGI:Ccnd2)\n",
      "act(p(MGI:Cebpe)) -| p(MGI:Cdk4)\n",
      "act(p(MGI:Cebpe)) -| p(MGI:Cdk6)\n",
      "act(p(MGI:Cebpe)) -> p(MGI:Cdkn1b)\n",
      "----------------------\n",
      "10032772 : Cited2(-/-) mice lack expression of the Nodal target genes Pitx2c, Nodal and Ebaf in the left lateral plate mesoderm, where they are required for establishing laterality and cardiovascular development. CITED2 and TFAP2 were detected at the Pitx2c promoter in embryonic hearts, and they activate Pitx2c transcription in transient transfection assays\n",
      "act(p(MGI:Cited2)) -> r(MGI:Lefty2)\n",
      "act(p(MGI:Cited2)) -> r(MGI:Nodal)\n",
      "act(p(MGI:Cited2)) -> r(MGI:Pitx2)\n",
      "----------------------\n",
      "10011168 : CITED2 acted as a dose-dependent coactivator of PPARalpha-dependent transcriptional regulation in the presence of several exogenous ligands. CITED2 also increased PPARgamma-dependent regulation of reporter genes but had no effect on PPARbeta activity\n",
      "act(p(MGI:Cited2)) -> act(p(MGI:Ppara))\n",
      "act(p(MGI:Cited2)) -> act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10032790 : cAMP response unit of the Cpt1a gene is composed of a cAMP-response element motif and a Dr1 sequence located upstream of the transcription start site the coactivator Pgc-1 is involved in the regulation of this gene expression by cAMP in conbination with Hnf4 alpha and Creb\n",
      "act(p(MGI:Creb1)) -> r(MGI:Cpt1a)\n",
      "act(p(MGI:Hnf4a)) -> r(MGI:Cpt1a)\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Cpt1a)\n",
      "----------------------\n",
      "10032802 : The transcription factors implicated to date in regulation of the Mitf promoter include Pax3, CREB, Sox10, and Lef1 (Fig. 2A), with each factor able to confer on the Mitf promoter the capacity to respond to specific signals.\n",
      "act(p(MGI:Creb1)) -> r(MGI:Mitf)\n",
      "act(p(MGI:Lef1)) -> r(MGI:Mitf)\n",
      "act(p(MGI:Pax3)) -> r(MGI:Mitf)\n",
      "act(p(MGI:Sox10)) -> r(MGI:Mitf)\n",
      "----------------------\n",
      "10011182 : % Overexpressions of CREB and c-Jun, but not c-Fos, also significantly increased the promoter activity, which suggests that CREB and c-Jun are the crucial transcription factors involved in regulating nectin-2 gene transcription.\n",
      "act(p(MGI:Creb1)) -> r(MGI:Pvrl2)\n",
      "act(p(MGI:Fos)) -> r(MGI:Pvrl2)\n",
      "act(p(MGI:Jun)) -> r(MGI:Pvrl2)\n",
      "----------------------\n",
      "10032810 : from full ext - Figure 2 (DâF) Transient transfection assays showing that Gal-HIF-1a function is reduced in MEFs with multiple DCH1 alleles (mean7s.e.m., NÂ¼3) (D), and can be rescued by WT CBP (E, F) or p300 (F), but not by CBPDCH1 (E) (mean7s.e.m., NÂ¼2â4). (G, H) Transactivation by factors utilizing other domains of p300 and CBP or other coactivators is unimpaired (mean7s.d., NÂ¼4).\n",
      "act(p(MGI:Crebbp)) -> act(p(MGI:Hif1a))\n",
      "act(p(MGI:Ep300)) -> act(p(MGI:Hif1a))\n",
      "act(p(HGNC:CREBBP)) -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10011188 : We find that C/ebpalpha is derepressed in Klf3 and Ctbp knockout fibroblasts and adipocytes from Klf3 knockout mice.\n",
      "act(p(MGI:Ctbp1)) -> r(MGI:Cebpa)\n",
      "act(p(MGI:Klf3)) -> r(MGI:Cebpa)\n",
      "----------------------\n",
      "10032820 : Surplus ??catenin then translocates to the nucleus, interacts with the LEF and TCF transcription factors, and persistently transactivates genes associated with the regulation of cell proliferation, such as MYC and cyclin D1 (Refs 30,32,106,135â137).\n",
      "act(p(MGI:Ctnnb1)) -> r(MGI:Ccnd1)\n",
      "act(p(MGI:Ctnnb1)) -> r(MGI:Myc)\n",
      "----------------------\n",
      "10032836 : Our studies further show regulation of the Runx2 gene by several homeodomain proteins: MSX2 and CDP/cut repress whereas DLX3 and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.\n",
      "act(p(MGI:Cux1)) -| r(MGI:Runx2)\n",
      "act(p(MGI:Dlx3)) -> r(MGI:Runx2)\n",
      "act(p(MGI:Dlx5)) -> r(MGI:Runx2)\n",
      "act(p(MGI:Msx2)) -| r(MGI:Runx2)\n",
      "----------------------\n",
      "10018220 : In accordance with published results (18), amino acid depletion induced CA-VI and advillin mRNA in NIH-3T3 cells in a CHOP-dependent manner.\n",
      "act(p(MGI:Ddit3)) -> r(EGID:765)\n",
      "act(p(MGI:Ddit3)) -> r(MGI:Avil)\n",
      "----------------------\n",
      "10032854 : Expression of either E2F1 or E2F2 can induce postmitotic lens fiber cells to re-enter the cell cycle.\n",
      "act(p(MGI:E2f1)) -> bp(GOBP:\"cell cycle\")\n",
      "act(p(MGI:E2f2)) -> bp(GOBP:\"cell cycle\")\n",
      "----------------------\n",
      "10032858 : Bcl-2 homology 3 (BH3)-only proteins are pro-apoptotic members of the Bcl-2 protein family that trigger apoptosis in response to diverse stimuli. We show here that E2F1 up-regulates the expression of the pro-apoptotic BH3-only proteins PUMA, Noxa, Bim, and Hrk/DP5 through a direct transcriptional mechanism.\n",
      "act(p(MGI:E2f1)) -> r(MGI:Bbc3)\n",
      "act(p(MGI:E2f1)) -> r(MGI:Bcl2l11)\n",
      "act(p(MGI:E2f1)) -> r(MGI:Hrk)\n",
      "act(p(MGI:E2f1)) -> r(MGI:Pmaip1)\n",
      "----------------------\n",
      "10032862 : Subsets of E2Fs were specifically bound to the Dmp1 promoter upon mitogenic signaling and E2Fs 1-4 inhibited the Dmp1 promoter in a reporter assay.\n",
      "act(p(MGI:E2f1)) -| r(MGI:Dmtf1)\n",
      "act(p(MGI:E2f2)) -| r(MGI:Dmtf1)\n",
      "act(p(MGI:E2f3)) -| r(MGI:Dmtf1)\n",
      "act(p(MGI:E2f4)) -| r(MGI:Dmtf1)\n",
      "----------------------\n",
      "10032868 : In both the E2F3a and E2F4 transgenic lenses, cyclin A2 and cyclin B1 expression were upregulated. E2F3a and E2F4, but not E2F5, function to induce cell cycle entry, although E2F4 has more modest activity.\n",
      "act(p(MGI:E2f4)) -> bp(GOBP:\"cell cycle\")\n",
      "act(p(MGI:E2f4)) -> r(MGI:Ccna2)\n",
      "act(p(MGI:E2f4)) -> r(MGI:Ccnb1)\n",
      "----------------------\n",
      "10011230 : Reconstitution of primary leukemia cells showed that these tumors express high densities of the B-cell surface proteins CD19 and CD38, which are EBF targets.\n",
      "act(p(MGI:Ebf1)) -> p(MGI:Cd19)\n",
      "act(p(MGI:Ebf1)) -> p(MGI:Cd38)\n",
      "act(p(MGI:Ebf1)) -> r(MGI:Cd19)\n",
      "act(p(MGI:Ebf1)) -> r(MGI:Cd38)\n",
      "----------------------\n",
      "10032886 : provide newinsights of Egr1 involvement in proliferation and survival of TRAMP C2 prostatecancer cells by the identification of several new target genes controllinggrowth, cell cycle progression, and apoptosis such as cyclin D2, P19ink4d, andFas.\n",
      "act(p(MGI:Egr1)) -> r(MGI:Ccnd2)\n",
      "act(p(MGI:Egr1)) -> r(MGI:Cdkn2d)\n",
      "act(p(MGI:Egr1)) -> r(MGI:Fas)\n",
      "----------------------\n",
      "10032888 : Egr-1 has been characterized as a transcriptional regulator of both PDGF-A and PDGF-C gene expression (18, 19).\n",
      "act(p(MGI:Egr1)) -> r(MGI:Pdgfa)\n",
      "act(p(MGI:Egr1)) -> r(MGI:Pdgfc)\n",
      "----------------------\n",
      "10029414 : promoter for the Fas ligand, which has been implicated as a target gene for Egr2 and Egr3, demonstrated robust NAB coactivation similar to Lhb\n",
      "act(p(MGI:Egr2)) -> r(MGI:Fasl)\n",
      "act(p(MGI:Egr3)) -> r(MGI:Fasl)\n",
      "----------------------\n",
      "10032896 : Both the model promoter and the macrophage-specific mouse and human c-fms promoters were activated in RAW264 cells by other Ets family transcription factors, Ets-2 and Elf-1.\n",
      "act(p(MGI:Elf1)) -> r(MGI:Csf1r)\n",
      "act(p(MGI:Ets2)) -> r(MGI:Csf1r)\n",
      "----------------------\n",
      "10032902 : In the absence of PGN (Fig. 5, open bars), Elk-1 and Ets-2 were the most potent inducers of the HO-1 promoter (P < 0.05; Fig. 5A).\n",
      "act(p(MGI:Elk1)) -> r(MGI:Hmox1)\n",
      "act(p(MGI:Ets2)) -> r(MGI:Hmox1)\n",
      "----------------------\n",
      "10032906 : In normoxia, at 0 h, Net is a transcriptional repressor of PAI-1, c-fos, and egr-1 and an activator of VEGF (Fig. 7B, panel a),\n",
      "act(p(MGI:Elk3)) -| r(MGI:Egr1)\n",
      "act(p(MGI:Elk3)) -| r(MGI:Fos)\n",
      "act(p(MGI:Elk3)) -| r(MGI:Serpine1)\n",
      "act(p(MGI:Elk3)) -> r(MGI:Vegfa)\n",
      "----------------------\n",
      "10032914 : It has been shown that EOMES directly regulates expression of perforin (PRF1), granzyme B (GZMB), and IFN ? (IFNG), and promotes effector function in CD8 T cells (5)\n",
      "act(p(MGI:Eomes)) -> r(MGI:Gzmb)\n",
      "act(p(MGI:Eomes)) -> r(MGI:Ifng)\n",
      "act(p(MGI:Eomes)) -> r(MGI:Prf1)\n",
      "----------------------\n",
      "10032918 : a minimum amount of aP2 and PPARgamma2 mRNA was induced in the EPAS1-(1-485) cells. , minimum amounts of PPAR{gamma}2 and C/EBP family were induced in the EPAS1(1-485)-expressing cells\n",
      "act(p(MGI:Epas1)) -> r(MGI:Cebpa)\n",
      "act(p(MGI:Epas1)) -> r(MGI:Cebpb)\n",
      "act(p(MGI:Epas1)) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10032924 : Overexpression of EPAS1(1-485) in 3T3-L1 adipocytes dramatically suppressed the expression of GLUT1, GLUT4, and IRS3 EPAS1 activates the promoter activity of GLUT1 (A), GLUT4 (B), and IRS3\n",
      "act(p(MGI:Epas1)) -> r(MGI:Irs3)\n",
      "act(p(MGI:Epas1)) -> r(MGI:Slc2a1)\n",
      "act(p(MGI:Epas1)) -> r(MGI:Slc2a4)\n",
      "----------------------\n",
      "10032930 : RNA levels for TCR{beta}, IFN-{gamma}, TNF-alpha, and lymphotoxin-alpha were strongly up-regulated within the spinal cord of ERalpha-{Delta}2-/- mice and their WT littermate controls. Interestingly, while E2 treatment abolished the expression of these transcripts to nearly basal levels in ERalpha-{Delta}2+/+ mice, it had no effect in ERalpha-{Delta}2-/- mice for both doses of E2 tested.\n",
      "act(p(MGI:Esr1)) -| r(EGID:100124672)\n",
      "act(p(MGI:Esr1)) -| r(MGI:Ifng)\n",
      "act(p(MGI:Esr1)) -| r(MGI:Lta)\n",
      "act(p(MGI:Esr1)) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10032940 : In addition, the dehydrogenase Mthfd2 (cluster M), which may provide the formyltetrahydrofolate for formylmethionyl-tRNA synthesis, was also induced (75).\n",
      "act(p(MGI:Esr1)) -> r(MGI:Mthfd2)\n",
      "act(p(MGI:Esr2)) -> r(MGI:Mthfd2)\n",
      "----------------------\n",
      "10032944 : From text: In addition, medium-chain acyl-CoA dehydrogenase (MCAD), a known PPARalpha target that catalyzes the initial step in mitochodrial fatty acid beta-oxidation, is also regulated by ERRalpha (Sladek et al. 1997; Vega and Kelly 1997; Huss et al 2002).\n",
      "act(p(MGI:Esrra)) -> bp(GOBP:\"fatty acid oxidation\")\n",
      "act(p(MGI:Ppara)) -> bp(GOBP:\"fatty acid oxidation\")\n",
      "----------------------\n",
      "10032952 : The fP-2 segment, with a second Sp1 binding site, a CAAT box and putative specific binding sites for myeloid zinc finger protein 1 (MZF1), acute myeloid leukemia 1a (AML-1a) and cellular progenitor of viral oncogene from E26 acute leukemia retrovirus (c-Ets-1) produced about twice as much luciferase activity as fP-4.\n",
      "act(p(MGI:Ets1)) -> r(MGI:Flot1)\n",
      "act(p(MGI:Mzf1)) -> r(MGI:Flot1)\n",
      "----------------------\n",
      "10003484 : Ets-1 and Ets-2 both induce HO-1 promoter activity; however, Ets-2 was a more potent transactivator of HO-1 in macrophages.\n",
      "act(p(MGI:Ets1)) -> r(MGI:Hmox1)\n",
      "act(p(MGI:Ets2)) -> r(MGI:Hmox1)\n",
      "----------------------\n",
      "10032956 : the COUP-TFII promoter activity is indeed regulated by Ets-1 Ets-1 to enhance the COUP-TFII promoter activity. Furthermore, other members of the ETS family such as Ets-2 or ETV1 are also potent regulators of the COUP-TFII promoter.\n",
      "act(p(MGI:Ets1)) -> r(MGI:Nr2f2)\n",
      "act(p(MGI:Ets2)) -> r(MGI:Nr2f2)\n",
      "act(p(MGI:Etv1)) -> r(MGI:Nr2f2)\n",
      "----------------------\n",
      "10011296 : By comparing S100A8 and S100A9 mRNA levels in wild type and c-Fos deficient mice (c-fos(-/-)) we found that expression is negatively regulated by c-Fos/AP-1.\n",
      "act(p(MGI:Fos)) -| r(MGI:S100a8)\n",
      "act(p(MGI:Fos)) -| r(MGI:S100a9)\n",
      "----------------------\n",
      "10011302 : induction of DN-Foxa2 also reduces the expression of beta-cell K(ATP) channel subunits Sur1 and Kir6.2 by 70%.\n",
      "act(p(MGI:Foxa2)) -| r(MGI:Abcc8)\n",
      "act(p(MGI:Foxa2)) -| r(MGI:Kcnj11)\n",
      "----------------------\n",
      "10011304 : The expression of insulin and islet amyloid polypeptide is markedly suppressed after induction of Foxa2, while the glucagon mRNA levels are significantly increased.\n",
      "act(p(MGI:Foxa2)) -> r(MGI:Gcg)\n",
      "act(p(MGI:Foxa2)) -| r(MGI:Iapp)\n",
      "act(p(MGI:Foxa2)) -| r(MGI:Ins2)\n",
      "----------------------\n",
      "10011306 : loss of Foxa2 function leads to up-regulation of hexokinase (HK) I and II and glucokinase (HK-IV) mRNA expression.\n",
      "act(p(MGI:Foxa2)) -| r(MGI:Gck)\n",
      "act(p(MGI:Foxa2)) -| r(MGI:Hk1)\n",
      "act(p(MGI:Foxa2)) -| r(MGI:Hk2)\n",
      "----------------------\n",
      "10032984 : Foxa2 occupied its binding sites in all three target genes... Therefore, the decreased activation of the PEPCK, TAT, and IGFBP-1 genes in Foxa2-deficient hepatocytes that we observed solely in the fasted state (Figure 2) indicates that Foxa2 is essential to the transcriptional response to food deprivation.\n",
      "act(p(MGI:Foxa2)) -> r(MGI:Igfbp1)\n",
      "act(p(MGI:Foxa2)) -> r(MGI:Pck1)\n",
      "act(p(MGI:Foxa2)) -> r(MGI:Tat)\n",
      "----------------------\n",
      "10032998 : This element contains three binding sites for the transcription factor FAST. The FAST binding sites function as Nodal-responsive elements and are sufficient for the initiation but not for the maintenance of asymmetric expression. The maintenance requires an Nkx2-5 binding site also present within the ASE\n",
      "act(p(MGI:Foxh1)) -> r(MGI:Pitx2)\n",
      "act(p(MGI:\"Nkx2-5\")) -> r(MGI:Pitx2)\n",
      "----------------------\n",
      "10011334 : Disinhibition of the forkhead transcription factor FoxO1, increases expression of the biliary cholesterol transporters Abcg5 and Abcg8, resulting in an increase in biliary cholesterol secretion.\n",
      "act(p(MGI:Foxo1)) -> r(MGI:Abcg5)\n",
      "act(p(MGI:Foxo1)) -> r(MGI:Abcg8)\n",
      "act(p(MGI:Foxo1)) -> tloc(a(CHEBI:cholesterol))\n",
      "----------------------\n",
      "10011338 : Remarkably, Foxo1 interacted with SHP in vivo and in vitro, which led to the repression of Foxo1-mediated G6Pase transcription by competition with a coactivator cAMP response element-binding protein-binding protein. These findings reveal a novel mechanism by which bile acids regulate gluconeogenic gene expression via an SHP-dependent regulatory pathway.\n",
      "act(p(MGI:Foxo1)) -> r(MGI:G6pc)\n",
      "act(p(MGI:Nr0b2)) -| act(p(MGI:Foxo1))\n",
      "----------------------\n",
      "10033028 : We show that Foxp1 and Foxp2 act as transcriptional repressors that are able to repress the mouse CC10 and human SP-C promoters to differing degrees.\n",
      "act(p(MGI:Foxp2)) -| r(MGI:Scgb1a1)\n",
      "act(p(MGI:Foxp2)) -| r(MGI:Sftpc)\n",
      "----------------------\n",
      "10033042 : Blocking both ERK and JNK/SAPK pathways abolishes the DSE induction. Our data suggest that GABP is targeted by signaling events from both ERK and JNK/SAPK pathways. GABP therefore is a candidate for signal integration and regulation of IL-2 transcription in T lymphocytes.\n",
      "act(p(MGI:Gabpa)) -> r(MGI:Il2)\n",
      "act(p(MGI:Gabpb1)) -> r(MGI:Il2)\n",
      "----------------------\n",
      "10011352 : \\\"Supershift\\\" analysis indicated that the protein-probe complexes detected by electrophoretic mobility shift assays contain GABP. Endogenous GABP bound to Skp2 promoter element in a cell cycle-dependent manner. Furthermore, overexpression of GABPbeta increased Skp2 promoter activity, and suppression of GABPalpha or GABPbeta by a small interfering RNA resulted in the reduction of Skp2 promoter activity.\n",
      "act(p(MGI:Gabpa)) -> r(MGI:Skp2)\n",
      "act(p(MGI:Gabpb1)) -> r(MGI:Skp2)\n",
      "----------------------\n",
      "10011354 : Double-point mutant analysis indicated a major role for the NRF2/GABP site in the enhancer capacity of this element in brown fat cells. It is proposed that NRF2/GABP plays a pivotal role in the co-ordinated enhancement of OXPHOS gene expression associated with mitochondrial biogenesis in brown adipocyte differentiation.\n",
      "act(p(MGI:Gabpb2)) -> r(MGI:Actb)\n",
      "act(p(MGI:Gabpb2)) -> r(MGI:Cox4i1)\n",
      "act(p(MGI:Gabpb2)) -> r(MGI:\"mt-Co2\")\n",
      "act(p(MGI:Gabpb2)) -> r(MGI:Ucp1)\n",
      "----------------------\n",
      "10033046 : GATA-1 inhibited expression of cyclin-dependent kinase (Cdk) 6 and cyclin D2 and induced the Cdk inhibitors p18(INK4C) and p27(Kip1) with associated inactivation of all G(1) Cdks.\n",
      "act(p(MGI:Gata1)) -| r(MGI:Ccnd2)\n",
      "act(p(MGI:Gata1)) -| r(MGI:Cdk6)\n",
      "act(p(MGI:Gata1)) -> r(MGI:Cdkn1b)\n",
      "act(p(MGI:Gata1)) -> r(MGI:Cdkn2c)\n",
      "----------------------\n",
      "10033048 : FOG-1 stimulates GATA-1-dependent alphaIIb gene expression in a manner that requires their direct physical interaction.\n",
      "act(p(MGI:Gata1)) -> r(MGI:Itga2b)\n",
      "act(p(MGI:Zfpm1)) -> r(MGI:Itga2b)\n",
      "act(p(MGI:Zfpm1)) -> act(p(MGI:Gata1))\n",
      "act(p(HGNC:ZFPM1)) -> act(p(HGNC:GATA1))\n",
      "----------------------\n",
      "10033054 : These effects were dependent on GATA-1-mediated repression of the c-myc (Myc) proto-oncogene. GATA-1 inhibited Myc expression within 3 h, and chromatin immunoprecipitation studies indicated that GATA-1 occupies the Myc promoter in vivo, suggesting a direct mechanism for gene repression.\n",
      "act(p(MGI:Gata1)) -| r(MGI:Myc)\n",
      "act(p(MGI:Myc)) -> r(MGI:Ccnd2)\n",
      "act(p(MGI:Myc)) -> r(MGI:Cdk6)\n",
      "----------------------\n",
      "10033056 : Moreover, GATA-1 transactivated the Stat1 promoter in luciferase reporter assays (Supplemental Figure 1). STAT1 and IRF-1 reciprocally activated each otherâs transcription, as previously reported (Figure ?(Figure1D1D and Supplemental Table 1; also reviewed in ref. 26).\n",
      "act(p(MGI:Gata1)) -> r(MGI:Stat1)\n",
      "act(p(MGI:Irf1)) -> r(MGI:Stat1)\n",
      "act(p(MGI:Stat1)) -> r(MGI:Irf1)\n",
      "----------------------\n",
      "10011358 : In vitro deletion of Gata3 diminished both interleukin 4 (IL-4)-dependent and IL-4-independent T(H)2 cell differentiation; without GATA-3, T(H)1 differentiation occurred in the absence of IL-12 and interferon-gamma.\n",
      "act(p(MGI:Gata3)) -| bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "act(p(MGI:Gata3)) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "----------------------\n",
      "10011372 : GATA protein consensus sequence in the proximal MLC3 promoter but not the MLC1 promoter binds with high affinity to GATA-4, a cardiac muscle- and gut-specific transcription factor. Mutation of either the MEF2 or GATA motifs in the MLC3 promoter attenuates its activity in both heart and skeletal muscles, demonstrating that MLC3 expression in these two diverse muscle types is dependent on common regulatory elements.\n",
      "act(p(MGI:Gata4)) -> r(MGI:Myl3)\n",
      "act(p(MGI:Mef2a)) -> r(MGI:Myl3)\n",
      "----------------------\n",
      "10011376 : Mice lacking Gfi1 show reduced thymic cellularity due to an increased cell death rate, lack of proliferation, and a differentiation block\n",
      "act(p(MGI:Gfi1)) -| bp(GOBP:\"cell death\")\n",
      "act(p(MGI:Gfi1)) -> bp(GOBP:\"cell differentiation\")\n",
      "act(p(MGI:Gfi1)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10033078 : Absence of Gfi1 correlates with high level expression of the genes for lung Kruppel-like factor (LKLF), inhibitor of DNA binding (Id)1 and Id2\n",
      "act(p(MGI:Gfi1)) -| r(MGI:Id1)\n",
      "act(p(MGI:Gfi1)) -| r(MGI:Id2)\n",
      "act(p(MGI:Gfi1)) -| r(MGI:Klf2)\n",
      "----------------------\n",
      "10011386 : Dominant-negative and RNAi-mediated knockdown experiments indicate that BEN can both positively and negatively regulate IgH promoter activity, depending on the cell line.\n",
      "act(p(MGI:Gtf2ird1)) -> r(EGID:111507)\n",
      "act(p(MGI:Gtf2ird1)) -| r(EGID:111507)\n",
      "----------------------\n",
      "10033088 : Our detailed investigation showed that both Cyclin D1 and c-MYC expression was extinguished upon HBP1 expression.\n",
      "act(p(MGI:Hbp1)) -| p(MGI:Myc)\n",
      "act(p(MGI:Hbp1)) -| r(MGI:Ccnd1)\n",
      "----------------------\n",
      "10017948 : For example, aging decreases the stability of hypoxia-inducible factor 1? (HIF-1? )âa transcription factor that mediates the adaptive response to hypoxiaâ resulting in decreased expression of stromalcell- derived factor and vascular endothelial growth factor.65,66\n",
      "act(p(MGI:Hif1a)) -> p(MGI:Cxcl12)\n",
      "act(p(MGI:Hif1a)) -> p(MGI:Vegfa)\n",
      "----------------------\n",
      "10011414 : We show that Npt1 and Npt4 genes were expressed at reduced levels in the kidneys of HNF1alpha -/- mice,\n",
      "act(p(MGI:Hnf1a)) -> r(MGI:Slc17a1)\n",
      "act(p(MGI:Hnf1a)) -> r(MGI:Slc17a3)\n",
      "----------------------\n",
      "10011418 : By using reporter assays and chromatin immunoprecipitations, we showed that HNF4alpha and surprisingly, NF-E2, enhanced the mAbcc6 promoter activity.\n",
      "act(p(MGI:Hnf4a)) -> r(MGI:Abcc6)\n",
      "act(p(MGI:Nfe2)) -> r(MGI:Abcc6)\n",
      "----------------------\n",
      "10011432 : Western blots showed that siRNA-down regulation of Hoxb-5 led to decreased tenascin-C and FGF10 and was associated with increased Hoxb-4 and decreased Hoxb-6 protein levels.\n",
      "act(p(MGI:Hoxb5)) -> r(MGI:Fgf10)\n",
      "act(p(MGI:Hoxb5)) -> r(MGI:Tnc)\n",
      "----------------------\n",
      "10033156 : Fig. 5. Identification of genes differentially expressed in HOXC13 overexpressing skin upregulated\n",
      "act(p(MGI:Hoxc13)) -> r(MGI:Itm2b)\n",
      "act(p(MGI:Hoxc13)) -> r(MGI:Krt1)\n",
      "act(p(MGI:Hoxc13)) -> r(MGI:Stfa3)\n",
      "act(p(MGI:Hoxc13)) -> r(MGI:Ywhab)\n",
      "----------------------\n",
      "10033172 : including the putative Sp1 transcription factor (Sp1) and zinc finger protein, subfamily 1a, 1 (Ikaros) (Lyf-1) binding sites led to only basal transcription.\n",
      "act(p(MGI:Ikzf1)) -> r(MGI:Flot1)\n",
      "act(p(MGI:Sp1)) -> r(MGI:Flot1)\n",
      "----------------------\n",
      "10033180 : Both the 65-kDa family members, mGBP-2 and mag-2, were absolutely IRF-1 dependent, as documented elsewhere also for the promoters of mGBP-1 and mGBP-2\n",
      "act(p(MGI:Irf1)) -> r(MGI:Gbp2)\n",
      "act(p(MGI:Irf1)) -> r(MGI:Gbp2b)\n",
      "----------------------\n",
      "10033182 : In addition, STAT1 or IRF-1 induced the expression of CD42, a late marker of megakaryocyte maturation, albeit to a much lesser extent than GATA-1 (Figure ?(Figure1C).1C).\n",
      "act(p(MGI:Irf1)) -> r(MGI:Gp1ba)\n",
      "act(p(MGI:Stat1)) -> r(MGI:Gp1ba)\n",
      "----------------------\n",
      "10033186 : Functionally, IRF-1 is a negative regulator of Il23a in LPS-stimulated BMMs. IRF-1(-/-) BMMs demonstrated enhanced LPS-induced Il23a expression compared with WT BMMs. Moreover, IRF-1 deficiency resulted in prolonged occupancy of RelA on the Il23a promoter.\n",
      "act(p(MGI:Irf1)) -| r(MGI:Il23a)\n",
      "act(p(MGI:Rela)) -> r(MGI:Il23a)\n",
      "----------------------\n",
      "10033196 : Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-alpha. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired\n",
      "act(p(MGI:Irf5)) -> r(MGI:Il12a)\n",
      "act(p(MGI:Irf5)) -> r(MGI:Il12b)\n",
      "act(p(MGI:Irf5)) -> r(MGI:Il6)\n",
      "act(p(MGI:Irf5)) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10033210 : Cells lacking JunB show severely delayed kinetics of cyclin A mRNA expression due to the loss of proper transcriptional activation mediated via binding of JunB to the CRE element in the cyclin A promoter. Thus, cyclin A is a direct transcriptional target of JunB driving cell proliferation.\n",
      "act(p(MGI:Junb)) -> bp(GOBP:\"cell cycle\")\n",
      "act(p(MGI:Junb)) -> r(MGI:Ccna1)\n",
      "----------------------\n",
      "10020394 : AP-1 complexes with c-Jun, JunD, or JunB synergize with p50/c-Rel to potently transactivate the relB promoter in NIH 3T3 cells.\n",
      "act(p(MGI:Junb)) -> r(MGI:Relb)\n",
      "act(p(MGI:Jund)) -> r(MGI:Relb)\n",
      "act(p(MGI:Jun)) -> r(MGI:Relb)\n",
      "----------------------\n",
      "10011462 : TIEG1 expression in OBs is critical for both osteoblast-mediated mineralization and osteoblast support of osteoclast differentiation\n",
      "act(p(MGI:Klf10)) -> bp(GOBP:\"bone mineralization\")\n",
      "act(p(MGI:Klf10)) -> bp(GOBP:\"osteoclast differentiation\")\n",
      "----------------------\n",
      "10011464 : Examination of gene expression in the TIEG(-/-) OBs revealed decreased RANKL and increased OPG expression compared to TIEG(+/+) OBs\n",
      "act(p(MGI:Klf10)) -| r(MGI:Tnfrsf11b)\n",
      "act(p(MGI:Klf10)) -> r(MGI:Tnfsf11)\n",
      "----------------------\n",
      "10033222 : Inhibition of the function of KLF15, either by expression of a dominant negative mutant or by RNA interference, both reduced the expression of peroxisome proliferator-activated receptor gamma (PPARgamma) and blocked adipogenesis in 3T3-L1 preadipocytes exposed to inducers of adipocyte differentiation.\n",
      "act(p(MGI:Klf15)) -> bp(GOBP:\"fat cell differentiation\")\n",
      "act(p(MGI:Klf15)) -> r(MGI:Pparg)\n",
      "----------------------\n",
      "10011476 : Mechanism studies indicated that promoter hypermethylation and hemizygous deletion contributed to the down-regulation of KLF4 expression and the induction of apoptosis contributed to the antitumor activity of KLF4.\n",
      "act(p(MGI:Klf4)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Klf4)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10011486 : KLF5 accelerates mitotic entry in H-Ras-transformed cells by transcriptionally activating cyclin B1 and Cdc2, which leads to an increase in cyclin B1/Cdc2 kinase activity\n",
      "act(p(MGI:Klf5)) -> act(p(EGID:12534))\n",
      "act(p(MGI:Klf5)) -> r(EGID:12534)\n",
      "act(p(MGI:Klf5)) -> r(MGI:Ccnb1)\n",
      "----------------------\n",
      "10011488 : angiotensin II induced expression of KLF5, which in turn activated platelet-derived growth factor-A (PDGF-A) and transforming growth factor-beta (TGF-beta) expression.\n",
      "act(p(MGI:Klf5)) -> r(MGI:Pdgfa)\n",
      "act(p(MGI:Klf5)) -> r(MGI:Tgfb1)\n",
      "----------------------\n",
      "10011490 : Cell transfection experiments, on the other hand, demonstrated that the promoters of the genes encoding the OSN-specific OMP and the adhesion molecule L1 are both activated by KLF7 binding to CACCC motifs.\n",
      "act(p(MGI:Klf7)) -> r(MGI:Gap43)\n",
      "act(p(MGI:Klf7)) -> r(MGI:L1cam)\n",
      "act(p(MGI:Klf7)) -> r(MGI:Omp)\n",
      "----------------------\n",
      "10033256 : Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27Kip1 and p18Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27Kip1 and p18Ink4c expression and deregulated cell growth.\n",
      "act(p(MGI:Kmt2a)) -> r(MGI:Cdkn1b)\n",
      "act(p(MGI:Kmt2a)) -> r(MGI:Cdkn2c)\n",
      "act(p(MGI:Men1)) -> r(MGI:Cdkn1b)\n",
      "act(p(MGI:Men1)) -> r(MGI:Cdkn2c)\n",
      "----------------------\n",
      "10033264 : Using biochemical and genetic experiments, we demonstrate here that WT1 and LHX9 function as direct activatorsof the Sf1 gene.\n",
      "act(p(MGI:Lhx9)) -> r(MGI:Sf1)\n",
      "act(p(MGI:Wt1)) -> r(MGI:Sf1)\n",
      "----------------------\n",
      "10033276 : When the intact rat insulin I enhancer/promoter (-410 to + 1 bp relative to the transcription start site) is inserted in place of the minienhancer-prolactin promoter in the luciferase reporter plasmid, shPan-1 alone cannot activate luciferase expression. Cotransfected lmx-1, however, activates the intact enhancer/promoter, and shPan-1 plus lmx-1 causes further activation (Fig. 8B).\n",
      "act(p(MGI:Lmx1a)) -> r(MGI:Ins1)\n",
      "act(p(MGI:Tcf3)) -> act(p(MGI:Lmx1a))\n",
      "----------------------\n",
      "10033286 : Because c-Maf is a transcription factor, it is of interest to identify downstream target genes of its action that might contribute to malignant transformation of T cells. We used RT-PCR analysis to show that cyclin D2, integrin Ã7, and ARK5 were up-regulated in c-Maf transgenic thymocytes and T lymphoma cells.\n",
      "act(p(MGI:Maf)) -> r(MGI:Ccnd2)\n",
      "act(p(MGI:Maf)) -> r(MGI:Itgb7)\n",
      "act(p(MGI:Maf)) -> r(MGI:Nuak1)\n",
      "----------------------\n",
      "10011508 : Pur-1 (for purine binding), binds to the GAGA boxes of the rat insulin I and II genes and the human islet amyloid polypeptide gene.\n",
      "act(p(MGI:Maz)) -> r(MGI:Iapp)\n",
      "act(p(MGI:Maz)) -> r(MGI:Ins1)\n",
      "act(p(MGI:Maz)) -> r(MGI:Ins2)\n",
      "----------------------\n",
      "10033298 : (ResnetDB) In this in vivo study, overexpressing MEF2 (both MEF2A and MEF2C) enhanced MLC2slow promoter activity in the SOL+ muscles.\n",
      "act(p(MGI:Mef2a)) -> r(MGI:Myl2)\n",
      "act(p(MGI:Mef2c)) -> r(MGI:Myl2)\n",
      "----------------------\n",
      "10011516 : Mutagenesis and protein-DNA binding assays suggested that at least three positive factors interact with this (GAX) fragment and are required for transcriptional activity. One of these factors, HRF-1, recognizes a cis element consisting of an inverted palindromic motif. A second factor is Sp1, that binds to a G/C- rich element. The third is the MADS box factor referred to as MEF2 or RSRF\n",
      "act(p(MGI:Mef2a)) -> act(p(MGI:Meox2))\n",
      "act(p(MGI:Sp1)) -> act(p(MGI:Meox2))\n",
      "----------------------\n",
      "10033312 : The expression of mXinalpha in Nkx2.5 or MEF2C knockout mouse embryos was drastically reduced, suggesting that mXinalpha is a downstream target of the Nkx2.5 and MEF2C transcription factors.\n",
      "act(p(MGI:Mef2c)) -> r(MGI:Xirp1)\n",
      "act(p(MGI:\"Nkx2-5\")) -> r(MGI:Xirp1)\n",
      "----------------------\n",
      "10011524 : Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.\n",
      "act(p(MGI:Mitf)) -> r(MGI:Dct)\n",
      "act(p(MGI:Mitf)) -> r(MGI:Tyr)\n",
      "act(p(MGI:Mitf)) -> r(MGI:Tyrp1)\n",
      "----------------------\n",
      "10011526 : The role of Mitf must therefore be to regulate genes required for melanoblast survival, proliferation, or the maintenance of melanoblast identity. Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.\n",
      "act(p(MGI:Mitf)) -> r(MGI:Dct)\n",
      "act(p(MGI:Mitf)) -> r(MGI:Tyr)\n",
      "act(p(MGI:Mitf)) -> r(MGI:Tyrp1)\n",
      "----------------------\n",
      "10011528 : We found that the microphthalmia-associated transcription factor (MITF), an essential transcription factor for melanocyte development and pigmentation, induces anchorage-independent growth of NIH-3T3 cells in cooperation with STAT3C. Microarray analysis revealed that c-fos is highly expressed in transformants expressing STAT3C and MITF.\n",
      "act(p(MGI:Mitf)) -> r(MGI:Fos)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Fos)\n",
      "----------------------\n",
      "10011536 : Previous work has established that the melanocyte-specific tyrosinase-related protein-1 (TRP-1) promoter is regulated positively by the microphthalmia-associated transcription factor Mitf, acting through the conserved M box and negatively by the T-box factor Tbx2,\n",
      "act(p(MGI:Mitf)) -> r(MGI:Tyrp1)\n",
      "act(p(MGI:Tbx2)) -| r(MGI:Tyrp1)\n",
      "----------------------\n",
      "10011538 : Decreased ChREBP gene expression, achieved using small interfering RNA, results in a loss of glucose effect on endogenous glycolytic (l-PK) and lipogenic (FAS, ACC) gene expression,\n",
      "act(p(MGI:Mlxipl)) -> r(MGI:Acaca)\n",
      "act(p(MGI:Mlxipl)) -> r(MGI:Fasn)\n",
      "act(p(MGI:Mlxipl)) -> r(MGI:Pklr)\n",
      "----------------------\n",
      "10011542 : Msx1/2 mutants also exhibited increased Bmp4 expression in migratory cranial neural crest and pharyngeal arches.\n",
      "act(p(MGI:Msx1)) -| r(MGI:Bmp4)\n",
      "act(p(MGI:Msx2)) -| r(MGI:Bmp4)\n",
      "----------------------\n",
      "10033346 : these studies demonstrated that MTF-1 is essential for the heightened expression of MT-I in the visceral endoderm of the developing mouse embryo and suggest that zinc modulates the ability of MTF-1 to transactivate gene expression in these cells. It was also found that MTF-1 cooperates with USF1 to regulate endoderm-specific expression of the mouse MT-I gene.\n",
      "act(p(MGI:Mtf1)) -> r(MGI:Mt1)\n",
      "act(p(MGI:Usf1)) -> r(MGI:Mt1)\n",
      "----------------------\n",
      "10011552 : A-myb protein is nuclear and that it activates transcription from the KHK-CAT reporter 6-%10 times more strongly than c-myb\n",
      "act(p(MGI:Mybl1)) -> r(MGI:Cat)\n",
      "act(p(MGI:Mybl1)) -> r(MGI:Khk)\n",
      "act(p(MGI:Myb)) -> r(MGI:Cat)\n",
      "act(p(MGI:Myb)) -> r(MGI:Khk)\n",
      "----------------------\n",
      "10033354 : binding sites for c-Myb and Sp1 on Mat2a, promoter activity increased expression of c-Myb and Sp1 and binding to the Mat2a promoter contribute to transcriptional up-regulation of Mat2a\n",
      "act(p(MGI:Myb)) -> r(MGI:Mat2a)\n",
      "act(p(MGI:Sp1)) -> r(MGI:Mat2a)\n",
      "----------------------\n",
      "10033360 : The c-Myc oncoprotein is strongly induced during the G0 to S-phase transition and is an important regulator of cell cycle entry.\n",
      "act(p(MGI:Myc)) -> bp(GOBP:\"cell cycle\")\n",
      "act(p(HGNC:MYC)) -> bp(GOBP:\"cell cycle\")\n",
      "----------------------\n",
      "10033364 : Using both chromatin immunoprecipitation and luciferase reporter analyses, c-MYC was shown to repress FLIP transcription, causing increased caspase-8 activation (Ricci et al., 2004).\n",
      "act(p(MGI:Myc)) -> act(p(MGI:Casp8))\n",
      "act(p(MGI:Myc)) -| r(MGI:Cflar)\n",
      "----------------------\n",
      "10033368 : In primary cultures of lymphoid cells from Em-myc transgenic mice, MYC activation suppresses Bcl-X(L) RNA and protein, and Bcl-X(L) and Bcl-2 expression are inhibited by MYC in precancerous B cells from these mice. That suppression of Bcl-X(L) RNA levels by MYC requires de novo protein synthesis indicates that repression is indirect (Eischen et al., 2001a).\n",
      "act(p(MGI:Myc)) -| p(MGI:Bcl2)\n",
      "act(p(MGI:Myc)) -| p(MGI:Bcl2l1)\n",
      "act(p(MGI:Myc)) -| r(MGI:Bcl2l1)\n",
      "----------------------\n",
      "10033384 : MYC can upregulate expression of the TRAIL receptor DR5 at the cell surface (Wang et al., 2004). Furthermore, c-MYC has also been shown to transcriptionally induce expression of FasL (Amanullah et al., 2002; Brunner et al., 2000; Kasibhatla et al., 2000).\n",
      "act(p(MGI:Myc)) -> r(MGI:Fas)\n",
      "act(p(MGI:Myc)) -> r(MGI:Tnfrsf10b)\n",
      "----------------------\n",
      "10011570 : The myogenic basic helix-loop-helix (bHLH) proteins, MyoD and Myf5, are required for myoblast specification\n",
      "act(p(MGI:Myf5)) -> bp(GOBP:\"myoblast differentiation\")\n",
      "act(p(MGI:Myod1)) -> bp(GOBP:\"myoblast differentiation\")\n",
      "----------------------\n",
      "10033390 : Whereas all four myogenic factors bound with similar affinities to the MCK enhancer in the presence of the widely expressed HLH protein E12, only MyoD1, myogenin, and myf-5 efficiently trans-activated the enhancer in transiently transfected 10T1/2 and 3T3 cells.\n",
      "act(p(MGI:Myf5)) -> r(MGI:Ckm)\n",
      "act(p(MGI:Myod1)) -> r(MGI:Ckm)\n",
      "act(p(MGI:Myog)) -> r(MGI:Ckm)\n",
      "----------------------\n",
      "10011572 : We previously identified the Hom3a region as the major DNA element responsible for Fgf4 expression in the myotomes and AER, and showed that a conserved E-box is a target for the myogenic bHLH transcription factors MYF5 and MYOD\n",
      "act(p(MGI:Myf5)) -> r(MGI:Fgf4)\n",
      "act(p(MGI:Myod1)) -> r(MGI:Fgf4)\n",
      "----------------------\n",
      "10033394 : This control region is a direct target for the binding of myogenic bHLH and MEF2 proteins. Mutagenesis of the Mef2c control region shows that a binding site for myogenic bHLH proteins is essential for expression at all stages of skeletal muscle development, whereas an adjacent MEF2 binding site is required for maintenance but not for initiation of Mef2c transcription.\n",
      "act(p(MGI:Myf5)) -> r(MGI:Mef2c)\n",
      "act(p(MGI:Myf6)) -> r(MGI:Mef2c)\n",
      "act(p(MGI:Myod1)) -> r(MGI:Mef2c)\n",
      "act(p(MGI:Myog)) -> r(MGI:Mef2c)\n",
      "----------------------\n",
      "10033396 : RESULTS Myf5, MyoD, and MEF2 transactivate the myostatin promoter. The results show that both MyoD and Myf5 induced the activation of the myostatin promoter (Fig. 5A, panel i).\n",
      "act(p(MGI:Myf5)) -> r(MGI:Mstn)\n",
      "act(p(MGI:Myod1)) -> r(MGI:Mstn)\n",
      "----------------------\n",
      "10033398 : in 10T1/2 fibroblasts the MRF4 promoter is trans-activated by myogenin, MyoD, myf5, and by the MEF2 factors, but that MRF4 does not activate expression of its own promoter. Myogenin activated the MRF4 promoter directly by an E box-dependent mechanism, while MEF2 factors activated the promoter through an indirect pathway.\n",
      "act(p(MGI:Myf5)) -> r(MGI:Myf6)\n",
      "act(p(MGI:Myod1)) -> r(MGI:Myf6)\n",
      "act(p(MGI:Myog)) -> r(MGI:Myf6)\n",
      "----------------------\n",
      "10033400 : mRNA concentration of MYF5, a member of the bHLH family of myogenic transcription factors (TFs), was increased 3-fold. MyoD, was increased MYF5 and MyoD preferentially activate the skeletal MHCIIb gene, specifying the myosin isoform that is highest expressed in the glycolytic fast-type fiber IIB. In parallel, a role for MyoD has been proposed in the maintenance of fast-fiber characteristics\n",
      "act(p(MGI:Myf5)) -> r(MGI:Myh4)\n",
      "act(p(MGI:Myod1)) -> r(MGI:Myh4)\n",
      "----------------------\n",
      "10033402 : Most importantly, forced expression of myocardin activated expression of the SM22 alpha, smooth muscle alpha-actin, and calponin-h1 genes in undifferentiated mouse ES cells.\n",
      "act(p(MGI:Myocd)) -> r(MGI:Acta2)\n",
      "act(p(MGI:Myocd)) -> r(MGI:Cnn1)\n",
      "----------------------\n",
      "10011582 : In 10T1/2 fibroblasts the approximately 2.8-kb alpha7 promoter was trans-activated by the myogenic basic helix-loop-helix proteins myogenin and MyoD but not by MRF4 and myf5.\n",
      "act(p(MGI:Myod1)) -> r(MGI:Itga7)\n",
      "act(p(MGI:Myog)) -> r(MGI:Itga7)\n",
      "----------------------\n",
      "10033414 : Among the Nanog-bound genes, notable ones are Pou5f1, Sox2, Rif1 and REST. Depletion of Nanog resulted in downregulation of their expression (Fig. 6f),\n",
      "act(p(MGI:Nanog)) -> r(MGI:Pou5f1)\n",
      "act(p(MGI:Nanog)) -> r(MGI:Rest)\n",
      "act(p(MGI:Nanog)) -> r(MGI:Rif1)\n",
      "act(p(MGI:Nanog)) -> r(MGI:Sox2)\n",
      "----------------------\n",
      "10033430 : We show that NFATc1 binds to the promoter regions of Atp6v0d2 and DC-STAMP in osteoclasts and directly induces their expression. Furthermore, overexpression of Atp6v0d2 and DC-STAMP rescues cell-cell fusion of preosteoclasts despite reduced NFATc1 activity.\n",
      "act(p(MGI:Nfatc1)) -> r(MGI:Atp6v0d2)\n",
      "act(p(MGI:Nfatc1)) -> r(MGI:Dcstamp)\n",
      "----------------------\n",
      "10033440 : In naive CD4(+) T cells, NFATx up-regulated the expression of several cytokine genes and activation markers and suppressed the expression of CD154. Th1 cytokines IFN-{gamma} and TNF-{alpha} were up-regulated in transgenic Th1 cells (a), while Th2 cytokines IL-4, IL-5, IL-10, and IL-13 were suppressed in transgenic Th2 cells\n",
      "act(p(MGI:Nfatc3)) -| r(MGI:Il10)\n",
      "act(p(MGI:Nfatc3)) -| r(MGI:Il13)\n",
      "act(p(MGI:Nfatc3)) -| r(MGI:Il4)\n",
      "act(p(MGI:Nfatc3)) -| r(MGI:Il5)\n",
      "----------------------\n",
      "10033446 : Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants.\n",
      "act(p(MGI:Nfe2l1)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Nfe2l1)) -| bp(GOBP:\"response to oxidative stress\")\n",
      "act(p(MGI:Nfe2l2)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Nfe2l2)) -| bp(GOBP:\"response to oxidative stress\")\n",
      "act(p(HGNC:NFE2L2)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10033450 : RT-PCR showed a significant induction of cytochrome P450 4a10 and 4a14 (CYP4a10 and CYP4a14) in Nrf1LKO livers.\n",
      "act(p(MGI:Nfe2l1)) -| r(MGI:Cyp4a10)\n",
      "act(p(MGI:Nfe2l1)) -| r(MGI:Cyp4a14)\n",
      "----------------------\n",
      "10011612 : Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.\n",
      "act(p(MGI:Nfe2l1)) -> r(MGI:Prdx1)\n",
      "act(p(MGI:Nfe2l2)) -> r(MGI:Hmox1)\n",
      "act(p(MGI:Nfe2l2)) -> r(MGI:Prdx1)\n",
      "act(p(MGI:Nfe2l2)) -> r(MGI:Sqstm1)\n",
      "----------------------\n",
      "10017590 : Western blot analysis of lung proteins showed that Srx1 proteinwas present constitutively, and its level increased significantly on exposure to CS in Nrf2+/+ mice. By contrast, expression of Srx1 protein was low in Nrf2?/? mice and did not change significantly with CS exposure (Figs. 1B and C).\n",
      "act(p(MGI:Nfe2l2)) -> p(MGI:Srxn1)\n",
      "act(p(HGNC:NFE2L2)) -> p(HGNC:SRXN1)\n",
      "----------------------\n",
      "10033482 : As shown in Fig. 3, all NFI family members increased SP-C promoter transactivation by TTF-1.....All NFI family members interact with TTF-1.\n",
      "act(p(MGI:Nfia)) -> act(p(MGI:\"Nkx2-1\"))\n",
      "act(p(MGI:Nfib)) -> act(p(MGI:\"Nkx2-1\"))\n",
      "----------------------\n",
      "10011650 : Genes preferentially expressed in oocytes, including Oct4 and Gdf9, are down-regulated in Nobox-/- mice, whereas ubiquitous genes such as Bmp4, Kit, and Bax remain unaffected.\n",
      "act(p(MGI:Nobox)) -> r(MGI:Gdf9)\n",
      "act(p(MGI:Nobox)) -> r(MGI:Pou5f1)\n",
      "----------------------\n",
      "10033506 : Hepatic expression of E4BP4 and the orphan nuclear receptor small heterodimer partner (SHP), both negative regulators of CYP7A1 expression, is increased in Rev-erbalpha-deficient mice. Promoter analysis and chromatin immunoprecipitation experiments demonstrated that SHP and E4BP4 are direct Rev-erbalpha target genes.\n",
      "act(p(MGI:Nr1d1)) -| r(MGI:Nfil3)\n",
      "act(p(MGI:Nr1d1)) -| r(MGI:Nr0b2)\n",
      "----------------------\n",
      "10033508 : Exogenous expression of a dominant negative version of mouse Rev-erbbeta decreases the expression of many genes involved in fatty acid/lipid absorption (including Cd36, and Fabp-3 and -4). Interestingly, we observed a robust induction (15-fold) in mRNA expression of interleukin-6\n",
      "act(p(MGI:Nr1d2)) -> r(MGI:Cd36)\n",
      "act(p(MGI:Nr1d2)) -> r(MGI:Fabp3)\n",
      "act(p(MGI:Nr1d2)) -> r(MGI:Fabp4)\n",
      "act(p(MGI:Nr1d2)) -| r(MGI:Il6)\n",
      "----------------------\n",
      "10033514 : treatment of adipocytes derived from 3T3-L1 cells and mouse embryonic fibroblasts in vitro with synthetic or natural LXR agonists decreases mRNA expression of 11beta-HSD-1 by approximately 50%, paralleled by a significant decline in 11beta-HSD-1 enzyme activity.\n",
      "act(p(MGI:Nr1h2)) -| r(MGI:Hsd11b1)\n",
      "act(p(MGI:Nr1h3)) -| r(MGI:Hsd11b1)\n",
      "----------------------\n",
      "10011660 : We cloned and identified the oxysterol receptors liver X receptor (LXRalpha) and LXRbeta as strong activators of the mouse SREBP-1c promoter\n",
      "act(p(MGI:Nr1h2)) -> r(MGI:Srebf1)\n",
      "act(p(MGI:Nr1h3)) -> r(MGI:Srebf1)\n",
      "----------------------\n",
      "10011662 : However, LXR alpha has several important roles in adipocyte function. Our studies show that this nuclear receptor increases basal glucose uptake and glycogen synthesis in 3T3-L1 adipocytes. In addition, LXR alpha increases cholesterol synthesis and release of nonesterified fatty acids. F\n",
      "act(p(MGI:Nr1h3)) -> a(CHEBI:cholesterol)\n",
      "act(p(MGI:Nr1h3)) -> bp(GOBP:\"glucose import\")\n",
      "----------------------\n",
      "10033516 : In addition to its regulatory role in inflammation processes, and in association with Pparg, Ppara was shown to mediate cholesterol efflux from human macrophages. This is likely due to the induction of the nuclear receptor LXR (NR1H3) expression, which in turn upregulates the expression of the reverse cholesterol transporter ABCA1.\n",
      "act(p(MGI:Nr1h3)) -> r(MGI:Abca1)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Nr1h3)\n",
      "----------------------\n",
      "10011664 : Lxralpha(-/-) mice were not able to induce expression of hepatic Abcg5/Abcg8, and massive accumulation of free cholesterol and cholesteryl esters (CEs) occurred. Interestingly, despite the inability to upregulate Abcg5/Abcg8,\n",
      "act(p(MGI:Nr1h3)) -> r(MGI:Abcg5)\n",
      "act(p(MGI:Nr1h3)) -> r(MGI:Abcg8)\n",
      "----------------------\n",
      "10033520 : In the liver, activation of LXR led to the suppression of the gluconeogenic program including down-regulation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1),phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase expression\n",
      "act(p(MGI:Nr1h3)) -| r(MGI:G6pc)\n",
      "act(p(MGI:Nr1h3)) -| r(MGI:Pck1)\n",
      "act(p(MGI:Nr1h3)) -| r(MGI:Ppargc1a)\n",
      "----------------------\n",
      "10033564 : In contrast, the newly identified target genes in skin, plasma glutathione peroxidase and HSP-27, were induced by GC in wild-type, but not in GR(dim) mice. Thus, these data suggest that the DNA binding-independent function of the GR is dispensable for repression of AP-1 activity in vivo and responsible for the antitumor promoting activity of GCs.\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Gpx3)\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Hspb2)\n",
      "----------------------\n",
      "10033566 : glucocorticoid receptor occupies the promoter of the IGFBP-1 gene and the -2.5 kb enhancer of the TAT gene in wild-type liver, and this binding is enhanced more than 4-fold during fasting\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Igfbp1)\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Tat)\n",
      "----------------------\n",
      "10033572 : An attractive mode of regulation, especially in light of the coordinated effects of glucocorticoids in maintaining homeostasis, is the opposing control of the same gene in different tissues by GR. PEPCK-C gene provides an optimal model for studying this mode of regulation. The transcription of this gene is stimulated by glucocorticoids in the liver and kidney (6, 7) but is repressed in the adipose tissue (8).\n",
      "act(p(MGI:Nr3c1)) -> r(MGI:Pck1)\n",
      "act(p(MGI:Nr3c1)) -| r(MGI:Pck1)\n",
      "----------------------\n",
      "10011730 : Transcriptional profiling of Nur77-expressing preadipocytes led to the identification of gap-junction protein alpha1 (Gja1) and tolloid-like 1 (Tll1) as Nur77-responsive genes.\n",
      "act(p(MGI:Nr4a1)) -> r(MGI:Gja1)\n",
      "act(p(MGI:Nr4a1)) -> r(MGI:Tll1)\n",
      "----------------------\n",
      "10011736 : Cytochrome c expression was increased approximately twofold and delta- aminolevulinate synthase was increased approximately 50% in NRF-1 transgenic muscle\n",
      "act(p(MGI:Nrf1)) -> r(MGI:Alas1)\n",
      "act(p(MGI:Nrf1)) -> r(MGI:Cycs)\n",
      "----------------------\n",
      "10011748 : In transfection experiments HNF-6 stimulated the expression of HNF-4 and of HNF-3 beta, two transcription factors known to be involved in liver\n",
      "act(p(MGI:Onecut1)) -> r(MGI:Foxa2)\n",
      "act(p(MGI:Onecut1)) -> r(MGI:Hnf4a)\n",
      "----------------------\n",
      "10033606 : OTX2 binds specifically to a bicoid motif present in the promoter regions of three Mitf target genes, QNR71, TRP-1, and tyrosinase, leading to their transactivation.\n",
      "act(p(MGI:Otx2)) -> r(MGI:Tyr)\n",
      "act(p(MGI:Otx2)) -> r(MGI:Tyrp1)\n",
      "----------------------\n",
      "10011756 : Pax3 induced the expression of the transcription factor Six1, its cofactor Eya2, and the transcription factor Mox1 prior to inducing the expression of MyoD and myogenin.\n",
      "act(p(MGI:Pax3)) -> r(MGI:Eya2)\n",
      "act(p(MGI:Pax3)) -> r(MGI:Meox1)\n",
      "act(p(MGI:Pax3)) -> r(MGI:Six1)\n",
      "----------------------\n",
      "10011764 : This study revealed that the transcript levels were significantly altered for 508 of the 9700 genes analysed, including five genes encoding the cell adhesion molecules beta1-integrin, JAM1, L1 CAM, NCAM-140 and neogenin.\n",
      "act(p(MGI:Pax6)) -> r(MGI:F11r)\n",
      "act(p(MGI:Pax6)) -> r(MGI:L1cam)\n",
      "act(p(MGI:Pax6)) -> r(MGI:Ncam1)\n",
      "act(p(MGI:Pax6)) -> r(MGI:Neo1)\n",
      "----------------------\n",
      "10011766 : The results indicate that Pax6 controls the lateral limit of the expression of Nkx2.1, Shh, and Lhx6 in the prechordal neural tube, the telencephalon.\n",
      "act(p(MGI:Pax6)) -| r(MGI:Lhx6)\n",
      "act(p(MGI:Pax6)) -| r(MGI:\"Nkx2-1\")\n",
      "act(p(MGI:Pax6)) -| r(MGI:Shh)\n",
      "----------------------\n",
      "10033622 : Pax-6 mutants lack SFRP-2 expression in the PSB and diencephalon. Pax-6 mutants also lack Wnt-7b expression in the PSB Furthermore, in the spinal cord of Pax-6 mutants, SFRP-2 and Wnt-7b expression was greatly reduced.\n",
      "act(p(MGI:Pax6)) -> r(MGI:Sfrp2)\n",
      "act(p(MGI:Pax6)) -> r(MGI:Wnt7b)\n",
      "----------------------\n",
      "10029574 : We show that Phox2b has a dual action on pan-neuronal differentiation. It upregulates the expression of proneural genes (Ngn2) when expressed alone and upregulates the expression of Mash1 when expressed in combination with Nkx2.2.\n",
      "act(p(MGI:Phox2b)) -> r(MGI:Ascl1)\n",
      "act(p(MGI:Phox2b)) -> r(MGI:Neurog2)\n",
      "----------------------\n",
      "10033644 : We show these elements to bind PITX2 specifically in vitro. The PLOD-1 promoter induces the expression of a luciferase reporter gene in the presence of PITX2 in cotransfection experiments.\n",
      "act(p(MGI:Pitx2)) -> r(MGI:Plod1)\n",
      "act(p(MGI:Pitx2)) -> r(MGI:Plod2)\n",
      "----------------------\n",
      "10011776 : the PLAG1- and PLAGL2-induced transformation is accompanied by a drastic up-regulation of insulin-like growth factor-II, which we prove is a target of PLAG1 and PLAGL2\n",
      "act(p(MGI:Plagl1)) -> r(MGI:Igf2)\n",
      "act(p(MGI:Plagl2)) -> r(MGI:Igf2)\n",
      "----------------------\n",
      "10033684 : Here, we show that aortic explants isolated from PPARalpha-null mice display an exacerbated response to inflammatory stimuli, such as lipopolysaccharide (LPS), as demonstrated by increased IL-6 secretion.\n",
      "act(p(MGI:Ppara)) -| bp(GOBP:\"inflammatory response\")\n",
      "act(p(MGI:Ppara)) -| tloc(p(MGI:Il6))\n",
      "----------------------\n",
      "10033690 : PPAR-alpha-dependent stimulation of lipoprotein lipase and of apolipoprotein (apo)A-V and to an inhibition of apoC-III expression,\n",
      "act(p(MGI:Ppara)) -> act(p(MGI:Lpl))\n",
      "act(p(MGI:Ppara)) -> r(MGI:Apoa5)\n",
      "act(p(MGI:Ppara)) -| r(MGI:Apoc3)\n",
      "----------------------\n",
      "10033692 : supplementation with RXR attenuated these inhibitions by Ppars implicating receptor interaction among LXR, Ppar and RXR as a plausible mechanism Pparalpha activation can suppress LXR-Srebp1c pathway through reduction of LXR/RXR formation, proposing a novel transcription factor cross-talk between LXR and Pparalpha in hepatic lipid homeostasis\n",
      "act(p(MGI:Ppara)) -| complex(p(MGI:Nr1h3),p(MGI:Rxra))\n",
      "act(p(MGI:Ppara)) -| complex(p(MGI:Nr1h3),p(MGI:Rxrb))\n",
      "act(p(MGI:Ppara)) -| complex(p(MGI:Nr1h3),p(MGI:Rxrg))\n",
      "----------------------\n",
      "10011790 : By using the various transcription factor-null mice, PPAR-alpha was shown to play a central role in the down-regulation of Oatp1a1, 1a4, 1b2, and Ntcp by PFDA.\n",
      "act(p(MGI:Ppara)) -| r(EGID:20493)\n",
      "act(p(MGI:Ppara)) -| r(MGI:Slco1a1)\n",
      "act(p(MGI:Ppara)) -| r(MGI:Slco1a4)\n",
      "act(p(MGI:Ppara)) -| r(MGI:Slco1b2)\n",
      "----------------------\n",
      "10033710 : PPARa activation stimulates fatty acids catabolism in these organella by increasing the transcription of proteins involved in its transport into the mitochondria (carnitine palmitoyltransferase I) [15-17] and in the mitochondrial b-oxidation cycle (medium-chain acyl- CoA dehydrogenase) [18].\n",
      "act(p(MGI:Ppara)) -> r(MGI:Acadm)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Cpt1a)\n",
      "----------------------\n",
      "10033676 : The hypotriglyceridemic action of fibrates and fatty acids also involves PPARs and can be summarized as follows: ... (2) a stimulation of cellular fatty acid uptake and their conversion to acyl-CoA derivatives by the induction of FAT, FATP and ACS activity, (3) an induction of fatty acid beta-oxidation pathways, (4) a reduction in fatty acid and triglyceride synthesis, and finally (5) a decrease in VLDL production.\n",
      "act(p(MGI:Ppara)) -> r(MGI:Acss2)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Slc27a1)\n",
      "----------------------\n",
      "10011796 : Importantly, Wy-14,643 treatment upregulated expression of the adiponectin receptor (AdipoR)-1 and AdipoR2 in WAT\n",
      "act(p(MGI:Ppara)) -> r(MGI:Adipor1)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Adipor2)\n",
      "----------------------\n",
      "10011798 : Hepatic expression of Ccnd1, cMyc, IL-1r1, and IL-6r was induced in wild-type mice, but not Pparalpha-null mice, after acute exposure to the potent Pparalpha agonist Wy-14,643, indicating a role for Pparalpha in regulating the expression of these genes.\n",
      "act(p(MGI:Ppara)) -> r(MGI:Ccnd1)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Il1r1)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Il6ra)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Myc)\n",
      "----------------------\n",
      "10011800 : Northern blot analysis confirmed the differential expression of some of the genes identified in the present study, and also some genes identified previously as PPARalpha regulated, such as CD36, lymphocyte antigen 6 complex locus (Ly-6D), and C3f.\n",
      "act(p(MGI:Ppara)) -> r(MGI:Cd36)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Lpcat3)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Ly6d)\n",
      "----------------------\n",
      "10033726 : Heat stress in PPAR{alpha}-null but not wild-type mice led to an increase in one gene (Sui1-rs1) and decreases in three genes (Gspt1, Tcea1, and 2300002G02Rik).\n",
      "act(p(MGI:Ppara)) -| r(MGI:Eif1)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Gspt1)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Tcea1)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Tufm)\n",
      "----------------------\n",
      "10033732 : Exposure of these stimulated cells to a PPAR activator 5,8,11,14-eicosatetraynoic acid (ETYA) results in the accumulation of fat droplets and expression of the adipocyte-enriched genes aP2 and glycerol phosphate dehydrogenase (GPD)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Fabp4)\n",
      "act(p(MGI:Ppara)) -> r(MGI:Gpd1)\n",
      "----------------------\n",
      "10033746 : in addition, the Lxra gene is induced by Pparg and Ppara that may in turn be activated by the newly synthesized unsaturated fatty acids\n",
      "act(p(MGI:Ppara)) -> r(MGI:Nr1h3)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Nr1h3)\n",
      "----------------------\n",
      "10011814 : Experiments investigating endogenous and overexpressed PPARalpha and PPARgamma activation of COX-2 mRNA and protein\n",
      "act(p(MGI:Ppara)) -> r(MGI:Ptgs2)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ptgs2)\n",
      "----------------------\n",
      "10033766 : All three UCPs are expressed in brown fat with IUCP1 being most abundant.Activation of Ppard induces expression of UCP1 and UCP3 in brown fat by 3.0- and 2.8-fold, respecitvely, but ahs no effect on the expression of UCP2\n",
      "act(p(MGI:Ppard)) -> r(MGI:Ucp1)\n",
      "act(p(MGI:Ppard)) -> r(MGI:Ucp3)\n",
      "----------------------\n",
      "10011824 : PPARalpha (NR1C1) controls lipid oxidation and clearance in hepatocytes and PPARgamma (NR1C3) promotes preadipocyte differentiation and lipogenesis.\n",
      "act(p(MGI:Pparg)) -> bp(GOBP:\"fat cell differentiation\")\n",
      "act(p(MGI:Pparg)) -> bp(GOBP:\"lipid biosynthetic process\")\n",
      "----------------------\n",
      "10033798 : Results CPT1 and MCAD are two enzymes essential for te mitochondrial transport and B-oxidation of fatty acids. As seen in Fig.2, the infection of primary hepatocytes with adenoviral PGC-1a strongly induces mRNAs for both of these genes.\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Acadm)\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Cpt1a)\n",
      "----------------------\n",
      "10033800 : Fig.2 demonstrates that the expression of PGC-1a potently increases mRNA levels for 3-keto-thiolase (Acat1)and HMG-Co-lyase.\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Acat1)\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Hmgcl)\n",
      "----------------------\n",
      "10033804 : Second, forced expression studies in adipogenic and myogenic mammalian cell lines demonstrated that PGC-1{alpha} markedly induces the expression of NRF-1, NRF-2, and Tfam (Wu et al. 1999Go).\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Nrf1)\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Tfam)\n",
      "----------------------\n",
      "10011828 : Peroxisome proliferator-activated receptor gamma (PPAR gamma) and PPAR gamma coactivator 1 alpha (PGC-1 alpha) activate mouse UCP1 gene transcription. We show here that human PGC-1 alpha induced the activation of the human UCP1 promoter by PPAR gamma\n",
      "act(p(MGI:Ppargc1a)) -> r(MGI:Ucp1)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ucp1)\n",
      "----------------------\n",
      "10011830 : Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1.\n",
      "act(p(MGI:Ppargc1a)) -> act(p(MGI:Hnf4a))\n",
      "act(p(MGI:Ppargc1a)) -> act(p(MGI:Nr3c1))\n",
      "----------------------\n",
      "10033816 : Human PGC1beta-1a and -2a isoforms localized to the cell nucleus and, specifically, the isoform PGC1beta-1a co-activated peroxisome-proliferator-activated receptor-gamma, -alpha and the thyroid hormone receptor beta1.\n",
      "act(p(MGI:Ppargc1b)) -> act(p(MGI:Thrb))\n",
      "act(p(MGI:Ppargc1b)) -> act(p(MGI:Ppara))\n",
      "act(p(MGI:Ppargc1b)) -> act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10033822 : However, plaque formation is also appreciated to be an inflammoratory response and it has been shown that activators of Pparg inhibit the production of inflammoratory cytokines such as TNFa, Il6 and Il1b.\n",
      "act(p(MGI:Pparg)) -| p(MGI:Il1b)\n",
      "act(p(MGI:Pparg)) -| p(MGI:Il6)\n",
      "act(p(MGI:Pparg)) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10033830 : Expression of adipocyte-secreted proteins, ACRP30 and resistin, which areare also regulated by Pparg and are implicated in fatty acid and glucose metabolism.\n",
      "act(p(MGI:Pparg)) -> r(MGI:Adipoq)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Retn)\n",
      "----------------------\n",
      "10011840 : We conclude that AQPap is a novel adipose-specific target gene of PPARgamma through the binding of PPARgamma-retinoid X receptor complex to the PPRE region in its promoter.\n",
      "act(p(MGI:Pparg)) -> r(MGI:Aqp7)\n",
      "act(p(MGI:Rxra)) -> r(MGI:Aqp7)\n",
      "----------------------\n",
      "10033836 : Ciglitazone (1, 10, and 20 micromol/L) also inhibited cyclin D1 expression by 37 +/- 8%, 79 +/- 15%, and 87 +/- 12%, respectively (P < 0.001 to 0.001), and p21 expression\n",
      "act(p(MGI:Pparg)) -| r(MGI:Ccnd1)\n",
      "act(p(MGI:Pparg)) -| r(MGI:Cdkn1a)\n",
      "----------------------\n",
      "10033848 : A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue of obese mice showed a 2.5 to 5 fold increase in the mRNA of fatty acid transporter protein, lipoprotein lipase, fat specific gene 27, cytochrome C oxidase polypeptide VIB and Ras like Rap1b protein\n",
      "act(p(MGI:Pparg)) -> r(MGI:Cidec)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Cox6b1)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Lpl)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Rab1b)\n",
      "----------------------\n",
      "10033850 : A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue and muscle cells of obese mice showed a 5 to 10 fold and 10 to 20 fold increase in the mRNA of alpha1 type 1 procollagen and PK-120 precursor protein.\n",
      "act(p(MGI:Pparg)) -> r(MGI:Col1a1)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Itih4)\n",
      "----------------------\n",
      "10033854 : Beta-catenin itself was overexpressed in the majority of the tumors studied, as was the Wnt receptor Frizzled homolog 4 (Fzd4). In contrast, the levels of Wnt5a and Fzd9 were down-regulated in PyV/Vp PPARG tumors\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ctnnb1)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Fzd4)\n",
      "act(p(MGI:Pparg)) -| r(MGI:Fzd9)\n",
      "act(p(MGI:Pparg)) -| r(MGI:Wnt5a)\n",
      "----------------------\n",
      "10011844 : Furthermore, the PPARgamma2-regulated induction of both SREBP-1 and FAS parallels an increase in de novo triacylglycerol synthesis in hepatocytes.\n",
      "act(p(MGI:Pparg)) -> r(MGI:Fas)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Srebf1)\n",
      "----------------------\n",
      "10033856 : treatment of hairless mice with ciglitazone or troglitazone increases loricrin, involucrin, and filaggrin expression\n",
      "act(p(MGI:Pparg)) -> r(MGI:Flg)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ivl)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Lor)\n",
      "----------------------\n",
      "10011856 : To focus attention on the uncharacterized genes in the up-regulated category, we cloned the full-length cDNAs of two novel candidates, which we designated as promethin and PGLP.\n",
      "act(p(MGI:Pparg)) -> r(MGI:Paqr7)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Tmem159)\n",
      "----------------------\n",
      "10030460 : PPAR gamma, in the presence of RXR, formed a strong complex with a retinoic acid response element (beta retinoic acid response element) in the RAR beta promoter.\n",
      "act(p(MGI:Pparg)) -> r(MGI:Rara)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Rarb)\n",
      "----------------------\n",
      "10033890 : we measured peroxisome proliferator-activated receptor (PPAR)-gamma mRNA and protein in BAT, because PPAR-gamma agonist can elevate UCPs mRNA levels in BAT.\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ucp1)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ucp2)\n",
      "act(p(MGI:Pparg)) -> r(MGI:Ucp3)\n",
      "----------------------\n",
      "10033896 : PPARgamma agonists activated NF-kappaB (p50, Rel A, c-Rel) binding to the upstream kappaB regulatory element site of c-myc. Only doses of agonists that induced apoptosis stimulated NF-kappaB-DNA binding.\n",
      "act(p(MGI:Pparg)) -> act(p(MGI:Rel))\n",
      "act(p(MGI:Pparg)) -> act(p(MGI:Rela))\n",
      "----------------------\n",
      "10011864 : Paired-related homeobox 1 (Prx1) encodes a homeobox transcription factor that induces TN-C by interacting with a binding site within the TN-C promoter, and it also promotes fibroblast migration.\n",
      "act(p(MGI:Prrx1)) -> bp(GOBP:\"cell migration\")\n",
      "act(p(MGI:Prrx1)) -> r(MGI:Tnc)\n",
      "----------------------\n",
      "10033910 : Figure 4. Rbp2 is required for the repression of PRC2 target genes. Importantly, ChIP experiments performed in the same cells showed that inhibition of Rbp2 expression also correlates with decreased binding of Rbp2 to its target promoters\n",
      "act(p(MGI:Rbp2)) -> r(MGI:Igf2)\n",
      "act(p(MGI:Rbp2)) -> r(MGI:Irx3)\n",
      "act(p(MGI:Rbp2)) -> r(MGI:Wnt5a)\n",
      "----------------------\n",
      "10033912 : NICD activates the HERP1 promoter in an RBP-J kappa-dependent manner, and induces expression of endogenous HERP1 mRNA as well as HERP1 protein in A10 cells.\n",
      "act(p(MGI:Rbpj)) -> p(MGI:Hey2)\n",
      "act(p(MGI:Rbpj)) -> r(MGI:Hey2)\n",
      "act(p(HGNC:RBPJ)) -> p(HGNC:HEY2)\n",
      "----------------------\n",
      "10032022 : Notch signaling is involved in many cell fate determination events in metazoans. Ligand binding results in proteolytic cleavage to release the signal-transducing Notch intracellular domain (NICD). The nuclear protein RBP-J kappa, when complexed with NICD, acts as a transcriptional activator which, in turn, induces a target gene of Notch such as the repressors HES/E(spl) and HERP2.\n",
      "act(p(MGI:Rbpj)) -> r(MGI:Hes1)\n",
      "act(p(MGI:Rbpj)) -> r(MGI:Hey1)\n",
      "----------------------\n",
      "10033918 : Mice lacking colonic RelA were sensitive to dextran sodium sulfate-induced colitis. Although experimental colitis enhanced proliferation in cells lacking RelA, sustained epithelial cell apoptosis precluded mucosal healing and decreased animal survival.\n",
      "act(p(MGI:Rela)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Rela)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(MGI:Rela)) -| path(MESHD:Colitis)\n",
      "----------------------\n",
      "10011878 : IkappaBalpha and IkappaBbeta were significantly diminished in RelA-null epithelia, and endotoxin challenge revealed elevated p50 and c-Rel DNA binding activity as compared with controls.\n",
      "act(p(MGI:Rela)) -> p(MGI:Nfkbia)\n",
      "act(p(MGI:Rela)) -> p(MGI:Nfkbib)\n",
      "----------------------\n",
      "10033920 : Antiapoptotic Bcl-xL expression was significantly decreased in isolated RelA-null colonocytes (Fig. 4E). Other NF-{kappa}B-target genes such as XIAP, cellular inhibitor of apoptosis 2, Casp8 and FADD-like apoptosis regulator (CFLAR, also called cFLIP), and survivin were not affected. We also found a notable decrease of IL-11 and IL-18 expression in isolated colonocytes of IEC-RelA?/? mice.\n",
      "act(p(MGI:Rela)) -> r(MGI:Bcl2l1)\n",
      "act(p(MGI:Rela)) -> r(MGI:Il11)\n",
      "act(p(MGI:Rela)) -> r(MGI:Il18)\n",
      "----------------------\n",
      "10033924 : MnSOD and Survivin are RelB targets in WEHI 231 cells. Knockdown of RelB caused a decrease in MnSod and Survivin gene and protein expression levels.\n",
      "act(p(MGI:Relb)) -> r(MGI:Birc5)\n",
      "act(p(MGI:Relb)) -> r(MGI:Sod2)\n",
      "----------------------\n",
      "10033926 : (from text): Both basal expression and induction of BLC, SDF-1, ELC and SLC mRNAs were defective in IkkalphaAA/AA (nonactivatable form) stromal cells. Similar defects in expression of these chemokines have been described in RelB-/- and Nfkb2-/- mice (Poljak et al, 1999; Weih et al, 2001)...(Figure 3 - legend): IKKalpha is required for recruitment of RelB to the Blc, Sdf-1, Elc and Slc promoters.\n",
      "act(p(MGI:Relb)) -> r(MGI:Ccl19)\n",
      "act(p(MGI:Relb)) -> r(MGI:Ccl21a)\n",
      "act(p(MGI:Relb)) -> r(MGI:Cxcl12)\n",
      "act(p(MGI:Relb)) -> r(MGI:Cxcl13)\n",
      "----------------------\n",
      "10011888 : Our studies indicate that loss of RORgamma disturbs homeostasis in the thymus by enhancing apoptosis and cellular proliferation.\n",
      "act(p(MGI:Rorc)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(MGI:Rorc)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10011898 : both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 (Il4) in T(H)1 cells.\n",
      "act(p(MGI:Runx3)) -> r(MGI:Ifng)\n",
      "act(p(MGI:Runx3)) -| r(MGI:Il4)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Ifng)\n",
      "act(p(MGI:Tbx21)) -| r(MGI:Il4)\n",
      "----------------------\n",
      "10033962 : Consistent with this finding, we report that p53 physically associates in vivo with HDACs. This interaction is not direct but, rather, is mediated by the corepressor mSin3a. Both wild-type p53 and mSin3a, but not mutant p53, can be found bound to the Map4 promoter at times when this promoter preferentially associates with deacetylated histones in vivo.\n",
      "act(p(MGI:Sin3a)) -| r(MGI:Map4)\n",
      "act(p(MGI:Sin3a)) -| r(MGI:Stmn1)\n",
      "act(p(MGI:Trp53)) -| r(MGI:Map4)\n",
      "act(p(MGI:Trp53)) -| r(MGI:Stmn1)\n",
      "----------------------\n",
      "10033974 : A similar BRE element is present within the BMP-responsive Nkx2-5 gene promoter (52, 55), suggesting that the Hex BRE represents a common response element for genes regulated by BMP signaling in the foregut region of the embryo.\n",
      "act(p(MGI:Smad1)) -> r(MGI:\"Nkx2-5\")\n",
      "act(p(MGI:Smad4)) -> r(MGI:\"Nkx2-5\")\n",
      "----------------------\n",
      "10011906 : Analysis of the downstream signaling pathways shows that Smad2/3 are crucial for efficient FGF-BP1 repression by TGF-beta.\n",
      "act(p(MGI:Smad2)) -| r(MGI:Fgfbp1)\n",
      "act(p(MGI:Smad3)) -| r(MGI:Fgfbp1)\n",
      "----------------------\n",
      "10033980 : Overexpression of Smad3/4 enhanced the TGF-?1-induced BAFF mRNA expression, and overexpression of a DN-Smad3 abrogated BAFF transcription in a dose-dependent manner (Fig. 2A ).\n",
      "act(p(MGI:Smad3)) -> r(MGI:Tnfsf13b)\n",
      "act(p(MGI:Smad4)) -> r(MGI:Tnfsf13b)\n",
      "----------------------\n",
      "10011918 : When overexpressed in C2C12 myoblasts, wild type SOX15, but not a C-terminal truncated form or the related protein SOX11, specifically inhibited activation of muscle-specific genes and expression of the basic helix-loop-helix myogenic factors myogenin and MyoD\n",
      "act(p(MGI:Sox15)) -| bp(GOBP:\"skeletal muscle tissue development\")\n",
      "act(p(MGI:Sox15)) -| r(MGI:Myod1)\n",
      "act(p(MGI:Sox15)) -| r(MGI:Myog)\n",
      "----------------------\n",
      "10033986 : Gel shift assays showed that the Sox1 and Sox2 proteins preferentially bound to E2 and E4. Moreover, disruption of E2 and E4 abolished the reporter gene expression in the lens. These results indicate that the newly identified enhancer with Sox elements activates the alphaB-crystallin promoter in the lens,\n",
      "act(p(MGI:Sox1)) -> r(MGI:Cryab)\n",
      "act(p(MGI:Sox2)) -> r(MGI:Cryab)\n",
      "----------------------\n",
      "10034000 : Figure 5. R-Sp1 decoy ODN suppressed TGF-beta1, fibronectin and alpha-SMA expression at 4, 6 and 8 weeks after transfection. (A) Western blot shows the inhibition of TGF-beta1, fibronectin and alpha-SMA expression by R-Sp1 decoy ODN injection.\n",
      "act(p(MGI:Sp1)) -> p(MGI:Acta2)\n",
      "act(p(MGI:Sp1)) -> p(MGI:Fn1)\n",
      "act(p(MGI:Sp1)) -> p(MGI:Tgfb1)\n",
      "act(p(HGNC:SP1)) -> p(HGNC:TGFB1)\n",
      "----------------------\n",
      "10034002 : Figure 6. R-Sp1 decoy ODN suppressed MMP-13 and TIMP-1 expression. (A) Western blot shows the inhibition of MMP-13 and TIMP-1 expression by R-Sp1 decoy ODN injection. CCl4+ Scr: hepatic damage treated with scramble decoy ODN; CCl4+ Sp1: hepatic damage treated with R-Sp1 decoy ODN.\n",
      "act(p(MGI:Sp1)) -> p(MGI:Mmp13)\n",
      "act(p(MGI:Sp1)) -> p(MGI:Timp1)\n",
      "----------------------\n",
      "10011938 : Gel shift analysis demonstrated that in addition to Sp1, Sp3 could interact with this Sp1 element. The requirement for Sp family transcription factors in dynamin I gene expression was confirmed by using mithramycin, an inhibitor of Sp1/Sp3 binding. Mithramycin repressed dynamin I gene expression and resulted in blocking of neuronal differentiation of N1E-115 cells.\n",
      "act(p(MGI:Sp1)) -> r(MGI:Dnm1)\n",
      "act(p(MGI:Sp3)) -> r(MGI:Dnm1)\n",
      "----------------------\n",
      "10009052 : In vitro, IFN-alpha decreased transcription of VEGF gene expression through an Sp1- and/or Sp3-dependent inhibition of VEGF promoter activity.\n",
      "act(p(MGI:Sp1)) -| r(MGI:Vegfa)\n",
      "act(p(MGI:Sp3)) -| r(MGI:Vegfa)\n",
      "----------------------\n",
      "10011958 : Both Sp3 and Sp4 transcription factors can interact with the two Sp1 binding sites within the minimal promoter and are critical for maximal activity of the promoter in neurons.\n",
      "act(p(MGI:Sp3)) -> r(MGI:Gabra4)\n",
      "act(p(MGI:Sp4)) -> r(MGI:Gabra4)\n",
      "----------------------\n",
      "10034062 : Our results demonstrate that the synergistic action of SREBP-1c and glucose metabolism via GK is necessary for the maximal induction of l-PK, ACC, FAS, and Spot 14 gene expression.\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Acaca)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Fasn)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Pklr)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Thrsp)\n",
      "----------------------\n",
      "10034064 : mRNA abundance of lipogenic enzymes, FAS, glycerol -3-phosphate acyltransferase, ATP citrate lyase, Spot14, was markedly reduced by SREBP1 deletion in Leptin deficient mice.\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Acly)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Fasn)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Gpam)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Thrsp)\n",
      "----------------------\n",
      "10034066 : At least 10 additional genes involved in the detoxification of oxidized lipids (8 glutathione S-transferase family members; cysteine sulfinic acid decarboxylase; and M-LP, Mpv17-like protein) were also induced in TgSREBP-1a mouse livers\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Csad)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Mpv17l)\n",
      "----------------------\n",
      "10019048 : Srebflc preferentially activates the long-chain fatty acyl elongase, a microsomal enzyme that carries out the rate-limiting condensation reaction required for elongating palmitate to stearate, and stearoyl-CoA desaturatase-1.\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Elovl6)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Scd1)\n",
      "----------------------\n",
      "10034070 : The delta 5 desaturase and delta 6 desaturase enzymes carry out the desaturation reactions both genes are transcriptionally activated by SREBP-1c isoforms.\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Fads1)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Fads2)\n",
      "----------------------\n",
      "10034078 : Srebf1a expression had a dose-dependent increase in both LDL receptor and Star promoter activities\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Ldlr)\n",
      "act(p(MGI:Srebf1)) -> r(MGI:Star)\n",
      "----------------------\n",
      "10011994 : Regulation of actin dynamics is necessary for serum induction of a subset of SRF target genes, including vinculin, cytoskeletal actin, and srf itself, and also suffices for their activation.\n",
      "act(p(MGI:Srf)) -> r(MGI:Srf)\n",
      "act(p(MGI:Srf)) -> r(MGI:Vcl)\n",
      "----------------------\n",
      "10034122 : enforced STAT1 expression promoted several features of megakaryocytic differentiation of G1ME cells, as evidenced by increased cell size (forward scatter) and increased DNA content, reflecting polyploidization (Figure ?(Figure1,1, A and B). Similar effects were produced by enforced expression of IRF-1, a major STAT1 effector (reviewed in ref. 26).\n",
      "act(p(MGI:Stat1)) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "act(p(MGI:Stat1)) -> act(p(MGI:Irf1))\n",
      "----------------------\n",
      "10011998 : Electromobility shift assays show increased STAT1, STAT3, STAT5, and AP-1 DNA binding activity in RAW 264.7 cells after hyperoxia. Taken together, our data suggest that the 5' distal enhancer elements of the HO-1 gene in concert with the promoter regulate HO-1 gene induction and highlight the complexity of HO-1 gene transcription in response to hyperoxia.\n",
      "act(p(MGI:Stat1)) -> r(MGI:Hmox1)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Hmox1)\n",
      "----------------------\n",
      "10034138 : events lead to activation of Stat signaling and result in the induction of proteins, such as bcl-2 and cMyc, both of which are critical regulators of cell cycle progression and apoptosis\n",
      "act(p(MGI:Stat3)) -> r(MGI:Bcl2)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Myc)\n",
      "----------------------\n",
      "10034134 : the down-regulation of D1 and D2 cyclins by OSM was mediated by STAT3 but not by SHP2/Ras STAT3 activation is necessary and sufficient for down-regulation of D1 and D2 cyclins in fetal hepatocytes\n",
      "act(p(MGI:Stat3)) -| r(MGI:Ccnd1)\n",
      "act(p(MGI:Stat3)) -| r(MGI:Ccnd2)\n",
      "----------------------\n",
      "10034142 : Moreover, STAT3 overactivation also reduced GATA3 and T-bet expression but increased the expression of RORgammat, a transcription regulator of THi differentiation (20).\n",
      "act(p(MGI:Stat3)) -| r(MGI:Gata3)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Rorc)\n",
      "act(p(MGI:Stat3)) -| r(MGI:Tbx21)\n",
      "----------------------\n",
      "10034144 : Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined\n",
      "act(p(MGI:Stat3)) -> r(MGI:Hes1)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Jag1)\n",
      "act(p(MGI:Stat3)) -> r(MGI:Trp63)\n",
      "----------------------\n",
      "10019892 : IL-12 activates STAT4, which is a critical regulator of inflammation and T helper type I (Th1) lineage development in murine systems.\n",
      "act(p(MGI:Stat4)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "act(p(HGNC:STAT4)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "----------------------\n",
      "10012008 : In addition, pulmonary levels of chemokines were decreased in the STAT4(-/-) mice, including CC chemokine ligand (CCL)5, CCL6, CCL11, and CCL17.\n",
      "act(p(MGI:Stat4)) -> r(MGI:Ccl11)\n",
      "act(p(MGI:Stat4)) -> r(MGI:Ccl17)\n",
      "act(p(MGI:Stat4)) -> r(MGI:Ccl5)\n",
      "act(p(MGI:Stat4)) -> r(MGI:Ccl6)\n",
      "----------------------\n",
      "10034154 : Second, mice deficient for both STAT5A and STAT5B are thrombocytopenic, likely due to a reduction in functional hematopoietic progenitors (18).\n",
      "act(p(MGI:Stat5a)) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "act(p(MGI:Stat5b)) -> bp(GOBP:\"megakaryocyte differentiation\")\n",
      "----------------------\n",
      "10034162 : IL-4 develops Th2-biased immunity or allergic inflammation through activation of STAT6-dependent signaling.\n",
      "act(p(MGI:Stat6)) -> bp(GOBP:\"inflammatory response\")\n",
      "act(p(HGNC:STAT6)) -> bp(GOBP:\"inflammatory response\")\n",
      "----------------------\n",
      "10034166 : Elevated c-jun mRNA and Rapid Pregnant Mare Serum Gonadotropin (PMSG)-Responsiveness in the Mouse Ovary. TAF4b Knockdown in SIGCs Decreases c-jun {mRNA} Expression. Taf4b bound to the c-jun promoter via ChIP analysis. Importantly, we also detected the binding of TAF4b to the core promoter regions of the Ccnd2, Fst, Inhba genes but not to the 5? distal AP-1 enhancer region of the Vim promoter.\n",
      "act(p(MGI:Taf4b)) -> r(MGI:Ccnd2)\n",
      "act(p(MGI:Taf4b)) -> r(MGI:Fst)\n",
      "act(p(MGI:Taf4b)) -> r(MGI:Inhba)\n",
      "act(p(MGI:Taf4b)) -> r(MGI:Jun)\n",
      "----------------------\n",
      "10034170 : T-bet is required for the progression to the Th1 phenotype, because Tbx21-/- Th1beta cultures maintain the IL-17-secreting phenotype after 2 weeks of culture. Addition of IFN-gamma to Tbx21-/- Th1beta cultures cannot recover the progression to the Th1 phenotype, suggesting T-bet, rather than IFN-gamma, mediates Th1beta to Th1 progression.\n",
      "act(p(MGI:Tbx21)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "act(p(HGNC:TBX21)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "----------------------\n",
      "10034176 : In addition to the secretion of IFN{gamma}, overexpression of T-bet in T-betâ/â V{alpha}14i NKT cells was sufficient to induce granzyme B protein (Figure 4C) and the capacity to kill antigen-loaded CD1d+ target cells (Figure 5).\n",
      "act(p(MGI:Tbx21)) -> act(p(MGI:Gzmb))\n",
      "act(p(MGI:Tbx21)) -> tloc(p(MGI:Ifng))\n",
      "----------------------\n",
      "10034182 : Ectopic expression of T-bet both transactivates the IFNgamma gene and induces endogenous IFNgamma production.\n",
      "act(p(MGI:Tbx21)) -> p(MGI:Ifng)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Ifng)\n",
      "----------------------\n",
      "10034198 : Our data indicate that cytokine gene expression in T(H)1 cells may be controlled by a feed-forward regulatory circuit in which T-bet induces Runx3 and then 'partners' with Runx3 to direct lineage-specific gene activation and silencing.\n",
      "act(p(MGI:Tbx21)) -> p(MGI:Runx3)\n",
      "act(p(HGNC:TBX21)) -> p(HGNC:RUNX3)\n",
      "----------------------\n",
      "10034204 : As was observed when T-bet was introduced into T-betâ/â V{alpha}14i NKT cells, introduction of T-bet into wild-type immature V{alpha}14i NKT cells induced the up-regulation of CCR5, CxCR3, FasL, and CD122 mRNA levels, while the expression of IFN{gamma} and granzyme B mRNA were unchanged (Figure 3D).\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Ccr5)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Cxcr3)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Fasl)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Il2rb)\n",
      "----------------------\n",
      "10034206 : To assess whether TCR signaling could account for these differences, T-betâ/â V{alpha}14i NKT cells were infected as previously, sorted, placed on anti-CD3/CD28âcoated plates for 2 days, and expanded in IL-2 for several days. Under these in vitro experimental conditions, CxCR3, CCR5, CD122, and CD95L mRNA levels were up-regulated in the T-betâexpressing cells, in agreement with our previous results.\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Ccr5)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Cxcr3)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Fasl)\n",
      "act(p(MGI:Tbx21)) -> r(MGI:Il2rb)\n",
      "----------------------\n",
      "10034224 : Ectopic T-bet expression in Th1beta cells promotes IFN-gamma secretion but decreases IL-17 production.\n",
      "act(p(MGI:Tbx21)) -> tloc(p(MGI:Ifng))\n",
      "act(p(MGI:Tbx21)) -| tloc(p(MGI:Il17a))\n",
      "----------------------\n",
      "10034234 : Hearts of transgenic embryos that expressed Tbx2 in the prechamber myocardium completely failed to form chambers and to express the chamber myocardium-specific genes Nppa, Cx40, and Chisel, whereas other cardiac genes were normally expressed.\n",
      "act(p(MGI:Tbx2)) -| r(MGI:Gja1)\n",
      "act(p(MGI:Tbx2)) -| r(MGI:Gja5)\n",
      "act(p(MGI:Tbx2)) -| r(MGI:Nppa)\n",
      "----------------------\n",
      "10012038 : PAR bZip-deficient mice show decreased brain levels of PLP, serotonin, and dopamine, and such changes have previously been reported to cause epilepsies in other systems.\n",
      "act(p(MGI:Tef)) -> a(CHEBI:dopamine)\n",
      "act(p(MGI:Tef)) -> a(CHEBI:serotonin)\n",
      "----------------------\n",
      "10034256 : thyroid hormone, which controls some fatty acid metabolism genes via its nuclear receptor (TR), seems to act negatively on Ppar action.\n",
      "act(p(MGI:Thra)) -| act(p(MGI:Ppara))\n",
      "act(p(MGI:Thra)) -| act(p(MGI:Pparg))\n",
      "act(p(MGI:Thrb)) -| act(p(MGI:Ppara))\n",
      "act(p(MGI:Thrb)) -| act(p(MGI:Pparg))\n",
      "----------------------\n",
      "10034258 : Moreover, the expression level of the transcription factor Brn3a, the AMPA receptors, GluR2, and GluR4, and VGLUT2 in Tlx3-expressing ES-derived cells became significantly higher than that in control cells after 4 days of neural induction, and this trend continued at neural induction day 7.\n",
      "act(p(MGI:Tlx3)) -> r(MGI:Gria2)\n",
      "act(p(MGI:Tlx3)) -> r(MGI:Gria4)\n",
      "act(p(MGI:Tlx3)) -> r(MGI:Pou4f1)\n",
      "act(p(MGI:Tlx3)) -> r(MGI:Slc17a6)\n",
      "----------------------\n",
      "10034268 : Compound mutant cells also show increased levels of p53 and induction of Noxa, a death effector p53 target gene, suggesting that cell death is potentially mediated by reactive oxygen species activation of p53.\n",
      "act(p(MGI:Trp53)) -> p(MGI:Pmaip1)\n",
      "act(p(MGI:Trp53)) -> r(MGI:Pmaip1)\n",
      "----------------------\n",
      "10012092 : Transfection of the macrophagelike cell line THP-1 with the GILZ gene inhibited the expression of CD80 and CD86\n",
      "act(p(MGI:Tsc22d3)) -| r(MGI:Cd80)\n",
      "act(p(MGI:Tsc22d3)) -| r(MGI:Cd86)\n",
      "----------------------\n",
      "10034294 : Twist-1 and -2 inhibited both basal and inducible activity of the IL-1 promoter (Figure 6A). Basal activity of the TNF promoter was also inhibited by both twists (Figure 6A).\n",
      "act(p(MGI:Twist1)) -| r(MGI:Il1a)\n",
      "act(p(MGI:Twist1)) -| r(MGI:Tnf)\n",
      "act(p(MGI:Twist2)) -| r(MGI:Il1a)\n",
      "act(p(MGI:Twist2)) -| r(MGI:Tnf)\n",
      "----------------------\n",
      "10034332 : ZEB also binds to the promoter of pivotal hematopoietic genes (including those encoding interleukin-2, CD4, GATA-3, and alpha(4)-integrin), and mice in which ZEB has been genetically targeted show thymic atrophy, severe defects in lymphocyte differentiation, and increased expression of the alpha(4)-integrin and CD4.\n",
      "act(p(MGI:Zeb1)) -| r(MGI:Cd4)\n",
      "act(p(MGI:Zeb1)) -| r(MGI:Gata3)\n",
      "act(p(MGI:Zeb1)) -| r(MGI:Il2)\n",
      "act(p(MGI:Zeb1)) -| r(MGI:Itga4)\n",
      "----------------------\n",
      "10034360 : The levels of phospho-p38 were increased 2-fold within 5 min of acrolein exposure.\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK14,pmod(P))\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK14,pmod(P))\n",
      "----------------------\n",
      "10034362 : A similar rapid response was observed with ERK, which was modestly (1.2 to 2.0-fold) stimulated 5 to 15 min of acrolein exposure (Fig. 4B).\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK1,pmod(P))\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK1,pmod(P))\n",
      "----------------------\n",
      "10034364 : After 30 min, treatment with 10 uM acrolein resulted in a 3.4- and 5.6-fold increase in the phosphorylation of p54 and p46, respectively.\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK8,pmod(P))\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK8,pmod(P))\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK9,pmod(P))\n",
      "a(CHEBI:acrolein) -> p(HGNC:MAPK9,pmod(P))\n",
      "----------------------\n",
      "10034424 : Here we demonstrate that cholesterol was absolutely required for polarized redistribution of key chemotactic mediators in human neutrophils in response to all chemoattractants tested (fMet-Leu-Phe, and the chemokines CXCL1, CXCL8 and CXCL12).\n",
      "a(CHEBI:cholesterol) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(HGNC:CXCL1) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "p(HGNC:IL8) -> bp(GOBP:\"neutrophil chemotaxis\")\n",
      "----------------------\n",
      "10034464 : Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).\n",
      "a(CHEBI:\"hyaluronic acid\") -> act(p(HGNC:TLR2))\n",
      "a(CHEBI:\"hyaluronic acid\") -> act(p(HGNC:TLR4))\n",
      "p(HGNC:HMGB1) -> act(p(HGNC:TLR2))\n",
      "p(HGNC:HMGB1) -> act(p(HGNC:TLR4))\n",
      "----------------------\n",
      "10034486 : we show that exposure to cigarette smoke over the indicated time points or doses results in an increase in total EGFR phosphorylation in a timeand dose-dependent manner (Fig. 1). As with EGF and H2O2, cigarette smoke is able to induce EGFR phosphorylation significantly compared to nontreated cells. Note: human airway epithelial (HAE; A549 or HBE1) were used in the paper\n",
      "a(CHEBI:\"hydrogen peroxide\") -> p(HGNC:EGFR,pmod(P))\n",
      "p(HGNC:EGF) -> p(HGNC:EGFR,pmod(P))\n",
      "----------------------\n",
      "10034532 : LipoxinA4 rapidly stimulates macrophages to phagocytose apoptotic neutrophils, induces RhoA- and Rac-dependent cytoskeleton re-organization of macrophages and inhibits macrophage CXCL8 release, supporting macrophage-mediated resolution of inflammation. In turn,as a result of engulfment of apoptotic neutrophils, macrophages themselves become a primary source of lipoxins\n",
      "a(CHEBI:\"lipoxin A4\") -> bp(GOBP:phagocytosis)\n",
      "a(CHEBI:\"lipoxin A4\") -> act(p(HGNC:RHOA))\n",
      "----------------------\n",
      "10034600 : We conclude that multiple TLR ligands induce airway epithelial cell production of IL-8 and VEGF via a Duox1--> ROS--> TACE--> TGF-alpha--> EGFR phosphorylation pathway.\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:ADAM17))\n",
      "act(p(HGNC:ADAM17)) -> p(HGNC:TGFA)\n",
      "----------------------\n",
      "10034612 : activated neutrophils secrete TNF, which induces EGFR expression in airway epithelial cells, activated neutrophils release reactive oxygen species, which activate EGFR , neutrophil elastase cleaves the EGFR proligand, pro-transforming growth factor (TGF)-alpha, releasing mature TGF alpha which activates EGFR in a ligand-dependent fashion , neutrophil elastase causes potent goblet cell degranulation\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:EGFR))\n",
      "p(HGNC:ELANE) -> p(HGNC:TGFA)\n",
      "----------------------\n",
      "10034624 : These data demonstrate that it is the hemin-induced surge in cellular ROS levels, in particular the superoxide generated most likely from NADPH oxidase activity, and consequent oxidative stress which mediates Egr-1 upregulation via ERK-1/2 activation.\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:MAPK1))\n",
      "a(CHEBI:\"reactive oxygen species\") -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10035008 : Reconstitution of the AT cells with wild-type ATM increases TonEBP/OREBP transactivating activity both at 300 and 500 mosmol/kg, but the inactive mutant, ATM S1981A, does not (Fig. 3E). We conclude that ATM regulates transactivating activity of TonEBP/OREBP.\n",
      "bp(GOBP:\"hyperosmotic response\") -> act(p(HGNC:ATM))\n",
      "act(p(HGNC:ATM)) -> act(p(HGNC:NFAT5))\n",
      "----------------------\n",
      "10035020 : Ag stimulation of Lyn unique domain transfectants was accompanied by enhanced phosphorylation of MEK and ERK-2, which are required for leukotriene C4 (LTC4) release, and production of LTC4 was increased 3- to 5-fold, compared with cells transfected with vector alone.\n",
      "bp(GOBP:\"mast cell activation\") -> a(CHEBI:\"leukotriene C4\")\n",
      "act(p(HGNC:LYN)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:MAPK1)) -> bp(GOBP:\"mast cell activation\")\n",
      "----------------------\n",
      "10035024 : Calgranulins comprise three proteins, S100A8 (calgranulin A), S100A9 (calgranulin B), and S100A12 (calgranulin C), that are predominantly released by necrotic neutrophils, monocytes, and activated macrophages, respectively, and stimulate TLR4 or RAGE (receptor for advanced glycation end-products)\n",
      "bp(GOBP:\"necrotic cell death\") -> p(HGNC:S100A12)\n",
      "bp(GOBP:\"necrotic cell death\") -> p(HGNC:S100A8)\n",
      "bp(GOBP:\"necrotic cell death\") -> p(HGNC:S100A9)\n",
      "----------------------\n",
      "10035026 : Multiple agents, including cigarette smoke (15), activated eosinophils (16), interleukin-13 (17), neutrophil elastase (18), Pseudomonas aeruginosa (19), and phorbol 12-myristate 13- acetate (PMA) (20) increase MUC5AC in airway epithelial cells (NCI-H292)...\n",
      "bp(GOBP:\"neutrophil activation\") -> p(HGNC:MUC5AC)\n",
      "p(EGID:1991) -> p(HGNC:MUC5AC)\n",
      "p(HGNC:IL13) -> p(HGNC:MUC5AC)\n",
      "----------------------\n",
      "10035034 : SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)\n",
      "bp(GOBP:\"replicative cell aging\") -> p(HGNC:IGFBP2)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:CCL5)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:CXCL5)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:IGFBP2)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:IGFBP3)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:IGFBP5)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:IL1A)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:KITLG)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:TNFRSF1B)\n",
      "bp(GOBP:\"stress-induced premature senescence\") -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10035040 : By Western blot analysis of senescing MDAH041 cells (PD 23), we observed increased expression of IRF5, IRF7, and STAT1 proteins during senescence, as well as an increase in STAT1 phosphorylation at Tyr701 (Fig. 1  ).\n",
      "bp(GOBP:\"replicative cell aging\") -> p(HGNC:IRF5)\n",
      "bp(GOBP:\"replicative cell aging\") -> p(HGNC:STAT1,pmod(P))\n",
      "----------------------\n",
      "10035054 : In the present study, we found that when RSK4 is inhibited in vitro using short hairpin RNA technology, cells can bypass stress-induced senescence and oncogene-induced senescence: normal human fibroblasts grew following oxidative stress, induction of DNA damage and KRAS(V12) or BRAF(E600) overexpression.\n",
      "bp(GOBP:\"cellular response to DNA damage stimulus\") -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "bp(GOBP:\"response to oxidative stress\") -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "----------------------\n",
      "10035058 : Oxidative stress and DNA damage can induce premature senescence in vascular cells, and it has been theorized that both processes contribute to atherogenesis.33,34\n",
      "bp(GOBP:\"cellular response to DNA damage stimulus\") -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "bp(GOBP:\"response to oxidative stress\") -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "----------------------\n",
      "10035062 : activation of the G2 checkpoint begins with the detection of DNA damage by the sensory molecules ATM and ATR\n",
      "bp(GOBP:\"cellular response to DNA damage stimulus\") -> act(p(HGNC:ATM))\n",
      "bp(GOBP:\"cellular response to DNA damage stimulus\") -> act(p(HGNC:ATR))\n",
      "----------------------\n",
      "10035074 : Excessive and prolonged ER stress triggers cell suicide, usually in the form of apoptosis, representing a last resort of multicellular organisms to dispense of dysfunctional cells. Progress in understanding the mechanisms underlying these 3 phases of adaptation, alarm, and apoptosis has improved our knowledge of ER stress, and its role in disease.\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> bp(GOBP:\"cell death\")\n",
      "bp(GOBP:\"response to endoplasmic reticulum stress\") -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10035186 : Intratumoral hypoxia and genetic alterations can lead to HIF-1a overexpression, which has been associated with increased patient mortality in several cancer types. In preclinical studies, inhibition of HIF-1 activity has marked effects on tumour growth. Efforts are underway to identify inhibitors of HIF-1 and to test their efficacy as anticancer therapeutics.\n",
      "bp(GOBP:\"response to hypoxia\") -> act(p(HGNC:HIF1A))\n",
      "complex(p(HGNC:HIF1A),p(HGNC:ARNT)) -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10035282 : VEGF enhanced cell adhesion, migration, soluble ligand binding, and adenovirus gene transfer mediated by alphavbeta3 and also activated other integrins, alphavbeta5, alpha5beta1, and alpha2beta1, involved in angiogenesis.  The major findings of our studies are as follows. First, VEGF165 can activate integrin aVb3, leading to enhanced adhesion of endothelial cells to a variety of ligands.\n",
      "act(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) -> bp(GOBP:\"cell adhesion\")\n",
      "act(complex(p(HGNC:ITGA5),p(HGNC:ITGB1))) -> bp(GOBP:\"cell adhesion\")\n",
      "act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) -> bp(GOBP:\"cell adhesion\")\n",
      "----------------------\n",
      "10035284 : Major functions of the alpha2beta1 receptor include the induction of MMP1, % MMP13 and MT1-MMP, as well as activation of proMMP2\n",
      "act(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) -> act(p(HGNC:MMP14))\n",
      "act(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) -> act(p(HGNC:MMP1))\n",
      "act(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) -> act(p(HGNC:MMP2))\n",
      "----------------------\n",
      "10035290 : TGF-B is a potent regulator of cellular adhesion, motility, and the extracellular matrix. TGF-B regulates the adhesive properties of cells by decreasing the expression of E-cadherin59 to decrease cell adhesion, by increasing the expression of invasion-associated integrins including AIIIB1 integrin, and by increasing the expression of integrin-binding proteins including fibulin\n",
      "act(complex(p(HGNC:ITGA3),p(HGNC:ITGB1))) -| bp(GOBP:\"cell adhesion\")\n",
      "p(HGNC:TGFB1) -| p(HGNC:CDH1)\n",
      "----------------------\n",
      "10035292 : MMP-2 binds to ?v?3 at the cell surface, and blocking this binding inhibits MMP-2 protease activity in cultured cells, suppressing angiogenesis and tumour growth in chorioallantoic membrane assays43.Conversely, the membrane MMP (MT-1) cleaves ?v?3, enhancing the ligand binding activity of this integrin44. So,?v?3 seems to be important in regulating angiogenesis in adult animals.\n",
      "act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) -> act(p(HGNC:MMP2))\n",
      "act(p(HGNC:MMP14)) -> act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))\n",
      "----------------------\n",
      "10035300 : VEGFR-2 phosphorylation and mitogenicity induced by VEGF-A165 were enhanced in cells plated on the alphavbeta3 ligand, vitronectin\n",
      "act(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) -> act(p(HGNC:KDR))\n",
      "act(p(HGNC:KDR)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10035302 : For example, integrin a5b1 binding to fibronectin suppresses cell migration [48], while aVb6-mediated fibronectin binding promotes it [49].\n",
      "act(complex(p(HGNC:ITGAV),p(HGNC:ITGB6))) -> bp(GOBP:\"cell migration\")\n",
      "p(HGNC:FN1) -> complex(p(HGNC:ITGA5),p(HGNC:ITGB1))\n",
      "p(HGNC:FN1) -> complex(p(HGNC:ITGAV),p(HGNC:ITGB6))\n",
      "----------------------\n",
      "10035322 : Mechanistic studies revealed that HER2 trans-activation by IL-1?? required a disintegrin and metalloprotease 17 (ADAM17)-dependent shedding of the ligand neuregulin-1 (NRG-1). In murine models of ALI, NRG-1-HER2 signaling was activated, and ADAM17 blockade resulted in decreased NRG-1 shedding, HER2 activation, and lung injury in vivo.\n",
      "act(p(HGNC:ADAM17)) -> p(HGNC:NRG1)\n",
      "p(HGNC:IL1B) -> act(p(HGNC:ADAM17))\n",
      "p(HGNC:NRG1) -> act(p(HGNC:ERBB2))\n",
      "----------------------\n",
      "10035340 : In addition to NF-?B, among the known pathways that can be activated by RAGE are phosphoinositide 3-kinases (PI3K)/Akt (also termed as protein kinase B), and mitogen-activated protein kinase members (MAPKs) (52,53). The latter group includes Jun-N-terminal kinase (JNK), p38, and extracellular signal-regulated kinases (ERK) (54,55) (Figure 2).\n",
      "act(p(HGNC:AGER)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:AGER)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10035358 : In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A\n",
      "act(p(HGNC:APEX1)) -> bp(GOBP:\"single strand break repair\")\n",
      "act(p(HGNC:POLA1)) -> bp(GOBP:\"single strand break repair\")\n",
      "act(p(HGNC:POLB)) -> bp(GOBP:\"single strand break repair\")\n",
      "act(p(HGNC:POLE)) -> bp(GOBP:\"single strand break repair\")\n",
      "act(p(HGNC:UNG)) -> bp(GOBP:\"single strand break repair\")\n",
      "act(p(HGNC:XRCC1)) -> bp(GOBP:\"single strand break repair\")\n",
      "p(HGNC:CCNA2) -> bp(GOBP:\"single strand break repair\")\n",
      "----------------------\n",
      "10035364 : another family share only the short BH3 domain, which is necessary and probably sufficient for their killing activity this family contains Bim, Bik, Bad, Puma, Bid, Noxa, Hrk, and Bmf\n",
      "act(p(HGNC:BAD)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:BCL2L11)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:BID)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10035386 : In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells.\n",
      "act(p(HGNC:BBC3)) -> act(p(HGNC:BAX))\n",
      "act(p(HGNC:BBC3)) -> act(p(HGNC:BAK1))\n",
      "act(p(HGNC:PMAIP1)) -> act(p(HGNC:BAK1))\n",
      "act(p(HGNC:PMAIP1)) -> act(p(HGNC:BAX))\n",
      "----------------------\n",
      "10035392 : Bcl2 and 4 relatives, Bcl-xl, Bcl-w, A1 and Mcl-1, promote cell survival\n",
      "act(p(HGNC:BCL2)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:BCL2L1)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10035398 : from full text - STAT-3 itself induces the anti-apoptotic factors Bcl-2 and Bcl-xL\n",
      "act(p(HGNC:BCL2)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:BCL2L1)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10035402 : Pro-death Bcl-2 family members are sequestered in the cytoplasm until activated, at which time they complex with Bcl-2 or Bcl-xL and inhibit their function\n",
      "act(p(HGNC:BCL2)) -| bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:BCL2L1)) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10035408 : We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).\n",
      "act(p(HGNC:BCL2L11)) -> act(p(HGNC:BAK1))\n",
      "act(p(HGNC:BCL2L11)) -> act(p(HGNC:BAX))\n",
      "act(p(HGNC:BID)) -> act(p(HGNC:BAK1))\n",
      "act(p(HGNC:BID)) -> act(p(HGNC:BAX))\n",
      "----------------------\n",
      "10035418 : We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A).\n",
      "act(p(HGNC:BCL2L1)) -| act(p(HGNC:BAK1))\n",
      "act(p(HGNC:BCL2L1)) -| act(p(HGNC:BAX))\n",
      "act(p(HGNC:MCL1)) -| act(p(HGNC:BAK1))\n",
      "act(p(HGNC:MCL1)) -| act(p(HGNC:BAX))\n",
      "----------------------\n",
      "10035420 : NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).\n",
      "act(p(HGNC:BCL2L1)) -| act(p(HGNC:BAX))\n",
      "p(HGNC:CFLAR) -| act(p(HGNC:FADD))\n",
      "act(p(HGNC:TP53)) -| p(HGNC:BCL2)\n",
      "----------------------\n",
      "10035422 : Oxaliplatin-induced apoptosis, potentiated by kinase-defective c-Src mutants, was dependent on activation of caspase 8 and associated with Bid cleavage.\n",
      "act(p(HGNC:BID)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP8)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP8)) -> act(p(HGNC:BID))\n",
      "----------------------\n",
      "10035424 : STAT3 is also able to prevent cell death through inhibition of the extrinsic apoptotic pathway. This pathway is activated upon binding of extracellular ligands such as FAS ligand (FAS-L) to cell-surface death receptors. Upon interaction with FAS-L, the FAS death receptor induces cell death through caspase-8 activation and truncation of the death agonist BID.\n",
      "act(p(HGNC:BID)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP8)) -> act(p(HGNC:BID))\n",
      "----------------------\n",
      "10035434 : Upon activation, NLRP3 forms a so-called inflammasome complex with the adaptor molecule ASC, which controls the activation of caspase-1. Activated caspase-1, in turn, cleaves pro-IL-1b and pro-IL-18 into the biologically active, secreted forms (9).\n",
      "act(p(HGNC:CASP1)) -> p(HGNC:IL1B)\n",
      "act(p(HGNC:CASP1)) -> p(HGNC:IL8)\n",
      "----------------------\n",
      "10035436 : initiator caspases - casp8,10,9,1,5a,4a,12a,2\n",
      "act(p(HGNC:CASP2)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP4)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP8)) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10035446 : figure 1 - conservation of caspase clevage sites\n",
      "act(p(HGNC:CASP3)) -> deg(p(HGNC:LMNB1))\n",
      "act(p(HGNC:CASP3)) -> deg(p(HGNC:LMNB2))\n",
      "----------------------\n",
      "10035456 : by Western analysis, electron microscopy, and immunoflourescence, there is increased expression of the autophagic proteins LC3B-II/LC3B-I, Atg4, Atg5-artg12, and Atg7, as well as increased numbers of different stages of autophagic vacuoles in the lungs of COPD patients in all GOLD categories, with a corresponding increase in caspase 3 activity, a marker of apoptosis in GOLD 3/4 patients.54\n",
      "act(p(HGNC:CASP3)) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:ATG4A) -> bp(GOBP:autophagy)\n",
      "p(HGNC:ATG5) -> bp(GOBP:autophagy)\n",
      "p(HGNC:ATG7) -> bp(GOBP:autophagy)\n",
      "p(HGNC:MAP1LC3A) -> bp(GOBP:autophagy)\n",
      "----------------------\n",
      "10035470 : Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice.\n",
      "act(p(HGNC:CASP3)) -> bp(GOBP:\"apoptotic process\")\n",
      "act(p(HGNC:CASP3)) -> path(MESHD:Emphysema)\n",
      "----------------------\n",
      "10035484 : when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7\n",
      "act(p(HGNC:CASP8)) -> act(p(HGNC:CASP3))\n",
      "act(p(HGNC:CASP9)) -> act(p(HGNC:CASP3))\n",
      "act(p(HGNC:CASP9)) -> act(p(HGNC:CASP6))\n",
      "act(p(HGNC:CASP9)) -> act(p(HGNC:CASP7))\n",
      "----------------------\n",
      "10035488 : c-Flip inhibits apoptosis by blocking the activation of caspase-8.\n",
      "act(p(HGNC:CASP8)) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:CFLAR) -| act(p(HGNC:CASP8))\n",
      "----------------------\n",
      "10035548 : Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF) alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction.\n",
      "act(p(HGNC:EGLN1)) -> deg(p(HGNC:HIF1A))\n",
      "act(p(HGNC:EGLN2)) -> deg(p(HGNC:HIF1A))\n",
      "act(p(HGNC:EGLN3)) -> deg(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10035590 : At such low concentration, ethanol-induced apoptosis in human hepatocellular carcinoma (HepG2) cells is triggered by activation of the Fas receptor, a member of the tumor necrosis family, with subsequent activation of the intracellular adapter protein FADD (Fas Associated Death Domain) and caspase-8.\n",
      "act(p(HGNC:FADD)) -> act(p(HGNC:CASP8))\n",
      "act(p(HGNC:FAS)) -> act(p(HGNC:FADD))\n",
      "----------------------\n",
      "10035594 : It also associates with death domain-containing adaptor proteins, such as TNF-receptor-associated death domain  (TRADD) and Fas-associated death domain (FADD), that are required for caspase-8  activation and apoptosis ([Schutze et al., 2008] and [Wilson et al., 2009])\n",
      "act(p(HGNC:FADD)) -> act(p(HGNC:CASP8))\n",
      "act(p(HGNC:TRADD)) -> act(p(HGNC:CASP8))\n",
      "----------------------\n",
      "10035616 : As mentioned above, GGT is the only enzyme located on the external surface of epithelial cells that is able to hydrolyze the peptidic bond of GSH to provide a continuous source of cysteine through the ?-glutamyl cycle. As such GGT plays an integral role in GSH homeostasis and has been traditionally regarded as a component of the cellular defense system against oxidative stress (Pompella et al., 2007).\n",
      "act(p(HGNC:GGT1)) -| a(CHEBI:glutathione)\n",
      "act(p(HGNC:GGT1)) -> a(CHEBI:cysteine)\n",
      "----------------------\n",
      "10035620 : Importantly, knockdown of PYGL, GLUL, or GLUD1  partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells\n",
      "act(p(HGNC:GLUD1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:GLUL)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:PYGL)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10035622 : RIP3 increases the activities of glycogen phosphorylase, glutamate ammonia ligase, and glutamate dehydrogenase 1. This stimulates the production of reactive oxygen species (ROS) due to increased oxidative phosphorylation. In some cells, ROS production as a consequence of RIP3 signaling is required for necroptosis\n",
      "act(p(HGNC:GLUD1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:GLUL)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:PYGL)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:RIPK3)) -> act(p(HGNC:GLUD1))\n",
      "act(p(HGNC:RIPK3)) -> act(p(HGNC:GLUL))\n",
      "act(p(HGNC:RIPK3)) -> act(p(HGNC:PYGL))\n",
      "----------------------\n",
      "10035632 : we provide evidence that Ski-mediated repression of PU.1 is due to Ski's ability to recruit histone deacetylase 3 to PU.1 bound to DNA.\n",
      "act(p(HGNC:HDAC3)) -| act(p(HGNC:SPI1))\n",
      "act(p(HGNC:SKI)) -> act(p(HGNC:HDAC3))\n",
      "----------------------\n",
      "10035652 : p38 MAPK was required for the IL-33-mediated responses of endothelial cells, whereas ERK was required for IL-33-mediated IL-8 production by epithelial cells.\n",
      "act(p(HGNC:IL1RL1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:IL1RL1)) -> act(p(HGNC:MAPK3))\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:IL8)\n",
      "act(p(HGNC:MAPK3)) -> p(HGNC:IL8)\n",
      "----------------------\n",
      "10035654 : we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).\n",
      "act(p(HGNC:IL1RL1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:IL1RL1)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10035684 : from full text - The avb6 integrin mediates activation of TGF-b through a mechanism involving the conformational alteration of TGF-b; the avb8 integrin mediates activation of TGF-b through the transmembrane matrix-metalloprotease- 1 (MT1-MMP)-dependent cleavage\n",
      "act(p(HGNC:MMP14)) -> p(HGNC:TGFB1)\n",
      "complex(p(HGNC:ITGAV),p(HGNC:ITGB6)) -> p(HGNC:TGFB1)\n",
      "complex(p(HGNC:ITGAV),p(HGNC:ITGB8)) -> act(p(HGNC:MMP14))\n",
      "----------------------\n",
      "10035686 : This gene encodes a secreted enzyme which breaks down the interstitial collagens, types I, II, and III.\n",
      "act(p(HGNC:MMP1)) -> deg(p(HGNC:COL1A1))\n",
      "act(p(HGNC:MMP1)) -> deg(p(HGNC:COL1A2))\n",
      "act(p(HGNC:MMP1)) -> deg(p(HGNC:COL2A1))\n",
      "act(p(HGNC:MMP1)) -> deg(p(HGNC:COL3A1))\n",
      "----------------------\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10035688 : Figure 2. Inhibition by doxycycline (DOXY) of digestion of type II collagen by collagenases 1, 2, or 3.\n",
      "act(p(HGNC:MMP1)) -> deg(p(HGNC:COL2A1))\n",
      "act(p(HGNC:MMP8)) -> deg(p(HGNC:COL2A1))\n",
      "----------------------\n",
      "10035696 : This gene encodes an enzyme which degrades type IV collagen, the major structural component of basement membranes. The enzyme plays a role in endometrial menstrual breakdown, regulation of vascularization and the inflammatory response.\n",
      "act(p(HGNC:MMP2)) -> deg(p(HGNC:COL4A1))\n",
      "act(p(HGNC:MMP2)) -> deg(p(HGNC:COL4A2))\n",
      "----------------------\n",
      "10035706 : TPO to c-Mpl (a receptor tyrosine kinase) activates both Janus Kinase 2 (JAK2) and Tyk2\n",
      "act(p(HGNC:MPL)) -> act(p(HGNC:JAK2))\n",
      "act(p(HGNC:MPL)) -> act(p(HGNC:TYK2))\n",
      "----------------------\n",
      "10035712 : MyD88 promotes association with IRAK4 and IRAK1.  During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK1, which then induces interaction of TRAF6 with the complex.\n",
      "act(p(HGNC:MYD88)) -> act(p(HGNC:IRAK4))\n",
      "act(p(HGNC:IRAK4)) -> act(p(HGNC:IRAK1))\n",
      "----------------------\n",
      "10035748 : Moreover, in vascular SMCs, uPA increases ROS production (Menshikov et al. 2006b). Using small interfering RNA (siRNA), we proved that the NAD(P)H oxidases Nox1 and Nox4 are the primary source of ROS generation stimulated by uPA in vascular SMCs\n",
      "act(p(HGNC:NOX1)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:NOX4)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10035776 : Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.We provide evidence that uPAR activation by uPA induces its association with platelet-derived growth factor receptor (PDGFR)-beta. The interaction results in PDGF-independent PDGFR-beta activation by phosphorylation of cytoplasmic tyrosine kinase domains and receptor dimerization.\n",
      "act(p(HGNC:PLAU)) -> complex(p(HGNC:PDGFRB),p(HGNC:PLAUR))\n",
      "complex(p(HGNC:PDGFRB),p(HGNC:PLAUR)) -> act(p(HGNC:PDGFRB))\n",
      "----------------------\n",
      "10035820 : Inhibition of cyclooxygenase-2 activity by specific chemical inhibitor or siRNA attenuates the H(2)O(2)-induced increase of senescence associated beta-galactosidase positive cells and attenuates growth arrest. In this work, p38(MAPK) activation and increased DNA binding activities of ATF-2 and p53 are shown to mediate cyclooxygenase-2 overexpression in premature senescence.\n",
      "act(p(HGNC:PTGS2)) -> bp(GOBP:\"stress-induced premature senescence\")\n",
      "act(p(HGNC:ATF2)) -> act(p(HGNC:PTGS2))\n",
      "act(p(HGNC:TP53)) -> act(p(HGNC:PTGS2))\n",
      "----------------------\n",
      "10035840 : Smo is targeted to cilia and activates Gli proteins in a cilia-dependent manner.\n",
      "act(p(HGNC:SMO)) -> act(p(HGNC:GLI1))\n",
      "act(p(HGNC:SMO)) -> act(p(HGNC:GLI2))\n",
      "act(p(HGNC:SMO)) -> act(p(HGNC:GLI3))\n",
      "----------------------\n",
      "10035850 : Copper-Zinc (Cu-Zn), manganese (Mn), and extracellular (EC) superoxide dismutase (SOD) are three main isoforms of the enzymatic system that catalyzes superoxide to hydrogen peroxide. These enzymes play a central role in the protection against oxidative stress originated from cellular oxygenases and from mitochondrial sources.\n",
      "act(p(HGNC:SOD1)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:SOD2)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(HGNC:SOD3)) -| a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10035872 : TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway\n",
      "act(p(HGNC:TICAM1)) -> act(p(HGNC:IRF3))\n",
      "act(p(HGNC:TLR3)) -> act(p(HGNC:TICAM1))\n",
      "act(p(HGNC:TLR3)) -> act(p(HGNC:IRF3))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:TICAM1))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:IRF3))\n",
      "----------------------\n",
      "10035876 : while TRAM recruits TRIF to TLR4 for activation of IRF3.\n",
      "act(p(HGNC:TICAM1)) -> act(p(HGNC:IRF3))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:TICAM1))\n",
      "----------------------\n",
      "10035882 : To determine if the ERK-MAPK pathway was also activated by TLR2 in megakaryocytes, lysates of Meg-01 cells were treated with 1 ?g/mL Pam3CSK4 for up to 1 hour and were immunoblotted for phosphorylated ERK1/2. As shown in Figure 1A, there was an increase in the phosphorylation of ERK beginning at 5 minutes that peaks at 30 minutes (105.8% Â±3.9).\n",
      "act(p(HGNC:TLR2)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:TLR2)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10035908 : F ig. 2. Effect of Toll-like receptor signalling on macrophage cholesterol metabolism. Stimulation of TLR3 or TLR4 leads to TRIFdependent activation of IRF3, which inhibits transcription of liver X receptor-dependent genes, many of which (e.g. ATP-binding cassette transporter A1, PLTP, apoE and ABCG-1) are critically involved in the efflux of cholesterol from macrophages.\n",
      "act(p(HGNC:TLR3)) -> act(p(HGNC:IRF3))\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:IRF3))\n",
      "----------------------\n",
      "10035916 : MyD88 also interacts with IRF5 and IRF1 and is required for the activation of these IRFs. IRF5 was identified as being crucial for the induction of proinflammatory cytokines and type I IFNs by all TLRs tested...other TLR4-mediated MyD88-dependent signals, such as IRF5 activation,\n",
      "act(p(HGNC:TLR4)) -> act(p(HGNC:MYD88))\n",
      "act(p(HGNC:TLR4)) -> p(HGNC:MYD88)\n",
      "----------------------\n",
      "10035988 : Regulation of the stability of the PRC1 complex also appears to be another facet, as the de-ubiquitination of the PRC1 components BMI1 and MEL18 by the ubiquitin-specific proteases 7 and 11 has been shown to increase their abundance (Maertens et al., 2010), whereas the loss of these ubiquitin-specific proteases promotes INK4A transcriptional activation.\n",
      "act(p(HGNC:USP11)) -> p(HGNC:BMI1)\n",
      "act(p(HGNC:USP11)) -> p(HGNC:PCGF2)\n",
      "act(p(HGNC:USP7)) -> p(HGNC:BMI1)\n",
      "act(p(HGNC:USP7)) -> p(HGNC:PCGF2)\n",
      "----------------------\n",
      "10036028 : Upon stimulation with soluble CD154, cultured fibroblasts induced to express CD40 by adenoviral gene transfer proliferated and showed up-regulation of the genes for intercellular adhesion molecule 1, interleukin-6 (IL-6), IL-8, monocyte chemoattractant protein 1 (MCP-1), and RANTES, as well as up-regulation of their proteins.\n",
      "complex(p(HGNC:CD40LG),p(HGNC:CD40)) -> p(HGNC:CCL2)\n",
      "complex(p(HGNC:CD40LG),p(HGNC:CD40)) -> p(HGNC:CCL5)\n",
      "complex(p(HGNC:CD40LG),p(HGNC:CD40)) -> p(HGNC:IL6)\n",
      "complex(p(HGNC:CD40LG),p(HGNC:CD40)) -> p(HGNC:IL8)\n",
      "----------------------\n",
      "10036030 : In human HaCaT keratinocytes for instance, ERK1/2 phosphorylation increases in dependence of EGF-R recruitment to transadhering E-cadherin, and E-cadherin-mediated activation of MAPK was also reported in intestinal epithelial cells (Pece and Gutkind, 2000; Laprise et al., 2004).\n",
      "complex(p(HGNC:CDH1),p(HGNC:EGFR)) -> act(p(HGNC:MAPK1))\n",
      "complex(p(HGNC:CDH1),p(HGNC:EGFR)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10036052 : S6K and RSK phosphorylate eIF4B at Ser422, thus enhancing its interaction with the eIF3 and promoting protein translation (Shahbazian et al., 2006).\n",
      "complex(p(HGNC:EIF4E),p(HGNC:EIF3A)) -> bp(GOBP:\"protein metabolic process\")\n",
      "act(p(HGNC:RPS6KA1)) -> p(HGNC:EIF4E,pmod(P))\n",
      "act(p(HGNC:RPS6KB1)) -> p(HGNC:EIF4E,pmod(P))\n",
      "p(HGNC:EIF4E,pmod(P)) -> complex(p(HGNC:EIF4E),p(HGNC:EIF3A))\n",
      "----------------------\n",
      "10036086 : In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.\n",
      "complex(p(HGNC:JUNB),p(HGNC:NFE2L1)) -> act(p(HGNC:NFE2L1))\n",
      "complex(p(HGNC:JUNB),p(HGNC:NFE2L2)) -> act(p(HGNC:NFE2L2))\n",
      "complex(p(HGNC:JUND),p(HGNC:NFE2L1)) -> act(p(HGNC:NFE2L1))\n",
      "complex(p(HGNC:JUND),p(HGNC:NFE2L2)) -> act(p(HGNC:NFE2L2))\n",
      "complex(p(HGNC:JUN),p(HGNC:NFE2L1)) -> act(p(HGNC:NFE2L1))\n",
      "complex(p(HGNC:JUN),p(HGNC:NFE2L2)) -> act(p(HGNC:NFE2L2))\n",
      "----------------------\n",
      "10036090 : MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2\n",
      "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) -> act(p(HGNC:ATM))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:CHEK2,pmod(P))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:H2AFX,pmod(P))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:TP53,pmod(P))\n",
      "----------------------\n",
      "10036100 : Bif-1 interacts with Beclin 1 through UVRAG and functions as a positive mediator of the class III PI3K, and its knockout significantly enhances the development of spontaneous tumors in mice.\n",
      "complex(p(HGNC:SH3GLB1),p(HGNC:UVRAG)) -> complex(p(HGNC:PIK3C3),p(HGNC:BECN1))\n",
      "p(HGNC:SH3GLB1) -> act(p(HGNC:PIK3C3))\n",
      "----------------------\n",
      "10036104 : from full text - Smad2 and Smad3 are bound to SARA (SMAD anchor for receptor activation) in the cytoplasm (Tsukazaki et al., 1998) which presents Smad2 and Smad3 to the activated TGF-b receptor complex. TbRI then directly phosphorylates the carboxy terminal of Smad2 and Smad3, resulting in decreased affinity to SARA and heterotrimerization of Smad2 and Smad3 with Smad4  (SARA = ZFYVE9)\n",
      "complex(p(HGNC:SMAD2),p(HGNC:SMAD3),p(HGNC:SMAD4)) -> act(p(HGNC:SMAD2))\n",
      "complex(p(HGNC:SMAD2),p(HGNC:SMAD3),p(HGNC:SMAD4)) -> act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10036122 : Serine-642 was identified as an Akt-dependent phosphorylation site. WEE1Hu kinase activity was not affected by serine-642 phosphorylation. We revealed that serine-642 phosphorylation promoted cytoplasmic localization of WEE1Hu. The nuclear-to-cytoplasmic translocation was mediated by phosphorylation-dependent WEE1Hu binding to 14-3-3theta but not 14-3-3beta or -sigma preventing Y15 phosphorylation of Cdc2 by WEE1.\n",
      "complex(p(HGNC:YWHAQ),p(HGNC:WEE1)) -> tloc(p(HGNC:WEE1))\n",
      "p(HGNC:WEE1,pmod(P)) -> complex(p(HGNC:YWHAQ),p(HGNC:WEE1))\n",
      "----------------------\n",
      "10036488 : Expression of N17Ras attenuated activation of ERK (Figure 4A) and JNK (Figure 4B). In contrast, selective activation of Ras was sufficient for ERK but not JNK activation.\n",
      "act(p(HGNC:HRAS)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:HRAS)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10035784 : Figure 1 | The ErbB signalling network.\n",
      "act(p(HGNC:KRAS)) -> act(p(HGNC:RAF1))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:RAC1))\n",
      "act(p(HGNC:MAP2K4)) -> act(p(HGNC:MAPK8))\n",
      "act(p(HGNC:MAP2K4)) -> act(p(HGNC:MAPK9))\n",
      "act(p(HGNC:MAPK8)) -> act(p(HGNC:JUN))\n",
      "act(p(HGNC:MAPK9)) -> act(p(HGNC:JUN))\n",
      "----------------------\n",
      "10036524 : Finally, we determined that STAT3 expression is required for PDGF-mediated regulation of cell cycle targets cyclin D3 and p27. These data define a novel mitogenic signaling pathway in airway smooth muscle cells leading from PDGF to Rac1 and STAT3 and subsequent cell cycle gene regulation\n",
      "act(p(HGNC:RAC1)) -> act(p(HGNC:STAT3))\n",
      "act(p(HGNC:STAT3)) -> p(HGNC:CCND3)\n",
      "act(p(HGNC:STAT3)) -> p(HGNC:CDKN1B)\n",
      "----------------------\n",
      "10036608 : Recently, it has been demonstrated that Thr229 phosphorylation is mediated by PDK1 (15, 16), whereas Thr389 as well as Ser411, Thr421, and Ser424 phosphorylation have been shown to be regulated by mTOR (17).\n",
      "act(p(EGID:2475)) -> p(HGNC:RPS6KB1,pmod(P))\n",
      "act(p(EGID:2475)) -> p(HGNC:RPS6KB1,pmod(P))\n",
      "act(p(EGID:2475)) -> p(HGNC:RPS6KB1,pmod(P))\n",
      "----------------------\n",
      "10036622 : TGF-? activated ALK1 can phosphorylate Smad1 and Smad5, and consequently, promote endothelial migration, an effect mediated through induction of the dominant-negative helixloop- helix transcription factor Id1 which can promote cell proliferation.151, 154\n",
      "act(p(HGNC:ACVRL1)) -> act(p(HGNC:SMAD1))\n",
      "act(p(HGNC:ACVRL1)) -> act(p(HGNC:SMAD5))\n",
      "----------------------\n",
      "10036626 : GSK3b phosphorylation of Bcl3 has previously been shown to result in its degradation (Viatour et al., 2004), whereas GSK3b activity can be repressed by Akt (PKB) induced phosphorylation on serine 9 (Emamian et al., 2004).\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:GSK3B,pmod(P))\n",
      "p(HGNC:GSK3B,pmod(P)) -| act(p(HGNC:GSK3B))\n",
      "----------------------\n",
      "10036628 : Akt then phosphorylates tuberin on three residues (S939, S1130 and T1462 of full length human tuberin), and this inhibits the tuberin-hamartin complex through an as-yet-undefined mechanism (reviewed in [8]).\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:TSC2,pmod(P))\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:TSC2,pmod(P))\n",
      "p(HGNC:TSC2,pmod(P)) -| act(complex(p(HGNC:TSC1),p(HGNC:TSC2)))\n",
      "----------------------\n",
      "10036630 : Figure 4. S939 and T1462 Are the Major PI3K-Dependent Phosphorylation Sites on Tuberin\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:TSC2,pmod(P))\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:TSC2,pmod(P))\n",
      "p(HGNC:TSC2,pmod(P)) -| act(p(HGNC:TSC2))\n",
      "----------------------\n",
      "10036660 : we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells\n",
      "act(p(HGNC:ATM)) -> p(HGNC:BRCA1,pmod(P))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:BRCA1,pmod(P))\n",
      "act(p(HGNC:ATM)) -> p(HGNC:BRCA1,pmod(P))\n",
      "----------------------\n",
      "10036680 : The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)\n",
      "act(p(HGNC:ATM)) -> p(HGNC:H2AFX,pmod(P))\n",
      "act(p(HGNC:PRKDC)) -> p(HGNC:H2AFX,pmod(P))\n",
      "----------------------\n",
      "10036136 : The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAâPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.\n",
      "act(p(HGNC:ATM)) -> act(p(HGNC:TP53))\n",
      "act(p(HGNC:CHEK1)) -> act(p(HGNC:TP53))\n",
      "act(p(HGNC:CHEK2)) -> act(p(HGNC:TP53))\n",
      "----------------------\n",
      "10036708 : Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.\n",
      "act(p(HGNC:ATR)) -> p(HGNC:CHEK1,pmod(P))\n",
      "p(HGNC:CHEK1,pmod(P)) -> act(p(HGNC:CHEK1))\n",
      "----------------------\n",
      "10036198 : cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin\n",
      "act(p(HGNC:CDK2)) -> p(HGNC:CTNNB1,pmod(P))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "p(HGNC:CTNNB1,pmod(P)) -> deg(p(HGNC:CTNNB1))\n",
      "----------------------\n",
      "10036730 : \\\"progression through G1 phase of cell cycle requires phosphorylation of the retinoblastoma gene product (pRb) by the cyclin D-dependent serine-threonine kinases CDK4 and CDK6\n",
      "act(p(HGNC:CDK4)) -> p(HGNC:RB1,pmod(P))\n",
      "act(p(HGNC:CDK6)) -> p(HGNC:RB1,pmod(P))\n",
      "p(HGNC:RB1,pmod(P)) -| act(p(HGNC:RB1))\n",
      "----------------------\n",
      "10036732 : The primary substrates of CDK4/6 and CDK2 in G1 progression are the members of the retinoblastoma protein family  RB,p107 and p130 The activity of the RB proteins is modulated by sequential phosphorylation by CDK4/6cyclinD and CDK2cyclinE complexes\n",
      "act(p(HGNC:CDK4)) -> p(HGNC:RBL1,pmod(P))\n",
      "act(p(HGNC:CDK6)) -> p(HGNC:RBL1,pmod(P))\n",
      "----------------------\n",
      "10036736 : Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha.\n",
      "act(p(HGNC:CHEK1)) -> p(HGNC:TP73,pmod(P))\n",
      "p(HGNC:TP73,pmod(P)) -> act(p(HGNC:TP73))\n",
      "----------------------\n",
      "10036758 : activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK3))\n",
      "act(p(HGNC:RAF1)) -> act(p(HGNC:MAPK3))\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10036760 : addition of AG1478 also suppressed ATP-mediated phosphorylation of ERK1/2 and I-?B? (Fig. 4A), indicating the involvement of EGFR activation in these signaling events.\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10036762 : An important finding is that intact BRCA1 also prevents EGF and IGF-I signaling through ERK to cell proliferation. EGF and IGF-1 are strongly implicated in the biology of human breast cancer, where they signal through this member of the MAP kinase family to cell growth (27, 52).\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:MAPK1)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10036768 : Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:EGFR)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10036806 : Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. This leads to nuclear export, ubiquitination, and degradation of Nrf2\n",
      "act(p(HGNC:FYN)) -> p(HGNC:NFE2L2,pmod(P))\n",
      "p(HGNC:NFE2L2,pmod(P)) -| tloc(p(HGNC:NFE2L2))\n",
      "----------------------\n",
      "10036370 : Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005\n",
      "act(p(HGNC:IKBKB)) -| p(HGNC:NFKBIA)\n",
      "p(HGNC:NFKBIA,pmod(P)) -> deg(p(HGNC:NFKBIA))\n",
      "p(HGNC:NFKBIA,pmod(P)) -> deg(p(HGNC:NFKBIA))\n",
      "----------------------\n",
      "10036844 : Here we demonstrate, using several different approaches, that inhibiting ILK kinase activity, or expression, results in the inhibition of cell attachment, cell migration, F-actin organization, and the specific cytoskeletal localization of CH-ILKBP and paxillin in human cells.\n",
      "act(p(HGNC:ILK)) -> bp(GOBP:\"cell adhesion\")\n",
      "act(p(HGNC:ILK)) -> bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10035974 : FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined.\n",
      "act(p(HGNC:IRAK1)) -> act(p(HGNC:TRAF6))\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:ITGAM)\n",
      "act(p(HGNC:MAPK3)) -> p(HGNC:ITGAM)\n",
      "----------------------\n",
      "10036876 : ligand-receptor binding activated STAT3, STAT5 and STAT6\n",
      "act(p(HGNC:JAK2)) -> act(p(HGNC:STAT3))\n",
      "act(p(HGNC:JAK2)) -> act(p(HGNC:STAT5B))\n",
      "act(p(HGNC:JAK3)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10036878 : IL-12 activates the Janus family tyrosine kinases JAK2 and Tyk2, which in turn phosphorylate STAT4 on tyrosine 693.\n",
      "act(p(HGNC:JAK2)) -> act(p(HGNC:STAT4))\n",
      "act(p(HGNC:TYK2)) -> act(p(HGNC:STAT4))\n",
      "----------------------\n",
      "10036880 : 1) STAT proteins play an essential role in angiotensin II-induced vascular smooth muscle cell proliferation, 2) JAK2 plays an essential role in the tyrosine phosphorylation of Raf-1, and 3) convergent mitogenic signaling cascades involving the cytosolic kinases JAK2, MEK1, and ERK1 mediate vascular smooth muscle cell proliferation\n",
      "act(p(HGNC:JAK2)) -> act(p(HGNC:RAF1))\n",
      "act(p(HGNC:MAPK3)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10036724 : FIGURE 6 | Integration of the signalling pathways induced by the G-protein-coupled receptors FcepsilonRI and KIT.\n",
      "act(p(HGNC:KIT)) -> act(p(HGNC:PIK3CD))\n",
      "act(p(HGNC:PIK3CD)) -> act(p(HGNC:BTK))\n",
      "p(HGNC:KITLG) -> act(p(HGNC:KIT))\n",
      "----------------------\n",
      "10036926 : Once activated, Raf-1 phosphorylates serines in the catalytic sites of MKK/MEK [345,367]. MKK1/MEK1 and MKK2/MEK2 activate members of the MAP kinase family (ERK-1/ERK-2),\n",
      "act(p(HGNC:MAP2K1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:MAP2K1)) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10036928 : Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)\n",
      "act(p(HGNC:MAP2K1)) -> act(p(HGNC:MAPK1))\n",
      "act(p(HGNC:MAP2K1)) -> act(p(HGNC:MAPK3))\n",
      "act(p(HGNC:RAF1)) -> act(p(HGNC:MAP2K1))\n",
      "----------------------\n",
      "10036940 : 7750576;16083285;15674326;15735648;10781613;15972258\n",
      "act(p(HGNC:MAP2K3)) -> p(HGNC:MAPK14,pmod(P))\n",
      "act(p(HGNC:MAP2K6)) -> p(HGNC:MAPK14,pmod(P))\n",
      "----------------------\n",
      "10036942 : 15592455;16083285;15659558;15674326;10781613;15972258;15735649;17081983\n",
      "act(p(HGNC:MAP2K3)) -> p(HGNC:MAPK14,pmod(P))\n",
      "act(p(HGNC:MAP2K6)) -> p(HGNC:MAPK14,pmod(P))\n",
      "----------------------\n",
      "10036944 : \\\"Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.\\\" Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183)\n",
      "act(p(HGNC:MAP2K4)) -> act(p(HGNC:MAPK8))\n",
      "act(p(HGNC:MAP2K4)) -> act(p(HGNC:MAPK9))\n",
      "----------------------\n",
      "10037006 : prominent p38 MAPK target, the Ser/Thr kinase MAPKAP2, is also activated by PM, as evidenced by phosphorylation of the actin-binding protein, HSP27. These events are again consistent with PM-mediated activation of p38 MAPK (10)\n",
      "act(p(HGNC:MAPK11)) -> act(p(HGNC:MAPKAPK2))\n",
      "act(p(HGNC:MAPKAPK2)) -> p(HGNC:HSPB1,pmod(P))\n",
      "----------------------\n",
      "10037008 : As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1).\n",
      "act(p(HGNC:MAPK11)) -> p(HGNC:NFE2L2,pmod(P))\n",
      "act(p(HGNC:MAPK12)) -> p(HGNC:NFE2L2,pmod(P))\n",
      "act(p(HGNC:MAPK13)) -> p(HGNC:NFE2L2,pmod(P))\n",
      "act(p(HGNC:MAPK14)) -> p(HGNC:NFE2L2,pmod(P))\n",
      "----------------------\n",
      "10037026 : It is known that there are two isoforms of ERK, ERK1 and ERK2, and they phosphorylate and activate various transcription factors, such as Elk-1 and Elk-2. These transcription factors regulate expression of diverse genes that relates to the proliferation and growth of the cells.\n",
      "act(p(HGNC:MAPK1)) -> act(p(HGNC:ELK1))\n",
      "act(p(HGNC:MAPK3)) -> act(p(HGNC:ELK1))\n",
      "----------------------\n",
      "10037028 : In many cells PKA inhibits the extracellular receptor kinase (ERK1/2) cascade of the mitogen-activated protein kinase (MAPK) pathway leading to inhibition of cell proliferation.\n",
      "act(p(HGNC:MAPK1)) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:MAPK3)) -> bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10037036 : acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:ALOX5)\n",
      "act(p(HGNC:MAPK3)) -> p(HGNC:ALOX5)\n",
      "p(HGNC:ALOX5) -> a(CHEBI:\"leukotriene B4\")\n",
      "----------------------\n",
      "10037032 : MAPK activation appears to play a prominent role in IL-18 signaling, being involved in transcription and translation of IL-18-induced IFN-gamma mRNA and IL-18-induced cytolytic effects.\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:IFNG)\n",
      "act(p(HGNC:MAPK3)) -> p(HGNC:IFNG)\n",
      "----------------------\n",
      "10037038 : SDF-1alpha-induced chemokine expression was abrogated upon inclusion of U0126, a pharmacological inhibitor of ERK1/2, indicating that the ERK signaling cascade is involved in this response.\n",
      "act(p(HGNC:MAPK1)) -> p(HGNC:IL8)\n",
      "act(p(HGNC:MAPK3)) -> p(HGNC:IL8)\n",
      "----------------------\n",
      "10037048 : Overexpression of the ERK-1 mutant, but not the ERK-2 mutant, significantly inhibited hyperoxia-induced ARE transcription, suggesting that ERK-1 at least in part mediates Nrf2 translocation and its downstream target expression (Fig. 7B).\n",
      "act(p(HGNC:MAPK3)) -> act(p(HGNC:NFE2L2))\n",
      "path(MESHD:Hyperoxia) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10037068 : 93076920;15302935;1730670;10383393;12096113;11383510;17081983\n",
      "act(p(HGNC:MAPKAPK2)) -> p(HGNC:HSPB1,pmod(P))\n",
      "act(p(HGNC:RPS6KB2)) -> p(HGNC:HSPB1,pmod(P))\n",
      "----------------------\n",
      "10037098 : Our findings suggest that insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T410 loop phosphorylation, (b) T560 autophosphorylation\n",
      "act(p(HGNC:PDPK1)) -> act(p(HGNC:PRKCZ))\n",
      "act(p(HGNC:PDPK1)) -> p(HGNC:PRKCZ,pmod(P))\n",
      "p(HGNC:PRKCZ,pmod(P)) -> act(p(HGNC:PRKCZ))\n",
      "----------------------\n",
      "10037122 : Inhibitory phosphorylation of adjacent threonine and tyrosine residues (T14/Y15 in CDK1) is mediated by dualspecificity kinases (such as WEE1 and MYT1). This inhibition is relieved when the CDC25 phosphatases (CDC25A,CDC25B and CDC25C) dephosphorylate these residues, which triggers entry into mitosis\n",
      "act(p(HGNC:PKMYT1)) -> p(EGID:5424,pmod(P))\n",
      "act(p(HGNC:WEE1)) -> p(EGID:5424,pmod(P))\n",
      "----------------------\n",
      "10037138 : 10867018;15383279;11741879;15024053;11948398\n",
      "act(p(HGNC:PRKCA)) -> p(HGNC:PRKD1,pmod(P))\n",
      "act(p(HGNC:PRKCA)) -> p(HGNC:PRKD1,pmod(P))\n",
      "act(p(HGNC:PRKCD)) -> p(HGNC:PRKD1,pmod(P))\n",
      "act(p(HGNC:PRKCD)) -> p(HGNC:PRKD1,pmod(P))\n",
      "----------------------\n",
      "10037166 : <p6> DNA-PK phosphorylates P53 at Ser15 and Ser37 dependent on DNA double-strand ends\n",
      "act(p(HGNC:PRKDC)) -> p(HGNC:TP53,pmod(P))\n",
      "act(p(HGNC:PRKDC)) -> p(HGNC:TP53,pmod(P))\n",
      "----------------------\n",
      "10037230 : In the first case, recruited FAK autophosphorylates at 397Y and associates with c-Src or Fyn, which further phosphorylates it at 925Y. Phosphorylated FAK binds to the Grb2-Sos complex and activates the Ras-ERK cascade [60,61].\n",
      "act(p(HGNC:SRC)) -> act(p(HGNC:PTK2))\n",
      "p(HGNC:PTK2,pmod(P)) -> act(p(HGNC:PTK2))\n",
      "----------------------\n",
      "10037260 : It has been reported that inhibition of FoxO activity is an important mechanism for Ang1-stimulated Tie2-mediated endothelial function. Consistent with this, we found that phosphorylation of FoxO mediated by Tie2 activation was attenuated by lipid raft disruption. Therefore, we propose that lipid rafts serve as signaling platforms for Tie2 receptor tyrosine kinase in vascular endothelial cells\n",
      "act(p(HGNC:TEK)) -| act(p(HGNC:FOXO1))\n",
      "act(p(HGNC:TEK)) -| act(p(HGNC:FOXO3))\n",
      "----------------------\n",
      "10037266 : P/CAF potentiated the transcriptional activity of heterologous Gal4-Smad2 and Gal4-Smad3 fusion proteins. In addition, P/CAF potentiated the TGF-beta/Smad3-induced transcriptional responses, which could be further enhanced by co-activators p300 and Smad4.\n",
      "act(p(HGNC:TGFBR1)) -> act(p(HGNC:SMAD2))\n",
      "act(p(HGNC:TGFBR1)) -> act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10037294 : dual phosphorylation by ZAP70 and Itk triggers the activation of PLCg1\n",
      "act(p(HGNC:ZAP70)) -> p(HGNC:PLCG1,pmod(P))\n",
      "p(HGNC:PLCG1,pmod(P)) -> act(p(HGNC:PLCG1))\n",
      "----------------------\n",
      "10037570 : Here we show that in human airway epithelial cells HNE increases TGF-alpha release, EGFR phosphorylation, and MUC5AC mucin expression, effects that were attenuated by TACE inhibitor TAPI-1 and by specific knockdown of TACE expression with small interfering RNA, implicating TACE in HNE-induced responses.\n",
      "p(EGID:1991) -> p(HGNC:MUC5AC)\n",
      "p(HGNC:ELANE) -> p(HGNC:TGFA)\n",
      "----------------------\n",
      "10037594 : endonuclease G and apoptosis-inducing factor (AIP) might induce cell death independently of caspase activation\n",
      "p(HGNC:AIFM1) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:ENDOG) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10037610 : mTORC2 can be activated by PI3K directly and phosphorylates Akt at S473, which together with phosphorylation at T308 results in the full activation of Akt [12,13].\n",
      "p(HGNC:AKT1,pmod(P)) -> act(p(HGNC:AKT1))\n",
      "p(HGNC:AKT1,pmod(P)) -> act(p(HGNC:AKT1))\n",
      "----------------------\n",
      "10037614 : Phosphorylation at Ser473 in the hydrophobic motif, along with Thr308 in its activation loop, is considered necessary for Akt function.\n",
      "p(HGNC:AKT1,pmod(P)) -> act(p(HGNC:AKT1))\n",
      "p(HGNC:AKT1,pmod(P)) -> act(p(HGNC:AKT1))\n",
      "----------------------\n",
      "10037618 : three isoforms, AKT1 (PKBalpha), AKT2 (PKBbeta) and AKT3 (PKBgamma) they all contain a central kinase domain with an activation-loop phosphorylation site, Thr308, and a conserved, regulatory C-terminal phosphorylation site, Ser473\n",
      "p(HGNC:AKT1,pmod(P)) -> act(p(HGNC:AKT1))\n",
      "p(HGNC:AKT1,pmod(P)) -> act(p(HGNC:AKT1))\n",
      "----------------------\n",
      "10037650 : from full text - Furthermore, the decreased expression of either b-arrestin 1 or b-arrestin 2 (via siRNA) resulted in a decrease in ERK1/2 activity\n",
      "p(HGNC:ARRB1) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:ARRB1) -> act(p(HGNC:MAPK3))\n",
      "p(HGNC:ARRB2) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:ARRB2) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10037666 : Atgs such as Atg5, Atg7, and Atg16L1 are required for the induction of autophagy in human DCs and the subsequent promotion of antigen presentation by MDP (Cooney et al., 2010).\n",
      "p(HGNC:ATG5) -> bp(GOBP:autophagy)\n",
      "p(HGNC:ATG7) -> bp(GOBP:autophagy)\n",
      "----------------------\n",
      "10037676 : NNK enhanced the levels of phospho-Bad (Ser112, Ser136 and Ser155; fig. 3c and d), which indicates that Bad was inactivated by NNK.\n",
      "p(HGNC:BAD,pmod(P)) -| act(p(HGNC:BAD))\n",
      "p(HGNC:BAD,pmod(P)) -| act(p(HGNC:BAD))\n",
      "----------------------\n",
      "10037686 : These genes can be divided in three classes: one that controls cell-cycle arrest and senescence, one that controls apoptosis and one that regulates glucose metabolism and autophagy [42]. p53 is essentially known as a pro-apoptotic transcription factor that upregulates the expression of proteins such as BCL2-associated X protein (BAX), p53 upregulated modulator of apoptosis (PUMA) or NOXA.\n",
      "p(HGNC:BAX) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BBC3) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10037692 : BH3-only proteins are members of the BCL- 2 protein family; they trigger apoptosis and integrate diverse apoptotic stimuli into a common cell-death pathway that is governed by other multidomain BCL-2 family members.\n",
      "p(HGNC:BBC3) -> bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BCL2L11) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10037702 : longer term effects of VEGF on cell survival may be mediated through the upregulation of the antiapoptotic proteins BCL2 and A1\n",
      "p(HGNC:BCL2A1) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BCL2) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10037712 : Figure 1. Bcl-2 and Bcl-xL inhibit caspase-3 processing and cell death in CD95-stimulated cells.\n",
      "p(HGNC:BCL2) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BCL2L1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10037716 : # Pubmed:gene: A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.\n",
      "p(HGNC:BCL2) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BCL2L1) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10037746 : A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy.\n",
      "p(HGNC:BECN1) -> bp(GOBP:autophagy)\n",
      "p(HGNC:BNIP3) -> bp(GOBP:autophagy)\n",
      "p(HGNC:GABARAP) -> bp(GOBP:autophagy)\n",
      "----------------------\n",
      "10037750 : Antisense-mediated reductions in IAP-family members XIAP, cIAP1, Survivin, or Apollon can induce apoptosis of tumor cell lines in culture, or sensitize cells to cytotoxic anticancer drugs, thus providing proof-of-concept evidence that the pathological elevations of IAPs found in cancers are important for maintaining tumor cell survival and resistance to chemotherapy (Table 1C).\n",
      "p(HGNC:BIRC2) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:BIRC5) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:XIAP) -| bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10037802 : We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis ... from full text, embryonic stem cells\n",
      "p(HGNC:BRCA1) -> act(p(HGNC:PARP1))\n",
      "p(HGNC:BRCA2) -> act(p(HGNC:PARP1))\n",
      "----------------------\n",
      "10037804 : the second group betacellulin (BTC), heparin-binding EGF (HB-EGF), and epiregulin (EPR), which exhibit dual specificity in that they bind ErbB1 and ErbB4.\n",
      "p(HGNC:BTC) -> complex(p(HGNC:EGFR),p(HGNC:ERBB3))\n",
      "p(HGNC:BTC) -> complex(p(HGNC:ERBB4),p(HGNC:ERBB4))\n",
      "p(HGNC:EREG) -> complex(p(HGNC:EGFR),p(HGNC:ERBB3))\n",
      "p(HGNC:HBEGF) -> complex(p(HGNC:EGFR),p(HGNC:ERBB3))\n",
      "----------------------\n",
      "10037858 : CDK2 is sequentially activated by the E-type cyclins  cyclin E1 and E2  during the G1/S transition, and the A-type cyclins  cyclin A1 and A2 during S phase\n",
      "p(HGNC:CCNA1) -> act(p(HGNC:CDK2))\n",
      "p(HGNC:CCNA2) -> act(p(HGNC:CDK2))\n",
      "p(HGNC:CCNE1) -> act(p(HGNC:CDK2))\n",
      "p(HGNC:CCNE2) -> act(p(HGNC:CDK2))\n",
      "----------------------\n",
      "10037864 : Breaking down CDKx:CCNDx to just CDK so modulation of CDKs is consolidated to the CDKx node. CDK4&CCND1 CDK4_CCND1=CDK4:CCND1 \\\"PD 0183812\\\"-|kaof(CDK4_CCND1) CDK6&CCND2 CDK6_CCND2=CDK6:CCND2 \\\"PD 0183812\\\"-|kaof(CDK6_CCND2) CDK6&CCND3 CDK6_CCND3=CDK6:CCND3 \\\"PD 0183812\\\"-|kaof(CDK6_CCND3)\n",
      "p(HGNC:CCND1) -> act(p(HGNC:CDK4))\n",
      "p(HGNC:CCND2) -> act(p(HGNC:CDK4))\n",
      "p(HGNC:CCND3) -> act(p(HGNC:CDK4))\n",
      "----------------------\n",
      "10037890 : Following activation with proliferative stimuli, including ligation of CD40, dense human tonsillar B cells (>98% cells in G(0)) have increased cleavage and activation of caspase-8 and -6 accompanied by decreased caspase-3 activation and apoptosis.\n",
      "p(HGNC:CD40) -| bp(GOBP:\"apoptotic process\")\n",
      "p(HGNC:CD40) -| act(p(HGNC:CASP3))\n",
      "p(HGNC:CD40) -> act(p(HGNC:CASP6))\n",
      "----------------------\n",
      "10037900 : Stimulation of cells isolated from atherosclerotic plaques with soluble CD40L (10 microgram/ml) induced the NFkB (c-Rel) DNA binding activity and TNF alpha production was significantly inhibited by dominant negative IKK-2, indicating that CD40L induced TNF alpha expression was via c-Rel.\n",
      "p(HGNC:CD40LG) -> act(p(HGNC:REL))\n",
      "act(p(HGNC:REL)) -> p(HGNC:TNF)\n",
      "----------------------\n",
      "10037918 : The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes\n",
      "p(HGNC:CDKN1B) -| act(p(HGNC:CDK2))\n",
      "p(HGNC:CDKN1B) -| act(p(HGNC:CDK4))\n",
      "----------------------\n",
      "10037966 : The transactivation activity of HIF complexes requires the recruitment of p300/CREB-binding protein (CBP) by HIF-1 alpha and HIF-2 alpha that undergo oxygen-dependent degradation.\n",
      "p(HGNC:CREBBP) -> act(p(HGNC:EPAS1))\n",
      "p(HGNC:CREBBP) -> act(p(HGNC:HIF1A))\n",
      "p(HGNC:EP300) -> act(p(HGNC:EPAS1))\n",
      "p(HGNC:EP300) -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10037970 : Table 1. Production of pro- and anti-angiogenic mediators by DCs Pro-angiogenic mediators: VEGF, FGF2, TNF-a, IL-6, TGF-b, CXCL8, CXCL5, CXCL1, 2, 3, CCL2, GM-CSF, ET-1, OPN,  Anti-angiogenic mediators: IL-12, IL-18, IL-10, TSP-1, PTX3, IFN-a/b, CXCL9, CXCL10, CXCL13, CCL21\n",
      "p(HGNC:CSF2) -> bp(GOBP:angiogenesis)\n",
      "p(HGNC:CXCL1) -> bp(GOBP:angiogenesis)\n",
      "p(HGNC:CXCL2) -> bp(GOBP:angiogenesis)\n",
      "p(HGNC:VEGFA) -> bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10037996 : T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.\n",
      "p(HGNC:CXCL10) -> act(p(HGNC:CXCR3))\n",
      "p(HGNC:CXCL11) -> act(p(HGNC:CXCR3))\n",
      "p(HGNC:CXCL9) -> act(p(HGNC:CXCR3))\n",
      "----------------------\n",
      "10035670 : Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6.\n",
      "p(HGNC:DKK1) -| act(p(HGNC:LRP5))\n",
      "p(HGNC:DKK1) -| act(p(HGNC:LRP6))\n",
      "p(HGNC:DKK2) -| act(p(HGNC:LRP5))\n",
      "p(HGNC:DKK2) -| act(p(HGNC:LRP6))\n",
      "p(HGNC:DKK3) -| act(p(HGNC:LRP5))\n",
      "p(HGNC:DKK3) -| act(p(HGNC:LRP6))\n",
      "p(HGNC:DKK4) -| act(p(HGNC:LRP5))\n",
      "p(HGNC:DKK4) -| act(p(HGNC:LRP6))\n",
      "p(HGNC:DKKL1) -| act(p(HGNC:LRP5))\n",
      "p(HGNC:DKKL1) -| act(p(HGNC:LRP6))\n",
      "----------------------\n",
      "10038050 : IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group.  po0.05, po0.01 as determined by unpaired, two-tailed Studentâs t-test. Results shown are representative of three independent experiments.\n",
      "p(HGNC:DPP4) -| p(HGNC:IL13)\n",
      "p(HGNC:DPP4) -| p(HGNC:IL4)\n",
      "p(HGNC:DPP4) -| p(HGNC:IL5)\n",
      "----------------------\n",
      "10038068 : Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B.\n",
      "p(HGNC:EDN1) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:EDN1) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10038184 : Activated ERK enters the nucleus to promote transcription [64]. The MAPK pathway is critically involved in controlling proliferation, survival, and migration of endothelial cells. Angiogenesis in the chorio-allantoid membrane (CAM) model requires two waves of ERK activation, the first one being dependent on FGF-2, and the second one on aVh3 integrin ligation [65].\n",
      "p(HGNC:FGF2) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:FGF2) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10038186 : After bFGF was added to pulmonary fibroblasts, the kinase activities of p44/p42 ERK1/2 were determined by an in-gel assay at various times after exposure (Fig. 1). The data demonstrate that the addition of bFGF results in activation of ERK1/2 within 5 min, with the highest activity at 30 min, followed by a lower level of activity that persists for 8-12 h.\n",
      "p(HGNC:FGF2) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:FGF2) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10038222 : During IL-6-induced macrophage differentiation of M1 cells, IL-6 down-regulated cyclin D1 expression and induced p19(INK4D) expression, leading to reduction in cdk4 activities. In contrast, sustained expression of cyclin D1 and a significantly lesser amount of p19(INK4D) induction were observed in IL-6-treated M1 cells overexpressing GATA-1.\n",
      "p(HGNC:GATA1) -> p(HGNC:CCND1)\n",
      "p(HGNC:IL6) -| p(HGNC:CCND1)\n",
      "p(HGNC:IL6) -> p(HGNC:CDKN2D)\n",
      "----------------------\n",
      "10038226 : Both EGFR and GRPR are activated in NSCLC by their corresponding ligands, TGF-a and GRP, in an autocrine manner.\n",
      "p(HGNC:GRP) -> act(p(HGNC:GRPR))\n",
      "p(HGNC:TGFA) -> act(p(HGNC:EGFR))\n",
      "----------------------\n",
      "10038264 : We show a mechanistic link from NOTCH3 receptor signaling through the Hairy and enhancer of Split-5 (HES-5) protein to smooth muscle cell proliferation\n",
      "p(HGNC:HES5) -> bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:NOTCH3)) -> p(HGNC:HES5)\n",
      "----------------------\n",
      "10038268 : siRNA-mediated knockdown of HEY1 and HEY2 (Figure S4E) suppressed BMP9-mediated inhibition of tube formation and effects on downstream gene expression (Figures 4A, 4D, 4E, and 4G)\n",
      "p(HGNC:HEY1) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "p(HGNC:HEY2) -| bp(GOBP:\"patterning of blood vessels\")\n",
      "----------------------\n",
      "10038280 : HGF induced activation of ERK1 and ERK2 was shown to be dependent on the presence of HS moieties.\n",
      "p(HGNC:HGF) -> act(p(HGNC:MAPK1))\n",
      "p(HGNC:HGF) -> act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10038328 : Th1 cells produce interleukin (IL)-2, interferon-gamma (IFN-gamma) and lymphotoxin-beta, which mediate pro-inflammatory functions critical for the development of cell-mediated immune responses, whereas Th2 cells secrete cytokines such as IL-4, IL-5 and IL-10 that enhance humoral immunity.\n",
      "p(HGNC:IFNG) -> bp(GOBP:\"T-helper 1 type immune response\")\n",
      "p(HGNC:IL2) -> bp(GOBP:\"T-helper 1 type immune response\")\n",
      "p(HGNC:LTB) -> bp(GOBP:\"T-helper 1 type immune response\")\n",
      "----------------------\n",
      "10038348 : the CXC chemokines Mig and interferon-? inducible protein 10 can be expressed and bound by endothelium stimulated with interferon-? and tumor necrosis factor (TNF) ?, and can induce the firm adhesion of T lymphocyte in shear flow via CXCR3.\n",
      "p(HGNC:IFNG) -> p(HGNC:CXCL10)\n",
      "p(HGNC:TNF) -> p(HGNC:CXCL10)\n",
      "----------------------\n",
      "10038368 : IL-4, IL-13, and IL-10 significantly up-regulated CCL18 production by AMs (Figure 4).\n",
      "p(HGNC:IL10) -> p(HGNC:CCL18)\n",
      "p(HGNC:IL13) -> p(HGNC:CCL18)\n",
      "p(HGNC:IL4) -> p(HGNC:CCL18)\n",
      "----------------------\n",
      "10038372 : Immunohistochemical staining revealed that both hCLCA1 and MUC5AC proteins increased in NHBE cells cultured with IL-13 for 14 days at an air-liquid interface (fig. 4).\n",
      "p(HGNC:IL13) -> p(HGNC:CLCA1)\n",
      "p(HGNC:IL13) -> p(HGNC:MUC5AC)\n",
      "----------------------\n",
      "10038394 : from full text - Table 3.  IL-17 markedly augments production of proangiogenic factors of fibroblast\n",
      "p(HGNC:IL17A) -> a(CHEBI:\"nitric oxide\")\n",
      "p(HGNC:IL17A) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10038418 : Thus, IL-6 release was substantially increased by both IL-1 and to a lesser extent by TNF. In each case, prior infection with the null adenovirus showed no significant effect, whereas dominant IBN reduced IL-6 release to near-background levels. Likewise, the dominant-negative IKK2 adenovirus prevented IL-6 release\n",
      "p(HGNC:IL1B) -> p(HGNC:IL6)\n",
      "p(HGNC:TNF) -> p(HGNC:IL6)\n",
      "----------------------\n",
      "10038422 : IL-1beta induced the expression of MMP-12 mRNA via activation of JNK and PI3K (357). IL-1beta-mediated expression of MMP-9 and -12 was demonstrated in IL-1beta overexpressing transgenic mice as well (175).\n",
      "p(HGNC:IL1B) -> p(HGNC:MMP12)\n",
      "p(HGNC:IL1B) -> p(HGNC:MMP9)\n",
      "----------------------\n",
      "10038468 : The enhanced functions of Th2 memory cells induced by IL-25 are associated with sustained expression of GATA-3, c-MAF, and JunB in an IL-4-independent manner.\n",
      "p(HGNC:IL25) -> p(HGNC:GATA3)\n",
      "p(HGNC:IL25) -> p(HGNC:JUNB)\n",
      "p(HGNC:IL25) -> p(HGNC:MAF)\n",
      "----------------------\n",
      "10038472 : STAT5, which is downstream of IL-2 signalling, and STAT1, which is downstream of IL-27 signalling, as well as ETS1, are negative regulators of TH17-cell differentiation.\n",
      "p(HGNC:IL27) -> act(p(HGNC:STAT1))\n",
      "p(HGNC:IL2) -> act(p(HGNC:STAT5A))\n",
      "act(p(HGNC:ETS1)) -| bp(GOBP:\"T-helper 17 cell differentiation\")\n",
      "act(p(HGNC:STAT1)) -| bp(GOBP:\"T-helper 17 cell differentiation\")\n",
      "act(p(HGNC:STAT5A)) -| bp(GOBP:\"T-helper 17 cell differentiation\")\n",
      "----------------------\n",
      "10038496 : In normal fibroblasts, IL-4 stimulates proliferation, chemotaxis, and collagen synthesis and enhances the production of TGF-B1 and CTGF (82).\n",
      "p(HGNC:IL4) -> p(HGNC:CTGF)\n",
      "p(HGNC:IL4) -> p(HGNC:TGFB1)\n",
      "----------------------\n",
      "10038504 : Cytokines control the outcome of TH immunity, with IL-12, acting via signal transducer and activator of transcription 4 (STAT4), to promote TH1 development, whereas IL-4 promotes TH2 development via the actions of STAT6 (2).\n",
      "p(HGNC:IL4) -> act(p(HGNC:STAT6))\n",
      "act(p(HGNC:STAT4)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "act(p(HGNC:STAT6)) -> bp(GOBP:\"T-helper 2 cell differentiation\")\n",
      "----------------------\n",
      "10038512 : Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6.\n",
      "p(HGNC:IL4) -> act(p(HGNC:STAT6))\n",
      "act(p(HGNC:TBX21)) -> bp(GOBP:\"T-helper 1 cell differentiation\")\n",
      "----------------------\n",
      "10038514 : SOCS-1 and SOCS-3 inhibit interleukin (IL)-4-dependent signal transducer and activator of transcription 6 (Stat6) activation of and subsequent gene induction. By contrast, SOCS-2 and cytokine-inducible Src homology domain 2 (SH2)-containing protein up-regulate these processes\n",
      "p(HGNC:IL4) -> act(p(HGNC:STAT6))\n",
      "p(HGNC:SOCS1) -| act(p(HGNC:STAT6))\n",
      "p(HGNC:SOCS3) -| act(p(HGNC:STAT6))\n",
      "----------------------\n",
      "10038522 : TNF-alpha, IL-1beta, and IFN-gamma expression were slightly decreased in cultures from blm-treated IL-5-/- mice relative to cultures from blm-treated IL-5+/+ mice (Table IV?), whereas TGF-beta levels were significantly increased. Anti-CD3-induced expression of IL-4 and IL-13 were dramatically diminished in IL-5?/? T cells in comparison to IL-5+/+ T cells.\n",
      "p(HGNC:IL5) -> p(HGNC:IL13)\n",
      "p(HGNC:IL5) -> p(HGNC:IL4)\n",
      "----------------------\n",
      "10038560 : We next determined whether the ?EGFR-expressing MCF-10A cells produced high levels of IL-6, leading to activation of STAT3, as was observed in lung adenocarcinomaâderived cell lines harboring mutant EGFR. The ?EGFRâMCF-10A cells were treated with P6, gp130, and IL-6 blocking antibodies, which inhibited STAT3 activation.\n",
      "p(HGNC:IL6) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:IL6ST) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10038626 : Bradykinin (BK) is a potent inflammatory mediator, which can release other inflammatory mediators by interacting with bradykinin B1 and B2 receptors ... It is concluded that BK causes increased leak by inducing PMN elastase release via activation of both B1 and B2 receptors\n",
      "p(HGNC:KNG1) -> act(p(HGNC:BDKRB1))\n",
      "p(HGNC:KNG1) -> act(p(HGNC:BDKRB2))\n",
      "----------------------\n",
      "10036364 : Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.\n",
      "p(HGNC:NFKBIA,pmod(P)) -> deg(p(HGNC:NFKBIA))\n",
      "p(HGNC:NFKBIA,pmod(P)) -> deg(p(HGNC:NFKBIA))\n",
      "----------------------\n",
      "10038762 : Lung levels of TNF-[alpha] and IL-1[beta] were significantly higher in PPAR-[alpha]-deficient mice in comparison with those of PPAR-[alpha] WT animals (Fig. 3).\n",
      "p(HGNC:PPARA) -| p(HGNC:IL1B)\n",
      "p(HGNC:PPARA) -| p(HGNC:TNF)\n",
      "----------------------\n",
      "10038788 : PTEN inhibits MAPK through the negative regulation of integrin signaling (Gu et al., 1998).\n",
      "p(HGNC:PTEN) -| act(p(HGNC:MAPK1))\n",
      "p(HGNC:PTEN) -| act(p(HGNC:MAPK3))\n",
      "----------------------\n",
      "10038790 : Moreover, substituting Ser-380/Thr-382/Thr-383 to phosphomimic residues reversed the phosphatase activity of the S385A mutation.\n",
      "p(HGNC:PTEN,pmod(P)) -| act(p(HGNC:PTEN))\n",
      "p(HGNC:PTEN,pmod(P)) -| act(p(HGNC:PTEN))\n",
      "p(HGNC:PTEN,pmod(P)) -| act(p(HGNC:PTEN))\n",
      "----------------------\n",
      "10038794 : we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin.  Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells\n",
      "p(HGNC:PTGS1) -> bp(GOBP:\"wound healing\")\n",
      "p(HGNC:PTGS2) -> bp(GOBP:\"wound healing\")\n",
      "----------------------\n",
      "10037446 : The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo.\n",
      "p(HGNC:RAF1,pmod(P)) -| act(p(HGNC:RAF1))\n",
      "p(HGNC:RAF1,pmod(P)) -| act(p(HGNC:RAF1))\n",
      "----------------------\n",
      "10038836 : TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4\n",
      "p(HGNC:RB1,pmod(P)) -| act(p(HGNC:RB1))\n",
      "p(HGNC:RB1,pmod(P)) -| act(p(HGNC:RB1))\n",
      "p(HGNC:RB1,pmod(P)) -| act(p(HGNC:RB1))\n",
      "p(HGNC:TGFB1) -> p(HGNC:EIF4EBP1,pmod(P))\n",
      "p(HGNC:TGFB1) -> p(HGNC:EIF4EBP1,pmod(P))\n",
      "p(HGNC:TGFB1) -> p(HGNC:RB1,pmod(P))\n",
      "p(HGNC:TGFB1) -> p(HGNC:RB1,pmod(P))\n",
      "p(HGNC:TGFB1) -> p(HGNC:RB1,pmod(P))\n",
      "----------------------\n",
      "10038856 : from full text - T229 is situated in the catalytic domain of p70S6K, and in addition to T389, its phosphorylation is necessary for full activation of the protein. Residues T421 and S424 are situated in the autoinhibitory/pseudosubstrate domain of the C-terminus, and phosphorylation of these residues is proposed to be one of the early steps of p70S6K activation (2).\n",
      "p(HGNC:RPS6KB1,pmod(P)) -> act(p(HGNC:RPS6KB1))\n",
      "p(HGNC:RPS6KB1,pmod(P)) -> act(p(HGNC:RPS6KB1))\n",
      "----------------------\n",
      "10038942 : . Furthermore, the bFGF-induced activation of ERK1/2 seems to enhance the transcriptional activity of STAT3. Co-stimulation of KMS-11 with bFGF and IL-6 leads to marked expression of STAT3 target genes, such as c-myc and bcl-2, further suggesting the relevance of STAT3 phosphorylated at both Tyr705 and Ser727 for the full activation as a transcription factor (Fig. 5). In addition, the\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10038944 : leads to phosphorylation of MITF at S73 and of STAT3 at both tyrosine 705 and S727. This phosphorylation increases the transcriptional activity of MITF and STAT3 as indicated by mRNA accumulation of their target genes such as Bcl-2, granzyme B, and c-Myc\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "p(HGNC:STAT3,pmod(P)) -> act(p(HGNC:STAT3))\n",
      "----------------------\n",
      "10034818 : RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation\n",
      "p(HGNC:STIL) -| p(HGNC:SUFU)\n",
      "p(HGNC:SUFU) -| act(p(HGNC:GLI1))\n",
      "p(HGNC:SUFU) -| act(p(HGNC:GLI2))\n",
      "p(HGNC:SUFU) -| act(p(HGNC:GLI3))\n",
      "----------------------\n",
      "10037582 : TGF-?1 induced a marked up-regulation of mesenchymal markers ?-SMA and vimentin and down-regulation of the epithelial marker E-cadherin in WT AECs, which was evident after 48 hours.\n",
      "p(HGNC:TGFB1) -| p(HGNC:CDH1)\n",
      "p(HGNC:TGFB1) -> p(HGNC:ACTA2)\n",
      "p(HGNC:TGFB1) -> p(HGNC:VIM)\n",
      "----------------------\n",
      "10038986 : A complex containing Smad3, the transcription factors E2F4/5 and DP1, and the corepressor p107 preexists in the cytoplasm. In response to TGFbeta, this complex moves into the nucleus and associates with Smad4, recognizing a composite Smad-E2F site on c-myc for repression\n",
      "p(HGNC:TGFB1) -> complex(p(HGNC:SMAD4),p(HGNC:SMAD3),p(HGNC:E2F4),p(HGNC:TFDP1),p(HGNC:RBL1))\n",
      "p(HGNC:TGFB1) -> complex(p(HGNC:SMAD4),p(HGNC:SMAD3),p(HGNC:E2F5),p(HGNC:TFDP1),p(HGNC:RBL1))\n",
      "----------------------\n",
      "10039008 : Stimulation of healthy fibroblasts with TGF increased mRNA and protein levels of c-Jun (E and G) and c-Fos (F and H) in a time-dependent manner\n",
      "p(HGNC:TGFB1) -> p(HGNC:FOS)\n",
      "p(HGNC:TGFB1) -> p(HGNC:JUN)\n",
      "----------------------\n",
      "10039038 : By RT-PCR we have shown that TGFbeta up-regulates expression not only of plasminogen activator inhibitor type-1 (PAI-1), but also of the urokinase-type plasminogen activator receptor (uPAR), whose inhibition by specific antibodies blunted the TGFbeta angiogenic response in vitro. The SMAD2/3 and FAK signaling pathways were activated by TGFbeta in MVEC\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD2))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10039044 : In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD2))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10039030 : The changes in glucocorticoid binding were associated with identical changes in GR protein and mRNA levels Functional inactivation of Smad 2/3 and AP-1 limited the response to TGF-beta 1, indicating a role for these transcription factors TGF-beta 1 increases glucocorticoid binding and signaling in inflammatory cells through a Smad 2/3- and AP-1-mediated process\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD2))\n",
      "p(HGNC:TGFB1) -> act(p(HGNC:SMAD3))\n",
      "----------------------\n",
      "10039074 : TIMPs 1-4 all reduced ASM migration, with TIMP-4 being the most potent, resulting in a 50% reduction in migration (Fig. 7C).\n",
      "p(HGNC:TIMP1) -| bp(GOBP:\"cell migration\")\n",
      "p(HGNC:TIMP3) -| bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10039158 : The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9\n",
      "p(HGNC:TNF) -> p(HGNC:MMP14)\n",
      "p(HGNC:TNF) -> p(HGNC:MMP9)\n",
      "----------------------\n",
      "10039176 : TNF-alpha-induced secretion of cytokines such as IL-1beta and IL-8, as well as the expression of adhesion molecules such as ICAM-1, VCAM-1 and E-selction in HUVECs.\n",
      "p(HGNC:TNF) -> p(HGNC:SELE)\n",
      "p(HGNC:TNF) -> p(HGNC:VCAM1)\n",
      "----------------------\n",
      "10039178 : TNF increased the expression of TRAIL-R1 and TRAILR2 proteins in A549 cells (Figure 6).\n",
      "p(HGNC:TNF) -> p(HGNC:TNFRSF10A)\n",
      "p(HGNC:TNF) -> p(HGNC:TNFRSF10B)\n",
      "----------------------\n",
      "10039270 : The chemotherapeutic drugs (paclitaxel, vincristine, vinblastine, etoposide, camptothecin, and Adriamycin) induced death receptors (DRs) TRAIL receptor 1/DR4 and TRAIL receptor 2/DR5, and successive treatment with TRAIL resulted in apoptosis of both TRAIL-sensitive and -resistant cells.\n",
      "p(HGNC:TNFSF10) -> act(p(HGNC:TNFRSF10A))\n",
      "p(HGNC:TNFSF10) -> act(p(HGNC:TNFRSF10B))\n",
      "----------------------\n",
      "10039272 : TRAIL binds to five cognate cell surface receptors, but only two of these receptors TRAIL-R1 and TRAIL-R2\n",
      "p(HGNC:TNFSF10) -> act(p(HGNC:TNFRSF10A))\n",
      "p(HGNC:TNFSF10) -> act(p(HGNC:TNFRSF10B))\n",
      "----------------------\n",
      "10039278 : Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.\n",
      "p(HGNC:TP53BP2) -> act(p(HGNC:TP73))\n",
      "act(p(HGNC:PPP1R13B)) -> act(p(HGNC:TP73))\n",
      "----------------------\n",
      "10039306 : from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:FLT1))\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:KDR))\n",
      "p(HGNC:VEGFB) -> act(p(HGNC:FLT1))\n",
      "p(HGNC:VEGFC) -> act(p(HGNC:FLT4))\n",
      "p(HGNC:VEGFC) -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10039310 : VEGF actions are mediated through binding to 2 receptor tyrosine kinases, VEGFR1 (FLT1) and VEGFR2 (KDR)\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:FLT1))\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10039312 : VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:FLT1))\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:KDR))\n",
      "p(HGNC:VEGFB) -> act(p(HGNC:FLT1))\n",
      "p(HGNC:VEGFC) -> act(p(HGNC:FLT4))\n",
      "p(HGNC:VEGFC) -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10039316 : as well as VEGFA, other VEGF-family members are produced by human tumors, including VEGFC and VEGFD, which both bind to VEGFR2 and activate many of the same pathways as VEGFA\n",
      "p(HGNC:VEGFA) -> act(p(HGNC:KDR))\n",
      "p(HGNC:VEGFC) -> act(p(HGNC:KDR))\n",
      "----------------------\n",
      "10036246 : Under normoxia, HIFs are targeted for proteasomal degradation by the von HippelâLindau (VHL) tumor suppressor, pVHL. It has been shown that pVHL is the substrate recognition component of an E3 ubiquitin ligase complex that interacts with HIF-a in an oxygen-dependent manner.\n",
      "p(HGNC:VHL) -> deg(p(HGNC:HIF3A))\n",
      "p(HGNC:VHL) -> deg(p(HGNC:EPAS1))\n",
      "p(HGNC:VHL) -> deg(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10039406 : The PAC1 receptor is more selective for PACAP while the VPAC1 and VPAC2 receptors can be potently activated by VIP or PACAP .\n",
      "p(HGNC:VIP) -> act(p(HGNC:VIPR1))\n",
      "p(HGNC:VIP) -> act(p(HGNC:VIPR2))\n",
      "----------------------\n",
      "10039480 : Two cytoplasmic protein tyrosine phosphatases, PTP-PEST and PTP-1B, target p130CAS and may specifically inhibit some of the signals downstream of FAK (20).\n",
      "act(p(HGNC:PTPN12)) -| p(HGNC:BCAR1)\n",
      "act(p(HGNC:PTPN1)) -| p(HGNC:BCAR1)\n",
      "----------------------\n",
      "10039528 : We demonstrated that overexpression of miR-15b in a bronchial epithelial cell line reduced SMAD7, SMURF2 and downstream decorin protein. Conversely, knockdown of miR-15b resulted in increased SMAD7, decorin and SMURF2 proteins. Functionally, miR-15b manipulation altered early SMAD3 phosphorylation in response to TGFb treatment.\n",
      "r(HGNC:MIR15B) -| p(HGNC:DCN)\n",
      "r(HGNC:MIR15B) -| p(HGNC:SMAD7)\n",
      "r(HGNC:MIR15B) -| p(HGNC:SMURF2)\n",
      "----------------------\n",
      "10039744 : endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.\n",
      "act(p(HGNC:SMAD2)) -| bp(GOBP:\"cell migration\")\n",
      "act(p(HGNC:SMAD2)) -| bp(GOBP:\"cell proliferation\")\n",
      "act(p(HGNC:SMAD3)) -| bp(GOBP:\"cell migration\")\n",
      "act(p(HGNC:SMAD3)) -| bp(GOBP:\"cell proliferation\")\n",
      "----------------------\n",
      "10039802 : In this paper we demonstrate that expression of CD72 down-modulates both extracellular signal-related kinase (ERK) activation and Ca2+ mobilization induced by BCR ligation in the mouse B lymphoma line K46^mA, whereas BCR-mediated ERK activation was not reduced by the ITIM-mutated form of CD72.\n",
      "r(MGI:Cd72) -| a(CHEBI:\"calcium(2+)\")\n",
      "r(MGI:Cd72) -| p(MGI:Mapk3,pmod(P))\n",
      "r(MGI:Cd72) -| p(MGI:Mapk1,pmod(P))\n",
      "----------------------\n",
      "10039804 : Results CD72 negatively regulates both ERK activation and Ca2+ mobilization induced by BCR ligation in the K46^mk B lymphoma cells To investigate the signaling function of CD72, we assessed CD72 expression on the surface of B cell lines by flow cytometry.\n",
      "r(MGI:Cd72) -| act(p(MGI:Mapk3))\n",
      "r(MGI:Cd72) -| act(p(MGI:Mapk1))\n",
      "----------------------\n",
      "10039810 : However, both of the CD72 transfectants showed reduced phosphorylation of ERK1 and ERK2 compared to that of the parent cells regardless of the duration of Ag stimulation.\n",
      "r(MGI:Cd72) -| p(MGI:Mapk3,pmod(P))\n",
      "r(MGI:Cd72) -| p(MGI:Mapk1,pmod(P))\n",
      "----------------------\n",
      "10039812 : Taken together, expression of CD72 most probably down-modu-lates phosphorylation of ERK induced by BCR signaling.\n",
      "r(MGI:Cd72) -| p(MGI:Mapk1,pmod(P))\n",
      "r(MGI:Cd72) -| p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10039814 : Indeed, in vitro kinase assay showed that the activity of ERK2 in Ag-stimulated K46^mA CD72 transfectants was lower than that of Ag-stimulated K46^mA (Fig. 3).\n",
      "p(MGI:Cd72) -| act(p(MGI:Mapk1))\n",
      "p(MGI:Cd72) -| act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10039822 : Taken together, CD72 down-modulates both ERK activation and Ca2+ mobilization induced by BCR ligation, strongly suggesting that CD72 negatively regulates BCR signaling in K46^mA cells.\n",
      "p(MGI:Cd72) -| a(CHEBI:\"calcium(2+)\")\n",
      "p(MGI:Cd72) -| p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Cd72) -| p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10039826 : However, BCR ligation induced stronger ERK phosphorylation than coligation of CD72 with BCR did, indicating that BCR ligation-induced phosphorylation of ERK is down-modulated when CD72 is coligated with BCR.\n",
      "p(MGI:Cd72) -| p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Cd72) -| p(MGI:Mapk3,pmod(P))\n",
      "----------------------\n",
      "10039832 : Taken together, these results indicate that coligation with CD72 negatively regulates BCR-induced ERK activation and Ca2+ concentration in normal spleen B cells.\n",
      "p(MGI:Cd72) -| p(MGI:Mapk3,pmod(P))\n",
      "p(MGI:Cd72) -| p(MGI:Mapk1,pmod(P))\n",
      "p(MGI:Cd72) -| a(CHEBI:\"calcium(2+)\")\n",
      "----------------------\n",
      "10039868 : These results suggest that (a) IL-10 produced from B cells lowers IFN-g production and (b) this effect is partially CD40-CD40L dependent.\n",
      "tloc(p(MGI:Il10)) -| tloc(p(MGI:Ifng))\n",
      "complex(p(MGI:Cd40lg),p(MGI:Cd40)) -> tloc(p(MGI:Il10))\n",
      "----------------------\n",
      "10039876 : The transition from normal to neoplastic glands in prostate cancer (PCa) is marked by a dramatic decline of IL-7 and BAFF/ BLyS production.\n",
      "bp(GOBP:\"response to tumor cell\") -| tloc(p(HGNC:TNFSF13B))\n",
      "bp(GOBP:\"response to tumor cell\") -| tloc(p(HGNC:IL7))\n",
      "----------------------\n",
      "10039884 : Prostate-infiltrating lymphocytes display low proliferation but wide expression of the antiapoptotic protein bcl-2.\n",
      "bp(GOBP:\"response to tumor cell\") -| bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\")\n",
      "bp(GOBP:\"response to tumor cell\") -> p(HGNC:BCL2)\n",
      "----------------------\n",
      "10039892 : Expression of the chemokines B lymphocyte chemo-attractant, also called CXCL13, and secondary lymphoid tissue chemokine, also known as CCL21, which we previously found (2) associated with LFs, was lost too (Fig. 5B, c-e).\n",
      "bp(GOBP:\"response to tumor cell\") -| p(HGNC:CXCL13)\n",
      "bp(GOBP:\"response to tumor cell\") -| r(HGNC:CCL21)\n",
      "----------------------\n",
      "10039954 : Similarly, we observed a higher release of IL-18 (Figure E4B) and TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling)-positive cells (data not shown) in the lungs of tumor-bearing mice adoptively transferred with CpG-pulsed B cells than in the other group of animals.\n",
      "act(p(MGI:Tlr9)) -> tloc(p(MGI:Il18))\n",
      "act(p(MGI:Tlr9 )) -> bp(GOBP:\"apoptotic process\")\n",
      "----------------------\n",
      "10039956 : CpG treatment of B cells increased the levels of IFN-b (Figure 3B), lymphotoxin-b (LTb) (Figure 3C), IL-1b (Figure 3D), and IL-12p40 (Figure 3E) but reduced those of TNF-a (Figure 3F) and IL-10 (Figure 3G).\n",
      "act(p(MGI:Tlr9)) -> r(HGNC:IFNB1)\n",
      "act(p(MGI:Tlr9)) -> r(MGI:Ltb)\n",
      "act(p(MGI:Tlr9)) -> r(MGI:Il1b)\n",
      "act(p(MGI:Tlr9)) -> r(HGNC:IL12B)\n",
      "act(p(MGI:Tlr9)) -| p(MGI:Il10)\n",
      "act(p(MGI:Tlr9)) -| p(MGI:Tnf)\n",
      "----------------------\n",
      "10040024 : Instead, B cells from these mice activated T-cell responses, as they induced proliferation of T cells (Fig. 5C and Supplementary Fig. S4A) and expanded GrzB-expressing CD8+ T cells (Supplementary Fig. S4B and S4C) that readily and significantly lysed 4T1.2 cancer cells (Fig. 5D).\n",
      "act(p(MGI:Tlr9)) -> bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\")\n",
      "act(p(MGI:Tlr9)) -> bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10040104 : Unlike control B cells from naive BALB/c mice, which did not induce Foxp3 in non-Tregs, regardless of the presence or absence of the inhibitor (Fig. 6A), tBregs or tumor B cells only converted Foxp3+ Tregs in the absence of SB431542 (Fig. 6A).\n",
      "bp(GOBP:\"regulatory T cell differentiation\") -> bp(GOBP:\"regulatory T cell differentiation\")\n",
      "act(p(MGI:Tgfb1)) -> bp(GOBP:\"regulatory T cell differentiation\")\n",
      "----------------------\n",
      "10040208 : To determine if 4T1-induced MDSC from EP2_/~ mice inhibit by the same mechanism, nor-NOHA, an inhibitor of arginase, was added to some of the D011.10 and clone 4 transgenic T-cell cultures of Fig. 4. Nor-NOHA reverses the suppression CD4+ and CD8+ T cells by both BALB/c and EP2_/~ MDSC, although it is more effective in reducing suppression of CD4+ T cells than of CD8+ T cells.\n",
      "act(p(MGI:Arg1)) -| bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\")\n",
      "act(p(MGI:Arg1)) -| bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10040218 : Canonical proinflammatory cytokines, such as IL-6, MCP-1, TGFh, and IL-1h were significantly elevated in 4T1 tumor tissue.\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(MGI:Ccl2))\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(MGI:Il6))\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(MGI:Il1b))\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(MGI:Tgfb1))\n",
      "----------------------\n",
      "10040222 : Additionally, IL-1Râ/â tumor tissue had less IL-12p70 and more TGFh and IFNg than tumor tissue from wild-type BALB/c mice.\n",
      "p(MGI:Il1r1) -| tloc(p(MGI:Tgfb1))\n",
      "p(MGI:Il1r1) -> tloc(p(MGI:Il12a))\n",
      "act(p(MGI:Il1r1)) -| tloc(p(MGI:Ifng))\n",
      "----------------------\n",
      "10040294 : However, NF-kB was phosphorylated in MDSC from both tumor-bearing and tumor-free mice within the first 10 min of incubation at a level comparable to activation by TNF-a, a NF-KB-dependent gene that is known to be activated by S100A8/A9 (22) (Fig. 3E).\n",
      "p(MGI:S100a9) -> p(MGI:Nfkb1, pmod(P,S,536))\n",
      "p(MGI:S100a8) -> p(MGI:Nfkb1, pmod(P,S,536))\n",
      "----------------------\n",
      "10040308 : Gr-1+ cells isolated after a 5-d culture of HPCs with GM-CSF and IL-4 in TCM expressed substantially more S100A8 and S100A9 proteins than did Gr-1_ cells (Fig. 1 C).\n",
      "path(MESHD:Neoplasms) -> p(MGI:S100a8)\n",
      "path(MESHD:Neoplasms) -> p(MGI:S100a9)\n",
      "----------------------\n",
      "10040442 : Following separation of CD11b+ cells from MCA203 tumor infiltrate, we found that loss of C/EBPp caused a significant reduction in both arginase 1 (Arg1) and nitric oxide synthase 2 (Nos2) proteins (Figure 6A), two enzymes that were described as crucial components of MDSC inhibitory machinery (Bronte and Zanovello, 2005; Gabrilovich and Nagaraj, 2009).\n",
      "p(MGI:Cebpb) -> p(MGI:Arg1)\n",
      "p(MGI:Cebpb) -> p(MGI:Nos2)\n",
      "----------------------\n",
      "10040466 : Inhibition of iNOS with LMMA and of arginase I with nor-NOH completely abrogated suppressive activity of tumor-derived MDSC (Fig. 2 F).\n",
      "act(p(MGI:Nos2)) -| bp(GOBP:\"T cell proliferation\")\n",
      "act(p(MGI:Arg1)) -| bp(GOBP:\"T cell proliferation\")\n",
      "----------------------\n",
      "10040468 : Thus, MDSCs from the tumor use primarily arginase and NO to suppress T cell role, whereas splenic MDSCs use primarily ROS.\n",
      "act(p(MGI:Arg1)) -| bp(GOBP:\"T cell proliferation\")\n",
      "a(CHEBI:\"nitric oxide\") -| bp(GOBP:\"T cell proliferation\")\n",
      "----------------------\n",
      "10040480 : In contrast, hypoxia dramatically up-regulated expression of argl and inos (Fig. 5 C).\n",
      "bp(GOBP:\"response to hypoxia\") -> r(MGI:Nos2)\n",
      "bp(GOBP:\"response to hypoxia\") -> r(MGI:Arg1)\n",
      "----------------------\n",
      "10040488 : DFO caused significant up-regulation of the expression of argl and inos and a decrease in the expression of NOX components p47phox andgp91phox (Fig. 6, D and E).\n",
      "act(p(MGI:Hif1a)) -> r(MGI:Nos2)\n",
      "act(p(MGI:Hif1a)) -> r(MGI:Arg1)\n",
      "act(p(MGI:Hif1a)) -| r(MGI:Ncf1)\n",
      "act(p(MGI:Hif1a)) -| r(MGI:Cybb)\n",
      "----------------------\n",
      "10040490 : Expression of argl and inos in HIF-1a-positive MDSC was dramatically up-regulated after transfer into the tumor site (Fig. 6 I).\n",
      "act(p(MGI:Hif1a)) -> r(MGI:Arg1)\n",
      "act(p(MGI:Hif1a)) -> r(MGI:Nos2)\n",
      "----------------------\n",
      "10040502 : Hypoxia caused a dramatic up-regulation of arg1 and inos in HIF-1a WT MDSC, whereas a much smaller effect was observed in HIF-1a-deficient MDSC (Fig. 7 B).\n",
      "act(p(MGI:Hif1a)) -> p(MGI:Nos2)\n",
      "act(p(MGI:Hif1a)) -> p(MGI:Arg1)\n",
      "----------------------\n",
      "10040526 : The reduced expression of NKG2D occurred earlier and was more pronounced in 4T1/IL-ip-than in 4T1-tumor mice (Figure 5A and data not shown).\n",
      "p(MGI:Il1b) -| p(MGI:Klrk1)\n",
      "path(MESHD:\"Breast Neoplasms\") -| p(MGI:Klrk1)\n",
      "----------------------\n",
      "10040546 : As shown in Figure 1c, with the differentiation of CD11b+Gr1+ cells from BMCs upon exposure to CT26 tumor, 1D8 tumor and tumor-associated factor PGE2, the expression of both pri-miR-223 and mature miR-223 was downregulated although there had a temporary up-regulation.\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir223)\n",
      "p(HGNC:PTGS2) -| m(MGI:Mir223)\n",
      "----------------------\n",
      "10040558 : Similarly, the expression of MEF2C was upregulated in the tumor-induced MDSCs (Fig. 3b) although there had a temporary downregulation.\n",
      "bp(GOBP:\"response to tumor cell\") -> r(MGI:Mef2c)\n",
      "p(HGNC:PTGS2) -> r(MGI:Mef2c)\n",
      "----------------------\n",
      "10040594 : The culture medium showed decreased secretion of IL-2, IL-4, and IFN7 in the activated MMP12-treated samples (Figure 2F).\n",
      "act(p(MGI:Mmp12)) -| tloc(p(MGI:Il2))\n",
      "act(p(MGI:Mmp12)) -| tloc(p(MGI:Il4))\n",
      "act(p(MGI:Mmp12)) -| tloc(p(MGI:Ifng))\n",
      "----------------------\n",
      "10040600 : This inhibition was further confirmed by a significant reduction of IL-2 and IL-4 secretion, implicating a functional impairment of CD4+ T cells by CD11b+/Gr-1+ cells from doxcycline-treated bitransgenic mice (Figure 3D).\n",
      "act(p(MGI:Mmp12)) -| tloc(p(MGI:Il2))\n",
      "act(p(MGI:Mmp12)) -| tloc(p(MGI:Il4))\n",
      "----------------------\n",
      "10040608 : Compared with doxycycline-untreated bitransgenic mice, the expression levels of IL-1p, IL-6, MIP-2, and TNF-a were abnormally increased in the plasma of doxycycline-treated bitransgenic mice (Figure 4A).\n",
      "act(p(MGI:Mmp12)) -> r(MGI:Il6)\n",
      "act(p(MGI:Mmp12)) -> r(MGI:Il1b)\n",
      "act(p(MGI:Mmp12)) -> p(MGI:Wdr26)\n",
      "act(p(MGI:Mmp12)) -> r(MGI:Tnf)\n",
      "----------------------\n",
      "10040636 : The expression of miR-17-5p and miR-20a in tumor-associated MDSCs was found to be lower than in Gr1+CD11b+ cells isolated from the spleens of disease-free mice.\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir20a)\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir17)\n",
      "----------------------\n",
      "10040638 : Tumor-associated factor downregulates the expression of both miR-17-5p and miR-20a.\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir17)\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir20a)\n",
      "----------------------\n",
      "10040640 : STAT3 is regulated by miR-17-5p and miR-20a.\n",
      "m(MGI:Mir17) -| p(MGI:Stat3)\n",
      "m(MGI:Mir20a) -| p(MGI:Stat3)\n",
      "----------------------\n",
      "10040642 : We found that miR17-5p or miR-20a affects STAT3 expression only at the protein level.\n",
      "m(MGI:Mir17) -| p(MGI:Stat3)\n",
      "m(MGI:Mir20a) -| p(MGI:Stat3)\n",
      "----------------------\n",
      "10040644 : As shown in Fig. 2, the levels of STAT3 protein in RAW 264.7 cells transfected with miR17-5p or miR-20a mimics were indeed lower than in negative control transfected cells, whereas the transcription level of STAT3 was not affected.\n",
      "m(MGI:Mir17) -| p(MGI:Stat3)\n",
      "m(MGI:Mir20a) -| p(MGI:Stat3)\n",
      "----------------------\n",
      "10040646 : As shown in Fig. 2, miR-17-5p and miR-20a also reduced the transcriptional and protein levels of p47phox and gp91 phox, two subunits of NADPH oxidase.\n",
      "m(MGI:Mir20a) -| r(MGI:Cybb)\n",
      "m(MGI:Mir20a) -| r(MGI:Ncf1)\n",
      "m(MGI:Mir17) -| r(MGI:Cybb)\n",
      "m(MGI:Mir17) -| r(MGI:Ncf1)\n",
      "----------------------\n",
      "10040648 : Thus, our results demonstrate that both miR-17-5p and miR-20a target the STAT3 3'UTR to reduce the expression of STAT3.\n",
      "complex(m(MGI:Mir20a),act(p(MGI:Stat3))) -| p(MGI:Stat3)\n",
      "complex(m(MGI:Mir17),act(p(MGI:Stat3))) -| p(MGI:Stat3)\n",
      "----------------------\n",
      "10040652 : As a positive control, STAT3-targeted siRNAs also inhibit the expression of ROS and the production of H2O2 (Supplemental Fig. 3).\n",
      "act(p(MGI:Stat3)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "act(p(MGI:Stat3)) -> a(CHEBI:dioxidaniumyl)\n",
      "----------------------\n",
      "10040654 : As shown in Fig. 3A and 3B, the transfection of miR-17-5p and miR-20a mimics reduces the expression of ROS and the production of H2O2 in the isolated tumor-associated MDSCs in the presence of PMA.\n",
      "m(MGI:Mir17) -| a(CHEBI:\"reactive oxygen species\")\n",
      "m(MGI:Mir17) -| a(CHEBI:dioxidaniumyl)\n",
      "m(MGI:Mir20a) -| a(CHEBI:dioxidaniumyl)\n",
      "m(MGI:Mir20a) -| a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10040668 : As shown in Fig. 5A, Gr1+CD11b+ cells isolated from the spleens of CT-26 tumor-bearing mice have lower levels of expression of both pri- and mature miR-17-5p and miR-20a than do Gr1+CD11b+ cells from the spleens of disease-free mice (p < 0.05).\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir17)\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir20a)\n",
      "----------------------\n",
      "10040670 : As shown in Fig. 5B, tumor-associated factors can upregulate the expression of miR-17-5p and miR-20a, but the expression of miR-17-5p and miR-20a is downregulated after 6 h exposure to tumor supernatants.\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir17)\n",
      "bp(GOBP:\"response to tumor cell\") -| m(MGI:Mir20a)\n",
      "----------------------\n",
      "10040678 : The role of miR-17-5p and miR-20a in the expression of ROS and production of H2O2 by CD11b+Ly6G+ can be blocked by miR-17-5p or miR-20a inhibitors.\n",
      "m(MGI:Mir17) -> a(CHEBI:\"reactive oxygen species\")\n",
      "m(MGI:Mir17) -> a(CHEBI:dioxidaniumyl)\n",
      "m(MGI:Mir20a) -> a(CHEBI:\"reactive oxygen species\")\n",
      "m(MGI:Mir20a) -> a(CHEBI:dioxidaniumyl)\n",
      "----------------------\n",
      "10040724 : LPS-stimulated CD19+ B cells isolated from Tnf mice produced less IL-10 and more total IL-12 (IL-12p70) than did CD19+ B cells from wild-type mice (Fig. 3C; P < 0.05).\n",
      "p(MGI:Tnf) -> p(MGI:Il10)\n",
      "p(MGI:Tnf) -| p(MGI:Il12b)\n",
      "----------------------\n",
      "10040800 : This effect was abrogated by the addition of COX2 inhibitor during the generation of CM from cancer ascites cells.\n",
      "act(p(HGNC:PTGS2)) -> p(HGNC:IDO1)\n",
      "act(p(HGNC:PTGS2)) -> r(HGNC:NOS2)\n",
      "act(p(HGNC:PTGS2)) -> r(HGNC:IL10)\n",
      "act(p(HGNC:PTGS2)) -> r(HGNC:IL4R)\n",
      "----------------------\n",
      "10040912 : Western blot analyses also detected reduced SHIP-1 activity, increased AKT-1 and BAD hyper-phosphorylation and up-regulation of BCL-2 expression in splenocytes from TB mice.\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Bcl2)\n",
      "bp(GOBP:\"response to tumor cell\") -| p(MGI:Inpp5d,pmod(P))\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Akt1,pmod(P))\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Bad,pmod(P))\n",
      "----------------------\n",
      "10040914 : In vitro, qRT-PCR and Western blot analyses detected reduced SHIP-1 mRNA and protein expression in control splenocytes co-cultured with Panc 02.03 cells.\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Inpp5d)\n",
      "bp(GOBP:\"response to tumor cell\") -| p(MGI:Inpp5d)\n",
      "----------------------\n",
      "10040918 : Results from the Inflammatory Cytometric Bead Analysis (CBA) Kit detected pro-inflammatory factors Interleukin-6 (IL-6), Interleukin-10 (IL-10) and Monocyte Chemoattractant Protein-1 (MCP-1) to a greater extent than Tumor Necrosis Factor (TNF), Interferon gamma (IFN-y and Interleukin-12p 70 (IL-12p70) in the supernatants of cultured murine Panc 02.03 cells (Figure 1a).\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Il6)\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Il10)\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Ccl2)\n",
      "----------------------\n",
      "10040944 : These results correlate with our in vivo data and show that Panc 02.03 cells are able to suppress SHIP-1 mRNA and protein expression in vitro.\n",
      "bp(GOBP:\"response to tumor cell\") -| p(MGI:Inpp5d)\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Inpp5d)\n",
      "----------------------\n",
      "10040962 : L-NIL downregulates STAT3 activation and inhibits ROS production in MDSC.\n",
      "act(p(MGI:Nos2)) -> p(MGI:Stat3,pmod(P))\n",
      "act(p(MGI:Nos2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10040964 : However, ROS levels were dramatically upregulated in Transwell culture with MT-RET-1 cells (Fig. 2A, 2B), and upregulation of ROS was suppressed to levels below baseline by addition of L-NIL to coculture.\n",
      "act(p(MGI:Nos2)) -> a(CHEBI:\"reactive oxygen species\")\n",
      "bp(GOBP:\"response to tumor cell\") -> a(CHEBI:\"reactive oxygen species\")\n",
      "----------------------\n",
      "10040968 : Release of VEGF from tumor cells has also been shown to be upregulated by iNOS expression.\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(MGI:Vegfa))\n",
      "p(MGI:Nos2) -> tloc(p(MGI:Vegfa))\n",
      "----------------------\n",
      "10040982 : Western blot analysis of total and phospho-STAT3 levels in MT-RET-1 tumors demonstrated robust phosphorylation of serine 727 and tyrosine 705 in tumors from untreated mice.\n",
      "act(p(HGNC:NOS2)) -> p(HGNC:STAT3,pmod(P))\n",
      "act(p(MGI:Nos2)) -> p(MGI:Stat3,pmod(P))\n",
      "----------------------\n",
      "10040984 : Treatment of both 4-d (data not shown) and 14-d MT-RET-1 tumors with L-NIL increased numbers of tumor-infiltrating and splenic CD4 and CD8 T cells in wild-type mice (Fig. 4B).\n",
      "act(p(MGI:Nos2)) -| bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\")\n",
      "act(p(MGI:Nos2)) -| bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10040990 : L-NIL treatment of iNOS-deficient mice led to robust recovery of splenic CD4 and CD8 T cell numbers (Fig. 4B), demonstrating that the failure of host iNOS ablation to restore T cell numbers in tumor-bearing mice is not due to upregulation of iNOS-independent compensatory mechanisms in iNOS KO mice.\n",
      "act(p(MGI:Nos2)) -| bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\")\n",
      "act(p(MGI:Nos2)) -| bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10041022 : As expected, the expression levels of ARG1, MMP2, MMP13, and MMP14 were significantly upregulated in lv-494-infected MDSCs compared with those in lv-ctrl-infected MDSCs (Fig. 4B); moreover, lv-sponge overtly blocked the induction in the expression of these molecules.\n",
      "m(MGI:Mir494) -> r(MGI:Mmp14)\n",
      "m(MGI:Mir494) -> r(MGI:Mmp13)\n",
      "m(MGI:Mir494) -> r(MGI:Tinagl1)\n",
      "m(MGI:Mir494) -> r(MGI:Mmp2)\n",
      "----------------------\n",
      "10041028 : As shown in Fig. 4G, OT-1 CD8+ T cell proliferation was significantly suppressed by lv-494-infected MDSCs in comparison with lv-ctrl-infected MDSCs, and this suppressive activity could be partially blocked by an ARG1 inhibitor nor-NOHA.\n",
      "m(MGI:Mir494) -| act(p(MGI:Arg1))\n",
      "act(p(MGI:Arg1)) -| bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10041044 : Overexpression of PTEN in Gr-1+ CD11b+ cells did not affect the TDF-induced miR-494 up-regulation, whereas the increased expression of MMPs induced by TCCM were significantly blocked (Fig. 6D), and SDF-1/CXCL12-mediated MDSC migration was abrogated (Fig. 6E).\n",
      "p(MGI:Pten) -| r(MGI:Mmp2)\n",
      "p(MGI:Pten) -| r(MGI:Mmp14)\n",
      "----------------------\n",
      "10041048 : As shown in Fig. 6H, the increased levels of MMPs induced by TCCM were completely abolished by LY294002, suggesting that the Akt activity is indispensable for the activation of MDSCs.\n",
      "act(p(MGI:Akt1)) -> r(MGI:Mmp14)\n",
      "act(p(MGI:Akt1)) -> r(MGI:Mmp2)\n",
      "----------------------\n",
      "10041052 : TGF-p1-induced miR-494 was involved in the negative regulation of PTEN expression.\n",
      "p(MGI:Tgfb1) -> m(MGI:Mir494)\n",
      "m(MGI:Mir494) -| p(MGI:Pten)\n",
      "----------------------\n",
      "10041144 : Expression of Notch target genes hesl and hes5 was dramatically reduced in all 3 populations of cells isolated from TB mice as compared with the cells from naive mice (Fig. 1A and B).\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Hes5)\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Helt)\n",
      "----------------------\n",
      "10041154 : Dramatic downregulation of all studied Notch ligands (Jag1, Jag2, Dll1, 3, and 4) was found in bone marrow from CT26 TB mice as compared with naive tumor-free mice (Fig. 2E).\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Dll3)\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Jag2)\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Jag1)\n",
      "bp(GOBP:\"response to tumor cell\") -| r(MGI:Dll4)\n",
      "----------------------\n",
      "10041160 : Culture of HPC with TCM resulted in an increase in serine phosphorylation of Notch1 (Fig. 4A), whereas no tyrosine phosphorylation was detected (data not shown).. Analysis of the structure of Notch suggested a number of serine residues in RAM domain, phosphorylation of which could affect binding of Notch1 with CSL.\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Notch1,pmod(P))\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Notch1,pmod(P))\n",
      "----------------------\n",
      "10041200 : A significant prevention in the production of PNT by G-MDSC, but not by Mo-MDSC, was found in tumor-bearing gp91phox and eNOS null mice, as compared to MDSC from control mice (Fig. 4a).\n",
      "act(p(MGI:Nos3)) -> a(CHEBI:peroxynitrite)\n",
      "act(p(MGI:Cybb)) -> a(CHEBI:peroxynitrite)\n",
      "----------------------\n",
      "10041210 : High levels of miR-155 and miR-21 also were detected in bone marrow and spleen MDSC isolated from tumor-bearing mice.\n",
      "bp(GOBP:\"response to tumor cell\") -> m(MGI:Mir21)\n",
      "bp(GOBP:\"response to tumor cell\") -> m(MGI:Mir155)\n",
      "----------------------\n",
      "10041212 : As shown in Fig. 2C, the levels of miR-155 and miR-21 were significantly higher in MDSC derived from the BM, spleen, or tumor tissue in tumor-bearing mice than those in control mice.\n",
      "bp(GOBP:\"response to tumor cell\") -> m(MGI:Mir155)\n",
      "bp(GOBP:\"response to tumor cell\") -> m(MGI:Mir21)\n",
      "----------------------\n",
      "10041228 : Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).\n",
      "act(p(MGI:Csf1r)) -| r(MGI:Tnf)\n",
      "act(p(MGI:Csf1r)) -| r(MGI:Ifng)\n",
      "act(p(MGI:Csf1r)) -| r(MGI:Il12b)\n",
      "act(p(MGI:Csf1r)) -> r(MGI:Arg1)\n",
      "act(p(MGI:Csf1r)) -> r(MGI:Il6)\n",
      "act(p(MGI:Csf1r)) -> p(MGI:Tgfb1)\n",
      "act(p(MGI:Csf1r)) -> p(MGI:Il10)\n",
      "----------------------\n",
      "10041254 : Rip2-deficient tumors showed enhanced epithelial-to-mesenchymal transition, with elevated expression of zebl, zeb2, twist, and snail in the tumor microenvironment.\n",
      "p(MGI:Ripk2) -| p(MGI:Zeb1)\n",
      "p(MGI:Ripk2) -| p(MGI:Twist1)\n",
      "----------------------\n",
      "10041276 : The majority were associated with myeloid differentiation and chemotaxis, including G-CSF, M-CSF, IL-16, MCP-1, TREM-1, TIMP-1, and IL-1a with relative levels shown schematically [27-33] (Fig 4A).\n",
      "p(MGI:Ripk2) -| p(MGI:Il1a)\n",
      "p(MGI:Ripk2) -| p(MGI:Trem1)\n",
      "p(MGI:Ripk2) -| p(MGI:Ccl2)\n",
      "p(MGI:Ripk2) -| p(MGI:Il16)\n",
      "----------------------\n",
      "10041280 : Increased levels of IL-4, G-CSF, and GM-CSF were observed in bladder tumors from Rip2-deficient compared to wild-type mice, while no differences were detected in IFNy and M-CSF expression, consistent with a tumor microenvironment fostering development of the tumor associated MDSCs (Fig 4C).\n",
      "p(MGI:Ripk2) -| p(MGI:Il4)\n",
      "p(MGI:Ripk2) -| p(MGI:Csf3)\n",
      "----------------------\n",
      "10041282 : To investigate the influence ofRip2 in development of EMT, we examined expression of adhesion markers in intravesical tumors and observed decreased E-cadherin expression throughout the tumor with concomitant increased N-cadherin expression at the peripheral of the tumor in Rip2-deficient relative to wild-type mice (Fig 6A).\n",
      "p(MGI:Ripk2) -> p(MGI:Cdh1)\n",
      "p(MGI:Ripk2) -> p(MGI:Cdh2)\n",
      "----------------------\n",
      "10041344 : Blocking STAT3 activation by JSI-124 dramatically decreased the levels of p52 and RelB in nuclei (Fig. 2C, p < 0.05).\n",
      "p(HGNC:STAT3,pmod(P)) -> p(HGNC:RELB)\n",
      "p(HGNC:STAT3,pmod(P)) -> p(HGNC:NFKB2)\n",
      "----------------------\n",
      "10041354 : In contrast, both IDO and NIK expression were reduced by JSI-124 treatment in MDSCs (Fig. 3A).\n",
      "p(HGNC:STAT3,pmod(P)) -> r(HGNC:MAP3K14)\n",
      "p(HGNC:STAT3,pmod(P)) -> r(HGNC:IDO1)\n",
      "----------------------\n",
      "10041356 : RelB/p52 dimers directly bind to the IDO promoter to regulate IDO expression in MDSCs.\n",
      "complex(p(HGNC:RELB),p(HGNC:NFKB2)) -> act(p(HGNC:IDO1))\n",
      "act(p(HGNC:IDO1)) -> r(HGNC:IDO1)\n",
      "----------------------\n",
      "10041366 : We isolated CD11b+ MDSCs from the spleen of JSI-124-treated mice and found decreased expression of p-STAT3, NIK, and IDO protein in CD11b+ MDSCs compared with those isolated from the controls (Fig. 6D).\n",
      "p(MGI:Stat3,pmod(P)) -> r(MGI:Map3k14)\n",
      "p(MGI:Stat3,pmod(P)) -> p(MGI:Ido1)\n",
      "----------------------\n",
      "10041374 : Furthermore, a specific IL-6-neutralizing Ab significantly decreased the levels of p-STAT3, NIK, and IDO in MDSCs (Fig. 7E, p < 0.05).\n",
      "p(HGNC:IL6) -> p(HGNC:STAT3,pmod(P))\n",
      "p(HGNC:IL6) -> p(HGNC:IDO1)\n",
      "p(HGNC:IL6) -> p(HGNC:MAP3K14)\n",
      "----------------------\n",
      "10041470 : In addition, T cells cultured with CM produced high levels of IL-10 and TGF-0 as compared with T cells cultured with T cell medium (Fig. 3, B and C).\n",
      "bp(GOBP:\"regulatory T cell differentiation\") -> tloc(p(MGI:Il10))\n",
      "bp(GOBP:\"regulatory T cell differentiation\") -> tloc(p(MGI:Tgfb1))\n",
      "----------------------\n",
      "10041478 : Furthermore, neutralization of TGF-^ completely changed the profile of cytokine production of these T cells, and cells now expressed high levels of IL-2 and low levels of IL-10 and TGF-^ (Fig. 3).\n",
      "act(p(MGI:Tgfb1)) -> tloc(p(MGI:Il10))\n",
      "act(p(MGI:Tgfb1)) -> tloc(p(MGI:Tgfb1))\n",
      "act(p(MGI:Tgfb1)) -| tloc(p(MGI:Il2))\n",
      "----------------------\n",
      "10041498 : Down-regulation of Foxp3 with small interfering RNA (siRNA) in pancreatic carcinoma cells resulted in the up-regulation of interleukin 6 (IL-6) and IL-8 expression, providing evidence for a negative transcriptional activity of Foxp3 also in these epithelial cells.\n",
      "p(HGNC:FOXP3) -| r(HGNC:IL8)\n",
      "p(HGNC:FOXP3) -| r(HGNC:IL6)\n",
      "----------------------\n",
      "10041504 : In accordance with the immunohistochemistry data pointing to FoxP3 expression in tumor cells (see above), Foxp3 expression was clearly detectable in several pancreatic carcinoma cell lines at both mRNA (Fig. 2A) and protein levels (Fig. 2B).\n",
      "bp(GOBP:\"response to tumor cell\") -> r(HGNC:FOXO3)\n",
      "bp(GOBP:\"response to tumor cell\") -> p(HGNC:FOXP3)\n",
      "----------------------\n",
      "10041512 : Specific down-regulation of Foxp3 in pancreatic carcinoma cells results in up-regulation of IL-6 and IL-8.\n",
      "p(HGNC:FOXP3) -| p(HGNC:IL8)\n",
      "p(HGNC:FOXP3) -| p(HGNC:IL6)\n",
      "----------------------\n",
      "10041514 : A screen for changes in cytokine secretion in these cells using the Raybiotec Cytokine Array (Hoelzel Diagnostica) revealed an increase of IL-6 and IL-8 in the culture supernatant, whereas other cytokines remained unchanged (data not shown).\n",
      "p(HGNC:FOXP3) -| tloc(p(HGNC:IL8))\n",
      "p(HGNC:FOXP3) -| tloc(p(HGNC:IL6))\n",
      "----------------------\n",
      "10041520 : As shown in Fig. 5B, CD25 GITR and CD69 were up-regulated after anti-CD3/anti-CD28 stimulation, irrespective of the presence or absence of tumor cells.\n",
      "bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\") -> p(HGNC:TNFRSF18)\n",
      "bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\") -> p(HGNC:CD69)\n",
      "bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\") -> p(HGNC:ISG20)\n",
      "----------------------\n",
      "10041534 : In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) -> r(HGNC:CTLA4)\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) -> r(HGNC:TNFRSF18)\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) -> r(HGNC:FASLG)\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) -> r(HGNC:CCR7)\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) -> r(HGNC:TGFB1)\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) -> r(HGNC:PRF1)\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) -> r(HGNC:GZMB)\n",
      "----------------------\n",
      "10041544 : In addition, intracytoplasmic expression of phosphorylated SMAD2/3 and phosphorylated STAT3 in Treg was increased in the presence of TMV relative to Treg incubated in the absence of TMV (Figure 7C).\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases(bp(GOBP:\"regulatory T cell differentiation\") -> complex(p(HGNC:SMAD2,pmod(P)),p(HGNC:SMAD3,pmod(P))))\n",
      "complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases(bp(GOBP:\"regulatory T cell differentiation\") -> p(HGNC:STAT3,pmod(P)))\n",
      "----------------------\n",
      "10041546 : These results demonstrate that the TLR1/TLR2 agonist BLP may have a general tumor therapeutic property involving reciprocal downregulation of Treg and upregulation of CTL function.\n",
      "act(p(MGI:Tlr2)) -| bp(GOBP:\"regulatory T cell differentiation\")\n",
      "act(p(MGI:Tlr1)) -| bp(GOBP:\"regulatory T cell differentiation\")\n",
      "----------------------\n",
      "10041550 : CD8+ T cells isolated from BLP-treated tumor-bearing mice exhibited vigorous proliferation upon in vitro restimulation with 3LL tumor cells, whereas CD8+ T cells isolated from PBS-treated mice failed to do so (Fig. 2A).\n",
      "act(p(MGI:Tlr1)) -> bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "act(p(MGI:Tlr2)) -> bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10041552 : Whereas PBS-treated Tregs retained their function and effectively suppressed CTL proliferation, BLP-treated Tregs lost their suppressive function, resulting in a marked CTL expansion in vitro (Fig. 3B).\n",
      "act(p(MGI:Tlr1)) -> bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "act(p(MGI:Tlr2)) -> bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10041554 : BLP-treated Tregs from WT but not TLR2_/_ mice lost their suppressive function, as demonstrated indirectly by the increased CTL numbers in the DLNs and the higher levels of serum IL-2 and IFN-g found in mice receiving BLP-treated WT as compared with TLR2_/_ Tregs, regardless of whether the cotransferred CTL were from either WT or TLR2_/_ mice (Fig. 4B, 4C).\n",
      "act(p(MGI:Tlr2)) -> bp(GOBP:\"CD8-positive, alpha-beta T cell proliferation\")\n",
      "act(p(MGI:Tlr2)) -> p(MGI:Il2)\n",
      "act(p(MGI:Tlr2)) -> p(MGI:Ifng)\n",
      "----------------------\n",
      "10041642 : The mRNA expression of Foxp3 and RORyt in the spleen was very low in the normal control group but significantly higher in the model control group (P < 0.05).\n",
      "bp(GOBP:\"response to tumor cell\") -> r(MGI:Rorc)\n",
      "bp(GOBP:\"response to tumor cell\") -> r(MGI:Foxp3)\n",
      "----------------------\n",
      "10041648 : Jak2 and STAT3 protein expression was significantly higher in the model control group than in all other groups (P < 0.05).\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Stat3)\n",
      "bp(GOBP:\"response to tumor cell\") -> p(MGI:Jak2)\n",
      "----------------------\n",
      "10041650 : We found that PI3K-Akt pathway inhibitors selectively inhibit Tregs with minimal effect on conventional T cells (Tconv).\n",
      "act(p(MGI:Pik3ca)) -> bp(GOBP:\"regulatory T cell differentiation\")\n",
      "act(p(MGI:Akt1)) -> bp(GOBP:\"regulatory T cell differentiation\")\n",
      "----------------------\n",
      "10041718 : LDR reduces CTLA-4 expression on the CD4+CD25+Treg cell surface and inhibits CD4+CD25+Treg cell suppression of CD4+CD25-T cells CD4+CD25-T cells significantly proliferated because of the effects of anti-CD3 and anti-CD28 stimulating factors.\n",
      "bp(GOBP:\"response to tumor cell\") -> bp(GOBP:\"regulatory T cell differentiation\")\n",
      "bp(GOBP:\"regulatory T cell differentiation\") -| bp(GOBP:\"CD4-positive, alpha-beta T cell proliferation\")\n",
      "----------------------\n",
      "10041730 : Hypoxia was capable of inducing VEGF mRNA in both immortalized and transformed endothelial cells (4.5-fold in cells expressing SV40 large T antigen alone or in combination with H-ras), but both baseline and induced VEGF mRNA expression was increased in cells containing activated ras (Fig. 4).\n",
      "act(p(MGI:Hras)) -> r(MGI:Vegfa)\n",
      "bp(GOBP:\"response to hypoxia\") -> r(MGI:Vegfa)\n",
      "----------------------\n",
      "10041734 : Cells with activated ras demonstrated high level of expression of 72-kDa metalloproteinase (MMP-2, gelatinase A), and 92-kDa metalloproteinase (MMP-9, gelatinase B) compared with cells containing SV40 large T antigen alone.\n",
      "act(p(MGI:Hras)) -> p(MGI:Mmp2)\n",
      "act(p(MGI:Hras)) -> p(MGI:Mmp9)\n",
      "----------------------\n",
      "10041736 : Treatment of ras-containing cells with wortmannin resulted in a decrease in MMP expression (Fig. 6).\n",
      "act(p(MGI:Pik3cg)) -> p(MGI:Mmp2)\n",
      "act(p(MGI:Pik3cg)) -> p(MGI:Mmp9)\n",
      "----------------------\n",
      "10041806 : Again, this effect was paralleled by comparable decreases in TSP-1 mRNA and protein expression in these cells exposed to 528ras1 conditioned medium (Fig. 2C).\n",
      "p(MGI:Hras) -| p(MGI:Thbs1)\n",
      "p(MGI:Hras) -| r(MGI:Thbs1)\n",
      "----------------------\n",
      "10041816 : Paracrine effects of various ras-driven cancer cells were detected at the level of TSP-1 protein, mRNA, and promoter activity (Fig. 2C).\n",
      "r(MGI:Hras) -| r(MGI:Thbs1)\n",
      "r(MGI:Hras) -| p(MGI:Thbs1)\n",
      "r(MGI:Hras) -| act(p(MGI:Thbs1))\n",
      "----------------------\n",
      "10041852 : Antagonists of a4h1 blocked monocyte attachment to VCAM, indicating that integrin a4h1 is a functionally active receptor for both CS-1 fibronectin and VCAM (Supplementary Fig. S4).\n",
      "p(HGNC:SSFA2) -> complex(p(MGI:Itgav),p(MGI:Itgb1))\n",
      "p(HGNC:VCAM1) -> complex(p(MGI:Itgav),p(MGI:Itgb1))\n",
      "----------------------\n",
      "10041866 : Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.\n",
      "r(MGI:Fbln5) -| r(HGNC:MMP3)\n",
      "r(MGI:Efemp1) -| r(HGNC:MMP2)\n",
      "p(HGNC:EFEMP1) -| r(HGNC:MMP3)\n",
      "r(MGI:Fbln5) -| r(HGNC:MMP2)\n",
      "r(MGI:Fbln5) -> r(HGNC:TIMP1)\n",
      "r(MGI:Fbln5) -> r(HGNC:TIMP3)\n",
      "r(MGI:Efemp1) -> r(HGNC:TIMP3)\n",
      "r(MGI:Efemp1) -> r(HGNC:TIMP1)\n",
      "----------------------\n",
      "10041868 : Although MB114 cell expression of TIMP-2 was unaffected by either FBLN-3 or FBLN-5, both FBLNs induced MB114 cell expression of the angiostatic molecule, TSP-1 (Fig. 3A).\n",
      "r(MGI:Efemp1) -> r(HGNC:THBS1)\n",
      "r(MGI:Fbln5) -> r(HGNC:THBS1)\n",
      "----------------------\n",
      "10041872 : Gelatin zymography of MB114 cell conditioned medium confirmed that expression of either FBLN-3 or FBLN-5 significantly reduced MMP-2 protease activity in tubulating MB114 cells (Fig. 3C).\n",
      "r(MGI:Fbln5) -| act(p(HGNC:MMP2))\n",
      "r(MGI:Efemp1) -| act(p(HGNC:MMP2))\n",
      "----------------------\n",
      "10041874 : FBLN-3 and FBLN-5 antagonize angiogenesis in vivo.\n",
      "p(MGI:Efemp1) -| bp(GOBP:angiogenesis)\n",
      "p(MGI:Fbln5) -| bp(GOBP:angiogenesis)\n",
      "----------------------\n",
      "10041878 : Moreover, recombinant FBLN-3 and FBLN-5 (Fig. 4B) both inhibited human HMEC-1 endothelial cell migration to fibronectin (Fig. 4C), whereas FBLN-5, but not FBLN-3, mediated their adhesion in an RGD-dependent manner (Fig. 4D; refs.\n",
      "r(MGI:Fbln5) -| bp(GOBP:\"cell migration\")\n",
      "r(MGI:Efemp1) -| bp(GOBP:\"cell migration\")\n",
      "----------------------\n",
      "10041890 : More importantly, tumors derived from FBLN-expressing MCA102 fibrosarcoma cells also exhibited significantly reduced blood vessel densities compared with tumors derived from control cells (Fig. 6D ).\n",
      "r(MGI:Efemp1) -| bp(GOBP:\"blood vessel development\")\n",
      "p(MGI:Fbln5) -| bp(GOBP:\"blood vessel development\")\n",
      "----------------------\n",
      "10041896 : DLD-1 human colon cancer cells that secrete ;C or ;C399tr grew at similar levels in vitro but grew much slower in vivo than mock-transfected cells.\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(HGNC:FGG,trunc(399)))\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(HGNC:FGG))\n",
      "----------------------\n",
      "10041904 : DLD-1 colon carcinoma cells engineered to secrete ;C or ;C399tr grew slower than nonsecreting control cells in SCID mice.\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(MGI:Fgg,trunc(399)))\n",
      "tloc(p(MGI:Fgg,trunc(399))) -| bp(GOBP:\"cell growth\")\n",
      "bp(GOBP:\"response to tumor cell\") -> tloc(p(HGNC:FGG))\n",
      "tloc(p(HGNC:FGG)) -| bp(GOBP:\"cell growth\")\n",
      "----------------------\n",
      "10041972 : Hesl and Heyl mRNA was significantly increased in U87 cells (DLL4 cells versus EV cells, P < 0.01 for both genes; Supplementary Fig. S1C).\n",
      "p(HGNC:DLL4) -> r(HGNC:HELT)\n",
      "p(HGNC:DLL4) -> r(HGNC:HEYL)\n",
      "----------------------\n",
      "10041974 : Similarly, expression of mouse Hesl (mHesl) and mHey2 was also increased in B16 cells (DLL4 cells versus EV cells, P < 0.05 for both genes).\n",
      "p(MGI:Dll4) -> r(MGI:Helt)\n",
      "p(MGI:Dll4) -> r(MGI:Heyl)\n",
      "----------------------\n",
      "10041982 : In contrast, for B16 allograft tumors, all tested genes were significantly increased in DLL4-overexpressing tumors (P < 0.05).\n",
      "p(MGI:Dll4) -> r(MGI:Helt)\n",
      "p(MGI:Dll4) -> r(MGI:Hey1)\n",
      "p(MGI:Dll4) -> r(MGI:Hey2)\n",
      "p(MGI:Dll4) -> r(MGI:Efnb2)\n",
      "----------------------\n",
      "10042026 : Moreover, we found that EMT stimulated by TGF-P (Figure 2E) or the process of mammary tumorigenesis (Figure 2F) both induced Twist expression, and more importantly, that FBLN5 significantly enhanced resting and TGF-P-stimulated Twist expression in normal and malignant MECs (Figure 2E and F).\n",
      "p(MGI:Tgfb1) -> r(MGI:Twist1)\n",
      "p(MGI:Fbln5) -> r(MGI:Twist1)\n",
      "----------------------\n",
      "10042040 : As above, both transcriptional responses mediated by FBLN5 were reversed by treating the cells with the type I MMP-2/3 or MMP-2/9 inhibitors (Figure 5D and E).\n",
      "act(p(MGI:Mmp2)) -| r(MGI:Cdh1)\n",
      "act(p(MGI:Mmp2)) -> r(MGI:Twist1)\n",
      "act(p(MGI:Mmp9)) -> r(MGI:Twist1)\n",
      "----------------------\n",
      "10042050 : In particular, a6-integrin-deficient endothelial cells displayed increased levels of VEGF-receptor 2 (VEGFR2) and VEGF-mediated downstream ERK1/2 activation.\n",
      "p(MGI:Itga6) -> p(MGI:Kdr)\n",
      "p(MGI:Kdr) -> act(p(MGI:Mapk3))\n",
      "----------------------\n",
      "10042074 : MMP-2 transcriptional suppression decreased VEGF, phosphatidylinositol 3-kinase (PI3K) protein levels and AKT phosphorylation in lung cancer cells.\n",
      "p(HGNC:MMP2) -> p(HGNC:VEGFA,pmod(P))\n",
      "p(HGNC:MMP2) -> p(HGNC:AKT1,pmod(P))\n",
      "----------------------\n",
      "10042096 : Western blot analysis indicated that VEGF and VEGFR-2 protein expression was decreased in Ad-MMP-2-Si-infected cells as compared to mock and Ad-SV-infected cells (Fig. 2c).\n",
      "p(HGNC:MMP2) -> p(HGNC:KDR)\n",
      "p(HGNC:MMP2) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042098 : Ad-MMP-2-Si infection inhibited VEGF and VEGFR-2 expression by >85% (p < 0.01) and 65.00 Â± 4.45% (p < 0.05), respectively.\n",
      "p(HGNC:MMP2) -> p(HGNC:KDR)\n",
      "p(HGNC:MMP2) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042100 : As shown in Figure 2d, Ad-MMP-2-Si infection inhibited VEGF and VEGFR-2 mRNA transcription by 89.65 Â± 2.01% (p < 0.01) and 68.65 Â± 2.44% (p < 0.05), respectively.\n",
      "p(HGNC:MMP2) -> r(HGNC:KDR)\n",
      "p(HGNC:MMP2) -> r(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042110 : Ad-MMP-2-Si inhibits HIF-1a expression and activity in A549 cells A key stimulus for increased VEGF expression in lung cancer is hypoxia.\n",
      "p(HGNC:MMP2) -> p(HGNC:HIF1A)\n",
      "p(HGNC:MMP2) -> act(p(HGNC:HIF1A))\n",
      "----------------------\n",
      "10042122 : As shown in Figure 4b, ectopic expression of constitutively active-AKT restored AKT phosphorylation and VEGF expression in Ad-MMP-2-Si-infected A549 cells.\n",
      "act(p(HGNC:AKT1)) -> p(HGNC:AKT1,pmod(P))\n",
      "act(p(HGNC:AKT1)) -> r(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042126 : The addition of rhMMP-2 to Ad-MMP-2-Si-infected A549 cells restored PI3K expression (from 13.25 Â± 2.36%; p < 0.01 to 40.11 Â± 2.32%; p < 0.01), phospho-AKT (from 9.45 Â± 4.21% p < 0.01 to 60.22 Â± 3.33%; p < 0.01) and VEGF (from 15.55 Â± 6.21%; p < 0.01 to 67.96 Â± 4.01%; p < 0.01) in A549 cell line (Fig. 5a).\n",
      "p(HGNC:MMP2) -> p(HGNC:AKT1,pmod(P))\n",
      "p(HGNC:MMP2) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042140 : Addition of rhMMP-2 markedly increased the phosphorylation of AKT and expression of PI3K and VEGF in mock and Ad-MMP-2-Si-infected cells (Fig. 6e) as compared to cells treated with Ad-MMP-2-Si only.\n",
      "p(HGNC:MMP2) -> p(HGNC:AKT1,pmod(P))\n",
      "p(HGNC:MMP2) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042188 : Treatment significantly reduced the overall CD31-positive surface area of B16.F10 tumors by approximately 2-fold, which was confirmed by a 3-fold reduction in mRNA levels of the endothelial marker molecules CD31 and VE-cadherin in the tumor (Fig. 2g and h).\n",
      "act(p(MGI:Kdr)) -> p(MGI:Pecam1)\n",
      "act(p(MGI:Kdr)) -> r(MGI:Pecam1)\n",
      "act(p(MGI:Kdr)) -> p(MGI:Cdh5)\n",
      "----------------------\n",
      "10042190 : VEGFR2/EGFR inhibitor therapy significantly down-regulated mRNA expression of the proangiogenic/vascular destabilization molecules integrin p3 and Ang2 3-fold and significantly upregulated mRNA levels of the vascular stability molecules Tie2 and N-cadherin approximately 3-fold in LLC (Fig. 3).\n",
      "act(p(MGI:Kdr)) -> r(MGI:Itgb3)\n",
      "act(p(MGI:Kdr)) -> r(MGI:Angpt2)\n",
      "act(p(MGI:Kdr)) -| r(MGI:Tek)\n",
      "act(p(MGI:Kdr)) -| r(MGI:Cdh2)\n",
      "----------------------\n",
      "10042202 : Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.\n",
      "m(MGI:Mir190) -| r(MGI:Timp3)\n",
      "m(HGNC:MIR580) -| r(MGI:Timp3)\n",
      "m(HGNC:MIR588) -| r(MGI:Timp3)\n",
      "m(HGNC:MIR580) -| r(MGI:Fgf2)\n",
      "m(HGNC:MIR580) -| r(MGI:Tgfa)\n",
      "m(HGNC:MIR588) -| r(MGI:Tgfa)\n",
      "m(MGI:Mir190) -| r(MGI:Tgfa)\n",
      "----------------------\n",
      "10042214 : We found that antiangiogenic and dormancy promoting genes, Angiomotin (AMOT-1) and Eph receptor A5 (EphA5), were both upregulated in all DmiR expressing A-GBM tumors as compared to the GFP-vector- control A-GBM cells (Figure 4).\n",
      "m(MGI:Mir190) -> r(MGI:Amot)\n",
      "m(MGI:Mir190) -> r(MGI:Epha5)\n",
      "m(HGNC:MIR580) -> r(MGI:Epha5)\n",
      "m(HGNC:MIR580) -> r(MGI:Amot)\n",
      "m(HGNC:MIR588) -> r(HGNC:EPHA5)\n",
      "m(HGNC:MIR588) -> r(MGI:Amot)\n",
      "----------------------\n",
      "10042216 : In contrast, genes involved in pro-angiogenic signaling, including tissue inhibitor of metalloprotei-nases 3 (TIMP-3), hypoxia-induced factor 1 alpha (HIF-1-alpha), basic fibroblast growth factor (bFGF, FGF2), and the K-ras tumor oncogene, were consistently downregulated in DmiR expressing A-GBM.\n",
      "m(HGNC:MIR580) -| p(MGI:Fgf2)\n",
      "m(HGNC:MIR580) -| p(MGI:Hif1a)\n",
      "m(HGNC:MIR588) -| p(MGI:Hif1a)\n",
      "m(HGNC:MIR588) -| p(MGI:Tgfa)\n",
      "m(HGNC:MIR580) -| p(MGI:Tgfa)\n",
      "m(MGI:Mir190) -| p(MGI:Tgfa)\n",
      "----------------------\n",
      "10042218 : Importantly, we found Bv8 also known as prokineticin 2 (Prok2) to be markedly downregulated in all three DmiR expressing A-GBM (Figure 5A).\n",
      "m(HGNC:MIR588) -| r(MGI:Prok2)\n",
      "m(HGNC:MIR580) -| r(MGI:Prok2)\n",
      "----------------------\n",
      "10042226 : Over-expression of miR-580, miR-588 and miR-190 in fast-growing angiogenic glioblastoma.\n",
      "bp(GOBP:\"response to tumor cell\") -> m(HGNC:MIR190A)\n",
      "bp(GOBP:\"response to tumor cell\") -> m(HGNC:MIR580)\n",
      "bp(GOBP:\"response to tumor cell\") -> m(HGNC:MIR588)\n",
      "----------------------\n",
      "10042282 : These results suggest that although T4 increased complex formation between integrin av and NCoR/SMRT, the association between NCoR/SMRT and DNA was unchanged.\n",
      "a(CHEBI:\"thyroid hormone\") -> complex(p(HGNC:ITGAV),p(HGNC:NCOR1))\n",
      "a(CHEBI:\"thyroid hormone\") -> complex(p(HGNC:ITGAV),p(HGNC:NCOR2))\n",
      "----------------------\n",
      "10042284 : The transcription of COX-2, ERa, HIF-la, and TR$1 was increased in thyroid hormone-treated cells (Fig. 4B).\n",
      "a(CHEBI:\"thyroid hormone\") -> r(HGNC:PTGS2)\n",
      "a(CHEBI:\"thyroid hormone\") -> r(MGI:Esr1)\n",
      "a(CHEBI:\"thyroid hormone\") -> r(HGNC:HIF1A)\n",
      "a(CHEBI:\"thyroid hormone\") -> r(HGNC:TAS2R14)\n",
      "----------------------\n",
      "10042336 : PRBP2 stimulates HIF-1a and VEGF mRNA and protein expression.\n",
      "p(HGNC:KDM5A) -> r(HGNC:VEGFA)\n",
      "p(HGNC:KDM5A) -> p(HGNC:HIF1A)\n",
      "p(HGNC:KDM5A) -> p(HGNC:VEGFA)\n",
      "p(HGNC:KDM5A) -> r(HGNC:HIF1A)\n",
      "----------------------\n",
      "10042342 : As shown in Fig. 5B and Fig. 5C, the down-regulation of RBP2 in H1975 cells led to the decreased expression of HIF-1a and VEGF, whereas ectopic RBP2 expression in SK-MES-1 cells by pcDNA3-HA-RBP2 led to the up-regulation of HIF-1a and VEGF.\n",
      "p(HGNC:KDM5A) -> p(HGNC:VEGFA)\n",
      "p(HGNC:KDM5A) -> p(HGNC:HIF1A)\n",
      "----------------------\n",
      "10042344 : The mRNA expression levels of HIF-1a (PsiRNA1 =0.006, PsiRNA2 = 0.001) and VEGF (PsiRNA1 =0.000, PsiRNA2 = 0.000) were significantly decreased in RBP2-depleted H1975 cells.\n",
      "p(HGNC:KDM5A) -> r(HGNC:HIF1A)\n",
      "p(HGNC:KDM5A) -> r(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042346 : Moreover, HIF-1a (P = 0.001) and VEGF (P = 0.000) were increased in RBP2-overexpressing SK-MES-1 cells compared to the control cells (Fig. 5D and Fig. 5E).\n",
      "p(HGNC:KDM5A) -> r(HGNC:HIF1A)\n",
      "p(HGNC:KDM5A) -> r(HGNC:VEGFA)\n",
      "----------------------\n",
      "10042350 : Our results revealed that silencing RBP2 expression with either RBP2-siRNA1 or RBP2-siRNA2 in H1975 cells significantly decreased the phosphorylation of Akt, whereas the forced expression of RBP2 with pcDNA3-HA-RBP2 in SK-MES-1 cells increased the activity of Akt (Fig. 7A).\n",
      "p(HGNC:KDM5A) -> act(p(HGNC:AKT1))\n",
      "p(HGNC:KDM5A) -> p(HGNC:AKT1,pmod(P))\n",
      "----------------------\n",
      "10042352 : Moreover, when a constitutively active form of Akt in RBP2-siRNA2 H1975 cells was expressed, the expression of HIF-1a and VEGF were increased compared to the control; the PI3K/Akt inhibitor LY294002 significantly inhibited the expression of HIF-1a and VEGF in pcDNA3-HA-RBP2 SK-MES-1 cells (Fig. 7B).\n",
      "p(HGNC:AKT1,pmod(P)) -> r(HGNC:HIF1A)\n",
      "p(HGNC:AKT1,pmod(P)) -> p(HGNC:VEGFA)\n",
      "----------------------\n",
      "2992\n"
     ]
    }
   ],
   "source": [
    "# for s in BELofSentence['10020166']:\n",
    "#     print(tokeniseBEL(s))\n",
    "# for s in BELofSentence['10020166']:\n",
    "#     print(normaliseBEL(s))\n",
    "cnt = 0\n",
    "for sid in BELofSentence.keys():\n",
    "    sentenceList = BELofSentence[sid]\n",
    "    if len(sentenceList) > 1:\n",
    "        print(sid, ':', TrainingSentence[sid])\n",
    "        cnt += 1\n",
    "        for s in sentenceList:\n",
    "            # print(s)\n",
    "            # print(tokeniseBEL(s))\n",
    "            print(normaliseBEL(s))\n",
    "        print('----------------------')\n",
    "print(cnt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 300,
   "metadata": {},
   "outputs": [],
   "source": [
    "import unittest\n",
    "\n",
    "class TestDemo(unittest.TestCase):\n",
    "    @classmethod\n",
    "    def setUpClass(cls):\n",
    "        cls.s1 = 'cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:FOS))'\n",
    "        cls.s2 = 'a(CHEBI:\"(2Z,3Z)-bis\\{amino[(2-aminophenyl)sulfanyl]methylidene\\}butanedinitrile\") decreases (path(MESHD:Hyperoxia) increases tscript(p(MGI:Nfe2l2)))'\n",
    "        cls.s3 = 'path(MESHD:Hyperoxia) increases p(MGI:Nfe2l2,pmod(P))'\n",
    "        cls.s4 = 'cat(p(HGNC:HIF1AN)) directlyDecreases complex(p(HGNC:HIF1A),p(HGNC:EP300))'\n",
    "        cls.s5 = 'p(MGI:Nfe2l2,pmod(P,Y,576)) directlyIncreases tloc(p(MGI:Nfe2l2),GOCCID:0005634,GOCCID:0005737)'\n",
    "    \n",
    "    def test_normaliseBEL(self):\n",
    "        self.assertEqual(normaliseBEL(self.s1), 'act(p(HGNC:UBE2L3)) -> deg(p(HGNC:FOS))')\n",
    "        self.assertEqual(normaliseBEL(self.s2), 'a(CHEBI:\"(2Z,3Z)-bis\\{amino[(2-aminophenyl)sulfanyl]methylidene\\}butanedinitrile\") -| (path(MESHD:Hyperoxia) -> act(p(MGI:Nfe2l2)))')\n",
    "        self.assertEqual(normaliseBEL(self.s3), 'path(MESHD:Hyperoxia) -> p(MGI:Nfe2l2,pmod(P))')\n",
    "        self.assertEqual(normaliseBEL(self.s4), 'act(p(HGNC:HIF1AN)) -| complex(p(HGNC:HIF1A),p(HGNC:EP300))')\n",
    "        self.assertEqual(normaliseBEL(self.s5), 'p(MGI:Nfe2l2,pmod(P)) -> tloc(p(MGI:Nfe2l2))')\n",
    "    \n",
    "    def test_tokeniseBEL(self):\n",
    "        self.assertEqual(tokeniseBEL(self.s1), ['act','(', 'p', '(', 'HGNC:UBE2L3', ')', ')', ' -> ', 'deg', '(', 'p', '(', 'HGNC:FOS', ')', ')'])\n",
    "        self.assertEqual(tokeniseBEL(self.s2), ['a', '(', 'CHEBI:\"(2Z,3Z)-bis\\\\{amino[(2-aminophenyl)sulfanyl]methylidene\\\\}butanedinitrile\"', ')', ' -| ', '(', 'path', '(', 'MESHD:Hyperoxia', ')', ' -> ', 'act', '(', 'p', '(', 'MGI:Nfe2l2', ')', ')', ')'])\n",
    "        self.assertEqual(tokeniseBEL(self.s3), ['path', '(', 'MESHD:Hyperoxia', ')', ' -> ', 'p', '(', 'MGI:Nfe2l2', ',', 'pmod(P)', ')'])\n",
    "        self.assertEqual(tokeniseBEL(self.s4), ['act', '(', 'p', '(', 'HGNC:HIF1AN', ')', ')', ' -| ', 'complex', '(', 'p', '(', 'HGNC:HIF1A', ')', ',', 'p', '(', 'HGNC:EP300', ')', ')'])\n",
    "        self.assertEqual(tokeniseBEL(self.s5), ['p', '(', 'MGI:Nfe2l2', ',', 'pmod(P)', ')', ' -> ', 'tloc', '(', 'p', '(', 'MGI:Nfe2l2', ')', ')'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 301,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "..\n",
      "----------------------------------------------------------------------\n",
      "Ran 2 tests in 0.002s\n",
      "\n",
      "OK\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    unittest.main(argv=['first-arg-is-ignored'], exit=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
